<SEC-DOCUMENT>0001213900-21-044116.txt : 20211008
<SEC-HEADER>0001213900-21-044116.hdr.sgml : 20211008
<ACCEPTANCE-DATETIME>20210820182525
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-21-044116
CONFORMED SUBMISSION TYPE:	DRS
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20210823
<PUBLIC-REL-DATE>20211008
DATE AS OF CHANGE:		20210823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Blue Water Vaccines Inc.
		CENTRAL INDEX KEY:			0001782107
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-05397
		FILM NUMBER:		211194880

	BUSINESS ADDRESS:	
		STREET 1:		2041 COURTLAND AVENUE
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45212
		BUSINESS PHONE:		646-303-0737

	MAIL ADDRESS:	
		STREET 1:		2041 COURTLAND AVENUE
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45212
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
<BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">As submitted confidentially to the United States Securities and Exchange Commission on August</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> </FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">20, 2021.<BR>This draft registration statement has not been publicly filed with the U.S. Securities and <BR>Exchange Commission and all information herein remain strictly confidential.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-right:30pt;margin-top:0pt;text-align:right;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">No. 333-&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT></P>
		<DIV STYLE="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></DIV>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:4pt;text-align:center;margin-top:4pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> UNITED STATES<BR>SECURITIES AND EXCHANGE COMMISSION<BR>Washington, D.C. 20549</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">_________________</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:4pt;text-align:center;margin-top:4pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">FORM S</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-1</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><BR>REGISTRATION STATEMENT<BR></FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">UNDER<BR>THE SECURITIES ACT OF 1933</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">_________________</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:4pt;text-align:center;margin-top:4pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:16pt;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Exact name of registrant as specified in its charter)</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">_________________</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 32.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Delaware</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 32.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">2834</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">83-2262816</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 32.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(State or other jurisdiction of</FONT></P>
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">incorporation or organization)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 32.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Primary Standard Industrial<BR>Classification Code Number)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(I.R.S. Employer</FONT></P>
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Identification No.)</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;text-align:center;margin-top:5pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">201 E. Fifth Street, Suite 1900<BR>Cincinnati, Ohio 45202<BR>Telephone: (513) 620-4101<BR>(Address, including zip code, and telephone number, including area code, of registrant&#x2019;s principal executive offices)</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">_________________</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:2pt;text-align:center;margin-top:2pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Joseph Hernandez<BR>c/o Blue Water Vaccines, Inc.<BR>201 E. Fifth Street, Suite 1900<BR>Cincinnati, Ohio 45202<BR>Telephone: (513) 620-4101<BR>(Name, address, including zip code, and telephone number, including area code, of agent for service)</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">_________________</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:1pt;text-align:center;margin-top:1pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Copies of all communications, including communications sent to agent for service, should be sent to:</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-8" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 48.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Barry I, Grossman, Esq.<BR>Jessica Yuan, Esq.<BR>Ellenoff Grossman&#x00a0;&amp; Schole LLP<BR>1345 Avenue of the Americas, 11</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:58%;vertical-align:super;">th</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> Floor<BR>New York, New York 10105<BR>Telephone: (212) 370</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-1300</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><BR>Fax: (212) 370</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-7889</FONT></FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:0pt;text-align:center;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Mitchell Nussbaum, Esq.<BR></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Angela Dowd, Esq.<BR>Lili Taheri, Esq.<BR>Loeb &amp; Loeb LLP<BR>345 Park Avenue<BR>New York, New York 10154<BR>Telephone: (212) 407-4000<BR>Fax: (212) 407-4990</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;text-align:center;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">_________________</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:2pt;margin-top:2pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box:&#x00a0;</FONT><FONT CLASS="GrepStyle" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;">&#9744;</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#x00a0;</FONT><FONT CLASS="GrepStyle" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;">&#9744;</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">If this Form is a post</FONT><FONT CLASS="nobreak" STYLE="font-size:9pt;">-effective</FONT><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;"> amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#x00a0;</FONT><FONT CLASS="GrepStyle" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;">&#9744;</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">If this Form is a post</FONT><FONT CLASS="nobreak" STYLE="font-size:9pt;">-effective</FONT><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;"> amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#x00a0;</FONT><FONT CLASS="GrepStyle" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;">&#9744;</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non</FONT><FONT CLASS="nobreak" STYLE="font-size:9pt;">-accelerated</FONT><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;"> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b</FONT><FONT CLASS="nobreak" STYLE="font-size:9pt;">-2</FONT><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;"> of the Exchange Act.</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-13" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:1pt;width: 24.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Large&#x00a0;accelerated&#x00a0;filer</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 22.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-5" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 25.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Accelerated&#x00a0;filer</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 24.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-5" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 24.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Non</FONT><FONT CLASS="nobreak" STYLE="font-size:9pt;">-accelerated</FONT><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">&#x00a0;filer</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 22.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-5" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;">&#9744;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 25.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Smaller&#x00a0;reporting&#x00a0;company</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 24.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-5" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;">&#9746;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 24.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 22.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 25.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">Emerging&#x00a0;growth&#x00a0;company</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 24.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-5" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;">&#9746;</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:5pt;margin-top:5pt;"><FONT CLASS="CharOverride-4" STYLE="font-size:9pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.&#x00a0;</FONT><FONT CLASS="GrepStyle" STYLE="font-family:'Wingdings 24', sans-serif;font-size:9pt;">&#9744;</FONT></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>


	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">CALCULATION OF REGISTRATION FEE</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-18" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="CharOverride-6" STYLE="font-style:normal;font-weight:bold;">Title of Each Class of Securities to be Registered</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-6" STYLE="font-style:normal;font-weight:bold;">Proposed Maximum Aggregate Offering Price</FONT><FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-6" STYLE="font-style:normal;font-weight:bold;">Amount of Registration Fee</FONT><FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(2)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Common Stock, $0.00001 par value per share<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(3)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Representative&#x2019;s Warrants<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(4)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Common Stock underlying Representative&#x2019;s Warrants<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(5)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;margin-top:8pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act. Includes the offering price of additional shares that the underwriters have the option to purchase to cover over<FONT CLASS="nobreak">-allotments</FONT>, if any.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(2)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Registration fee will be paid when registration statement is first publicly filed under the Securities Act.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(3)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares as may from time to time become issuable by reason of stock splits, distributions, recapitalizations, or other similar transactions.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(4)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;In accordance with Rule 457(g) under the Securities Act, because the shares of the registrant&#x2019;s Common Stock underlying the Representative&#x2019;s warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(5)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;The Warrants are exercisable at a per share exercise price equal to 115% of the public offering price of the shares of Common Stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said section 8(a), may determine.</FONT></P>
		<DIV STYLE="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></DIV>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>


	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:justify;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;color:#d2232a;">The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</FONT></P>
		</DIV>
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;color:#d2232a;">SUBJECT TO COMPLETION, DATED&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; , 2021</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><IMG ALT="" SRC="tblue_logo.jpg" STYLE="height:145.92px;width:272.64px;max-width:100%;"></FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="CharOverride-9" STYLE="font-style:normal;font-weight:normal;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; </FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Shares</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Common Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This is the initial public offering of our common stock. Prior to this offering there has been no public market for our common stock. We are offering&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; shares of common stock. We currently expect the initial public offering price to be between $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; and $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; per share.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We intend to apply to list our common stock on the Nasdaq Capital Market, or Nasdaq, under the symbol &#x201c;BWV.&#x201d;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are an &#x201c;emerging growth company&#x201d; as that term is defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and, as such, have elected to take advantage of certain reduced public company reporting requirements for this prospectus and future filings.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Investing in our common stock involves a high degree of risk. Please read &#x201c;Risk Factors&#x201d; beginning on&#x00a0;page 11 of this prospectus.</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-19" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-6" STYLE="font-style:normal;font-weight:bold;">Per Share</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-6" STYLE="font-style:normal;font-weight:bold;">Total</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Public offering price</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Underwriting discounts and commissions<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds to us, before expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;We have also agreed to reimburse the underwriters for certain expenses incurred by them and the underwriters will receive compensation in addition to underwriting discounts and commissions. See &#x201c;Underwriting&#x201d; beginning on page 136 of this prospectus for more information about the compensation payable to the underwriters, including reimbursable expenses.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have granted to the underwriters an option to purchase up to &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;additional shares of common stock at the public offering price, less the underwriting discounts and commissions, for 45 days after the date of this prospectus. If the underwriters exercise the option in full, the total underwriting discounts and commissions payable by us will be $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, and the total proceeds to us, before expenses, will be $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; ,  based on the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share (the midpoint of the estimated price range set forth on the cover page of this prospectus).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Delivery of the common stock is expected to be made on or about&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; , 2021.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:15pt;text-align:center;margin-top:15pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Sole Book Running Manager</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:15pt;text-align:center;margin-top:15pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;font-size:14pt;">Maxim Group LLC</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:15pt;text-align:center;margin-top:15pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">The date of this prospectus is&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; , 2021</FONT></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1_TOC" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><A NAME="TOC001"></A>TABLE OF CONTENTS</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Page</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T18">PROSPECTUS <FONT CLASS="CharOverride-1" STYLE="font-variant:normal;text-transform:uppercase;">Summary</FONT></A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">1</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T17">SUMMARY FINANCIAL DATA</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">10</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T16">RISK FACTORS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">11</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T99871">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY <BR>AND MARKET DATA</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">55</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T15">USE OF PROCEEDS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">57</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T14">DIVIDEND POLICY</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">58</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T13">CAPITALIZATION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">59</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T12">DILUTION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">60</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T99872">MANAGEMENT&#x2019;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND <BR>RESULTS OF OPERATIONS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">62</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T11">BUSINESS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">74</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T10">MANAGEMENT</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">111</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T9">EXECUTIVE AND DIRECTOR COMPENSATION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">118</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T8">PRINCIPAL STOCKHOLDERS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">127</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T7">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">128</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T6">DESCRIPTION OF CAPITAL STOCK</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">130</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T5">SHARES ELIGIBLE FOR FUTURE SALE</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">134</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T4">UNDERWRITING</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">136</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T3">LEGAL MATTERS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">145</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T2">EXPERTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">145</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T1">WHERE YOU CAN FIND MORE INFORMATION</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">145</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 90.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T99873">INDEX TO FINANCIAL STATEMENTS</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:center;">F-1</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have not, and the underwriters have not, authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares offered hereby, but only under the circumstances and in the jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For investors outside the United States: We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus or any applicable free writing prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus and any applicable free writing prospectus must inform themselves, and observe any restrictions relating to, the offering of the common shares and the distribution of this prospectus outside the United States.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Through and including&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, 202&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;(25 days after the date of this prospectus), all dealers that buy, sell or trade shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the obligation of dealers to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We use our registered trademarks and trade names in this prospectus. This prospectus also includes trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this prospectus appear without the<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">&#x00ae;</FONT>&#x00a0;and &#x2122; symbols, but those references are not intended to indicate that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and trade names. We do not intend our use or display of other companies&#x2019; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;text-indent:0pt;">i</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>





	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T18"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PROSPECTUS SUMMARY</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">This summary highlights selected information contained elsewhere in this prospectus, and does not contain all of the information that you should consider before investing in our common stock. This summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing elsewhere in this prospectus. You should read this entire prospectus carefully, including the information set forth in the sections titled &#x201c;Risk Factors&#x201d; and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and our financial statements and related notes thereto included elsewhere in this prospectus, before making an investment decision. Unless the context requires otherwise, references in this prospectus to &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;our company,&#x201d; or similar terminology refer to Blue Water Vaccines, Inc.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi<FONT CLASS="nobreak">-targeted</FONT> vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or protein antigens, with cross<FONT CLASS="nobreak">-reactive</FONT> proprieties, that enables the potential development of a universal flu vaccine. We are focused on developing novel vaccines that induce durable and long<FONT CLASS="nobreak">-term</FONT> immunity. We believe that our pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve both health outcomes and quality of life globally.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our pipeline includes novel vaccine candidates exclusively licensed from renowned research institutions. We seek to develop vaccines that provide long<FONT CLASS="nobreak">-lasting</FONT> immunity to harmful viral and bacterial pathogens that cause infections in patient populations with high unmet needs. Our exclusive license agreements include the proprietary computational research and discovery of patented influenza epitopes of limited variability, or ELV, discovered by Dr. Sunetra Gupta and her team at the University of Oxford, or Oxford. Our collaborators are pioneers in vaccine discovery and development. We are exploring the development of these influenza ELVs utilizing our Norovirus shell and protrusion (S&amp;P) nanoparticle vaccine platform licensed from Cincinnati Children&#x2019;s Hospital Medical Center, or Cincinnati Children&#x2019;s. We are also utilizing our platform to develop a vaccine for the prevention of gastroenteritis cause by both norovirus and rotavirus. Our exclusively licensed <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae</FONT> vaccine candidate is from St. Jude Children&#x2019;s Hospital, or St. Jude. The vaccine, designed to prevent harmful middle<FONT CLASS="nobreak">-ear</FONT> infections in children, is being developed for intranasal delivery. We leverage the expertise of our collaborators to pursue the discovery and development of vaccines for these diseases, which are high unmet needs globally.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, we have expertise in identifying assets for our portfolio. This allows for both internal pipeline expansion and the ability to seek non<FONT CLASS="nobreak">-dilutive</FONT> revenue from potential partners to utilize our discovery engine vaccine platform. Our business development is opportunistic in accelerating, assisting or expanding the potential of our vaccine platform or vaccine candidates. There is potential for adjunctive or next generation therapeutic exploration to enhance current standard of care options.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Vaccination is an effective method of protecting individuals against harmful diseases by utilizing the body&#x2019;s natural defense system to develop resistance or immunity to infections. The body&#x2019;s immune system naturally creates antibodies and cell <FONT CLASS="nobreak">-mediated</FONT> immunity to defend against foreign pathogens. Vaccines introduce or present these foreign pathogens in a safe manner, prompting the body&#x2019;s immune system produce a response protective against the pathogen without exposing the body to the relevant lethal or harmful infection. While vaccines are generally able to provide resistance against disease, many infectious diseases can evolve or mutate leading to shortcomings of traditional vaccines, such as yearly reformulations. We believe our vaccine candidates can provide an alternative to the current standards of care by harnessing durable and long<FONT CLASS="nobreak">-lived</FONT> immune response to specific or multiple antigens.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The global vaccine market has recently experienced major growth caused by rising awareness of the importance of immunization and vaccination benefits in emerging markets as well as by projects to fuel further global market expansion. For instance, The World Health Organization (WHO) has undertaken initiatives to increase immunization awareness through its Global Vaccine Action Plan and Global Immunization Vision and Strategy. </P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As such, market research professionals project the global vaccine market size to reach $73.78<FONT CLASS="nobreak"> </FONT>billion by 2028, representing a CAGR of 7.3% over the forecast period, driven by rising prevalence of infectious diseases, increasing government funding for vaccine production and growing emphasis on becoming immunized. </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">1</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This market acceleration has been coupled with various strategic transactions in the sector, including consolidations and mergers and acquisitions in recent years. Major market participants have strategically acquired start<FONT CLASS="nobreak">-ups</FONT> and mid<FONT CLASS="nobreak">-sized</FONT> companies to broaden their products portfolios and service offerings. For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, one of the leading manufacturers of rabies vaccines across the globe. Additionally, in October 2018, Emergent BioSolutions, a multinational specialty biopharmaceutical company, acquired PaxVax for $270<FONT CLASS="nobreak"> </FONT>million, and in July 2017 Sanofi acquired Protein Sciences for $650<FONT CLASS="nobreak"> </FONT>million. The appetite of these companies to buttress their vaccine programs and pipelines reflects the increasing importance of vaccines in the healthcare sector, both nationally and worldwide.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Pipeline</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our vaccine candidates are being developed in a manner that is scalable, designed to be cost<FONT CLASS="nobreak">-effective</FONT> and provide long<FONT CLASS="nobreak">-term</FONT> benefit to patients from infectious agents.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><IMG ALT="" SRC="timage_001.jpg" STYLE="height:215.04px;width:538.88px;max-width:100%;"></FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Our Vaccine Platform</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV Norovirus (NoV) S&amp;P Nanoparticle Versatile Vaccine Platform</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Our Approach to Stimulating the Immune System for Infectious Disease Protection</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our S&amp;P platform combines two or more immunogenic components, a norovirus antigen plus at least one additional antigen, together creating novel constructs. The norovirus nanoparticle can enhance immunogenicity of the inserted antigen. The S &amp; P particles act as antigens themselves, and are large enough to trigger an immune response. By combining the norovirus nanoparticle with one or more antigens from other infectious disease(s), the immune system is stimulated to create antibodies to both the norovirus and the additional antigen(s).</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Key Elements of our Platform</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are leveraging our disruptive norovirus nanoparticle platform to develop novel, broad<FONT CLASS="nobreak">-spectrum</FONT> vaccines for adult and child infectious disease prevention by taking advantage of:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Flexible and Scalable discovery platform engine.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We are able to design and create novel vaccines that are stable and scalable for broad spectrum prophylactics. Through this platform&#x2019;s adaptability, we may opportunistically expand our pipeline and potentially collaborate with third parties for additional vaccines, as well as therapeutics.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;font-style:italic;font-weight:normal;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Cost</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-effective</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> and Rapid Production of Novel Vaccines.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We are able to significantly reduce the cost and time to market of traditional vaccines. We have bioengineered these nanoparticles to be stable and effective using <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">E.coli</FONT> expression, which provides cost savings and efficiency.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">2</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;font-style:italic;font-weight:normal;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Multi</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-antigen</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> and Pathogen Capabilities.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The power of our platform is its ability to carry multiple antigens at a time, thereby creating a multi<FONT CLASS="nobreak">-targeted</FONT> vaccine. It also provides the opportunity to develop vaccines for protection against not only viral pathogens, but also bacterial, parasitic and fungal pathogens.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Therapeutic potential.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We believe our platform may offer opportunities to develop non<FONT CLASS="nobreak">-infectious</FONT> disease therapeutic products, for example, being used as a carrier or vehicle to transport drugs to specific target locations.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Our Vaccine Candidates</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-101 and BWV-102: Influenza vaccine program</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The company&#x2019;s lead vaccine program is focused on developing a transformational novel universal influenza vaccine, BWV<FONT CLASS="nobreak">-101</FONT>. We are developing a broad<FONT CLASS="nobreak">-spectrum</FONT> vaccine using patented epitopes of limited variability, or ELV, that provide cross reactive immune response to multiple historical flu strains. Additionally, based upon the successful pre<FONT CLASS="nobreak">-clinical</FONT> proof<FONT CLASS="nobreak">-of-concept</FONT> (POC) of our H1 epitopes, we are developing a stand<FONT CLASS="nobreak">-alone</FONT> H1 influenza vaccine, BWV<FONT CLASS="nobreak">-102</FONT>, to provide a long<FONT CLASS="nobreak">-lasting</FONT> induced immune response. Data in mice models have demonstrated proof of concept of neutralization against historical and current H1 strains, which includes annual and pandemic strains. This would negate annual flu shots, reformulation and potentially provide protection against future influenza pandemics.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-201: Streptococcus pneumoniae (S. pneumoniae) vaccine program</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are developing BWV<FONT CLASS="nobreak">-201</FONT> to prevent Acute Otitis Media, or AOM, in children and adults, a leading cause of hospital visits, prescription antibiotics and potentially permanent hearing loss. AOM due to <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae</FONT> infections range from 30 to 50% of all AOM infections each year. BWV<FONT CLASS="nobreak">-201</FONT> is a live attenuated serotype<FONT CLASS="nobreak">-independent</FONT> intranasal vaccine candidate for <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S.&#x00a0;pneumoniae</FONT> induced AOM. </P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-301: Norovirus-rotavirus vaccine program</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are developing a norovirus<FONT CLASS="nobreak">-rotavirus</FONT> vaccine, BWV<FONT CLASS="nobreak">-301</FONT>, to prevent gastroenteritis. Preclinical data from gnotobiotic pig studies have shown our vaccine can prevent severe gastroenteritis and reduces viral shedding. While rotavirus vaccines exist in the market, no norovirus vaccine is available to date. Our vaccine would protect people from two of the most globally prevalent viruses causing vomiting and diarrhea.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-302: Norovirus-malaria vaccine program</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, we are currently investigating a malaria vaccine, BWV<FONT CLASS="nobreak">-302</FONT>, utilizing our norovirus platform. The vaccine is designed to offer protection from both norovirus and malaria, infectious diseases that occur frequently together in geographic regions. The vaccine utilizes a protein identified on the surface of the plasmodium parasite being presented on the surface of the norovirus nanoparticle. Preclinical study results testing our vaccine design are expected in 2022.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Strategy</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We aim to identify, discover and develop novel preventive vaccines for infectious diseases. Key elements of our strategy include: </P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Investment in advancing the development of our novel vaccine pipeline programs through</FONT> <FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">IND</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-enabling</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> activities, clinical development and regulatory approval.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We plan to advance our main vaccine programs: influenza, norovirus<FONT CLASS="nobreak">-rotavirus</FONT>, and <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae </FONT>induced AOM.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-left:72pt;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our in<FONT CLASS="nobreak">-licensed</FONT> vaccine candidates are carefully selected based on the following criteria: area of significant unmet medical need for preventive long<FONT CLASS="nobreak">-term</FONT> vaccine; strong scientific rationale and established clinical and regulatory pathways; defined competitive landscape and potential future commercial opportunity; and license exclusivity.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">3</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;font-style:normal;font-weight:bold;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Prioritizing the research and development for our lead influenza vaccine candidates, BWV101 and BWV</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-102</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> through Phase 1.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our goal is to develop a universal influenza vaccine that protects against all strains of influenza, including pandemic strains. In collaboration with The University of Oxford and Cincinnati Children&#x2019;s, we are evaluating vaccine candidates to pursue the best development path forward to stimulate durable and broad<FONT CLASS="nobreak">-spectrum</FONT> immunogenicity.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We will leverage the pre<FONT CLASS="nobreak">-clinical</FONT> and clinical experience from the development of BWV<FONT CLASS="nobreak">-102</FONT>, H1&#x00a0;vaccine candidate, to accelerate the development of the of BWV<FONT CLASS="nobreak">-101</FONT> program.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Maximize and utilize the value of our collaborators and third</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-party</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> vendors.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We will combine disciplined business strategies to further expand the potential synergies with current collaborators. </P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Deploy and expand our proprietary norovirus S&amp;P nanoparticle platform.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our immunogenic multi<FONT CLASS="nobreak">-purpose</FONT> vaccine platform technologies can be utilized with an array of infectious disease agents to access multiple development pathways and allow for potential next<FONT CLASS="nobreak">-generation</FONT> life cycle management to expand our pipeline and pursue business development opportunities. There is potential for the platform to pursue adjunctive therapies to currently available drugs, and for current therapies to be re<FONT CLASS="nobreak">-optimized</FONT> and formulated to protect against multiple antigens.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Management and History</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Blue Water Vaccines, Inc. was founded in October 2018 by our Chief Executive Officer, or CEO, Joseph Hernandez, with the initial goal of developing a transformational universal flu vaccine to treat and prevent infections in patients globally. Our initial technology, licensed from the University of Oxford, provides a novel approach to developing a universal influenza vaccine. Subsequently, our team has identified other program candidates and technologies to broaden and diversify our vaccine pipeline.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Mr.<FONT CLASS="nobreak"> </FONT>Hernandez, our Chairman and CEO, is a veteran entrepreneur, philanthropist, and operator with a broad skillset of founding, building, and selling companies, as well as executing business development transactions and securing private and public capital, including Digene, Noachis Terra and Blue Water Acquisition Corp. Mr.<FONT CLASS="nobreak"> </FONT>Hernandez was responsible for our initial $7<FONT CLASS="nobreak"> </FONT>million seed funding round from investors including CincyTech. Subsequently, a team of veteran industry executives and advisors were assembled, bringing valuable expertise to our growing infectious disease company. Jon Garfield, who will be our Chief Financial Officer upon the completion of this offering, is a veteran executive in life sciences. Andrew Skibo is our Head of Biologic Operations and was recently Head of Global Biologics Operations at MedImmune / AstraZeneca and previously worked for Amgen and Genentech (now Roche), where he was responsible for operations, engineering, construction, and validation for large<FONT CLASS="nobreak">-scale</FONT> capital projects related to bio<FONT CLASS="nobreak">-pharmaceutical</FONT> manufacturing. Ronald Cobb, Ph.D., our Head of Science and Discovery, was recently Chief Scientific Officer at Ology Bioservices (formerly Nanotherapeutics) and previously worked for RTI Biologics and Berlex Biosciences. Brian Price, PhD, our Head of Technology Strategy, brings over 20 years of successful product development experience and business development growth based on programs in toxicology, analytics, and therapeutic and vaccine development. Erin Henderson serves as our Chief Business Officer and has over 20 years of leading strategic transactions, governmental and stakeholder relations and corporate expansion. Previously, she was the Managing Principal at The Aetos Group, a management consulting firm serving both the public and private sectors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, members of our Board of Directors have extensive expertise in the fields of life sciences, business, and finance. In addition to Mr.<FONT CLASS="nobreak"> </FONT>Hernandez, our directors upon the consummation of this offering include Michael Venerable, CEO of CincyTech, Kimberly Murphy, former VP, Commercialization Leader, influenza at GlaxoSmithKlein, Allan Shaw, an experienced biotechnology CFO and director nominee James Sapirstein, R.Ph., M.B.A, President and CEO of AzurRx BioPharma (NASDAQ:AZRX).</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">4</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Scientific Advisory Board includes Sunetra Gupta, Ph.D. Professor of Theoretical Epidemiology at The University of Oxford, a leading voice in infectious disease globally; David Zarley, PhD, with more than 30 years of experience in vaccine research and development, including former leadership roles at Pfizer and Wyeth; and, following the consummation of this offering, John Rice, Ph.D., Managing Director at CincyTech with more than 30&#x00a0;years of biotechnology advising experience.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Implications of Being an Emerging Growth Company</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We qualify as an &#x201c;emerging growth company,&#x201d; as defined in the JOBS Act. For as long as we remain an emerging growth company, we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies. These provisions include, but are not limited to:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>being permitted to have only two years of audited financial statements and only two years of related selected financial data and management&#x2019;s discussion and analysis of financial condition and results of operations disclosure;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>an exemption from compliance with the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to Section 404 of the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act of 2002, as amended, or the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reduced disclosure about executive compensation arrangements in our periodic reports, registration statements and proxy statements; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>exemptions from the requirements to seek non<FONT CLASS="nobreak">-binding</FONT> advisory votes on executive compensation or golden parachute arrangements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, the JOBS Act permits emerging growth companies to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We are not choosing to &#x201c;opt out&#x201d; of this provision. We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the completion of this offering, (ii) the last day of the first fiscal year in which our annual gross revenues exceed $1.07<FONT CLASS="nobreak"> </FONT>billion, (iii) the date on which we have, during the immediately preceding three<FONT CLASS="nobreak">-year</FONT> period, issued more than $1.0<FONT CLASS="nobreak"> </FONT>billion in non<FONT CLASS="nobreak">-</FONT><FONT CLASS="nobreak">convertible</FONT> debt securities and (iv) the end of any fiscal year in which the market value of our common stock held by non<FONT CLASS="nobreak">-affiliates</FONT> exceeds $700<FONT CLASS="nobreak"> </FONT>million as of the end of the second quarter of that fiscal year. We have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus forms a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our shareholders may be different than you might receive from other public reporting companies in which you hold equity interests.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Summary of Risks Related to Our Business</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our business is subject to a number of risks, including risks that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, results of operations, cash flows and prospects that you should consider before making a decision to invest in our common stock. These risks are discussed more fully in &#x201c;Risk Factors&#x201d; beginning on page 11 of this prospectus. These risks include, but are not limited to, the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We are in the early stages of vaccine development and have a very limited operating history and no products approved for commercial sale, which may make it difficult for you to evaluate the success of our business to date and to assess our future viability.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We have incurred significant net losses since inception and anticipate that we will continue to incur substantial net losses for the foreseeable future and may never achieve or maintain profitability. Our stock is a highly speculative investment.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Even after this offering, we will require substantial additional funding to finance our operations. If we are unable to raise additional capital when needed, we could be forced to delay, reduce or terminate certain of our development programs or other operations.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">5</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Due to the significant resources required for the development of our vaccine candidates, and depending on our ability to access capital, we must prioritize development of certain vaccine candidates. Moreover, we may expend our limited resources on vaccine candidates that do not yield a successful vaccine and fail to capitalize on vaccine candidates that may be more profitable or for which there is a greater likelihood of success.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>There is substantial doubt about our ability to continue as a going concern.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We depend entirely on the success of a limited number of product candidates, which are in preclinical development and none of which have commenced a clinical trial. If we do not obtain regulatory approval for and successfully commercialize one or more of our product candidates or we experience significant delays in doing so, we may never become profitable.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The marketing approval process of the U.S Food and Drug Association, or FDA, is lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain marketing approval for our current product candidates and future product candidates we intend to develop, our business will be substantially harmed.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The future results of our current or future clinical trials may not support our product candidates claims or may result in the discovery of unexpected adverse side effects.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Even if we obtain regulatory approval of our vaccine candidates, the products may not gain market acceptance among regulators, advisory boards, physicians, patients, third<FONT CLASS="nobreak">-party</FONT> payors and others in the medical community.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We may be adversely affected by the ongoing coronavirus pandemic.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We intend to rely on third parties to conduct our clinical trials and to conduct some aspects of our research and pre<FONT CLASS="nobreak">-clinical</FONT> testing and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We may have conflicts with our partners that could delay or prevent the development or commercialization of our current and future product candidates.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>It is difficult and costly to protect our proprietary rights, and we may not be able to ensure their protection. If our patent position does not adequately protect our product candidates, others could compete against us more directly, which would harm our business, possibly materially.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We are dependent on licensed intellectual property. If we were to lose our rights to licensed intellectual property, we may not be able to continue developing or commercializing our product candidates, if approved. If we breach any of the agreements under which we license the use, development and commercialization rights to our product candidates or technology from third parties or, in certain cases, we fail to meet certain development deadlines, we could lose license rights that are important to our business.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Some of the intellectual property covered by our licenses concerns patent applications and provisional applications. We cannot assure investors that any of the currently pending or future patent applications will result in granted patents, nor can we predict how long it will take for such patents to be granted.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>If we fail to comply with healthcare regulations, we could face substantial enforcement actions, including civil and criminal penalties and our business, operations and financial condition could be adversely affected.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Healthcare Reform in the United States has been implemented in the past, and we expect further changes to be proposed in the future, leading to potential uncertainty in the healthcare industry. Violations of healthcare laws can have an adverse impact on our ability to advance our product candidates and our operating results.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The market price of our common stock may be highly volatile, and you could lose all or part of your investment.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">6</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We have broad discretion in the use of the net proceeds from this offering and may invest or spend the proceeds in ways with which you disagree or that may not yield a return.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our failure to meet the continued listing requirements of Nasdaq could result in a de<FONT CLASS="nobreak">-listing</FONT> of our common stock.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We are an &#x201c;emerging growth company&#x201d; and the reduced disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our amended and restated certificate of incorporation (&#x201c;Amended and Restated Certificate of Incorporation&#x201d;) and our amended and restated bylaws (&#x201c;Amended and Restated Bylaws&#x201d;) to be adopted in connection with the consummation of this offering, and Delaware law may have anti<FONT CLASS="nobreak">-takeover</FONT> effects that could discourage, delay or prevent a change in control, which may cause our stock price to decline.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>A possible &#x201c;short squeeze&#x201d; due to a sudden increase in demand of our common stock that largely exceeds supply may lead to price volatility in our common stock.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Corporate Information</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We were incorporated in Delaware on October<FONT CLASS="nobreak"> </FONT>26, 2018. Our principal executive offices are located at 201&#x00a0;E.&#x00a0;Fifth Street, Suite 1900, Cincinnati, Ohio 45202, and our telephone number is (513) 620<FONT CLASS="nobreak">-4101</FONT>. Our corporate website address is <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.bluewatervaccines.com</FONT>. The information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">7</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold-AllCaps" STYLE="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">THE OFFERING</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Common stock outstanding before this offering</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:14pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:11pt;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Common stock offered by us</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Option to purchase additional shares</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">We have granted the underwriters an option for a period of 45 days from the date of this prospectus to purchase an additional &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Representative&#x2019;s Warrants</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">We will issue to Maxim Group, LLC, the representative of the several underwriters, or the Representative, upon the closing of this offering, compensation warrants, or the representative&#x2019;s warrants, entitling the Representative to purchase &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock, representing 5.0% of the aggregate number of shares of common stock issued in this offering, including any shares issued pursuant to the exercise of the underwriters&#x2019; over<FONT CLASS="nobreak">-allotment</FONT>&#x00a0;option, at an exercise price per share equal to 115% of the initial public offering price per share. The representative&#x2019;s warrants will have a term of five years from the effective date of the registration statement of which this prospectus forms a part and may be exercised commencing 180 days following the date of commencement of sales of the offering. The representative&#x2019;s warrants may be exercised on a cash or cashless basis. This prospectus also relates to the offering of the&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock issuable upon exercise of the representative&#x2019;s warrants.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-8" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Common stock to be outstanding after this offering</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:21pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:19pt;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Shares</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Use of proceeds</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">We currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents, to fund our research and development activities, clinical trials and the regulatory review process for our product candidates, and the remainder for working capital and other general corporate purposes. See &#x201c;Use of Proceeds&#x201d; on page 57.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Lock-up Agreements</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">We and our directors, officers any other holder(s) of three percent (3.0%) or more of our outstanding shares of common stock have agreed with the representative not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our common stock or securities convertible into common stock for a period of six (6) months initial public offering is completed. See &#x201c;Underwriting&#x201d; on page 136.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Transfer Agent</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">Continental Stock Transfer &amp; Trust Company</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-11" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Risk Factors</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">See &#x201c;Risk Factors&#x201d; on page 11 for a discussion of certain of factors to consider carefully before deciding to purchase any shares of our common stock.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 39.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Proposed Nasdaq Capital Market Symbol</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x201c;BWV&#x201d;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The number of shares of our common stock to be outstanding after this offering is based on 2,136,855<FONT CLASS="nobreak"> </FONT>shares of common stock outstanding as of August<FONT CLASS="nobreak"> </FONT>1, 2021 (after giving effect to the conversion of all outstanding shares of convertible preferred stock into an aggregate of 1,336,855<FONT CLASS="nobreak"> </FONT>shares of common stock), and excludes:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>195,160<FONT CLASS="nobreak"> </FONT>shares of common stock issuable upon the exercise of outstanding stock options under our 2019 Equity Incentive Plan, or the 2019 Plan, as of August<FONT CLASS="nobreak"> </FONT>1, 2021;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">8</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>154,840&#x00a0;shares of our common stock reserved for future issuance under the 2019 Plan, which, upon adoption of our 2021 Equity Incentive Plan, or the 2021 Plan, will be issuable under the 2021 Plan; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>shares of our common stock issuable upon the exercise of the warrant issued to the representative of the underwriters at the closing of this offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Unless otherwise indicated, all information contained in this prospectus assumes:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>no exercise by the underwriters of their over<FONT CLASS="nobreak">-allotment</FONT> option to purchase up to &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;additional shares of our common stock;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>no exercise of the outstanding stock options described above;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>no exercise of the outstanding warrant described above;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the filing of our Amended and Restated Certificate of Incorporation and the adoption of our Amended and Restated Bylaws immediately prior to the closing of this offering.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">9</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="BOXSTYLE" STYLE="margin:0;padding:0;border-width:0;border-color:#000000;border-width:1pt;border: solid windowtext 1.0pt; padding: 10.0pt 4.0pt 10.0pt 4.0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T17"></A><FONT CLASS="Bold-AllCaps" STYLE="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">SUMMARY FINANCIAL DATA</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following tables set forth a summary of our historical financial data as of, and for the periods ended on, the dates indicated. The statements of operations data for the years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019 and balance sheet data as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and December<FONT CLASS="nobreak"> </FONT>31, 2019 are derived from our audited financial statements included elsewhere in this prospectus. The statements of operations data for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020 and the balance sheet data as of June<FONT CLASS="nobreak"> </FONT>30, 2021 are derived from our unaudited financial statements included elsewhere in this prospectus. The unaudited financial statements were prepared on the same basis as the audited financial statements. Our management believes that the unaudited financial statements reflect all adjustments necessary for the fair presentation of the financial condition and results of operations for such periods.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following summary financial information should be read in connection with, and is qualified by reference to, our financial statements related notes thereto and the section titled &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; included elsewhere in this prospectus. Our historical results are not necessarily indicative of results to be expected in any future period.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Statement of Operations Data:</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-8" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended June 30, <BR>2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended June 30, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating costs and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">General and administrative</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">500,276</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">559,775</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,097,161</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">820,058</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Research and development</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">617,779</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">320,336</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">524,908</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">60,174</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880,111</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,622,069</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880,232</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss from operations</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(880,111</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,622,069</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(880,232</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-18" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,603</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">58,317</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,603</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">58,317</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(860,680</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,599,466</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(821,915</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cumulative preferred stock dividends</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">276,904</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">278,434</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">559,928</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">279,964</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss applicable to common stockholders</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,394,959</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,139,114</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(2,159,394</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,101,879</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-18" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss per share attributable to common stockholders, basic and diluted</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1.74</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1.42</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(2.70</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1.38</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-18" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 41.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average number of common shares outstanding, basic and diluted</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Balance Sheet Data:</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-20" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">June 30, 2021 <BR>(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.32%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">December 31, <BR>2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,669,468</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,308,821</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Working capital</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,586,704</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,527,811</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">5,983,327</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total assets</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,182,719</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,812,080</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,081,020</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total liabilities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">490,359</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">78,310</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">82,621</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Preferred stock</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Common stock</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Additional paid-in-capital</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">7,349,732</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">7,273,087</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,938,250</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accumulated deficit</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(3,657,391</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(2,539,336</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(939,870</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.77%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total stockholders&#x2019; equity</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,692,360</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.62%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,733,770</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">5,998,399</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">10</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T16"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">RISK FACTORS</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-indent:24pt;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Investing in our common stock involves a high degree of risk. You should carefully consider the following information about these risks, together with the other information appearing elsewhere in this prospectus, including our financial statements, the notes thereto and the section entitled &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations,&#x201d; before deciding to invest in our common stock. The occurrence of any of the following risks could have a material adverse effect on our business, reputation, financial condition, results of operations and future growth prospects, as well as our ability to accomplish our strategic objectives. As&#x00a0;a result, the trading price of our common stock could decline and you could lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations and stock price.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Related to our Financial Position and Need for Capital</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We are in the early stages of vaccine development and have a very limited operating history and no products approved for commercial sale, which may make it difficult for you to evaluate the success of our business to date and to assess our future viability.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To date, we have devoted substantially all of our resources to performing research and development, undertaking preclinical studies and enabling manufacturing activities in support of our product development efforts, hiring personnel, licensing and developing our technology and vaccine candidates, organizing and staffing our company, performing business planning, establishing our intellectual property portfolio and raising capital to support and expand such activities. As an organization, we have not yet demonstrated an ability to successfully complete clinical development, obtain regulatory approvals, manufacture a commercial<FONT CLASS="nobreak">-scale</FONT> product or conduct sales and marketing activities necessary for successful commercialization or arrange for a third party to conduct these activities on our behalf. Consequently, any predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our current vaccine candidate pipeline includes four preclinical programs. We may encounter unforeseen expenses, difficulties, complications, delays and other known or unknown factors in achieving our business objectives, including with respect to our vaccine candidates. We will need to transition in the future from a company with a research and development focus to a company capable of supporting commercial activities and may not be successful in such a transition.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We have incurred significant net losses since inception and anticipate that we will continue to incur substantial net losses for the foreseeable future and may never achieve profitability. Our stock is a highly speculative investment.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are a preclinical stage biotechnology vaccine company that was incorporated in October 2018. Investment in preclinical stage companies and vaccine development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential vaccine candidate will not gain regulatory approval or become commercially viable. We do not have any products approved for sale and have not generated any revenue from product sales. As a result, we are not profitable and have incurred losses in each year since inception. Our net losses were $1.6&#x00a0;million and $0.8&#x00a0;million for the years ended December&#x00a0;31, 2020 and 2019, respectively, and $1.1<FONT CLASS="nobreak"> </FONT>million and $0.9<FONT CLASS="nobreak"> </FONT>million for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020, respectively. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, we had an accumulated deficit of $3.7&#x00a0;million.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We expect to continue to spend significant resources to fund research and development of, and seek regulatory approvals for, our vaccine candidates. We expect to incur substantial and increasing operating losses over the next several years as our research, development, manufacturing, preclinical testing and clinical trial activities increase. As a result, our accumulated deficit will also increase significantly. Additionally, there can be no assurance that the product candidates currently under development or that may be under development by us in the future will be approved for sale in the U.S. or elsewhere. Furthermore, there can be no assurance that if such products are approved they will be successfully commercialized, and the extent of our future losses and the timing of our profitability are highly uncertain. If we are unable to achieve profitability, we may be unable to continue our operations.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">11</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Even after this offering, we will require substantial additional funding to finance our operations. If we are unable to raise additional capital when needed, we could be forced to delay, reduce or terminate certain of our development programs or other operations.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of June<FONT CLASS="nobreak"> </FONT>30, 2021, we had cash and cash equivalents of $3.7&#x00a0;million. We believe that the net proceeds from this offering will be approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million, based on an assumed public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the estimated price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. We believe that such proceeds, together with our existing cash and cash equivalents as of the date of this prospectus, will fund our current operating plans through at least the next 12<FONT CLASS="nobreak"> </FONT>months from the date of this offering. Accordingly, we believe that we will need to raise substantial additional capital to fund our continuing operations and the development and commercialization of our current product candidates and future product candidates. Our business or operating plan may change as a result of many factors currently unknown to us, and we may need to seek additional funds sooner than planned. We will need to raise additional capital before we can progress any of our vaccine candidates into a pivotal clinical trial. We expect to finance our subsequent cash needs through public or private equity or debt financings, third<FONT CLASS="nobreak">-party</FONT> (including government) funding and marketing and distribution arrangements, as well as other collaborations, strategic alliances and licensing arrangements or any combination of these approaches. In addition, we may need to accelerate the growth of our sales capabilities and distribution beyond what is currently envisioned, and this would require additional capital.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">However, we may not be able to secure funding when we need it or on favorable terms and we may not be able to raise sufficient funds to commercialize our current and future product candidates we intend to develop. Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide, including the trading price of common stock, resulting from the ongoing COVID<FONT CLASS="nobreak">-19</FONT> pandemic. Our future capital requirements will depend on many factors, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the timing, scope, progress, results and costs of research and development, testing, screening, manufacturing, preclinical development and clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the outcome, timing and cost of seeking and obtaining regulatory approvals from the FDA and comparable foreign regulatory authorities, including the potential for such authorities to require that we perform field efficacy studies for our vaccine candidates, require more studies than those that we currently expect or change their requirements regarding the data required to support a marketing application;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the cost of building a sales force in anticipation of any product commercialization;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the costs of future commercialization activities, including product manufacturing, marketing, sales, royalties and distribution, for any of our vaccine candidates for which we receive marketing approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to maintain existing, and establish new, strategic collaborations, licensing or other arrangements and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty or other payments due under any such agreement;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any product liability or other lawsuits related to our products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the expenses needed to attract, hire and retain skilled personnel;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the revenue, if any, received from commercial sales, or sales to foreign governments, of our vaccine candidates for which we may receive marketing approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the costs to establish, maintain, expand, enforce and defend the scope of our intellectual property portfolio, including the amount and timing of any payments we may be required to make, or that we may receive, in connection with licensing, preparing, filing, prosecuting, defending and enforcing of any patents or other intellectual property rights;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the expenses needed to attract, hire and retain skilled personnel;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">12</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the costs of operating as a public company; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the impact of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic, which may exacerbate the magnitude of the factors discussed above.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our ability to raise additional funds will depend on financial, economic and other factors, many of which are beyond our control. We cannot be certain that additional funding will be available on acceptable terms, or at all. We have no committed source of additional capital and if we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our vaccine candidates or other research and development initiatives. Our license agreements may also be terminated if we are unable to meet the payment obligations or milestones under the agreements. We could be required to seek collaborators for our vaccine candidates at an earlier stage than otherwise would be desirable or on terms that are less favorable than might otherwise be available, or relinquish or license on unfavorable terms our rights to our vaccine candidates in markets where we otherwise would seek to pursue development or commercialization ourselves.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may consider strategic alternatives in order to maximize stockholder value, including financings, strategic alliances, licensing arrangements, acquisitions or the possible sale of our business. We may not be able to identify or consummate any suitable strategic alternatives and any consummated strategic alternatives may have an adverse impact on our vaccine candidates.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may consider all strategic alternatives that may be available to us to maximize stockholder value, including financings, strategic alliances, licensing arrangements, acquisitions or the possible sale of our business. We currently have no agreements or commitments to engage in any specific strategic transactions, and our exploration of various strategic alternatives may not result in any specific action or transaction. To the extent that this engagement results in a transaction, our business objectives may change depending upon the nature of the transaction. There can be no assurance that we will enter into any transaction as a result of the engagement. Furthermore, if we determine to engage in a strategic transaction, we cannot predict the impact that such strategic transaction might have on our operations or stock price. We also cannot predict the impact on our stock price if we fail to enter into a transaction.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, we face significant competition in seeking appropriate strategic partners, and the negotiation process is time<FONT CLASS="nobreak">-consuming</FONT> and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our vaccine candidates because they may be deemed to be at too early of a stage of development for collaborative effort, and third parties may not view our vaccine candidates as having the requisite potential to demonstrate safety and efficacy. Any delays in entering into new strategic partnership agreements related to our vaccine candidates could delay the development and commercialization of our vaccine candidates in certain geographies for certain indications, which would harm our business prospects, financial condition and results of operations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If we license products or businesses, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following a strategic transaction or license, we will achieve the results, revenue or specific net income that justifies such transaction.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Raising additional capital may cause dilution to our existing stockholders and investors in this offering, restrict our operations or require us to relinquish rights to our product candidates on unfavorable terms to us.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may seek additional capital through a variety of means, including through private and public equity offerings and debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, or through the issuance of shares under other types of contracts, or upon the exercise or conversion of outstanding options, warrants, convertible debt or other similar securities, the ownership interests of our stockholders will be diluted, and the terms of such financings may include liquidation or other preferences, anti<FONT CLASS="nobreak">-dilution</FONT>&#x00a0;rights, conversion and exercise price adjustments and other provisions that adversely affect the rights of our stockholders, including rights, preferences and privileges that are senior to those of our holders of common stock in terms of the payment of dividends or in the event of a liquidation. In addition, debt financing, if available, could include covenants limiting or restricting our ability to take certain actions, such as incurring additional debt, </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">13</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">making capital expenditures, entering into licensing arrangements, or declaring dividends and may require us to grant security interests in our assets. If we raise additional funds through collaborations, strategic alliances, or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, product or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may need to curtail or cease our operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Due to the significant resources required for the development of our vaccine candidates, and depending on our ability to access capital, we must prioritize development of certain vaccine candidates. Moreover, we may expend our limited resources on vaccine candidates that do not yield a successful vaccine and fail to capitalize on vaccine candidates that may be more profitable or for which there is a greater likelihood of success.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Due to the significant resources required for the development of our vaccine candidates, we must decide which vaccine candidates to pursue and advance and the amount of resources to allocate to each. Our decisions concerning the allocation of research, development, management and financial resources toward particular vaccine candidates may not lead to the development of any viable commercial vaccines and may divert resources away from better opportunities. Similarly, our potential decisions to delay, terminate, license or collaborate with third parties in respect of certain vaccine candidates may subsequently also prove to be less than optimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the viability or market potential of any of our vaccine candidates or misread trends in the biopharmaceutical industry, in particular for vaccines, our business could be seriously harmed. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other vaccine candidates that may later prove to have greater commercial potential than those we choose to pursue or relinquish valuable rights to such vaccine candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">There is substantial doubt about our ability to continue as a going concern.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of December<FONT CLASS="nobreak"> </FONT>31, 2020, December<FONT CLASS="nobreak"> </FONT>31, 2019, and June<FONT CLASS="nobreak"> </FONT>30, 2021, we had cash of $4.3<FONT CLASS="nobreak"> </FONT>million, $6.1<FONT CLASS="nobreak"> </FONT>million, and $3.7<FONT CLASS="nobreak"> </FONT>million, respectively. In addition, we had current liabilities of approximately $0.5<FONT CLASS="nobreak"> </FONT>million as of June<FONT CLASS="nobreak"> </FONT>30, 2021. We expect our existing cash as of June<FONT CLASS="nobreak"> </FONT>30, 2021 together with proceeds from this offering will enable us to fund our operating expenses and capital expenditure requirements for at least 12<FONT CLASS="nobreak"> </FONT>months from the date of this prospectus. In the event that we are unable to obtain additional financing, we may be unable to continue as a going concern. There is no guarantee that we will be able to secure additional financing, including in connection with this offering. Changes in our operating plans, our existing and anticipated working capital needs, costs related to legal proceedings we might become subject to in the future, the acceleration or modification of our development activities, any near<FONT CLASS="nobreak">-term</FONT>&#x00a0;or future expansion plans, increased expenses, potential acquisitions or other events may further affect our ability to continue as a going concern. Similarly, the report of our independent registered public accounting firm on our financial statements as of and for the year ended December&#x00a0;31, 2020 includes an explanatory paragraph indicating that there is substantial doubt about our ability to continue as a going concern. If we cannot continue as a viable entity, our stockholders may lose some or all of their investment in us.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited, each of which could harm our business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of December<FONT CLASS="nobreak"> </FONT>31, 2020, we had U.S. federal and state net operating loss carryforwards of approximately $2.1<FONT CLASS="nobreak"> </FONT>million. Under Sections 382 and 383 of the Internal Revenue Code, or the Code, if a corporation undergoes an &#x201c;ownership change,&#x201d; the corporation&#x2019;s ability to use its pre<FONT CLASS="nobreak">-ownership</FONT> change net operating loss carryforwards and other pre<FONT CLASS="nobreak">-ownership</FONT> change tax attributes, such as research tax credits, to offset its post<FONT CLASS="nobreak">-ownership</FONT> change income and taxes may be limited. In general, an ownership change will occur when the percentage of the Corporation&#x2019;s ownership (by value) of one or more &#x201c;5<FONT CLASS="nobreak">-percent</FONT> shareholders&#x201d; (as defined in the Code) has increased by more than 50 percent over the lowest percentage owned by such shareholders at any time during the prior three years (calculated on a rolling basis). Similar rules may apply under state tax laws. An entity that experiences an ownership change generally will be subject to an annual limitation on its pre<FONT CLASS="nobreak">-ownership</FONT> change tax loss and credit carryforwards equal to the equity value of the corporation immediately before the ownership change, multiplied by the long<FONT CLASS="nobreak">-term</FONT>, tax<FONT CLASS="nobreak">-exempt</FONT> rate posted monthly by the U.S. Internal Revenue Service (subject to certain adjustments). </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">14</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">The annual limitation would be increased each year to the extent that there is an unused limitation in a prior year. In the event that it is determined that we have in the past experienced an ownership change as a result of transactions in our stock, or if we experience one or more ownership changes as a result of future transactions in our stock, then we may be limited in our ability to use our net operating loss carryforwards and other tax assets to reduce taxes owed on the net taxable income that we earn. Any limitations on the ability to use our net operating loss carryforwards and other tax assets could harm our business.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Related to the Development of our Product Candidates</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We depend entirely on the success of a limited number of product candidates, which are in preclinical development and none of which have commenced a clinical trial. If we do not obtain regulatory approval for and successfully commercialize one or more of our product candidates or we experience significant delays in doing so, we may never become profitable.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We do not have any products that have received regulatory approval and may never be able to develop marketable product candidates. We expect that a substantial portion of our efforts and expenses over the next few years will be devoted to the development of our product candidates; specifically, the commencement of Phase I clinical trials for our vaccine candidates. As a result, our business currently depends heavily on the successful development, regulatory approval and, if approved, commercialization of these product candidates. We cannot be certain that our product candidates will receive regulatory approval or will be successfully commercialized even if they receive regulatory approval. The research, testing, manufacturing, safety, efficacy, labeling, approval, sale, marketing and distribution of our product candidates are, and will remain, subject to comprehensive regulation by the FDA and similar foreign regulatory authorities. Before obtaining regulatory approvals for the commercial sale of any product candidate, we must demonstrate through pre<FONT CLASS="nobreak">-clinical</FONT> studies and clinical trials that the product candidate is safe and effective for use in each target indication. Vaccine development is a long, expensive and uncertain process, and delay or failure can occur at any stage of any of our clinical trials. Failure to obtain regulatory approval for our product candidates in the United States will prevent us from commercializing and marketing our product candidates. The success of our product candidates will depend on several additional factors, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>completing clinical trials that demonstrate their efficacy and safety;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>receiving marketing approvals from applicable regulatory authorities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>completing any post<FONT CLASS="nobreak">-marketing</FONT> studies required by applicable regulatory authorities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>establishing commercial manufacturing capabilities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>launching commercial sales, marketing and distribution operations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the prevalence and severity of adverse events experienced with our product candidates;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>acceptance of our product candidates by patients, the medical community and third<FONT CLASS="nobreak">-party</FONT> payors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a continued acceptable safety profile following approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>obtaining and maintaining healthcare coverage and adequate reimbursement for our product candidates;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>competing effectively with other therapies, including with respect to the sales and marketing of our product candidates, if approved; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>qualifying for, maintaining, enforcing and defending our intellectual property rights and claims.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Many of these factors are beyond our control, including the time needed to adequately complete clinical testing, the regulatory submission process, potential threats to our intellectual property rights and changes in the competitive landscape. It is possible that none of our product candidates will ever obtain regulatory approval, even if we expend substantial time and resources seeking such approval. If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully complete clinical trials, obtain regulatory approval or, if approved, commercialize our product candidates, which would materially harm our business, financial condition and results of operations.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">15</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">The marketing approval process of the FDA is lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain marketing approval for our current product candidates and future product candidates we intend to develop, our business will be substantially harmed.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are at a very early stage of development for all of our product candidates. The product candidates we intend to develop have not gained marketing approval in the U.S., and we cannot guarantee that we will ever have marketable products. Our business is substantially dependent on our ability to complete the development of, obtain marketing approval for, and successfully commercialize our current and future product candidates in a timely manner. We cannot commercialize our product candidates in the United States without first obtaining approval from the FDA to market each product candidate. Our product candidates could fail to receive marketing approval for many reasons, including among others:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the FDA may disagree with the design or implementation of our clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our clinical trials for our product candidate(s) must be successful if we are to seek and obtain regulatory marketing application through the submission of a new Biological License Application (BLA) and marketing authorization application (MAA) with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), respectively. Advanced clinical trials are often not successful even if prior trials were successful, and even if we are able to conduct advanced clinical trials and those trials are successful, we may not obtain necessary regulatory approvals for our product candidate(s) or we may be unable to successfully commercialize our products even if we receive the necessary regulatory approvals</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, the process of seeking regulatory approval to market the product candidates we intend to develop is expensive and time consuming and, notwithstanding the effort and expense incurred, approval is never guaranteed. If we are not successful in obtaining timely approval of our product candidates from the FDA, we may never be able to generate significant revenue and may be forced to cease operations. The new Biological License Application, or BLA, process is costly, lengthy and uncertain. Any BLA application filed by us will have to be supported by extensive data, including, but not limited to, technical, pre<FONT CLASS="nobreak">-clinical</FONT>, clinical, manufacturing and labeling data, to demonstrate to the FDA&#x2019;s satisfaction the safety and efficacy of the product for its intended use.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In order to commence a clinical trial in the United States, we will be required to seek FDA acceptance of an IND for each of our product candidates. We cannot be sure any IND we submit to the FDA, or any similar clinical trial application we submit in other countries, will be accepted. If we will be required by regulatory authorities to conduct additional preclinical testing prior to filing an IND or similar application to clinically evaluate any of our product candidates, this may result in delay in our product candidate development. The results of any such preclinical testing may not be positive and may not support an application to study any of our product candidates in additional clinical trials.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">It is possible that the FDA or EMA will not view our ongoing or planned trials as providing adequate support for future clinical trials or for an application for marketing approval, for any one or more reasons, including elements of the design or execution of the trials or safety concerns or other trial results. If we are unable to confirm or replicate the results of our trials in larger patient group or if negative results are obtained, we would likely be further delayed or prevented from advancing further clinical development any of our product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, the FDA or EMA may disagree with the sufficiency of our proposed reliance upon the preclinical, manufacturing or clinical data generated by third<FONT CLASS="nobreak">-party</FONT> academic<FONT CLASS="nobreak">-sponsored</FONT> trials, or our interpretation of preclinical, manufacturing or clinical data from our ongoing trials. If so, the FDA or EMA may require us to obtain and submit additional preclinical, manufacturing or clinical data.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Obtaining approvals from the FDA and from the regulatory agencies in other countries is an expensive and time<FONT CLASS="nobreak">-consuming</FONT> process and is uncertain as to outcome. The FDA and other agencies could ask us to supplement our submissions, collect non<FONT CLASS="nobreak">-clinical</FONT> data, conduct additional clinical trials or engage in other time-consuming actions, or it could simply deny our applications. In addition, even if we obtain a BLA approval or pre-market approvals in other countries, the approval could be revoked or other restrictions imposed if post<FONT CLASS="nobreak">-market</FONT> data demonstrate safety issues or lack of effectiveness. We cannot predict with certainty how, or when, the FDA will act. If we are unable to obtain the necessary regulatory approvals, our financial condition and cash flow may be adversely affected, </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">16</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">and our ability to grow domestically and internationally may be limited. Additionally, even if cleared or approved, our products may not be approved for the specific indications that are most necessary or desirable for successful commercialization or profitability.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may encounter substantial delays in completing our clinical studies which in turn will require additional costs, or we may fail to demonstrate adequate safety and efficacy to the satisfaction of applicable regulatory authorities.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">It is impossible to predict if or when our current or future product candidates, will prove safe or effective in humans or&#x00a0;will&#x00a0;receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must conduct extensive clinical studies to demonstrate the safety and efficacy of the product candidates in humans. Clinical testing is expensive, time<FONT CLASS="nobreak">-consuming</FONT> and uncertain as to outcome. We&#x00a0;cannot guarantee that any clinical studies will be conducted as planned or completed on schedule, if at all. A&#x00a0;failure of one or more clinical studies can occur at any stage of testing. Events that may prevent successful or timely completion of clinical development include:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>delays in reaching, or failing to reach, a consensus with regulatory agencies on study design;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>delays in reaching, or failing to reach, agreement on acceptable terms with a sufficient number of prospective contract research organizations, or CROs, and clinical study sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>delays in recruiting a sufficient number of suitable patients to participate in our clinical studies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>imposition of a clinical hold by regulatory agencies, after an inspection of our clinical study operations or study sites;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>failure by our&#x00a0;CROs, other third parties or us to adhere to clinical study, regulatory or legal requirements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>failure to perform in accordance with the FDA&#x2019;s good clinical practices, or GCPs, or applicable regulatory guidelines in other countries;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>delays in the testing, validation, manufacturing and delivery of sufficient quantities of our product candidates to the clinical sites;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>delays in having patients complete participation in a study or return for post<FONT CLASS="nobreak">-treatment</FONT> follow<FONT CLASS="nobreak">-up</FONT>;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>clinical study sites or patients dropping out of a study;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>delay or failure to address any patient safety concerns that arise during the course of a trial;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>unanticipated costs or increases in costs of clinical trials of our product candidates;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>occurrence of serious adverse events associated with the product candidates that are viewed to outweigh its potential benefits; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>changes in regulatory requirements and guidance that require amending or submitting new clinical protocols.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We could also encounter delays if a clinical trial is suspended or terminated by us, by the Institutional Review Board, or IRB, or the Ethics Commission of the institutions in which such trials are being conducted, by an independent Safety Review Board, or SRB, for such trial or by the FDA or other regulatory authorities. Such authorities&#x00a0;may&#x00a0;suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any inability to successfully complete pre<FONT CLASS="nobreak">-clinical</FONT> and clinical development could result in additional costs to us or impair our ability to generate revenues from product sales, regulatory and commercialization milestones and royalties. In addition, if we make manufacturing or formulation changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates to earlier versions.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">17</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Clinical study delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates.&#x00a0;In addition, any delays in completing our clinical trials will increase our costs, slow down&#x00a0;our&#x00a0;product candidates&#x2019; development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The outcome of pre<FONT CLASS="nobreak">-clinical</FONT> studies and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Further, pre<FONT CLASS="nobreak">-clinical</FONT> and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in pre<FONT CLASS="nobreak">-clinical</FONT> studies and clinical trials have nonetheless failed to obtain marketing approval.&#x00a0;If the results of our clinical studies are inconclusive or if there are safety concerns or adverse events associated with our product candidates, we may:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be delayed in obtaining marketing approval for our product candidates, if approved at all;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>obtain approval for indications or patient populations that are not as broad as intended or desired;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>obtain approval with labeling that includes significant use or distribution restrictions or safety warnings;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be required to change the way the product is administered;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be required to perform additional clinical studies to support approval or be subject to additional post<FONT CLASS="nobreak">-marketing</FONT> testing requirements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>have regulatory authorities withdraw their approval of a product or impose restrictions on its distribution in the form of a modified risk evaluation and mitigation strategy;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be sued; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>experience damage to our reputation.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, our product candidates could potentially cause other adverse events that have not yet been predicted. The inclusion of ill patients in our clinical studies may result in deaths or other adverse medical events due to other therapies or medications that such patients may be using. As described above, any of these events could prevent us from achieving or maintaining market acceptance of our product candidates and impair our ability to commercialize our products.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Obtaining and maintaining regulatory approval of our vaccine candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our vaccine candidates in other jurisdictions.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Obtaining and maintaining regulatory approval of our vaccine candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a vaccine candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion of the vaccine candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional preclinical studies or clinical trials as clinical studies conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a vaccine candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">18</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the United States have requirements for approval of vaccine candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets and/or receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our vaccine candidates will be harmed.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Modifications to our products may require new BLA approvals.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Once a particular product receives FDA approval, expanded uses or uses in new indications of our products may require additional human clinical trials and new regulatory approvals, including additional IND and BLA submissions and premarket approvals before we can begin clinical development, and/or prior to marketing and sales. If the FDA requires new approvals for a particular use or indication, we may be required to conduct additional clinical studies, which would require additional expenditures and harm our operating results. If the products are already being used for these new indications, we may also be subject to significant enforcement actions. Conducting clinical trials and obtaining approvals can be a time<FONT CLASS="nobreak">-consuming</FONT> process, and delays in obtaining required future approvals could adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our future growth.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Additional delays to the completion of clinical studies may result from modifications being made to the protocol during the clinical trial, if such modifications are warranted and/or required by the occurrences in the given trial</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Each modification to the protocol during a clinical trial has to be submitted to the FDA. This could result in the delay or halt of a clinical trial while the modification is evaluated. In addition, depending on the quantity and nature of the changes made, the FDA could take the position that the data generated by the clinical trial are not poolable because the same protocol was not used throughout the trial. This might require the enrollment of additional subjects, which could result in the extension of the clinical trial and the FDA delaying approval of a product. Any such delay could have a material adverse effect on our business and results of operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">There can be no assurance that the data generated from our clinical trials using modified protocols will be acceptable to the FDA or other regulatory authorities.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There can be no assurance that the data generated using modified protocols will be acceptable to the FDA or other regulatory authorities or that if future modifications during the trial are necessary, that any such modifications will be acceptable to the FDA or other regulatory authorities. If the FDA or other regulatory authorities believe that prior approval is required for a particular modification, they can delay or halt a clinical trial while they evaluate additional information regarding the change.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Serious injury or death resulting from a failure of our product candidates during current or future clinical trials could also result in the FDA or other regulatory authority delaying our clinical trials or denying or delaying approval of a product.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Even though an adverse event may not be the result of the failure of our product candidate, the FDA or other regulatory authority could delay or halt a clinical trial for an indefinite period of time while an adverse event is reviewed, and likely would do so in the event of multiple such events.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any delay or termination of our current or future clinical trials as a result of the risks summarized above, including delays in obtaining or maintaining required approvals from the FDA or other regulatory authorities, delays in patient enrollment, the failure of patients to continue to participate in a clinical trial, and delays or termination of clinical trials as a result of protocol modifications or adverse events during the trials, may cause an increase in costs and delays in the filing of any product submissions with the FDA or other regulatory authorities, delay the approval and commercialization of our products or result in the failure of the clinical trial, which could adversely affect our business, operating results and prospects.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">19</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We will depend on enrollment and retention of patients in our clinical trials for our product candidates. If we experience delays or difficulties enrolling or retaining patients in our clinical trials, our research and development efforts and business, financial condition, and results of operations could be materially adversely affected.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Successful and timely completion of clinical trials will require that we enroll and retain a sufficient number of patient candidates. Any clinical trials we conduct may be subject to delays for a variety of reasons, including as a result of patient enrollment taking longer than anticipated, patient withdrawal, or adverse events. These types of developments could cause us to delay the trial or halt further development.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our clinical trials will compete with other clinical trials that are in the same therapeutic areas as our product candidates, and this competition reduces the number and types of patients available to us, as some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Moreover, enrolling patients in clinical trials for diseases in which there is an approved standard of care is challenging, as patients will first receive the applicable standard of care. Many patients who respond positively to the standard of care do not enroll in clinical trials. This may limit the number of eligible patients able to enroll in our clinical trials who have the potential to benefit from our product candidates and could extend development timelines or increase costs for these programs. Patients who fail to respond positively to the standard of care treatment will be eligible for clinical trials of unapproved drug candidates. However, these prior treatment regimens may render our therapies less effective in clinical trials.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Because the number of qualified clinical investigators and clinical trial sites is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical trial sites.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Patient enrollment depends on many factors, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the size and nature of the patient population;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the severity of the disease, condition or infection under investigation;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>eligibility criteria for the trial;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the proximity of patients to clinical sites;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the design of the clinical protocol;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the ability to obtain and maintain patient consents;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>perceived risks and benefits of the product candidate under evaluation;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the ability to recruit clinical trial investigators with the appropriate competencies and experience;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the risk that patients enrolled in clinical trials will drop out of the trials before the administration of our product candidates or trial completion;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the availability of competing clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the availability of such patients during the COVID<FONT CLASS="nobreak">-19</FONT> pandemic;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the availability of new drugs approved for the indication the clinical trial is investigating; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>clinicians&#x2019; and patients&#x2019; perceptions as to the potential advantages of the drug being studied in relation to other available therapies.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These factors may make it difficult for us to enroll enough patients to complete our clinical trials in a timely and cost<FONT CLASS="nobreak">-effective</FONT> manner. Delays in the completion of any clinical trial of our product candidates will increase our costs, slow down our product candidate development and approval process, and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, some of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">20</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Conducting successful clinical studies may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Patient enrollment in clinical trials and completion of patient participation and follow<FONT CLASS="nobreak">-up</FONT> depends on many factors, including the size of the patient population; the nature of the trial protocol; the attractiveness of, or the discomforts and risks associated with, the treatments received by enrolled subjects; the availability of appropriate clinical trial investigators; support staff; and the proximity of patients to clinical sites and ability to comply with the eligibility and exclusion criteria for participation in the clinical trial and patient compliance. For example, patients may be discouraged from enrolling in our clinical trials if the trial protocol requires them to undergo extensive post<FONT CLASS="nobreak">-treatment</FONT> procedures or follow<FONT CLASS="nobreak">-up</FONT> to assess the safety and effectiveness of our products or if they determine that the treatments received under the trial protocols are not attractive or involve unacceptable risks or discomforts. Patients may also not participate in our clinical trials if they choose to participate in contemporaneous clinical trials of competitive products.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">The future results of our current or future clinical trials may not support our product candidates claims or may result in the discovery of unexpected adverse side effects.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Even if our clinical trials are completed as planned, we cannot be certain that their results will support our product candidates claims or that the FDA or foreign authorities will agree with our conclusions regarding them. Success in pre<FONT CLASS="nobreak">-clinical</FONT> studies and early clinical trials does not ensure that later clinical trials will be successful, and we cannot be sure that the later trials will replicate the results of prior trials and pre<FONT CLASS="nobreak">-clinical</FONT> studies. The clinical trial process may fail to demonstrate that our product candidates are safe and effective for the proposed indicated uses. If the FDA concludes that the clinical trials for any product for which we might seek approval, has failed to demonstrate safety and effectiveness, we would not receive FDA approval to market that product in the United States for the indications sought.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, such an outcome could cause us to abandon a product candidate and might delay development of others. Any delay or termination of our clinical trials will delay the filing of any product submissions with the FDA and, ultimately, our ability to commercialize our product candidates and generate revenues. It is also possible that patients enrolled in clinical trials will experience adverse side effects that are not currently part of our product candidate&#x2019;s profile.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Adverse events involving our products may lead the FDA or other regulatory authorities to delay or deny approval for our products or result in product recalls that could harm our reputation, business and financial results.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, if any of our product candidates receives marketing approval, the FDA could require us to adopt a Risk Evaluation and Mitigation Strategy, or REMS, and other non<FONT CLASS="nobreak">-U</FONT>.S. regulatory authorities could impose other specific obligations as a condition of approval to ensure that the benefits outweigh its risks, which may include, among other things, a medication guide outlining the risks of the product for distribution to patients, a communication plan to health care practitioners, and restrictions on how or where the product can be distributed, dispensed or used. Furthermore, if we or others later identify undesirable side effects caused by any of our product candidates, several potentially significant negative consequences could result, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>regulatory authorities may suspend or withdraw approvals of such a product candidate;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>regulatory authorities may require additional warnings or limitations of use in product labeling;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>we may be required to change the way a product candidate is distributed, dispensed, or administered or conduct additional clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>we could be sued and held liable for harm caused to patients; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our reputation may suffer.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any of these events could prevent us from achieving or maintaining market acceptance of our product candidates and could significantly harm our business, prospects, financial condition and results of operations.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">21</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Once a product receives FDA approval, the agency has the authority to require the recall of commercialized products in the event of adverse side effects, material deficiencies or defects in design or manufacture. The authority to require a recall must be based on an FDA finding that there is a reasonable probability that the product would cause serious injury or death. Manufacturers may, under their own initiative, recall a product if any material deficiency in a product is found. A government<FONT CLASS="nobreak">-mandated</FONT> or voluntary recall by us or one of our distributors could occur as a result of adverse side effects, impurities or other product contamination, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our financial condition and results of operations. The FDA requires that certain classifications of recalls be reported to FDA within ten working days after the recall is initiated. Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA. We may initiate voluntary recalls involving our products in the future. A future recall announcement could harm our reputation with customers and negatively affect our sales. In addition, the FDA and/or other regulatory agencies could take enforcement action for failing to report the recalls when they were conducted.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Even if we obtain regulatory approval of our vaccine candidates, the products may not gain market acceptance among regulators, advisory boards, physicians, patients, third-party payors and others in the medical community.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Even if any of our vaccine candidates receive marketing approval, they may fail to receive recommendations for use by regulators or advisory boards that recommend vaccines, or gain market acceptance by physicians, patients, third<FONT CLASS="nobreak">-party</FONT> payors and others in the medical community. If such vaccine candidates do not achieve an adequate level of acceptance, we may not generate significant product revenue and may not become profitable. The degree of market acceptance of any vaccine candidate, if approved for commercial sale, will depend on a number of factors, including but not limited to:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>receiving CDC and ACIP recommendations for use, as well as recommendations of comparable foreign regulatory and advisory bodies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>prevalence and severity of the disease targets for which our vaccine candidates are approved;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>physicians, hospitals, third<FONT CLASS="nobreak">-party</FONT> payors and patients considering our vaccine candidates as safe and effective;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the potential and perceived advantages of our vaccine candidates over existing vaccines, including with respect to spectrum coverage or immunogenicity;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the prevalence and severity of any side effects;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>product labeling or product insert requirements of the FDA or comparable foreign regulatory and advisory bodies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>limitations or warnings contained in the labeling approved by the FDA or comparable foreign regulatory and advisory bodies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the timing of market introduction of our vaccine candidates as well as competitive products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the cost of treatment in relation to alternative treatments;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the availability of coverage and adequate reimbursement and pricing by third<FONT CLASS="nobreak">-party</FONT> payors, including government authorities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the willingness of patients to pay&#x00a0;out<FONT CLASS="nobreak">-of-pocket</FONT>&#x00a0;in the absence of coverage and adequate reimbursement by third<FONT CLASS="nobreak">-party</FONT> payors, including government authorities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>relative convenience and ease of administration, including as compared to competitive vaccines and alternative treatments; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the effectiveness of our sales and marketing efforts.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">22</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the United States, the CDC and ACIP develop vaccine recommendations for both children and adults, as do similar agencies around the world. To develop its recommendations, ACIP forms working groups that gather, analyze and prepare scientific information. The ACIP also considers many of the factors above, as well as myriad additional factors such as the value of vaccination for the target population regarding the outcomes, health economic data and implementation issues. ACIP recommendations are also made within categories, such as in an age group or a specified risk group. For example, the ACIP may determine that a preferred recommendation in a smaller child population may be more economical than recommending vaccinations for a larger adult population, which could adversely impact our market opportunity.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">New pediatric vaccines that receive an ACIP preferred recommendation are almost universally adopted, and adult vaccines that receive a preferred recommendations are widely adopted. For example, in 2014, the ACIP voted to recommend Prevnar 13 for routine use to help protect adults ages 65 years and older against pneumococcal disease, which caused Prevnar 13 to become the standard of care along with continued use of Pneumovax 23. ACIP can also modify its preferred recommendation. For instance, in June 2019, the ACIP voted to revise the pneumococcal vaccination guidelines and recommend Prevnar 13 for adults 65 and older based on the shared clinical decision making of the provider and patient, rather than a preferred use recommendation, which means the decision to vaccinate should be made at the individual level between health care providers and their patients. Pfizer recently noted that this revised recommendation is expected to have a negative effect on Prevnar 13 revenue for future periods.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If our vaccine candidates are approved but fail to receive CDC and ACIP recommendations, or recommendations of other comparable foreign regulatory and advisory bodies, or achieve market acceptance among physicians, healthcare providers, patients, third<FONT CLASS="nobreak">-party</FONT> payors or others in the medical community, we will not be able to generate significant revenue. Even if our products achieve market acceptance, we may not be able to maintain that market acceptance over time if new products or technologies are introduced that are more favorably received than our products, are more cost effective or render our products obsolete.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Even if we are able to commercialize our product candidates, such products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which would harm our business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drugs vary widely from country to country. In the United States, new and future legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product<FONT CLASS="nobreak">-licensing</FONT> approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial marketing approval is granted. As a result, we might obtain marketing approval for a drug in a particular country but then be subject to price regulations that delay its commercial launch, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the drug in that country. Adverse pricing limitations may hinder our ability to commercialize and generate revenue from our product candidates, even if our product candidates obtain marketing approval.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our ability to commercialize our current and any future product candidates successfully also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health programs, private health insurers, integrated delivery networks and other third<FONT CLASS="nobreak">-party</FONT> payors. Third<FONT CLASS="nobreak">-party</FONT> payors decide which medications they will pay for and establish reimbursement levels. A significant trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third<FONT CLASS="nobreak">-party</FONT> payors have attempted to control costs by limiting coverage and the amount of payment for particular medications. Increasingly, third<FONT CLASS="nobreak">-party</FONT> payors are requiring that drug companies provide predetermined discounts from list prices and are challenging the prices charged for medical products. Coverage and reimbursement may not be available for any product that we commercialize and, if reimbursement is available, the level of reimbursement may not be sufficient for commercial success. Coverage and reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. If coverage and reimbursement is not available or is available only to limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">23</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There may be significant delays in obtaining coverage and adequate reimbursement for newly approved products, and coverage may be more limited than the purposes for which the product is approved by the FDA or similar regulatory authorities outside the United States. Moreover, eligibility for coverage and reimbursement does not imply that any product will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Coverage and reimbursement rates may vary according to the use of the drug and the medical circumstances under which it is used may be based on reimbursement levels already set for lower cost products or procedures or may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Commercial third<FONT CLASS="nobreak">-party</FONT> payors often rely upon Medicare coverage policies and payment limitations in setting their own reimbursement policies. Our inability to promptly obtain coverage and profitable payment rates from both government<FONT CLASS="nobreak">-funded</FONT> programs and private payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize our approved products and our overall financial condition.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Any product candidate for which we obtain marketing approval could be subject to marketing restrictions or withdrawal from the market and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our products.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any product candidate for which we obtain marketing approval, along with the manufacturing processes and facilities, post<FONT CLASS="nobreak">-approval</FONT> clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA and other regulatory authorities. These requirements include submissions of promotional materials and safety and other post<FONT CLASS="nobreak">-marketing</FONT> information and reports, registration and listing requirements, current Good Manufacturing Practice (&#x201c;cGMP&#x201d;) requirements for product facilities, quality assurance and corresponding maintenance of records and documents and requirements regarding the distribution of samples to physicians and related recordkeeping. Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval or contain requirements for costly post<FONT CLASS="nobreak">-marketing</FONT> testing and surveillance to monitor the safety or efficacy of the medicine. &#x00a0;The FDA closely regulates the post<FONT CLASS="nobreak">-approval</FONT> marketing and promotion of drugs to ensure that they are marketed only for the approved indications and in accordance with the provisions of the approved labeling. However, companies may share truthful and not misleading information that is otherwise consistent with the product&#x2019;s FDA approved labeling. The FDA imposes stringent restrictions on manufacturers&#x2019; communications regarding off<FONT CLASS="nobreak">-label</FONT> use and if we do not comply with these restrictions, we may be subject to enforcement actions.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, later discovery of previously unknown problems with our products, manufacturers or manufacturing processes and facilities or failure to comply with regulatory requirements, may result in, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>restrictions on such products, manufacturers or manufacturing processes or facilities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>restrictions on the labeling, marketing, distribution or use of a product;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>requirements to conduct post<FONT CLASS="nobreak">-approval</FONT> clinical trials, other studies or other post<FONT CLASS="nobreak">-approval</FONT> commitments;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>warning or untitled letters;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>withdrawal or recall of the products from the market;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>refusal to approve pending applications or supplements to approved applications that we submit;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>fines, restitution or disgorgement of profits or revenue;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>suspension or withdrawal of marketing approvals;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>refusal to permit the import or export of our products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>product seizure; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>injunctions or the imposition of civil or criminal penalties.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">24</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Failure to obtain regulatory approvals in foreign jurisdictions will prevent us from marketing our products internationally.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We intend to market future products in international markets. In order to market our future products in regions such as the European Economic Area, or EEA, Asia Pacific, or APAC, and many other foreign jurisdictions, we must obtain separate regulatory approvals.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For example, in the EEA, medicinal products can only be commercialized after obtaining a Marketing Authorization, or MA. Before granting the MA, the European Medicines Agency or the competent authorities of the member states of the EEA make an assessment of the risk<FONT CLASS="nobreak">-benefit</FONT> balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy. In Japan, the Pharmaceuticals and Medical Devices Agency, or the PMDA, of the Ministry of Health Labour and Welfare, or MHLW, must approve an application under the Pharmaceutical Affairs Act before a new drug product may be marketed in Japan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have had limited interactions with foreign regulatory authorities. The approval procedures vary among countries and can involve additional clinical testing, and the time required to obtain approval may differ from that required to obtain FDA approval. Moreover, clinical studies conducted in one country may not be accepted by regulatory authorities in other countries. Approval by the FDA does not ensure approval by regulatory authorities in other countries, and approval by one or more foreign regulatory authorities does not ensure approval by regulatory authorities in other foreign countries or by the FDA. However, a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory process in others. The foreign regulatory approval process may include all of the risks associated with obtaining FDA approval. We may not obtain foreign regulatory approvals on a timely basis, if at all. We may not be able to file for regulatory approvals and even if we file we may not receive necessary approvals to commercialize our products in any market.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If our products do not receive favorable third-party reimbursement, or if new restrictive legislation is adopted, market acceptance of our products may be limited and we may not generate significant revenues.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our ability to commercialize our products will depend in part on the extent to which appropriate reimbursement levels for the cost of our proposed formulations and products and related treatments are obtained by governmental authorities, private health insurers and other organizations, such as Health Maintenance Organizations, or HMOs. Reimbursement from third parties depends greatly on our ability to present data which demonstrate positive outcomes and reduced utilization of other products or services as well as cost data which show that treatment costs using the new product are equal to or less than what is currently covered for other products. If our products do not receive favorable third<FONT CLASS="nobreak">-party</FONT> reimbursement and patients are unwilling or unable to pay for our products out<FONT CLASS="nobreak">-of-pocket</FONT>, it could limit our revenues and harm our business.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The continuing efforts of government and insurance companies, health maintenance organizations and other payers of healthcare costs to contain or reduce costs of health care may affect our future revenues and profitability, and the future revenues and profitability of our potential customers, suppliers and collaborative partners and the availability of capital. For example, in certain foreign markets, pricing or profitability of prescription pharmaceuticals is subject to government control. In the United States, recent federal and state government initiatives have been directed at lowering the total cost of health care. In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act, a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. Federal and state legislatures will likely continue to focus on health care reform, controlling the cost of prescription pharmaceuticals and on the reform of the Medicare and Medicaid systems. While we cannot predict whether any such legislative or regulatory proposals will be adopted, the announcement or adoption of such proposals could materially harm our business, financial condition and results of operations.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">25</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Related to our Business and Industry</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may be adversely affected by the ongoing coronavirus pandemic.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The outbreak of the novel coronavirus COVID<FONT CLASS="nobreak">-19</FONT> (&#x201c;COVID<FONT CLASS="nobreak">-19</FONT>&#x201d;) has evolved into a global pandemic. The coronavirus has spread to many regions of the world. The extent to which the coronavirus impacts our business and operating results will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning the coronavirus and the actions to contain the coronavirus or treat its impact, among others.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As a result of the continuing spread of COVID<FONT CLASS="nobreak">-19</FONT>, our business operations could be delayed or interrupted. Currently, we operate virtually, i.e., our program activities are and will continue to be carried out, on our behalf, by competent contract research organizations (CROs) with expertise in pre<FONT CLASS="nobreak">-clinical</FONT>, clinical and/or chemistry and manufacturing areas. Due to COVID<FONT CLASS="nobreak">-19</FONT>, our planned project timelines may be delayed due to reduced availability of human resources or critical supplies needed to carry out such plans. Due to shelter<FONT CLASS="nobreak">-in-place</FONT>/stay<FONT CLASS="nobreak">-at-home</FONT>&#x00a0;orders and other government restrictions, our employees conducting research and development or manufacturing activities at external vendor locations across the globe may not be able to access their laboratory or manufacturing space which may result in our core activities being significantly limited or curtailed, possibly for an extended period of time.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Moreover, our clinical trials may be affected by the COVID<FONT CLASS="nobreak">-19</FONT> pandemic. Site initiation, participant recruitment and enrollment, participant dosing, availability and distribution of clinical trial materials, study monitoring and data analysis may be paused or delayed due to changes in hospital or university policies, federal, state or local regulations, prioritization of hospital resources toward pandemic efforts, or other reasons related to the COVID<FONT CLASS="nobreak">-19</FONT> pandemic. If the coronavirus continues to spread, some participants and clinical investigators may not be able to execute clinical trial protocols per the expected timelines. The new mutations of the virus may also make it harder for us to predict the exact impact (if any) on the progression of COVID<FONT CLASS="nobreak">-19</FONT> on our development programs. For example, quarantines or other travel limitations (whether voluntary or required) may impede participant movement, affect sponsor access to study sites, or interrupt healthcare services, and we may be unable to conduct our clinical trials. Further, if the spread of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic continues and our operations are adversely impacted, we risk a delay, default and/or nonperformance under existing agreements which may increase our costs. These cost increases may not be fully recoverable or adequately covered by insurance.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Infections and deaths related to the pandemic may disrupt the United&#x00a0;States&#x2019; healthcare and healthcare regulatory systems. Such disruptions could divert healthcare resources away from, or materially delay FDA review or review by other regulatory agencies and/or approval with respect to, our clinical trials. It is unknown how long these disruptions could continue, were they to occur. Any elongation or&#x00a0;de<FONT CLASS="nobreak">-prioritization</FONT>&#x00a0;of our clinical trials or delay in regulatory review resulting from such disruptions could materially affect the development and study of our product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The spread of the coronavirus, which has caused a broad impact globally, including restrictions on travel and quarantine policies put into place by businesses and governments, may have a material economic effect on our business. While the potential economic impact brought by and the duration of the pandemic may be difficult to assess or predict, it has already caused, and is likely to result in further, significant disruption of global financial markets, which may reduce our ability to access capital either at all or on favorable terms. In addition, a recession, depression or other sustained adverse market event resulting from the spread of the coronavirus could materially and adversely affect our business and the value of our common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The ultimate impact of the current pandemic, or any other health epidemic, is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole. However, these effects could have a material impact on our operations, and we will continue to monitor the situation closely.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">26</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our reliance on third parties heightens the risks faced by our business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We rely on suppliers, vendors and partners for certain key aspects of our business, including support for information technology systems and certain human resource functions. We do not control these partners, but we depend on them in ways that may be significant to us. If these parties fail to meet our expectations or fulfill their obligations to us, we may fail to receive the expected benefits. In addition, if any of these third parties fails to comply with applicable laws and regulations in the course of its performance of services for us, there is a risk that we may be held responsible for such violations as well. This risk is particularly serious in emerging markets, where corruption is often prevalent and where many of the third parties on which we rely do not have internal compliance resources comparable to our own. Any such failures by third parties, in emerging markets or elsewhere, could adversely affect our business, reputation, financial condition or results of operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We rely on, and intend to continue to rely on third parties to conduct our pre-clinical testing, research and clinical trials, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have been relying on third parties for our preclinical studies, and we expect to continue to rely on third parties, such as CROs, contract manufacturers of clinical supplies, clinical data management organizations, medical institutions and clinical investigators, to conduct our clinical trials and to conduct some aspects of our research and pre<FONT CLASS="nobreak">-clinical</FONT> testing. These third parties may terminate their engagements with us at any time. If these third parties do not successfully carry out their duties, meet expected deadlines or conduct our studies in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for our product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our product candidates. Furthermore, these third parties may also have relationships with other entities, some of which may be our competitors. If we are required to enter into alternative arrangements, it could delay our product development activities.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our reliance on third parties for research and development activities will reduce our control over these activities but will not relieve us of our responsibilities. For example, we will remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA and other international regulatory authorities require us to comply with GCP standards for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. We also are required to register ongoing clinical trials and post the results of completed clinical trials on a government<FONT CLASS="nobreak">-sponsored</FONT> database, available at <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.clinicaltrials.gov</FONT>, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Upon commercialization of our products, we may be dependent on third parties to market, distribute and sell our products.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our ability to receive revenues may be dependent upon the sales and marketing efforts of any future co<FONT CLASS="nobreak">-marketing</FONT> partners and third<FONT CLASS="nobreak">-party</FONT> distributors. At this time, we have not entered into an agreement with any commercialization partner and only plan to do so prior to commercialization. If we fail to reach an agreement with any commercialization partner, or upon reaching such an agreement that partner fails to sell a large volume of our products, it may have a negative impact on our business, financial condition and results of operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We have no experience manufacturing product candidates on a clinical or commercial scale and will be dependent on third parties for the manufacture of our product candidates. If we experience problems with any of these third parties, they could delay clinical development or marketing approval of our product candidates or our ability to sell any approved products.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We do not have any manufacturing facilities. We expect to rely on third<FONT CLASS="nobreak">-party</FONT> manufacturers for the manufacture of our product candidates for clinical trials and for commercial supply of any product candidate for which we obtain marketing approval.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">27</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may be unable to establish agreements with third<FONT CLASS="nobreak">-party</FONT> manufacturers for clinical or commercial supply on terms favorable to us, or at all. Even if we are able to establish agreements with third<FONT CLASS="nobreak">-party</FONT> manufacturers, reliance on third<FONT CLASS="nobreak">-party</FONT> manufacturers entails additional risks, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reliance on the third party for regulatory compliance and quality assurance;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the possible breach of the manufacturing agreement by the third party, including the inability to supply sufficient quantities or to meet quality standards or timelines; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Third<FONT CLASS="nobreak">-party</FONT> manufacturers may not be able to comply with U.S. cGMPs or similar regulatory requirements outside the United States. Our failure, or the failure of our third<FONT CLASS="nobreak">-party</FONT> manufacturers, to comply with cGMPs or other applicable regulations, even if such failures do not relate specifically to our product candidates or approved products, could result in sanctions being imposed on us or the manufacturers, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates, operating restrictions and criminal prosecutions, any of which could adversely affect supplies of our product candidates and harm our business and results of operations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any product that we develop may compete with other product candidates and products for access to these manufacturing facilities. There are a limited number of manufacturers that operate under cGMPs and that might be capable of manufacturing for us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any performance failure on the part of our manufacturers, including a failure that may not relate specifically to our product candidates or approved products, could delay clinical development or marketing approval or adversely impact our ability to generate commercial sales. If our contract manufacturers cannot perform as agreed, we may be required to replace that manufacturer.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our anticipated future dependence upon others for the manufacture of our current and future product candidates or products may adversely affect our future profit margins and our ability to commercialize any product candidates that receive marketing approval on a timely and competitive basis.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Furthermore, we expect to rely on third parties to release, label, store and distribute drug supplies for our clinical trials. Any performance failure on the part of these third parties, including a failure that may not relate specifically to our product candidates, could delay or otherwise adversely impact clinical development or marketing approval of our product candidates or commercialization of our drug, producing losses and depriving us of potential revenue.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Moreover, our manufacturers and suppliers may experience difficulties related to their overall businesses and financial stability, which could result in delays or interruptions of supply of our product candidates.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Manufacturing&#x00a0;risks may adversely affect our ability to manufacture our product and could reduce our gross margin and profitability.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our business strategy depends on our ability to manufacture our product candidates s in sufficient quantities and on a timely basis so as to meet our obligations with respect to our clinical trials and upon marketing approval, to meet consumer demand, while adhering to product quality standards, complying with regulatory requirements and managing manufacturing costs. We are subject to numerous risks relating to our manufacturing capabilities, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>quality or reliability defects in product components that we source from third<FONT CLASS="nobreak">-party</FONT> suppliers, including&#x00a0;manufacturing&#x00a0;compliance with federal and state regulations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our inability to secure product components in a timely manner, in sufficient quantities or on commercially reasonable terms;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our failure to increase production of products to meet demand</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our inability to modify production lines to enable us to efficiently produce future products or implement changes in current products in response to regulatory requirements; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Potential damage to or destruction of our&#x00a0;manufacturing&#x00a0;equipment or&#x00a0;manufacturing&#x00a0;facility.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">28</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If demand for our product candidates increases in the future, we will have to invest additional resources to purchase components, hire and train employees, and enhance our&#x00a0;manufacturing&#x00a0;processes. If we fail to increase our production capacity efficiently, our sales may not increase in line with our forecasts and our operating margins could fluctuate or decline. In addition, although we expect some of our product candidates in development to share product features and components,&#x00a0;manufacturing&#x00a0;of some of our product candidates may require the modification of our production lines, the hiring of specialized employees, the identification of new suppliers for specific components, or the development of new&#x00a0;manufacturing&#x00a0;technologies. It may not be possible for us to manufacture these product candidates at a cost or in quantities sufficient to make these product candidates commercially viable. Any of these factors may affect our ability to manufacture our product and could reduce our gross margin and profitability.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">The Company maintains single supply relationships for certain key components, and its business and operating results could be harmed if supply is restricted or ends or the price of raw materials used in its&#x00a0;manufacturing&#x00a0;process increases.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company is dependent on sole suppliers or a limited number of suppliers for certain components that are integral to its finished products. If these or other suppliers encounter financial, operating or other difficulties or if the Company&#x2019;s relationship with them changes, it may be unable to quickly establish or qualify replacement sources of supply and could face production interruptions, delays and inefficiencies. In addition, technology changes by the Company&#x2019;s vendors could disrupt access to required&#x00a0;manufacturing&#x00a0;capacity or require expensive, time consuming development efforts to adapt and integrate new equipment or processes. The Company&#x2019;s growth may exceed the capacity of one or more of these suppliers to produce the needed equipment and materials in sufficient quantities to support its growth. Any one of these factors could harm the Company&#x2019;s business and growth prospects.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may not be able to manage our&#x00a0;manufacturing&#x00a0;and supply chain effectively, which would harm our results of operations.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We must accurately forecast our clinical trial obligations, and, in the future, market demand, for our product candidates in order to have adequate product inventory available to fulfil our timeline and customer orders timely. Our forecasts will be based on multiple assumptions that may cause our estimates to be inaccurate, and thus affect our ability to ensure adequate manufacturing capability to satisfy product candidate needs or market demand. Any material delay in our ability to obtain timely product inventories from our manufacturing facility and our ingredient suppliers could prevent us from satisfying increased consumer demand for our products, resulting in material harm to our clinical trials, brand and business. In addition, we will need to continuously monitor our inventory and product mix against forecasted demand to avoid having inadequate product inventory or having too much product inventory on hand. If we are unable to manage our supply chain effectively, our operating costs may increase materially.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may in the future have conflicts with our current or future partners or third party providers that could delay or prevent the development or commercialization of our current and future product candidates.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may in the future have conflicts with our current or future partners or third party providers, such as conflicts concerning the interpretation of pre<FONT CLASS="nobreak">-clinical</FONT> or clinical data, the achievement of milestones, the interpretation of contractual obligations, payments for services, development obligations or the ownership of intellectual property developed during our collaboration. If any conflicts arise with any of our partners, such partner may act in a manner that is adverse to our best interests. Any such disagreement could result in one or more of the following, each of which could delay or prevent the development or commercialization of our current and future product candidates, and in turn prevent us from generating revenues:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>unwillingness on the part of a partner to pay us milestone payments or royalties we believe are due to us under a collaboration;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>uncertainty regarding ownership of intellectual property rights arising from our collaborative activities, which could prevent us from entering into additional collaborations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>unwillingness by the partner to cooperate in the development or manufacture of the product, including providing us with product data or materials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>unwillingness on the part of a partner to keep us informed regarding the progress of its development and commercialization activities or to permit public disclosure of the results of those activities;</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">29</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>initiating of litigation or alternative dispute resolution options by either party to resolve the dispute; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>attempts by either party to terminate the agreement.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our product candidates may face competition sooner than anticipated from biosimilar products.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Even if we are successful in achieving regulatory approval to commercialize a product candidate faster than our competitors, our product candidates may face competition from biosimilar products. In the United States, our product candidates are regulated by the FDA as biologic products and we intend to seek approval for these product candidates pursuant to the BLA pathway. The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an abbreviated pathway for the approval of biosimilar and interchangeable biologic products. The abbreviated regulatory pathway establishes legal authority for the FDA to review and approve biosimilar biologics, including the possible designation of a biosimilar as &#x201c;interchangeable&#x201d; based on its similarity to an existing brand product. Under the BPCIA, an application for a biosimilar product cannot be approved by the FDA until 12 years after the original branded product was approved under a BLA. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There is a risk that any exclusivity we may be afforded if any of our product candidates are approved as a biologic product under a BLA could be shortened due to congressional action, the results of recent litigation, or otherwise, or that the FDA will not consider our product candidates to be reference products for competing products, potentially creating the opportunity for generic or biosimilar competition sooner than anticipated. Moreover, the extent to which a biosimilar product, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non<FONT CLASS="nobreak">-biologic</FONT> products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing. In addition, a competitor could decide to forego the biosimilar approval path and submit a full BLA after completing its own preclinical studies and clinical trials. In such cases, any exclusivity to which we may be eligible under the BPCIA would not prevent the competitor from marketing its product as soon as it is approved.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, critics of the 12<FONT CLASS="nobreak">-year</FONT> exclusivity period in the biosimilar pathway law will likely continue to seek to shorten the data exclusivity period and/or to encourage the FDA to interpret narrowly the law&#x2019;s provisions regarding which new products receive data exclusivity. In December 2019, the US agreed to remove from the United States<FONT CLASS="nobreak">-Mexico-Canada</FONT> Agreement a requirement for at least 10 years of data exclusivity for biologic products. Also, the FDA is considering whether subsequent changes to a licensed biologic would be protected by the remainder of the reference product&#x2019;s original 12<FONT CLASS="nobreak">-year</FONT> exclusivity period (a concept known in the generic drug context as &#x201c;umbrella exclusivity&#x201d;). If the FDA were to decide that umbrella exclusivity does not apply to biological reference products or were to make other changes to the exclusivity period, this could expose us to biosimilar competition at an earlier time. There also have been, and may continue to be, legislative and regulatory efforts to promote competition through policies enabling easier generic and biosimilar approval and commercialization, including efforts to lower standards for demonstrating biosimilarity or interchangeability, limit patents that may be litigated and/or patent settlements and implement preferential reimbursement policies for biosimilars.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If competitors are able to obtain marketing approval for biosimilars referencing our product candidates, if approved, such products may become subject to competition from such biosimilars, with the attendant competitive pressure and potential adverse consequences. Such competitive products may be able to immediately compete with us in each indication for which our product candidates may have received approval.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our primary competitors have significantly greater resources and experience than we do, which may make it difficult for us to successfully develop our vaccine candidates, or may result in others discovering, developing or commercializing products before or more successfully than us.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The vaccine market is intensely competitive and is dominated by a small number of multinational, globally established pharmaceutical corporations with significant resources; Pfizer, Merck, GlaxoSmithKline and Sanofi together control approximately 75% of the global vaccine market. We may also face competition from many different sources, including pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions. For example, Sanofi and SK Chemicals have partnered to develop a PCV, and Affinivax and Astellas have partnered to develop an affinity<FONT CLASS="nobreak">-bound</FONT> pneumococcal vaccine.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">30</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Vaccine candidates that we successfully develop and commercialize may compete with existing vaccines and new vaccines that may become available in the future. Many of our competitors have substantially greater financial, lobbying, technical, human and other resources than we do and may be better equipped to develop, manufacture and market technologically superior vaccines, including the potential that our competitors may develop chemical processes or utilize novel technologies for developing vaccines that may be superior to those we employ. In addition, many of these competitors have significantly greater experience than we have in undertaking preclinical testing and clinical trials of new products and in obtaining regulatory approvals, including for many vaccine franchises. Accordingly, our competitors may succeed in obtaining FDA approval or a preferred recommendation for their products. For example, Prevnar 13 obtained FDA approval for the prevention of invasive pneumococcal disease, or IPD, in infants based on non<FONT CLASS="nobreak">-inferior</FONT> IgG antibody responses relative to Prevnar, using the surrogate immune endpoints established by the prior Prevnar field efficacy study. Pfizer is currently implementing a similar approach to development of its 20<FONT CLASS="nobreak">-valent</FONT> PCV vaccine candidate, and may have a more efficient path to regulatory approval given Pfizer&#x2019;s and the FDA&#x2019;s previous experience with Prevnar 13. For more information, see the section entitled &#x201c;Business &#x2014; Competition.&#x201d;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Many of our competitors have established distribution channels for the commercialization of their vaccine products, whereas we have no such established channels or capabilities. In addition, many competitors have greater name recognition, more extensive collaborative relationships or the ability to leverage a broader vaccine portfolio. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize vaccines that are safer, more effective, more convenient, less expensive or with a more favorable label than any vaccine candidates that we may develop.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As a result of these factors, our competitors may obtain regulatory approval of their products before we are able to, which may limit our ability to develop or commercialize our vaccine candidates. Our competitors may also develop vaccines that are safer, more effective, more widely accepted or less expensive than ours, and may also be more successful than we are in manufacturing and marketing their products. These advantages could render our vaccine candidates obsolete or non<FONT CLASS="nobreak">-competitive</FONT> before we can recover the costs of such vaccine candidates&#x2019; development and commercialization.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and early<FONT CLASS="nobreak">-stage</FONT> companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and subject enrollment for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We face an inherent risk of product liability exposure related to the testing of our current product candidates or future product candidates in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop. Product liability claims may be brought against us by subjects enrolled in our clinical trials, patients, healthcare providers or others using, administering or selling our product. If we cannot successfully defend ourselves against claims that our product candidates or product caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>decreased demand for any product candidates or products that we may develop;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>termination of clinical trial sites or entire clinical trial programs;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>injury to our reputation and significant negative media attention;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>withdrawal of clinical trial participants;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>significant costs to defend the related litigation;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>substantial monetary awards to trial subjects or patients;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>loss of revenue;</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">31</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>diversion of management and scientific resources from our business operations; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the inability to commercialize any products that we may develop.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to engaging in future clinical trials, we intend to obtain product liability insurance coverage at a level that we believe is customary for similarly situated companies and adequate to provide us with insurance coverage for foreseeable risks; however, we may be unable to obtain such coverage at a reasonable cost, if at all. If we are able to obtain product liability insurance, we may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise and such insurance may not be adequate to cover all liabilities that we may incur. Furthermore, we intend to expand our insurance coverage for products to include the sale of commercial products if we obtain regulatory approval for our product candidates in development, but we may be unable to obtain commercially reasonable product liability insurance for any products that receive regulatory approval. Large judgments have been awarded in class&#x00a0;action lawsuits based on drugs that had unanticipated side effects. A successful product liability claim or series of claims brought against us, particularly if judgments exceed our insurance coverage, could decrease our cash and adversely affect our business.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may engage in acquisitions that could disrupt our business, cause dilution to our stockholders or reduce our financial resources.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the future, we may enter into transactions to acquire other businesses, products or technologies. If we do identify suitable candidates, we may not be able to make such acquisitions on favorable terms, or at all. Any acquisitions we make may fail to strengthen our competitive position and these transactions may be viewed negatively by customers or investors. We may decide to incur debt in connection with an acquisition or issue our common stock or other equity securities to the stockholders of the acquired company, which would reduce the percentage ownership of our existing stockholders. We could incur losses resulting from undiscovered liabilities of the acquired business that are not covered by the indemnification we may obtain from the seller. In addition, we may not be able to successfully integrate the acquired personnel, technologies and operations into our existing business in an effective, timely and non<FONT CLASS="nobreak">-disruptive</FONT> manner. Acquisitions may also divert management attention from day<FONT CLASS="nobreak">-to-day</FONT> responsibilities, increase our expenses and reduce our cash available for operations and other uses. We cannot predict the number, timing or size of future acquisitions or the effect that any such transactions might have on our operating results.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Security threats to our information technology infrastructure and/or our physical buildings could expose us to liability and damage our reputation and business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">It is essential to our business strategy that our technology and network infrastructure and our physical buildings remain secure and are perceived by our customers and corporate partners to be secure. Despite security measures, however, any network infrastructure may be vulnerable to cyber<FONT CLASS="nobreak">-attacks</FONT> by hackers and other security threats. We may face cyber<FONT CLASS="nobreak">-attacks</FONT> that attempt to penetrate our network security, sabotage or otherwise disable our research, products and services, misappropriate our or our customers&#x2019; and partners&#x2019; proprietary information, which may include personally identifiable information, or cause interruptions of our internal systems and services. Despite security measures, we also cannot guarantee security of our physical buildings. Physical building penetration or any cyber<FONT CLASS="nobreak">-attacks</FONT> could negatively affect our reputation, damage our network infrastructure and our ability to deploy our products and services, harm our relationship with customers and partners that are affected, and expose us to financial liability.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, there are a number of state, federal and international laws protecting the privacy and security of health information and personal data. For example, the Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes limitations on the use and disclosure of an individual&#x2019;s healthcare information by healthcare providers, healthcare clearinghouses, and health insurance plans, or, collectively, covered entities, and also grants individuals rights with respect to their health information. HIPAA also imposes compliance obligations and corresponding penalties&#x00a0;for&#x00a0;non<FONT CLASS="nobreak">-compliance</FONT> on individuals and entities that provide services to healthcare providers and other covered entities. As part of the American Recovery and Reinvestment Act of 2009, or ARRA, the privacy and security provisions of HIPAA were amended. ARRA also made significant increases in the penalties for improper use or disclosure of an individual&#x2019;s health information under HIPAA and extended enforcement authority to state attorneys general. As amended by ARRA and subsequently by the final omnibus rule adopted in 2013, HIPAA </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">32</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">also imposes notification requirements on covered entities in the event that certain health information has been inappropriately accessed or disclosed, notification requirements to individuals, federal regulators, and in some cases, notification to local and national media. Notification is not required under HIPAA if the health information that is improperly used or disclosed is deemed secured in accordance with encryption or other standards developed by the U.S. Department of Health and Human Services. Most states have laws requiring notification of affected individuals and/or state regulators in the event of a breach of personal information, which is a broader class of information than the health information protected by HIPAA. Many state laws impose significant data security requirements, such as encryption or mandatory contractual terms, to ensure ongoing protection of personal information. Activities outside of the U.S. implicate local and national data protection standards, impose additional compliance requirements and generate additional risks of enforcement&#x00a0;for&#x00a0;non<FONT CLASS="nobreak">-compliance</FONT>.&#x00a0;We&#x00a0;may be required to expend significant capital and other resources to ensure ongoing compliance with applicable privacy and data security laws, to protect against security breaches and hackers or to alleviate problems caused by such breaches.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We will need to grow the size of our organization in the future, and we may experience difficulties in managing this growth.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of August<FONT CLASS="nobreak"> </FONT>1, 2021, we had 2 full<FONT CLASS="nobreak">-time</FONT> and 7 subcontracted employees. We will need to grow the size of our organization in order to support our continued development and potential commercialization of our product candidates. As our development and commercialization plans and strategies continue to develop, our need for additional managerial, operational, manufacturing, sales, marketing, financial and other resources may increase. Our management, personnel and systems currently in place may not be adequate to support this future growth. Future growth would impose significant added responsibilities on members of management, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>managing our clinical trials effectively;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>identifying, recruiting, maintaining, motivating and integrating additional employees;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>managing our internal development efforts effectively while complying with our contractual obligations to licensors, licensees, contractors and other third parties;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>improving our managerial, development, operational, information technology, and finance systems; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>expanding our facilities.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If our operations expand, we will also need to manage additional relationships with various strategic partners, suppliers and other third parties. Our future financial performance and our ability to commercialize our product candidates and to compete effectively will depend, in part, on our ability to manage any future growth effectively, as well as our ability to develop a sales and marketing force when appropriate. To that end, we must be able to manage our development efforts and pre<FONT CLASS="nobreak">-clinical</FONT> studies and clinical trials effectively and hire, train and integrate additional management, research and development, manufacturing, administrative and sales and marketing personnel. The failure to accomplish any of these tasks could prevent us from successfully growing our company.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our future success depends on our ability to retain our executive officers and to attract, retain and motivate qualified personnel.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are highly dependent upon our personnel, including Joseph Hernandez, our Chief Executive Officer and members of our board of directors. The loss of Mr.<FONT CLASS="nobreak"> </FONT>Hernandez&#x2019;s services could impede the achievement of our research, development and commercialization objectives. We have not obtained, do not own, nor are we the beneficiary of, key<FONT CLASS="nobreak">-person</FONT>&#x00a0;life insurance. Our future growth and success depend on our ability to recruit, retain, manage and motivate our employees. The loss of any member of our senior management team or the inability to hire or retain experienced management personnel could compromise our ability to execute our business plan and harm our operating results. Because of the specialized scientific and managerial nature of our business, we rely heavily on our ability to attract and retain qualified scientific, technical and managerial personnel. The competition for qualified personnel in the biotechnology field is intense and as a result, we may be unable to continue to attract and retain qualified personnel necessary for the development of our business.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">33</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our Chief Executive Officer, Joseph Hernandez, also holds certain management positions and directorships of other companies and may allocate his time to such other businesses, thereby causing conflicts of interest in his determination as to how much time to devote to our affairs. This could have a negative impact on our ability to implement our plan of operation.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Chief Executive Officer, Joseph Hernandez, also holds certain management positions and directorships of other companies and may allocate his time to such other businesses, thereby causing conflicts of interest in his determination as to how much time to devote to our affairs. This could have a negative impact on our ability to implement our plan of operation.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Inadequate funding for the FDA, the </FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">SEC</FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;"> and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including beginning on December&#x00a0;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, upon completion of this offering and in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may be adversely affected by natural disasters, pandemics and other catastrophic events, and by man-made problems such as terrorism, that could disrupt our business operations and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If a disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that damaged critical infrastructure, such as enterprise financial systems, manufacturing resource planning or enterprise quality systems, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. Our contract manufacturers&#x2019; and suppliers&#x2019; facilities are located in multiple locations, where other natural disasters or similar events, such as blizzards, tornadoes, fires, explosions or large<FONT CLASS="nobreak">-scale</FONT> accidents or power outages, and other public health emergencies could severely disrupt our operations and have a material adverse effect on our business, financial condition, operating results and prospects. For example, the recent COVID<FONT CLASS="nobreak">-19</FONT> pandemic may cause significant disruption to our business operations, the operations of our third<FONT CLASS="nobreak">-party</FONT> contractors and suppliers and the operations of our clinical trials, including as a result of significant restrictions or bans on travel into and within the geographic areas in which our manufacturers product our product candidates or where we conduct our clinical trials. A public health emergency could also affect the operations of the FDA and other regulatory or public health authorities, resulting in delays to meetings related to planned or completed clinical trials and ultimately of reviews and approvals of our product candidates. Such disruption could impede, delay, limit or prevent our employees and third<FONT CLASS="nobreak">-party</FONT> contractors from beginning or continuing research and development or clinical trial<FONT CLASS="nobreak">-related</FONT> activities, which may impede, delay, limit or prevent initiation or completion of our ongoing clinical trials and preclinical research and ultimately lead to the delay or denial of regulatory approval of our product candidates, which could seriously harm our operations and financial condition.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">34</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our employees, independent contractors, principal investigators, consultants, vendors and clinical</FONT> <FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">research</FONT> <FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">organizations, or CROs, may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are exposed to the risk that our employees, independent contractors, principal investigators, consultants, vendors and CROs may engage in fraudulent or other illegal activity. Misconduct by these persons could include intentional, reckless or negligent conduct or unauthorized activity that violates: laws or regulations, including those laws requiring the reporting of true, complete and accurate information to the FDA or foreign regulatory authorities; manufacturing standards; federal, state and foreign healthcare fraud and abuse laws and data privacy; or laws that require the true, complete and accurate reporting of financial information or data. In particular, sales, marketing and other business arrangements in the healthcare industry are subject to extensive laws intended to prevent fraud, kickbacks, self<FONT CLASS="nobreak">-dealing</FONT> and other abusive practices. These laws may restrict or prohibit a wide range of business activities, including research, manufacturing, distribution, pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws also involve the improper use of information obtained in the course of clinical trials, or illegal misappropriation of drug product, which could result in regulatory sanctions or other actions or lawsuits stemming from a failure to comply with such laws or regulations, and serious harm to our reputation. In addition, federal procurement laws impose substantial penalties for misconduct in connection with government contracts and require certain contractors to maintain a code of business ethics and conduct. If any such actions are instituted against us, we may have to terminate employees or others involved and the impact of such termination can result in our experiencing delays and additional costs associated with replacing the services being provided. If we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, FDA debarment, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our operating results.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Macroeconomic pressures in the markets in which we operate, including, but not limited to, the effect of the COVID-19</FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;"> pandemic </FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">may alter the ways in which we conduct our business operations and manage our financial capacities.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To varying degrees, the ways in which we conduct our business operations and manage our financial capacities are influenced by macroeconomic conditions that affect companies directly involved in or providing services related to the drug and biological product development. For example, real GDP growth, business and investor confidence, the COVID<FONT CLASS="nobreak">-19</FONT> pandemic, inflation, employment levels, oil prices, interest rates, tax rates, availability of consumer and business financing, housing market conditions, foreign currency exchange rate fluctuations, costs for items such as fuel and food and other macroeconomic trends can adversely affect not only our decisions and ability to engage in research and development and clinical trials, but also those of our management, employees, third<FONT CLASS="nobreak">-party</FONT> contractors, manufacturers and suppliers, competitors, shareholders and regulatory authorities. In addition, geopolitical issues around the world and how our markets are positioned can also impact the macroeconomic conditions and could have a material adverse impact on our financial results.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Economic uncertainty may adversely affect our access to capital, cost of capital and ability to execute our business plan as scheduled.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Generally, worldwide economic conditions remain uncertain. Access to capital markets is critical to our ability to operate. Traditionally, biotechnology companies have funded their research and development expenditures through raising capital in the equity markets. Declines and uncertainties in these markets in the past have severely restricted raising new capital and have affected companies&#x2019; ability to continue to expand or fund existing research and development efforts. We require significant capital for research and development for our vaccine candidates and clinical trials. The general economic and capital market conditions, both in the U.S. and worldwide, have been volatile in the past and at times have adversely affected our access to capital and increased the cost of capital. There is no certainty that the capital and credit markets will be available to raise additional capital on favorable terms. If economic conditions become worse, our future cost of equity or debt capital and access to the capital markets could be adversely affected. In addition, if we are unable to access the capital markets on favorable terms, our ability to </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">35</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">execute our business plan as scheduled would be compromised. Moreover, we rely and intend to rely on third<FONT CLASS="nobreak">-parties</FONT>, including clinical research organizations, contract manufacturing organizations and other important vendors and consultants. Global economic conditions may result in a disruption or delay in the performance of our third<FONT CLASS="nobreak">-party</FONT> contractors and suppliers. If such third<FONT CLASS="nobreak">-parties</FONT> are unable to adequately satisfy their contractual commitments to us in a timely manner, our business could be adversely affected.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Related to Our Intellectual Property</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">It is difficult and costly to protect our proprietary rights, and we may not be able to ensure their protection. If our patent position does not adequately protect our product candidates, others could compete against us more directly, which would harm our business, possibly materially.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our commercial success will depend in part on obtaining and maintaining patent protection and trade secret protection of our current product candidates and future product candidates, the processes used to manufacture them and the methods for using them, as well as successfully defending these patents against third<FONT CLASS="nobreak">-party</FONT>&#x00a0;challenges. Our ability to stop third parties from making, using, selling, offering to sell or importing our product candidates is dependent upon the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The patent positions of biotechnology and pharmaceutical companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. No consistent policy regarding the breadth of claims allowed in pharmaceutical patents has emerged to date in the U.S. or in foreign jurisdictions outside of the U.S. Changes in either the patent laws or interpretations of patent laws in the U.S. and other countries may diminish the value of our intellectual property. Accordingly, we cannot predict the breadth of claims that may be enforced in the patents that may be issued from the applications we currently license or may in the future own or license from third parties. Further, if any patents we obtain or license are deemed invalid and unenforceable, our ability to commercialize or license our product candidates or technology could be adversely affected.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Others may file patent applications covering products and technologies that are similar, identical or competitive to ours or important to our business. We cannot be certain that any patent application owned by a third party will not have priority over patent applications filed or in<FONT CLASS="nobreak">-licensed</FONT>&#x00a0;by us, or that we or our licensors will not be involved in interference, opposition, reexamination, review, reissue, post grant review or invalidity proceedings before U.S. or non<FONT CLASS="nobreak">-U</FONT>.S. patent offices. Such proceedings are also expensive and time consuming.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>others may be able to make compounds that are similar to our product candidates, but that are not covered by the claims of our licensed patents;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any patents that we obtain from licensing or otherwise may not provide us with any competitive advantages;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any granted patents that we rely upon may be held invalid or unenforceable as a result of legal challenges by third parties; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the patents of others may have an adverse effect on our business.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">36</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We are dependent on licensed intellectual property. If we were to lose our rights to licensed intellectual property, we may not be able to continue developing or commercializing our product candidates, if approved. If we breach any of the agreements under which we license the use, development and commercialization rights to our product candidates or technology from third parties or, in certain cases, we fail to meet certain development deadlines, we could lose license rights that are important to our business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We do not currently own any patents, and we are heavily reliant upon a number of license agreements under which we are granted rights to intellectual property that are important to our business and we may need or choose to enter into additional license agreements in the future. Our existing license agreements impose, and we expect that future license agreements will impose on us, various development, regulatory and/or commercial diligence obligations, payment of milestones and/or royalties and other obligations. If we fail to comply with our obligations under these agreements, or we are subject to a bankruptcy, the licensor may have the right to terminate the license, in which event we would not be able to market products covered by the license. Our business could suffer, for example, if any current or future licenses terminate, if the licensors fail to abide by the terms of the license, if the licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Licensing of intellectual property is of critical importance to our business and involves complex legal, business and scientific issues. Disputes may arise between us and our licensors regarding intellectual property subject to a license agreement, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the scope of rights granted under the license agreement and other interpretation<FONT CLASS="nobreak">-related</FONT> issues;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our right to sublicense patent and other rights to third parties;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our obligation to pursue or license others to pursue development of indications we are not currently pursuing;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the ownership of inventions and know<FONT CLASS="nobreak">-how</FONT> resulting from the joint creation or use of intellectual property by our licensors and us and our partners;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our right to transfer or assign the license; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the effects of termination.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have entered into several licenses to support our various programs. Termination of any of these license agreements would have a material adverse impact on our ability to develop and commercialize derived products under each respective agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may enter into additional licenses to third<FONT CLASS="nobreak">-party</FONT> intellectual property that are necessary or useful to our business. Our current licenses and any future licenses that we may enter into impose various royalty payment, milestone, and other obligations on us. Under some license agreements, we may not control prosecution of the licensed intellectual property, or may not have the first right to enforce the intellectual property. In those cases, we may not be able to adequately influence patent prosecution or enforcement, or prevent inadvertent lapses of coverage due to failure to pay maintenance fees. If we fail to comply with any of our obligations under a current or future license agreement, the licensor may allege that we have breached our license agreement, and may accordingly seek to terminate our license. Termination of any of our current or future licenses could result in our loss of the right to use the licensed intellectual property, which could materially adversely affect our ability to develop and commercialize a product candidate or product, if approved, as well as harm our competitive business position and </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">37</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">our business prospects. Under some license agreements, termination may also result in the transfer of or granting in rights under certain of our intellectual property and information related to the product candidate being developed under the license, such as regulatory information.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The agreements under which we license intellectual property or technology to or from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, if our licensors fail to abide by the terms of the license, if the licensors fail to prevent infringement by third parties, if the licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms, our business could suffer.&#x00a0; Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing, misappropriating or otherwise violating the licensor&#x2019;s rights.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Similarly, if we are unable to successfully obtain rights to required third<FONT CLASS="nobreak">-party</FONT> intellectual property rights or maintain the existing intellectual property rights we have, we may have to seek alternative options, such as developing new product candidates with design<FONT CLASS="nobreak">-around</FONT> technologies, which may require more time and investment, or abandon development of the relevant research programs or product candidates and our business, financial condition, results of operations and prospects could suffer.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Some of the intellectual property covered by our licenses concerns patent applications and provisional applications. We cannot assure investors that any of the currently pending or future patent applications will result in granted patents, nor can we predict how long it will take for such patents to be granted.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Some of intellectual property covered by our licenses concerns certain, specified patent rights (including patent applications, provisional patent applications and PCT patent applications). While in some instances, the licensors have agreed to assume responsibility for the preparation, filing, prosecution and maintenance of patent applications covered by the licensed patent rights, we cannot be certain as to when or if final patents will be issued for those patent applications covered by the licensed patent rights. However, the licensors may not successfully prosecute certain patent applications, the prosecution of which they control, under which we are only a licensee and on which our business substantially depends. Even if patents issue from these applications, there is no assurance that the patents will be free from defects or survive validity or enforceability challenges, the licensors may fail to maintain these patents, may decide not to pursue litigation against third<FONT CLASS="nobreak">-party</FONT> infringers, may fail to prove infringement or may fail to defend against counterclaims of patent invalidity or unenforceability.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Moreover, it is possible that the licensed pending patent applications will not result in granted patents, and even if such pending patent applications grant as patents, they may not provide a basis for intellectual property protection of commercially viable vaccine products or may not provide us with any competitive advantages. Further, it is possible that, for any of the patents that may be granted in the future, others will design around the licensed patent rights or identify methods for preventing or treating infectious diseases that do not concern the rights covered by our licenses. Further, we cannot assure investors that other parties will not challenge any patents granted to the licensors or that courts or regulatory agencies will hold licensor&#x2019;s patents to be valid or enforceable. We cannot guarantee investors that, if required to defend the covered patents, we will have the funds to or be successful in defending challenges made against the licensed patents and patent applications. Any successful third<FONT CLASS="nobreak">-party</FONT> challenge to the licensed patents could result in the unenforceability or invalidity of such patents, or to such patents being interpreted narrowly or otherwise in a manner adverse to our interests. Our ability to establish or maintain a technological or competitive advantage over our competitors may be diminished because of these uncertainties.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">38</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Even if patents are issued based on patent applications to which we have been granted a license, because the patent positions of pharmaceutical and biotechnology products are complex and uncertain, we cannot predict the scope and extent of patent protection for our product candidates.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any patents that may be issued based on patent applications that we have been granted licenses to will not ensure sufficient protection with respect to our activities for a number of reasons, including without limitation the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any issued patents may not be broad or strong enough to prevent competition from other vaccine products including identical or similar products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>if patents are not issued or if issued patents expire, there would be no protections against competitors making generic equivalents;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>there may be prior art of which we are not aware that may affect the validity or enforceability of a patent claim;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>there may be other patents existing, now or in the future, in the patent landscape for our product candidates that we seek to commercialize or develop, if any, that will affect our freedom to operate;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>if patents that we have been granted licenses to are challenged, a court could determine that they are not valid or enforceable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a court could determine that a competitor&#x2019;s technology or product does not infringe patents that we have been granted licenses to;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>patents to which we have been granted licenses could irretrievably lapse due to failure to pay fees or otherwise comply with regulations, or could be subject to compulsory licensing; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>if we encounter delays in our development or clinical trials, the period of time during which we could market our products under patent protection would be reduced.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and patent protection could be reduced or eliminated for noncompliance with these requirements.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Periodic maintenance fees on any issued patent are due to be paid to the United States Patent and Trademark Office (USPTO) and foreign Intellectual Property Offices in several stages over the term of the patent. Maintenance fees are also due for pending patent applications in some countries. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to office actions within prescribed time limits, non<FONT CLASS="nobreak">-payment</FONT> of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our business.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">The life of patent protection is limited, and third parties could develop and commercialize products and technologies similar or identical to ours and compete directly with us after the patent licensed to us expires, which could materially and adversely affect our ability to commercialize our products and technologies.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The life of a patent and the protection it affords is limited. For example, in the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non<FONT CLASS="nobreak">-provisional</FONT> filing date. In Europe, the expiration of an invention patent is 20 years from its filing date. Even if we successfully obtain patent protection for an approved vaccine candidate, it may face competition from biosimilar medications. Manufacturers of biosimilar drugs may challenge the scope, validity or enforceability of the patents underlying our </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">39</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">technology in court or before a patent office, and the patent holder may not be successful in enforcing or defending those intellectual property rights and, as a result, we may not be able to develop or market the relevant product candidate exclusively, which would materially adversely affect any potential sales of that product.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Given the amount of time required for the development, testing and regulatory review of new vaccine candidates, patents protecting such vaccine candidates might expire before or shortly after such vaccine candidates are commercialized. As a result, the patents and patent applications licensed to us may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. Even if we believe that the patents involved are eligible for certain (and time<FONT CLASS="nobreak">-limited</FONT>) patent term extensions, there can be no assurance that the applicable authorities, including the FDA and the USPTO, and any equivalent regulatory authority in other countries, will agree with our assessment of whether such extensions are available, and such authorities may refuse to grant extensions to such patents, or may grant more limited extensions than requested. For example, depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of the U.S. patents licensed to us may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984, or Hatch<FONT CLASS="nobreak">-Waxman</FONT> Amendments. The Hatch<FONT CLASS="nobreak">-Waxman</FONT> Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than requested. If we are unable to obtain patent term extension or term of any such extension is less than requested, our competitors may obtain approval of competing products following our patent expiration, and our business could be harmed. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The patents and pending patent applications licensed to us for our product candidates are expected to expire on various dates. Upon the expiration, we will not be able to assert such licensed patent rights against potential competitors, which would materially adversely affect our business, financial condition, results of operations and prospects.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may need to license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms or at all.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There may be intellectual property rights existing now, or in the future, relevant to our product candidates that we seek to commercialize or develop, if any, that may affect our ability to commercialize such product candidates. Although the Company is not aware of any such intellectual property rights, a third<FONT CLASS="nobreak">-party</FONT> may hold intellectual property rights, including patent rights, that are important or necessary to the development or manufacture of our product candidates. Even if all our main product candidates are covered by patents, it may be necessary for us to use the patented or proprietary technology of third parties to commercialize our product candidates, in which case we would be required to obtain a license from these third parties. Such a license may not be available on commercially reasonable terms, or at all, and we could be forced to accept unfavorable contractual terms. In that event, we may be required to expend significant time and resources to redesign our technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, our business could be harmed.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The licensing or acquisition of third<FONT CLASS="nobreak">-party</FONT> intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third party intellectual </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">40</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant program or product candidate, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may infringe the intellectual property rights of others, which may prevent or delay our product development efforts and stop us from commercializing or increase the costs of commercializing our product candidates.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our success will depend in part on our ability to operate without infringing the proprietary rights of third parties. We are not aware of any third party proprietary rights that our planned products will infringe or misappropriate, but we have not conducted any freedom to operate study as we are in the earliest stages of development. We thus cannot guarantee that our product candidates, or manufacture or use of our product candidates, will not infringe third<FONT CLASS="nobreak">-party</FONT>&#x00a0;patents. Furthermore, a third party may claim that we are using inventions covered by the third party&#x2019;s patent rights and may go to court to stop us from engaging in our normal operations and activities, including making or selling our product candidates. These lawsuits are costly and could affect our results of operations and divert the attention of managerial and scientific personnel. Some of these third parties may be better capitalized and have more resources than us. There is a risk that a court would decide that we are infringing the third party&#x2019;s patents and would order us to stop the activities covered by the patents. In that event, we may not have a viable way around the patent and may need to halt commercialization of our product candidates. In addition, there is a risk that a court will order us to pay the other party damages for having violated the other party&#x2019;s patents. In addition, we may be obligated to indemnify our licensors and collaborators against certain intellectual property infringement claims brought by third&#x00a0;parties, which could require us to expend additional resources. The pharmaceutical and biotechnology industries have produced a proliferation of patents, and it is not always clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of patents is subject to interpretation by the courts, and the interpretation is not always uniform.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If we are sued for patent infringement, we would need to demonstrate that our product candidates or methods either do not infringe the patent claims of the relevant patent or that the patent claims are invalid, and we may not be able to do this. Proving invalidity is difficult. For example, in the U.S., proving invalidity requires a showing of clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents. Even if we are successful in these proceedings, we may incur substantial costs and diversion of management&#x2019;s time and attention in pursuing these proceedings, which could have a material adverse effect on us. If we are unable to avoid infringing the patent rights of others, we may be required to seek a license, which may not be available, defend an infringement action or challenge the validity of the patents in court. Patent litigation is costly and time consuming. We may not have sufficient resources to bring these actions to a successful conclusion. In addition, if we do not obtain a license, develop or obtain non<FONT CLASS="nobreak">-infringing</FONT>&#x00a0;technology, fail to defend an infringement action successfully or have infringed patents declared invalid, we may incur substantial monetary damages, encounter significant delays in bringing our product candidates to market and be precluded from manufacturing or selling our product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than us or the third parties from whom we license intellectual property because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may become involved in lawsuits to protect or enforce our intellectual property, which could be expensive, time consuming and unsuccessful.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition to the possibility of litigation relating to infringement claims asserted against it, we may become a party to other patent litigation and other proceedings, including <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">inter partes</FONT> review proceedings, post<FONT CLASS="nobreak">-grant</FONT> review proceedings, derivation proceedings declared by the USPTO and similar proceedings in foreign countries, regarding intellectual property rights with respect to our current or future technologies or product candidates or products. The cost to us of any patent litigation or other proceeding, even if resolved in our favor, could be substantial. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Patent litigation and other proceedings may also absorb significant management time. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could impair our ability to compete in the marketplace.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">41</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Competitors may infringe or otherwise violate our intellectual property, including patents that may issue to or be licensed by us. As a result, we may be required to file claims in an effort to stop third<FONT CLASS="nobreak">-party</FONT> infringement or unauthorized use. Any such claims could provoke these parties to assert counterclaims against us, including claims alleging that we infringe their patents or other intellectual property rights, and/or that any of our intellectual property, including licensed intellectual property, is invalid and/or unenforceable. This can be prohibitively expensive, particularly for a company of our size, and time<FONT CLASS="nobreak">-consuming</FONT>, and even if we are successful, any award of monetary damages or other remedy we may receive may not be commercially valuable. In addition, in an infringement proceeding, a court may decide that our asserted intellectual property is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our intellectual property does not cover its technology. An adverse determination in any litigation or defense proceedings could put our intellectual property at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If the breadth or strength of our patent or other intellectual property rights is compromised or threatened, it could allow third parties to exploit and, in particular, commercialize our technology or products or result in our inability to exploit and/or commercialize our technology and products without infringing third<FONT CLASS="nobreak">-party</FONT> intellectual property rights. Further, third parties may be dissuaded from collaborating with us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Interference or derivation proceedings brought by the USPTO or its foreign counterparts may be necessary to determine the priority of inventions with respect to our patent applications, and we may also become involved in other proceedings, such as re<FONT CLASS="nobreak">-examination</FONT> proceedings, before the USPTO or its foreign counterparts. Due to the substantial competition in the pharmaceutical space, the number of such proceedings may increase. This could delay the prosecution of our pending patent applications or impact the validity and enforceability of any future patents that we may obtain. In addition, any such litigation, submission or proceeding may be resolved adversely to us and, even if successful, may result in substantial costs and distraction to our management.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If we are not able to adequately prevent disclosure of trade secrets and other proprietary information, the value of our technology and product could be significantly diminished.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We also rely on trade secrets to protect our proprietary technologies, especially where we do not believe patent protection is appropriate or obtainable. However, trade secrets are difficult to protect. We rely in part on confidentiality agreements with our employees, consultants, outside scientific collaborators, sponsored researchers and other advisors to protect our trade secrets and other proprietary information. These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. In addition, others may independently discover our trade secrets and proprietary information. For example, the FDA, as part of its transparency initiative, is currently considering whether to make additional information publicly available on a routine basis, including information that we may consider to be trade secrets or other proprietary information, and it is not clear at the present time how the FDA&#x2019;s disclosure policies may change in the future, if at all. Costly and time<FONT CLASS="nobreak">-consuming</FONT>&#x00a0;litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may be subject to claims that our employees or consultants have wrongfully used or disclosed alleged trade secrets.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As is common in the biotechnology and pharmaceutical industries, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know<FONT CLASS="nobreak">-how</FONT>&#x00a0;of others in their work for us, we may be subject to claims that we or our employees or consultants have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we could lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">42</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our intellectual property may not be sufficient to protect our product candidates from competition, which may negatively affect our business as well as limit our partnership or acquisition appeal.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may be subject to competition despite the existence of intellectual property we license or may in the future own. We can give no assurances that our intellectual property claims will be sufficient to prevent third parties from designing around patents we own or license and developing and commercializing competitive products. The existence of competitive products that avoid our intellectual property could materially adversely affect our operating results and financial condition. Furthermore, limitations, or perceived limitations, in our intellectual property may limit the interest of third parties to partner, collaborate or otherwise transact with us, if third parties perceive a higher than acceptable risk to commercialization of our product candidates or future product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may elect to sue a third party, or otherwise make a claim, alleging infringement or other violation of patents, trademarks, trade dress, copyrights, trade secrets, domain names or other intellectual property rights that we either own or license from a third party. If we do not prevail in enforcing our intellectual property rights in this type of litigation, we may be subject to:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>paying monetary damages related to the legal expenses of the third party;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>facing additional competition that may have a significant adverse effect on our product pricing, market share, business operations, financial condition, and the commercial viability of our product; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>restructuring our company or delaying or terminating select business opportunities, including, but not limited to, research and development, clinical trial, and commercialization activities, due to a potential deterioration of our financial condition or market competitiveness.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A third party may also challenge the validity, enforceability or scope of the intellectual property rights that we license or own and the result of these challenges may narrow the scope or claims of or invalidate patents that are integral to our product candidates in the future. There can be no assurance that we will be able to successfully defend patents we own or license in an action against third parties due to the unpredictability of litigation and the high costs associated with intellectual property litigation, amongst other factors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Intellectual property rights may be less extensive and enforcement more difficult in jurisdictions outside of the U.S. Therefore, we may not be able to protect our intellectual property and third parties may be able to market competitive products that may use some or all of our intellectual property.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Changes to patent law, including the Leahy<FONT CLASS="nobreak">-Smith</FONT>&#x00a0;America Invests Act of 2011 and the Patent Reform Act of 2009 and other future article of legislation, may substantially change the regulations and procedures surrounding patent applications, issuance of patents and prosecution of patents. We can give no assurances that the patents of our licensor can be defended or will protect us against future intellectual property challenges, particularly as they pertain to changes in patent law and future patent law interpretations.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Related to Healthcare Compliance and Other Regulations</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If we fail to comply with healthcare regulations, we could face substantial enforcement actions, including civil and criminal penalties and our business, operations and financial condition could be adversely affected.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We could be subject to healthcare fraud and abuse laws and patient privacy laws of both the federal government and the states in which we conduct our business. The laws include:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the federal healthcare program anti<FONT CLASS="nobreak">-kickback</FONT> law, which prohibits, among other things, persons from soliciting, receiving or providing remuneration, directly or indirectly, to induce either the referral of an individual, for an item or service or the purchasing or ordering of a good or service, for which payment may be made under federal healthcare programs such as the Medicare and Medicaid programs;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>federal false claims laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third<FONT CLASS="nobreak">-party</FONT> payers that are false or fraudulent, and which may apply to entities like us which provide coding and billing information to customers;</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">43</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>HIPAA which prohibits executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters and which also imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the FDCA which among other things, strictly regulates drug manufacturing and product marketing, prohibits manufacturers from marketing drug products&#x00a0;for&#x00a0;off<FONT CLASS="nobreak">-label</FONT>&#x00a0;use&#x00a0;and regulates the distribution of drug samples; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>state law equivalents of each of the above federal laws, such as anti<FONT CLASS="nobreak">-kickback</FONT> and false claims laws which may apply to items or services reimbursed by any third<FONT CLASS="nobreak">-party</FONT> payer, including commercial insurers, and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by federal laws, thus complicating compliance efforts.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If our operations are found to be in violation of any of the laws described above or any governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment or restructuring of our operations. Any penalties, damages, fines, curtailment or restructuring of our operations could adversely affect our ability to operate our business and our financial results. Although compliance programs can mitigate the risk of investigation and prosecution for violations of these laws, the risks cannot be entirely eliminated. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert management&#x2019;s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security and fraud laws may prove costly.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Healthcare Reform in the United States has been implemented in the past, and we expect further changes to be proposed in the future, leading to potential uncertainty in the healthcare industry. Violations of healthcare laws can have an adverse impact on our ability to advance our product candidates and our operating results.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the United States, there have been, and continue to be, a number of legislative and regulatory changes and proposed changes to the healthcare system that could affect the future results of pharmaceutical manufactures&#x2019; operations. In particular, there have been and continue to be a number of initiatives at the federal and state levels that seek to reduce healthcare costs. For example, the Affordable Care Act, or the ACA, which was originally enacted in March 2010 and subsequently amended, includes measures to significantly change the way healthcare is financed by both governmental and private insurers. Among the provisions of the ACA of greatest importance to the pharmaceutical and biotechnology industry are the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>an annual, nondeductible fee on any entity that manufactures or imports certain branded prescription drugs and biologic agents, apportioned among these entities according to their market share in certain government healthcare programs;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>implementation of the federal physician payment transparency requirements, sometimes referred to as the &#x201c;Physician Payments Sunshine Act&#x201d;;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a licensure framework for&#x00a0;follow<FONT CLASS="nobreak">-on</FONT>&#x00a0;biologic products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a new Patient<FONT CLASS="nobreak">-Centered</FONT> Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>establishment of a Center for Medicare Innovation at the Centers for Medicare&#x00a0;&amp; Medicaid Services to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program, to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively and capped the total rebate amount for innovator drugs at 100% of the Average Manufacturer Price;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">44</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for certain drugs and biologics, including our product candidates, that are inhaled, infused, instilled, implanted or injected;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>extension of manufacturers&#x2019; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#x2019; Medicaid rebate liability;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50%&#x00a0;point<FONT CLASS="nobreak">-of-sale</FONT>&#x00a0;discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#x2019;s outpatient drugs to be covered under Medicare Part D; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>expansion of the entities eligible for discounts under the Public Health program.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Some of the provisions of the ACA have yet to be implemented, and there have been legal and political challenges to certain aspects of the ACA. The former Trump administration issued certain executive orders and other directives designed to delay, circumvent, or loosen certain requirements mandated by the ACA. Concurrently, Congress considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed repeal legislation, the Tax Cuts and Jobs Act of 2017 included a provision repealing, effective January&#x00a0;1, 2019, the&#x00a0;tax<FONT CLASS="nobreak">-based</FONT>&#x00a0;shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#x201c;individual mandate.&#x201d; Congress may consider other legislation to repeal or replace elements of the ACA.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Many of the details regarding the implementation of the ACA are yet to be determined, and at this time, the full effect that the ACA would have on a pharmaceutical manufacturer remains unclear. In particular, there is uncertainty surrounding the applicability of the biosimilars provisions under the ACA. This uncertainty is heightened by President Biden&#x2019;s January<FONT CLASS="nobreak"> </FONT>28, 2021 Executive Order on Strengthening Medicaid and the Affordable Care Act, which indicates that the Biden administration may significantly modify the ACA and potentially revoke any changes implemented by the Trump administration.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The FDA has issued several guidance documents, but no implementing regulations, on biosimilars. A number of biosimilar applications have been approved over the past few years. The regulations that are ultimately promulgated and their implementation are likely to have considerable impact on the way pharmaceutical manufacturers conduct their business and may require changes to current strategies. A biosimilar is a biological product that is highly similar to an approved drug notwithstanding minor differences in clinically inactive components, and for which there are no clinically meaningful differences between the biological product and the approved drug in terms of the safety, purity, and potency of the product.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Individual states have become increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access, and marketing cost disclosure and transparency measures, and to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third<FONT CLASS="nobreak">-party</FONT> payors or other restrictions could harm a pharmaceutical manufacturer&#x2019;s business, results of operations, financial condition and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce ultimate demand for certain products or put pressure product pricing, which could negatively affect a pharmaceutical manufacturer&#x2019;s business, results of operations, financial condition and prospects.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">It is also possible that President Biden will further reform the ACA and other federal programs in a manner that may impact our operations. For example, the Biden administration has indicated that a goal of its administration is to expand and support Medicaid and the ACA and to make high<FONT CLASS="nobreak">-quality</FONT> healthcare accessible and affordable. The potential increase in patients covered by government funded insurance may impact our pricing. Further, it is possible that the Biden administration may further increase the scrutiny on drug pricing.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">45</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, given recent federal and state government initiatives directed at lowering the total cost of healthcare, the Biden administration, Congress and state legislatures will likely continue to focus on healthcare reform, the cost of prescription drugs and biologics and the reform of the Medicare and Medicaid programs. For example, there have been several recent U.S. congressional inquiries and proposed federal and proposed and enacted state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, reduce the costs of drugs under Medicare and reform government program reimbursement methodologies for drug products. Further, in July 2020, former President Trump issued a number of executive orders that are intended to lower the costs of prescription drug products including one that directs HHS to finalize the rulemaking process on modifying the anti<FONT CLASS="nobreak">-kickback</FONT> law safe harbors for discounts for plans, pharmacies, and pharmaceutical benefit managers. No assurance can be given whether these orders will remain in effect under the&#x00a0;Biden&#x00a0;administration.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">While no one can predict the full outcome of any such legislation, it may result in decreased reimbursement for drugs and biologics, which may further exacerbate industry<FONT CLASS="nobreak">-wide</FONT> pressure to reduce prescription drug prices. This could harm a pharmaceutical manufacturer&#x2019;s ability to generate revenue. Increases in importation or&#x00a0;re<FONT CLASS="nobreak">-importation</FONT>&#x00a0;of pharmaceutical products from foreign countries into the United States could put competitive pressure on a pharmaceutical manufacturer&#x2019;s ability to profitably price products, which, in turn, could adversely affect business, results of operations, financial condition and prospects. A pharmaceutical manufacturer might elect not to seek approval for or market products in foreign jurisdictions in order to minimize the risk of&#x00a0;re<FONT CLASS="nobreak">-importation</FONT>,&#x00a0;which could also reduce the revenue generated from product sales. It is also possible that other legislative proposals having similar effects will be adopted.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Furthermore, regulatory authorities&#x2019; assessment of the data and results required to demonstrate safety and efficacy can change over time and can be affected by many factors, such as the emergence of new information, including on other products, changing policies and agency funding, staffing and leadership. We cannot be sure whether future changes to the regulatory environment will be favorable or unfavorable to our business prospects. For example, average review times at the FDA for marketing approval applications can be affected by a variety of factors, including budget and funding levels and statutory, regulatory and policy changes.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could cause significant liability for us and harm our reputation.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are exposed to the risk of employee fraud or other misconduct, including intentional failures to comply with FDA regulations or similar regulations of comparable foreign regulatory authorities, provide accurate information to the FDA or comparable foreign regulatory authorities, comply with manufacturing standards we have established, comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable foreign regulatory authorities, report financial information or data accurately or disclose unauthorized activities to us. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant civil, criminal and administrative penalties, damages, fines, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and integrity oversight and reporting obligations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may rely on government funding and collaboration with government entities for our vaccine development, which adds uncertainty to our research and development efforts and may impose requirements that increase the costs of development, commercialization and production of any programs developed under those government-funded programs.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Because we anticipate the resources necessary to develop our vaccine product candidates will be substantial, we may explore funding and development collaboration opportunities with the U.S. government and its agencies. For example, we may apply for certain grant funding from BARDA, the NIH or other government agencies to further the </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">46</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">research, development, manufacture, testing, and regulatory approval of our vaccine product candidates. We have no control or input over whether an application for BARDA grant funding or any other funding will be accepted or approved, in full or in part, and we cannot provide investors with any assurances that we will receive such funding.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Contracts and grants funded by the U.S. government and its agencies, contain provisions that reflect the government&#x2019;s substantial rights and remedies, many of which are not typically found in commercial contracts, including powers of the government to:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reduce or modify the government&#x2019;s obligations under such agreements without the consent of the other party;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>claim rights, including Intellectual Property rights, in products and data developed under such agreements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>audit contract<FONT CLASS="nobreak">-related</FONT> costs and fees, including allocated indirect costs;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>suspend the contractor or grantee from receiving new contracts pending resolution of alleged violations of procurement laws or regulations.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>impose U.S. manufacturing requirements for products that embody inventions conceived or first reduced to practice under such agreements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>suspend or debar the contractor or grantee from doing future business with the government;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>control and potentially prohibit the export of products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>pursue criminal or civil remedies under the False Claims Act, False Statements Act, and similar remedy provisions specific to government agreements; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>limit the government&#x2019;s financial liability to amounts appropriated by the U.S. Congress on a fiscal<FONT CLASS="nobreak">-year</FONT> basis, thereby leaving some uncertainty about the future availability of funding for a program even after it has been funded for an initial period.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If we received such grants or agreements, we may not have the right to prohibit the U.S. government from using certain technologies developed by us, and we may not be able to prohibit third<FONT CLASS="nobreak">-parties</FONT>, including our competitors, from using those technologies in providing products and services to the U.S. government. Further, under such agreements we could be subject to obligations to and the rights of the U.S. government set forth in the Bayh<FONT CLASS="nobreak">-Dole</FONT> Act of 1980, meaning the U.S. government may have rights in certain inventions developed under these government<FONT CLASS="nobreak">-funded</FONT> agreements, including a non<FONT CLASS="nobreak">-exclusive</FONT>, non<FONT CLASS="nobreak">-transferable</FONT>, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government could have the right to require us to grant exclusive, partially exclusive, or nonexclusive licenses to any of these inventions to a third party if it determines that: (i) adequate steps have not been taken to commercialize the invention; (ii) government action is necessary to meet public health or safety needs; or (iii) government action is necessary to meet requirements for public use under federal regulations, also referred to as &#x201c;march<FONT CLASS="nobreak">-in</FONT> rights.&#x201d; Although the U.S. government&#x2019;s historic restraint with respect to these rights indicates they are unlikely to be used, any exercise of the march<FONT CLASS="nobreak">-in</FONT> rights could harm our competitive position, business, financial condition, results of operations, and prospects. In the event we would be subject to the U.S. government&#x2019;s exercise such march<FONT CLASS="nobreak">-in</FONT> rights, we may receive compensation that is deemed reasonable by the U.S. government in its sole discretion, which may be less than what we might be able to obtain in the open market.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, the U.S. government requires that any products embodying any invention generated through the use of U.S. government funding be manufactured substantially in the United States. The manufacturing preference requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. manufacturers may limit our ability to contract with non<FONT CLASS="nobreak">-U</FONT>.S. manufacturers for products covered by such intellectual property.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">47</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Although we may need to comply with some of these obligations, not all of the aforementioned obligations may be applicable to us unless and only to the extent that we receive a government grant, contract or other agreement. However, as an organization, we are relatively new to government contracting and new to the regulatory compliance obligations that such contracting entails. If we were to fail to maintain compliance with those obligations, we may be subject to potential liability and to termination of our contracts, which may have a materially adverse effect on our ability to develop our vaccine product candidates.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws and anti-money laundering laws and regulations.&#x00a0;Compliance with these legal standards could impair our ability to compete in domestic and international markets.&#x00a0;We can face criminal liability and other serious consequences for violations, which can harm our business.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#x2019;s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. &#x00a7; 201, the U.S. Travel Act, the USA PATRIOT Act and other state and national anti<FONT CLASS="nobreak">-bribery</FONT> and anti<FONT CLASS="nobreak">-money</FONT> laundering laws in the countries in which we conduct activities.&#x00a0;Anti<FONT CLASS="nobreak">-corruption</FONT> laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering or providing, directly or indirectly, improper payments or anything else of value to recipients in the public or private sector.&#x00a0;We may engage third parties for clinical trials outside of the United States, to sell our products abroad once we enter a commercialization phase and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals.&#x00a0; We have direct or indirect interactions with officials and employees of government agencies or government<FONT CLASS="nobreak">-affiliated</FONT> hospitals, universities and other organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. &#x00a0;Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm and other consequences.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Risks Related to Owning our Common Stock and this Offering</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">The market price of our common stock may be highly volatile, and you could lose all or part of your investment.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to this offering, there was no public market for shares of our common stock. The offering price for the shares of our common stock sold in this offering will be determined by negotiation between the underwriters and us. This price may not reflect the market price of our common stock following this offering. As a result, the trading price of our common stock is likely to be volatile, which may prevent you from being able to sell your shares at or above the public offering price. Our stock price could be subject to wide fluctuations in response to a variety of factors, which include:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>whether we achieve our anticipated corporate objectives;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>actual or anticipated fluctuations in our financial condition and operating results;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>changes in financial or operational estimates or projections;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the development status of our product candidates and when our products receive regulatory approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our execution of our sales and marketing, manufacturing and other aspects of our business plan;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>performance of third parties on whom we rely to manufacture our products, product components and product candidates, including their ability to comply with regulatory requirements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the results of our clinical studies and clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>results of operations that vary from those of our competitors and the expectations of securities analysts and investors;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">48</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>changes in expectations as to our future financial performance, including financial estimates by securities analysts and investors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our announcement of significant contracts, acquisitions or capital commitments;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>announcements by our competitors of competing products or other initiatives;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>announcements by third parties of significant claims or proceedings against us;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>regulatory and reimbursement developments in the United States and abroad;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>future sales of our common stock;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>product liability claims;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>healthcare reform measures in the United States;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>additions or departures of key personnel; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>general economic or political conditions in the United States or elsewhere.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, the stock market in general, and the stock of medical technology companies like ours, in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the issuer. Such broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We may be subject to securities litigation, which is expensive and could divert our management&#x2019;s attention.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The market price of our securities may be volatile, and in the past, companies that have experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management&#x2019;s attention from other business concerns, which could seriously harm our business.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We have broad discretion in the use of the net proceeds from this offering and may invest or spend the proceeds in ways with which you disagree or that may not yield a return.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">While we set forth our anticipated use for the net proceeds from this offering in the section titled &#x201c;Use of Proceeds,&#x201d; our management will have broad discretion on how to use and spend any proceeds that we receive from this offering and may use the proceeds in ways that differ from the anticipated uses set forth in this prospectus. Investors in this offering will need to rely upon the judgment of our management with respect to the use of proceeds with only limited information concerning management&#x2019;s specific intentions. It is possible that we may decide in the future not to use the proceeds of this offering in the manner described in this offering. Our management may spend a portion or all of the net proceeds from this offering in ways that holders of our common stock may not desire or that may not yield a significant return or any return at all. Investors will receive no notice or vote regarding any such change and may not agree with our decision on how to use such proceeds. If we fail to utilize the proceeds we receive from this offering effectively, our business and financial condition could be harmed and we may need to seek additional financing sooner than expected. Pending their use, we may also invest the net proceeds from this offering in a manner that does not produce income or that loses value.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">There is no existing market for our common stock and we do not know if one will develop to provide you with adequate liquidity.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to this offering, there has not been a public market for our common stock. Although we intend to apply to have our common stock listed on Nasdaq, an active trading market for our common stock may never develop or be sustained following this offering. You may not be able to sell your shares quickly or at the market price if trading in our common stock is not active. The initial public offering price for the shares will be determined by negotiations between us and the underwriters and may not be indicative of prices that will prevail in the trading market. You may not be able to sell your shares of our common stock at or above the price you paid in the offering. As a result, you </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">49</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">could lose all or part of your investment. Further, an inactive market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to enter into strategic partnerships or acquire companies or products by using our shares of common stock as consideration.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our principal stockholders and management own a significant percentage of our capital stock and will be able to exert a controlling influence over our business affairs and matters submitted to stockholders for approval.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">After this offering, it is anticipated that our officers and directors, together with holders of 5% or more of our outstanding common stock before this offering and their respective affiliates, will beneficially own or control &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of our common stock, which in the aggregate will represent approximately&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; % of the outstanding shares of our common stock, or &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;% if the underwriters&#x2019; option to purchase additional shares is exercised in full. As a result, if some of these persons or entities act together, they will have the ability to exercise significant influence over matters submitted to our stockholders for approval, including the election and removal of directors, amendments to our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, the approval of any business combination and any other significant corporate transaction. These actions may be taken even if they are opposed by other shareholders. This concentration of ownership may also have the effect of delaying or preventing a change of control of our company or discouraging others from making tender offers for our shares, which could prevent our stockholders from receiving a premium for their shares. Some of these persons or entities who make up our principal stockholders may have interests different from yours.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our failure to meet the continued listing requirements of Nasdaq could result in a de-listing of our common stock.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If, after listing, we fail to satisfy the continued listing requirements of Nasdaq, such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to de<FONT CLASS="nobreak">-list</FONT> our common stock. Such a de<FONT CLASS="nobreak">-listing</FONT> would likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a de<FONT CLASS="nobreak">-listing</FONT>, we would take actions to restore our compliance with Nasdaq Marketplace Rules, but our common stock may not be listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the Nasdaq minimum bid price requirement or prevent future non<FONT CLASS="nobreak">-compliance</FONT> with the Nasdaq Marketplace Rules.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If our shares become subject to the penny stock rules, it would become more difficult to trade our shares.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The SEC has adopted rules that regulate broker<FONT CLASS="nobreak">-dealer</FONT> practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If we do not obtain or retain a listing on Nasdaq and if the price of our common stock is less than $5.00, our common stock will be deemed a penny stock. The penny stock rules require a broker<FONT CLASS="nobreak">-dealer</FONT>, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker<FONT CLASS="nobreak">-dealer</FONT> must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser&#x2019;s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our common stock, and therefore shareholders may have difficulty selling their shares.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Future sales of shares by existing stockholders could cause our stock price to decline.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If our existing stockholders sell, or indicate an intent to sell, substantial amounts of our common stock in the public market after the 180<FONT CLASS="nobreak">-day</FONT> contractual lock<FONT CLASS="nobreak">-up</FONT> and other legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline significantly and could decline below the initial public offering price. Based on 2,136,855<FONT CLASS="nobreak"> </FONT>shares of common stock outstanding as of August<FONT CLASS="nobreak"> </FONT>1, 2021 (after giving effect to the conversion of all outstanding shares of convertible preferred stock into an aggregate of 1,336,855<FONT CLASS="nobreak"> </FONT>shares </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">50</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">of common stock), upon the completion of this offering, we will have outstanding&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock, assuming no exercise of outstanding options or warrants, including the Representative&#x2019;s warrants. Of these shares,&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock, plus any shares sold pursuant to the underwriters&#x2019; option to purchase additional shares, will be immediately freely tradable, without restriction, in the public market. If our existing stockholders sell substantial amounts of our common stock in the public market, or if the public perceives that such sales could occur, this could have an adverse impact on the market price of our common stock, even if there is no relationship between such sales and the performance of our business. We also intend to register all shares of common stock that we may issue under our equity compensation plan. Once we register these shares, they can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates and the lock<FONT CLASS="nobreak">-up</FONT> agreements described in the &#x201c;Underwriting&#x201d; section of this prospectus.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">After the lock<FONT CLASS="nobreak">-up</FONT> agreements pertaining to this offering expire and based on shares outstanding after this offering, an additional &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares will be eligible for sale in the public market. In addition, upon issuance, the 195,160<FONT CLASS="nobreak"> </FONT>shares subject to outstanding options under our stock option plan and the shares reserved for future issuance under our stock option plan will become eligible for sale in the public market in the future, subject to certain legal and contractual limitations. If our existing stockholders sell substantial amounts of our common stock in the public market, or if the public perceives that such sales could occur, this could have an adverse impact on the market price of our common stock, even if there is no relationship between such sales and the performance of our business.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If you purchase shares of common stock in this offering, you will suffer immediate dilution of your investment.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The public offering price of our common stock will be substantially higher than the net tangible book value per share of our common stock. Therefore, if you purchase shares of our common stock in this offering, you will pay a price per share that substantially exceeds our net tangible book value per share after this offering. To the extent shares subsequently are issued under outstanding stock options, you will incur further dilution. Based on an assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; per share, which is the midpoint of the price range set forth on the cover page of this prospectus, you will experience immediate dilution of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; per share, representing the difference between our pro forma net tangible book value per share, after giving effect to this offering, and the assumed initial public offering price. In addition, purchasers of common stock in this offering will have contributed approximately &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;% of the aggregate price paid by all purchasers of our stock but will own only approximately&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; % of our common stock outstanding after this offering.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We are an &#x201c;emerging growth company&#x201d; and the reduced disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are an &#x201c;emerging growth company,&#x201d; as defined in the JOBS Act. We may remain an &#x201c;emerging growth company&#x201d; until as late as December<FONT CLASS="nobreak"> </FONT>31, 2026 (the fiscal year<FONT CLASS="nobreak">-end</FONT> following the fifth anniversary of the completion of our initial public offering), though we may cease to be an &#x201c;emerging growth company&#x201d; earlier under certain circumstances, including (1) if the market value of our common stock that is held by nonaffiliates exceeds $700<FONT CLASS="nobreak"> </FONT>million as of any June<FONT CLASS="nobreak"> </FONT>30, in which case we would cease to be an &#x201c;emerging growth company&#x201d; as of the following December<FONT CLASS="nobreak"> </FONT>31, or (2) if our gross revenue exceeds $1.07<FONT CLASS="nobreak"> </FONT>billion in any fiscal year. &#x201c;Emerging growth companies&#x201d; may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Investors could find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, Section 102 of the JOBS Act also provides that an &#x201c;emerging growth company&#x201d; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards. An &#x201c;emerging growth company&#x201d; can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">51</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We will incur significant costs as a result of operating as a public company and our management expects to devote substantial time to public company compliance programs.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As a public company, we will incur significant legal, accounting and other expenses due to our compliance with regulations and disclosure obligations applicable to us, including compliance with the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act, as well as rules implemented by the SEC and Nasdaq. Shareholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact, in ways we cannot currently anticipate, the manner in which we operate our business. Our management and other personnel will devote a substantial amount of time to these compliance programs and monitoring of public company reporting obligations and as a result of the new corporate governance and executive compensation related rules, regulations and guidelines prompted by the Dodd<FONT CLASS="nobreak">-Frank</FONT> Act and further regulations and disclosure obligations expected in the future, we will likely need to devote additional time and costs to comply with such compliance programs and rules. These rules and regulations will cause us to incur significant legal and financial compliance costs and will make some activities more time<FONT CLASS="nobreak">-consuming</FONT> and costly.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To comply with the requirements of being a public company, we may need to undertake various actions, including implementing new internal controls and procedures and hiring new accounting or internal audit staff. The Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that information required to be disclosed in reports under the Securities Exchange Act of 1934, as amended, or the Exchange Act, is accumulated and communicated to our principal executive and financial officers. Our current controls and any new controls that we develop may become inadequate and weaknesses in our internal control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls when we become subject to this requirement could negatively impact the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we may be required to include in our periodic reports we will file with the SEC under Section 404 of the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act of 2002, or the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act, harm our operating results, cause us to fail to meet our reporting obligations or result in a restatement of our prior period financial statements. In the event that we are not able to demonstrate compliance with the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act, that our internal control over financial reporting is perceived as inadequate or that we are unable to produce timely or accurate financial statements, investors may lose confidence in our operating results and the price of our common stock could decline. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on Nasdaq.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our management team has limited experience managing a public company.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Most members of our management team have limited experience managing a publicly<FONT CLASS="nobreak">-traded</FONT> company, interacting with public company investors and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage our transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will require significant attention from our senior management and could divert their attention away from the day<FONT CLASS="nobreak">-to-day</FONT> management of our business, which could adversely affect our business, financial condition and operating results.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud which could subject us to regulatory sanctions, harm our business and operating results and cause the trading price of our stock to decline.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Effective internal controls required under Section 404 of the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act, are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our business, reputation and operating results could be harmed. We have discovered, and may in the future discover, areas of our internal controls that need improvement. We cannot be certain that the measures we have taken or intend to take will ensure that we maintain adequate controls over our financial processes and reporting in the future. Any failure to implement required new or improved controls or difficulties encountered in their implementation could subject us to regulatory sanctions, harm our business and operating results or cause us to </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">52</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">fail to meet our reporting obligations. Inferior internal controls could also harm our reputation and cause investors to lose confidence in our reported financial information, which could have a negative impact on the trading price of our stock.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, our stock price and trading volume could decline.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The trading market for our common stock will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on us. If no securities or industry analysts commence coverage of us, the price for our common stock could be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, our stock price could decline. In addition, if our operating results fail to meet the forecast of analysts, our stock price could decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our stock price and trading volume to decline.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws to be adopted in connection with the consummation of this offering, and Delaware law may have anti-takeover effects that could discourage, delay or prevent a change in control, which may cause our stock price to decline.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws and Delaware law could make it more difficult for a third party to acquire us, even if closing such a transaction would be beneficial to our stockholders. We are authorized to issue up to &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; shares of preferred stock. This preferred stock may be issued in one or more series, the terms of which may be determined at the time of issuance by our board of directors without further action by stockholders. The terms of any series of preferred stock may include voting rights (including the right to vote as a series on particular matters), preferences as to dividend, liquidation, conversion and redemption rights and sinking fund provisions. The issuance of any preferred stock could materially adversely affect the rights of the holders of our common stock, and therefore, reduce the value of our common stock. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with, or sell our assets to, a third party and thereby preserve control by the present management.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware law also could have the effect of discouraging potential acquisition proposals or making a tender offer or delaying or preventing a change in control, including changes a stockholder might consider favorable. Such provisions may also prevent or frustrate attempts by our stockholders to replace or remove our management. In particular, our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware law, as applicable, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide the board of directors with the ability to alter the bylaws without stockholder approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>place limitations on the removal of directors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>establish advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted upon at stockholder meetings; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that vacancies on the board of directors may be filled by a majority of directors in office, although less than a quorum.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As a Delaware corporation, we are also subject to provisions of Delaware law, including Section&#x00a0;203 of the Delaware General Corporation law, which prevents certain stockholders holding more than 15% of our outstanding capital stock from engaging in certain business combinations without approval of the holders of at least two<FONT CLASS="nobreak">-thirds</FONT> of our outstanding common stock not held by such stockholder.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">53</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any provision of our Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws or Delaware law that has the effect of delaying, preventing or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock, and could also affect the price that some investors are willing to pay for our common stock.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">We do not anticipate paying any cash dividends on our common stock in the foreseeable future and, as such, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have never declared or paid cash dividends on our common stock. We do not anticipate paying any cash dividends on our common stock in the foreseeable future. We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. In addition, and any future loan arrangements we enter into may contain, terms prohibiting or limiting the amount of dividends that may be declared or paid on our common stock. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">A possible &#x201c;short squeeze&#x201d; due to a sudden increase in demand of our common stock that largely exceeds supply may lead to price volatility in our common stock.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Following this offering, investors may purchase our common stock to hedge existing exposure in our common stock or to speculate on the price of our common stock. Speculation on the price of our common stock may involve long and short exposures. To the extent aggregate short exposure exceeds the number of shares of our common stock available for purchase in the open market, investors with short exposure may have to pay a premium to repurchase our common stock for delivery to lenders of our common stock. Those repurchases may in turn, dramatically increase the price of our common stock until investors with short exposure are able to purchase additional common shares to cover their short position. This is often referred to as a &#x201c;short squeeze.&#x201d; A short squeeze could lead to volatile price movements in our common stock that are not directly correlated to the performance or prospects of our company and once investors purchase the shares of common stock necessary to cover their short position the price of our common stock may decline.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">54</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T99871"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEM</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">ENTS AND <BR>INDUSTRY AND MARKE</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">T DATA</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Special Note Regarding Forward-Looking Statements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This prospectus contains forward<FONT CLASS="nobreak">-looking</FONT> statements that involve substantial risks and uncertainties. The forward<FONT CLASS="nobreak">-looking</FONT> statements are contained principally in the sections titled &#x201c;Prospectus Summary,&#x201d; &#x201c;Risk Factors,&#x201d; &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and &#x201c;Business,&#x201d; but are also contained elsewhere in this prospectus. In some cases, you can identify forward<FONT CLASS="nobreak">-looking</FONT> statements by the words &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;could,&#x201d; &#x201c;would,&#x201d; &#x201c;should,&#x201d; &#x201c;expect,&#x201d; &#x201c;intend,&#x201d; &#x201c;plan,&#x201d; &#x201c;objective,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;project,&#x201d; &#x201c;potential,&#x201d; &#x201c;continue&#x201d; and &#x201c;ongoing,&#x201d; or the negative of these terms, or other comparable terminology intended to identify statements about the future, although not all forward<FONT CLASS="nobreak">-looking</FONT> statements contain these words. These statements relate to future events or our future financial performance or condition and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward<FONT CLASS="nobreak">-looking</FONT> statements. These forward<FONT CLASS="nobreak">-looking</FONT> statements include, but are not limited to, statements about:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our projected financial position and estimated cash burn rate;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our estimates regarding expenses, future revenues and capital requirements;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to continue as a going concern;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our need to raise substantial additional capital to fund our operation;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the success, cost and timing of our clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our dependence on third parties in the conduct of our clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to obtain the necessary regulatory approvals to market and commercialize our product candidates;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the ultimate impact of the ongoing COVID<FONT CLASS="nobreak">-19</FONT> pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the potential that results of pre<FONT CLASS="nobreak">-clinical</FONT> and clinical trials indicate our current product candidates or any future product candidates we may seek to develop are unsafe or ineffective;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the results of market research conducted by us or others;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to obtain and maintain intellectual property protection for our current product candidates;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to protect our intellectual property rights and the potential for us to incur substantial costs from lawsuits to enforce or protect our intellectual property rights;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the possibility that a third party may claim we or our third<FONT CLASS="nobreak">-party</FONT> licensors have infringed, misappropriated or otherwise violated their intellectual property rights and that we may incur substantial costs and be required to devote substantial time defending against claims against us;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our reliance on third parties;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the success of competing therapies and products that are or become available;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to expand our organization to accommodate potential growth and our ability to retain and attract key personnel;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the potential for us to incur substantial costs resulting from product liability lawsuits against us and the potential for these product liability lawsuits to cause us to limit our commercialization of our product candidates;</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">55</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>market acceptance of our product candidates, the size and growth of the potential markets for our current product candidates and any future product candidates we may seek to develop, and our ability to serve those markets; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the successful development of our commercialization capabilities, including sales and marketing capabilities.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These forward<FONT CLASS="nobreak">-looking</FONT> statements are subject to a number of risks, uncertainties and assumptions, including those described in &#x201c;Risk Factors.&#x201d; Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward<FONT CLASS="nobreak">-looking</FONT> statements we may make. In light of these risks, uncertainties and assumptions, the forward<FONT CLASS="nobreak">-looking</FONT> events and circumstances discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward<FONT CLASS="nobreak">-looking</FONT> statements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">You should not rely upon forward<FONT CLASS="nobreak">-looking</FONT> statements as predictions of future events. Although we believe that the expectations reflected in the forward<FONT CLASS="nobreak">-looking</FONT> statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward<FONT CLASS="nobreak">-looking</FONT> statements will be achieved or occur. Moreover, except as required by law, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward<FONT CLASS="nobreak">-looking</FONT> statements. We undertake no obligation to update publicly any forward<FONT CLASS="nobreak">-looking</FONT> statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in our expectations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus forms a part with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Industry and Market Data</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our general expectations and market opportunity and market size, is based on information from various sources, including independent industry publications. In presenting this information, we have also made assumptions based on such data and other similar sources, and on our knowledge of, and our experience to date in, the markets for our products. This information involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. We believe that the information from these industry publications that is included in this prospectus is reliable. The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#x201c;Risk Factors.&#x201d; These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">56</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T15"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">USE OF PROCEEDS</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We estimate that the net proceeds to us from our issuance and sale of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock in this offering will be approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million (or $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million if the underwriters exercise their option to purchase additional shares of common stock in full), based upon an assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the mid<FONT CLASS="nobreak">-point</FONT> of the price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Each $1.00 increase or decrease in the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, would increase or decrease, as applicable, the net proceeds to us from this offering by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same. We may also increase or decrease the number of shares we are offering. Each increase or decrease of 1.0<FONT CLASS="nobreak"> </FONT>million in the number of shares we are offering at the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, would increase or decrease, as applicable, the net proceeds to us from this offering by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million, assuming the assumed initial public offering price remains the same.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We intend to use the net proceeds from this offering as follows:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million to fund our research and development activities;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million to fund clinical trials and regulatory review process for our products; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the remainder for working capital and other general corporate purposes, including the additional costs associated with being a public company.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This expected use of net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our development, the status of and results from clinical trials, our sales, marketing and manufacturing efforts, any collaborations that we may enter into with third parties for our products and any unforeseen cash needs. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We believe opportunities may exist from time to time to expand our current business through the acquisition or in<FONT CLASS="nobreak">-license</FONT> of complementary products and product candidates. While we have no current agreements or commitments for any specific acquisitions or in<FONT CLASS="nobreak">-licenses</FONT> at this time, we may use a portion of the net proceeds for these purposes.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of capital preservation investments, including short<FONT CLASS="nobreak">-term</FONT>, investment<FONT CLASS="nobreak">-grade</FONT>, interest<FONT CLASS="nobreak">-bearing</FONT> instruments and U.S.&#x00a0;government securities.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">57</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T14"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DIVIDEND POLICY</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have never declared or paid any cash dividends on our capital stock. We do not anticipate paying cash dividends on our common stock in the foreseeable future. We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business. Any future determination related to our dividend policy will be made at the discretion of our board of directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects, the requirements of current or then<FONT CLASS="nobreak">-existing</FONT> debt instruments and other factors our board of directors may deem relevant.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">58</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T13"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">CAPITALIZATION</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table sets forth our cash and capitalization as of June<FONT CLASS="nobreak"> </FONT>30, 2021:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>on an actual basis;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>on a pro forma basis to reflect the filing of our Amended and Restated Certificate of Incorporation upon the closing of this offering; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>on a pro forma as adjusted basis to give further effect to our issuance and sale of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock in this offering at an assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The pro forma and pro forma as adjusted information below is illustrative only and our capitalization following the completion of this offering is subject to adjustment based on the initial public offering price of our common stock and other terms of this offering determined at pricing. You should read the following table in conjunction with &#x201c;Use of Proceeds,&#x201d; &#x201c;Selected Financial Data,&#x201d; &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations,&#x201d; &#x201c;Description of Capital Stock&#x201d; and other financial information contained in this prospectus, including the financial statements and related notes appearing elsewhere in this prospectus.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="7" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 39.32%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">As of June 30, 2021</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-8" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Actual <BR>(unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Pro Forma <BR>(unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Pro Forma<BR>As Adjusted</FONT><FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><BR>(unaudited)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,669,468</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accounts payable and accrued expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">490,359</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total liabilities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">490,359</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stockholders&#x2019; equity:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series Seed Preferred Stock: 1,150,000 shares designated; 1,146,138&#x00a0;shares issued and outstanding at June 30, 2021;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Common stock, $0.00001 par value, 2,300,000 shares authorized; 800,000 shares outstanding at June 30, 2021</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Additional paid-in-capital</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">7,349,732</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accumulated deficit</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(3,657,391</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total stockholders&#x2019; equity</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,692,360</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.40%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total liabilities and stockholders&#x2019; equity</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,182,719</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;A $1.00 increase or decrease in the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, each of cash and cash equivalents, additional paid<FONT CLASS="nobreak">-in</FONT> capital, total shareholders&#x2019; (deficit) equity and total capitalization by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million, assuming the number of shares offered by us, as stated on the cover page of this prospectus, remains unchanged and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase or decrease of 1.0<FONT CLASS="nobreak"> </FONT>million in the number of shares we are offering would increase or decrease, as applicable, each of cash and cash equivalents, additional paid<FONT CLASS="nobreak">-in</FONT> capital, total shareholders&#x2019; (deficit) equity and total capitalization by $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;million, assuming the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The number of shares of our common stock to be outstanding after this offering is based on 2,136,855<FONT CLASS="nobreak"> </FONT>shares of common stock outstanding as of August<FONT CLASS="nobreak"> </FONT>1, 2021 (after giving effect to the conversion of all outstanding shares of preferred stock into an aggregate of 1,336,855<FONT CLASS="nobreak"> </FONT>shares of common stock), and excludes:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>195,160<FONT CLASS="nobreak"> </FONT>shares of common stock issuable upon the exercise of outstanding stock options under our 2019 Equity Incentive Plan, or the 2019 Plan, as of August<FONT CLASS="nobreak"> </FONT>1, 2021;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>154,840<FONT CLASS="nobreak"> </FONT>shares of our common stock reserved for future issuance under the 2019 Plan, which, upon adoption of our 2021 Equity Incentive Plan, or the 2021 Plan, will be issuable under the 2021 Plan; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="CharOverride-2" STYLE="font-size:9pt;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>shares of our common stock issuable upon the exercise of the warrant issued to the representative of the underwriters at the closing of this offering.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">59</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T12"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DILUTION</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the initial public offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after this offering. Net tangible book value per share of common stock is determined by dividing our total tangible assets less total liabilities by the number of outstanding shares of our common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our historical net tangible book value (deficit) as of June<FONT CLASS="nobreak"> </FONT>30, 2021 was approximately $3.7<FONT CLASS="nobreak"> </FONT>million or $4.60 per share of common stock. Our pro forma net tangible book value (deficit) as of &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021 was&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;or&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share of common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pro forma as adjusted net tangible book value (deficit) is our pro forma net tangible book value, after giving further effect to (i) the sale of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of our common stock in this offering at an assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, and (ii) the application of the net proceeds from this offering as described in the section of this prospectus entitled &#x201c;Use of Proceeds.&#x201d; This amount represents an immediate increase in pro forma net tangible book value (deficit) of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share to our existing shareholders, and an immediate dilution of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share to new investors participating in this offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table illustrates this dilution on a per share basis to new investors:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Assumed initial public offering price per share</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical net tangible book value (deficit) per share as of [&#x2022;], 2021</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Pro forma net tangible book value (deficit) per share as of [&#x2022;], 2021, before giving effect to this offering</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Increase in pro forma net tangible book value (deficit) per share attributable to new investors participating in this offering</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Pro forma as adjusted net tangible book value (deficit) per share after this offering</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Dilution in pro forma net tangible book value (deficit) per share to new investors participating in this offering</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A $1.00 increase or decrease in the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the pro forma as adjusted net tangible book value (deficit) per share after this offering by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share and decrease or increase, as appropriate, the dilution in pro forma net tangible book value (deficit) per share to investors participating in this offering by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Similarly, a 1.0<FONT CLASS="nobreak"> </FONT>million share increase or decrease in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase or decrease, as appropriate, the pro forma as adjusted net tangible book value (deficit) per share after this offering by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;and decrease or increase, as appropriate, the dilution in pro forma net tangible book value (deficit) per share to investors participating in this offering by approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, assuming the assumed initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, remains the same, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The pro forma information discussed above is illustrative only and will change based on the actual initial public offering price, number of shares and other terms of this offering determined at pricing.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If the underwriters exercise in full their option to purchase&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;additional shares of our common stock in this offering, the pro forma as adjusted net tangible book value will increase to $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, representing an immediate increase in pro forma net tangible book value to existing shareholders of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share and an immediate dilution of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share to new investors participating in this offering.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">60</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table sets forth, as of August<FONT CLASS="nobreak"> </FONT>1, 2021, on the pro forma as adjusted basis described above, the differences between our existing shareholders and the purchasers of shares of common stock in this offering with respect to the number of shares of common stock purchased from us, the total consideration paid to us and the weighted average price paid per share paid to us, based on an assumed initial public offering price of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, before deducting underwriting discounts and commissions and estimated offering expenses payable by us:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-8" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 41.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 21.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><BR><BR>Shares Purchased</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="5" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 21.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"><BR><BR>Total Consideration</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Weighted <BR>Average <BR>Price <BR>per&#x00a0;Share</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 41.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Number</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Percent</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Percent</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 41.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Existing shareholders</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 9.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 41.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">New investors</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="top">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 9.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 41.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">100</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="top">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 8.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="top">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">100</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="top">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 9.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If the underwriters exercise in full their option to purchase additional shares of our common stock in this offering, the number of shares held by existing shareholders will be reduced to&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;% of the total number of shares of common stock that will be outstanding upon completion of this offering, and the number of shares of common stock held by new investors participating in this offering will be further increased to&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;% of the total number of shares of common stock that will be outstanding upon completion of the offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may choose to raise additional capital through the sale of equity or equity<FONT CLASS="nobreak">-linked</FONT> securities due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that any options are issued under our equity incentive plan or we issue additional shares of common stock or equity<FONT CLASS="nobreak">-linked</FONT> securities in the future, there will be further dilution to investors purchasing in this offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The number of shares of our common stock to be outstanding after this offering is based on 2,136,<FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">85</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">5</FONT><FONT CLASS="nobreak"> </FONT>shares of common stock outstanding as of August<FONT CLASS="nobreak"> </FONT>1, 2021 (after giving effect to the conversion of all outstanding shares of convertible preferred stock into an aggregate of 1,336,855<FONT CLASS="nobreak"> </FONT>shares of common stock), and excludes:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>195,160<FONT CLASS="nobreak"> </FONT>shares of common stock issuable upon the exercise of outstanding stock options under our 2019 Equity Incentive Plan, or the 2019 Plan, as of August<FONT CLASS="nobreak"> </FONT>1, 2021;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>154,840<FONT CLASS="nobreak"> </FONT>shares of our common stock reserved for future issuance under the 2019 Plan, which, upon adoption of our 2021 Equity Incentive Plan, or the 2021 Plan, will be issuable under the 2021 Plan; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of our common stock issuable upon the exercise of the warrant issued to the representative of the underwriters at the closing of this offering.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">61</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T99872"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">MANAGEMENT&#x2019;S DISCUSSION AND ANALYSIS OF FINANC</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">IAL CONDITION</FONT> <BR><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">AND RESULTS OF OPERAT</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">IONS</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">You should read the following discussion of our financial condition and results of operations in conjunction with &#x201c;Selected Financial Data&#x201d; and our financial statements and related notes included elsewhere in this prospectus. This discussion and analysis and other parts of this prospectus contain forward</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-looking</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions. Our actual results and the timing of selected events could differ materially from those anticipated in these forward</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-looking</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> statements as a result of several factors, including those set forth under &#x201c;Risk Factors&#x201d; and elsewhere in this prospectus. You should carefully read the &#x201c;Risk Factors&#x201d; section of this prospectus to gain an understanding of the important factors that could cause actual results to differ materially from our forward</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-looking</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> statements. Please also see the section entitled &#x201c;Cautionary Note Regarding Forward</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-Looking</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> Statements and Industry and Market Data&#x201d; in this prospectus.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Overview</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi<FONT CLASS="nobreak">-targeted</FONT> vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins of antigens, with cross<FONT CLASS="nobreak">-reactive</FONT> properties, that enable the potential development of a universal flu vaccine. We are focused on developing novel vaccines that induce durable and long<FONT CLASS="nobreak">-term</FONT> immunity. We believe that our pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve both health outcomes and quality of life globally.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_001.jpg" STYLE="height:215.04px;width:538.88px;max-width:100%;"></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Since our inception in October 2018, we have devoted substantially all of our resources to performing research and development, undertaking preclinical studies and enabling manufacturing activities in support of our product development efforts, hiring personnel, acquiring and developing our technology and vaccine candidates, organizing and staffing our company, performing business planning, establishing our intellectual property portfolio and raising capital to support and expand such activities. We do not have any products approved for sale and have not generated any revenue from product sales. To date, we have financed our operations primarily with proceeds from our sale of preferred securities to seed investors. We will continue to require additional capital to develop our vaccine candidates and fund operations for the foreseeable future. Accordingly, until such time as we can generate significant revenue from sales of our vaccine candidates, if ever, we expect to finance our cash needs through public or private equity or debt financings, third<FONT CLASS="nobreak">-party</FONT> (including government) funding and marketing and distribution arrangements, as well as other collaborations, strategic alliances and licensing arrangements, or any combination of these approaches.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have incurred net losses since inception and expect to continue to incur net losses in the foreseeable future. Our net losses may fluctuate significantly from quarter<FONT CLASS="nobreak">-to-quarter</FONT> and year<FONT CLASS="nobreak">-to-year</FONT>, depending in large part on the timing of our preclinical studies, clinical trials and manufacturing activities, and our expenditures on other research </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">62</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">and development activities. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, the Company had working capital of approximately $3.6<FONT CLASS="nobreak"> </FONT>million and an accumulated deficit of approximately $3.7<FONT CLASS="nobreak"> </FONT>million. We will need to raise additional capital to fund our planned operations within one year from the issuance date of our financial statements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">While we believe that we can raise additional capital to fund our planned operations, until we generate revenue sufficient to support self<FONT CLASS="nobreak">-sustaining</FONT> cash flows, if ever, we will need to raise additional capital to fund our continued operations, including our product development and commercialization activities related to our current and future products. There can be no assurance that additional capital will be available to us on acceptable terms, or at all, or that we will ever generate revenue sufficient to provide for self<FONT CLASS="nobreak">-sustaining</FONT> cash flows. These circumstances raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We do not expect to generate any revenue from commercial product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our vaccine candidates, which we expect will take a number of years. We expect our expenses will increase substantially in connection with our ongoing activities, as we:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>advance vaccine candidates through preclinical studies and clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>require the manufacture of supplies for our preclinical studies and clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>pursue regulatory approval of vaccine candidates;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>hire additional personnel;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>operate as a public company.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>acquire, discover, validate and develop additional vaccine candidates; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>obtain, maintain, expand and protect our intellectual property portfolio.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We rely and will continue to rely on third parties in the conduct of our preclinical studies and clinical trials and for manufacturing and supply of our vaccine candidates. We have no internal manufacturing capabilities, and we will continue to rely on third parties, of which the main suppliers are single<FONT CLASS="nobreak">-source</FONT> suppliers, for our preclinical and clinical trial materials. Given our stage of development, we do not yet have a marketing or sales organization or commercial infrastructure. Accordingly, if we obtain regulatory approval for any of our vaccine candidates, we also expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Because of the numerous risks and uncertainties associated with vaccine development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate revenue from the sale of our vaccines, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and may be forced to reduce our operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Certain Significant Relationships</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have entered into grant, license and collaboration arrangements with various third parties as summarized below. For further details regarding these and other agreements, see the section titled &#x201c;Business &#x2014; Intellectual Property&#x201d; and Note 5 to each of our audited financial statements and unaudited financial statements included elsewhere in this prospectus.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-indent:24pt;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Ology Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In July 2019, we entered into a development and manufacturing master services agreement with Ology Bioservices (which was later acquired by National Resilience, Inc.) (&#x201c;Ology&#x201d;), which we refer to as the Ology Agreement, pursuant to which Ology is obligated to perform manufacturing process development and clinical manufacture and supply of components.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">63</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the Ology Agreement, we will pay Ology agreed upon fees for Ology&#x2019;s performance of manufacturing services, and we will reimburse Ology for its out<FONT CLASS="nobreak">-of-pocket</FONT> costs associated with purchasing raw materials, plus a customary handling fee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For additional details regarding our relationship with Ology, see the section entitled &#x201c;Business &#x2014; Manufacturing and Supply&#x201d; and Note 5 to our financial statements included elsewhere in this prospectus.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-indent:24pt;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Cincinnati Children&#x2019;s Hospital Medical Center Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On June<FONT CLASS="nobreak"> </FONT>1, 2021, we entered into an exclusive, worldwide license agreement with Children&#x2019;s Hospital Medical Center, d/b/a Cincinnati Children&#x2019;s Hospital Medical Center, or CHMC, which we refer to as the CHMC Agreement, pursuant to which we obtained the right to develop and commercialize certain CHMC patents and related technology directed at a virus<FONT CLASS="nobreak">-like</FONT> particle (VLP) vaccine platform that utilizes nanoparticle delivery technology, which may have potential broad application to develop vaccines for multiple infectious diseases.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the CHMC Agreement, we agreed to pay CHMC certain license fees, deferred license fees, development milestone fees, and running royalties beginning on the first net sale (among others). For additional details regarding our relationship with CHMC, see the section entitled &#x201c;Business &#x2014; Intellectual Property &#x2014; Exclusive License Agreement with Children&#x2019;s Hospital Medical Center, d/b/a Cincinnati Children&#x2019;s Hospital Medical Center&#x201d; included elsewhere in this prospectus. The CHMC license includes U.S. patent nos. 8,486,421 (expires January<FONT CLASS="nobreak"> </FONT>13, 2031), 9,096,644 (expires September<FONT CLASS="nobreak"> </FONT>20, 2030), and 9,562,077 (expires April<FONT CLASS="nobreak"> </FONT>10, 2034) and pending U. S. patent application no. 16/489,095 and pending U.S. provisional application nos. 63/149,742 and 63/162,369.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-indent:24pt;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Oxford University Innovation Limited Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On July<FONT CLASS="nobreak"> </FONT>16, 2019, we entered into an exclusive, worldwide license agreement with Oxford University Innovation Limited, which we refer to as the OUI Agreement, pursuant to which we obtained the right to develop and commercialize certain licensed technology entitled &#x201c;Immunogenic Composition.&#x201d;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the OUI Agreement, we agreed to fund three years&#x2019; worth of salaries for Dr. Craig Thompson in the University&#x2019; Department of Zoology through a sponsored research agreement with Oxford University, as well as royalties on all net sales of licensed products, along with certain development and milestone payments (among others). For additional details regarding our relationship with OUI, see the section entitled &#x201c;Business &#x2014; Intellectual Property &#x2014; License Agreement Between Oxford University Innovation Limited and Blue Water Vaccines Inc.&#x201d; included elsewhere in this prospectus. The OUI license includes pending U. S. patent application no.16/326,749.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-indent:24pt;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">St. Jude Children&#x2019;s Research Hospital, Inc. Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On January<FONT CLASS="nobreak"> </FONT>27, 2020, we entered into an exclusive, worldwide license agreement with St. Jude Children&#x2019;s Research Hospital, Inc., which we refer to as the St. Jude Agreement, pursuant to which we acquired the right to develop certain licensed products and produce vaccines for use in humans.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the St. Jude Agreement, we agreed to pay an initial license fee, an annual maintenance fee, milestone payments, patent reimbursement, and running royalties based on the net sales of licensed products. For additional details regarding our relationship with St. Jude, see the section entitled &#x201c;Business &#x2014; Intellectual Property &#x2014; Exclusive License Agreement between St. Jude Children&#x2019;s Research Hospital, Inc. &amp; Blue Water Vaccines&#x201d; included elsewhere in this prospectus. The St. Jude license includes U.S. patent nos. 9,265,819 (expires September<FONT CLASS="nobreak"> </FONT>19, 2032) and provisional U. S. patent application no. 62/817,748.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">COVID-19 Impacts</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are continuing to closely monitor the impact of the global COVID<FONT CLASS="nobreak">-19</FONT> pandemic on our business and are taking proactive efforts designed to protect the health and safety of our employees and to maintain business continuity. We believe that the measures we are implementing are appropriate, and we will continue to monitor and seek to comply with guidance from governmental authorities and adjust our activities as appropriate. Based on guidance issued by federal, state and local authorities, we transitioned to a remote work model for a vast </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">64</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">majority of our employees in March 2020. The COVID<FONT CLASS="nobreak">-19</FONT> pandemic has resulted in an impact to our development timelines, as the pandemic continues, we could continue to see an impact on our ability to advance our programs, obtain supplies from our contract manufacturer or interact with regulators, ethics committees or other important agencies due to limitations in regulatory authority, employee resources or otherwise. In any event, if the COVID<FONT CLASS="nobreak">-19</FONT> pandemic continues and persists for an extended period of time, we could experience significant disruptions to our development timelines, which would adversely affect our business, financial condition, results of operations and growth prospects.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, while the potential economic impact brought by, and the duration of, the COVID<FONT CLASS="nobreak">-19</FONT> pandemic may be difficult to assess or predict, the pandemic could result in significant and prolonged disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity. In addition, a recession or market correction resulting from the spread of COVID<FONT CLASS="nobreak">-19</FONT> could materially affect our business and the potential value of our common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The extent of the impact of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic on our development and regulatory efforts, our ability to raise sufficient additional capital on acceptable terms, if at all, and the future value of and market for our common stock will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the U.S. and in other countries, and the effectiveness of actions taken globally to contain and treat COVID<FONT CLASS="nobreak">-19</FONT>. For additional information about risks and uncertainties related to the COVID<FONT CLASS="nobreak">-19</FONT> pandemic that may impact our business, financial condition and results of operations, see the section titled &#x201c;Risk Factors.&#x201d;</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Components of Results of Operations</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Research and Development Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Substantially all of our research and development expenses consist of expenses incurred in connection with the development of our product candidates. These expenses include fees paid to third parties to conduct certain research and development activities on our behalf, consulting costs, costs for laboratory supplies, product acquisition and license costs, certain payroll and personnel<FONT CLASS="nobreak">-related</FONT> expenses, including salaries and bonuses, employee benefit costs and stock<FONT CLASS="nobreak">-based</FONT> compensation expenses for our research and product development employees and allocated overheads, including information technology costs and utilities and expenses for the issuance of shares pursuant to the anti<FONT CLASS="nobreak">-dilution</FONT> clause in the purchase of in process research and development technology. We expense both internal and external research and development expenses as they are incurred.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We do not allocate our costs by product candidate, as a significant amount of research and development expenses include internal costs, such as payroll and other personnel expenses, laboratory supplies and allocated overhead, and external costs, such as fees paid to third parties to conduct research and development activities on our behalf, are not tracked by product candidate.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We expect our research and development expenses to increase substantially for at least the next few years, as we seek to initiate additional clinical trials for our product candidates, complete our clinical programs, pursue regulatory approval of our product candidates and prepare for the possible commercialization of such product candidates. Predicting the timing or cost to complete our clinical programs or validation of our commercial manufacturing and supply processes is difficult and delays may occur because of many factors, including factors outside of our control. For example, if the FDA or other regulatory authorities were to require us to conduct clinical trials beyond those that we currently anticipate, we could be required to expend significant additional financial resources and time on the completion of clinical development. Furthermore, we are unable to predict when or if our product candidates will receive regulatory approval with any certainty.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">65</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">General and Administrative Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">General and administrative expenses consist principally of payroll and personnel expenses, including salaries and bonuses, benefits and stock<FONT CLASS="nobreak">-based</FONT> compensation expenses, professional fees for legal, consulting, accounting and tax services, including information technology costs, and other general operating expenses not otherwise classified as research and development expenses.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We anticipate that our general and administrative expenses will increase as a result of increased personnel costs, expanded infrastructure and higher consulting, legal and accounting services costs associated with complying with the applicable stock exchange and the SEC requirements, investor relations costs and director and officer insurance premiums associated with being a public company.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Other Income</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Other income consists primarily of interest income.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Results of Operations</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Comparison of Six Months ended June, 2021 and 2020</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table summarizes our statements of operations for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-21" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, <BR>2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">$ Change</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.46%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">% Change</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating costs and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">General and administrative</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">500,276</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">559,775</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(59,499</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(10.6</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Research and development</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">617,779</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">320,336</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">297,443</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">92.9</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880,111</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">237,944</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">27.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss from operations</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(880,111</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(237,944</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">27.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-22" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(100.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(100.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net Loss</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.76%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(860,680</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(257,375</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">29.9</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Operating Expenses</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Research and Development Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021, research and development expenses increased by approximately $0.3<FONT CLASS="nobreak"> </FONT>million compared to the comparable prior year period. The increase was primarily attributable to an increase in licensing fees.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">General and Administrative Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021, general and administrative expenses decreased by approximately $60,000 compared to the comparable prior year period. The decrease was mainly due to decrease in stock<FONT CLASS="nobreak">-based</FONT> compensation expenses of approximately $159,000, offset partially by an increase of professional and outside service fees of approximately $70,000.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">66</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Other Income</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021, other income decreased by approximately $19,000 compared to the corresponding period in 2020. The decrease was primarily due to decrease in interest income after transitioning our bank account from a money market account to a business checking account.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Comparison of the Years Ended December 31, 2020 and 2019</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table summarizes our statements of operations and comprehensive loss for the periods indicated:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-8" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2019</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">$ Change</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">% Change</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating costs and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">General and administrative</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,097,161</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">820,058</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">277,103</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">33.8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Research and development</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">524,908</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">60,174</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">464,734</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">772.3</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,622,069</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880,232</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">741,837</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">84.3</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss from operations</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,622,069</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(880,232</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(741,837</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">84.3</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-22" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,603</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">58,317</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(35,714</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(61.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,603</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">58,317</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(35,714</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(61.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,599,466</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(821,915</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(777,551</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">94.6</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Research and Development Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020, research and development expenses increased by approximately $0.5<FONT CLASS="nobreak"> </FONT>million compared to 2019. The increase was primarily attributable to an increase in research contract expenses mainly related to our lead vaccine candidates, BWV<FONT CLASS="nobreak">-101</FONT> and BWV<FONT CLASS="nobreak">-102</FONT>, of approximately $0.2<FONT CLASS="nobreak"> </FONT>million, stock<FONT CLASS="nobreak">-based</FONT> compensation expenses of approximately $0.2<FONT CLASS="nobreak"> </FONT>million and licensing fees of approximately $0.1<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">General and Administrative Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020, general and administrative expenses increased by $0.3<FONT CLASS="nobreak"> </FONT>million compared to 2019. The increase was primarily attributable to an increase in personnel<FONT CLASS="nobreak">-related</FONT> costs of approximately $0.2<FONT CLASS="nobreak"> </FONT>million, and stock<FONT CLASS="nobreak">-based</FONT> compensation expenses of $0.1<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Other Income</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020, other income decreased by $36,000 compared to 2019. The decrease was primarily due to decrease in interest income after transitioning our bank account from a money market account to a business checking account.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Going Concern, Liquidity and Capital Resources</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Going Concern</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There is substantial doubt about our ability to continue as a going concern for one year after the date that our June<FONT CLASS="nobreak"> </FONT>30, 2021 financial statements are available to be issued, which is not alleviated by our plans. The financial statements do not reflect any adjustments relating to the recoverability and reclassification of assets and liabilities that might be necessary from the outcome of this uncertainty.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">67</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Since inception, we have devoted substantially all of our efforts to research and development, undertaking preclinical studies and enabling manufacturing activities in support of our product development efforts, hiring personnel, acquiring and developing our technology and vaccine candidates, organizing and staffing our company, performing business planning, establishing our intellectual property portfolio and raising capital to support and expand such activities. We do not have any products approved for sale and have not generated any revenue from product sales. We have incurred net losses in each year since inception and expect to continue to incur net losses in the foreseeable future. Our net loss was $1.6<FONT CLASS="nobreak"> </FONT>million for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020. As of December<FONT CLASS="nobreak"> </FONT>31, 2020, we had an accumulated deficit of $2.5<FONT CLASS="nobreak"> </FONT>million. We also generated negative operating cash flows of $1.7<FONT CLASS="nobreak"> </FONT>million for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021, our net loss was $1.1<FONT CLASS="nobreak"> </FONT>million and we used $0.6<FONT CLASS="nobreak"> </FONT>million of cash in operations. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, we had an accumulated deficit of $3.7<FONT CLASS="nobreak"> </FONT>million. Our cash is sufficient to continue operations, satisfy its obligations and fund the future expenditures that will be required to conduct the clinical and regulatory work to develop its product candidates until the second quarter of 2022.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Liquidity and Capital Resources</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have incurred losses since inception and have incurred negative cash flows from operations from inception through June<FONT CLASS="nobreak"> </FONT>30, 2021. We have funded our operations to date primarily from the sale of preferred securities to seed investors totalling approximately $6.9<FONT CLASS="nobreak"> </FONT>million in net proceeds. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, we had $3.7<FONT CLASS="nobreak"> </FONT>million of cash and an accumulated deficit of $3.7<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We will require significant amounts of additional capital to continue to fund our operations and commence and complete our research and development activities. We currently have limited resources to continue to fund our operations and if we are not able to obtain additional cash resources, we will not be able to continue operations. We will continue seeking additional financing sources to meet our working capital requirements, make continued investment in research and development and make capital expenditures needed for us to maintain and expand our business. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, or if we expend capital on projects that are not successful, our ability to continue to support our business growth and to respond to business challenges could be significantly limited, or we may even have to cease our operations. If we raise additional funds through further issuances of equity or convertible debt securities, our existing shareholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock, including shares of common stock sold in this offering.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Future Funding Requirements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our primary uses of cash are to fund our operations, which consist primarily of research and development expenditures related to our programs and general and administrative expenditures. We anticipate that we will continue to incur significant expenses for the foreseeable future as we continue to advance our vaccine candidates, expand our corporate infrastructure, including the costs associated with being a public company and further our research and development initiatives for our vaccine candidates. We are subject to all of the risks typically related to the development of new drug candidates, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. We anticipate that we will need substantial additional funding in connection with our continuing operations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We believe that our existing cash as of the date of this prospectus, together with the net proceeds from this offering, will fund our current operating plans through at least the next 12<FONT CLASS="nobreak"> </FONT>months from the date of this offering. However, we will need to raise additional capital prior to commencing pivotal trials for any of our vaccine candidates. Until we can generate a sufficient amount of revenue from the commercialization of our vaccine candidates or from collaboration agreements with third parties, if ever, we expect to finance our future cash needs through public or private equity or debt financings, third<FONT CLASS="nobreak">-party</FONT> (including government) funding and marketing and distribution arrangements, as well as other collaborations, strategic alliances and licensing arrangements, or any combination of these approaches. The future sale of equity or convertible debt securities may result in dilution to our stockholders and, in the case of preferred equity securities or convertible debt, those securities could provide for </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">68</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">rights, preferences or privileges senior to those of our common stock. Debt financings may subject us to covenant limitations or restrictions on our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Our ability to raise additional funds may be adversely impacted by deteriorating global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from the ongoing COVID<FONT CLASS="nobreak">-19</FONT> pandemic. There can be no assurance that we will be successful in acquiring additional funding at levels sufficient to fund our operations or on terms favorable or acceptable to us. If we are unable to obtain adequate financing when needed or on terms favorable or acceptable to us, we may be forced to delay, reduce the scope of or eliminate one or more of our research and development programs.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our future capital requirements will depend on many factors, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the timing, scope, progress, results and costs of research and development, testing, screening, manufacturing, preclinical and non<FONT CLASS="nobreak">-clinical</FONT> studies and clinical trials, including any impacts related to the COVID<FONT CLASS="nobreak">-19</FONT> pandemic;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the outcome, timing and cost of seeking and obtaining regulatory approvals from the FDA and comparable foreign regulatory authorities, including the potential for such authorities to require that we perform field efficacy studies for our vaccine candidates, require more studies than those that we currently expect or change their requirements regarding the data required to support a marketing application;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the cost of building a sales force in anticipation of any product commercialization;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the costs of future commercialization activities, including product manufacturing, marketing, sales, royalties and distribution, for any of our vaccine candidates for which we receive marketing approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our ability to maintain existing, and establish new, strategic collaborations, licensing or other arrangements and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty or other payments due under any such agreement;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any product liability or other lawsuits related to our products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the expenses needed to attract, hire and retain skilled personnel;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the revenue, if any, received from commercial sales, or sales to foreign governments, of our vaccine candidates for which we may receive marketing approval;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the costs to establish, maintain, expand, enforce and defend the scope of our intellectual property portfolio, including the amount and timing of any payments we may be required to make, or that we may receive, in connection with licensing, preparing, filing, prosecuting, defending and enforcing our patents or other intellectual property rights;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>expenses needed to attract, hire and retain skilled personnel;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the costs of operating as a public company; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the impact of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic, which may exacerbate the magnitude of the factors discussed above.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;margin-top:8pt;">A change in the outcome of any of these or other variables could significantly change the costs and timing associated with the development of our vaccine candidates. Furthermore, our operating plans may change in the future, and we may need additional funds to meet operational needs and capital requirements associated with such change.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">69</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Cash Flows</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table summarizes our cash flows for the periods indicated:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-28" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-top:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, <BR>2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30,</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash used in operating activities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(639,353</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,252,208</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,730,138</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(825,126</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash used in investing activities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(6,027</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(11,792</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(4,500</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash provided by financing activities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,880,377</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net (decrease) increase in cash</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(639,353</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,258,235</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,741,930</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Cash Flows from Operating Activities</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in operating activities for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 was $0.6<FONT CLASS="nobreak"> </FONT>million, which primarily resulted from a net loss of $1.1<FONT CLASS="nobreak"> </FONT>million, and partially offset by a net change in our operating assets and liabilities of $0.4<FONT CLASS="nobreak"> </FONT>million and stock<FONT CLASS="nobreak">-based</FONT> compensation of $77,000.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in operating activities for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2020 was $1.3<FONT CLASS="nobreak"> </FONT>million, which primarily resulted from a net loss of $0.9<FONT CLASS="nobreak"> </FONT>million and a net change in our operating assets and liabilities of $0.6<FONT CLASS="nobreak"> </FONT>million, partially offset by stock<FONT CLASS="nobreak">-based</FONT> compensation of $0.2<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in operating activities for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020 was $1.7<FONT CLASS="nobreak"> </FONT>million, which primarily resulted from a net loss of $1.6<FONT CLASS="nobreak"> </FONT>million and a net change in our operating assets and liabilities of $0.5<FONT CLASS="nobreak"> </FONT>million, partially offset by stock<FONT CLASS="nobreak">-based</FONT> compensation of $0.3<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in operating activities for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2019 was $0.8<FONT CLASS="nobreak"> </FONT>million, which primarily resulted from a net loss of $0.8<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Cash Flows from Investing Activities</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in investing activities for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 was $0.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in investing activities for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2020 was $6,000, which resulted from purchase of property and equipment.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in investing activities for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020 was $12,000, which resulted from purchase of property and equipment.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in investing activities for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2019 was $5,000, which resulted from purchase of property and equipment.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Cash Flows from Financing Activities</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Net cash used in financing activities for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020, and for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020 was $0.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Cash provided by financing activities for the year ended December<FONT CLASS="nobreak"> </FONT>31, 2019 was $6.9<FONT CLASS="nobreak"> </FONT>million, which primarily consisted of net proceeds from the issuance of our Series Seed preferred stock of $6.9<FONT CLASS="nobreak"> </FONT>million, partially offset by repayment of related party loan of $55,000.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Legal Contingencies</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">From time to time, we may become involved in legal proceedings arising from the ordinary course of business. We record a liability for such matters when it is probable that future losses will be incurred and that such losses can be reasonably estimated.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">70</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Off-Balance Sheet Arrangements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the periods presented we did not have, nor do we currently have, any off<FONT CLASS="nobreak">-balance</FONT> sheet arrangements as defined in the rules and regulations of the SEC.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Recent Accounting Pronouncements Not Yet Adopted</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">See Note 3 to our financial statements included elsewhere in this prospectus for more information.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Critical Accounting Policies and Estimates</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to accrued research and development expenses fair value of common stock and stock<FONT CLASS="nobreak">-based</FONT> compensation. We base our estimates on historical experience, known trends and events and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">While our significant accounting policies are described in more detail in Note 3 to our financial statements included elsewhere in this prospectus, we believe the following accounting policies and estimates to be most critical to the judgments and estimates used in the preparation of our financial statements.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Accrued Research and Development Expenses</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have entered into various agreements with contract manufacturing organizations, or CMOs, and may enter into contracts with clinical research organizations, or CROs, in the future. As part of the process of preparing our financial statements, we are required to estimate our accrued research and development expenses as of each balance sheet date. This process involves reviewing open contracts and purchase orders, communicating with our personnel and third parties to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of the actual cost. We make estimates of our accrued research and development expenses as of each balance sheet date based on facts and circumstances known to us at that time. We periodically confirm the accuracy of our estimates with the service providers and make adjustments, if necessary. The significant estimates in our accrued research and development expenses include the costs incurred for services performed by our vendors in connection with research and development activities for which we have not yet been invoiced.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We accrue for costs related to research and development activities based on our estimates of the services received and efforts expended pursuant to quotes and contracts with vendors, including CMOs, that conduct research and development on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the research and development expense. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. We make significant judgments and estimates in determining accrued research and development liabilities as of each reporting period based on the estimated time period over which services will be performed and the level of effort to be expended. If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or prepaid expense accordingly.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Although we do not expect our estimates to be materially different from amounts actually incurred, if our estimates of the status and timing of services performed differ from the actual status and timing of services performed, it could result in us reporting amounts that are too high or too low in any particular period. To date, there have been no material differences between our estimates of such expenses and the amounts actually incurred.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">71</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;"></FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Stock-Based Compensation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company expensed stock<FONT CLASS="nobreak">-based</FONT> compensation to employees and non<FONT CLASS="nobreak">-employees</FONT> over the requisite service period based on the estimated grant<FONT CLASS="nobreak">-date</FONT> fair value of the awards. Stock<FONT CLASS="nobreak">-based</FONT> awards to employees with graded<FONT CLASS="nobreak">-vesting</FONT> schedules are recognized, using the accelerated attribution method, on a straight<FONT CLASS="nobreak">-line</FONT> basis over the requisite service period for each separately vesting portion of the award. Changes in the estimated fair value of awards are recognized as compensation expense in the period of change.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company estimates the fair value of stock option grants using the Black<FONT CLASS="nobreak">-Scholes</FONT> option pricing model and the assumptions used in calculating the fair value of stock<FONT CLASS="nobreak">-based</FONT> awards represent management&#x2019;s best estimates and involve inherent uncertainties and the application of management&#x2019;s judgment.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Expected Term</FONT> &#x2014; The expected term of options represents the period that the Company&#x2019;s stock<FONT CLASS="nobreak">-based</FONT> awards are expected to be outstanding based on the simplified method, which is the half<FONT CLASS="nobreak">-life</FONT> from vesting to the end of its contractual term.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Expected Volatility </FONT>&#x2014; The Company computes stock price volatility over expected terms based on comparable companies historical common stock trading prices.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Common Stock Fair Value</FONT> &#x2014; The fair value of the common stock underlying the Company&#x2019;s stock options was estimated at each grant date and was determined with the assistance of an independent third<FONT CLASS="nobreak">-party</FONT> valuation expert. The assumptions underlying these valuations represented management&#x2019;s best estimates, which involved inherent uncertainties and the application of significant levels of management judgment.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Risk</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-Free</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> Interest Rate</FONT> &#x2014; The Company bases the risk<FONT CLASS="nobreak">-free</FONT> interest rate on the implied yield available on U.S. Treasury securities with a remaining term commensurate with the estimated expected term.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Expected Dividend</FONT> &#x2014; The Company has never declared or paid any cash dividends on its common shares and does not plan to pay cash dividends in the foreseeable future, and, therefore, uses an expected dividend yield of zero in its valuation models.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company recognizes forfeitures of equity awards as they occur.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Fair value of common stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In order to determine the fair value of shares of common stock of the Company when issuing stock options and computing their estimated stock<FONT CLASS="nobreak">-based</FONT> compensation expense, its board of directors considered with input from third party valuations, among other things, contemporaneous valuations of the Company&#x2019;s common stock. Given the absence of a public trading market of the Company&#x2019;s capital stock to date, its board of directors has exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of our common and preferred stock, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the prices, rights, preferences and privileges of our preferred stock relative to our common stock;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our business, financial condition and results of operations, including related industry trends affecting our operations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the likelihood of achieving a liquidity event, such as an initial public offering, or IPO, or sale of our company, given prevailing market conditions;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the lack of marketability of our common stock;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the market performance of comparable publicly traded companies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>U.S. and global economic and capital market conditions and outlook; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Common stock valuation methodology.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In estimating the fair market value of common stock of the Company, its board of directors first determined the equity value of its business using accepted valuation methods.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">72</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company engaged a third party valuation specialist to conduct a valuation, which used its recent preferred stock financing as a starting point and determined the equity value of the company based on the Backsolve method using an Option Pricing Method (OPM) to calculate the implied value based on a market approach. The Company&#x2019;s equity value was allocated using OPM to estimate the fair market value of the Company&#x2019;s classes of equity.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Quantitative and Qualitative Disclosures About Market Risk</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are a smaller reporting company as defined by Rule 12b<FONT CLASS="nobreak">-2</FONT> of the Exchange Act and are not required to provide the information otherwise required under this item.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">JOBS Act</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Section 107 of the JOBS Act also provides that an &#x201c;emerging growth company&#x201d; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an &#x201c;emerging growth company&#x201d; can delay the adoption of new or revised accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this extended transition period.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For as long as we remain an &#x201c;emerging growth company&#x201d; under the recently enacted JOBS Act, we will, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be exempt from the provisions of Section 404(b) of the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act, which requires that our independent registered public accounting firm provide an attestation report on the effectiveness of our internal control over financial reporting;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be permitted to omit the detailed compensation discussion and analysis from proxy statements and reports filed under the Exchange Act and instead provide a reduced level of disclosure concerning executive compensation; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>be exempt from any rules that may be adopted by the Public Company Accounting Oversight Board requiring mandatory audit firm rotation or a supplement to the auditor&#x2019;s report on the financial statements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Although we are still evaluating the JOBS Act, we currently intend to take advantage of some or all of the reduced regulatory and reporting requirements that will be available to us so long as we qualify as an &#x201c;emerging growth company,&#x201d; including the extension of time to comply with new or revised financial accounting standards available under Section 102(b) of the JOBS Act. Among other things, this means that our independent registered public accounting firm will not be required to provide an attestation report on the effectiveness of our internal control over financial reporting so long as we qualify as an emerging growth company, which may increase the risk that weaknesses or deficiencies in our internal control over financial reporting go undetected. Likewise, so long as we qualify as an emerging growth company, we may elect not to provide you with certain information, including certain financial information and certain information regarding compensation of our executive officers, that we would otherwise have been required to provide in filings we make with the SEC, which may make it more difficult for investors and securities analysts to evaluate our company. As a result, investor confidence in our company and the market price of our common stock may be materially and adversely affected.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">73</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T11"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">BUSINESS</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Overview</FONT>&#x00a0;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are a biotechnology company&#x00a0;focused on the research and development of transformational vaccines to prevent infectious diseases worldwide.&#x00a0;Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi<FONT CLASS="nobreak">-targeted</FONT> vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross<FONT CLASS="nobreak">-reactive</FONT> properties that enables the potential development of a universal flu vaccine. We are focused on developing novel vaccines that induce durable and long<FONT CLASS="nobreak">-term</FONT> immunity. We believe that our pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve&#x00a0;both health&#x00a0;outcomes and quality of life&#x00a0;globally.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our pipeline includes novel vaccine candidates exclusively licensed from renowned research institutions. We seek to develop vaccines that provide long<FONT CLASS="nobreak">-lasting</FONT> immunity to harmful viral and bacterial pathogens that cause infections in patient populations with high unmet needs. Our&#x00a0;exclusive license agreements include patented influenza epitopes of limited variability, or ELV, identified through a proprietary computational research and discovery process, discovered by Dr. Sunetra Gupta and her team at the University of Oxford. Our collaborators are pioneers in drug discovery and development in vaccine drug discovery and development. We are exploring the development of these influenza ELV&#x2019;s utilizing our Norovirus shell and protrusion (S&amp;P) nanoparticle vaccine platform licensed from Cincinnati&#x00a0;Children&#x2019;s&#x00a0;Hospital&#x00a0;Medical Center, or Cincinnati Children&#x2019;s. We are also utilizing our platform to develop a vaccine for the prevention of gastroenteritis cause by both norovirus and rotavirus. Our exclusively licensed S. pneumoniae vaccine candidate is from St. Jude Children&#x2019;s Hospital. The vaccine is designed to prevent harmful middle<FONT CLASS="nobreak">-ear</FONT> infections in children and is being developed for intranasal delivery well suited for pediatric patients. We leverage the expertise of our collaborators to pursue the discovery and development of vaccines for these diseases, which is a high unmet need globally.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, we have expertise in identifying business development opportunities for our platform vaccines technologies and portfolio. This allows for both internal pipeline expansion and the ability to generate non<FONT CLASS="nobreak">-dilutive</FONT> revenue from potential licensing partners to utilize our discovery engine vaccine platform. There is potential for adjunctive or next generation therapeutic exploration to enhance current standard of care options.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Vaccination is an effective method of protecting individuals against harmful diseases by utilizing the body&#x2019;s natural defense system to develop resistance or immunity to infections. The body&#x2019;s immune system naturally creates antibodies and cell<FONT CLASS="nobreak">-mediated</FONT> immunity to defend against foreign pathogens. Vaccines introduce or present these foreign pathogens in a safe manner, prompting the body&#x2019;s immune system to produce a response protective against the pathogen without exposing the body to the relevant lethal or harmful infection. While vaccines are generally able to provide resistance against disease, many infectious diseases can evolve leading to shortcomings of traditional vaccines, such as yearly reformulations. We believe our vaccine candidates can provide an alternative to the current standards of care by inducing durable and long<FONT CLASS="nobreak">-lived</FONT> immune response to specific or multiple antigens.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The&#x00a0;global vaccine market&#x00a0;has recently experienced significant growth caused by rising awareness&#x00a0;of the importance of&#x00a0;immunization and vaccination benefits in emerging markets as well as by projects to fuel further global market expansion.&#x00a0;For instance, The&#x00a0;World Health Organization (WHO) has undertaken initiatives to increase&#x00a0;immunization&#x00a0;awareness through&#x00a0;its Global&#x00a0;Vaccine&#x00a0;Action&#x00a0;Plan and&#x00a0;Global Immunization&#x00a0;Vision and&#x00a0;Strategy.&#x00a0;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As such, market research professionals project&#x00a0;the global vaccine market&#x00a0;size to reach&#x00a0;$73.78<FONT CLASS="nobreak"> </FONT>billion by 2028, representing a CAGR of 7.3%&#x00a0;over the forecast period, driven by&#x00a0;rising prevalence of infectious diseases, increasing government funding for vaccine production and growing&#x00a0;emphasis&#x00a0;on&#x00a0;becoming immunized.&#x00a0;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This market acceleration has been coupled with various&#x00a0;strategic transactions in the sector, including consolidations&#x00a0;and mergers and acquisitions in recent years.&#x00a0;Major market participants have&#x00a0;strategically acquired&#x00a0;start<FONT CLASS="nobreak">-ups</FONT> and mid<FONT CLASS="nobreak">-sized</FONT> companies&#x00a0;to&#x00a0;broaden&#x00a0;their&#x00a0;products portfolios and service offerings.&#x00a0;&#x00a0;For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, one of the leading manufacturers of rabies vaccines across the globe.&#x00a0;Additionally, in October 2018, Emergent BioSolutions, a multinational specialty biopharmaceutical company, acquired PaxVax for $270<FONT CLASS="nobreak"> </FONT>million, and&#x00a0;in July 2017 Sanofi acquired Protein Sciences for $650<FONT CLASS="nobreak"> </FONT>million.&#x00a0;&#x00a0;The appetite of these companies to buttress their vaccine programs and pipelines reflects the increasing importance of vaccines in the healthcare sector, both nationally and worldwide.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">74</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The U.S. Centers for Disease Control, or CDC, its Advisory Committee on Immunization Practices, or ACIP, and similar international advisory bodies develop vaccine recommendations for both children and adults. New pediatric vaccines that receive ACIP preferred recommendations are almost universally adopted, and adult vaccines that receive a preferred recommendation are widely adopted. We believe that our vaccine candidates will be&#x00a0;well<FONT CLASS="nobreak">-positioned</FONT>&#x00a0;to obtain these preferred recommendations, by virtue of their longer and more durable immunity, which could drive rapid and significant market adoption.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PIPELINE</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our vaccine candidates are being developed in a manner that is scalable, designed to be cost<FONT CLASS="nobreak">-effective</FONT> and provide long term benefit to patients from infectious agents</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:12pt;text-align:center;margin-top:12pt;"><IMG ALT="" SRC="timage_001.jpg" STYLE="height:215.04px;width:538.88px;max-width:100%;"></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Strategy</FONT>&#x00a0;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We aim to identify,&#x00a0;discover&#x00a0;and&#x00a0;develop&#x00a0;novel preventive vaccines for&#x00a0;infectious diseases.&#x00a0;Key elements of our strategy include:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Investment&#x00a0;in&#x00a0;advancing&#x00a0;the&#x00a0;development&#x00a0;of&#x00a0;our novel vaccine pipeline programs through&#x00a0;IND</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-enabling</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> activities&#x00a0;and Phase 1 clinical studies.</FONT>&#x00a0;&#x00a0;</P>
		<P CLASS="BL_m_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:72pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We plan to advance our main vaccine programs: influenza, norovirus<FONT CLASS="nobreak">-rotavirus</FONT>, and S.<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> pneumoniae </FONT>induced AOM.</P>
		<P CLASS="BL_m_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:72pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our in<FONT CLASS="nobreak">-licensed</FONT> vaccine candidates&#x00a0;are carefully&#x00a0;selected&#x00a0;based&#x00a0;on&#x00a0;the&#x00a0;following criteria: area of significant&#x00a0;unmet medical need&#x00a0;for preventive long<FONT CLASS="nobreak">-term</FONT> vaccine;&#x00a0;strong scientific rationale&#x00a0;and established clinical and regulatory pathways; defined competitive landscape and potential future commercial opportunity; and license exclusivity.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Prioritizing&#x00a0;the&#x00a0;research and&#x00a0;development&#x00a0;for&#x00a0;our&#x00a0;lead&#x00a0;influenza vaccine&#x00a0;candidates, BWV</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-101</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> and BWV</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-102</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> through&#x00a0;Phase 1.</FONT></P>
		<P CLASS="BL_m_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:72pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our goal is to develop a universal influenza vaccine that protects against all strains of influenza,&#x00a0;including pandemic strains. In collaboration with The University of Oxford and Cincinnati Children&#x2019;s, we are evaluating vaccine candidates to pursue the best development path forward to stimulate durable and broad<FONT CLASS="nobreak">-spectrum</FONT> immunogenicity.</P>
		<P CLASS="BL_m_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:72pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We&#x00a0;will leverage the learnings from the development of BMW<FONT CLASS="nobreak">-102</FONT>, H1 vaccine candidate, to accelerate the development of the of&#x00a0;BWV<FONT CLASS="nobreak">-101</FONT> universal influenza vaccine program.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Maximize&#x00a0;and utilize&#x00a0;the value of&#x00a0;our collaborators and third</FONT><FONT CLASS="nobreak"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">-party</FONT></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> vendors.</FONT></P>
		<P CLASS="BL_m_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:72pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We will combine&#x00a0;disciplined&#x00a0;business&#x00a0;strategies to&#x00a0;further&#x00a0;expand&#x00a0;the potential&#x00a0;synergies with current collaborators.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">75</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;font-style:normal;font-weight:bold;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Deploy&#x00a0;and expand&#x00a0;our proprietary norovirus S&amp;P nanoparticle platform.</FONT></P>
		<P CLASS="BL_m_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:72pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our immunogenic multi<FONT CLASS="nobreak">-purpose</FONT> vaccine platform technologies can be utilized with an array of infectious disease&#x00a0;agents to access multiple development pathways and allows for potential next<FONT CLASS="nobreak">-generation</FONT> life cycle&#x00a0;management to expand our pipeline and pursue business development opportunities.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Management and History</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Blue Water Vaccines, Inc.&#x00a0;was founded in October&#x00a0;2018&#x00a0;by our Chairman and Chief Executive Officer, or CEO, Joseph Hernandez,&#x00a0;with the&#x00a0;initial goal of developing&#x00a0;a transformational&#x00a0;universal flu&#x00a0;vaccine to treat and prevent&#x00a0;patients&#x00a0;globally. Our&#x00a0;initial technology, licensed from the University of Oxford, provides a novel approach to developing a universal influenza vaccine.&#x00a0;Subsequently,&#x00a0;our team has identified other program candidates and&#x00a0;technologies to broaden and diversify our vaccine pipeline.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Mr.<FONT CLASS="nobreak"> </FONT>Hernandez, is a veteran entrepreneur, philanthropist, and operator with a broad skillset of founding, building, and selling companies, as well as executing business development transactions and securing private and public capital, including Digene, Noachis Terra and Blue Water Acquisition Corp. Mr.<FONT CLASS="nobreak"> </FONT>Hernandez was responsible for our initial $7<FONT CLASS="nobreak"> </FONT>million seed funding round from investors including Our vaccine candidates are being developed in a manner that is scalable, designed to be cost<FONT CLASS="nobreak">-effective</FONT> and provide long term benefit to patients from infectious agents CincyTech. Subsequently, a team of veteran industry executives and advisors were assembled, bringing valuable expertise to our growing infectious disease company. Jon Garfield, who will be our Chief Financial Officer upon the completion of this offering, is a veteran executive in the life sciences industry. Andrew Skibo is our Head of Biologic Operations and was recently Head of Global Biologics Operations at MedImmune / AstraZeneca and previously worked for Amgen and Genentech (now Roche), where he was responsible for operations, engineering, construction, and validation for large<FONT CLASS="nobreak">-scale</FONT> capital projects related to bio<FONT CLASS="nobreak">-pharmaceutical</FONT> manufacturing. Ronald Cobb, Ph.D., our Head of Science and Discovery, was recently Chief Scientific Officer at Ology Bioservices (formerly Nanotherapeutics) and previously worked for RTI Biologics and Berlex Biosciences. Brian Price, PhD, our Head of Technology Strategy, brings over 20 years of successful product development experience and business development growth based on programs in toxicology, analytics, and therapeutic and vaccine development. Erin Henderson serves as our Chief Business Officer and has over 20 years of leading strategic transactions, governmental and stakeholder relations and corporate expansion. Previously, she was the Managing Principal at The Aetos Group, a management consulting firm serving both the public and private sectors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, members of our board of directors have extensive expertise in the fields of life sciences, business, and finance. In addition to Mr.<FONT CLASS="nobreak"> </FONT>Hernandez,&#x00a0;our directors upon the consummation of this offering will include&#x00a0;Michael Venerable, CEO of CincyTech, Kimberly Murphy, former VP, Commercialization Leader, Influenza, at GlaxoSmithKlein, Allan Shaw,&#x00a0;an experienced biotechnology CFO and director nominee James Sapirstein, R.Ph., M.B.A., President and CEO of AzurRx BioPharma (NASDAQ:AZRX).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Scientific Advisory Board includes Sunetra Gupta, Ph.D. Professor of Theoretical Epidemiology at The University of Oxford, a leading voice in infectious disease globally; David Zarley, PhD, with more than 30&#x00a0;years&#x00a0;of&#x00a0;experience in vaccine research and development, including former leadership roles at Pfizer and Wyeth; and, following the consummation of this offering, John Rice, Ph.D., Managing Director at CincyTech, with more than 30 years of biotechnology advising experience.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Our&#x00a0;Vaccine&#x00a0;Platform</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV&#x00a0;Norovirus (NoV) S&amp;P Nanoparticle Versatile Vaccine Platform</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Our Approach to Stimulating the Immune System for Infectious Disease Protection</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our S&amp;P platform combines two or more immunogenic components, a norovirus antigen plus at least one additional antigen, together creating novel constructs. The norovirus nanoparticle enhances immunogenicity </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">76</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">of the inserted antigen. The S &amp; P particles themselves also act as antigens, and are large enough to trigger an immune response to a foreign substance. By combining the norovirus nanoparticle with one or more antigens from other infectious disease(s), the immune system is stimulated to create antibodies to both the norovirus and the additional antigen(s).</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Key Elements of our Platform</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are leveraging our disruptive norovirus nanoparticle platform to develop novel, broad<FONT CLASS="nobreak">-spectrum</FONT> vaccines for adult and child infectious disease prevention by taking advantage of:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Flexible and Scalable discovery platform engine.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We are able to design and create novel vaccines that are stable and scalable for broad spectrum prophylactics. Through this platform&#x2019;s adaptability, we may opportunistically expand our pipeline and collaborate with third parties for additional vaccines, as well as therapeutics.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Cost</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-effective</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> and Rapid Production of Novel Vaccines.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;font-style:normal;font-weight:normal;">We believe this technology will be able to significantly reduce the cost and time to market of traditional vaccines. We have bioengineered these nanoparticles to be stable and effective using </FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">E.coli</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;font-style:normal;font-weight:normal;"> expression which provides cost savings and efficiency.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Multi</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-antigen</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> and Pathogen Capabilities.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>One of the key features of our platform is its ability to carry multiple antigens at a time, thereby creating a multi<FONT CLASS="nobreak">-targeted</FONT> vaccine. It also provides the opportunity to develop vaccines for protection against not only viral pathogens, but also bacterial and potentially parasitic and fungal pathogens.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Therapeutic potential.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>We believe our platform may offer opportunities to develop non<FONT CLASS="nobreak">-infectious</FONT> disease therapeutic products, for example being used as a carrier or vehicle to transport drugs to specific target locations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Viral capsid proteins are responsible for many&#x00a0;basic functions necessary for viral life cycles, such as viral&#x00a0;attachment and entry, and thus can elicit neutralizing&#x00a0;antibodies against viral infection after immunization to humans&#x00a0;and animals. Consequently, viral capsid proteins are promising&#x00a0;vaccine targets against viral infection. Indeed, various capsid&#x00a0;protein nanoparticles and complexes have been developed and&#x00a0;used as nonreplicating subunit vaccines to combat various infectious diseases.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Unlike traditional live<FONT CLASS="nobreak">-attenuated</FONT> and inactivated virus vaccines that need cultivation&#x00a0;of infectious virions and are associated with certain safety&#x00a0;concerns, the nonreplicating VLP vaccines derived from&#x00a0;bioengineered viral capsid proteins do not involve an infectious agent and, therefore, are safer and have lower manufacturing&#x00a0;costs than traditional vaccines. Thus, VLP vaccines&#x00a0;represent a next generation of innovative vaccine strategy.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Structure</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The&#x00a0;NoV&#x00a0;(VP1)&#x00a0;capsid structure consists of two major domains a N<FONT CLASS="nobreak">-terminal</FONT> shell (S) and C<FONT CLASS="nobreak">-terminal</FONT> protruding (P) domains. The S domain builds the interior shell of the&#x00a0;capsid&#x00a0;and the P domain forms the dimeric protrusions of the capsid.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The protrusions&#x00a0;(P)&#x00a0;of norovirus capsid interact with viral glycan receptors for attachment to host&#x00a0;cells to initiate an infection.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The S domain interacts&#x00a0;homotypically&#x00a0;and drives self<FONT CLASS="nobreak">-formation</FONT> of an approximately 60 nm VLP.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The P domain exhibits homotypic interactions, forming a 24 nm VLP with dimeric protrusions for stabilization of the viral capsid.&#x00a0;&#x00a0;Additionally, it can also form&#x00a0;oliogomers&#x00a0;or polymers.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">77</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_002.jpg" STYLE="height:221.44px;width:154.88px;max-width:100%;"></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">Through bioengineering two subviral nanoparticles,&#x00a0;the 24<FONT CLASS="nobreak">-valent</FONT> P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24&#x00a0;</FONT>and the 60<FONT CLASS="nobreak">-valent</FONT> S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticles have been&#x00a0;designed and&#x00a0;generated&#x00a0;to serve as a&#x00a0;multifunctional vaccine platform&#x00a0;against different pathogens and illnesses.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>These nanoparticles and polymers are&#x00a0;easily produced, highly stable, and extremely immunogenic&#x00a0;and&#x00a0;serve to display foreign antigens,&#x00a0;self<FONT CLASS="nobreak">-assembling</FONT> into chimeric nanoparticles or polymers as vaccines.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Such VLPs and capsid<FONT CLASS="nobreak">-like</FONT> nanoparticles are excellent vaccine candidates against corresponding viral&#x00a0;pathogens because&#x00a0;they retain arrays of antigenic epitopes that faithfully mimic those of the native&#x00a0;virions, and these repeated viral antigens and epitopes stimulate strong immune responses in their&#x00a0;animal and human hosts.&#x00a0;In addition, such highly immunogenic subviral nanoparticles also serve&#x00a0;as versatile platforms that&#x00a0;are able to&#x00a0;display foreign antigens for improved immune responses to&#x00a0;facilitate development of novel vaccines against various pathogens and diseases.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The fact that the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLP nanoparticles and polymers are composed of authentic norovirus antigens and retain norovirus<FONT CLASS="nobreak">-specific</FONT> molecular patterns make it an excellent vaccine candidate against the norovirus.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>In addition, the&#x00a0;natures of self<FONT CLASS="nobreak">-formation</FONT>, high stability, polyvalence, and high immunogenicity of&#x00a0;the nanoparticles and polymers make them potent platforms to display foreign antigens, resulting&#x00a0;in&#x00a0;chimeric&#x00a0;nanoparticles as vaccine candidates against further pathogens and <BR>diseases.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our multifunctional vaccine platform is a robust discovery engine and has broad application using both S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> and P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> nanoparticles to target multiple pathogens and illnesses.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">78</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="ttable_001.jpg" STYLE="height:308.48px;width:384.0px;max-width:100%;"></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">The S</FONT><FONT CLASS="Italic-Subscript" STYLE="font-style:italic;font-weight:normal;vertical-align:sub;font-size:58%;">60</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> Nanoparticle as a&#x00a0;Multifunctional&#x00a0;vaccine&#x00a0;platform</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Recent&#x00a0;technology has generated&#x00a0;S nanoparticles using an&#x00a0;<FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">E. coli</FONT>&#x00a0;system&#x00a0;with stabilized expression and self<FONT CLASS="nobreak">-assembly</FONT>.&#x00a0;The S nanoparticles feature exposed&#x00a0;C<FONT CLASS="nobreak">-terminal</FONT>&#x00a0;flexible hinge sites that offer ideal fusion sites for displaying foreign antigens.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We&#x00a0;have developed a technology to produce&#x00a0;uniform 60<FONT CLASS="nobreak">-valent</FONT>&#x00a0;NoV&#x00a0;S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60 </FONT>nanoparticles with high efficiency&#x00a0;using a simple bacterial expression system. This was achieved&#x00a0;by taking advantage of the homotypic interactions of the NoVVP1 S domain that naturally builds the interior shells of&#x00a0;NoV&#x00a0;capsids, as well as several modifications to stabilize the S&#x00a0;domain proteins and enhance the inter<FONT CLASS="nobreak">-S</FONT> domain interactions,&#x00a0;respectively. Specifically, we introduced an R69A mutation to&#x00a0;destruct the exposed protease cleavage sites on the surface of&#x00a0;the native shell that otherwise leads to easy degradation of the&#x00a0;S proteins. In addition, we introduced triple (V57C/Q58C/S136&#x2019;C) cysteine mutations to establish inter<FONT CLASS="nobreak">-S</FONT> domain disulfide&#x00a0;bonds between two pairs of sterically close residues&#x00a0;that belong to two neighboring S&#x00a0;domains. This led to significantly enhanced stability and yields&#x00a0;of the self<FONT CLASS="nobreak">-assembled</FONT> S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticles produced by the simple&#x00a0;<FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">E.&#x00a0;</FONT><FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">c</FONT><FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">oli</FONT>&#x00a0;system.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>An important feature of our technology was to rationally introduce intermolecular disulfide bonds to stabilize the S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticles. This approach could also be used to stabilize other viral protein particles or complexes.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The 60 freely exposed C<FONT CLASS="nobreak">-termini</FONT> are a key feature facilitating&#x00a0;the S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticle to be a useful vaccine platform. Foreign antigens or epitopes can simply be fused to the end of the S domain via flexible linker through recombinant DNA technology.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Uniform 60<FONT CLASS="nobreak">-valent</FONT>&#x00a0;NoV&#x00a0;VLPs or S particles&#x00a0;produced in a bacterial expression system have not been&#x00a0;produced before.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Importantly, our S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticles&#x00a0;maintained the native conformation with authentic antigenicity;&#x00a0;thus,&#x00a0;our&#x00a0;NoV&#x00a0;S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> nanoparticle technology represents a&#x00a0;significant bioengineering advancement.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Uniform complexity and size of vaccine particles are&#x00a0;important factors in quality control of vaccine products, as&#x00a0;variations in complexity and size will result in variations in&#x00a0;immunization outcomes of the vaccines.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">79</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Broad application to fuse several antigens to the S</FONT><FONT CLASS="Italic-Subscript" STYLE="font-style:italic;font-weight:normal;vertical-align:sub;font-size:58%;">60</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> nanoparticle</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:12pt;text-align:center;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"><IMG ALT="" SRC="ttable_002.jpg" STYLE="height:209.92px;width:267.52px;max-width:100%;"></FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> nanoparticles may serve as a polyvalent potent vaccine platform.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The self<FONT CLASS="nobreak">-assembled</FONT>, polyvalent S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticle with 60&#x00a0;flexibly exposed S domain C<FONT CLASS="nobreak">-termini</FONT> is an ideal vaccine&#x00a0;platform for antigen presentation and immunogenicity&#x00a0;enhancement.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This has been confirmed by when Hisx6 tag was fused to the hinge of the S domain via a linker, fusion proteins self<FONT CLASS="nobreak">-formed</FONT> into the S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> nanoparticles.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This has been demonstrated by constructing a&#x00a0;chimeric S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT>&#x00a0;nanoparticle displaying 60 RV VP8*&#x00a0;proteins, the&#x00a0;major rotavirus neutralizing antigen. The S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60 </FONT><FONT CLASS="nobreak">-VP8</FONT>*particles can be&#x00a0;easily produced with high stability. The chimeric nanoparticle induced&#x00a0;higher immunoglobulin, or IgG, response in mice toward the displayed VP8*antigen than soluble VP8* antigen.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60 </FONT><FONT CLASS="nobreak">-VP8</FONT>*particles&#x00a0;exhibited significantly stronger blockade.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:7pt;margin-top:7pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The polyvalent B- and T<FONT CLASS="nobreak">-cell</FONT> epitopes of the antigens on the polyvalent VLP platform led to induction of stronger humoral and cellular immune responses, respectively, in animals and humans compared with those elicited by the monovalent epitopes of the free antigen. Thus, the polyvalent VLP platform is likely to increase the immunogenicity of the displayed antigens.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_003.jpg" STYLE="height:294.4px;width:161.28px;max-width:100%;"></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">80</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">The&#x00a0;</FONT>P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">&#x00a0;Nanoparticle as a&#x00a0;versatile&#x00a0;platform</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The crystal structure of norovirus VLPs indicates that P domain is involved in strong dimeric interactions forming dimeric protrusions on the viral surface. The oligomeric interactions of the P domains are also observed at the five<FONT CLASS="nobreak">-fold</FONT> axes to&#x00a0;further stabilize the capsid structure.&#x00a0;When the P domain protein was expressed using the <FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">E. coli</FONT> system, it self<FONT CLASS="nobreak">-assembled</FONT> into P dimers, as well as 24 valent&#x00a0;P nanoparticles, P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT>.&#x00a0;P dimers and P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> nanoparticles can exchange dynamically, depending on concentration of the P domain protein, indication that the assembled P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> particles at this stage were unstable and easy to disassemble back into P dimers.&#x00a0;To facilitate P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT>&#x00a0;nanoparticle formation, inter<FONT CLASS="nobreak">-P</FONT> domain disulfide bonds were introduced&#x00a0;through fusion of a cysteine<FONT CLASS="nobreak">-containing</FONT> peptide to the end of the P domain. During the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24 </FONT>nanoparticle assembly, the cysteine patches were brought to the center of the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT>&#x00a0;nanoparticles, resulting in sterically&#x00a0;close contact and thus forming inter<FONT CLASS="nobreak">-P</FONT> domain disulfide bonds that significantly stabilized the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT>&#x00a0;nanoparticles, which could no longer disassemble back into the P dimers.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> nanoparticles can be produced using an <FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">E. coli</FONT> expression system faster and a lower cost than VLPs.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Both VLP and P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> nanoparticles without adjuvant produce innate,&#x00a0;humoral,&#x00a0;and cellular immunity.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The platform can be used to display foreign antigens, epitopes and viral pathogens and&#x00a0;non<FONT CLASS="nobreak">-infectious</FONT> disease.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Studies have demonstrated immune response against flu using&#x00a0;bi- or trivalent&#x00a0;vaccine candidates developed using this approach, noting the potential for the development of&#x00a0;a&#x00a0;universal flu vaccine.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Our Infectious Disease Vaccine Candidates</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Infectious diseases are one of the leading causes of death worldwide. Infectious disease is caused by microorganisms or pathogens, including viruses, bacteria, fungi, and parasites that infect an individual and cause disease. Diseases often cause high fever, inflammation, or other symptoms. While some diseases can be treated with drugs or therapeutics, some infectious agents evolve to become resistant to commonly used drugs, such as antibiotics, and can become difficult to control. Infectious diseases can be passed from person to person or transmitted by insects or other animals. In many cases, vaccines are used to elicit a protective immune response in the absence of an infection to render an individual immune to a particular infectious disease.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-101: UNIVERSAL INFLUENZA &amp; BWV-102 H1 INFLUENZA</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The company&#x2019;s&#x00a0;lead&#x00a0;vaccine&#x00a0;programs are focused on developing transformational and novel influenza vaccines: BWV<FONT CLASS="nobreak">-101</FONT> for an influenza vaccine to provide protection against H1, H3 and Flu B infections; and BWV<FONT CLASS="nobreak">-102</FONT> for a H1 only vaccine.&#x00a0;Our goal is to develop a vaccine that protects against all influenza strains that commonly infect humans by targeting specific parts of the&#x00a0;influenza&#x00a0;viruses, which are of limited variability across flu strains and induce a strong protective immune response. The BWV<FONT CLASS="nobreak">-101</FONT> vaccine candidate may potentially provide a therapeutic benefit that negates the need for annual vaccination,&#x00a0;vaccine reformulation, and provide long<FONT CLASS="nobreak">-lasting</FONT> broad protection against the flu to millions globally.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Influenza</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Influenza is a viral infection of the respiratory system, causing an infected person to suffer from certain symptoms, including fever, muscle aches, runny nose, cough, congestion, headaches, and fatigue. The four types of influenza viruses include type A, B, C, and D. The type A and B influenza viruses are referred to as human influenza viruses that are primarily responsible for seasonal flu epidemics each year. Type A flu viruses are further divided into two subtypes, named based on differences in two viral surface proteins called hemagglutinin (H) and neuraminidase (N). Influenza types C and D present a lower priority for vaccination, as Type C viruses cause a mild respiratory illness in humans and has not been associated with human epidemics, and Type D viruses primarily affect cattle and are not known to cause illness in humans.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">81</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;"><IMG ALT="" SRC="timage_004.jpg" STYLE="height:258.56px;width:600.32px;max-width:100%;"></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">There is a major unmet need for the development of a novel universal flu vaccine as a prophylactic therapy. Influenza is a major respiratory pathogen. The WHO estimates&#x00a0;there are an estimated 1<FONT CLASS="nobreak"> </FONT>billion cases of influenza infection with 3<FONT CLASS="nobreak">-5</FONT><FONT CLASS="nobreak"> </FONT>million severe cases and 290,000<FONT CLASS="nobreak">-650</FONT>,000 related respiratory human deaths worldwide every year. The estimate does not take into account deaths from other diseases such as cardiovascular disease, which can be influenza related.&#x00a0;The next influenza pandemic is believed by many experts to be a potentially devastating global health threat. Influenza&#x00a0;mortality rates are highest for the very young and elderly.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">The global influenza vaccine market was valued at $3.96<FONT CLASS="nobreak"> </FONT>billion in 2018, and is projected to reach $6.20<FONT CLASS="nobreak"> </FONT>billion by 2026, representing a CAGR of 5.9% from&#x00a0;2019 to 2026.&#x00a0;&#x00a0;Currently, the standard of care and most effective protection&#x00a0;against flu is through annual vaccination.&#x00a0;The WHO estimates that worldwide, approximately&#x00a0;$4<FONT CLASS="nobreak"> </FONT>billion is spent&#x00a0;on influenza vaccines&#x00a0;annually. However, the flu also a major cause of work&#x00a0;absenteeism, leading to an estimated&#x00a0;annual&#x00a0;productivity loss&#x00a0;in the U.S. of $87<FONT CLASS="nobreak"> </FONT>billion.&#x00a0;&#x00a0;Flu vaccination&#x00a0;consists of a yearly injection of attenuated or inactivated (dead) influenza viruses&#x00a0;to induce humoral immunity in the form of the antibodies against the&#x00a0;current circulating or anticipated&#x00a0;seasonal influenza strains.&#x00a0;The induction of antibody<FONT CLASS="nobreak">-producing</FONT> B<FONT CLASS="nobreak">-cells</FONT>&#x00a0;through vaccination&#x00a0;allows the immune system to&#x00a0;defend the body&#x00a0;against&#x00a0;the&#x00a0;influenza&#x00a0;virus circulating&#x00a0;during the winter months.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">An annual seasonal flu vaccine is the best way to help protect against flu. Vaccination has been shown to have many&#x00a0;benefits&#x00a0;including reducing the risk of flu illnesses, hospitalizations and even the risk of flu<FONT CLASS="nobreak">-related</FONT> death in children. The CDC recommends use of any licensed, age<FONT CLASS="nobreak">-appropriate</FONT> influenza vaccine during the 2020<FONT CLASS="nobreak">-2021</FONT> influenza season, including inactivated influenza vaccine (IIV), recombinant influenza vaccine (RIV), or&#x00a0;live attenuated influenza vaccine (LAIV).&#x00a0;No preference is expressed for any influenza vaccine over another. Both trivalent and quadrivalent influenza vaccines will be available. The trivalent vaccines formulation will include A(H1N1) pdm09, A(H3N2) and B/Victoria. The quadrivalent vaccine formulations will include A(H1N1) pdm09, A(H3N2) and B/Victoria, plus B/Yamagata.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">The current influenza vaccines induce antibodies that target&#x00a0;regions of the virus that are highly variable and have serious shortcomings, as they:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">(i)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;must be administered annually,</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">(ii)&#x00a0;&#x00a0;&#x00a0;&#x00a0;typically provide&#x00a0;protection to only 50% of the individuals&#x00a0;who&#x00a0;receive it; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">(iii)&#x00a0;&#x00a0;&#x00a0;need&#x00a0;to be updated annually and reformulated 6<FONT CLASS="nobreak"> </FONT>months prior to influenza season, such that strains that are subsequently prevalent during the applicable &#x201c;flu season&#x201d; are not protected against by the vaccine.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">82</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Our Proprietary Epitope Discovery</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">Using the technology that we have&#x00a0;exclusively&#x00a0;licensed&#x00a0;from the University of Oxford, we are developing a universal influenza vaccine. We have acquired intellectual property for cross<FONT CLASS="nobreak">-protective</FONT> epitopes to be used for our vaccine candidates that were developed and identified through a unique computational discovery process at Oxford University. The data produced through computational analysis at Oxford&#x00a0;has shown that antigen evolution in influenza is limited to certain regions of the&#x00a0;virus that facilitate binding and entry to host cells and these regions of limited antigenic variability are naturally immunogenic and therefore may be used to develop universal immunity to influenza viruses. We have identified epitopes of limited variability in H1&#x00a0;influenza that&#x00a0;have circulated&#x00a0;throughout history (since 1918) and make ideal vaccine targets and have completed similar analysis of H3 and Flu B strains for similar epitopes which will be used to produce our lead vaccine candidate BWV<FONT CLASS="nobreak">-101</FONT> as a universal vaccine for influenza infection.&#x00a0;&#x00a0;&#x00a0;Due to the cross<FONT CLASS="nobreak">-reactive</FONT> nature of the H1 epitopes in pre<FONT CLASS="nobreak">-pandemic</FONT> H1 influenza A, we are also pursuing the development of a stand<FONT CLASS="nobreak">-alone</FONT> H1 vaccine&#x00a0;(BWV<FONT CLASS="nobreak">-102</FONT>) These epitopes are able to be formulated into a vaccine using our VLP platform technologies and may be evaluated using other vaccine technologies through partnerships in order to accelerate development of vaccines or to explore adjunct therapies.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_005.jpg" STYLE="height:153.6px;width:509.44px;max-width:100%;"></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Antigenic Drift</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">A&#x00a0;single conformational&#x00a0;epitope is typically 8 to 15 amino acids in length and in an extreme circumstance (where every change creates&#x00a0;an escape mutant),&#x00a0;a&#x00a0;single&#x00a0;epitope could theoretically&#x00a0;vary&#x00a0;from 208&#x00a0;to 2015&#x00a0;different ways.&#x00a0;Therefore,&#x00a0;a highly variable virus&#x00a0;like influenza should be able to mutate in&#x00a0;countless ways during each&#x00a0;subsequent&#x00a0;season. This would inevitability&#x00a0;lead&#x00a0;to an explosion of genetic diversity and numerous circulating strains. </P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">However, it seems that there is&#x00a0;a&#x00a0;constraint limiting how influenza evolves, leading&#x00a0;to a single or limited number of strains dominating each&#x00a0;season.&#x00a0;In 2007, Sunetra Gupta led a group of researchers at the University of Oxford who published&#x00a0;a mathematical model proposing that the single strain dominance, typically seen worldwide annually, could be explained by hypothesising that epitopes of&#x00a0;&#x2018;limited variability&#x2019;&#x00a0;exist (Antigenic Drift Hypothesis). The model hypothesizes that while there is a significant amount of mutation of influenza strains, this variability occurs in a specific portion of the virus, while certain epitopes are required to remain relatively constant and are more limited in their variability in order for the virus to infect individuals, thus clarifying how influenza is not as variable as commonly thought.&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;margin-top:6pt;">Antigenic Drift Hypothesis Illustration</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><IMG ALT="" SRC="timage_006.jpg" STYLE="height:221.44px;width:417.28px;max-width:100%;"></P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">83</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Antigenic Drift Hypothesis suggests the existence of&#x00a0;epitopes of limited variability mediate a&#x00a0;population&#x2019;s immunity to influenza strains.&#x00a0;As a particular influenza strain circulates in the population, immunity to a specific pattern of epitopes is induced.&#x00a0;This leads the virus to change its antigenic configuration and cycle&#x00a0;through its limited repertoire of antigenic conformations. However, population immunity also changes due to birth and death within the population (i.e. individuals in the population who had experienced and developed immunity to certain&#x00a0;conformations&#x00a0;die). This allows prior epitope conformations to reappear.&#x00a0;The&#x00a0;loss of herd immunity&#x00a0;to these epitope of limited variability causes the emergence of epidemics</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Scientists have identified&#x00a0;the naturally antigenic regions that drive immunity&#x00a0;to influenza&#x00a0;by evaluating serum from these from various age groups&#x00a0;of humans.&#x00a0;These laboratory assays&#x00a0;were used to detect antibodies&#x00a0;and&#x00a0;demonstrated&#x00a0;that&#x00a0;young children ages 6 to 12 had immunity to historical influenza strains&#x00a0;that circulated many years prior to when they were born and they could never have possibly been exposed to, one of which&#x00a0;that last circulated in 1934.&#x00a0;Mutagenesis of the identified regions of limited variability&#x00a0;in various historical viruses&#x00a0;removed the protective immunity. Furthermore, vaccination&#x00a0;of&#x00a0;mice with these regions of the influenza virus produced an identical immune response that was observed in the children. For example, the mice vaccinated with either the region&#x00a0;from&#x00a0;the influenza virus&#x00a0;circulating in&#x00a0;2006&#x00a0;or 1977&#x00a0;were&#x00a0;protected&#x00a0;against&#x00a0;infection with an&#x00a0;influenza with a virus that last circulated in 1934,&#x00a0;replicating&#x00a0;the&#x00a0;immunity seen in children ages 6 to 12.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This work demonstrated that vaccination with just four&#x00a0;variants of one region of limited variability&#x00a0;in H1&#x00a0;influenza was able to&#x00a0;elicit&#x00a0;immunity to&#x00a0;all historical H1 influenza strains.&#x00a0;As these regions periodically reappear and disappear over time, vaccination with all of the possible variants would provide protection against future influenza&#x00a0;as well.&#x00a0;&#x00a0;The identified epitopes are restricted in their variability due to presence of a&#x00a0;receptor<FONT CLASS="nobreak">-binding</FONT>&#x00a0;site&#x00a0;and small&#x00a0;alpha helix&#x00a0;structure&#x00a0;between disulphide&#x00a0;bonds.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">The following research findings form the basis for our influenza vaccine candidates:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">1.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Epitopes of limited variability which are under strong&#x00a0;immune selection exist within influenza.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">2.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;These epitopes drive the antigenic evolution of influenza.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">3.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;These epitopes cycle between a limited number of&#x00a0;different conformations.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">4.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Epitopes of limited variability would make ideal vaccine&#x00a0;targets.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-101: Universal Influenza Vaccine</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our approach to developing a novel, universal flu vaccine for the prevention and protection against human influenza strains and potential pandemic strains by targeting specific limited variability epitopes includes the following steps and processes.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are exploring development of an influenza vaccine utilizing both the S &amp; P nanoparticles to determine the most effective and efficient presentation of our ELVs and the versatile S&amp;P nanoparticle vaccine platform from CHMC with the H1 influenza antigens.&#x00a0;This dual approach will allow us to gain valuable information as we further the development and manufacturing of&#x00a0;the&#x00a0;BWV<FONT CLASS="nobreak">-102</FONT>&#x00a0;program&#x00a0;and utilize it for the development of BWV<FONT CLASS="nobreak">-101</FONT>. We are currently assessing the ELVs to determine the most effective and efficient route of antigen presentation. Additionally,&#x00a0;we are currently optimizing antigens for H3 and&#x00a0;Flu B to be included with the identified H1 antigens to finalize our universal influenza vaccine formulation.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are using established manufacturing methods, including&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">E.coli</FONT>&#x00a0;fermentation to produce our chimeric proteins, to reduce the cost and increase the efficiency and scalability of our manufacturing process for the vaccine.&#x00a0;The antigens will be displayed by a&#x00a0;proprietary&#x00a0;virus<FONT CLASS="nobreak">-like</FONT> particle&#x00a0;(VLP)&#x00a0;that can&#x00a0;be produced in&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">E.&#x00a0;coli</FONT>.&#x00a0;Our research and discovery model uses bioinformatics and phylogenetic analysis to identify possible sites of epitopes of limited variability before confirming their existence experimentally.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To date, we have identified&#x00a0;naturally immunogenic epitopes for H1, H3 and influenza B. Bioinformatics studies and wet lab studies suggest that these&#x00a0;epitopes, especially H1N1, and the chimeric scaffold configuration of our vaccine induce immunity due to induction of broad cross<FONT CLASS="nobreak">-reactive</FONT> antibodies in other strains such as H10N3 (bird flu), and pandemic strains including H5NX, H7NX, and H9NX. Therefore, we foresee the development of H1N1 vaccine as a priority due to its high cross<FONT CLASS="nobreak">-reactive</FONT> priorities.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">84</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-102 Stand-Alone H1 Vaccine</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are developing our H1 stand<FONT CLASS="nobreak">-alone</FONT> influenza prophylactic product, BWV<FONT CLASS="nobreak">-102</FONT>, to address potential pandemic zoonotic H1 strains, specifically the G4 EA H1N1 identified by scientists and reported in June 2020, as a potential next pandemic strain. BWV<FONT CLASS="nobreak">-102</FONT> is being developed using the H1 ELVs identified by the team at the University of Oxford. While the product is designed to protect against infection from any H1 strain, there is potential for cross protection from H5 and H10 strain infections as well. Preclinical studies were conducted in Balb C mice using a prime<FONT CLASS="nobreak">-boost-boost</FONT> protocol. The proposed Phase 1 clinical study will employ this prime <FONT CLASS="nobreak">-boost</FONT> protocol; however, it is possible that a single dose of the vaccine candidate will confer protection against current and historical H1 strains with a prime<FONT CLASS="nobreak">-boost</FONT> dose or a single dose.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As reported in 2020, the G4 EA H1N1 strain is the most prevalent influenza strain circulating among swine populations in China. The strain was first identified in 2016 and has been monitored by scientists in China through their swine surveillance program. The strain has genes from a mix of pig, avian and human viruses, including genes from the 2009 H1N1 flu pandemic virus.&#x00a0;Currently, the G4 EA H1N1 strain is not transmissible human to human, however, scientists hypothesize that there is a high likelihood of strain reassortment occurring that could make human to human transmissibility possible. The current H1N1 influenza strain circulating may provide some protection against disease induced by G4 EA H1N1 infection.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The ability of the BWV<FONT CLASS="nobreak">-102</FONT> ELVs to induce an immune response and protection against heterologous challenge with historical strains was assessed in Balb<FONT CLASS="nobreak">-C</FONT> mice. We are currently assessing the ELVs in combination with the S60 particle, P24 particle and a proprietary VLP, currently in development, to determine the most effective and efficient route of antigen presentation. Manufacturing of the product is expected to occur in <FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">E. coli</FONT>. We anticipate results of the VLP presentation assessments in the first half of 2022.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-201 Streptococcus&#x00a0;pneumoniae (S. pneumoniae) Vaccine</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our BWV<FONT CLASS="nobreak">-201</FONT> vaccine&#x00a0;candidate is a&#x00a0;live&#x00a0;attenuated&#x00a0;serotype<FONT CLASS="nobreak">-independent</FONT>&#x00a0;vaccine, for which early data supports further investigation to pursue a long<FONT CLASS="nobreak">-term</FONT> preventive intranasal&#x00a0;vaccine&#x00a0;for&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S.&#x00a0;pneumoniae</FONT>&#x00a0;induced acute otitis media, or AOM.&#x00a0;We in<FONT CLASS="nobreak">-licensed</FONT> the&#x00a0;novel&#x00a0;live attenuated<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">&#x00a0;S.&#x00a0;pneumoniae</FONT>&#x00a0;strain&#x00a0;from&#x00a0;St. Jude Children&#x2019;s Research Hospital, or St. Jude, as a potential serotype independent vaccine.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The potential of this vaccine to provide a long<FONT CLASS="nobreak">-term</FONT>, leading alternative treatment for AOM and subsequent introduction of a novel preventative standard of care.&#x00a0;&#x00a0;&#x00a0;The development of a novel vaccine could eradicate potential&#x00a0;short<FONT CLASS="nobreak">-term</FONT> pain and/or&#x00a0;long<FONT CLASS="nobreak">-term</FONT> harmful side effects from contracting the virus.&#x00a0;&#x00a0;&#x00a0;Complications from AOM include&#x00a0;sensorineural&#x00a0;hearing loss, or SNHL,&#x00a0;in adults&#x00a0;but are more relevant for the endangerment of children.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Researchers from St. Jude developed a strain of <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S.&#x00a0;pneumoniae</FONT>&#x00a0;that contains greatly reduced virulence yet can transiently colonize the&#x00a0;nasopharyngeal cavity, inducing immune responses&#x00a0;to&#x00a0;significantly decrease the incidence of AOM and sinusitis&#x00a0;as demonstrated in&#x00a0;animal models.&#x00a0;Our vaccine production is a straightforward process, utilizing the entire novel attenuated bacterium with&#x00a0;purification and concentration steps only in the downstream process, thereby&#x00a0;reducing the time and cost of production significantly compared to commonly used polysaccharide or&#x00a0;conjugate vaccines.&#x00a0;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Based on information from the American Academy of Pediatrics, over 5<FONT CLASS="nobreak"> </FONT>million cases of AOM are reported annually in the U.S., resulting in approximately 30<FONT CLASS="nobreak"> </FONT>million medical care visits and over 10<FONT CLASS="nobreak"> </FONT>million antibiotic prescriptions.&#x00a0;AOM is the most common condition treated with antibiotics in the United States and increasing antibiotic resistance among the organisms responsible for AOM is of concern to researchers.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additional&#x00a0;statistics&#x00a0;supporting the need for a novel preventive vaccine:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The global AOM rate is 10.85%, or 709<FONT CLASS="nobreak"> </FONT>million cases per year, with 51%&#x00a0;occurring in children under 5 years old.&#x00a0;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>By 3 years of age, 80% of children globally are expected to have at least one&#x00a0;episode of AOM.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Current treatment for AOM is by antibiotic prescription, with more than&#x00a0;80% of all consultations resulting in a prescription. </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">85</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Even with the introduction of the pneumococcal conjugate vaccine (PCV13) in 2010, 26<FONT CLASS="nobreak">-36</FONT>% of cases of AOM in U.S.&#x00a0;were caused by&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae.</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Worldwide cases of AOM due to&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae&#x00a0;</FONT>is estimated to be 30<FONT CLASS="nobreak">-50</FONT>%.&#x00a0;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>An estimated&#x00a0;$4.3<FONT CLASS="nobreak"> </FONT>billion USD<FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT>is spent on AOM treatment each year in&#x00a0;the U.S. alone.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The current standard of care treatment for AOM in children is reliant on antibiotics. The resolution rate of AOM in children is 81% without antibiotic treatment vs. 93% with antibiotic treatment. &#x00a0;Antibiotic treatment of AOM in children&#x00a0;has&#x00a0;limitations, including recurrence within 30 days.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The CDC recommends broad pneumococcal vaccines for children younger than 2 and for adults over 65 years of age (CDC). The CDC also recommends vaccinations for children and adults age 2 through 64 either previously unvaccinated or partially vaccinated. Two vaccines are currently approved in the U.S. and other countries: Prevnar13 or PCV13 (Pfizer) (ii) Pneumovax or PPSV23 (Merck). An additional vaccine, Synflorix, is for approved use outside of the U.S. for the prevention of pneumococcal disease and <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae</FONT> induced AOM for the 10 serotypes included in the vaccine.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Therefore, an effective&#x00a0;serotype independent <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae</FONT>&#x00a0;AOM vaccine could significantly impact pediatric healthcare demand.&#x00a0;As&#x00a0;a preventative treatment, the vaccine&#x2019;s advantages include:&#x00a0;reduction of near<FONT CLASS="nobreak">-term</FONT> pain; reduction of recurrent AOM that may result in the need for&#x00a0;tympanostomy tube placement; lessening of antibiotic usage, which would decrease the number of antibiotic resistant organisms in the environment; and avoiding potential long<FONT CLASS="nobreak">-term</FONT> hearing loss. </P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Previous live, attenuated strains of&#x00a0;S. pneumoniae&#x00a0;were generated by deleting several highly immunogenic virulent genes.&#x00a0;Some of these deletions include antigens that induce potent antibody responses following pneumococcal carriage and otitis media in young children and therefore may not be optimal vaccine candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our technology in<FONT CLASS="nobreak">-licensed</FONT>&#x00a0;from St.&#x00a0;Jude focuses on candidate genes essential for microbial adaptation to the host environment while maintaining virulence determinants. The St. Jude researchers developed a&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae strain</FONT>&#x00a0;with a deletion in&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">ftsY</FONT>, a central component of the signal recognition pathway (SRP).&#x00a0;SRP mutants have greatly reduced virulence, although virulence factors are still produced. The&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae&#x00a0;ftsY</FONT>&#x00a0;deletion strain may make an ideal live attenuated vaccine, as it can transiently colonize the nasopharyngeal cavity inducing immune responses to virulence protein antigens but does not cause invasive disease.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our&#x00a0;candidate vaccine&#x00a0;is a&#x00a0;live&#x00a0;attenuated&#x00a0;serotype<FONT CLASS="nobreak">-independent</FONT>&#x00a0;vaccine, that early data supports further development to pursue a long<FONT CLASS="nobreak">-term</FONT> preventive intranasal treatment.&#x00a0;BWV<FONT CLASS="nobreak">-201</FONT> will likely require two doses to provide life<FONT CLASS="nobreak">-long</FONT> protection.&#x00a0;&#x00a0;&#x00a0;BWV<FONT CLASS="nobreak">-201</FONT>&#x2019;s&#x00a0;has the ability to transiently colonize the nasopharyngeal cavity and significantly decrease the incidence of AOM and sinusitis in animal models. The vaccine candidate is derived from the noninvasive serotype 19F strain BHN97, which normally causes sinusitis/purulent rhinitis and AOM.&#x00a0;As previously noted, the&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">ftsY</FONT>&#x00a0;gene was deleted by St. Jude researchers, and is&#x00a0;designated BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our vaccine production is a straightforward approach, utilizing the entire bacterium with&#x00a0;purification and concentration steps only in the downstream process thereby&#x00a0;significantly reducing the time and cost of production compared to polysaccharide or&#x00a0;conjugate vaccines.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Preclinical data&#x00a0;colonization and invasiveness</FONT> <FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">and </FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Otitis Media/Sinusitis Efficacy</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our pre<FONT CLASS="nobreak">-clinical</FONT> data has shown encouraging results from the research and development of BWV-201 as a potential intranasal delivered vaccine candidate. Multiple animal models have demonstrated protection from AOM.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To demonstrate vaccine efficacy against AOM and sinusitis, mice were immunized (prime and two boosts) with Prevnar<FONT CLASS="nobreak"> </FONT>7, Pneumovax, D39x and BHN197&#x00a0;caxP&#x00a0;and&#x00a0;ftsY&#x00a0;deletion mutants.&#x00a0;Two weeks following the second boost, the bioluminescent strain BNH97x (type 19F), a serotype included in Prevnar<FONT CLASS="nobreak"> </FONT>7, Pneumovax and BHN97ftsY&#x00a0;(referred to as homologous challenge) were introduced to the mice.&#x00a0;Only BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY,&#x00a0;and to a lesser extent Prevnar<FONT CLASS="nobreak"> </FONT>7, showed significant reduction in AOM and only BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY&#x00a0;demonstrated significantly reduced sinusitis compared to mock infected animals.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">86</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To determine if BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY&#x00a0;(serotype 19F) can induce heterotypic AOM protection (AOM caused by a&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae&#x00a0;</FONT>serotype not contained in the vaccine), mice were immunized as detailed above and challenged with BHN54 (serotype 7), which causes otitis media in about 50% of challenged animals.&#x00a0;The control vaccine Prevnar 13 contains serotype 7;&#x00a0;therefore,&#x00a0;this study compares heterotypic (BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY) versus homotypic (Prevnar 13) vaccine protection.&#x00a0;BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY&#x00a0;had a 10<FONT CLASS="nobreak">-fold</FONT> lower incidence of AOM when compared to mock immunized animals, demonstrating that the attenuated vaccine does induce heterotypic protection.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY induced protection from AOM was additionally confirmed in a chinchilla animal model. Animals were immunized (prime and two boosts) and then challenged with BHN97 two weeks after the final boost. Vaccinated animals had a decreased incidence of culture<FONT CLASS="nobreak">-positive</FONT> ears and had a significantly decreased number of recoverable bacteria from the middle ear.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A potential advantage of an attenuated&#x00a0;<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">S. pneumoniae&#x00a0;</FONT>vaccine such as&#x00a0;BHN97<FONT CLASS="CharOverride-5" STYLE="font-family:Symbol, sans-serif;">D</FONT>ftsY&#x00a0;is that immune responses are directed to bacterial proteins rather than just&#x00a0;polysaccharides and&#x00a0;should not be limited to serotype specific protection.&#x00a0;Purified polysaccharide (PPV) vaccines such as Pneumovax (produced by Merck &amp;Co.) and pneumococcal conjugate vaccines such as Prevnar 7/13/20 (produced by Wyeth/Pfizer) or&#x00a0;Synflorix&#x00a0;(produced by GlaxoSmithKline plc) are generally considered serotype specific, inducing protection to disease caused only by pneumococcal strains contained in the vaccines.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">BWV-301 Norovirus-Rotavirus Vaccine Program</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are developing BWV<FONT CLASS="nobreak">-201</FONT> to prevent acute gastroenteritis, or AGE, caused by norovirus and rotavirus, utilizing the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> nanoparticle of our vaccine platform. The vaccine is based on one or two doses of the norovirus P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> nanoparticle presenting 24 rotavirus VP8* antigens. Most cases of gastroenteritis are caused by viruses. The CDC reports that viral gastroenteritis infections cause 200,000 deaths in children worldwide each year. Common symptoms of viral gastroenteritis causes nausea, vomiting, diarrhea, anorexia, weight loss, and dehydration.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Gastroenteritis</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Gastroenteritis, often called stomach flu, is inflammation of the gastrointestinal tract &#x2014; the stomach and intestine. Symptoms may include diarrhea, vomiting and abdominal pain. Fever, lack of energy and dehydration may also occur. While gastroenteritis is usually caused by viruses, bacteria, parasites, and fungus can also cause gastroenteritis. Eating improperly prepared food, drinking contaminated water or close contact with a person who is infected can spread the disease. Norovirus and rotavirus are two viruses that cause gastroenteritis in adults and children.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In 2015, there were two billion cases of gastroenteritis, resulting in 1.3<FONT CLASS="nobreak"> </FONT>million deaths globally. Children and those in the developing world are affected the most. In 2011, there were about 1.7<FONT CLASS="nobreak"> </FONT>billion cases, resulting in about 700,000 deaths of children under the age of five. In the developing world, children less than two years of age frequently get six or more infections a year. It is less common in adults, partly due to the development of immunity. In adults, norovirus is the most common cause of severe disease. IRota virus, however, is the common cause of AGE in children.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Norovirus</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Norovirus causes significant debilitating AGE, with a reported 700<FONT CLASS="nobreak"> </FONT>million infections and 20% of all diarrheal cases reported annually worldwide. Norovirus is the cause of approximately 20% of all AGE cases worldwide each year. It is estimated that 68.9 cases of norovirus infection occur in every 1000 people. In North America, norovirus induced AGE tends to be seasonal, occurring in cooler, rainy months and particularly impacts groups in close proximity, such as in schools, dormitories, medical facilities, and cruise ships.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Norovirus costs $60.3<FONT CLASS="nobreak"> </FONT>billion worldwide each year. Globally, norovirus resulted in a total of approximately $4.2<FONT CLASS="nobreak"> </FONT>billion in direct health system costs and approximately $60.3<FONT CLASS="nobreak"> </FONT>billion in societal costs per year. Disease among children younger than 5 years cost society $39.8<FONT CLASS="nobreak"> </FONT>billion, compared to $20.4<FONT CLASS="nobreak"> </FONT>billion for all other age groups combined. Costs per norovirus illness varied by both region and age and was highest among adults ages 55 years and older. Productivity losses represented 84<FONT CLASS="nobreak">-99</FONT>% of total costs varying by region. While low and middle income countries and high income countries had similar disease incidence (10,148 vs. 9,935 illness per 100,000 persons), high income countries generated 62% of global health system costs.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">87</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In North America, the median yearly cost of outbreaks was $7.6<FONT CLASS="nobreak"> </FONT>million in direct medical costs, and $165.3<FONT CLASS="nobreak"> </FONT>million in productivity losses. An average of approximately 113,000 hospitalizations, 8.2<FONT CLASS="nobreak">-122</FONT>.9<FONT CLASS="nobreak"> </FONT>million missed school/work days, $0.2-$2.3<FONT CLASS="nobreak"> </FONT>billion in direct medical costs, and $1.4-$20.7<FONT CLASS="nobreak"> </FONT>billion in productivity losses was due to sporadic illness. The total economic impact of norovirus infection was $10.6<FONT CLASS="nobreak"> </FONT>billion based on the current incidence estimate 68.9 cases per 1000 population, or approximately $0.15<FONT CLASS="nobreak"> </FONT>million per person infected.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The total economic burden is greatest in young children but the highest cost per illness is among older age groups in some regions. These large costs overwhelmingly are from productivity losses resulting from acute illness. Low, middle, and high income countries all have a considerable economic burden, suggesting that norovirus gastroenteritis is a truly global economic problem.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There is not a norovirus vaccine on the market presently. There are, however, a number of rotavirus vaccines currently marketed around the world. RotaTeq, owned by Merck, a live, oral pentavalent vaccine and Rotarix, owned by GSK, a monovalent, human, live attenuated vaccine are recommended by the World Health Organization (WHO) for global use in children and approved for use in the U.S., Canada and Europe. Other monovalent vaccines are available but only approved for use in one country, either China, Vietnam or India.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Development</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLPs produced in <FONT CLASS="CharOverride-4" STYLE="font-style:italic;font-weight:normal;">E. coli</FONT> and norovirus VP1 VLPs produced in a baculovirus expression system were both demonstrated to elicit innate, humoral and cellular immunity in a mouse model, indicating that both constructs have potential as norovirus virus candidates. In addition, when delivered intranasally both constructs were able to induce partial cross<FONT CLASS="nobreak">-variant</FONT> protection against diarrhea in a gnotobiotic pig model.</P>
		<P CLASS="H5" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Rotavirus</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Rotavirus is the most common cause of diarrheal disease among infants and young children. After the introduction of live attenuated oral vaccines the incidence of rotaviral hospitalizations and deaths have significantly declined. However, there is still a need for efficacious, cost<FONT CLASS="nobreak">-effective</FONT> rotavirus vaccines.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The rotavirus vaccine is recommended by the CDC and ACIP as a prevention for children. However, managing the symptoms is the only way to help adults and children infected with either of the viruses. Due to the potential of death, most treatments are focused on dehydration prevention and management. Treatment involves getting enough fluids. For mild or moderate cases, this can typically be achieved by drinking oral rehydration solution (a combination of water, salts and sugar).<FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;"> </FONT>In those who are breastfed, continued breastfeeding is recommended. For more severe cases, intravenous fluids may be needed and care provided in the hospital. Fluids may also be given by a nasogastric tube. Zinc supplementation is recommended in children. Antibiotics are generally not needed. However, antibiotics are recommended for young children with a fever and bloody diarrhea.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To determine the potential of the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLP to serve as a rotavirus vaccine candidate, the 159 amino acid VP8* protein was inserted into a P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> domain surface loop. The fusion proteins self<FONT CLASS="nobreak">-assembled</FONT> into P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLPs, and the 24 rotavirus VP8* antigens were demonstrated by cryo<FONT CLASS="nobreak">-EM</FONT> to be displayed on the outermost surface of the chimeric P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLP. Mice immunized intranasally with the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-VP8</FONT>* or intramuscularly with Freund&#x2019;s adjuvant elicited significantly higher rotavirus neutralizing antibodies than the free VP8* immunized under the same conditions (IN&#x00a0;or IM).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-VP8</FONT>* VLPs were further characterized as a potential rotavirus vaccine in mouse and gnotobiotic pig challenge studies. A construct consisting of P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> and the VP8* antigen from the murine rotavirus EDIM strain was constructed and tested using a murine rotavirus challenge model. Mice were immunized with P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-mouseVP8</FONT>*, mouseVP8* alone or P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-human</FONT> VP8* 3 times intranasally without adjuvant. Rotavirus shedding was significantly lower in animals immunized with P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-mouseVP8</FONT>* than mock vaccinated or animals that received mouseVP8* only or P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-humanVP8</FONT>* (Tan et al. J. Virol. 85(2):753<FONT CLASS="nobreak">-764</FONT>. 2011). A construct of P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> and the VP8* antigen corresponding to human rotavirus Wa strain was tested in a gnotobiotic pig challenge model. Animals were immunized intramuscularly (IM) three times with either P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-WuVP8</FONT>* with aluminum hydroxide adjuvant or aluminum hydroxide alone and were challenged with human Wa rotavirus 7 days post dose three. Animals immunized with P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-WuVP8</FONT>* showed a significant reduction in the mean duration of diarrhea, virus shedding and significantly lower fecal cumulative consistency scores compared to adjuvant only control group (Ramesh et al. Vaccines 7: 177 2019; doi:10.3390/vaccines7040177).</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">88</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">An effective norovirus culture<FONT CLASS="nobreak">-based</FONT> neutralization assay is not available, due to the lack of an efficient cell culture system to produce human norovirus. Therefore, a surrogate neutralization assay has been developed in the field, measuring the ability of antisera to block norovirus VLP binding to host receptors. In addition to generating rotavirus neutralizing antibody, Tan et al (J. Virol. 86:753<FONT CLASS="nobreak">-764</FONT>. 2011) demonstrated that anti- P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-VP8</FONT>* mouse sera blocked norovirus VLP binding, indicating that the insertion of the VP8* fragment did not inhibit induction of norovirus VLP binding antibodies and suggesting the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT><FONT CLASS="nobreak">-VP8</FONT> construct could potentially serve as a single vaccine against both rotavirus and norovirus disease.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Our Vaccine</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We hold the exclusive global license for the novel norovirus<FONT CLASS="nobreak">-rotavirus</FONT> combination vaccine (except in China and Hong Kong) from Cincinnati Children&#x2019;s Hospital Medical Center, or CHMC, CHMC researchers engineered the norovirus major structural protein VP1 such that the N<FONT CLASS="nobreak">-terminal</FONT> shell (S) and C<FONT CLASS="nobreak">-terminal</FONT> protruding (P) domains of VPI could be expressed as separate S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> and P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> virus<FONT CLASS="nobreak">-like</FONT> particles (VLPs). Unlike norovirus VLPs composed of the intact VP1 protein or the unmodified S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> fragment, our S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> and P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT>VLPs can be expressed in <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">E. coli</FONT>. The researchers demonstrated that S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> VLPs could be used to present foreign antigens on the surface of the S<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">60</FONT> VLP. Further, it has also demonstrated that foreign antigens could also be expressed on the surface of the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLP. The proposed norovirus<FONT CLASS="nobreak">-rotavirus</FONT> vaccine is based on the P<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">24</FONT> VLP technology.Our vaccine production is based on an <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">E.coli</FONT> expression platform.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Development</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Following IND submission, if accepted, we intend to initiate our Phase I clinical trial in healthy adults ages 18 to 54. If approved, we believe our vaccine is well positioned to receive a recommendation from the CDC, ACIP, and similar international advisory groups for inclusion in vaccine programs.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Government Regulation and Product Approval</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post<FONT CLASS="nobreak">-approval</FONT> monitoring and post<FONT CLASS="nobreak">-approval</FONT> reporting of drugs and biologics such as those we are developing.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Small molecule drugs are subject to regulation under the Food, Drug, and Cosmetic Act, or FDCA, and biological products are additionally subject to regulation under the Public Health Service Act, or PHSA, and both are subject to additional federal, state, local and foreign statutes and regulations. We, along with third<FONT CLASS="nobreak">-party</FONT> contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"></FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">United States</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">U. S. Biopharmaceuticals Regulation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The process required by the FDA before drug and biologic product candidates may be marketed in the United States generally involves the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>completion of extensive preclinical laboratory tests and animal studies performed in accordance with applicable regulations, including the FDA&#x2019;s Good Laboratory Practice, or GLP, regulations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>submission to the FDA of an investigational new drug application, IND, which must become effective before clinical trials may begin;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>approval by an independent institutional review board or ethics committee at each clinical site before the trial is commenced;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>performance of adequate and well<FONT CLASS="nobreak">-controlled</FONT> human clinical trials in accordance with FDA&#x2019;s Good Clinical Practice, or GCP, regulations to establish the safety and efficacy of a drug candidate and safety, purity and potency of a proposed biologic product candidate for its intended purpose;</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">89</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>preparation of and submission to the FDA of a new drug application, or NDA, or biologics license application, or BLA, as applicable, after completion of all pivotal clinical trials;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>satisfactory completion of an FDA Advisory Committee review, if applicable;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>a determination by the FDA within 60 days of its receipt of an NDA or BLA to file the application for review;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>satisfactory completion of an FDA&#x00a0;pre<FONT CLASS="nobreak">-approval</FONT>&#x00a0;inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with current Good Manufacturing Practice requirements, or cGMPs, and of selected clinical investigation sites to assess compliance with GCPs; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>FDA review and approval of an NDA, or licensure of a BLA, to permit commercial marketing of the product for particular indications for use in the United States.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">Preclinical and Clinical Development</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to beginning the first clinical trial with a product candidate, we must submit an IND to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol or protocols for preclinical studies and clinical trials. The IND also includes results of animal and in vitro studies assessing the toxicology, pharmacokinetics, pharmacology and pharmacodynamic characteristics of the product, chemistry, manufacturing and controls information, and any available human data or literature to support the use of the investigational product. An IND must become effective before human clinical trials may begin. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the&#x00a0;30<FONT CLASS="nobreak">-day</FONT>&#x00a0;period, raises safety concerns or questions about the proposed clinical trial. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each successive clinical trial conducted during product development and for any subsequent protocol amendments. Furthermore, an independent institutional review board for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the institutional review board or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For purposes of biopharmaceutical development, human clinical trials are typically conducted in three sequential phases that may overlap or be combined;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Phase 1.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The investigational product is initially introduced into patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;font-style:italic;font-weight:normal;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Phase 2.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The investigational product is administered to a limited patient population to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">90</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;font-style:italic;font-weight:normal;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Phase 3.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more information about the product. These&#x00a0;so<FONT CLASS="nobreak">-called</FONT>&#x00a0;Phase 4 studies may be made a condition to approval of the application. Concurrent with clinical trials, companies may complete additional animal studies and develop additional information about the characteristics of the product candidate and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data, and clinical study investigators. The FDA or the sponsor or its data safety monitoring board may suspend a clinical study at any time on various grounds, including a finding that the research patients or patients are being exposed to an unacceptable health risk. Similarly, an institutional review board can suspend or terminate approval of a clinical study at its institution if the clinical study is not being conducted in accordance with the institutional review board&#x2019;s requirements or if the biological product candidate has been associated with unexpected serious harm to patients. There are also requirements governing the reporting of ongoing clinical trials and completed clinical trial results to public registries. Sponsors of clinical trials of&#x00a0;FDA<FONT CLASS="nobreak">-regulated</FONT>&#x00a0;products are required to register and disclose certain clinical trial information, which is publicly available at <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.clinicaltrials.gov</FONT>.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">NDA/BLA Submission and Review</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of an NDA or BLA, as applicable, requesting approval to market the product for one or more indications. The application must include all relevant data available from pertinent preclinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#x2019;s chemistry, manufacturing, controls, and proposed labeling, among other things. The submission of an application requires payment of a substantial application user fee to the FDA, unless a waiver or exemption applies. The FDA has sixty days from the applicant&#x2019;s submission to either issue a refusal to file letter or accept the application for filing, indicating that it is sufficiently complete to permit substantive review.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Once an NDA or BLA has been accepted for filing, the FDA&#x2019;s goal is to review standard applications within 10<FONT CLASS="nobreak"> </FONT>months after it accepts the application for filing, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process is often significantly extended by FDA requests for additional information or clarification. The FDA reviews an NDA to determine whether a drug is safe and effective for its intended use and a BLA to determine whether a biologic is safe, pure and potent. FDA also reviews whether the facility in which the product is manufactured, processed, packed or held meets standards designed to assure and preserve the product&#x2019;s identity, safety, strength, quality, potency and purity. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving an NDA or BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an application, the FDA will typically inspect one or more clinical sites to assure compliance with GCPs. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">91</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">After the FDA evaluates an application and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be manufactured, the FDA may issue an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter will describe all of the deficiencies that the FDA has identified in the application, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the Complete Response letter without first conducting required inspections, testing submitted product lots and/or reviewing proposed labeling. In issuing the Complete Response letter, the FDA may recommend actions that the applicant might take to place the application in condition for approval, including requests for additional information or clarification, which may include the potential requirement for additional clinical studies. The FDA may delay or refuse approval of an application if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post<FONT CLASS="nobreak">-marketing</FONT> testing and surveillance to monitor safety or efficacy of a product.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the application with a risk evaluation and mitigation strategy, or REMS, to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with&#x00a0;pre-&#x00a0;and post<FONT CLASS="nobreak">-marketing</FONT> requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more Phase 4 post<FONT CLASS="nobreak">-market</FONT> studies and surveillance to further assess and monitor the product&#x2019;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these post<FONT CLASS="nobreak">-marketing</FONT> studies.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">Expedited Development and Review Programs</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The FDA offers a number of expedited development and review programs for qualifying product candidates. The fast track program is intended to expedite or facilitate the process for reviewing new products that meet certain criteria. Specifically, new products are eligible for fast track designation if they are intended to treat a serious or life<FONT CLASS="nobreak">-threatening</FONT> disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a fast track product has opportunities for frequent interactions with the review team during product development and, once an NDA or BLA is submitted, the product may be eligible for priority review. A fast track product may also be eligible for rolling review, where the FDA may consider for review sections of the NDA or BLA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the application, the FDA agrees to accept sections of the application and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the application.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A product intended to treat a serious or life<FONT CLASS="nobreak">-threatening</FONT> disease or condition may also be eligible for breakthrough therapy designation to expedite its development and review. A product can receive breakthrough therapy designation if preliminary clinical evidence indicates that the product, alone or in combination with one or more other drugs or biologics, may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance beginning as early as Phase 1 and an organizational commitment to expedite the development and review of the product, including involvement of senior managers.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any marketing application for a drug or biologic submitted to the FDA for approval, including a product with a fast track designation and/or breakthrough therapy designation, may be eligible for other types of FDA programs intended to expedite the FDA review and approval process, such as priority review and accelerated approval. A product is eligible for priority review if it has the potential to provide a significant improvement in the treatment, diagnosis or prevention of a serious disease or condition. Priority review designation means the FDA&#x2019;s goal is to take action on the marketing application within six months of the&#x00a0;60<FONT CLASS="nobreak">-day</FONT>&#x00a0;filing date.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">92</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, products studied for their safety and effectiveness in treating serious or life<FONT CLASS="nobreak">-threatening</FONT> diseases or conditions may receive accelerated approval upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well<FONT CLASS="nobreak">-controlled</FONT> post<FONT CLASS="nobreak">-marketing</FONT> clinical studies to verify and describe the anticipated effect on irreversible morbidity or mortality or other clinical benefit. In addition, the FDA currently requires as a condition for accelerated approval&#x00a0;pre<FONT CLASS="nobreak">-approval</FONT>&#x00a0;of promotional materials, which could adversely impact the timing of the commercial launch of the product.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Fast track designation, breakthrough therapy designation and priority review do not change the standards for approval but may expedite the development or approval process. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened.</P>
		<P CLASS="H5" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">Orphan Drug Designation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States for which there is no reasonable expectation that the cost of developing and making available in the United States a drug or biologic for this type of disease or condition will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting an NDA or BLA. After the FDA grants orphan drug designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. The orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval process.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">If a product that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan drug exclusive approval (or exclusivity), which means that the FDA may not approve any other applications, including a full NDA or BLA, to market the same drug or biologic for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity or if the FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. Orphan drug exclusivity does not prevent the FDA from approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the NDA or BLA application fee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">Post-Approval Requirements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record<FONT CLASS="nobreak">-keeping</FONT>, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing user fee requirements, under which the FDA assesses an annual program fee for each product identified in an approved NDA or BLA. Biopharmaceutical manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMPs, which impose certain procedural and documentation requirements upon us and our third<FONT CLASS="nobreak">-party</FONT> manufacturers. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMPs and impose reporting requirements upon us and </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">93</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">any third<FONT CLASS="nobreak">-party</FONT> manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMPs and other aspects of regulatory compliance.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post<FONT CLASS="nobreak">-market</FONT> studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>fines, warning or untitled letters or holds on post<FONT CLASS="nobreak">-approval</FONT> clinical studies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>product seizure or detention, or refusal of the FDA to permit the import or export of products;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>mandated modification of promotional materials and labeling and the issuance of corrective information;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications containing warnings or other safety information about the product; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>injunctions or the imposition of civil or criminal penalties.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The FDA closely regulates the marketing, labeling, advertising and promotion of biopharmaceutical products. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#x2019;s FDA approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of&#x00a0;off<FONT CLASS="nobreak">-label</FONT>&#x00a0;uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may prescribe legally available products for uses that are not described in the product&#x2019;s labeling and that differ from those tested by us and approved by the FDA. Such&#x00a0;off<FONT CLASS="nobreak">-label</FONT>&#x00a0;uses are common across medical specialties. Physicians may believe that such&#x00a0;off<FONT CLASS="nobreak">-label</FONT>&#x00a0;uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#x2019;s communications on the subject of&#x00a0;off<FONT CLASS="nobreak">-label</FONT>&#x00a0;use of their products.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">U.S. </FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">M</FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">arket </FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">E</FONT><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">xclusivity</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A biological product can obtain pediatric market exclusivity in the U.S., which, if granted, adds six months to existing exclusivity periods, including some regulatory exclusivity periods tied to patent terms. This six<FONT CLASS="nobreak">-month</FONT> exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA<FONT CLASS="nobreak">-issued</FONT> &#x201c;Written Request&#x201d; for such a study.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an abbreviated approval pathway for biological products shown to be biosimilar to, or interchangeable with, an&#x00a0;FDA<FONT CLASS="nobreak">-licensed</FONT>&#x00a0;reference biological product. This amendment to the PHSA attempts to minimize duplicative testing.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and a clinical trial or trials. Interchangeability requires that a product is biosimilar to the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">94</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">product and, for products administered multiple times, the biologic and the reference biologic may be interchanged after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. However, complexities associated with the larger, and often more complex, structure of biological products, as well as the process by which such products are manufactured, pose significant hurdles to implementation that are still being worked out by the FDA.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product, and the FDA will not approve an application for a biosimilar or interchangeable product based on the reference biological product until 12 years after the date of first licensure of the reference product. &#x201c;First licensure&#x201d; typically means the initial date the particular product at issue was licensed in the U.S. Date of first licensure does not include the date of licensure of (and a new&#x00a0;period of exclusivity is not available for) a biological product if the licensure is for a supplement for the biological product or for a subsequent application by the same sponsor or manufacturer of the biological product (or licensor, predecessor in interest, or other related entity) for a change (not including a modification to the structure of the biological product) that results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or for a modification to the structure of the biological product that does not result in a change in safety, purity, or potency.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, government proposals have sought to reduce the&#x00a0;12<FONT CLASS="nobreak">-year</FONT>&#x00a0;reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate implementation and impact of the BPCIA is subject to significant uncertainty.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">Patent Term Restoration and Extension</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Depending upon the timing, duration and specifics of the FDA approval of our product candidates, some of our U.S. patents may be eligible for limited patent term extension. The provisions of the Drug Price Competition and Patent Term Restoration Act, informally known as the Hatch<FONT CLASS="nobreak">-Waxman</FONT> Act, permit a patent restoration term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#x2019;s approval date. The patent term restoration period is generally one<FONT CLASS="nobreak">-half</FONT> the time between the effective date of an IND and the submission date of a BLA plus the time between the submission date of a BLA and the approval of that application. Only one patent applicable to an approved product is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may apply for restoration of patent term for one of our currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant BLA.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Many other countries also provide for patent term extensions or similar extensions of patent protection for biologic products. For example, in Japan, it may be possible to extend the patent term for up to five years and in Europe, it may be possible to obtain a supplementary patent certificate that would effectively extend patent protection for up to five years.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;font-style:italic;font-weight:normal;">Federal and State Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition to FDA restrictions on marketing of pharmaceutical products, federal and state healthcare laws and regulations restrict business practices in the biopharmaceutical industry. These laws may impact, among other things, our current and future business operations, including our clinical research activities, and proposed sales, marketing and education programs and constrain the business or financial arrangements and relationships with healthcare providers and other parties through which we market, sell and distribute our products for which we obtain marketing approval. These laws include anti<FONT CLASS="nobreak">-kickback</FONT> and false claims laws and regulations, data privacy and security, and transparency laws and regulations, including, without limitation, those laws described below.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The U.S. federal Anti<FONT CLASS="nobreak">-Kickback</FONT> Statute prohibits any person or entity from, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or in return for purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order of any item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term &#x201c;remuneration&#x201d; has been broadly interpreted </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">95</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">to include anything of value. The U.S. federal Anti<FONT CLASS="nobreak">-Kickback</FONT> Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Several courts have interpreted the statute&#x2019;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the statute has been violated.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A person or entity does not need to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the U.S. federal Anti<FONT CLASS="nobreak">-Kickback</FONT> Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act or the civil monetary penalties laws.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Federal civil and criminal false claims laws and civil monetary penalties laws, including the federal civil False Claims Act, which can be enforced by individuals through civil whistleblower and qui tam actions, prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false claim for payment to the federal government or knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. A claim includes &#x201c;any request or demand&#x201d; for money or property presented to the U.S. government. Several pharmaceutical and other healthcare companies have been prosecuted under these laws for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Other companies have been prosecuted for causing false claims to be submitted because of the companies&#x2019; marketing of products for unapproved, and thus&#x00a0;non<FONT CLASS="nobreak">-reimbursable</FONT>,&#x00a0;uses.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, created additional federal criminal statutes that prohibit, among other things, knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private third<FONT CLASS="nobreak">-party</FONT> payors and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Also, many states have similar fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, we may be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their respective implementing regulations, impose specified requirements on certain types of individuals and entities relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#x2019;s security standards directly applicable to &#x201c;business associates,&#x201d; defined as independent contractors or agents of covered entities, which include certain healthcare providers, healthcare clearinghouses and health plans, that create, receive, maintain or transmit individually identifiable health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorney&#x2019;s fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain circumstances, many of which are not&#x00a0;pre<FONT CLASS="nobreak">-empted</FONT>&#x00a0;by HIPAA, differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare&#x00a0;&amp; Medicaid Services, or CMS, information related to payments or other transfers of value made to physicians and teaching hospitals, and applicable manufacturers and applicable group purchasing organizations to report annually to CMS ownership and investment interests held by physicians and their immediate family members.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">96</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We may also be subject to state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, state laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, marketing expenditures or drug pricing, and state and local laws that require the registration of pharmaceutical sales representatives.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Because of the breadth of these laws and the narrowness of available statutory exceptions and regulatory safe harbors, it is possible that some of our business activities could be subject to challenge under one or more of such laws. If our operations are found to be in violation of any of the federal and state laws described above or any other governmental regulations that apply to us, we may be subject to significant criminal, civil and administrative penalties including damages, fines, imprisonment, disgorgement, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of&#x00a0;non<FONT CLASS="nobreak">-compliance</FONT>&#x00a0;with these laws, contractual damages, reputational harm, diminished profits and future earnings, disgorgement, exclusion from participation in government healthcare programs and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. To the extent that any of our products are sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post<FONT CLASS="nobreak">-marketing</FONT> requirements, including safety surveillance, anti<FONT CLASS="nobreak">-fraud</FONT> and abuse laws, implementation of corporate compliance programs, reporting of payments or transfers of value to healthcare professionals, and additional data privacy and security requirements.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Healthcare Reform</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Coverage and Reimbursement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The future commercial success of our product candidates, if approved, will depend in part on the extent to which third<FONT CLASS="nobreak">-party</FONT> payors, such as governmental payor programs at the federal and state levels, including Medicare and Medicaid, private health insurers and other third<FONT CLASS="nobreak">-party</FONT> payors, provide coverage of and establish adequate reimbursement levels for our product candidates. Third<FONT CLASS="nobreak">-party</FONT> payors generally decide which products they will pay for and establish reimbursement levels for those products. In particular, in the United States, no uniform policy for coverage and reimbursement exists. Private health insurers and other third<FONT CLASS="nobreak">-party</FONT> payors often provide coverage and reimbursement for products based on the level at which the government, through the Medicare program, provides coverage and reimbursement for such products, but also on their own methods and approval process apart from Medicare determinations. Therefore, coverage and reimbursement can differ significantly from payor to payor.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the United States, the European Union, or EU, and other potentially significant markets for our product candidates, government authorities and third<FONT CLASS="nobreak">-party</FONT> payors are increasingly attempting to limit or regulate the price of products, particularly for new and innovative products, which often has resulted in average selling prices lower than they would otherwise be. Further, the increased emphasis on managed healthcare in the United States and on country and regional pricing and reimbursement controls in the EU will put additional pressure on product pricing, reimbursement and usage. These pressures can arise from rules and practices of managed care groups, judicial decisions and laws and regulations related to Medicare, Medicaid and healthcare reform, pharmaceutical coverage and reimbursement policies and pricing in general.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Third<FONT CLASS="nobreak">-party</FONT> payors are increasingly imposing additional requirements and restrictions on coverage and limiting reimbursement levels for products. For example, federal and state governments reimburse products at varying rates generally below average wholesale price. These restrictions and limitations influence the purchase of products. Third<FONT CLASS="nobreak">-party</FONT> payors may limit coverage to specific products on an approved list, or formulary, which might not include all of the&#x00a0;FDA<FONT CLASS="nobreak">-approved</FONT>&#x00a0;products for a particular indication. Similarly, because certain of our product candidates are physician<FONT CLASS="nobreak">-administered</FONT>, separate reimbursement for the product itself may or may not be available. Instead, the administering physician may only be reimbursed for providing the treatment or procedure in which our product is used. Third<FONT CLASS="nobreak">-party</FONT> payors are increasingly challenging the price and examining the medical necessity and cost<FONT CLASS="nobreak">-effectiveness</FONT> of products, in addition to their safety and efficacy. We may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost<FONT CLASS="nobreak">-effectiveness</FONT> of our product candidates, in addition to the costs required to obtain the FDA approvals. Our product candidates may not be considered medically necessary or cost<FONT CLASS="nobreak">-effective</FONT>. A payor&#x2019;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Adequate third<FONT CLASS="nobreak">-party</FONT> payor reimbursement may not be available to enable us to realize an appropriate return on our investment in product development. </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">97</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">Legislative proposals to reform healthcare or reduce costs under government insurance programs may result in lower reimbursement for our product candidates, if approved, or exclusion of our product candidates from coverage and reimbursement. The cost containment measures that third<FONT CLASS="nobreak">-party</FONT> payors and providers are instituting and any healthcare reform could significantly reduce our revenue from the sale of any approved product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The United States and some foreign jurisdictions are considering enacting or have enacted a number of additional legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our product candidates profitably, if approved. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts, which include major legislative initiatives to reduce the cost of care through changes in the healthcare system, including limits on the pricing, coverage, and reimbursement of pharmaceutical and biopharmaceutical products, especially under government<FONT CLASS="nobreak">-funded</FONT> healthcare programs, and increased governmental control of drug pricing.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There have been several U.S. government initiatives over the past few years to fund and incentivize certain comparative effectiveness research, including creation of the Patient<FONT CLASS="nobreak">-Centered</FONT> Outcomes Research Institute under the ACA. It is also possible that comparative effectiveness research demonstrating benefits in a competitor&#x2019;s product could adversely affect the sales of our product candidates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The ACA became law in March 2010 and substantially changed the way healthcare is financed by third<FONT CLASS="nobreak">-party</FONT> payors, and significantly impacts the U.S. pharmaceutical industry. Among other measures that may have an impact on our business, the ACA established an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription drugs and biologic agents; a new Medicare Part D coverage gap discount program; and a new formula that increased the rebates a manufacturer must pay under the Medicaid Drug Rebate Program. Additionally, the ACA extended manufacturers&#x2019; Medicaid rebate liability, expands eligibility criteria for Medicaid programs, and expanded entities eligible for discounts under the Public Health Service Act. At this time, we are unsure of the full impact that the ACA will have on our business.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA, as well as recent efforts by the Trump administration to repeal or replace certain aspects of the ACA, and we expect such challenges and amendments to continue. Since January 2017, President Trump has signed two Executive Orders and other directives designed to delay the implementation of certain ACA provisions or otherwise circumvent requirements for health insurance mandated by the ACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, two bills affecting the implementation of certain taxes under the ACA have been signed into law. The Tax Cuts and Jobs Act of 2017, or Tax Act, includes a provision that repealed, effective January&#x00a0;1, 2019, the&#x00a0;tax<FONT CLASS="nobreak">-based</FONT>&#x00a0;shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#x201c;individual mandate.&#x201d; On January&#x00a0;22, 2018, President Trump signed a continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of certain&#x00a0;ACA<FONT CLASS="nobreak">-mandated</FONT>&#x00a0;fees, including the&#x00a0;so<FONT CLASS="nobreak">-called</FONT>&#x00a0;&#x201c;Cadillac&#x201d; tax on certain high cost employer<FONT CLASS="nobreak">-sponsored</FONT> insurance plans, the annual fee imposed on certain health insurance providers based on market share, and the medical device excise tax on nonexempt medical devices. The Bipartisan Budget Act of 2018, or the BBA, among other things, amended the ACA, effective January&#x00a0;1, 2019, to increase from 50% to 70% the&#x00a0;point<FONT CLASS="nobreak">-of-sale</FONT>&#x00a0;discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and to close the coverage gap in most Medicare drug plans, commonly referred to as the &#x201c;donut hole.&#x201d; In July 2018, CMS published a final rule permitting further collections and payments to and from certain ACA qualified health plans and health insurance issuers under the ACA adjustment program in response to the outcome of federal district court litigation regarding the method CMS uses to determine this risk adjustment. In December 2018, a U.S. District Court Judge in the Northern District of Texas, or Texas District Court Judge, ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. While the Texas District Court Judge, as well as the Trump administration and CMS, have stated that the ruling will have no immediate effect, it is unclear how this decision, subsequent appeals, and other efforts to repeal and replace the ACA will impact the ACA.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">98</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. In August 2011, the President signed into law the Budget Control Act of 2011, as amended, which, among other things, included aggregate reductions to Medicare payments to providers of 2% per fiscal year, which began in 2013 and, following passage of subsequent legislation, including the BBA, will continue through 2027 unless additional Congressional action is taken. In January 2013, the American Taxpayer Relief Act of 2012 was enacted which, among other things, reduced Medicare payments to several types of providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Further, there has been increasing legislative and enforcement interest in the United States with respect to drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. At the federal level, the Trump administration&#x2019;s budget proposal for fiscal year 2019 contains further drug price control measures that could be enacted during the 2019 budget process or in other future legislation, including, for example, measures to permit Medicare Part D plans to negotiate the price of certain drugs under Medicare Part B, to allow some states to negotiate drug prices under Medicaid, and to eliminate cost sharing for generic drugs for&#x00a0;low<FONT CLASS="nobreak">-income</FONT>&#x00a0;patients. Additionally, the Trump administration released a &#x201c;Blueprint&#x201d; to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers. The U.S. Department of Health and Human Services, or HHS, has already started the process of soliciting feedback on some of these measures and is implementing others under its existing authority. For example, in September 2018, CMS announced that it will allow Medicare Advantage plans the option to use step therapy for Part B drugs beginning January&#x00a0;1, 2019. On January&#x00a0;31, 2019, the HHS Office of Inspector General proposed modifications to U.S. federal Anti<FONT CLASS="nobreak">-Kickback</FONT> Statute safe harbors which, among other things, may affect rebates paid by manufacturers to Medicare Part D plans, the purpose of which is to further reduce the cost of drug products to consumers. In addition, CMS issued a final rule, effective on July&#x00a0;9, 2019, that requires&#x00a0;direct<FONT CLASS="nobreak">-to-consumer</FONT>&#x00a0;television advertisements of prescription drugs and biological products, for which payment is available through or under Medicare or Medicaid, to include in the advertisement the Wholesale Acquisition Cost, or list price, of that drug or biological product if it is equal to or greater than $35 for a monthly supply or usual course of treatment. Prescription drugs and biological products that are in violation of these requirements will be included on a public list. Congress and the Trump administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine which drugs and suppliers will be included in their healthcare programs. Furthermore, there has been increased interest by third party payors and governmental authorities in reference pricing systems and publication of discounts and list prices. These measures could reduce future demand for our products or put pressure on our pricing.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, in May 2018, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, or the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase&#x00a0;1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Foreign Regulation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In order to market any product outside of the United States, we would need to comply with numerous and varying regulatory requirements of other countries regarding safety and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of our product candidates. For example, in the EU, we must obtain authorization of a clinical trial application, or CTA, in each member state in which we intend </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">99</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">to conduct a clinical trial. Whether or not we obtain FDA approval for a drug, we would need to obtain the necessary approvals by the comparable regulatory authorities of foreign countries before we can commence clinical trials or marketing of the drug in those countries. The approval process varies from country to country and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country may negatively impact the regulatory process in others.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Further, some countries outside of the United States, including the EU member states, Switzerland and the United Kingdom, have also adopted data protection laws and regulations, which impose significant compliance obligations. In the EU, the collection and use of personal health data is governed by the provisions of the General Data Protection Regulation, or GDPR. The GDPR became effective on May&#x00a0;25, 2018, repealing its predecessor directive and increasing responsibility and liability of pharmaceutical companies in relation to the processing of personal data of EU subjects. The GDPR, together with the national legislation of the EU member states governing the processing of personal data, impose strict obligations and restrictions on the ability to process personal data, including health data from clinical trials and adverse event reporting. In particular, these obligations and restrictions concern potentially burdensome documentation requirements, granting certain rights to individuals to control how we collect, use, disclose, retain and process information about them, the information provided to the individuals, the transfer of personal data out of the EU, security breach notifications, and security and confidentiality of the personal data. The processing of sensitive personal data, such as physical health condition, may impose heightened compliance burdens under the GDPR and is a topic of active interest among foreign regulators. In addition, the GDPR provides for more robust regulatory enforcement and fines of up to &#x20ac;20&#x00a0;million or 4% of the annual global revenue of the noncompliant company, whichever is greater. Data protection authorities from the different EU&#x00a0;member states may interpret the GDPR and national laws differently and impose additional requirements, which add to the complexity of processing personal data in the EU. Guidance on implementation and compliance practices are often updated or otherwise revised.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">European Union</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">European Union Coverage Reimbursement and Pricing</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that drug products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost<FONT CLASS="nobreak">-effectiveness</FONT> of a particular drug candidate to currently available therapies, or so called health technology assessments, in order to obtain reimbursement or pricing approval. For example, the European Union provides options for its member states to restrict the range of drug products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may approve a specific price for a drug product or may instead adopt a system of direct or indirect controls on the profitability of the company.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">EU </FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">D</FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">rug regulation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In order to market any product outside of the United States, we would need to comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we would need to obtain the necessary approvals by the comparable foreign regulatory authorities before we can commence clinical trials or marketing of the product in foreign countries and jurisdictions such as in China and&#x00a0;Japan. Although many of the issues discussed above with respect to the United States apply similarly in the context of the EU, the approval process varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others. Failure to comply with applicable foreign regulatory requirements, may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">100</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Non-clinical&#x00a0;studies and clinical trials</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Similarly to the United States, the various phases of&#x00a0;non<FONT CLASS="nobreak">-clinical</FONT>&#x00a0;and clinical research in the EU are subject to significant regulatory controls.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Non<FONT CLASS="nobreak">-clinical</FONT>&#x00a0;studies are performed to demonstrate the health or environmental safety of new chemical or biological substances.&#x00a0;Non<FONT CLASS="nobreak">-clinical</FONT>&#x00a0;studies must be conducted in compliance with the principles of good laboratory practice (GLP) as set forth in EU Directive 2004/10/EC. In particular,&#x00a0;non<FONT CLASS="nobreak">-clinical</FONT>&#x00a0;studies, both in vitro and in vivo, must be planned, performed, monitored, recorded, reported and archived in accordance with the GLP principles, which define a set of rules and criteria for a quality system for the organizational process and the conditions for&#x00a0;non<FONT CLASS="nobreak">-clinical</FONT>&#x00a0;studies. These GLP standards reflect the Organization for Economic&#x00a0;Co<FONT CLASS="nobreak">-operation</FONT>&#x00a0;and Development requirements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Clinical trials of medicinal products in the EU must be conducted in accordance with EU and national regulations and the International Conference on Harmonization (ICH) guidelines on good clinical practices (GCP) as well as the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. Additional GCP guidelines from the European Commission, focusing in particular on traceability, apply to clinical trials of advanced therapy medicinal products. If the sponsor of the clinical trial is not established within the EU, it must appoint an entity within the EU to act as its legal representative. The sponsor must take out a clinical trial insurance policy, and in most EU member states, the sponsor is liable to provide &#x2018;no fault&#x2019; compensation to any study subject injured in the clinical trial.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Certain countries outside of the United States, including the EU, have a similar process that requires the submission of a clinical study application (CTA) much like the IND prior to the commencement of human clinical studies. A CTA must be submitted to each country&#x2019;s national health authority and an independent ethics committee, much like the FDA and the IRB, respectively. Once the CTA is approved by the national health authority and the ethics committee has granted a positive opinion in relation to the conduct of the trial in the relevant member state(s), in accordance with a country&#x2019;s requirements, clinical study development may proceed.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The CTA must include, among other things, a copy of the trial protocol and an investigational medicinal product dossier containing information about the manufacture and quality of the medicinal product under investigation. Currently, CTAs must be submitted to the competent authority in each EU member state in which the trial will be conducted. Under the new Regulation on Clinical Trials, which is currently expected to become applicable by early 2022, there will be a centralized application procedure where one national authority takes the lead in reviewing the application and the other national authorities have only a limited involvement. Any substantial changes to the trial protocol or other information submitted with the CTA must be notified to or approved by the relevant competent authorities and ethics committees. Medicines used in clinical trials must be manufactured in accordance with good manufacturing practice (GMP). Other national and&#x00a0;EU<FONT CLASS="nobreak">-wide</FONT>&#x00a0;regulatory requirements also apply.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Marketing Authorizations</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To market a medicinal product in the EU and in many other foreign jurisdictions, we must obtain separate regulatory approvals. More concretely, in the EU, medicinal product candidates can only be commercialized after obtaining a Marketing Authorization (MA). To obtain regulatory approval of an investigational medicinal product under EU regulatory systems, we must submit a marketing authorization application (MAA.) The process for doing this depends, among other things, on the nature of the medicinal product. There are two types of MAs:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the &#x201c;Union MA&#x201d;, which is issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency&#x00a0;(EMA) and which is valid throughout the entire territory of the EU. The Centralized Procedure is mandatory for certain types of products, such as (i) medicinal products derived from biotechnology medicinal products, (ii) designated orphan medicinal products, (iii) advanced therapy products (such as gene therapy, somatic cell therapy or tissue<FONT CLASS="nobreak">-engineered</FONT> medicines), and (iv)&#x00a0;medicinal products containing a new active substance indicated for the treatment certain diseases, such as HIV/AIDS, cancer, neurodegenerative diseases, diabetes, other auto<FONT CLASS="nobreak">-immune</FONT> and viral diseases. The </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">101</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-position:inside;list-style-type:none;text-indent:0pt;margin-top:8pt;">Centralized Procedure is optional for products containing a new active substance not yet authorized in the EU, or for products that constitute a significant therapeutic, scientific or technical innovation or that the granting of authorization would be in the interest of public health in the EU; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>&#x201c;National MAs&#x201d;, which are issued by the competent authorities of the EU member states and only cover their respective territory, are available for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in an EU member state, this National MA can be recognized in another member state through the Mutual Recognition Procedure. If the product has not received a National MA in any member state at the time of application, it can be approved simultaneously in various member states through the Decentralized Procedure. Under the Decentralized Procedure an identical dossier is submitted to the competent authorities of each of the member states in which the MA is sought, one of which is selected by the applicant as the Reference member state.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the above<FONT CLASS="nobreak">-described</FONT> procedures, in order to grant the MA, the EMA or the competent authorities of the EU member states make an assessment of the risk<FONT CLASS="nobreak">-benefit</FONT> balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the Centralized Procedure, the maximum timeframe for the evaluation of a MAA by the EMA is 210 days. Where there is a major public health interest and an unmet medical need for a product, the CHMP may perform an accelerated review of a MA in no more than 150 days (not including clock stops). Innovative products that target an unmet medical need and are expected to be of major public health interest may be eligible for a number of expedited development and review programs, such as the PRIME scheme, which provides incentives similar to the breakthrough therapy designation in the US PRIME is a voluntary scheme aimed at enhancing the EMA&#x2019;s support for the development of medicines that target unmet medical needs. It is based on increased interaction and early dialogue with companies developing promising medicines, to optimize their product development plans and speed up their evaluation to help them reach patients earlier. Product developers that benefit from PRIME designation can expect to be eligible for accelerated assessment but this is not guaranteed. The benefits of a PRIME designation include the appointment of a CHMP rapporteur before submission of a MAA, early dialogue and scientific advice at key development milestones, and the potential to qualify products for accelerated review earlier in the application process.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">MAs have an initial duration of five years. After these five years, the authorization may be renewed for an unlimited period on the basis of a reevaluation of the risk<FONT CLASS="nobreak">-benefit</FONT> balance, unless the EMA decides, on justified grounds relating to pharmacovigilance, to mandate one additional five<FONT CLASS="nobreak">-year</FONT> renewal period.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Data and marketing exclusivity</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The EU also provides opportunities for market exclusivity. Upon receiving MA, new chemical entity, or reference product candidates, generally receive eight years of data exclusivity and an additional two years of market exclusivity. If granted, the data exclusivity period prevents generic or biosimilar applicants from relying on the&#x00a0;pre<FONT CLASS="nobreak">-clinical</FONT>&#x00a0;and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar MA in the EU during a period of eight years from the date on which the reference product was first authorized in the EU. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until 10 years have elapsed from the initial authorization of the reference product in the EU. The overall&#x00a0;10<FONT CLASS="nobreak">-year</FONT>&#x00a0;market exclusivity period can be extended to a maximum of eleven years if, during the first eight years of those 10 years, the MA holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. However, there is no guarantee that a product will be considered by the EU&#x2019;s regulatory authorities to be a new chemical entity, and products may not qualify for data exclusivity.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Pediatric Development</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the EU, MAAs for new medicinal products candidates have to include the results of trials conducted in the pediatric population, in compliance with a pediatric investigation plan (PIP) agreed with the EMA&#x2019;s Pediatric Committee (PDCO). The PIP sets out the timing and measures proposed to generate data to support a pediatric indication of the drug for which MA is being sought. The PDCO can grant a deferral of the obligation to implement some or all of the measures of the PIP until there are sufficient data to demonstrate the efficacy and safety of the </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">102</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">product in adults. Further, the obligation to provide pediatric clinical trial data can be waived by the PDCO when these data is not needed or appropriate because the product is likely to be ineffective or unsafe in children, the disease or condition for which the product is intended occurs only in adult populations, or when the product does not represent a significant therapeutic benefit over existing treatments for pediatric patients. Once the MA is obtained in all EU Member States and study results are included in the product information, even when negative, the product is eligible for six months&#x2019; supplementary protection certificate extension (if any is in effect at the time of authorization).</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Post-Approval Requirements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Similar to the United States, both MA holders and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission and/or the competent regulatory authorities of the member states. The holder of a MA must establish and maintain a pharmacovigilance system and appoint an individual qualified person for pharmacovigilance who is responsible for oversight of that system. Key obligations include expedited reporting of suspected serious adverse reactions and submission of periodic safety update reports (PSURs).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">All new MAA must include a risk management plan (RMP) describing the risk management system that the company will put in place and documenting measures to prevent or minimize the risks associated with the product. The regulatory authorities may also impose specific obligations as a condition of the MA. Such risk<FONT CLASS="nobreak">-minimization</FONT> measures or post<FONT CLASS="nobreak">-authorization</FONT> obligations may include additional safety monitoring, more frequent submission of PSURs, or the conduct of additional clinical trials or post<FONT CLASS="nobreak">-authorization</FONT> safety studies.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The advertising and promotion of medicinal products is also subject to laws concerning promotion of medicinal products, interactions with physicians, misleading and comparative advertising and unfair commercial practices. All advertising and promotional activities for the product must be consistent with the approved summary of product characteristics, and therefore all&#x00a0;off<FONT CLASS="nobreak">-label</FONT>&#x00a0;promotion is prohibited.&#x00a0;Direct<FONT CLASS="nobreak">-to-consumer</FONT>&#x00a0;advertising of prescription medicines is also prohibited in the EU. Although general requirements for advertising and promotion of medicinal products are established under EU directives, the details are governed by regulations in each member state and can differ from one country to another.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The aforementioned EU rules are generally applicable in the European Economic Area (EEA) which consists of the 27 EU member states plus Norway, Liechtenstein and Iceland.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For other countries outside of the EU, such as countries in Latin America or Asia (e.g. China and Japan), the requirements governing the conduct of clinical studies, product licensing, pricing and reimbursement vary from country to country. In all cases, again, the clinical studies are conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Privacy and data protection laws</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are also subject to laws and regulations in&#x00a0;non<FONT CLASS="nobreak">-US</FONT>&#x00a0;countries covering data privacy and the protection of health<FONT CLASS="nobreak">-related</FONT> and other personal information. For instance, EU member states and other jurisdictions have adopted data protection laws and regulations, which impose significant compliance obligations. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure, processing and security of personal information that identifies or may be used to identify an individual, such as names, contact information, and sensitive personal data such as health data. These laws and regulations are subject to frequent revisions and differing interpretations,</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of May 2018, the General Data Protection Regulation (GDPR) replaced the Data Protection Directive with respect to the processing of personal data in the European Union. The GDPR imposes many requirements for controllers and processors of personal data, including, for example, higher standards for obtaining consent from individuals to process their personal data, more robust disclosures to individuals and a strengthened individual data rights regime, shortened timelines for data breach notifications, limitations on retention and secondary use of information, increased requirements pertaining to health data and pseudonymised (i.e.,&#x00a0;key<FONT CLASS="nobreak">-coded</FONT>)&#x00a0;data and additional obligations when we contract third<FONT CLASS="nobreak">-party</FONT> processors in connection with the processing of the personal </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">103</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">data. The GDPR allows EU member states to make additional laws and regulations further limiting the processing of genetic, biometric or health data. Failure to comply with the requirements of GDPR and the applicable national data protection laws of the EU member states may result in fines of up to&#x00a0;&#x20ac;20,000,000 or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, and other administrative penalties.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Japan</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Japanese drug regulation</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Non-clinical studies and clinical trials</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Being a member of the International Conference on Harmonization (ICH),&#x00a0;Japan has pharmaceutical regulations fundamentally similar to those of the United States or EU.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Non<FONT CLASS="nobreak">-clinical</FONT> studies are performed to demonstrate the health safety of new chemical or biological substances. Non<FONT CLASS="nobreak">-clinical</FONT> studies must be conducted in compliance with the principles of Japanese good laboratory practice (GLP) which reflect the Organization for Economic Co<FONT CLASS="nobreak">-operation</FONT> and Development requirements. Currently,&#x00a0;Japan and EU have a mutual recognition agreement for GLP, and data generated compliant with EU requirements will be accepted by the Japanese authorities. There is no similar agreement with the United States.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Clinical trials of medicinal products in&#x00a0;Japan must be conducted in accordance with Japanese regulations based on ICH guidelines governing good clinical practices (GCP). They focus on ethics of the clinical trial and protection of the privacy of the trial subjects. If the sponsor of the clinical trial is not established within&#x00a0;Japan, it must appoint an entity within the country to act as its caretaker who should be authorized to act on the sponsor&#x2019;s behalf. The sponsor must take out a clinical trial insurance policy, and, according to the industry agreement, should put in place a common compensation policy for the injuries from the trial.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to the commencement of human clinical studies, the sponsor must complete evaluation of the safety of the investigative product, and submit a clinical trial notification and the protocol to the authorities in advance, upon agreement of the IRB of the participating institutions. When the authorities do not comment on the notification, the sponsor may proceed with the clinical trial.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any substantial changes to the trial protocol or other information submitted must be cleared by the IRB and notified to the authorities. Medicines used in clinical trials must be manufactured in accordance with good manufacturing practice (GMP).</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Product approval</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To market a medicinal product in&#x00a0;Japan, we must obtain regulatory approval. To obtain regulatory approval of an investigational medicinal product, we must submit a new drug application. The process for doing this depends, among other things, on the nature of the medicinal product and there are currently a few different pathways for approval. If the product is designed for treating certain &#x201c;difficult diseases&#x201d; or those whose patient size is limited, we may be able to obtain designation as an orphan drug product if it demonstrates unique therapeutic value. Approval application for such designated orphan products will be processed on an expedited basis and the authorities&#x2019; requirement for clinical data will be much limited. Separately, the latest amendment to the law introduced separate pathways for (i) truly innovative products with a unique mode of action and (ii) those which will satisfy unmet medical needs. These products will also be processed on an expedited basis.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The evaluation of applications will be based on an assessment of the risk<FONT CLASS="nobreak">-benefit</FONT> balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy. Once the review organization complete its review task, the matter will be considered by the advisory committee of experts, and the government will grant approval upon positive recommendation from the committee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The volume and quality of the clinical data will be the key determinant of the approval decision. Clinical trial data generated overseas will be accepted as part of the data package consistent with the ICH recommendation. Typically, a limited dose response clinical trial for Japanese subjects is required to ensure that data are extrapolatable for the Japanese population. In a more recent development, the authorities encourage manufacturers to organize an international joint clinical trial with some Japanese participation under a joint protocol, to expedite the clinical trial process. Regulatory approval does not expire.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">104</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Licensing requirement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Separate from the approval requirement, it is also mandatory to possess a distribution license of an appropriate class for the manufacturer to commercially distribute the product in&#x00a0;Japan. Non Japanese companies who possess only the product approval may designate an appropriate license holder in&#x00a0;Japan to commercially distribute the product, rather than distributing it on its own. The license is valid for 5 years.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Intellectual Property</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Exclusive License Agreement with Children&#x2019;s Hospital Medical Center, d/b/a Cincinnati Children&#x2019;s Hospital Medical Center</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On June<FONT CLASS="nobreak"> </FONT>1, 2021 (the &#x201c;Effective Date&#x201d;), the Company entered into a license agreement with Children&#x2019;s Hospital Medical Center, d/b/a Cincinnati Children&#x2019;s Hospital Medical Center (&#x201c;CHMC&#x201d;) to develop and commercialize certain CHMC patents and related technology directed at a virus<FONT CLASS="nobreak">-like</FONT> particle (VLP) vaccine platform that utilizes nanoparticle delivery technology, which may have potential broad application to develop vaccines for multiple infectious diseases (&#x201c;the CHMC Agreement&#x201d;). The license is exclusive, worldwide, and is for all uses (other than the &#x201c;Excluded Field&#x201d; of immunization against, and prevention, control, or reduction in severity of gastroenteritis caused by Rotavirus and Norovirus in China and Hong Kong). The license is sublicensable with prior CHMC written approval consistent with the terms of the CHMC Agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The CHMC Agreement includes U.S. Patent No. 8,486,421; U.S. Patent No. 9,096,644; U.S. Patent No.&#x00a0;9,562,077; European Patent No. 2440582; Japan Patent No. 5894528; any patents maturing from U.S. Patent Application No. 16/489,095, European Patent Application No. 18777340.3, Japan Patent Application No. 2019<FONT CLASS="nobreak">-546799</FONT>, China Patent Application No. 201880017019.3, Hong Kong Patent Application No. 62020005692.2, U.S. Provisional Patent Application No. 63/149,742, and U.S. Provisional Patent Application No. 63/162,369 (&#x201c;Licensed Patents&#x201d;), and any divisionals, continuations and continuations<FONT CLASS="nobreak">-in-part</FONT> thereto (solely to the extent that the claims in the continuations<FONT CLASS="nobreak">-in-part</FONT> are directed to the subject matter specifically claimed in the Licensed Patents, and they have the same priority date as the Licensed Patents, but do not include any different or additional claims), and any patents resulting therefrom. The CHMC Agreement also grants the Company a non<FONT CLASS="nobreak">-exclusive</FONT> limited license to use and copy internally any technical information in existence and known before the Effective Date by CHMC solely as necessary for the use and practice of the Licensed Patents (the &#x201c;Technology&#x201d;).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The term of the CHMC Agreement begins on the Effective Date and extends on a jurisdiction by jurisdiction and product by product basis until the later of: (i) the last to expire Licensed Patent; (ii) ten (10) years after the first commercial sale; or, (iii) entrance onto the market of a biosimilar or interchangeable product. CHMC has reserved the right to practice, have practiced, and transfer the Licensed Patents and Technology for research and development purposes, including education, research, teaching, publication and public service, but not to use or practice the Licensed Patents or Technology in Field of Use for any commercial or profit purpose.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Licensed Patents granted to the Company under the CHMC Agreement are also subject to any rights of the United States federal, state and/or local Government(s), as well as nonprofit entities, if certain patents or technologies were created in the course of Government<FONT CLASS="nobreak">-funded</FONT> or non<FONT CLASS="nobreak">-profit</FONT> entity<FONT CLASS="nobreak">-funded</FONT> research. The CHMC Agreement also contains compulsory licensing provisions under which CHMC must notify the Company in writing whenever CHMC may become aware of third parties that are interested in obtaining rights to the Licensed Patents or Technology for purposes that are beyond the scope of the Company&#x2019;s development and commercialization plan. The Company may elect to pursue the new purposes itself (and negotiate commercially reasonable development targets), or enter into sublicense negotiations with the interested third party. However, if the Company fails to meet its development targets for the new purposes or fails to enter into a sublicense agreement with the interested third party within nine (9) months of the notice from CHMC, then the new purpose will be excluded from the license grant and CHMC will be free to pursue licensing of the Licensed Patents or Technology within the Excluded Field to an interested third party.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any patented modification, alteration or improvement of any invention claimed in a Licensed Patents or Technology which is conceived or reduced to practice solely by the Company (&#x201c;Company Improvement&#x201d;) is owned by the Company; however, for any such Company Improvement, the Company will automatically grant to CHMC a worldwide, perpetual, sublicensable, nonexclusive, paid<FONT CLASS="nobreak">-up</FONT>, royalty<FONT CLASS="nobreak">-free</FONT> license to use any Company Improvements solely for clinical or non<FONT CLASS="nobreak">-clinical</FONT>, non<FONT CLASS="nobreak">-commercial</FONT> research, testing, educational and patient care purposes. The CHMC Agreement also provides the Company with an option to license any CHMC or jointly patented </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">105</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">modification, alteration or improvement of any invention claimed in a Licensed Patent (&#x201c;CHMC Improvement&#x201d; and &#x201c;Joint Improvement, respectively&#x201d;), with option fee for each Improvement that the Company elects to include in the license grant of the CHMC Agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the CHMC Agreement, the Company paid to CHMC a one<FONT CLASS="nobreak">-time</FONT> five<FONT CLASS="nobreak">-digit</FONT> initial license fee; thereafter, the Company is required to pay a six<FONT CLASS="nobreak">-digit</FONT> deferred license fee upon the earlier of the Company&#x2019;s first to occur convertible debt or equity raise after the Effective Date. On the one year anniversary of the Effective Date, the Company will be required to pay to CHMC an additional deferred six<FONT CLASS="nobreak">-digit</FONT> license fee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the CHMC Agreement, the Company is obligated to use commercially reasonable efforts to bring licensed products to market through diligent research and development, testing, manufacturing and commercialization and to use best efforts to make all necessary regulatory filings and obtain all necessary regulatory approvals, and achieve milestones relating to development and sales, and report to CHMC on progress. The Company will also be obligated to pay the agreed upon development milestone payments to CHMC.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Development milestones include: (i) IND filings of each Licensed Product; (ii) BLA or equivalent allowed for Licensed Product in U.S. or E.U.; (iii) first commercial sale of licensed product in the U.S.; (iv) first commercial sale of licensed product in the E.U.; (v) first commercial sale of licensed product in Japan; (vi) first commercial sale in ROW; (vii) conclusion of the first calendar year. The CHMC Agreement also includes sales<FONT CLASS="nobreak">-based</FONT> milestones. Pursuant to the terms of the CHMC Agreement, if the Company fails to achieve milestones or make milestone payments on certain milestones, and cannot mutually agree with CHMC on an amendment to the milestones, then CHMC will have the option of converting any and all of such exclusive licenses to nonexclusive licenses.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Beginning on the first Net Sale, the Company will pay CHMC running royalties on a quarterly basis as a percentage of Net Sales (as defined in the CHMC Agreement) of the Company, its affiliates and any subsidiaries. Similarly, in the event the Company enters into a sublicense agreement, the Company shall pay CHMC a percentage of all non<FONT CLASS="nobreak">-royalty</FONT> sublicensing revenues received from the sublicensee. There are single digit royalty rates for products and processes for P<FONT CLASS="nobreak">-Particle</FONT> VLP Bivalent vaccine for norovirus and rotavirus; for products and processes for Universal Flu Vaccine(s); and for all other products or processes for other indications. To date, no payments have been made related to the milestones or royalties. Before any Valid Claims (as defined in the CHMC Agreement) exist, the running royalty rates are reduced by fifty percent (50%).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The CHMC Agreement also contains an anti<FONT CLASS="nobreak">-stacking</FONT> provision pursuant to which in the event the Company is legally required to pay royalties to one or more third parties whose patent rights dominate the Licensed Patents, and would therefore be infringed by exercise of the license rights granted in the CHMC Agreement, the Company may reduce running royalty payments by fifty percent (50%). In the event the Company grants sublicenses, the Company is obligated to pay CHMC as follows: (i) specified percentage of revenue received prior to first Net Sale of first Licensed Product; (ii) specified percentage for revenue received after first Net Sales of first Licensed Product but before first Net Sales of second Licensed Product; or, (iii) specified percentage for revenues received after first Net Sales of second Licensed Product.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">CHMC reserved the first and sole right, using in<FONT CLASS="nobreak">-house</FONT> or outside legal counsel selected by CHMC, to prepare, file, prosecute, maintain and extend patents and patent applications, and the Company agreed to reimburse CHMC for its legal and administrative costs incurred in the course of doing such. The Company also agreed to reimburse CHMC for incurred legal fees as of the Effective Date. CHMC will provide the Company a reasonable opportunity to comment during prosecution and will consider the Company&#x2019;s comments, but CHMC retained control over all final decisions. If CHMC elects to not be responsible for the prosecution or maintenance of any such patents, the Company will receive a sixty (60) days&#x2019; written notice upon which the Company may elect, at the Company&#x2019;s expense, to assume the responsibilities and obligations to prosecute and maintain the patents (among other things); thereafter, the Company will use reasonable efforts to give CHMC an opportunity to comment, but the final decision with respect to such matter will remain with the Company.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The CHMC Agreement contains no CHMC representations or warranties. The CHMC Agreement also requires the Company to indemnify CHMC and other related parties against all claims, suit, actions, demands, judgments, or investigations arising out of any product the Company produces under the CHMC Agreement, as set forth in the CHMC Agreement, and requires the Company, beginning with the earlier of the first clinical trial or commercial sale or other commercialization to obtain liability insurance.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">106</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">CHMC will have the first and sole right but not the obligation, at its own expense, to initiate an infringement suit or other appropriate actions against third party infringers and receives all therefrom. For joint suits initiated against third party infringers and receives damages or profits recovered therefrom. In the event CHMC does not, within six (6) months after becoming aware of infringement, secure cessation of the infringement, the Company will have the right to initiate suit at its own expense. Any damages or profits that the Company recovers will be treated as Net Sales subject to royalties after the Company has been compensated for its costs in handling such action. In the event of a joint infringement suit, the Company and CHMC will agree in writing who will control the action and how cost and recoveries will be shared.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company may terminate the CHMC Agreement for convenience, at any time prior to first commercial sale of a product or process by providing one hundred and eighty (180) days&#x2019; written notice to CHMC. It may also terminate for a CHMC uncured material breach. CHMC may terminate the CHMC Agreement for an uncured Company material breach or insolvency or bankruptcy. In the event the Company&#x2019;s material breach is for failure to meet any of the milestone payments, the Company is entitled to a nonexclusive license to continue developing indications that have already entered development at any stage or in which the Company has invested in developing. CHMC may also terminate the CHMC Agreement to the fullest extent permitted by law in the countries of the worldwide territory, in the event the Company or its affiliates challenge or induce others set up challenges to the validity or enforceability of any of the Licensed Patents and the Company will be obligated reimburse CHMC for its costs, including reasonable attorneys&#x2019; fees.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Option Agreement between Oxford University Innovation Limited and Blue Water Vaccines Inc.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On December<FONT CLASS="nobreak"> </FONT>18, 2018, the Company entered into an option agreement with Oxford University Innovation Limited (&#x201c;OUI&#x201d;), pursuant to which the Company paid a five<FONT CLASS="nobreak">-digit</FONT> option fee to OUI in exchange for a period of exclusivity, in advance of a fundraising of fifteen million dollars ($15,000,000). Under the option agreement, the Company has the right to exercise the option for the grant of the right to the Company to an exclusive, worldwide license to PCT Patent Application number PCT/GB/2017/052510, any patents granted in response to that application, any corresponding foreign patents and applications deriving priority from that application, and any addition, continuation, continuation<FONT CLASS="nobreak">-in-part</FONT>, division, reissue, renewal or extension based thereon, and related know<FONT CLASS="nobreak">-how</FONT> and confidential information (the &#x201c;Technology&#x201d;).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Exercise of the option by the Company was conditional upon the Company submitting a business plan for the subsequent two years, including a development plan for the technology and a financial projection, demonstrating the Company&#x2019;s ability to develop the Technology and evidence of the Company&#x2019;s solvency and receipt of fifteen million dollars ($15,000,000) in funds for the development of the Technology. The Company has agreed that, as a condition precedent to the license becoming effective, it must provide funding for three years of salary for Dr. Craig Thompson in Oxford&#x2019;s Department of Zoology.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">License Agreement Between Oxford University Innovation Limited and Blue Water Vaccines Inc.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On July<FONT CLASS="nobreak"> </FONT>16, 2019, the Company entered into an exclusive, worldwide agreement (&#x201c;OUI Agreement&#x201d;) with Oxford University Innovation Limited (&#x201c;OUI&#x201d;), pursuant to which the Company obtained an exclusive worldwide license for all fields to PCT Patent Application number PCT/GB/2017/052510, entitled &#x201c;Immunogenic Composition,&#x201d; any patents granted in response to that application, any corresponding foreign patents and applications deriving priority from that application, and any addition, continuation, continuation<FONT CLASS="nobreak">-in-part</FONT>, division, reissue, renewal or extension based thereon, and a nonexclusive license to related know<FONT CLASS="nobreak">-how</FONT> and confidential information (the &#x201c;Licensed Technology&#x201d;).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The OUI Agreement has a term concluding ten years following the last to expire of all licensed patents and patent applications as defined under the terms of the OUI Agreement. The license was conditional upon the Company entering into a separate agreement with Oxford University to provide funding for three years&#x2019; salary for Dr. Craig Thompson in the University&#x2019;s Department of Zoology, which was paid by the Company in January 2020.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Improvements to the Licensed Technology as defined in the OUI Agreement belong to OUI and are included in the Licensed Technology. All Company Improvements of belong to the Company. The Company granted to OUI, and OUI subsequently granted to Oxford University, a non<FONT CLASS="nobreak">-transferable</FONT>, irrevocable, perpetual, royalty<FONT CLASS="nobreak">-free</FONT> license </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">107</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">to use and publish the Licensed Technology and the Company&#x2019;s Improvements upon the Licensed Technology for non<FONT CLASS="nobreak">-commercial</FONT> use. If a Licensed Product is covered by the Medicines Access Policy of Oxford University to promote, the Company shall adhere to the requirements of the Medicines Access Policy.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">The Company did not pay a signing fee to OUI and is obligated to pay a single digit royalty on all net sales of licensed products, as defined in the OUI Agreement, as well as double<FONT CLASS="nobreak">-digit</FONT> royalties on any sums received by the Company from any sublicensee (including all up<FONT CLASS="nobreak">-front</FONT>, milestone and other one<FONT CLASS="nobreak">-off</FONT> payments received by the Company from any sub<FONT CLASS="nobreak">-licenses</FONT> or other contracts granted by the Company with respect to the licensed technology). After the expiration or revocation of the last Valid Claim (as defined in the OUI Agreement) covering a Licensed Product, a &#x201c;step down&#x201d; royalty rate (50% of the initial royalty) shall apply to such Licensed Technology. If the Company has to pay royalties to a third party to use a proprietary manufacturing process proprietary adjuvants in order to make or have made a Licensed Product, the Company will be able to deduct from all royalty payments 50% of the royalties paid to the third party, up to a maximum amount of twenty<FONT CLASS="nobreak">-five</FONT> percent (25%) of the royalties due to OUI. The OUI Agreement entitles the Company to supply a commercially reasonable quantity (not exceeding 5% of units sold in any quarter) of licensed products for promotional sampling.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">In the event that royalties paid to OUI do not amount to the &#x201c;minimum sum&#x201d; under the OUI Agreement for a particular year, the Company is obligated to make up the difference between the royalties actually paid and such minimum sum. The minimum sums vary over time, and reduces to $0 once the &#x201c;step down&#x201d; applies. The minimum sums and milestone fees are indexed to the RPI (Retail Prices index for all items which is published in the United Kingdom by the Office for National Statistics, or any replacement of it) and will be increased or decreased as appropriate as set forth in the OUI Agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">The Company is obligated to use its best efforts to develop and market Licensed Products in accordance with its development plan report to OUI on progress and achieve the following milestones and must pay OUI nonrefundable milestone fees as follows when it achieves them: initiation of first Phase I study; initiation of first Phase II study; initiation of first Phase III/pivotal registration studies; first submission of application for regulatory approval (BLA/NDA); marketing authorization in the United States; marketing authorization in any EU country; marketing authorization in Japan; first marketing authorization in any other country; first commercial sale in Japan; first commercial sale in any ROW country; first year that annual sales equal or exceed certain thresholds.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">The Company is obligated to pay a fee to OUI for any past patent expenses that were incurred prior to the execution of the OUI Agreement. Upon consultation with the Company and at the Company&#x2019;s expense, OUI shall prosecute, use all reasonable endeavors to maintain and renew the patents throughout the duration of the OUI Agreement. The Company and OUI agreed to inform each other in writing of any misappropriation or infringement of any rights to the licensed technology; however, the Company has the first right to take legal action at its own cost in relation to any such misappropriation or infringement, but must discuss any proposed legal action with OUI and take into account any legitimate interest of OUI in the legal action that it takes. If the Company notifies OUI that it does not intend to take legal action in such matters, OUI may take any legal action at its own cost. All profits or damages recovered after unrecovered costs and expenses are deducted are treated as net sales for which royalties would be due.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">OUI makes no warranties at all with regard to the Licensed Technology or whether use of it will infringe third party rights. The Company is required to indemnify OUI and Oxford University from all third party claims, damages, and liabilities asserted by third parties arising directly or indirectly from use of the Licensed Technology; marketing of Licensed Products; or breach of the OUI Agreement. The OUI Agreement is governed by English law and the parties agreed to submit to the exclusive jurisdiction of English Courts for resolution of any disputes arising out of or in connection with the OUI Agreement, with the exception of actions relating to intellectual property disputes or confidential information which may be brought in any court of competent jurisdiction.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:6pt;">Either party may terminate the OUI Agreement for an uncured material breach. The Company may terminate the OUI Agreement for any reason at any time upon six months&#x2019; written notice expiring after the third anniversary of the OUI Agreement. OUI may terminate immediately if the Company has a petition presented for its winding<FONT CLASS="nobreak">-up</FONT> or passes a resolution for winding up other than for a bona fide amalgamation or reconstruction or compounds with its creditors or has a receiver or administrator appointed. OUI may also terminate if the Company opposes or challenges the validity of any of the patents or applications in the Licensed Technology; raises the claim that the know<FONT CLASS="nobreak">-how</FONT> of </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">108</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;text-indent:0pt;margin-top:6pt;text-indent:0pt;">the Licensed Technology is not necessary to develop and market Licensed Products; or in OUI&#x2019;s reasonable opinion, is taking inadequate or insufficient steps develop or market Licensed Products and does not take any further steps that OUI requests by written notice within a reasonable time.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Exclusive License Agreement between St. Jude Children&#x2019;s Research Hospital, Inc. &amp; Blue Water Vaccines</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">On January<FONT CLASS="nobreak"> </FONT>27, 2020 (the &#x201c;Effective Date&#x201d;), the Company entered into an exclusive, worldwide license agreement with St. Jude Children&#x2019;s Research Hospital, Inc. (&#x201c;St. Jude&#x201d;), pursuant to which St. Jude granted the Company an exclusive license to develop licensed products and produce vaccines for use in humans (&#x201c;St. Jude Agreement&#x201d;) under U.S. Provisional Patent Application No. 61/537,290(U.S. Patent No. 9,265,819 issued on February<FONT CLASS="nobreak"> </FONT>23, 2016), and U.S. Provisional Patent Application No. 62/817,748 (filed March<FONT CLASS="nobreak"> </FONT>13, 2019), and any issued patents, divisions, continuations, continuations<FONT CLASS="nobreak">-in-part</FONT>, to the extent that the claims are directed to subject matter described in the above<FONT CLASS="nobreak">-referenced</FONT> patent applications and are entitled to the priority date of the existing patent rights, reexaminations, substitutions, renewals, restorations, additions, or registrations thereof, as well as non<FONT CLASS="nobreak">-United</FONT> States counterparts thereof, and extensions and supplementary protection certificates thereon (&#x201c;Patent Rights&#x201d;).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The license is sublicensable consistent with the terms and conditions of the St. Jude Agreement, provided that the Company remains responsible for the performance by each of its sublicensees. The license is subject to any government rights the United States has reserved, and St. Jude retained the right to make, have made, provide and use for St. Jude&#x2019;s non<FONT CLASS="nobreak">-commercial</FONT> research and clinical purposes, including the right to distribute St. Jude&#x2019;s biological material disclosed and claimed in the Patent Rights for non<FONT CLASS="nobreak">-profit</FONT> academic research use to non<FONT CLASS="nobreak">-commercial</FONT> entities as is customary in the scientific community and to sell the biological materials as research reagents for research use only by the scientific community.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">In exchange for the licenses, the Company paid St. Jude an initial five<FONT CLASS="nobreak">-digit</FONT> license fee, and is required to pay a five<FONT CLASS="nobreak">-digit</FONT> annual maintenance fee beginning on the first anniversary of the Effective Date (which is waived if all of the developmental milestones scheduled for completion before such annual fee is due have been achieved), milestone payments, patent reimbursement, and running royalties based on net sales of licensed products under the St. Jude Agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">Under the St. Jude Agreement, the Company is obligated to use commercially reasonable efforts to develop and commercialize the licensed product(s). If the Company fails to achieve the development milestones contained in the St. Jude Agreement, and if the Company and St. Jude fail to agree upon a mutually satisfactory revised time line, St. Jude will have the right to terminate the St. Jude Agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The milestones include the following events: (i) complete IND enabling study by 2020; (ii) Initiate animal toxicology study by last half of 2020; (iii) file IND by first half of 2021; (iv) complete Phase I Clinical Trial by first half of 2022; (v) commence Phase II Clinical Trial by first half of 2024; (vi) commence Phase III Clinical Trial by 2026; and, (vii) regulatory approval, U.S. or foreign equivalent by 2026. Upon achievement of certain development and commercialization milestones, the Company is required to make milestone payments to St. Jude between the achievement of certain milestones (commencement of a Phase III clinical trial through first commercial sale).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">Additionally, the Company is obligated to make running single<FONT CLASS="nobreak">-digit</FONT> royalty payments payable, for each licensed product(s) sold by the Company or its affiliates, based on the net sales for the duration of the St. Jude Agreement. Furthermore, the Company is obligated to pay a double<FONT CLASS="nobreak">-digit</FONT> percentage of consideration received for any sublicenses.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The Company reimbursed St. Jude for certain patent costs incurred by St. Jude prior to the Effective Date of the St. Jude Agreement, and is obligated to reimburse St. Jude for reasonable patent costs incurred by St. Jude subsequent to the Effective Date.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The Company is responsible for and shall bear all expenses relating to the filing, prosecution, and maintenance of all patent rights licensed under the St. Jude Agreement. The Company has the first right to enforce any patent against infringement, and shall keep St. Jude informed of the status of such; however, before the Company may commence any action with respect to any such alleged infringement, the Company shall take into consideration the views of St. Jude and the potential effect on the public interest.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">109</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to initial human testing or first commercial sale of a licensed product, and thereafter so long as the licensed products are being sold in any particular country, the Company (and its sublicenses) is required to obtain and maintain insurance to cover its indemnity obligations, and to obtain and maintain product liability insurance coverage.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">St. Jude represented and warranted that it has good and marketable title to the Patent Rights, but made no other representations and warranties. The term of the agreement commenced on the Effective Date, and shall continue, in each country, until the date of expiration of the last to expire valid claim included within the Patent Rights in that country. Either party may terminate the St. Jude Agreement in the event the other party (a) files or has filed against it a petition under the Bankruptcy Act (among other things) or (b) fails to perform or otherwise breaches its obligations under the St. Jude Agreement, and has not cured such failure or breach within sixty (60) days. The Company may terminate for any reason on thirty (30) days written notice.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Manufacturing and Supply</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">We currently do not own or operate any manufacturing facilities, but our strategic partnership with Ology Bioservice (which was later acquired by National Resilience, Inc.) (&#x201c;Ology&#x201d;) provides us with access to substantial resources to facilitate an independent supply path to the market. Ology is a leading global contract manufacturer with deep domain expertise and experience in large and small<FONT CLASS="nobreak">-scale</FONT> production of clinical, as well as commercial<FONT CLASS="nobreak">-stage</FONT> products. We have entered into agreements with Ology to secure capacity, technical expertise and resources to support the production of&#x00a0;our products and processes that are intended to scale to commercial scale at Ology or other commercial manufacturing sites.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">In July 2019, we entered into a development and manufacturing master services agreement with Ology, which we refer to, as amended, as the Ology Agreement, pursuant to which Ology is obligated to perform manufacturing process development and clinical manufacture and supply of components.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">Under the Ology Agreement, we will pay Ology agreed upon fees for Ology&#x2019;s performance of manufacturing services, and we will reimburse Ology for its out<FONT CLASS="nobreak">-of-pocket</FONT> costs associated with purchasing raw materials, plus a customary handling fee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">For additional details regarding our relationship with Ology, see Note 5 to our financial statements included elsewhere in this prospectus.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Employees</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">As of August<FONT CLASS="nobreak"> </FONT>1, 2021, we had 2 full<FONT CLASS="nobreak">-time</FONT> and 7 subcontracted employees. None of our employees are represented by a collective bargaining agreement, and we have never experienced any work stoppage. We believe we have good relations with our employees.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Properties and Facilities</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">We are currently leasing an office located at 201 E Fifth Street, Suite 1900, Cincinnati, OH 45202, which is renewed on a monthly basis. All of our research and development is performed on the premises of our third<FONT CLASS="nobreak">-party</FONT> providers.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Legal Proceedings</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">From time to time we may be involved in various disputes and litigation matters that arise in the ordinary course of business. We are currently not a party to any material legal proceedings.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Changes in and Disagreements with Accountants</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">None.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Corporation Information</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">We were incorporated in Delaware on October<FONT CLASS="nobreak"> </FONT>26, 2018. Our principal executive offices are located at 201 E Fifth Street, Suite 1900, Cincinnati, OH 45202, and our telephone number is (513) 620<FONT CLASS="nobreak">-4101</FONT>. Our corporate website address is <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.bluewatervaccines.com</FONT>. The information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">110</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T10"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">MANAGEMENT</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Executive Officers and Directors</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table provides information regarding our executive officers and directors as of August<FONT CLASS="nobreak"> </FONT>1, 2021:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Name</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Age</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Position(s)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Executive Officers and Directors</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Joseph Hernandez</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">48</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Chief Executive Officer and Director</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Erin Henderson</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">47</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Chief Business Officer</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Non-Employee Directors</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Kimberly Murphy</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">58</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Director</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">John Rice, Ph.D.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">71</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Director<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Allan L. Shaw</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">57</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Director</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Michael Venerable</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">58</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Director</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">James Sapirstein</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 6.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">60</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 58.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Director Nominee</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Mr.<FONT CLASS="nobreak"> </FONT>Rice will be resigning from his position as a director upon the consummation of this offering.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Executive Officers and Directors</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Executive Officers</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Joseph Hernandez</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Joseph Hernandez has been the Chief Executive Officer &amp; Executive Chairman for Blue Water Vaccines Inc. since October 2018. He has a background in company creation, early stage technology development, as well as private and public market financing. He brings leadership to the team, backed by a strong educational foundation in biology, medicine, molecular genetics, microbiology, epidemiology, marketing, and finance. Over the course of his career, he has founded or led eight entrepreneurial companies in cutting edge areas of healthcare and pharmaceuticals. After years of building his career at Merck&#x00a0;&amp; Co. (NYSE:MRK) from December 1998 to January&#x00a0;2001 and Digene from 2005 to 2009 (acquired by Qiagen (NYSE:QGEN)) from 2005 to 2009, Mr.&#x00a0;Hernandez founded and became the President and CEO of Innovative Biosensors from 2004 to 2009. Later, Mr.&#x00a0;Hernandez served as the Founder and Chairman of Microlin Bio Inc. from August 2013 to January 2017 and as Chairman of the Board of Ember Therapeutics (OTCMKTS:EMBT) from April 2014 to January 2019. He was also the Chairman of Sydys Corporation from May 2016 to January 2019. In 2018, Mr.&#x00a0;Hernandez founded Blue Water Vaccines, an early stage biotechnology company focused on manufacturing a universal influenza vaccine in partnership with the University of Oxford in England. He has served as Chairman of Blue Water Vaccines, Inc. since 2019. Most recently, in January 2020, he founded and in May 2020 sold Noachis Terra, Inc. (acquired by Oragenics (NYSE:OGEN)) a company developing a vaccine for COVID<FONT CLASS="nobreak">-19</FONT>. Mr.<FONT CLASS="nobreak"> </FONT>Hernandez is also the chairman and chief executive officer of Blue Water Acquisition Corp. (NASDAQ: BLUW), a special purpose acquisition company which completed its initial public offering in December 2020 and is in the process of completing a business combination with Clarus Therapeutics. He completed his undergraduate studies in Neuroscience, M.Sc. in Molecular Genetics and Microbiology, M.B.A. all at the University of Florida and is completing his M.Sc. in Chronic Disease Epidemiology and Biostatistics at Yale University.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Erin Henderson</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Erin Henderson has been the Chief Business Officer for Blue Water Vaccines Inc. since September 2020 and has extensive experience in program and project management, business operational management, marketing, fundraising and public<FONT CLASS="nobreak">-private</FONT> partnership development and implementation. Since September 2018, Ms. Henderson has been the Founder and Managing Partner for The Aetos Group, a management consulting company working with public, private, governmental and non<FONT CLASS="nobreak">-governmental</FONT> organizations focused on operational efficiency, Lean Six Sigma implementation, revenue development strategy and real estate acquisition strategy. Erin began her career at Lockwood Greene Engineers, followed by The Facility Group. She led local, state and federal governmental relations for the University of West Georgia and was responsible for identifying and securing financial support from both the public and private sector. Erin completed her undergraduate studies in Chemical Engineering from Auburn University. Erin serves on the Board of the Greater Gainesville Chamber of Commerce and the Board of Danscompany of Gainesville.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">111</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Dr. Ronald R. Cobb, Ph.D.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Ron Cobb, Head of Science and Discovery for Blue Water Vaccines, Inc. since August 2021, is a Geneticist and Molecular Biologist with 25 years of pharmaceutical R&amp;D and manufacturing experience. At Research Triangle Institute, Dr. Cobb began his career at Research Triangle Institute where he had the unique opportunity to work with Drs. Wall and Wani, who discovered Camptothecin and Taxol. At Tanabe Research Laboratories, Dr. Cobb initiated discovery programs seeking small molecule inhibitors of inflammatory diseases both while supporting all internal drug discovery screening efforts with protein expression services. In 1999 Dr. Cobb was recruited to Berlex Biosciences (US Division of Schering AG) to head up the protein expression section of the Protein Expression and Gene Therapy Group, where he supported gene expression for both research and clinical development phase project and was a member of the Scientific Advisory Committee and Worldwide Antibody Development Committee for Schering. At the end of 2005, Dr. Cobb joined the Research and Development Group at RTI Biologics where he was named the Director of Research, then to the Director of Research and Development. Under his guidance, 21 new products were released in 2009. Dr. Cobb joined Nanotherapeutics, Inc as Vice President of Biologics in January 2011 and was Chief Scientific Officer in 2014 and was PI for over $200M in drug development contracts. He has co<FONT CLASS="nobreak">-authored</FONT> over 60 peer<FONT CLASS="nobreak">-reviewed</FONT> manuscripts and is currently working with BioDeals, LLC as Managing Director. Dr. Cobb received a BA in Biology at Wake Forest University and a Ph.D. in Biochemistry from the Medical College of Georgia.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Andrew Skibo, Ph.D.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Mr.<FONT CLASS="nobreak"> </FONT>Skibo has been the Head of Biologics Operations for Blue Water Vaccines, Inc. since June 2021. Mr.<FONT CLASS="nobreak"> </FONT>Skibo is a seasoned biopharmaceutical operations executive with deep cross<FONT CLASS="nobreak">-functional</FONT> experience in international biopharmaceutical manufacturing, process scale<FONT CLASS="nobreak">-up</FONT>, internal and external supply chain network design strategy and major capital project expansions. He has extensive international experience having been responsible for the design and startup of major pharmaceutical manufacturing facilities in USA, UK, Europe, Russia, Singapore and China. He is deeply familiar with all aspects of biotechnology product scale up and launch, having held related roles since the founding days of large<FONT CLASS="nobreak">-scale</FONT> biotechnology commercial production. He has a broad understanding of many enterprise operations having held roles in Research and Process Development, Commercial/Business Development, Engineering and Strategic Planning.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Mr.<FONT CLASS="nobreak"> </FONT>Skibo served as EVP Operations at Medimmune, and Head of Biologics Operations at Astra Zeneca for eleven years. He retired from that full time role in April 2019, but continues to serve as Technical Advisor to EVP Operations, AstraZeneca. In his role, he was responsible for the development and improvement of AstraZeneca&#x2019;s mono<FONT CLASS="nobreak">-clonal</FONT> antibody operations and influenza seasonal and pandemic LAIV Flu operations. He developed the network strategy for these operations and implemented them in ten plants across eight sites (including two new sites) in the USA, UK, Europe and China. He transformed a previously challenging regulatory quality environment (warning letter) to best in class status. He oversaw the development of four BLA&#x2019;s and biologics product launches in 2017 to 2019, and has held related roles for nine product launches in his career.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In both his role with MedImmune/AstraZeneca and his role on the Board of ISPE, Mr.<FONT CLASS="nobreak"> </FONT>Skibo routinely interfaced with leadership levels of major international regulatory agencies, especially the FDA. He was instrumental in resolving a dead<FONT CLASS="nobreak">-locked</FONT> product approval/cGMP regulatory issue, involving multiple firms, with the FDA associated with the recent launch of one of AstraZeneca&#x2019;s most significant oncology products.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Mr.<FONT CLASS="nobreak"> </FONT>Skibo received his B.S. degree in Chemistry and his M.S degree in Chemical Engineering from MIT. He holds patents in polymer film extrusion from his original career at Monsanto. He has served as a member of the Mayor&#x2019;s Fiscal Advisory Committee in San Francisco and has been a member and chairman of the Board of Supervisors in Birmingham/Chester County, PA.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Brian Price, Ph.D.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Brian Price has been Blue Water Vaccine, Inc.&#x2019;s Head of Technology Strategy since September 2020 after being the Chief Compliance Officer from August 2019 to September 2020. Mr.<FONT CLASS="nobreak"> </FONT>Price is an experienced professional in FDA<FONT CLASS="nobreak">-regulated</FONT> industries with a focus in CMC Development, regulatory compliance and QC analytical method development and validation. He has a successful track record of Business Development Growth with Government and Commercial funded toxicology, therapeutic and vaccine development, and analytical clientele. Brian&#x2019;s expertise is with molecular biology, microbiology, infectious disease, immunology, vaccines and drug </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">112</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">discovery and development, and FDA compliance. His prior experience includes, from August 2018 to March 2019, as Vice<FONT CLASS="nobreak">-President</FONT> of Pharmaceutical Development at Myonexus Therapeutics, Inc. and multiple positions with Battelle from November 2011 to August 2018, including his most recent role as Vice President of Business Development for the Health Business Unit. At Battelle, Brian supported sales for, directed and oversaw basic and applied research projects for a number of commercial and government clients in the areas of toxicology, vaccine and therapeutic efficacy evaluation, medical device development, environmental microbiology, assay development and validation, and vaccine production, including participating in the development of pre<FONT CLASS="nobreak">-clinical</FONT> trial material for the next generation Anthrax vaccine based on recombinant Protective Antigen for VaxGen, Inc. Mr.<FONT CLASS="nobreak"> </FONT>Price completed is undergraduate studies in Microbiology and Ph.D. in Microbiology at The Ohio State University.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Non-Employee Directors</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Allan L. Shaw</FONT>, one of our directors since January 2020, brings more than two decades of public company financial, operational, and strategic global business leadership. Mr.<FONT CLASS="nobreak"> </FONT>Shaw is a highly regarded biopharma executive and board member with extensive senior global strategic, financial, M&amp;A, operational, capital markets and governance experience. with proven skills across multiple disciplines: corporate finance, capital markets and strategic transactions. Mr.<FONT CLASS="nobreak"> </FONT>Shaw&#x2019;s notable accomplishments include raising more than $4<FONT CLASS="nobreak"> </FONT>billion in public/private financings (including 2 IPOs), scaling a company from $20<FONT CLASS="nobreak"> </FONT>million to $750<FONT CLASS="nobreak"> </FONT>million in revenue as well as being involved with the sourcing/development/commercialization of various drug products in numerous therapeutic areas. Mr.<FONT CLASS="nobreak"> </FONT>Shaw is the founder and since 2005, has served as senior managing director, of Shaw Strategic Capital LLC, an international financial advisory firm focused on providing strategic financial counsel on a wide variety of issues such as general corporate finance, mergers and acquisitions, capital structuring, licensing and capital markets, and serving as financial consultant to private and public companies. Mr.<FONT CLASS="nobreak"> </FONT>Shaw was the Chief Financial Officer and Treasurer of Syndax Pharmaceuticals, Inc. from January 2016 to February 2017 and from December 2011 to September 2015, was Managing Director of Alvarez &amp; Marsal LLC, a global professional services firm, where he led their biopharmaceutical consulting practice. Mr.<FONT CLASS="nobreak"> </FONT>Shaw has served on five public boards including chairing two audit committees, two compensation committees, and is currently involved with a portfolio of healthcare<FONT CLASS="nobreak">-related</FONT> business endeavors. Mr.<FONT CLASS="nobreak"> </FONT>Shaw served as the Chief Financial Officer of Serono S.A. from November 2002 to May 2004; NewLead Holdings Ltd from October 2009 to July 2011; and Viatel, Inc. from November 1994 to June 2002. He currently serves on the board of directors of Edith &amp; Carl Marks JCH of Bensonhurst, a non<FONT CLASS="nobreak">-profit</FONT> organization, and chairs their finance committee. Mr.<FONT CLASS="nobreak"> </FONT>Shaw is a certified public accountant in the State of New York as well as a Chartered Global Management Accountant (CGMA). Mr.<FONT CLASS="nobreak"> </FONT>Shaw received a B.S. from the State University of New York at Oswego College.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Kimberly Murphy</FONT>, one of our directors since January 2020, has more than 25 years of experience at leading pharmaceutical companies including Novartis (NYSE:&#x00a0;NVS) and Merck &amp; Co (NYSE:&#x00a0;MRK). In her distinguished career at Merck, she rose through various public affairs and business roles to leadership positions as Region Marketer for U.S. Commercial Operations, U.S. Marketing Leader for Adult Vaccines and Director of the HPV/Gardasil Franchise. Most recently, Ms. Murphy served as currently the Vice President of Global Vaccines Commercialization Leader, Influenza Franchise, at GlaxoSmithKline (NYSE:&#x00a0;GSK). Ms. Murphy has been with GSK since 2011, initially serving as VP of US Vaccines Customer Strategy from October 2012 to June 2014, then VP of the North America Vaccines Integration Planning from June 2014 to May 2015, followed by VP and Global Marketing Head for the Shingles Vaccines from May 2015 to February 2016, before transitioning to the Global Vaccines Commercialization Leader for the Influenza Franchise. Kim has Board and Advisory experience that includes serving on the boards of Oragenics, Inc. (NYSE:&#x00a0;OGEN) and Blue Water Blue Water Acquisition Corp. (NASDAQ:BLUW), as well as the GSK Representative to the Biotechnology Industry Organization&#x2019;s Biodefense Advisory Council, and on the St. Joseph&#x2019;s University Pharmaceutical &amp; Healthcare Marketing MBA Program&#x2019;s Advisory Board. Ms. Murphy received a B.A. in English from Old Dominion University, a M.B.A. in Marketing from St. Joseph&#x2019;s University, and the Marketing Excellence Program from the Wharton School of University of Pennsylvania. She is well qualified to serve on our Board due to her extensive experience in the healthcare industry.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Mike Venerable</FONT> has been one of Blue Water Vaccines, Inc.&#x2019;s directors since April 2020. As CEO and managing director of CincyTech, Mike Venerable leads with experience from both sides of the table: as a software industry entrepreneur and executive, and a seasoned investment and venture capital professional. Mike joined CincyTech in 2006, helping to raise its inaugural fund. He served as managing director for a decade, evaluating investment opportunities, advising startup companies, and helping to build a network of investors and strategic partners and raise CincyTech Funds II- IV. Previously, Mike was co<FONT CLASS="nobreak">-founder</FONT> and CEO of Talus, a leading data warehouse </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">113</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">consultancy, which was acquired by Sagent Technology. Mike led the company&#x2019;s services organization through the company&#x2019;s successful IPO in 1999. He has specific experience in raising angel and venture capital, software business design and operation, software product management, business valuation, financial analysis and intellectual property. As an industry practitioner, Mike is an expert on data warehouse design, business intelligence and analytic applications and software development processes. He has consulted on strategic product development initiatives for leading technology companies, including Siebel, Advent and Micros. Mike served in the US Army as a Korean linguist after graduating from the University of Dayton.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">James&#x00a0;Sapirstein</FONT>, who will serve as one of our directors upon the completion of this offering, has over 35 years of experience leading, founding, growing, and selling healthcare companies, specifically in the pharmaceutical space. Mr.<FONT CLASS="nobreak"> </FONT>Sapirstein is currently the President and CEO of AzurRx BioPharma (NASDAQ:&#x00a0;AZRX), where he has been since October 2019. His career began in sales at Eli Lilly, eventually rising to Director of International Marketing at Bristol Myers Squibb from July 1996 to June 2000, and later led the launch of Viread (tenofovir) at Gilead Sciences, Inc. (NASDAQ:&#x00a0;GILD), where he served as Global Marketing Lead from June 2020 to June 2002. From November 2006 to January 2011, he served as founding CEO of Tobira Therapeutics (NASDAQ:&#x00a0;TBRA), then a private company, and later acquired by Allergan (NYSE:&#x00a0;AGN). Since then, he has served as CEO of Alliqua Biomedical (NASDAQ:&#x00a0;ALQA) from September 2012 to February 2014 and CEO of Contravir Pharmaceuticals (NASDAQ:&#x00a0;CTRV&#x00a0;from March 2014 to October 2018. He has been part of almost two dozen drug product launches and specifically either led or has been a key member of several HIV product launches into different new classes of therapeutics at the time. Additionally, Mr.<FONT CLASS="nobreak"> </FONT>Sapirstein holds board positions on Marizyme (OTCMKTS:MRZM) (Executive Chairman) since December 2018 Enochian Biosciences (NASDAQ:&#x00a0;ENOB) since April 2018, and Leading Biosciences since March 2016. He previously served as a director of BioNJ from February 2017 to February 2019, an association of biopharma industries in New Jersey, from February 2017 to February 2019, RespireRX (OTCBB:RSPI) from April 2014 to January 2020, and NanoViricides Inc. (NYSE:&#x00a0;NNVC) from November 2018 to January 2020. He is also a Board Director for BIO, the leading Biopharma Industries Organization promoting public policy and networking in the healthcare space, where he sits on both the Health Section and Emerging Companies Section Governing Boards. Mr.<FONT CLASS="nobreak"> </FONT>Sapirstein received a B.S. in Pharmacy from Rutgers University and his MBA from Fairleigh Dickinson University. He is well qualified to serve on our Board due to his extensive network from decades in the healthcare industry.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Family Relationships</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">There are no family relationships between or among any of the current directors, executive officers or persons nominated or charged to become directors or executive officers. There are no family relationships among our officers and directors and those of our subsidiaries and affiliated companies.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Board Composition</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our business and affairs are organized under the direction of our board of directors, which will continue to consist of 5 members following the consummation of this offering. Our directors hold office until the earlier of their death, resignation, removal or disqualification, or until their successors have been elected and qualified. Our board of directors does not have a formal policy on whether the roles of Chief Executive Officer and Chairman of our board of directors should be separate. The primary responsibilities of our board of directors are to provide oversight, strategic guidance, counseling and direction to our management. Our board of directors meets on a regular basis. Upon completion of this offering, our bylaws will be amended and restated to provide that the authorized number of directors may be changed only by resolution of the board of directors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have no formal policy regarding board diversity. Our priority in selection of board members is identification of members who will further the interests of our stockholders through his or her established record of professional accomplishment, the ability to contribute positively to the collaborative culture among board members, knowledge of our business and understanding of the competitive landscape.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Director Independence</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Nasdaq Marketplace Rules require a majority of a listed company&#x2019;s board of directors to be comprised of independent directors within one year of listing. In addition, the Nasdaq Marketplace Rules require that, subject to specified exceptions, each member of a listed company&#x2019;s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A<FONT CLASS="nobreak">-3</FONT> under the Exchange Act.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">114</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under Rule 5605(a)(2) of the Nasdaq Marketplace Rules, a director will only qualify as an &#x201c;independent director&#x201d; if, in the opinion of our board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule 10A<FONT CLASS="nobreak">-3</FONT> of the Exchange Act, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors has reviewed the composition of our board of directors and its committees and the independence of each director. Based upon information requested from and provided by each director concerning his background, employment and affiliations, including family relationships, our board of directors has determined that each of Messrs. Allan Shaw and James Sapirstein as well as Ms. Kimberly Murphy, is an &#x201c;independent director&#x201d; as defined under Rule 5605(a)(2) of the Nasdaq Marketplace Rules. Our board of directors also determined that &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, who will comprise our audit committee following this offering, &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, who will comprise our compensation committee following this offering, and &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, who will be members of our nominating and corporate governance committee following this offering, satisfy the independence standards for such committees established by the SEC and the Nasdaq Marketplace Rules, as applicable. In making such determinations, our board of directors considered the relationships that each such non<FONT CLASS="nobreak">-employee</FONT> director has with our company and all other facts and circumstances our board of directors deemed relevant in determining independence, including the beneficial ownership of our capital stock by each non<FONT CLASS="nobreak">-employee</FONT> director.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Board Committees</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors has established three standing committees &#x2014; audit, compensation and nominating and corporate governance &#x2014; each of which operates under a charter that has been approved by our board of directors. Prior to the completion of this offering, copies of each committee&#x2019;s charter will be posted on the Investor Relations section of our website, which is located at <FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">www.epien.com</FONT>. Each committee has the composition and responsibilities described below. Our board of directors may from time to time establish other committees.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Audit Committee</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our audit committee consists of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, who is the chair of the committee, and&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;. Our board of directors has determined that each of the members of our audit committee satisfies the Nasdaq Marketplace Rules and SEC independence requirements. The functions of this committee include, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>evaluating the performance, independence and qualifications of our independent auditors and determining whether to retain our existing independent auditors or engage new independent auditors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing and approving the engagement of our independent auditors to perform audit services and any permissible non<FONT CLASS="nobreak">-audit</FONT> services;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing our annual and quarterly financial statements and reports, including the disclosures contained under the caption &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations,&#x201d; and discussing the statements and reports with our independent auditors and management;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing with our independent auditors and management significant issues that arise regarding accounting principles and financial statement presentation and matters concerning the scope, adequacy and effectiveness of our financial controls;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing our major financial risk exposures, including the guidelines and policies to govern the process by which risk assessment and risk management is implemented; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing and evaluating on an annual basis the performance of the audit committee, including compliance of the audit committee with its charter.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">115</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors has determined that&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;qualifies as an &#x201c;audit committee financial expert&#x201d; within the meaning of applicable SEC regulations and meets the financial sophistication requirements of the Nasdaq Marketplace Rules. In making this determination, our board has considered&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;extensive financial experience and business background. Both our independent registered public accounting firm and management periodically meet privately with our audit committee.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Compensation Committee</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our compensation committee consists of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, who is the chair of the committee, and&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;. Our board of directors has determined that each of the members of our compensation committee is an outside director, as defined pursuant to Section 162(m) of the Internal Revenue Code of 1986, as amended, or the Code, and satisfies the Nasdaq Marketplace Rules independence requirements. The functions of this committee include, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing, modifying and approving (or if it deems appropriate, making recommendations to the full board of directors regarding) our overall compensation strategy and policies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing and approving the compensation, the performance goals and objectives relevant to the compensation, and other terms of employment of our executive officers;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing and approving (or if it deems appropriate, making recommendations to the full board of directors regarding) the equity incentive plans, compensation plans and similar programs advisable for us, as well as modifying, amending or terminating existing plans and programs;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing and approving the terms of any employment agreements, severance arrangements, change in control protections and any other compensatory arrangements for our executive officers;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>reviewing with management and approving our disclosures under the caption &#x201c;Compensation Discussion and Analysis&#x201d; in our periodic reports or proxy statements to be filed with the SEC; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>preparing the report that the SEC requires in our annual proxy statement.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Nominating and Corporate Governance Committee</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our nominating and corporate governance committee consists of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, who is the chair of the committee, and&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;. Our board of directors has determined that each of the members of this committee satisfies the Nasdaq Marketplace Rules independence requirements. The functions of this committee include, among other things:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>identifying, reviewing and evaluating candidates to serve on our board of directors consistent with criteria approved by our board of directors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>evaluating director performance on the board and applicable committees of the board and determining whether continued service on our board is appropriate;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>evaluating, nominating and recommending individuals for membership on our board of directors; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>evaluating nominations by stockholders of candidates for election to our board of directors.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Code of Business Conduct and Ethics</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to the consummation of this offering, our board of directors will adopt a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. We intend to post on our website a current copy of the code and all disclosures that are required by law or Nasdaq Marketplace Rules concerning any amendments to, or waivers from, any provision of the code.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Board Leadership Structure</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors is free to select the Chairman of the board of directors and the Chief Executive Officer in a manner that it considers to be in the best interests of our company at the time of selection. Currently, Mr.<FONT CLASS="nobreak"> </FONT>Joseph Hernandez serves as our Chief Executive Officer. Three of our five members of our board of directors have been </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">116</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">deemed to be &#x201c;independent&#x201d; by the board of directors, which we believe provides sufficient independent oversight of our management. Because we have a non<FONT CLASS="nobreak">-executive</FONT> Chairman of the board of directors, our board of directors has not designated a lead independent director.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors, as a whole and also at the committee level, plays an active role overseeing the overall management of our risks. Our Audit Committee reviews risks related to financial and operational items with our management and our independent registered public accounting firm. Our board of directors is in regular contact with our Chief Executive Officer, who reports directly to the board of directors and who supervise day<FONT CLASS="nobreak">-to-day</FONT> risk management.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Appointment Rights</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to our amended and restated certificate of incorporation as currently in effect prior to the consummation this offering, certain of our stockholders had rights to appoint members of our board of directors. Pursuant to these rights, of our current directors,&#x00a0;Michael Venerable and John Rice were appointed by holders of our Series Seed Preferred Stock. These rights will terminate upon the consummation of this offering.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Role of Board in Risk Oversight Process</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We face a number of risks, including those described under the caption &#x201c;Risk Factors&#x201d; contained elsewhere in this prospectus. Our board of directors believes that risk management is an important part of establishing, updating and executing on our business strategy. Our board of directors has oversight responsibility relating to risks that could affect the corporate strategy, business objectives, compliance, operations, and the financial condition and performance of our company. Our board of directors focuses its oversight on the most significant risks facing us and on our processes to identify, prioritize, assess, manage and mitigate those risks. Our board of directors receives regular reports from members of our senior management on areas of material risk to us, including strategic, operational, financial, legal and regulatory risks. While our board of directors has an oversight role, management is principally tasked with direct responsibility for management and assessment of risks and the implementation of processes and controls to mitigate their effects on us.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">117</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T9"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">EXECUTIVE AND DIRECTOR COMPENSATION</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table sets forth total compensation paid to our named executive officers for the years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019. Individuals we refer to as our &#x201c;named executive officers&#x201d; include our Chief Executive Officer and our two other most highly compensated executive officers whose salary and bonus for services rendered in all capacities exceeded $100,000 during the fiscal year ended December<FONT CLASS="nobreak"> </FONT>31, 2020.</P>
		<TABLE CLASS="No-Table-Style _idGenTablePara-1" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-14" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 18.32%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Name and <BR>Principal&#x00a0;Position</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Year</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Salary <BR>($)</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Bonus <BR>($)</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Option <BR>Awards <BR>($)<FONT CLASS="Bold-Superscript" STYLE="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;">(2)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.81%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Non-Equity <BR>Incentive Plan <BR>Compensation <BR>($)</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Nonqualified <BR>Deferred <BR>Compensation <BR>Earnings <BR>($)</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">All Other Compensation <BR>($)</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Total <BR>($)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-15" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 18.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">Joseph Hernandez</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">2020</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">420,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.81%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">420,000</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 18.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">Chief Executive<BR>Officer</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">2019</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">420,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.81%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">420,000</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-15" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 18.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">Brian Price</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">2020</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">122,979</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.81%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">3,500</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">126,479</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 18.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">Head of Technology Strategy</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">2019</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">83,333</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 5.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">1,480</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.81%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 12.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-3" STYLE="font-size:9pt;">84,813</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Mr.<FONT CLASS="nobreak"> </FONT>Price resigned from his position as Chief Operating Officer, effective as of August 15, 2020 and became a consultant for the Company.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(2)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Consists of exercisable options to purchase 29,600, shares of common stock.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Employment Agreements of Named Executive Officers</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have entered into various employment agreements with certain of our executive officers. Set forth below is a summary of many of the material provisions of such agreements, which summaries do not purport to contain all of the material terms and conditions of each such agreement.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Joseph Hernandez</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021, we entered into an employment agreement with Mr.<FONT CLASS="nobreak"> </FONT>Hernandez, pursuant to which he is employed as the Chief Executive Officer of the Company, which supersedes Mr.<FONT CLASS="nobreak"> </FONT>Hernandez&#x2019;s prior consulting agreement with the Company. The employment agreement provides for an annual base salary, subject to annual increases in the discretion of our compensation committee, the Company, and an annual performance bonus. Pursuant to the employment agreement, following the completion of this offering, Mr.<FONT CLASS="nobreak"> </FONT>Hernandez&#x2019;s base salary will be $595,000. The annual performance bonus will be up to 50% of annual base salary (the &#x201c;Target Annual Bonus&#x201d;), with the actual bonus being based upon the level of achievement of annual Company and individual performance objectives for such fiscal year, as determined by our compensation committee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the event that Mr.<FONT CLASS="nobreak"> </FONT>Hernandez&#x2019;s employment is terminated by the Company without cause (as defined in the employment agreement), or if Mr.<FONT CLASS="nobreak"> </FONT>Hernandez terminates his employment for &#x201c;Good Reason&#x201d; (as defined in the employment agreement), in addition to accrued unpaid salary, reimbursements and vacation days, he will be entitled to certain severance payments and benefits, including: (i) a lump sum payment equal to 90 days of his base salary, (ii) any unpaid annual bonus in respect of any completed fiscal year that has ended prior to the date of such termination; (iii) subject to certain conditions set forth in the employment agreement, an amount equal to (A) the Target Annual Bonus otherwise for the fiscal year in which such termination occurred, assuming Mr.<FONT CLASS="nobreak"> </FONT>Hernandez had remained employed through the applicable payment date, multiplied by (B) a fraction, the numerator of which is the number of days elapsed from the commencement of such fiscal year through the date of such termination and the denominator of which is 365 (or 366, as applicable); (iv) a lump sum payment equal to twelve (12) months of his base salary; (v) payment of an amount equal to the difference between the monthly COBRA premium cost and the monthly contribution paid by active employees for the same coverage for twelve months following his termination.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The employment agreement also provides that if a change in control (as defined in the employment agreement) occurs, and during the period commencing three months prior to a change in control and ending on the eighteen (18)<FONT CLASS="nobreak">-month</FONT> anniversary of the change in control, Mr.<FONT CLASS="nobreak"> </FONT>Hernandez is terminated without cause or he resigns for good reason, Mr.<FONT CLASS="nobreak"> </FONT>Hernandez will be entitled to (i) any unpaid annual bonus in respect of any completed fiscal year that has ended prior to the date of such termination; (ii) subject to certain conditions set forth in the employment agreement, an amount equal to (A) the Target Annual Bonus otherwise for the fiscal year in which such termination occurred, </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">118</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">assuming Mr.<FONT CLASS="nobreak"> </FONT>Hernandez had remained employed through the applicable payment date, multiplied by (B) a fraction, the numerator of which is the number of days elapsed from the commencement of such fiscal year through the date of such termination and the denominator of which is 365 (or 366, as applicable); (iii) severance of 18<FONT CLASS="nobreak"> </FONT>months&#x2019; salary; and (iv) payment of an amount equal to the difference between the monthly COBRA premium cost and the monthly contribution paid by active employees for the same coverage for twelve months following his termination. Additionally, all, any unvested portion of the equity awards held subject to time<FONT CLASS="nobreak">-vesting</FONT> held by Mr, Hernandez will automatically vest.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The employment agreement is governed by the laws of the State of Delaware and contains non<FONT CLASS="nobreak">-solicitation</FONT> and non<FONT CLASS="nobreak">-competition</FONT> covenants (each of which remains in effect during the term of employment and for six months following termination of employment) and confidentiality, trade secrets and assignment of intellectual property clauses.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Brian Price &#x2014; Employment Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On August<FONT CLASS="nobreak"> </FONT>15, 2019, we entered into an employment agreement with Mr.<FONT CLASS="nobreak"> </FONT>Brian Price, which was subsequently superseded by the consultancy agreement described below, pursuant to which he was employed in the capacity of the Chief Operating Officer of the Company. The employment agreement was for a term of one (1) year, and was subject to automatic renewal for successive one (1) year terms upon the mutual agreement between Mr.<FONT CLASS="nobreak"> </FONT>Price and the Company. The employment agreement provided for an annual base salary of two hundred thousand dollars ($200,000), subject to an annual review by the Board of the Company. Additionally, the employment agreement contemplated: (a) an annual bonus of up to 30% of the base salary; (b) four (4) weeks of paid vacation during each calendar year, subject to the approval of the CEO; (c) reimbursement for medical insurance premiums of up to $2,000.00 per month, which was to continue until the Company offered comprehensive medical coverage (among others). Furthermore, the employment agreement contemplated an issuance of employee options to Mr.<FONT CLASS="nobreak"> </FONT>Price, equal to 2.5% of the then<FONT CLASS="nobreak">-available</FONT> equity of the Company, under the terms of the Company&#x2019;s 2019 Equity Incentive Plan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The employment agreement was terminable by the Company without cause (as defined in the employment agreement) or by Mr.<FONT CLASS="nobreak"> </FONT>Price for &#x201c;Good Reason&#x201d; (as defined in the employment agreement); and, in the event of such termination, the employment agreement entitled Mr.<FONT CLASS="nobreak"> </FONT>Price to receive any accrued unpaid salary, reimbursements and vacation days, as well as certain severance payments and benefits such as: a lump sum payment equal to six (6) months of base salary.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The employment agreement was governed by the laws of the State of New York, and contained non<FONT CLASS="nobreak">-solicitation</FONT> and non<FONT CLASS="nobreak">-competition</FONT> covenants (each of which remained in effect for the term of employment and for one (1) year following termination of employment), as well as confidentiality and non<FONT CLASS="nobreak">-disclosure</FONT>, trade secrets and assignment of intellectual property clauses.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Brian Price &#x2014; Consulting Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On August<FONT CLASS="nobreak"> </FONT>17, 2020, we entered into a consulting agreement with Mr.<FONT CLASS="nobreak"> </FONT>Brian Price, pursuant to which we retained Mr.<FONT CLASS="nobreak"> </FONT>Price&#x2019;s services as a consultant to the Company in the capacity of an &#x201c;independent contractor&#x201d; and not as an employee or agent of the Company. The term of the consulting agreement was one year and is subject to renewal by mutual agreement between Mr.<FONT CLASS="nobreak"> </FONT>Price and the Company. The Company and Mr.<FONT CLASS="nobreak"> </FONT>Price renewed the consulting agreement on August<FONT CLASS="nobreak"> </FONT>16, 2021. Pursuant to the consulting agreement, Mr.<FONT CLASS="nobreak"> </FONT>Price&#x2019;s compensation includes an hourly rate of two hundred and fifty dollars ($250.00) for services provided to the Company, along with a reimbursement for all reasonable and necessary expenses incurred by Mr.<FONT CLASS="nobreak"> </FONT>Price in connection with, or related to, the performance of his services under the consulting agreement. Under the terms of the consulting agreement, Mr.<FONT CLASS="nobreak"> </FONT>Price is not entitled to any benefits, coverages or privileges available to employees of the Company, including, but not limited to: social security, unemployment, medical or pension payments.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The consulting agreement is terminable by the Company and by Mr.<FONT CLASS="nobreak"> </FONT>Price (without prejudice to any right or remedy that either may have due to a failure of the other to perform obligations under the terms of the consulting agreement) upon thirty (30) days&#x2019; prior written notice. In the event of early termination, Mr.<FONT CLASS="nobreak"> </FONT>Price is entitled to payment for services performed and expenses paid or incurred prior to the effective date of the termination (subject to certain limitations on reimbursement of expenses, as defined in the consulting agreement). Additionally, if Mr.<FONT CLASS="nobreak"> </FONT>Price breaches or threatens a breach of certain provisions (defined in the consulting agreement), the Company may terminate the consulting agreement, effective immediately upon receipt of written notice.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">119</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The consulting agreement is governed by the laws of the State of Ohio, and contains non<FONT CLASS="nobreak">-solicitation</FONT> and non<FONT CLASS="nobreak">-competition</FONT> covenants (each of which remained in effect for the term of the consulting agreement and for one (1) year following the termination of the consulting agreement), as well as confidentiality and non<FONT CLASS="nobreak">-disclosure</FONT>, trade secrets and assignment of intellectual property clauses. The consulting agreement requires that Mr.<FONT CLASS="nobreak"> </FONT>Price was not authorized to assume or create any obligation or responsibility (express or implied) on behalf of or in the name of the Company.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Potential Payments Upon Termination or Change-in-Control</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">See &#x201c;Employment Agreements of Named Executive Officers&#x201d; above.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Employee Benefit Plans</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The principal features of our equity incentive plans are summarized below. These summaries are qualified in their entirety by reference to the actual text of the plans, which are filed as exhibits to the registration statement of which this prospectus forms a part.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">2021 Equity Incentive Plan</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors adopted our 2021 Plan in&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;2021, and we expect our stockholders to approve our 2021 Plan prior to the completion of this offering. Our 2021 Plan is a successor to and continuation of our 2019 Plan. Our 2021 Plan will become effective on the date of the underwriting agreement related to this offering. The 2021 Plan came into existence upon its adoption by our board of directors, but no grants will be made under the 2021 Plan prior to its effectiveness. Once the 2021 Plan is effective, no further grants will be made under the 2019 Plan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Awards.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our 2021 Plan provides for the grant of incentive stock options, or ISOs, within the meaning of Section&#x00a0;422 of the Internal Revenue Code, or the Code, to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options, or NSOs, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards and other forms of awards to employees, directors and consultants, including employees and consultants of our affiliates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Authorized Shares.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Initially, the maximum number of shares of our common stock that may be issued under our 2021 Plan after it becomes effective will not exceed&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of our common stock, which is the sum of (i)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;new shares, plus (ii)&#x00a0;an additional number of shares not to exceed&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, consisting of (A)&#x00a0;shares that remain available for the issuance of awards under our 2019 Plan as of immediately prior to the time our 2021 Plan becomes effective and (B)&#x00a0;shares of our common stock subject to outstanding stock options or other stock awards granted under our 2019 Plan that, on or after the 2021 Plan becomes effective, terminate or expire prior to exercise or settlement; are not issued because the award is settled in cash; are forfeited because of the failure to vest; or are reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price, if any, as such shares become available from time to time. The maximum number of shares of our common stock that may be issued on the exercise of ISOs under our 2021 Plan is&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Shares subject to stock awards granted under our 2021 Plan that expire or terminate without being exercised in full or that are paid out in cash rather than in shares do not reduce the number of shares available for issuance under our 2021 Plan. Shares withheld under a stock award to satisfy the exercise, strike or purchase price of a stock award or to satisfy a tax withholding obligation do not reduce the number of shares available for issuance under our 2021 Plan. If any shares of our common stock issued pursuant to a stock award are forfeited back to or repurchased or reacquired by us (i)&#x00a0;because of a failure to meet a contingency or condition required for the vesting of such shares, (ii)&#x00a0;to satisfy the exercise, strike or purchase price of an award or (iii)&#x00a0;to satisfy a tax withholding obligation in connection with an award, the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under the 2010 Plan. Any shares previously issued which are reacquired in satisfaction of tax withholding obligations or as consideration for the exercise or purchase price of a stock award will again become available for issuance under the 2021 Plan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Plan Administration.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our Board of Directors has assigned the authority to administer the 2021 Plan to our Compensation Committee, but may, at any time, re<FONT CLASS="nobreak">-vest</FONT> in itself some or all of the power delegated to our Compensation Committee. The Compensation Committee may delegate to one or more of our officers the authority </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">120</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">to (i)&#x00a0;designate employees (other than officers) to receive specified stock awards and (ii)&#x00a0;determine the number of shares subject to such stock awards. Under our 2021 Plan, our Compensation Committee has the authority to determine award recipients, grant dates, the numbers and types of stock awards to be granted, the applicable fair market value, and the provisions of each stock award, including the period of exercisability and the vesting schedule applicable to a stock award.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Stock Options.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>ISOs and NSOs are granted under stock option agreements in a form approved by the Compensation Committee. The Compensation Committee determines the exercise price for stock options, within the terms and conditions of the 2021 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted under the 2021 Plan vest at the rate specified in the stock option agreement as determined by the Compensation Committee.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Compensation Committee determines the term of stock options granted under the 2021 Plan, up to a maximum of 10&#x00a0;years. Unless the terms of an optionholder&#x2019;s stock option agreement, or other written agreement between us and the recipient approved by the Compensation Committee, provide otherwise, if an optionholder&#x2019;s service relationship with us or any of our affiliates ceases for any reason other than disability, death or cause, the optionholder may generally exercise any vested options for a period of three months following the cessation of service. This period may be extended in the event that exercise of the option is prohibited by applicable securities laws. If an optionholder&#x2019;s service relationship with us or any of our affiliates ceases due to death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 18&#x00a0;months following the date of death. If an optionholder&#x2019;s service relationship with us or any of our affiliates ceases due to disability, the optionholder may generally exercise any vested options for a period of 12&#x00a0;months following the cessation of service. In the event of a termination for cause, options generally terminate upon the termination date. In no event may an option be exercised beyond the expiration of its term.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the Compensation Committee and may include (i)&#x00a0;cash, check, bank draft or money order, (ii)&#x00a0;a broker<FONT CLASS="nobreak">-assisted</FONT> cashless exercise, (iii)&#x00a0;the tender of shares of our common stock previously owned by the optionholder, (iv)&#x00a0;a net exercise of the option if it is an NSO or (v)&#x00a0;other legal consideration approved by the Board of Directors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Unless the Compensation Committee provides otherwise, options or stock appreciation rights generally are not transferable except by will or the laws of descent and distribution. Subject to approval of the Compensation Committee or a duly authorized officer, an option may be transferred pursuant to a domestic relations order, official marital settlement agreement or other divorce or separation instrument.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Tax Limitations on ISOs.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an award holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our parent or subsidiary corporations unless (i)&#x00a0;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant and (ii)&#x00a0;the term of the ISO does not exceed five years from the date of grant.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Restricted Stock Unit Awards.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Restricted stock unit awards are granted under restricted stock unit award agreements in a form approved by the Compensation Committee. Restricted stock unit awards may be granted in consideration for any form of legal consideration that may be acceptable to our board of directors and permissible under applicable law. A restricted stock unit award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the Compensation Committee or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit award. Except as otherwise provided in the applicable award agreement, or other written agreement between us and the recipient approved by the Compensation Committee, restricted stock unit awards that have not vested will be forfeited once the participant&#x2019;s continuous service ends for any reason.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Restricted Stock Awards.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Restricted stock awards are granted under restricted stock award agreements in a form approved by the Compensation Committee. A restricted stock award may be awarded in consideration for cash, check, bank draft or money order, past or future services to us or any other form of legal consideration that may be </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">121</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">acceptable to our board of directors and permissible under applicable law. The Compensation Committee determines the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#x2019;s service relationship with us ends for any reason, we may receive any or all of the shares of common stock held by the participant that have not vested as of the date the participant terminates service with us through a forfeiture condition or a repurchase right.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Stock Appreciation Rights.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Stock appreciation rights are granted under stock appreciation right agreements in a form approved by the Compensation Committee. The Compensation Committee determines the strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of our common stock on the date of grant. A stock appreciation right granted under the 2021 Plan vests at the rate specified in the stock appreciation right agreement as determined by the Compensation Committee. Stock appreciation rights may be settled in cash or shares of common stock or in any other form of payment as determined by the Board and specified in the stock appreciation right agreement.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Compensation Committee determines the term of stock appreciation rights granted under the 2021 Plan, up to a maximum of 10&#x00a0;years. If a participant&#x2019;s service relationship with us or any of our affiliates ceases for any reason other than cause, disability or death, the participant may generally exercise any vested stock appreciation right for a period of three months following the cessation of service. This period may be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If a participant&#x2019;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12&#x00a0;months in the event of disability and 18&#x00a0;months in the event of death. In the event of a termination for cause, stock appreciation rights generally terminate immediately upon the occurrence of the event giving rise to the termination of the individual for cause. In no event may a stock appreciation right be exercised beyond the expiration of its term.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Performance Awards.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The 2021 Plan permits the grant of performance awards that may be settled in stock, cash or other property. Performance awards may be structured so that the stock or cash will be issued or paid only following the achievement of certain&#x00a0;pre<FONT CLASS="nobreak">-established</FONT>&#x00a0;performance goals during a designated performance period. Performance awards that are settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, the common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The performance goals may be based on any measure of performance selected by the board of directors or the Compensation Committee. The performance goals may be based on company<FONT CLASS="nobreak">-wide</FONT> performance or performance of one or more business units, divisions, affiliates or business segments, and may be either absolute or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the board of directors at the time the performance award is granted, the board or Compensation Committee will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (i)&#x00a0;to exclude restructuring and/or other nonrecurring charges; (ii)&#x00a0;to exclude exchange rate effects; (iii)&#x00a0;to exclude the effects of changes to generally accepted accounting principles; (iv)&#x00a0;to exclude the effects of any statutory adjustments to corporate tax rates; (v)&#x00a0;to exclude the effects of items that are &#x201c;unusual&#x201d; in nature or occur &#x201c;infrequently&#x201d; as determined under generally accepted accounting principles; (vi)&#x00a0;to exclude the dilutive effects of acquisitions or joint ventures; (vii)&#x00a0;to assume that any portion of our business which is divested achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (viii)&#x00a0;to exclude the effect of any change in the outstanding shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation,&#x00a0;spin<FONT CLASS="nobreak">-off</FONT>,&#x00a0;combination or exchange of shares or other similar corporate change or any distributions to common stockholders other than regular cash dividends; (ix)&#x00a0;to exclude the effects of stock based compensation and the award of bonuses under our bonus plans; (x)&#x00a0;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (xi)&#x00a0;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles; and (xi) to exclude the effects of the timing of acceptance for review and/or approval of submissions to the U.S. Food and Drug Administration or any other regulatory body.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Other Stock Awards.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The Compensation Committee may grant other awards based in whole or in part by reference to our common stock. The Compensation Committee will set the number of shares under the stock award (or cash equivalent) and all other terms and conditions of such awards.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">122</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Non</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">-Employee</FONT></FONT><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">&#x00a0;Director Compensation Limit.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The aggregate value of all compensation granted or paid to any&#x00a0;non<FONT CLASS="nobreak">-employee</FONT>&#x00a0;director with respect to any calendar year, including awards granted and cash fees paid by us to such&#x00a0;non<FONT CLASS="nobreak">-employee</FONT>&#x00a0;director, will not exceed $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;in total value; provided that such amount will increase to&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;for the first year for newly appointed or elected&#x00a0;non<FONT CLASS="nobreak">-employee</FONT>&#x00a0;directors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Changes to Capital Structure.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split or recapitalization, appropriate adjustments will be made to (i)&#x00a0;the class and maximum number of shares reserved for issuance under the 2021 Plan, (ii)&#x00a0;the class and maximum number of shares by which the share reserve may increase automatically each year, (iii)&#x00a0;the class and maximum number of shares that may be issued on the exercise of ISOs and (iv)&#x00a0;the class and number of shares and exercise price, strike price or purchase price, if applicable, of all outstanding stock awards.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Corporate Transactions.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The following applies to stock awards under the 2021 Plan in the event of a corporate transaction (as defined in the 2021 Plan), unless otherwise provided in a participant&#x2019;s stock award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the Board of Directors or Compensation Committee at the time of grant.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the event of a corporate transaction, any stock awards outstanding under the 2021 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be assigned to the successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such stock awards, then (i)&#x00a0;with respect to any such stock awards that are held by participants whose continuous service has not terminated prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of such stock awards will be accelerated in full to a date prior to the effective time of the corporate transaction (contingent upon the effectiveness of the corporate transaction), and such stock awards will terminate if not exercised (if applicable) at or prior to the effective time of the corporate transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards will lapse (contingent upon the effectiveness of the corporate transaction), and (ii)&#x00a0;any such stock awards that are held by persons other than current participants will terminate if not exercised (if applicable) prior to the effective time of the corporate transaction, except that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may continue to be exercised notwithstanding the corporate transaction.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the event a stock award will terminate if not exercised prior to the effective time of a corporate transaction, the board of directors may provide, in its sole discretion, that the holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any) of (i)&#x00a0;the per share amount payable to holders of common stock in connection with the corporate transaction over (ii)&#x00a0;any per share exercise price payable by such holder, if applicable. In addition, any escrow, holdback, earn out or similar provisions in the definitive agreement for the corporate transaction may apply to such payment to the same extent and in the same manner as such provisions apply to the holders of common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Plan Amendment or Termination.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our board of directors has the authority to amend, suspend or terminate our 2021 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#x2019;s written consent. Certain material amendments also require the approval of our stockholders. No ISOs may be granted after the tenth anniversary of the date our board of directors adopts our 2021 Plan. No stock awards may be granted under our 2021 Plan while it is suspended or after it is terminated.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">2019 Equity Incentive Plan</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors adopted and our stockholders approved our 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;) in July 2019 for grants of awards to employees, directors, officers and consultants of us or any of our subsidiaries. Once the 2021 Plan is effective, no further grants will be made under the 2019 Plan. However, the 2019 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2019 Plan.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">123</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Awards.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our 2019 Plan provides for the grant of stock awards (collectively, &#x201c;Stock Awards&#x201d;) to employees, directors, officers and consultants of us or any of our subsidiaries, consisting of (i) incentive stock options, (&#x201c;ISOs&#x201d;), within the meaning of Section&#x00a0;422 of the Internal Revenue Code (the &#x201c;Code&#x201d;); (ii) nonstatutory stock options (&#x201c;NSOs&#x201d;); (iii) stock appreciation rights; (iv) restricted stock awards; (v) restricted stock unit awards, and (vi) other forms of awards.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Authorized Shares.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>As of August<FONT CLASS="nobreak"> </FONT>1, 2021, stock options covering 195,160<FONT CLASS="nobreak"> </FONT>shares, each with an exercise price of $0.05 per share were the only outstanding Stock Awards outstanding under our 2019 Plan, and 154,840<FONT CLASS="nobreak"> </FONT>shares of our common stock remained available for the future grant of awards under our 2019 Plan, which upon the adoption of the 2021 Plan, will become issuable under the 2021 Plan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Plan Administration.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The 2019 Plan may be administered by our board of directors, and our board of directors may delegate such administration to a committee of the board of directors (as applicable, the &#x201c;Administrator&#x201d;). The Administrator, in its discretion, selects the individuals to whom awards may be granted, the time or times at which such awards are granted and the terms and conditions of such awards.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Stock Options.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Stock options entitle the holder to purchase a specified number of shares of common stock at a specified price (the exercise price), subject to the terms and conditions of the stock option grant. Our board of directors may grant either incentive stock options, which must comply with Code Section 422, or nonqualified stock options. ISO&#x2019;s may only be granted to employees of the Company or a &#x201c;parent corporation&#x201d; or &#x201c;subsidiary corporation&#x201d; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Our Administrator sets exercise prices and terms and conditions, except that stock options must be granted with an exercise price not less than 100% of the fair market value of our common stock on the date of grant. Unless our Administrator determines otherwise, fair market value means, as of a given date, the closing price of our common stock. At the time of grant, our board of directors determines the terms and conditions of stock options, including the quantity, exercise price, vesting periods, term (which may not exceed 10 years) and other conditions on exercise. Pursuant to the 2019 Plan, we may only issue 350,000 ISO&#x2019;s.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Eligibility.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Awards may be granted under the 2019 Plan to officers, employees, directors, officers and of us and our subsidiaries. Incentive stock options may be granted only to employees of us or our subsidiaries.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Restricted Stock, Restricted Stock Units and Other Stock<FONT CLASS="nobreak">-Based</FONT> Awards.&#x00a0;Our board of directors may grant awards of restricted stock, which are shares of common stock subject to specified restrictions, and restricted stock units, or RSUs, which represent the right to receive shares of our common stock in the future. These awards may be made subject to repurchase, forfeiture or vesting restrictions at the discretion of our board of directors discretion. The restrictions may be based on continuous service with us or the attainment of specified performance goals, as determined by the board of directors. Stock units may be paid in stock or cash or a combination of stock and cash, as determined by the board of directors. Other stock awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than one hundred percent (100%) of the fair market value of the common stock at the time of grant) may be granted either alone or in addition to stock awards provided for under the 2019 Plan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Stock Appreciation Rights.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Upon exercise, SARs entitle the holder to receive payment per share in stock or cash, or in a combination of stock and cash, equal to the excess of the share&#x2019;s fair market value on the date of exercise over the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date (the &#x201c;grant price&#x201d;. Exercise of a SAR issued in tandem with a stock option will reduce the number of shares underlying the related stock option to the extent of the SAR exercised. The term of a SAR cannot exceed 10 years.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Changes to Capital Structure.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split or recapitalization, appropriate adjustments will be made to (i)&#x00a0;the class and maximum number of shares subject to the 2019 Plan, (ii)&#x00a0;the class and maximum number of shares that may be issued on the exercise of ISOs and (iii)&#x00a0;the class and number of shares and exercise price, strike price or purchase price, if applicable, of all outstanding stock awards.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">124</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Corporate Transactions.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The following applies to Stock Awards under the 2019 Plan in the event of a corporate transaction (as defined in the 2019 Plan), unless otherwise provided in a participant&#x2019;s stock award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the Board of Directors at the time of grant.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the event of a corporate transaction, the board of directors may take one of the following actions, contingent on the completion of the corporate transaction: (i) arrange for the surviving or acquiring corporation (or its parent company) to assume, continue or substitute the Stock Award for a similar stock award; (ii) arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of common stock issued pursuant to the Stock Award to the surviving or acquiring corporation (or its parent company); (iii) accelerate the vesting (in whole or in part) of the Stock Award; (iv) arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award; (v) cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the corporate transaction, in exchange for such cash consideration that the Board of Directors; and (vi) make a payment equal to the excess, if any, of (A) the value of the property the participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the corporate transaction, over (B) any exercise price payable by such holder in connection with such exercise The Board of Directors need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all participants. The Board of Directors may also take different actions with respect to the vested and unvested portions of a Stock Award.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, under the 2019 Plan, a Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control (as defined in the 2019 Plan) as may be provided in the Grant Agreement for such Stock Award or as may be provided in any other written agreement between the participant and the Company or any of its subsidiaries which may employ the participant, but in the absence of such provision, no such acceleration will occur.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Plan Amendment or Termination.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Our board of directors has the authority to amend, suspend or terminate our 2019 Plan, subject to certain conditions, including that such action does not materially impair the existing rights of any participant without such participant&#x2019;s written consent. Certain material amendments also require the approval of our stockholders. No ISOs may be granted after the tenth anniversary of the date our board of directors adopted our 2019 Plan.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Limitation of Liability and Indemnification Matters</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Amended and Restated Certificate of Incorporation, which will become effective immediately after the completion of this offering, and our Amended and Restated Bylaws, which will become effective immediately prior to the completion of this offering, limits our directors&#x2019; liability, and may indemnify our directors and officers to the fullest extent permitted under Delaware General Corporation Law, or the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability for any:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>transaction from which the director derives an improper personal benefit;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>unlawful payment of dividends or redemption of shares; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>breach of a director&#x2019;s duty of loyalty to the corporation or its stockholders.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or recession.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The DGCL and our Amended and Restated Bylaws provide that we will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment or reimbursement of reasonable expenses (including attorneys&#x2019; fees and disbursements) in advance of the final disposition of the proceeding.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">125</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition, we have entered, and intend to continue to enter, into separate indemnification agreements with some of our directors and officers. These indemnification agreements, among other things, require us to indemnify our directors and officers for certain expenses, including attorneys&#x2019; fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as a director or officer, or any other company or enterprise to which the person provides services at our request.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We maintain a directors&#x2019; and officers&#x2019; insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers. We believe that these provisions in our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, or the Securities Act, may be permitted to directors, officers or control persons, in the opinion of the SEC, such indemnification is against public policy, as expressed in the Securities Act and is therefore unenforceable.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">126</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T8"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PRINCIPAL STOCKHOLDERS</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table sets forth certain information concerning the ownership of our common stock as of August<FONT CLASS="nobreak"> </FONT>1, 2021, with respect to: (i) each person, or group of affiliated persons, known to us to be the beneficial owner of more than five percent of our common stock; (ii) each of our directors; (iii) each of our named executive officers; and (iv) all of our current directors and executive officers as a group.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Applicable percentage ownership is based on 2,136,855<FONT CLASS="nobreak"> </FONT>shares of common stock outstanding as of August<FONT CLASS="nobreak"> </FONT>1, 2021 (after giving effect to the conversion of all outstanding shares of convertible preferred stock into an aggregate of 1,336,855<FONT CLASS="nobreak"> </FONT>shares of common stock immediately prior to the offering).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The percentage of beneficial ownership after this offering assumes the sale and issuance of shares of common stock in this offering and no exercise by the underwriters of their option to purchase additional shares of common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting or investment power with respect to such securities. In addition, pursuant to such rules, we deemed outstanding shares of common stock subject to options or warrants held by that person that are currently exercisable or exercisable within 60 days of August<FONT CLASS="nobreak"> </FONT>1, 2021. We did not deem such shares outstanding, however, for the purpose of computing the percentage ownership of any other person. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the beneficial owners named in the table below have sole voting and investment power with respect to all shares of our common stock that they beneficially own, subject to applicable community property laws.</P>
		<TABLE CLASS="No-Table-Style _idGenTablePara-1" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TCH _idGenCellOverride-3" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="6" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 31.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Beneficial Ownership <BR>Prior to Offering</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 28.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Beneficial Ownership <BR>After the Offering</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TCH" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Name and Address of Beneficial Owner<FONT CLASS="Bold-Superscript" STYLE="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;">(1)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Number&#x00a0;of&#x00a0;Shares</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Percentage</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Number&#x00a0;of&#x00a0;Shares</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Percentage</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="No-Table-Style TB _idGenCellOverride-1" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">5% Stockholders</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-23" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cincinnati Cornerstone Investors BWV&#x00a0;I, LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">858,041</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">&#x200b;<FONT CLASS="CharOverride-4" STYLE="font-size:58%;vertical-align:super;">(1)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">40.15</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">CincyTech Fund IV, LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">191,526</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">&#x200b;<FONT CLASS="CharOverride-4" STYLE="font-size:58%;vertical-align:super;">(2)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8.96</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-23" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Named Executive Officers and Directors</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Joseph Hernandez</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">37.34</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Kimberly Murphy</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,541</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">&#x200b;<FONT CLASS="CharOverride-4" STYLE="font-size:58%;vertical-align:super;">(3)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">John Rice, Ph.D.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Allan L. Shaw</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,541</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">&#x200b;<FONT CLASS="CharOverride-4" STYLE="font-size:58%;vertical-align:super;">(3)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Michael Venerable</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">James Sapirstein</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Brian Price</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">9,086</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">&#x200b;<FONT CLASS="CharOverride-4" STYLE="font-size:58%;vertical-align:super;">(4)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-23" STYLE="height:12pt;">
					<TD CLASS="No-Table-Style TB" STYLE="width: 37.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">All directors and named executive officers as a group (7 persons)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">38.28</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">*&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Represents beneficial ownership of less than 1%.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Consists of 858,041<FONT CLASS="nobreak"> </FONT>shares of common stock (following the conversion of the preferred stock) held of record by Cincinnati Cornerstone Investors BWV I. Cincinnati Cornerstone Capital, LLC holds voting and dispositive power with respect to the shares of common stock held by Cincinnati Cornerstone Investors BWV I. The address for these entities is 2900 Reading Rd., Suite 410, Cincinnati, OH 45206.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(2)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Consists of 191,526<FONT CLASS="nobreak"> </FONT>shares of common stock (following the conversion of preferred stock) held of record by CincyTech Fund IV, LLC. CincyTech, LLC holds voting and dispositive power with respect to the shares of common stock held by CincyTech Fund IV, LLC. The address for these entities is 2900 Reading Rd., Suite 410, Cincinnati, OH 45206.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(3)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Consists of 4,541<FONT CLASS="nobreak"> </FONT>shares of common stock underlying options that are currently exercisable within 60 days of August 1, 2021.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">(4)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Consists of 9,086<FONT CLASS="nobreak"> </FONT>shares of common stock underlying options that are currently exercisable within 60 days of August 1, 2021.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">127</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T7"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following is a description of transactions since January<FONT CLASS="nobreak"> </FONT>1, 2020 to which we were a party in which (i) the amount involved exceeded or will exceed the lesser of $120,000 of one percent (1%) of our average total assets at year<FONT CLASS="nobreak">-end</FONT> for the last two completed fiscal years and (ii) any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of, or person sharing the household with, any of the foregoing persons, who had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other similar arrangements, which are described under &#x201c;Executive and Director Compensation.&#x201d;</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Equity Financings</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Series Seed Preferred Stock Financing</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In July 2019, we sold an aggregate of 1,146,138<FONT CLASS="nobreak"> </FONT>shares of our Series Seed Preferred Stock, par value $0.00001 par value per share (the &#x201c;Series Seed Stock&#x201d;), at a purchase price of $6.09 per share for an aggregate purchase price of $6,979,980. The following table summarize purchases of our shares of Series&#x00a0;Seed Stock by related persons:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-27" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Stockholder</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Number of Shares of Series Seed Stock</P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;">Total <BR>Purchase <BR>Price <BR>($)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cincinnati Cornerstone Investors BWV I, LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">735,632</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,479,998.88</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">CincyTech Fund IV, LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">164,203</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">999,996.27</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Great American Insurance Company</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">82,101</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">499,995.09</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Great American Life Insurance Company</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">82,101</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">499,995.09</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">John B. Berding Irrevocable Family Trust</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">82,101</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">499,995.09</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Rights of Appointment</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our board of directors currently consists of five directors. Pursuant to our amended and restated certificate of incorporation in effect prior to this offering, certain of our stockholders, including our related parties, had rights to appoint members of our board of directors. See the section titled &#x201c;Management &#x2014; Appointment Rights.&#x201d;</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">All rights to appoint directors will terminate upon the closing of this offering, although one currently serving director that was appointed prior to this offering will continue to serve pursuant to his appointment until the annual meeting of stockholders at which the term of their class of director expires.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Right of First Refusal and Co-Sale Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are party to a right of first refusal and co<FONT CLASS="nobreak">-sale</FONT> agreement, pursuant to which we had a right to purchase (and certain other investors had the right to purchase in the case we did not exercise our right to purchase) shares of our capital stock which certain holders of our common stock propose to sell to other parties. The right of first refusal and co<FONT CLASS="nobreak">-sale</FONT> agreement will terminate upon the completion of this offering.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Voting Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are party to a voting agreement under which certain holders of our capital stock have agreed as to the manner in which they will vote their shares of our capital stock on certain matters, including with respect to the election of directors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The voting agreement will terminate upon the completion of this offering, at which time there will be no further contractual obligations regarding the manner in which shares are voted with respect to the election of our directors. Our directors hold office until their successors have been elected and qualified or until the earlier of their resignation or removal.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">128</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Other Transactions</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Agreement with Blue Water Real Estate Holdings</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We leased office space in November<FONT CLASS="nobreak"> </FONT>28, 2018 from an affiliate of our chief executive officer, Blue Water Real Estate Holdings, Inc. Rental expense recorded for the years ended December&#x00a0;31, 2019, 2020, and through June<FONT CLASS="nobreak"> </FONT>30, 2021 was $66,308, $66,308, and $27,628, respectively. This lease was terminated on March<FONT CLASS="nobreak"> </FONT>31, 2021; however, the company did not vacate the premises until May<FONT CLASS="nobreak"> </FONT>26, 2021. As of the effective date of the registration statement of which this prospectus forms a part, we have no outstanding obligations under this agreement.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Consulting Agreement with Joseph Hernandez</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On October<FONT CLASS="nobreak"> </FONT>22, 2018, we entered into a Consulting Agreement with Joseph Hernandez, the Chief Executive Officer of Blue Water Vaccines. Consulting expense recorded for the years ended December&#x00a0;31, 2019, 2020, and through June<FONT CLASS="nobreak"> </FONT>30, 2021 was $420,000, $420,000, and $210,000, respectively. Pursuant to the Consulting Agreement, Joseph Hernandez provided us with consulting services, and we were required to pay an aggregate amount of $1.16<FONT CLASS="nobreak"> </FONT>million to Joseph Hernandez. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, we are obligated to pay a total of $105,000.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Agreement with Blue Water Venture Partners</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On October<FONT CLASS="nobreak"> </FONT>22, 2018, we entered into a verbal agreement with Blue Water Venture Partners. Our CEO, Joe Hernandez, is the sole shareholder of Blue Water Ventures. Pursuant to the verbal agreement, Blue Water Venture Partners provided (i) the company&#x2019;s option fee to Oxford University Innovation, Ltd, (ii) a lease deposit to Blue Water Real Estate Holdings, Inc., (iii) purchased office furniture on behalf of the company and (iv) paid our rent for the period from November<FONT CLASS="nobreak"> </FONT>28, 2019 through July<FONT CLASS="nobreak"> </FONT>31, 2019. Expenses recorded for the year ended December&#x00a0;31, 2019, 2020 and through June<FONT CLASS="nobreak"> </FONT>30, 2021 were $35,000, $0 and $0, respectively. We were required to pay an aggregate amount of $89,617 to Blue Water Venture Partners. As of the effective date of the registration statement of which this prospectus forms a part, we have no outstanding obligations under this agreement.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Indemnification of Officers and Directors</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, which will become effective in connection with the completion of this offering, will provide that we will indemnify each of our directors and officers to the fullest extent permitted by the DGCL. Further, we intend to enter into indemnification agreements with each of our directors and officers, and we have purchased a policy of directors&#x2019; and officers&#x2019; liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment under certain circumstances. For further information, see &#x201c;Executive and Director Compensation &#x2014; Limitations of Liability and Indemnification Matters.&#x201d;</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Policies and Procedures for Related Party Transactions</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">All future transactions between us and our officers, directors or five percent stockholders, and respective affiliates will be on terms no less favorable than could be obtained from unaffiliated third parties and will be approved by a majority of our independent directors who do not have an interest in the transactions and who had access, at our expense, to our legal counsel or independent legal counsel.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">To the best of our knowledge, during the past two fiscal years, other than as set forth above, there were no material transactions, or series of similar transactions, or any currently proposed transactions, or series of similar transactions, to which we were or are to be a party, in which the amount involved exceeds $120,000, and in which any director or executive officer, or any security holder who is known by us to own of record or beneficially more than 5% of any class of our common stock, or any member of the immediate family of any of the foregoing persons, has an interest (other than compensation to our officers and directors in the ordinary course of business).</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">129</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T6"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">DESCRIPTION OF CAPITAL STOCK</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following is a summary of the rights of our common stock and preferred stock, certain provisions of our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws as they will be in effect upon completion of this offering and applicable law. This summary does not purport to be complete and is qualified in its entirety by the provisions of our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws, copies of which have been filed as exhibits to the registration statement and are incorporated by reference to our registration statement, of which this prospectus forms a part.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Authorized Capital Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Immediately prior to the completion of this offering and upon the filing of our Amended and Restated Certificate of Incorporation, our authorized capital stock will consist of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock, par value $0.00001 per share and&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of preferred stock, par value $0.00001 per share.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Common Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of August<FONT CLASS="nobreak"> </FONT>1, 2021, and after giving effect to the conversion of all of our outstanding preferred stock into common stock in connection with this offering, there were 2,136,855<FONT CLASS="nobreak"> </FONT>shares of common stock issued and outstanding, no shares of common stock issuable upon exercise of outstanding warrants, and 195,160<FONT CLASS="nobreak"> </FONT>shares of common stock issuable upon exercise of outstanding stock options.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under the terms of our Amended and Restated Certificate of Incorporation, holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders, including the election of directors, and do not have cumulative voting rights. The holders of outstanding shares of common stock are entitled to receive dividends out of assets or funds legally available for the payment of dividends of such times and in such amounts as our board of directors from time to time may determine. Our common stock is not entitled to pre<FONT CLASS="nobreak">-emptive</FONT> rights and is not subject to conversion or redemption. Upon liquidation, dissolution or winding up of our company, the assets legally available for distribution to stockholders are distributable ratably among the holders of our common stock after payment of liquidation preferences, if any, on any outstanding payment of other claims of creditors. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Preferred Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Upon the closing of this offering, we will have no shares of preferred stock designated or outstanding, but our board of directors will be authorized, without further action by the shareholders, to establish one or more class or series, and fix the relative rights and preferences of the company&#x2019;s undesignated capital stock.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Options</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of August<FONT CLASS="nobreak"> </FONT>1, 2021, we had outstanding options to purchase an aggregate 195,160<FONT CLASS="nobreak"> </FONT>shares of our common stock, each with an exercise price of $0.05 per share.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Warrants</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have no outstanding warrants to purchase our common stock prior to the consummation of this offering. In connection with the offering, we will be providing the representative with a warrant to purchase
shares of common stock. For more about these warrants see the section titled Underwriting &#x2014; Representative&#x2019;s Warrants.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">130</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Anti-Takeover Provisions of Delaware Law and Our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Section&#x00a0;203 of the Delaware General Corporation Law</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are subject to Section&#x00a0;203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i)&#x00a0;by persons who are directors and also officers and (ii)&#x00a0;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">2</FONT>/<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">3</FONT>% of the outstanding voting stock that is not owned by the interested stockholder.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Section&#x00a0;203 defines a &#x201c;business combination&#x201d; to include the following:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any merger or consolidation involving the corporation and the interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In general, Section&#x00a0;203 defines an &#x201c;interested stockholder&#x201d; as an entity or person who, together with the person&#x2019;s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Among other things, our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws will:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>permit our board of directors to issue up to&#x00a0;10,000,000&#x00a0;shares of preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in control;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that the authorized number of directors may be changed only by resolution of our board of directors;</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">131</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that our board of directors will be classified into three classes of directors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that, subject to the rights of any series of preferred stock to elect directors, directors may only be removed for cause, which removal may be effected, subject to any limitation imposed by law, by the holders of at least 66<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">2</FONT>/<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">3</FONT>% of the voting power of all of our then<FONT CLASS="nobreak">-outstanding</FONT> shares of the capital stock entitled to vote generally at an election of directors;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent or electronic transmission;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#x2019;s notice;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>provide that special meetings of our stockholders may be called only by the chairman of our board of directors, our chief executive officer or president or by our board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors, and not by our stockholders; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The amendment of any of these provisions would require approval by the holders of at least 66<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">2</FONT>/<FONT CLASS="Subscript" STYLE="vertical-align:sub;font-size:58%;">3</FONT>% of the voting power of all of our then<FONT CLASS="nobreak">-outstanding</FONT> common stock entitled to vote generally in the election of directors, voting together as a single class.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The combination of these provisions will make it more difficult for our existing stockholders to replace our board of directors as well as for another party to obtain control of us by replacing our board of directors. Because our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals, because negotiation of takeover proposals could result in an improvement of their terms.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Choice of Forum</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Amended and Restated Certificate of Incorporation to be effective immediately after the closing of this offering will provide that the Court of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) will be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (i)&#x00a0;any derivative action or proceeding brought on our behalf; (ii)&#x00a0;any action or proceeding asserting a claim of breach of a fiduciary duty owed by any of our current or former directors, officers or other employees to us or our stockholders; (iii)&#x00a0;any action or proceeding asserting a claim against us or any of our current or former directors, officers or other employees, arising out of or pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws; (iv)&#x00a0;any action or proceeding to interpret, apply, </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">132</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">enforce or determine the validity of our certificate of incorporation or our bylaws; and (v)&#x00a0;any action asserting a claim against us or any of our directors, officers or other employees governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. Nothing in our Amended and Restated Certificate of Incorporation precludes stockholders that assert claims under the Securities Act from bringing such claims in state or federal court, subject to applicable law. Our Amended and Restated Certificate of Incorporation will further provide that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action under the Securities Act, unless we consent in writing to the selection of an alternative forum.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Limitation on Liability and Indemnification</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">See the section titled &#x201c;Management &#x2014; Limitation on Liability and Indemnification Matters.&#x201d;</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Listing</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We intend to apply to list our common stock on The Nasdaq Capital Market under the trading symbol &#x201c;BWV.&#x201d;</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Transfer Agent and Registrar</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The transfer agent and registrar for our common stock is Continental Stock Transfer &amp; Trust Company. The Transfer Agent&#x2019;s address is 1 State Street, 30<FONT CLASS="Superscript" STYLE="vertical-align:super;font-size:58%;">th</FONT> Floor, New York, New York 10004.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">133</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T5"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">SHARES ELIGIBLE FOR FUTURE SALE</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to this offering, no public market existed for our common stock. Future sales of substantial amounts of our common stock in the public market following this offering, or the possibility of such sales occurring, could adversely affect prevailing market prices and could impair our ability to raise capital through the offering of equity securities.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Based on the number of shares of common stock outstanding as of August<FONT CLASS="nobreak"> </FONT>1, 2021, upon the completion of this offering, we will have a total of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares of common stock outstanding, assuming an initial public offering price of $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share and assuming no exercise by the underwriters of their option to purchase additional shares of common stock and no exercise of outstanding options or warrants to purchase shares of common stock. All of the shares sold in this offering will be freely tradable unless held by our &#x201c;affiliates&#x201d;, as defined in Rule 144 under the Securities Act.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As a result of contractual restrictions described below and the provisions of Rules 144 and 701 promulgated under the Securities Act, the shares of common stock sold in this offering will be available for sale in the public market as follows:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>all the shares of common stock sold in this offering will be eligible for immediate sale upon the closing of this offering; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>common shares will be eligible for sale in the public market upon expiration of lock<FONT CLASS="nobreak">-up</FONT> agreements 180&#x00a0;days after the date of this prospectus, subject, in certain circumstances to the volume, manner of sale and other limitations under Rule 144 and Rule 701.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Rule 144</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In general, persons (or persons whose shares are required to be aggregated) who have beneficially owned shares of our common stock for at least six months, and any affiliate of ours who owns shares of our common stock, are entitled to sell their securities without registration with the SEC under an exemption from registration provided by Rule 144 under the Securities Act.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Non-Affiliates</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any person (or persons whose shares are required to be aggregated) who is not deemed to have been an affiliate of ours at any time during the three months preceding a sale, and who has beneficially owned restricted securities for at least six months, including the holding period of any prior owner other than one of our affiliates, is entitled to sell those shares, subject only to the availability of current public information about us and provided that we have been subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale. If such person has held our shares for at least one year, such person can resell such shares under Rule 144(b)(1) without regard to any Rule 144 restrictions, including the 90<FONT CLASS="nobreak">-day</FONT> public company and current public information requirements.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Affiliates</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Any person (or persons whose shares are required to be aggregated) who is deemed to be an affiliate of ours and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six months would be subject to the restrictions described above. Additionally, such person would be subject to additional restrictions, pursuant to which such person would be required to comply with the manner of sale and notice provisions of Rule 144 and would be entitled to sell within any three<FONT CLASS="nobreak">-month</FONT> period a number of shares that does not exceed the greater of:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>1% of the number of shares of common stock then outstanding, which will equal approximately&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;shares immediately after this offering, based on the number of shares outstanding as of&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021 and assuming no exercise by the underwriters of their option to purchase additional shares of common stock and no outstanding options or warrants; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the average weekly trading volume of our shares of common stock on the Nasdaq Capital Market during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">134</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Additionally, persons who are our affiliates at the time of, or any time during the three months preceding, a sale may sell unrestricted securities under the requirements of Rule 144 described above, without regard to the six<FONT CLASS="nobreak">-month</FONT> holding period of Rule 144, which does not apply to sales of unrestricted securities.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Rule 701</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under Rule 701 under the Securities Act, shares of our common stock acquired upon the exercise of currently outstanding options or pursuant to other rights granted under our stock plans may be resold, by:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>persons other than affiliates, beginning 90 days after the effective date of the registration statement of which this prospectus forms a part, subject only to the manner<FONT CLASS="nobreak">-of-sale</FONT> provisions of Rule 144; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our affiliates, beginning 90 days after the effective date of the registration statement of which this prospectus forms a part, subject to the manner<FONT CLASS="nobreak">-of-sale</FONT> and volume limitations, current public information and filing requirements of Rule 144, in each case, without compliance with the six<FONT CLASS="nobreak">-month</FONT> holding period requirement of Rule 144.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Notwithstanding the foregoing, all our Rule 701<FONT CLASS="nobreak"> </FONT>shares are subject to lock<FONT CLASS="nobreak">-up</FONT> agreements as described below and in the section titled &#x201c;Underwriting&#x201d; and will become eligible for sale upon the expiration of the restrictions set forth in those agreements.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Lock-Up Agreements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We and our directors, officers any other holder(s) of three percent (3.0%) or more of our outstanding common stock as of the effective date of the Registration Statement which this prospectus forms a part of (and all holders of securities exercisable for or convertible into three percent (3.0%) or more of our common stock) have entered into customary &#x201c;lock<FONT CLASS="nobreak">-up</FONT>&#x201d; agreements in favor of Maxim pursuant to which such persons and entities have agreed, for a period of six (6) months after the effective date of the registration statement related to this offering, that they shall neither offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any securities of the Company without Maxim&#x2019;s prior written consent, including the issuance of shares of common stock upon the exercise of currently outstanding options approved by Maxim.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Form S-8 Registration Statement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We intend to file a registration statement on Form S<FONT CLASS="nobreak">-8</FONT> under the Securities Act after the closing of this offering to register the shares of our common stock that are issuable pursuant to our 2021 Plan. The registration statement is expected to be filed and become effective as soon as practicable after the completion of this offering. Accordingly, shares registered under such registration statement will be available for sale in the open market following its effective date, subject to Rule 144 volume limitations and the lock<FONT CLASS="nobreak">-up</FONT> arrangement described above, if applicable.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">135</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T4"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">UNDERWRITING</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We are offering our common stock described in this prospectus through the underwriter named below. Maxim Group LLC, or Maxim or the representative, is acting as representative of the underwriter. We have entered into an underwriting agreement with the underwriter. Subject to the terms and conditions of the underwriting agreement, the underwriter has agreed to purchase, and we have agreed to sell to the underwriter, the number of common stock listed next to its name in the following table.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Underwriter</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Number of&#x00a0;Shares</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Maxim Group LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"> &#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The underwriting agreement provides that the underwriter must buy all of the shares of common stock being sold in this offering if they buy any of them. However, the underwriter is not required to take or pay for the shares of common stock covered by the underwriter&#x2019;s option to purchase additional common stock as described below.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our common stock are offered subject to a number of conditions, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>receipt and acceptance of our common stock by the underwriter; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the underwriter&#x2019;s right to reject orders in whole or in part.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have been advised by Maxim that the underwriter intends to make a market in our common stock but that it is not obligated to do so and may discontinue making a market at any time without notice.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In connection with this offering, the underwriter or securities dealers may distribute prospectuses electronically.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Option to Purchase Additional Common Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have granted the representative an option to buy up to an aggregate of additional shares of common stock. The representative has 45 days from the date of this prospectus to exercise this option. If the representative exercises this option, it will purchase additional shares of common stock approximately in proportion to the amounts specified in the table above.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Underwriting Discount</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Shares sold by the representative to the public will initially be offered at the initial offering price set forth on the cover of this prospectus. Any shares sold by the representative to securities dealers may be sold at a discount of up to $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;per share from the initial public offering price. The representative may offer the shares through one or more of their affiliates or selling agents. If all the shares are not sold at the initial public offering price, the representative may change the offering price and the other selling terms. Upon execution of the underwriting agreement, the representative will be obligated to purchase the shares at the prices and upon the terms stated therein.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have agreed to pay the underwriters a cash fee equal to eight percent (8.0%) of the aggregate gross proceeds from the sale of the common stock, provided however, that the discount or spread shall be three and one half percent (3.5%) for any investors initially introduced by us, so long as such investors do not require the services of Maxim registered representatives in connection with their participation in the offering (collectively, the &#x201c;Company Investors&#x201d;).</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table summarizes the public offering price, underwriting commissions and proceeds before expenses to us assuming both no exercise and full exercise of the underwriters&#x2019; option to purchase additional common stock.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">136</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<TABLE CLASS="No-Table-Style TableOverride-1" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-10" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Per Share</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Total without <BR>Over-Allotment <BR>Option</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Total with <BR>Over-Allotment <BR>Option</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Public offering price</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Underwriting discounts and commissions</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds, before expenses to us</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have agreed to pay Maxim&#x2019;s out<FONT CLASS="nobreak">-of-pocket</FONT> accountable expenses, including Maxim&#x2019;s legal fees, up to a maximum amount of $125,000 if this offering is completed. We are required to pay $25,000 to Maxim as an advance to be applied towards reasonable out<FONT CLASS="nobreak">-of-pocket</FONT> expenses, or the Advance. Any portion of the Advance shall be returned back to us to the extent not actually incurred.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We estimate that the total expenses of the offering payable by us, not including the underwriting discount, will be approximately $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;. We have also agreed to reimburse the underwriter for certain expenses incurred by them.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Representative&#x2019;s Warrants</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have also agreed to issue to Maxim (or its permitted assignees) warrants to purchase&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;a number of our shares equal to an aggregate of 5% of the total number of common stock sold in this offering, excluding Shares sold to existing Company stockholders, or the representative&#x2019;s warrants. The representative&#x2019;s warrants will have an exercise price equal to $&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;(115% of the offering price of the common stock sold in this offering) and may be exercised on a cashless basis. The representative&#x2019;s warrants are exercisable commencing six months after the effective date of the registration statement related to this offering, and will expire five years after such date. The representative&#x2019;s warrants are not redeemable by us. We have agreed to a one<FONT CLASS="nobreak">-time</FONT> demand registration of the shares of common stock underlying the representative&#x2019;s warrants at our expense for a period of five years from the effective date of the registration statement related to this offering. The representative&#x2019;s warrants also provide for unlimited &#x201c;piggyback&#x201d; registration rights at our expense with respect to the underlying common stock during the five<FONT CLASS="nobreak">-year</FONT> period commencing from the effective date of the registration statement related to this offering. The representative&#x2019;s warrants and the common stock underlying the representative&#x2019;s warrants, have been deemed compensation by the Financial Industry Regulatory Authority, or FINRA, and are therefore subject to a 180<FONT CLASS="nobreak">-day</FONT> lock<FONT CLASS="nobreak">-up</FONT> pursuant to Rule 5110(g)(1) of FINRA. Maxim (or permitted assignees under the Rule) may not sell, transfer, assign, pledge or hypothecate the representative&#x2019;s warrants or the securities underlying the representative&#x2019;s warrants, nor will they engage in any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the representative&#x2019;s warrants or the underlying securities for a period of six months from the effective date of this offering, except to any FINRA member participating in the offering and their bona fide officers or partners. The representative&#x2019;s warrants will provide for adjustment in the number and price of such representative&#x2019;s warrants (and the common stock underlying such representative&#x2019;s warrants) to prevent dilution in the event of a forward or reverse stock split, stock dividend or similar recapitalization.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Right of First Refusal</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have agreed to grant Maxim, for the period commencing on the effective date of the registration statement related to this offering and concluding fifteen (15) months thereafter, a right of first refusal to act as sole underwriter or placement agent for any and all future public and private equity and debt (excluding commercial bank debt) offerings of the Company, or any successor to or any subsidiary of the Company during such fifteen (15) month period, except for financing provided by or solicited from any person or entity who is a current holder of the Company&#x2019;s debt or equity.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Lock-Up Agreements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We and our directors, officers any other holder(s) of three percent (3.0%) or more of our outstanding common stock as of the effective date of the Registration Statement which this prospectus forms a part of (and all holders of securities exercisable for or convertible into three percent (3.0%) or more of our common stock) have entered into customary &#x201c;lock<FONT CLASS="nobreak">-up</FONT>&#x201d; agreements in favor of Maxim pursuant to which such persons and entities have agreed, for a period of six (6) months after the effective date of the registration statement related to this offering, that they shall neither offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any securities of the Company without Maxim&#x2019;s prior written consent, including the issuance of shares of common stock upon the exercise of currently outstanding options approved by Maxim.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">137</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Indemnification</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have agreed to indemnify the underwriter against certain liabilities, including certain liabilities under the Securities Act. If we are unable to provide this indemnification, we have agreed to contribute to payments the underwriter may be required to make in respect of those liabilities.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Other Relationships</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The underwriter and its affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">No Public Market</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to this offering, there has not been a public market for our securities in the U.S. and the public offering price for our common stock will be determined through negotiations between us and the underwriter. Among the factors to be considered in these negotiations will be prevailing market conditions, our financial information, market valuations of other companies that we and the underwriter believe to be comparable to us, estimates of our business potential, the present state of our development and other factors deemed relevant.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We offer no assurances that the initial public offering price will correspond to the price at which our common stock will trade in the public market subsequent to this offering or that an active trading market for our common stock will develop and continue after this offering.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Stock Exchange</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We intend to apply to list our common stock on the Nasdaq Capital Market, under the symbol &#x201c;BWV&#x201d; There can be no assurance that we will be successful in listing our common stock on the Nasdaq Capital Market.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Electronic Distribution</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A prospectus in electronic format may be made available on websites or through other online services maintained by the underwriter of this offering, or by their affiliates. Other than the prospectus in electronic format, the information on any underwriter&#x2019;s website and any information contained in any other website maintained by an underwriter is not part of this prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or any underwriter in its capacity as underwriter, and should not be relied upon by investors.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Price Stabilization, Short Positions</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In connection with this offering, the underwriter may engage in activities that stabilize, maintain or otherwise affect the price of our common stock during and after this offering, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>stabilizing transactions;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>short sales;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>purchases to cover positions created by short sales;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>imposition of penalty bids; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>syndicate covering transactions.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Stabilizing transactions consist of bids or purchases made for the purpose of preventing or retarding a decline in the market price of our common stock while this offering is in progress. Stabilization transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. These transactions may also include making short sales of our common stock, which involve the sale by the underwriter of a greater number of common stock than they are required to purchase in this offering and purchasing common stock </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">138</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">on the open market to cover short positions created by short sales. Short sales may be &#x201c;covered short sales,&#x201d; which are short positions in an amount not greater than the underwriter&#x2019;s option to purchase additional shares referred to above, or may be &#x201c;naked short sales,&#x201d; which are short positions in excess of that amount.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The underwriter may close out any covered short position by either exercising their option, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriter will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the over<FONT CLASS="nobreak">-allotment</FONT> option.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Naked short sales are short sales made in excess of the over<FONT CLASS="nobreak">-allotment</FONT> option. The underwriter must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriter is concerned that there may be downward pressure on the price of the common stock in the open market that could adversely affect investors who purchased in this offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The underwriter also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriter a portion of the underwriting discount received by it because Maxim has repurchased shares sold by or for the account of that underwriter in stabilizing or short covering transactions.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These stabilizing transactions, short sales, purchases to cover positions created by short sales, the imposition of penalty bids and syndicate covering transactions may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result of these activities, the price of our common stock may be higher than the price that otherwise might exist in the open market. The underwriter may carry out these transactions on the Nasdaq Capital Market, in the over<FONT CLASS="nobreak">-the-counter</FONT> market or otherwise. Neither we nor the underwriter make any representation or prediction as to the effect that the transactions described above may have on the price of the shares. Neither we, nor the underwriter make any representation that the underwriter will engage in these stabilization transactions or that any transaction, once commenced, will not be discontinued without notice.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Determination of Offering Price</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prior to this offering, there was no public market for our common stock. The initial public offering price will be determined by negotiation between us and Maxim. The principal factors to be considered in determining the initial public offering price include, but not limited to:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the information set forth in this prospectus and otherwise available to Maxim;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our history and prospects and the history and prospects for the industry in which we compete;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our past and present financial performance;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our prospects for future earnings and the present state of our development;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the general condition of the securities market at the time of this offering;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the recent market prices of, and demand for, publicly traded shares of generally comparable companies; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>other factors deemed relevant by the underwriter and us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The estimated public offering price range set forth on the cover page of this preliminary prospectus is subject to change as a result of market conditions and other factors. Neither we nor the underwriter can assure investors that an active trading market will develop for our common stock or that the common stock will trade in the public market at or above the initial public offering price.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Affiliations</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The underwriter and its respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. The underwriter and its affiliates may from time to time in the future engage with us and perform services for us or in </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">139</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">the ordinary course of their business for which they will receive customary fees and expenses. In the ordinary course of their various business activities, the underwriter and its respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of us. The underwriter and its respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of these securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in these securities and instruments.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Offer Restrictions Outside the United States</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">No action has been taken in any jurisdiction (except in the United States) that would permit a public offering of the common stock the possession, circulation or distribution of this prospectus or any other material relating to us or the common stock in any jurisdiction where action for that purpose is required. Accordingly, the common stock may not be offered or sold, directly or indirectly, and neither this prospectus nor any other material or advertisements in connection with the common stock may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable laws, rules and regulations of any such country or jurisdiction.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Australia.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>does not constitute a product disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth) (the &#x201c;Corporations Act&#x201d;);</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>has not been, and will not be, lodged with the Australian Securities and Investments Commission (&#x201c;ASIC&#x201d;), as a disclosure document for the purposes of the Corporations Act and does not purport to include the information required of a disclosure document under Chapter&#x00a0;6D.2 of the Corporations Act;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>does not constitute or involve a recommendation to acquire, an offer or invitation for issue or sale, an offer or invitation to arrange the issue or sale, or an issue or sale, of interests to a &#x201c;retail client&#x201d; (as defined in section 761G of the Corporations Act and applicable regulations) in Australia; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>may only be provided in Australia to select investors who are able to demonstrate that they fall within one or more of the categories of investors, or Exempt Investors, available under section&#x00a0;708 of the Corporations Act.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The common stock may not be directly or indirectly offered for subscription or purchased or sold, and no invitations to subscribe for or buy the common stock may be issued, and no draft or definitive offering memorandum, advertisement or other offering material relating to any common stock may be distributed in Australia, except where disclosure to investors is not required under Chapter&#x00a0;6D of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the common stock, you represent and warrant to us that you are an Exempt Investor.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As any offer of common stock under this prospectus will be made without disclosure in Australia under Chapter&#x00a0;6D.2 of the Corporations Act, the offer of those securities for resale in Australia within 12&#x00a0;months may, under section&#x00a0;707 of the Corporations Act, require disclosure to investors under Chapter&#x00a0;6D.2 if none of the exemptions in section&#x00a0;708 applies to that resale. By applying for the common stock, you undertake to us that you will not, for a period of 12&#x00a0;months from the date of issue of the common stock, offer, transfer, assign or otherwise alienate those securities to investors in Australia except in circumstances where disclosure to investors is not required under Chapter&#x00a0;6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">140</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Canada.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument&#x00a0;45<FONT CLASS="nobreak">-106</FONT> Prospectus Exemptions or subsection&#x00a0;73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument&#x00a0;31<FONT CLASS="nobreak">-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the common stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#x2019;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#x2019;s province or territory for particulars of these rights or consult with a legal advisor.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to section&#x00a0;3A.3 of National Instrument&#x00a0;33<FONT CLASS="nobreak">-105</FONT> Underwriting Conflicts (NI&#x00a0;33<FONT CLASS="nobreak">-105</FONT>), the underwriter is not required to comply with the disclosure requirements of NI&#x00a0;33<FONT CLASS="nobreak">-105</FONT> regarding underwriter conflicts of interest in connection with this offering.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Cayman Islands.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus does not constitute a public offer of the common stock, whether by way of sale or subscription, in the Cayman Islands. Common stock have not been offered or sold, and will not be offered or sold, directly or indirectly, in the Cayman Islands.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Dubai International Financial Centre (&#x201c;DIFC&#x201d;).&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus relates to an Exempt Offer in accordance with the Markets Rules&#x00a0;2012 of the Dubai Financial Services Authority (the &#x201c;DFSA&#x201d;). This prospectus is intended for distribution only to persons of a type specified in the Markets Rules&#x00a0;2012 of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this prospectus. The securities to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this prospectus you should consult an authorized financial advisor.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In relation to its use in the DIFC, this prospectus is strictly private and confidential and is being distributed to a limited number of investors and must not be provided to any person other than the original recipient, and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly or indirectly to the public in the DIFC.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">European Economic Area.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a Relevant Member State), with effect from and including the date on which the Prospectus Directive was implemented in that Relevant Member State (the Relevant Implementation Date), an offer of the common stock to the public may not be made in that Relevant Member State prior to the publication of a prospectus in relation to the common stock which has been approved by the competent authority in that Relevant Member State or, where appropriate, approved in another Relevant Member State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Directive, except that, with effect from and including the Relevant Implementation Date, an offer of common stock may be made to the public in that Relevant Member State at any time:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>to any legal entity which is a qualified investor as defined under the Prospectus Directive;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending <FONT CLASS="CharOverride-1" STYLE="">Directive, 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive); or</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>in any other circumstances falling within Article&#x00a0;3(2) of the Prospectus Directive, provided that no such offer of <FONT CLASS="CharOverride-1" STYLE="">securities described in this prospectus shall result in a requirement for the publication by us of a prospectus pursuant to Article&#x00a0;3 of the Prospectus Directive.</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the purposes of the above paragraph, the expression &#x201c;an offer of the common stock to the public&#x201d; in relation to any common stock in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the common stock to be offered so as to enable an </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">141</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;text-indent:0pt;">investor to decide to purchase or subscribe the common stock, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State. The expression Prospectus Directive means Directive 2003/71/EC (and any amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State) and includes any relevant implementing measure in each Relevant Member State, and the expression &#x201c;2010 PD Amending Directive&#x201d; means Directive 2010/73/EU.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Hong Kong.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The common stock may not be offered or sold by means of any document other than (i)&#x00a0;in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong), (ii)&#x00a0;to &#x201c;professional investors&#x201d; within the meaning of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) and any rules promulgated thereunder, or (iii)&#x00a0;in other circumstances which do not result in the document being a &#x201c;prospectus&#x201d; within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong), and no advertisement, invitation or document relating to the common stock may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to common stock which are or are intended to be disposed of only to persons outside Hong Kong or only to &#x201c;professional investors&#x201d; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules promulgated thereunder.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Japan.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Common stock have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&#x00a0;25 of 1948, as amended) and, accordingly, will not be offered or sold directly or indirectly in Japan or to, or for the benefit of any Japanese person or to others, for re<FONT CLASS="nobreak">-offering</FONT> or re<FONT CLASS="nobreak">-sale</FONT> directly or indirectly in Japan or to any Japanese person, except in each case pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Securities and Exchange Law of Japan and any other applicable laws, rules and regulations of Japan. For purposes of this paragraph, &#x201c;Japanese person&#x201d; means any person resident in Japan, including any corporation or other entity organized under the laws of Japan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Kuwait.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Unless all necessary approvals from the Kuwait Ministry of Commerce and Industry required by Law No.&#x00a0;31/1990 &#x201c;Regulating the Negotiation of Securities and Establishment of Investment Funds,&#x201d; its Executive Regulations and the various Ministerial Orders issued pursuant thereto or in connection therewith, have been given in relation to the marketing and sale of the common stock, these may not be marketed, offered for sale, nor sold in the State of Kuwait. Neither this prospectus (including any related document), nor any of the information contained therein is intended to lead to the conclusion of any contract of whatsoever nature within Kuwait.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Malaysia.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>No prospectus or other offering material or document in connection with the offer and sale of the common stock has been or will be registered with the Securities Commission of Malaysia (the &#x201c;Commission&#x201d;) for the Commission&#x2019;s approval pursuant to the Capital Markets and Services Act 2007. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the common stock may not be circulated or distributed, nor may the common stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Malaysia other than (i)&#x00a0;a closed end fund approved by the Commission; (ii)&#x00a0;a holder of a Capital Markets Services License; (iii)&#x00a0;a person who acquires the common stock , as principal, if the offer is on terms that the common stock may only be acquired at a consideration of not less than RM250,000 (or its equivalent in foreign currencies) for each transaction; (iv)&#x00a0;an individual whose total net personal assets or total net joint assets with his or her spouse exceeds RM3&#x00a0;million (or its equivalent in foreign currencies), excluding the value of the primary residence of the individual; (v)&#x00a0;an individual who has a gross annual income exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the preceding twelve months; (vi)&#x00a0;an individual who, jointly with his or her spouse, has a gross annual income of RM400,000 (or its equivalent in foreign currencies), per annum in the preceding twelve months; (vii)&#x00a0;a corporation with total net assets exceeding RM10&#x00a0;million (or its equivalent in a foreign currencies) based on the last audited accounts; (viii)&#x00a0;a partnership with total net assets exceeding RM10&#x00a0;million (or its equivalent in foreign currencies); (ix)&#x00a0;a bank licensee or insurance licensee as defined in the Labuan Financial Services and Securities Act 2010; (x)&#x00a0;an Islamic bank licensee or takaful licensee as defined in the Labuan Financial Services and Securities Act 2010; and (xi)&#x00a0;any other person as may be specified by the Commission; provided that, in the each of the preceding categories&#x00a0;(i) to (xi), the distribution of the common stock is made by a holder of a Capital Markets Services License who carries on the business of dealing in securities. The distribution in Malaysia of this prospectus is subject to Malaysian laws. This prospectus does not constitute and may not be used for the purpose of public offering or an issue, offer for subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of a prospectus with the Commission under the Capital Markets and Services Act 2007.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">142</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">People&#x2019;s Republic of China.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus may not be circulated or distributed in the PRC and the common stock may not be offered or sold, and will not offer or sell to any person for re<FONT CLASS="nobreak">-offering</FONT> or resale directly or indirectly to any resident of the PRC except pursuant to applicable laws, rules and regulations of the PRC. For the purpose of this paragraph only, the PRC does not include Taiwan and the special administrative regions of Hong Kong and Macau.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Qatar.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>In the State of Qatar, the offer contained herein is made on an exclusive basis to the specifically intended recipient thereof, upon that person&#x2019;s request and initiative, for personal use only and shall in no way be construed as a general offer for the sale of securities to the public or an attempt to do business as a bank, an investment company or otherwise in the State of Qatar. This prospectus and the underlying securities have not been approved or licensed by the Qatar Central Bank or the Qatar Financial Centre Regulatory Authority or any other regulator in the State of Qatar. The information contained in this prospectus shall only be shared with any third parties in Qatar on a need to know basis for the purpose of evaluating the contained offer. Any distribution of this prospectus by the recipient to third parties in Qatar beyond the terms hereof is not permitted and shall be at the liability of such recipient.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Saudi Arabia.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus may not be distributed in the Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations issued by the Capital Market Authority. The Capital Market Authority does not make any representation as to the accuracy or completeness of this prospectus, and expressly disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this prospectus. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the securities. If you do not understand the contents of this prospectus you should consult an authorized financial adviser.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Singapore.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus or any other offering material relating to the common stock has not been registered as a prospectus with the Monetary Authority of Singapore under the Securities and Futures Act, Chapter&#x00a0;289 of Singapore, or the SFA. Accordingly, (a)&#x00a0;the common stock have not been, and will not be, offered or sold or made the subject of an invitation for subscription or purchase of such common stock in Singapore, and (b)&#x00a0;this prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the common stock have not been and will not be circulated or distributed, whether directly or indirectly, to the public or any member of the public in Singapore other than (i)&#x00a0;to an institutional investor as specified in Section&#x00a0;274 of the SFA, (ii)&#x00a0;to a relevant person (as defined in Section&#x00a0;275 of the SFA) and in accordance with the conditions specified in Section&#x00a0;275 of the SFA or (iii)&#x00a0;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Where the common stock are subscribed or purchased under Section&#x00a0;275 of the SFA by a relevant person which is:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">(a)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;a corporation (which is not an accredited investor (as defined in Section&#x00a0;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">(b)&#x00a0;&#x00a0;&#x00a0;&#x00a0;a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities (as defined in Section&#x00a0;239(1) of the SFA) of that corporation or the beneficiaries&#x2019; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the common stock pursuant to an offer made under Section&#x00a0;275 of the SFA except:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(a)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;to an institutional investor or to a relevant person defined in Section&#x00a0;275(2) of the SFA, or to any person arising from an offer referred to in Section&#x00a0;275(1A) or Section&#x00a0;276(4)(i)(B) of the SFA;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(b)&#x00a0;&#x00a0;&#x00a0;&#x00a0;where no consideration is or will be given for the traIer;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(c)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;where the transfer is by operation of law;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(d)&#x00a0;&#x00a0;&#x00a0;&#x00a0;as specified in Section&#x00a0;276(7) of thIFA; or</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(e)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;as specified in Regulation&#x00a0;32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations&#x00a0;2005 of Singapore.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">143</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Switzerland.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The common stock will not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility in Switzerland. This prospectus has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this prospectus nor any other offering or marketing material relating to our company or the common stock have been or will be filed with or approved by any Swiss regulatory authority. In particular, this prospectus will not be filed with, and the offer of the common stock will not be supervised by, the Swiss Financial Market Supervisory Authority, and the offer of the common stock has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (the &#x201c;CISA&#x201d;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of the common stock.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Taiwan.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The common stock have not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice regarding or otherwise intermediate the offering and sale of the common stock in Taiwan.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">United Arab Emirates.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The common stock have not been offered or sold, and will not be offered or sold, directly or indirectly, in the United Arab Emirates, except: (i)&#x00a0;in compliance with all applicable laws and regulations of the United Arab Emirates; and (ii)&#x00a0;through persons or corporate entities authorized and licensed to provide investment advice and/or engage in brokerage activity and/or trade in respect of foreign securities in the United Arab Emirates. The information contained in this prospectus does not constitute a public offer of securities in the United Arab Emirates in accordance with the Commercial Companies Law (Federal Law No.&#x00a0;8 of 1984 (as amended)) or otherwise and is not intended to be a public offer and is addressed only to persons who are sophisticated investors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">United Kingdom.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This prospectus is only being distributed to and is only directed at, and any offer subsequently made may only be directed at: (i)&#x00a0;persons who are outside the United Kingdom; (ii)&#x00a0;investment professionals falling within Article&#x00a0;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#x201c;Order&#x201d;); or (iii)&#x00a0;high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article&#x00a0;49(2)(a) to (d)&#x00a0;of the Order (all such persons falling within (1)-(3) together being referred to as &#x201c;relevant persons&#x201d;). The common stock are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire the common stock will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this prospectus or any of its contents.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="BoldItalic" STYLE="font-style:italic;font-weight:bold;">Vietnam.&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>This offering of common stock has not been and will not be registered with the State Securities Commission of Vietnam under the Law on Securities of Vietnam and its guiding decrees and circulars.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">144</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T3"></A><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">LEGAL MATTERS</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The validity of the shares of common stock and representative&#x2019;s warrants offered hereby will be passed upon for us by  Ellenoff Grossman &amp; Schole LLP, New York, New York. Certain legal matters will be passed upon for the underwriters by Loeb &amp; Loeb LLP, New York, New York.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T2"></A><FONT CLASS="Bold-AllCaps" STYLE="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">EXPERTS</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The financial statements of Blue Water Vaccines, Inc. as of and for the years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019 included in this registration statement, of which this prospectus forms a part, have been audited by Mayer Hoffman McCann P.C., independent registered public accounting firm, as set forth in their report (which includes an explanatory paragraph related to the existence of substantial doubt about the Company&#x2019;s ability to continue as a going concern) appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in auditing and accounting in giving said report.</P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T1"></A><FONT CLASS="Bold-AllCaps" STYLE="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">WHERE YOU CAN FIND MORE INFORMATION</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have filed with the SEC a registration statement on Form S<FONT CLASS="nobreak">-1</FONT> under the Securities Act with respect to the common stock offered in this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement and its exhibits and schedules, portions of which have been omitted as permitted by the rules and regulations of the SEC. For further information about us and our common stock, we refer you to the registration statement and to its exhibits and schedules. Statements in this prospectus about the contents of any contract, agreement or other document are not necessarily complete and, in each instance, we refer you to the copy of such contract, agreement or document filed as an exhibit to the registration statement, with each such statement being qualified in all respects by reference to the document to which it refers. Anyone may inspect and copy the registration statement and its exhibits and schedules at the Public Reference Room the SEC maintains at 100 F Street, N.E., Washington, D.C. 20549. You may obtain further information about the operation of the SEC&#x2019;s Public Reference Room by calling the SEC at 1<FONT CLASS="nobreak">-800-SEC-0330</FONT>. You may also inspect the registration statement and its exhibits and schedules and other information without charge at the website maintained by the SEC. The address of this site is <FONT CLASS="CharOverride-2" STYLE="font-style:italic;font-weight:normal;">www.sec.gov</FONT>.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We also file periodic reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for inspection and copying at the public reference room and website of the SEC referred to above. We also maintain a website at <FONT CLASS="CharOverride-2" STYLE="font-style:italic;font-weight:normal;">www.bluewatervaccines.com</FONT>, by which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information that is contained on, or that may be accessed through, our website is not a part of this prospectus. We have included our website in this prospectus solely as an inactive textual reference.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">145</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>




	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T99873"></A><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">INDEX TO FINANCIAL STATEMENTS</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Page</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Financial Statements</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T500">Report of Independent Registered Public Accounting Firm</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-2</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T501">Balance Sheets as of June 30, 2021 (unaudited), December 31, 2020 and 2019</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-3</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T502">Statements of Operations for the six months ended June 30, 2021 and 2020 (unaudited) and for the years ended December 31, 2020 and 2019</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-4</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T503">Statements of Stockholders&#x2019; Equity for the six months ended June 30, 2021 and 2020 (unaudited) and for the years ended December 31, 2020 and 2019</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-5</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T504">Statements of Cash Flows for the six months ended June 30, 2021 and 2020 (unaudited) and for the years ended December 31, 2020 and 2019</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-6</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 87.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><A HREF="#T505">Notes to Financial Statements</A></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-7</P>
					</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-1</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T500"></A>Report of Independent Registered Public Accounting Firm</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">To the Board of Directors and Stockholders of <BR><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Blue Water Vaccines, Inc.</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">Opinion on the Financial Statements</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We have audited the accompanying balance sheets of <FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Blue Water Vaccines, Inc</FONT>. (the &#x201c;Company&#x201d;) as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, and the related statements of operations, stockholders&#x2019; equity, and cash flows for each of the two years in the period ended December<FONT CLASS="nobreak"> </FONT>31, 2020, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, and the results of its operations and its cash flows for each of the two years in the period ended December<FONT CLASS="nobreak"> </FONT>31, 2020, in conformity with accounting principles generally accepted in the United States of America.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">Going Concern Uncertainty</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred recurring losses and negative cash flows from operations and is dependent on additional financing to fund operations. These conditions raise substantial doubt about its ability to continue as a going concern. Management&#x2019;s plans regarding these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">Basis for Opinion</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on the Company&#x2019;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#x201c;PCAOB&#x201d;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">We have served as the Company&#x2019;s auditor since 2021.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">/s/ Mayer Hoffman McCann P.C.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">Los Angeles, California</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:0pt;margin-top:0pt;">August<FONT CLASS="nobreak"> </FONT>20, 2021</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-2</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T501"></A><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;"></FONT><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance Sheets</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-11" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">June 30, <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">December 31, <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">December 31, <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">ASSETS</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current assets</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,669,468</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,308,821</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses and other current assets</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">355,353</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">277,853</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred offering cost</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">30,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from related party</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,242</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">9,805</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8,330</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total current assets</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,077,063</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,596,479</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,059,089</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">92,467</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">184,934</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Property and equipment, net</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">13,189</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">15,667</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,931</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deposit</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">15,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">15,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total assets</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">4,182,719</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">4,812,080</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">6,081,020</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current liabilities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accounts payable</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">55,631</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">68,668</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">18,377</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accrued expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">434,728</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">57,385</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total current liabilities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">490,359</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">68,668</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">75,762</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred rent</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">9,642</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,859</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total liabilities</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">490,359</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">78,310</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">82,621</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Stockholders&#x2019; equity</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Preferred stock, $0.00001 par value, 1,150,000 shares authorized;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-13" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series Seed: 1,150,000 shares designated; 1,146,138 shares issued and outstanding at June 30, 2021 and December 31, 2020 and 2019; $8.1 million, $7.8 million and $7.3 million aggregate liquidation preference of Series Seed cumulative preferred stock at June 30, 2021 and December 31, 2020 and 2019, respectively</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-14" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Common stock, $0.00001 par value, 2,300,000 shares authorized; 800,000 shares outstanding at June 30, 2021 and December 31, 2020 and 2019</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Additional paid-in-capital</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">7,349,732</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">7,273,087</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,938,250</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accumulated deficit</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(3,657,391</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(2,539,336</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(939,870</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total stockholders&#x2019; equity</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,692,360</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,733,770</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">5,998,399</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total liabilities and stockholders&#x2019; equity</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">4,182,719</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">4,812,080</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">6,081,020</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these financial statements.</FONT></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-3</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T502"></A><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;"></FONT><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Statements of Operations</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, 2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, 2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating costs and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">General and administrative</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">500,276</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">559,775</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,097,161</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">820,058</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Research and development</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">617,779</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">320,336</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">524,908</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">60,174</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880,111</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,622,069</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880,232</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss from operations</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(880,111</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(1,622,069</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(880,232</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,603</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">58,317</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other income</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,431</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">22,603</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">58,317</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Net loss</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(1,118,055</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(860,680</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(1,599,466</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(821,915</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cumulative preferred stock dividends</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">276,904</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">278,434</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">559,928</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">279,964</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss applicable to common <BR>stockholders</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,394,959</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,139,114</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(2,159,394</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,101,879</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss per share attributable to common stockholders, basic and diluted</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1.74</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1.42</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(2.70</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1.38</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average number of common shares outstanding, basic and diluted</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">800,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these financial statements.</FONT></P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-4</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T503"></A><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;"></FONT><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Statements of Stockholders&#x2019; Equity</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the Years Ended December 31, 2020 and 2019</FONT></P>
		<TABLE CLASS="No-Table-Style _idGenTablePara-1" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-25" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;"><BR>Preferred Stock</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;"><BR>Common Stock</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Additional <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Paid-in <BR>Capital</FONT></P>
					</TD>
					<TD CLASS="TCH" ROWSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Accumulated <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Deficit</FONT></P>
					</TD>
					<TD CLASS="TCH" ROWSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total <BR>Stockholders&#x2019;<BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Equity</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.42%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at December 31, 2018</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x2014;</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(117,955</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(117,947</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-14" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Issuance of Series Seed Preferred stock to investors (net of issuance cost of $44,985)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,146,138</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,934,984</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,934,995</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,266</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,266</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(821,915</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(821,915</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at December 31, 2019</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,146,138</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">11</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">6,938,250</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(939,870</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">5,998,399</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">334,837</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">334,837</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,599,466</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,599,466</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at December 31, 2020</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">1,146,138</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">11</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">7,273,087</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">(2,539,336</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">4,733,770</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the Six Months Ended June 30, 2021</FONT></P>
		<TABLE CLASS="No-Table-Style _idGenTablePara-1" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-25" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;"><BR>Preferred Stock</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;"><BR>Common Stock</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Additional <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Paid-in <BR>Capital</FONT></P>
					</TD>
					<TD CLASS="TCH" ROWSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Accumulated <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Deficit</FONT></P>
					</TD>
					<TD CLASS="TCH" ROWSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total <BR>Stockholders&#x2019; <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Equity</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.42%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at December 31, 2020</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,146,138</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">11</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">7,273,087</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(2,539,336</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">4,733,770</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-26" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation (Unaudited)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">76,645</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">76,645</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss (Unaudited)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-26" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at June 30, 2021 (Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">1,146,138</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">11</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">7,349,732</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">(3,657,391</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">3,692,360</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the Six Months Ended June 30, 2020</FONT></P>
		<TABLE CLASS="No-Table-Style _idGenTablePara-1" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-25" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;"><BR>Preferred Stock</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="4" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;"><BR>Common Stock</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Additional <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Paid-in <BR>Capital</FONT></P>
					</TD>
					<TD CLASS="TCH" ROWSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Accumulated <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Deficit</FONT></P>
					</TD>
					<TD CLASS="TCH" ROWSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" ROWSPAN="2" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total <BR>Stockholders&#x2019; <BR></FONT><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Equity</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.42%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">Amount</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at December 31, 2019</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,146,138</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">11</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">6,938,250</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(939,870</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">5,998,399</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-26" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation (Unaudited)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">235,810</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">235,810</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss (Unaudited)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(860,680</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(860,680</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-26" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 26.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Balance at June 30, 2020 (Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">1,146,138</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">11</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">800,000</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">7,174,060</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">(1,800,550</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.14%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">5,373,529</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="CharOverride-1" STYLE="font-style:normal;font-weight:bold;">&#x00a0;</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these financial statements.</FONT></P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-5</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T504"></A><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;"></FONT><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Statements of Cash Flows</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, 2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Six months <BR>ended <BR>June 30, 2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Year Ended <BR>December 31, <BR>2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-27" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">(Unaudited)</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Cash flows from operating activities</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net loss</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,118,055</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(860,680</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,599,466</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(821,915</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Adjustments to reconcile net loss to net cash used in operating activities:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Depreciation expense</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">2,478</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,195</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,056</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">573</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">76,645</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">235,810</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">334,837</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,266</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Changes in assets and liabilities:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses and other assets</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(77,500</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(378,282</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(277,845</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred offering cost</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(30,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from related party</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(12,437</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,475</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(8,330</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">92,467</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;"> (184,934</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(184,934</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deposit</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">15,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accrued expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">434,728</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(57,385</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(57,385</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(22,905</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accounts payable</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(13,037</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(7,932</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">50,291</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">18,377</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred rent</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(9,642</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">2,783</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">5,808</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash used in operating activities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(639,353</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,252,208</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,730,138</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(825,126</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Cash flows from investing activities</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchase of property and equipment</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(6,027</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(11,792</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(4,500</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash used in investing activities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(6,027</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(11,792</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(4,500</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Cash flows from financing activities</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Repayment of loan from related party</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(54,617</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-14" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from issuance of Series Seed Preferred stock to investors (net of issuance cost of $44,985)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,934,994</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash provided by financing activities</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,880,377</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-top:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:0pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net (decrease) increase in cash</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(639,353</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,258,235</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(1,741,930</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash, beginning of period</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,308,821</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash, end of period</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,669,468</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,792,516</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,308,821</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">6,050,751</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these financial statements.</FONT></P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-6</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><A NAME="T505"></A><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;"></FONT><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 1 &#x2014; Organization, Plan of Business Operations</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Blue Water Vaccines, Inc. (the &#x201c;Company&#x201d;) was formed on October<FONT CLASS="nobreak"> </FONT>26, 2018, to focus on the research and development of transformational vaccines to prevent infectious diseases worldwide. The Company&#x2019;s lead vaccine candidates, BWV<FONT CLASS="nobreak">-101</FONT> and BWV<FONT CLASS="nobreak">-102</FONT>, are being investigated as a universal influenza vaccine with the potential against all influenza strains and may provide a first<FONT CLASS="nobreak">-in-class</FONT> long<FONT CLASS="nobreak">-term</FONT> global vaccine that protects millions. The Company&#x2019;s proprietary, immunogenic, multi<FONT CLASS="nobreak">-purpose</FONT> platform enables the Company to bioengineer viral nanoparticles to deliver antigens, enhancing immunity, in an array of infectious disease agents, including influenza. All of the Company&#x2019;s vaccine candidates are in the developmental stage.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 2 &#x2014; Liquidity, Financial Condition and Management&#x2019;s Plans</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company has had limited operating activities to date, substantially all of which have been devoted to seeking licenses and engaging in research and development activities. The Company&#x2019;s product candidates currently under development will require significant additional research and development efforts prior to commercialization. The Company has financed its operations since inception primarily using proceeds received from seed investors.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company has incurred substantial operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, the Company had cash of approximately $3.7<FONT CLASS="nobreak"> </FONT>million, working capital of approximately $3.6<FONT CLASS="nobreak"> </FONT>million and an accumulated deficit of approximately $3.7<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company will require significant additional capital to sustain its short<FONT CLASS="nobreak">-term</FONT> operations and make the investments it needs to execute its longer<FONT CLASS="nobreak">-term</FONT> business plan. The Company believes the existing cash at June<FONT CLASS="nobreak"> </FONT>30, 2021, will be sufficient to continue operations, satisfy its obligations and fund the future expenditures that will be required to conduct the clinical and regulatory work to develop its product candidates until the second quarter of 2022. The Company is currently seeking to obtain additional debt or equity financing, however, there are currently no commitments in place for further financing nor is there any assurance that such financing will be available to the Company on favorable terms, if at all. If the Company is unable to secure additional capital, it may be required to curtail any clinical trials and development of products and take additional measures to reduce expenses in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Because of operating losses and a net operating cash flow deficit, there is substantial doubt about the Company&#x2019;s ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management&#x2019;s plans. The financial statements have been prepared assuming the Company will continue as a going concern. These financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 3 &#x2014; Summary of Significant Accounting Policies</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Basis of Presentation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company&#x2019;s financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;).</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Unaudited Interim Financial Statements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The accompanying balance sheet as of June<FONT CLASS="nobreak"> </FONT>30, 2021, and the statements of operations, the statements of changes in stockholders&#x2019; equity, and the statements of cash flows for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020 are unaudited. These unaudited interim financial statements have been prepared on the same basis as the audited financial statements, and in management&#x2019;s opinion, include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company&#x2019;s financial position as of June<FONT CLASS="nobreak"> </FONT>30, 2021 and its results of operations and cash flows for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020. The financial data and the other financial information disclosed in the notes to these financial statements related to the six<FONT CLASS="nobreak">-month</FONT> periods are also unaudited. Operating results for the period for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 are not necessarily indicative of the results that may be expected through December<FONT CLASS="nobreak"> </FONT>31, 2021.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-7</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 3 &#x2014; Summary of Significant Accounting Policies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Use of Estimates</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. The most significant estimates in the Company&#x2019;s financial statements relate to the valuation of common stock, stock<FONT CLASS="nobreak">-based</FONT> compensation, accrued research and development expenses and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Concentration of Credit Risk</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Property and Equipment</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Property and equipment consists of leasehold improvements, computer, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization is recorded using the straight<FONT CLASS="nobreak">-line</FONT> method over the respective useful lives of the assets ranging from three to five years. Long<FONT CLASS="nobreak">-lived</FONT> assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Fair Value of Financial Instruments</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Financial instruments, including cash, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short<FONT CLASS="nobreak">-term</FONT> nature of these instruments. The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, <FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Fair Value Measurements</FONT>, approximates the carrying amounts represented in the balance sheet.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Fair Value Measurements</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three<FONT CLASS="nobreak">-tier</FONT> fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Level<FONT CLASS="nobreak"> </FONT>1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Level<FONT CLASS="nobreak"> </FONT>2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-8</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 3 &#x2014; Summary of Significant Accounting Policies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Level<FONT CLASS="nobreak"> </FONT>3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Deferred offering costs</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Deferred offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that are directly related to the proposed initial public offering and that will be charged to shareholders&#x2019; equity upon the completion of the proposed initial public offering. Should the proposed initial public offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Research and Development</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company expenses the cost of research and development as incurred. Research and development expenses include costs incurred in funding research and development activities, license fees, and other external costs. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company&#x2019;s behalf will be expensed as services are rendered or when the milestone is achieved.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In accordance with FASB ASC Topic 730<FONT CLASS="nobreak">-10-25-1</FONT>,&#x00a0;<FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Research and Development,</FONT> costs incurred in obtaining licenses and patent rights are charged to research and development expense if the technology licensed has not reached commercial feasibility and has no alternative future use. The licenses purchased by the Company (see Note 5) require substantial completion of research and development, regulatory and marketing approval efforts to reach commercial feasibility and has no alternative future use. Accordingly, the total purchase price for the licenses acquired is reflected as research and development on the Company&#x2019;s statements of operations.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Stock-Based Compensation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company expensed stock<FONT CLASS="nobreak">-based</FONT> compensation to employees and non<FONT CLASS="nobreak">-employees</FONT> over the requisite service period based on the estimated grant<FONT CLASS="nobreak">-date</FONT> fair value of the awards. Stock<FONT CLASS="nobreak">-based</FONT> awards to employees with graded<FONT CLASS="nobreak">-vesting</FONT> schedules are recognized, using the accelerated attribution method, on a straight<FONT CLASS="nobreak">-line</FONT> basis over the requisite service period for each separately vesting portion of the award. Changes in the estimated fair value of awards are recognized as compensation expense in the period of change.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company estimates the fair value of stock option grants using the Black<FONT CLASS="nobreak">-Scholes</FONT> option pricing model and the assumptions used in calculating the fair value of stock<FONT CLASS="nobreak">-based</FONT> awards represent management&#x2019;s best estimates and involve inherent uncertainties and the application of management&#x2019;s judgment.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Expected Term</FONT>&#x00a0;&#x2014; The expected term of options represents the period that the Company&#x2019;s stock<FONT CLASS="nobreak">-based</FONT> awards are expected to be outstanding based on the simplified method, which is the half<FONT CLASS="nobreak">-life</FONT> from vesting to the end of its contractual term.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Expected Volatility</FONT>&#x00a0;&#x2014; The Company computes stock price volatility over expected terms based on comparable companies historical common stock trading prices.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Common Stock Fair Value</FONT> &#x2014; The fair value of the common stock underlying the Company&#x2019;s stock options was estimated at each grant date and was determined with the assistance of an independent third<FONT CLASS="nobreak">-party</FONT> valuation expert. The assumptions underlying these valuations represented management&#x2019;s best estimates, which involved inherent uncertainties and the application of significant levels of management judgment.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-9</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 3 &#x2014; Summary of Significant Accounting Policies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Risk</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">-Free</FONT></FONT><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;"> Interest Rate</FONT>&#x00a0;&#x2014; The Company bases the risk<FONT CLASS="nobreak">-free</FONT> interest rate on the implied yield available on U.S.&#x00a0;Treasury securities with a remaining term commensurate with the estimated expected term.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Expected Dividend</FONT>&#x00a0;&#x2014; The Company has never declared or paid any cash dividends on its common shares and does not plan to pay cash dividends in the foreseeable future, and, therefore, uses an expected dividend yield of zero in its valuation models.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company recognizes forfeitures of equity awards as they occur.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Fair value of common stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In order to determine the fair value of shares of common stock of the Company when issuing stock options and computing their estimated stock<FONT CLASS="nobreak">-based</FONT> compensation expense, its board of directors considered with input from third party valuations, among other things, contemporaneous valuations of the Company&#x2019;s common stock. Given the absence of a public trading market of the Company&#x2019;s capital stock to date, its board of directors has exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of the Company common and preferred stock, including:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the prices, rights, preferences and privileges of our preferred stock relative to our common stock;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>our business, financial condition and results of operations, including related industry trends affecting our operations;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the likelihood of achieving a liquidity event, such as an initial public offering (&#x201c;IPO&#x201d;), or sale of our company, given prevailing market conditions;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the lack of marketability of our common stock;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the market performance of comparable publicly traded companies;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>U.S. and global economic and capital market conditions and outlook; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Common stock valuation methodology.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In estimating the fair market value of common stock of the Company, its board of directors first determined the equity value of its business using accepted valuation methods.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company engaged a third<FONT CLASS="nobreak">-party</FONT> valuation specialist to conduct a valuation, which used its recent preferred stock financing as a starting point and determined the equity value of the company based on the Backsolve method using an Option Pricing Method (OPM) to calculate the implied value based on a market approach. The Company&#x2019;s equity value was allocated using OPM to estimate the fair market value of the Company&#x2019;s classes of equity.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Income Taxes</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in operations in the period that includes the enactment date. Deferred tax assets are reduced to estimated amounts expected to be realized by the use of a valuation allowance.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Under U.S. GAAP, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more<FONT CLASS="nobreak">-likely-than-not</FONT> to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-10</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 3 &#x2014; Summary of Significant Accounting Policies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">Additionally, U.S. GAAP provides guidance on derecognition, classification, interest and penalties, accounting for interim periods, disclosure and transition. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company is required to report all components of comprehensive income (loss), including net income (loss), in the accompanying financial statements in the period in which they are recognized. Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non<FONT CLASS="nobreak">-owner</FONT> sources, including unrealized gains and losses on investments and foreign currency translation adjustments. Net loss and comprehensive loss were the same for all periods presented.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Net Loss Per Share</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the Company&#x2019;s preferred stock and options. Diluted loss per share excludes the shares issuable upon the conversion of preferred stock, common stock options from the calculation of net loss per share if their effect would be anti<FONT CLASS="nobreak">-dilutive</FONT>.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The two<FONT CLASS="nobreak">-class</FONT> method is used to determine earnings per share based on participation rights of participating securities in any undistributed earnings. Each preferred stock that includes rights to participate in distributed earnings is considered a participating security and the Company uses the two<FONT CLASS="nobreak">-class</FONT> method to calculate net income available to the Company&#x2019;s common shareholders per common share &#x2014; basic and diluted.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following were excluded from the computation of diluted shares outstanding due to the losses since inception, as they would have had an anti<FONT CLASS="nobreak">-dilutive</FONT> impact on the Company&#x2019;s net loss:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-11" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 29.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Six months ended <BR>June 30,</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 30.77%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Years Ended <BR>December 31,</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Options to purchase common stock</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">195,160</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">229,604</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">195,160</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">57,404</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Preferred stock Series Seed</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,146,138</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,146,138</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,146,138</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,146,138</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,341,298</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,375,742</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,341,298</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">1,203,542</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">New Accounting Pronouncement</FONT><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">s</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On February 2016, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016<FONT CLASS="nobreak">-02</FONT>,&#x00a0;<FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Leases (Topic&#x00a0;842)</FONT>. Under the new guidance, lessees will be required to recognize all leases (with the exception of short<FONT CLASS="nobreak">-term</FONT> leases) on the balance sheet as a lease liability, which is a lessee&#x2019;s obligation to make lease payments arising from a lease, measured on a discounted basis and a right<FONT CLASS="nobreak">-of-use</FONT> asset, which is an asset that represents the lessee&#x2019;s right to use, or control the use of, a specified asset for the lease term. This guidance is effective for fiscal years beginning after December<FONT CLASS="nobreak"> </FONT>15, 2020, and interim periods within fiscal years beginning after December<FONT CLASS="nobreak"> </FONT>15, 2021, with early adoption permitted. On January<FONT CLASS="nobreak"> </FONT>1, 2021, the Company adopted ASU No. 2016<FONT CLASS="nobreak">-02</FONT>, and the adoption of this standard did not have an impact on the Company&#x2019;s financial statements as the Company is currently not subject to any lease agreements with terms in excess of 12<FONT CLASS="nobreak"> </FONT>months.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In June 2018, the FASB issued ASU No. 2018<FONT CLASS="nobreak">-07</FONT>,&#x00a0;<FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Compensation &#x2014; Stock Compensation (Topic 718): Improvements to Nonemployee Share</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">-Based</FONT></FONT><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;"> Payment Accounting</FONT>&#x00a0;(&#x201c;ASU 2018<FONT CLASS="nobreak">-07</FONT>&#x201d;). ASU 2018<FONT CLASS="nobreak">-07</FONT> simplifies several aspects of the accounting for nonemployee share<FONT CLASS="nobreak">-based</FONT> payment transactions resulting from expanding the scope of </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-11</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 3 &#x2014; Summary of Significant Accounting Policies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">Topic 718, Compensation &#x2014; Stock Compensation, to include share<FONT CLASS="nobreak">-based</FONT> payment transactions for acquiring goods and services from non<FONT CLASS="nobreak">-employees</FONT>. ASU 2018<FONT CLASS="nobreak">-07</FONT> is effective for public business entities for fiscal years beginning after December<FONT CLASS="nobreak"> </FONT>15, 2018, including interim periods within that fiscal year. On January<FONT CLASS="nobreak"> </FONT>1, 2019, the Company adopted ASU 2018<FONT CLASS="nobreak">-07</FONT>, and the adoption did not have a material impact on its financial statements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In December 2019, the FASB issued ASU No. 2019<FONT CLASS="nobreak">-12</FONT>, <FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </FONT>(&#x201c;ASU 2019<FONT CLASS="nobreak">-12</FONT>&#x201d;), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019<FONT CLASS="nobreak">-12</FONT> removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December<FONT CLASS="nobreak"> </FONT>15, 2020, with early adoption permitted. The Company adopted ASU 2019<FONT CLASS="nobreak">-12</FONT> on January<FONT CLASS="nobreak"> </FONT>1, 2021. Adoption of the ASU did not impact the Company&#x2019;s financial position, results of operations or cash flows.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In August 2020, the FASB issued ASU No. 2020<FONT CLASS="nobreak">-06</FONT>,&#x00a0;<FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">-20</FONT></FONT><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815</FONT><FONT CLASS="nobreak"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">-40</FONT></FONT><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity</FONT>, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December<FONT CLASS="nobreak"> </FONT>15, 2021, with early adoption permitted. The Company is currently evaluating the impact of this standard on its financial statements and related disclosures.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company&#x2019;s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 4 &#x2014; Prepaid Expenses and Other Current Assets</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Prepaid expense and other current assets consisted of the following as of June<FONT CLASS="nobreak"> </FONT>30, 2021, December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">As of <BR>June 30, <BR>2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">As of <BR>December 31, <BR>2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">As of <BR>December 31, <BR>2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses &#x2013; research and development</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">260,985</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">233,532</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses &#x2013; insurance</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">19,368</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">4,321</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses &#x2013; consulting fees</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">70,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">35,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Prepaid expenses &#x2013; other</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">5,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">5,000</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">355,353</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">277,853</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">8</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The prepaid expenses &#x2014; consulting fees is prepaid to the Chief Executive Officer, pursuant to the consulting agreement as disclosed in Note 8.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 5 &#x2014; Significant Agreements</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Oxford University Innovation Limited</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In December 2018, the Company entered into an option agreement Oxford University Innovation (&#x201c;OUI&#x201d;), which was a precursor to a license agreement (the &#x201c;OUI Agreement&#x201d;), dated July<FONT CLASS="nobreak"> </FONT>16, 2019. Under the terms of the OUI Agreement, the Company holds an exclusive, worldwide license to certain specified patent rights and biological materials relating to the use of epitopes of limited variability and virus<FONT CLASS="nobreak">-like</FONT> particle products and practice processes that are covered by the licensed patent rights and biological materials for the purpose of developing and commercializing a vaccine product candidate for influenza. The Company is obligated to use its best efforts to develop and market Licensed Products in accordance with its development plan, report to OUI on progress and achieve the following milestones and must pay OUI nonrefundable milestone fees as follows when it </P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-12</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 5 &#x2014; Significant Agreements</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">achieves them: initiation of first Phase I study; initiation of first Phase II study; initiation of first Phase III/pivotal registration studies; first submission of application for regulatory approval (BLA/NDA); marketing authorization in the United States; marketing authorization in any EU country; marketing authorization in Japan; first marketing authorization in any other country; first commercial sale in Japan; first commercial sale in any ROW country; first year that annual sales equal or exceed certain thresholds. The OUI Agreement will expire upon ten (10) years from the expiration of the last patent contained in the licensed patent rights, unless terminated earlier. None of the applications included in the OUI licensed patent rights have been issued as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and as of June<FONT CLASS="nobreak"> </FONT>30, 2021. Either party may terminate the OUI Agreement for an uncured material breach. The Company may terminate the OUI Agreement for any reason at any time upon six months&#x2019; written notice expiring after the third anniversary of the OUI Agreement. OUI&#x00a0;may terminate immediately if the Company has a petition presented for its winding<FONT CLASS="nobreak">-up</FONT> or passes a resolution for winding up other than for a bona fide amalgamation or reconstruction or compounds with its creditors or has a receiver or administrator appointed. OUI may also terminate if the Company opposes or challenges the validity of any of the patents or applications in the Licensed Technology; raises the claim that the know<FONT CLASS="nobreak">-how</FONT> of the Licensed Technology is not necessary to develop and market Licensed Products; or in OUI&#x2019;s reasonable opinion, is taking inadequate or insufficient steps develop or market Licensed Products and does not take any further steps that OUI&#x00a0;requests by written notice within a reasonable time.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019 and for the six month periods ended June,<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020, the Company did not incur any licensing fee payments for intellectual property licenses. See Note 7.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">St. Jude Children&#x2019;s Hospital</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company entered into a license agreement (the &#x201c;St. Jude Agreement&#x201d;), dated January<FONT CLASS="nobreak"> </FONT>27, 2020, with St. Jude Children&#x2019;s Research Hospital (&#x201c;St. Jude&#x201d;). Under the terms of the St. Jude Agreement, the Company holds an exclusive, worldwide license to certain specified patent rights and biological materials relating to the use of live attenuated streptococcus pneumoniae and practice processes that are covered by the licensed patent rights and biological materials for the purpose of developing and commercializing a vaccine product candidate for streptococcus pneumoniae. The St. Jude Agreement will expire upon the expiration of the last valid claim contained in the licensed patent rights, unless terminated earlier. The Company is obligated to use commercially reasonable efforts to develop and commercialize the licensed product(s). The milestones include the following events: (i) complete IND enabling study; (ii) Initiate animal toxicology study; (iii) file IND; (iv) complete Phase I Clinical Trial; (v) commence Phase II Clinical Trial; (vi) commence Phase III Clinical Trial; and, (vii) regulatory approval, U.S. or foreign equivalent. If the Company fails to achieve the development milestones contained in the St. Jude Agreement, and if the Company and St. Jude fail to agree upon a mutually satisfactory revised timeline, St. Jude will have the right to terminate the St. Jude Agreement. Either party may terminate the St. Jude Agreement in the event the other party (a) files or has filed against it a petition under the Bankruptcy Act (among other things) or (b) fails to perform or otherwise breaches its obligations under the St. Jude Agreement, and has not cured such failure or breach within sixty (60) days. The Company may terminate for any reason on thirty (30) days written notice.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the years ended December<FONT CLASS="nobreak"> </FONT>31, 2019 and 2020 and for the six month periods ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020, the Company recognized $0, $15,000 and $10,000, $15,000, respectively, for intellectual property licenses, which is recorded as research and development expenses. See Note 7.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Cincinnati Children&#x2019;s Hospital Medical Center</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company entered into a license agreement (the &#x201c;CHMC Agreement&#x201d;), dated June<FONT CLASS="nobreak"> </FONT>1, 2021, with Children&#x2019;s Hospital Medical Center, d/b/a Cincinnati Children&#x2019;s Hospital Medical Center (&#x201c;CHMC&#x201d;). Under the terms of the CHMC Agreement, the Company holds an exclusive, worldwide license (other than the excluded field of immunization against, and prevention, control, or reduction in the severity of gastroenteritis caused by rotavirus and norovirus in China and Hong Kong) to certain specified patent and biological materials relating to the use of norovirus nanoparticles and practice processes that are covered by the licensed patent rights and biological materials for the purpose of developing and commercializing CHMC patents and related technology directed to a virus<FONT CLASS="nobreak">-like</FONT> particle </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-13</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 5 &#x2014; Significant Agreements</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">vaccine platform that utilizes nanoparticle delivery technology that may have potential broad application to develop vaccines for multiple infectious diseases. The term of the CHMC Agreement begins on the effective date and extends on a jurisdiction by jurisdiction and product by product basis until the later of: (i) the last to expire licensed patent; (ii) ten (10) years after the first commercial sale; or, (iii) entrance onto the market of a biosimilar or interchangeable product. The Company is obligated to use commercially reasonable efforts to bring licensed products to market through diligent research and development, testing, manufacturing and commercialization and to use best efforts to make all necessary regulatory filings and obtain all necessary regulatory approvals, and achieve milestones relating to development and sales, and report to CHMC on progress. The Company will also be obligated to pay the agreed upon development milestone payments to CHMC. The Company may terminate the CHMC Agreement for convenience, at any time prior to first commercial sale of a product or process by providing one hundred and eighty (180) days&#x2019; written notice to CHMC. It may also terminate for a CHMC uncured material breach. CHMC may terminate the CHMC Agreement for an uncured Company material breach or insolvency or bankruptcy. In the event the Company&#x2019;s material breach is for failure to meet any of the milestone payments, the Company is entitled to a nonexclusive license to continue developing indications that have already entered development at any stage or in which the Company has invested in developing. CHMC may also terminate the CHMC Agreement to the fullest extent permitted by law in the countries of the worldwide territory, in the event the Company or its affiliates challenge or induce others set up challenges to the validity or enforceability of any of the Licensed Patents and the Company will be obligated reimburse CHMC for its costs, including reasonable attorneys&#x2019; fees.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">For the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021, the Company accrued licensing fee payments for intellectual property licenses, which is recorded as research and development expenses in aggregate of $377,104. See note 7.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Ology Bioservices, Inc. (which was later acquired by National Resilience, Inc.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company entered into a Master Services Agreement (&#x201c;Ology MSA&#x201d;), dated July<FONT CLASS="nobreak"> </FONT>19, 2019, with Ology, Inc. (&#x201c;Ology&#x201d;) to provide service from time to time, including but not limited to technology transfer, process development, analytical method optimization, cGMP manufacture, regulatory affairs, and stability studies of biologic products. Pursuant to the Ology MSA, the Company and Ology&#x00a0;shall&#x00a0;enter into a&#x00a0;Project Addendum for&#x00a0;each&#x00a0;project&#x00a0;to be governed by the terms and conditions of the Ology MSA.&#x00a0;The Company has entered into two Project Addendums as of June<FONT CLASS="nobreak"> </FONT>30, 2021.&#x00a0; The initial Project Addendum&#x00a0;was executed October<FONT CLASS="nobreak"> </FONT>18, 2019&#x00a0;and&#x00a0;the Company&#x00a0;was&#x00a0;required to pay Ology an aggregate of approximately $4<FONT CLASS="nobreak"> </FONT>million.&#x00a0;Due to unforeseen delays associated with COVID<FONT CLASS="nobreak">-19</FONT>, the Company and Resilience entered into a letter agreement dated January<FONT CLASS="nobreak"> </FONT>9, 2020 to stop work on the project. The Company paid Ology $100,000 for services, of which $48,600 remains as prepaid expense as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and June<FONT CLASS="nobreak"> </FONT>30, 2021.&#x00a0;The second Project Addendum&#x00a0;was executed May<FONT CLASS="nobreak"> </FONT>21, 2021&#x00a0;and&#x00a0;the Company is obligated to pay Ology an aggregate amount of approximately $2.8<FONT CLASS="nobreak"> </FONT>million, plus reimbursement for materials and outsourced testing, which will be billed at cost plus 15%.&#x00a0;No work was started as of June<FONT CLASS="nobreak"> </FONT>30, 2021.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 6 &#x2014; Stockholders&#x2019; Equity</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Authorized Capital</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company is currently authorized to issue up to 2,300,000<FONT CLASS="nobreak"> </FONT>shares of common stock, par value $0.00001 per share, and 1,150,000<FONT CLASS="nobreak"> </FONT>shares of preferred stock, par value $0.00001 per share, of which 1,150,000 has been designated as Series Seed Preferred Stock.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Common Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of June<FONT CLASS="nobreak"> </FONT>30, 2021, December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, there were 800,000<FONT CLASS="nobreak"> </FONT>shares of common stock issued and outstanding.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-14</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 6 &#x2014; Stockholders&#x2019; Equity </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The holders of the Company&#x2019;s common stock are entitled to one vote for each share held of record, and are entitled upon liquidation of the Company to share ratably in the net assets of the Company available for distribution after payment of all obligations of the Company and after provision has been made with respect to each class of stock, if any, having preference over the common stock, currently including the Company&#x2019;s preferred stock. The shares of common stock are not redeemable and have no preemptive or similar rights.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Preferred Stock</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company has authorized 1,150,000<FONT CLASS="nobreak"> </FONT>shares of preferred stock as Series Seed Preferred Stock (&#x201c;Series Seed&#x201d;), with an original issue price of $6.09 per share (the &#x201c;Original Issue Price&#x201d;). As of June<FONT CLASS="nobreak"> </FONT>30, 2020, December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, there were 1,146,138<FONT CLASS="nobreak"> </FONT>shares issued and outstanding.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Conversion</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Each share of the Series Seed is convertible, at the option of the holder, at any time and from time to time, and without the payment of additional consideration by the holder, at a conversion price of $6.09 per share, subject to certain adjustments for stock splits, stock dividends, recapitalizations, and similar corporate transactions, into fully paid and non<FONT CLASS="nobreak">-assessable</FONT> shares of the Company&#x2019;s common stock. Each Series Seed is automatically converted into common stock of the Company, at a conversion price of $6.09 per share, subject to adjustment, upon the closing a firmly underwritten public offering netting proceeds of at least $50<FONT CLASS="nobreak"> </FONT>million with an offering price of at least three hundred percent (300%) of the Original Issue Price of the Series Seed.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Dividends</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Holders of the Series Seed are entitled to receive cumulative dividends at a per share rate of 8% per annum, compounded annually, on the initial investment amount commencing on the date of issue. Dividends are payable only when, as, and if declared by the Board of Directors or upon a Liquidation Event, as described below. Dividends on Series Seed are in preference to any dividend on the Company&#x2019;s common stock.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Liquidation Preference</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the event of certain voluntary or involuntary acquisition or sale transactions or upon the liquidation, dissolution or winding up of the Company (each, a &#x201c;Liquidation Event&#x201d;), the holders of Series Seed shall be entitled to receive out of the proceeds or assets of the Company legally available for distribution to its shareholders (the&#x00a0;&#x201c;Proceeds&#x201d;), prior and in preference to any distribution of the Proceeds of such Liquidation Event to the holders of common shares by reason of their ownership thereof, an amount per share equal to the greater of (i) the Original Issue Price per share, plus unpaid dividends at a per share rate of 8% per annum on the initial investment amount commencing on the date of issue and ending on the date of the Liquidation Event, or (ii) such amount per share as would have been payable had all shares of Series Seed been converted into common stock of the Company immediately prior to the Liquidation Event (the result referred to as the &#x201c;Liquidation Preference Amount&#x201d;). In the event that the Proceeds shall be insufficient to enable the distribution in full of the Liquidation Preference Amount to the holders of the Series Seed for all of the preferred shares held by them, all of the Proceeds shall be distributed among the holders of Series Seed on a pro rata basis. Upon completion of the distribution required to the holders of Series Seed, all of the remaining Proceeds available for distribution to shareholders shall be distributed among the holders of common shares pro rata based on the number of common shares held by each such holder.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Voting</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On any matter presented to the stockholders&#x2019; of the Company for their action or consideration at any meeting of stockholders&#x2019; of the Company (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series Seed will be entitled to cast the number of votes equal to the number of whole shares </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-15</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 6 &#x2014; Stockholders&#x2019; Equity </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">of common stock into which the shares of Series Seed held by such holder are convertible as of the record date for determining stockholders&#x2019; entitled to vote on such matter. Holders of Series Seed will vote together with the holders of common stock as a single class. Holders of Series Seed are entitled to nominate two out of five of the Company&#x2019;s directors.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Stock Transactions</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On July<FONT CLASS="nobreak"> </FONT>1, 2019, the Company entered into a Series Seed Preferred Stock Purchase Agreement (&#x201c;Purchase Agreement&#x201d;) with five qualified investors. The investors agreed to purchase and the Company agreed to sell and issue to investors a total of 1,146,138<FONT CLASS="nobreak"> </FONT>shares of Series Seed Preferred Stock, $0.00001 par value per share, at a purchase price of $6.09 per share. On July<FONT CLASS="nobreak"> </FONT>1, 2019, the Company&#x00a0;received approximately $6.9<FONT CLASS="nobreak"> </FONT>million (net of offering costs of approximately $45,000) in cash from investors in exchange for the issuance of 1,146,138<FONT CLASS="nobreak"> </FONT>shares of Series Seed Preferred Stock.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2019 Equity Incentive Plan</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company&#x2019;s 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;) was adopted by its board of directors and by its shareholders on July<FONT CLASS="nobreak"> </FONT>1, 2019. The Company has reserved 350,000<FONT CLASS="nobreak"> </FONT>shares of common stock for issuance pursuant to the 2019 Plan.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Stock Options</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">On December<FONT CLASS="nobreak"> </FONT>19, 2019, the Company granted options to purchase up to 57,404<FONT CLASS="nobreak"> </FONT>shares of the Company&#x2019;s common stock to an employee pursuant to the 2019 Plan. The aggregate grant date fair value of these options was approximately $0.2<FONT CLASS="nobreak"> </FONT>million. The employee resigned from the Company effective August<FONT CLASS="nobreak"> </FONT>31, 2020 and was retained as a consultant starting September<FONT CLASS="nobreak"> </FONT>1, 2020. Pursuant to the amended stock option agreement, the employee forfeited 34,444<FONT CLASS="nobreak"> </FONT>shares of options originally granted. The remaining shares of options remain original terms and conditions.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the year ended December<FONT CLASS="nobreak"> </FONT>31, 2020, the Company granted options to purchase up to 172,200<FONT CLASS="nobreak"> </FONT>shares of the Company&#x2019;s common stock to its board members and employees pursuant to the 2019 Plan. The aggregate grant date fair value of these options was approximately $0.5<FONT CLASS="nobreak"> </FONT>million.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The fair value of options granted in 2020 and 2019 was estimated using the following assumptions:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-35" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 63.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 35.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the Years Ended <BR>December 31,</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-27" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 63.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 16.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 17.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 63.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Exercise price</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">$0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">$0.05</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 63.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Term (years)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">5.03&#x00a0;&#x2013;&#x00a0;6.98</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">5.50&#x00a0;&#x2013;&#x00a0;7.02</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 63.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected stock price volatility</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">112.2%&#x00a0;&#x2013;&#x00a0;115.2%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">113.0%&#x00a0;&#x2013;&#x00a0;113.5%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 63.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Risk-free rate of interest</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">0.37%&#x00a0;&#x2013;&#x00a0;1.76%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_centeralign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">1.73%&#x00a0;&#x2013;&#x00a0;1.86%</P>
					</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-16</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 6 &#x2014; Stockholders&#x2019; Equity </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A summary of stock option activity for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019 is presented below:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-38" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Number of <BR>Shares</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Weighted <BR>Average <BR>Exercise <BR>Price</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total Intrinsic <BR>Value</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Weighted <BR>Average <BR>Remaining <BR>Contractual <BR>Life <BR>(in years)</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outstanding as of December 31, 2018</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Granted</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">57,404</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">156,713</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">10.0</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outstanding as of December 31, 2019</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">57,404</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">156,713</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">10.0</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Granted</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">172,200</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">470,106</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">9.1</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody-ind_1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forfeited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">(34,444</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-bracket-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outstanding as of December 31, 2020</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">195,160</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">532,787</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">9.1</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outstanding as of June 30, 2021</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">195,160</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">532,787</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8.6</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Options vested and exercisable as of June 30, 2021</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">85,134</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">0.05</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">232,416</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">8.6</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Stock-based compensation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Stock<FONT CLASS="nobreak">-based</FONT> compensation expense for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020, and for the years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019 were as follows:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-11" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="5" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 29.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the six months ended <BR>June 30,</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="5" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 30.77%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the Years Ended <BR>December 31,</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2021</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">General and administrative</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">23,876</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">62,950</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">89,555</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,633</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Research and development</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">52,769</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">172,860</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">245,282</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,633</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 37.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Total</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">76,645</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">235,810</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">334,837</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">$</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">3,266</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of June<FONT CLASS="nobreak"> </FONT>30, 2021, future stock<FONT CLASS="nobreak">-based</FONT> compensation expense relating to outstanding stock options is approximately $0.1<FONT CLASS="nobreak"> </FONT>million and will be recorded through December 2023.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 7 &#x2014; Commitments and Contingencies</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Office lease</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company leased office space for approximately $5,500 a month from a related party. The Company paid a $15,000 rental deposit and rent expense for the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and 2020 and for the years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019 was approximately $28,000, $33,000, $66,000 and $66,000, respectively. The Company terminated the related party lease in May 2021 and entered into a new lease with an unrelated party in April 2021. The Company is not a party to a lease with a term in excess of 12<FONT CLASS="nobreak"> </FONT>months and has a month<FONT CLASS="nobreak">-to-month</FONT> lease as of June<FONT CLASS="nobreak"> </FONT>30, 2021.</P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Litigation</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-17</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 7 &#x2014; Commitments and Contingencies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="H3" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="BoldItalic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:bold;">Significant agreements</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Oxford University Innovation Limited</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the OUI Agreement, as disclosed in Note<FONT CLASS="nobreak"> </FONT>5, the Company is obligated to pay a 6% royalty on all net sales of licensed products, as defined in the OUI Agreement, as well as on any sums received by the Company from any sublicensee (including all up<FONT CLASS="nobreak">-front</FONT>, milestone and other one<FONT CLASS="nobreak">-off</FONT> payments received by the Company from any sub<FONT CLASS="nobreak">-licenses</FONT> or other contracts granted by the Company with respect to the licensed technology). In addition, the Company is required to pay OUI milestone payments of up to an aggregate of $51<FONT CLASS="nobreak"> </FONT>million upon the achievement of specified development, regulatory and commercial milestones.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Oxford University Research Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the terms of the OUI Agreement, as disclosed in Note<FONT CLASS="nobreak"> </FONT>5, the Company entered into a sponsored research agreement dated December<FONT CLASS="nobreak"> </FONT>18, 2019 with Oxford University for research related to the OUI Agreement for a period of three years for a total of &#x00a3;420,000. The Company prepaid the full amount to Oxford of $554,802 for the services in January 2020, of which approximately $0.3<FONT CLASS="nobreak"> </FONT>million and $0.4<FONT CLASS="nobreak"> </FONT>million remains as prepaid expense as of June<FONT CLASS="nobreak"> </FONT>30, 2021 and December<FONT CLASS="nobreak"> </FONT>31, 2020, respectively.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">St. Jude Children&#x2019;s Hospital</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the St. Jude Agreement, as disclosed in Note<FONT CLASS="nobreak"> </FONT>5, the Company is obligated to make 4% royalty payments for each licensed product(s) sold by the Company or its affiliates, based on the net sales for the duration of the St. Jude Agreement and also pay 15% of consideration received for any sublicenses. The Company is required to pay an annual maintenance fee of $10,000 beginning on the first anniversary of the Effective Date (which is waived if all of the developmental milestones scheduled for completion before such annual fee is due have been achieved). In addition, the Company is required to pay St. Jude milestone payments of up to an aggregate of $1<FONT CLASS="nobreak"> </FONT>million upon the achievement of specified development, regulatory and commercial milestones.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">St. Jude Children&#x2019;s Sponsored Research Agreement</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In addition to the St. Jude Agreement, the Company also entered into a sponsored research agreement dated May<FONT CLASS="nobreak"> </FONT>3, 2021 with St. Jude for research related to the St. Jude Agreement. Pursuant to this research agreement, the Company is obligated to pay St. Jude an aggregate amount of $73,073 in two parts, Phase I for $57,624 and Phase II for $15,449. As of June<FONT CLASS="nobreak"> </FONT>30, 2021, the Company accrued the Phase I payment of $57,624 which is recorded as research and development expenses.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Cincinnati Children&#x2019;s Hospital Medical Center</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the CHMC Agreement, as disclosed in Note<FONT CLASS="nobreak"> </FONT>5, the Company is obligated to pay CHMC a single<FONT CLASS="nobreak">-digit</FONT> royalty on net sales, being 5%, 4% or 2% depending on the product, under the agreement and to pay up to a 25% royalty on any royalties paid to the Company by any sublicensee. In addition, the Company is required to pay CHMC and aggregate of up to $59.75<FONT CLASS="nobreak"> </FONT>million upon the achievement of specified development, regulatory and commercial milestones.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Ology Bioservices, Inc. (which was later acquired by National Resilience, Inc.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the Ology MSA and the second Project Addendum, as disclosed in Note<FONT CLASS="nobreak"> </FONT>5, the Company is obligated to pay Ology an aggregate amount of approximately $2.8<FONT CLASS="nobreak"> </FONT>million, plus reimbursement for materials and outsourced testing which will be billed at cost plus 15%.&#x00a0;No work was started as of June<FONT CLASS="nobreak"> </FONT>30, 2021.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-18</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 7 &#x2014; Commitments and Contingencies</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Indemnification</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may incur charges in the future as a result of these indemnification obligations.</P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Risks and Uncertainties &#x2014; COVID-19</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Management continues to evaluate the impact of the COVID<FONT CLASS="nobreak">-19</FONT> pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for drug candidates, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 8 &#x2014; Related Party Transactions</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company has engaged the Chief Executive Officer, who is also the Board Chairman and sole common stock shareholder, of the Company pursuant to a consulting agreement commencing October<FONT CLASS="nobreak"> </FONT>22, 2018, which calls for the Company to pay for consulting services performed on a monthly basis. For the six months ended June<FONT CLASS="nobreak"> </FONT>30, 2021 and years ended December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, the Company incurred approximately $0.2<FONT CLASS="nobreak"> </FONT>million, $0.4<FONT CLASS="nobreak"> </FONT>million and $0.4<FONT CLASS="nobreak"> </FONT>million, respectively in fees under the consulting agreement, which are recognized in general and administrative expenses in the statements of operations.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company also leased office space from a related party, through common ownership, and had a rental deposit of $15,000 on the balance sheets as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019. The lease is further described in Note 7 of these financial statements.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As of June<FONT CLASS="nobreak"> </FONT>30, 2021, December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019, the Company has a receivable from the related party of approximately $22,000, $10,000 and $8,000, respectively, as presented on the balance sheets. The receivable from related party consists of utility expense paid, rental deposit due subsequent to cancellation of the lease, and overpaid rent expenses.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">One of the Company&#x2019;s directors serves on the Advisory Board for the Cincinnati Children&#x2019;s Hospital Medical Center Innovation Fund, which is affiliated with CHMC. The Company has an exclusive license agreement with CHMC as disclosed in Note 5.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Note 9 &#x2014; Income Taxes</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">At December<FONT CLASS="nobreak"> </FONT>31, 2020, the Company had a net operating loss (&#x201c;NOL&#x201d;) carryforward for Federal and state income tax purposes totaling approximately $2.1<FONT CLASS="nobreak"> </FONT>million available to reduce future taxable income, all of which are carried forward indefinitely for federal tax purposes under the Tax Cuts and Jobs Act. The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) signed in to law on March<FONT CLASS="nobreak"> </FONT>27, 2020, provided that NOLs generated in a taxable year beginning in 2018, 2019, or 2020, may now be carried back five years and forward indefinitely. In addition, the limitation of NOL utilization up to 80% of taxable income limitation is temporarily removed, allowing NOLs to fully offset taxable income. Some of the state net operating losses follow the Federal Tax Cuts and Jobs Act and are carried over indefinitely, and others have various expiration dates.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The NOL carry forward is subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. Under the Internal Revenue Code (&#x201c;IRC&#x201d;) Sections 382 and 383, annual use of the Company&#x2019;s net operating loss carryforwards to offset taxable income may be limited based on cumulative changes in ownership. The Company has not completed an analysis to determine whether any such limitations have been triggered as </P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-19</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">BLUE WATER VACCINES, INC.</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:0pt;margin-top:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Notes to Financial Statements</FONT></P>
		<P CLASS="ParaOverride-9" STYLE="margin:0;padding:0;border-width:0;margin-bottom:10pt;margin-top:12pt;orphans:99;page-break-after:avoid;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:10pt;">Note 9 &#x2014; Income Taxes</FONT><FONT CLASS="CharOverride-3" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:bold;"> </FONT><FONT CLASS="CharOverride-4" STYLE="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">(cont.)</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">of December<FONT CLASS="nobreak"> </FONT>31, 2020. The amount of the annual limitation, if any, will be determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. Based on the Company&#x2019;s history of operating losses since inception, the Company has concluded that it is more likely than not that the benefit of its deferred tax assets will not be realized. Accordingly, the Company has provided a full valuation allowance for deferred tax assets as of December<FONT CLASS="nobreak"> </FONT>31, 2020 and 2019.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The tax effects of the temporary differences and carryforwards that give rise to deferred tax assets consist of the following:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-11" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="7" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 30.77%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">As of <BR>December 31, </FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="3" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net-operating loss carryforward</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">554,813</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">235,363</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">91,035</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">880</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">License agreement</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">20,848</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Charitable contributions</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">11,247</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">477</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other accrued expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">15,451</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total deferred tax assets</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">677,943</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">252,171</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Valuation allowance</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(677,943</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(252,171</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax asset, net of allowance</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x2014;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">A reconciliation of the statutory income tax rates and the Company&#x2019;s effective tax rate is as follows:</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-11" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="5" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 30.77%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">For the year ended <BR>December 31,</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2020</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">2019</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Statutory Federal income tax rate</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(21.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(21.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">State and local taxes, net of Federal tax benefit</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(5.9</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">(5.9</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">)%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Meals and entertainment</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">0.3</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">0.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_bracket" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in Valuation Allowance</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">26.6</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">26.8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule1-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Income Taxes Provision (Benefit)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">0.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;">0.0</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: none; border-bottom-style: none;" VALIGN="bottom">
						<P CLASS="Tbody_rule2-brack-" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;text-align:left;">%</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company&#x2019;s major tax jurisdictions are the United States and Connecticut and the Company does not have any pending tax audits.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-20</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;">
		<DIV STYLE="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"><P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;">&#x00a0;<FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">&#x00a0;</FONT></P></DIV>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:30pt;margin-top:30pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:14pt;"> &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; Shares</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:14pt;">Common Stock</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:30pt;text-align:center;margin-top:30pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;"><IMG ALT="" SRC="tblue_logo.jpg" STYLE="height:152.32px;width:288.0px;max-width:100%;"></FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:25pt;margin-top:25pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">_________________________</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">PROSPECTUS</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">_________________________</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:25pt;margin-top:25pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">, 2021</FONT></P>
		<P CLASS="H4" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:30pt;text-align:center;margin-top:30pt;"><FONT CLASS="Italic" STYLE="font-family:Times New Roman PS Std, serif;font-style:italic;font-weight:normal;">Sole Book-Running Manager</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;font-size:14pt;">Maxim Group LLC</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:30pt;text-indent:24pt;margin-top:30pt;"><FONT CLASS="Bold" STYLE="font-family:Times New Roman PS Std, serif;font-style:normal;font-weight:bold;">Through and including&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021 (25 days after the date of this prospectus), all dealers that buy, sell or trade shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the obligation of dealers to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.</FONT></P>
		<DIV STYLE="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></DIV>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">PART II</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Item 13. Other Expenses of Issuance and Distribution</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table sets forth the expenses in connection with this registration statement. All of such expenses are estimates, other than the filing fees payable to the Securities and Exchange Commission and to FINRA.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" COLSPAN="2" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Amount <BR>to&#x00a0;be&#x00a0;paid</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">SEC registration fee</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">FINRA filing fee</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,500</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Nasdaq initial listing fee</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Blue sky qualification fees and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Transfer agent and registrar fees</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accounting fees and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Legal fees and expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Printing and engraving expenses</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody_rightalign" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Miscellaneous</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">*</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 83.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;">$</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" VALIGN="bottom">
						<P CLASS="Tbody_rule2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">&#x00a0;&#x00a0;</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">*&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;To be completed by amendment. </P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Item 14. Indemnification of Directors and Officers</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As permitted by Section&#x00a0;102 of the Delaware General Corporation Law, we have adopted provisions in our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except for liability for:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any breach of the director&#x2019;s duty of loyalty to us or our stockholders;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends; or</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>any transaction from which the director derived an improper personal benefit.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our Amended and Restated Certificate of Incorporation also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">As permitted by Section&#x00a0;145 of the Delaware General Corporation Law, our Amended and Restated Bylaws provide that:</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>we may indemnify our directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions;</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">II-1</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;list-style-type:none;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; and</P>
		<P CLASS="BL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;"><FONT CLASS="bullet" STYLE="font-size:10pt;">&#x2022;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>the rights provided in our bylaws are not exclusive.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Our Amended and Restated Certificate of Incorporation and our Amended and Restated Bylaws provide for the indemnification provisions described above and elsewhere herein. We have entered or will enter into, and intend to continue to enter into, separate indemnification agreements with our directors and officers that may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification agreements generally require us, among other things, to indemnify our officers and directors against certain liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also generally require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended, or the Securities Act.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Registrant has purchased and currently intends to maintain insurance on behalf of each and every person who is or was a director or officer of the Registrant against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The form of underwriting agreement for this initial public offering provides for indemnification by the underwriters of us and our officers and directors who sign this registration statement for specified liabilities, including matters arising under the Securities Act.</P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Item 15. Recent Sales of Unregistered Securities</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Since October 2018 (our date of inception), we have made the following sales of unregistered securities:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">(1)&#x00a0;&#x00a0;&#x00a0;&#x00a0;We granted to certain employees, consultants and directors options to purchase an aggregate of 195,160&#x00a0;shares (net of certain forfeitures of grants) of our common stock at an exercise price of $0.05 per share.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">(2)&#x00a0;&#x00a0;&#x00a0;&#x00a0;We issued an aggregate of 1,146,138<FONT CLASS="nobreak"> </FONT>shares of Series Seed Preferred Stock (convertible (as of August&#x00a0;1, 2021) into 1,336,855<FONT CLASS="nobreak"> </FONT>shares of common stock) in July 2019 to 5 accredited investors at a price of $6.09 per share for an aggregate purchase price of $6,979,980.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The offers, sales and issuances of the securities described in paragraph (1)&#x00a0;were deemed to be exempt from registration under Rule 701 promulgated under the Securities Act as transactions under compensatory benefit plans and contracts relating to compensation, or under Section&#x00a0;4(a)(2) of the Securities Act as a transaction by an issuer not involving a public offering. The recipients of such securities were our directors, employees or bona fide consultants and received the securities under our equity incentive plans. Appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions had adequate access, through employment, business or other relationships, to information about us.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The offers, sales and issuances of the securities described in paragraph (2) were deemed to be exempt under Section&#x00a0;4(a)(2) of the Securities Act or Rule 506 of Regulation D under the Securities Act as a transaction by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an accredited investor within the meaning of Rule 501 of Regulation D under the Securities Act and had adequate access, through employment, business or other relationships, to information about us. No underwriters were involved in these transactions.</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">II-2</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Item 16. Exhibits and Financial Statement Schedules</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">

						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Exhibit No.</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Description</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">1.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Underwriting Agreement.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">3.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Certificate of Incorporation.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">3.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Amended and Restated Certificate of Incorporation.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">3.3</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Amended and Restated Certificate of Incorporation, effective upon the consummation of the offering.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">3.4</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Bylaws.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">3.5</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Amended and Restated Bylaws.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">4.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Specimen Common Stock Certificate.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">4.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Representative&#x2019;s Warrant (included in Exhibit 1.1)**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">5.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Opinion of Ellenoff Grossman &amp; Schole LLP.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">2019 Equity Incentive Plan and related form agreements.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">2021 Equity Incentive Plan and related form agreements.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.3#</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Exclusive License Agreement between the Registrant and Children&#x2019;s Hospital Medical Center, d/b/a Cincinnati Children&#x2019;s Hospital Medical Center, effective as of June<FONT CLASS="nobreak"> </FONT>1, 2021.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.4#</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July&#x00a0;16, 2019.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.5#</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Exclusive License Agreement between the Registrant and St. Jude Children&#x2019;s Research Hospital, Inc., effective as of January<FONT CLASS="nobreak"> </FONT>27, 2020.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-9" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.6</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Norwood Accelerator Space Lease, dated as of November<FONT CLASS="nobreak"> </FONT>22, 2018, between the Registrant and Blue Water Real Estate Holdings, Inc.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.7</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Employment Agreement with Joseph Hernandez.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">10.8</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Indemnification Agreement for Directors and Officers.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">14</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Code of Ethics.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">21.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Subsidiaries of the Registrant.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">23.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Consent of Mayer Hoffman McCann P.C.</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">23.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Consent of Ellenoff Grossman &amp; Schole LLP (included in Exhibit 5.1).**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">24.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Power of Attorney.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">99.1</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Audit Committee Charter.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">99.2</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Compensation Committee Charter.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="background: #CCEEFF;height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">99.3</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Form of Nominating and Corporate Governance Committee Charter.**</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;vertical-align:top;width: 10.26%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Tbody" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">99.4</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.46%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Consent of James Sapirstein.**</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Tablefootnotef" STYLE="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</P><P CLASS="Tablefootnote_f" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:10pt;">*&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Filed herewith.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">**&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;To be filed by amendment.</P>
		<P CLASS="Tablefootnote_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:0pt;">#&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Portions of this exhibit (indicated by asterisks) have been omitted as such information is (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">II-3</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Item 17. Undertakings</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The undersigned registrant hereby undertakes:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">1.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;To file, during any period in which offers or sales are being made, a post<FONT CLASS="nobreak">-effective</FONT> amendment to this Registration Statement:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(i)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(ii)&#x00a0;&#x00a0;&#x00a0;&#x00a0;To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post<FONT CLASS="nobreak">-effective</FONT> amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#x201c;Calculation of Registration Fee&#x201d; table in the effective registration statement.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(iii)&#x00a0;&#x00a0;&#x00a0;To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">2.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;For the purposes of determining any liability under the Securities Act of 1933, each post<FONT CLASS="nobreak">-effective</FONT> amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">3.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;To remove from registration by means of a post<FONT CLASS="nobreak">-effective</FONT> amendment any of the securities being registered which remain unsold at the termination of the offering.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">4.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;For the purpose of determining liability under the Securities Act of 1933 to any purchaser:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(i)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;If the registrant is relying on Rule 430B:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:96pt;margin-top:8pt;">(a)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:96pt;margin-top:8pt;">(b)&#x00a0;&#x00a0;&#x00a0;&#x00a0;Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or</P>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">II-4</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(ii)&#x00a0;&#x00a0;&#x00a0;&#x00a0;If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule&#x00a0;430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">5.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;For the purposes of determining liability under the Securities Act of 1933 to any purchaser in the initial distributions of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(i)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(ii)&#x00a0;&#x00a0;&#x00a0;&#x00a0;Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(iii)&#x00a0;&#x00a0;&#x00a0;The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(iv)&#x00a0;&#x00a0;&#x00a0;Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">6.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;The undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreements certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:8pt;">7.&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;The undersigned registrant hereby undertakes that:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(i)&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:72pt;margin-top:8pt;">(ii)&#x00a0;&#x00a0;&#x00a0;&#x00a0;For the purpose of determining any liability under the Securities Act of 1933, each post<FONT CLASS="nobreak">-effective</FONT> amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">II-5</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><A HREF="#TOC001">Table of Contents</A></P>



	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">SIGNATURES</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cincinnati, State of Ohio, on &#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 65.71%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 33.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Blue Water Vaccines, Inc.</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 65.71%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 33.01%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 65.71%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 33.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Name: Joseph Hernandez</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 65.71%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 33.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Title: Chief Executive Officer</P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">KNOW ALL MEN BY THESE PRESENTS</FONT>, that we, the undersigned officers and directors of Blue Water Vaccines, Inc., a Delaware corporation, do hereby constitute and appoint Joseph Hernandez, as his or her true and lawful attorney<FONT CLASS="nobreak">-in-fact</FONT> and agent, with full power of substitution and re<FONT CLASS="nobreak">-substitution</FONT>, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments (including post<FONT CLASS="nobreak">-effective</FONT> amendments, exhibits thereto and other documents in connection therewith) to this Registration Statement and any subsequent registration statement filed by the registrant pursuant to Rule&#x00a0;462(b) of the Securities Act of 1933, as amended, which relates to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney<FONT CLASS="nobreak">-in-fact</FONT> and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney<FONT CLASS="nobreak">-in-fact</FONT> and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-16" STYLE="height:12pt;">
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">

						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Name</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Position</FONT></P>
					</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TCH" STYLE="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="TCH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Date</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Chief Executive Officer, Acting Chief</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; &#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-17" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Joseph Hernandez</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Financial Officer and Director (Principal Executive Officer and Principal Financial Officer)</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Director</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; &#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Kimberly Murphy</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Director</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; &#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">John Rice, Ph.D.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Director</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; &#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Allan L. Shaw</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-12" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">&#x00a0;</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Director</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0; &#x00a0;&#x00a0;&#x00a0;&#x00a0;, 2021</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 32.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Michael Venerable</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="LRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">II-6</P>



</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tblue_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tblue_logo.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
MA  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(# @(" P,# P,# P,#
M P,# P,# P,# P,# P,$! 0$! ,$! 0$! 0$! 0$! 0$! 0$! 0$! 3_P  1
M" '9 W@# 1$  A$! Q$!_\0!H@    8" P$             !P@&!00) PH"
M 0 + 0  !@,! 0$            &!00#!P(( 0D "@L0  (! P0! P," P,#
M @8)=0$" P01!1(&(0<3(@ (,11!,B,5"5%"%F$D,Q=2<8$88I$E0Z&Q\"8T
M<@H9P=$U)^%3-H+QDJ)$5'-%1C='8RA55E<:LL+2XO)D@W23A&6CL\/3XRDX
M9O-U*CDZ2$E*6%E:9VAI:G9W>'EZA8:'B(F*E)66EYB9FJ2EIJ>HJ:JTM;:W
MN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ]/7V]_CY^A$  @$# @0$ P4$! 0&
M!@5M 0(#$00A$@4Q!@ B$T%1!S)A%'$(0H$CD152H6(6,PFQ),'10W+P%^&"
M-"624QAC1/&BLB8U&50V160G"G.#DT9TPM+B\E5E=58WA(6CL\/3X_,I&I2D
MM,34Y/25I;7%U>7U*$=79CAVAI:FML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(
MV.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H # ,!  (1 Q$ /P#?
MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T@^R^TNMNFMGY/L#MG?FTNMMD8;Q?Q
M/=>]L_C-MX*DDG;134\F1RM32TS5=7)Z(858RS.0J*S$#VMV_;=PW:[6QVN!
M[B9_A2-6=SZT503CS].FIIX;:,S7#A$'$L0 /S/6N7\K?^%,OQVZZJ<GMCXK
M]:;B[^SE+))3)OO=,U3USUBLBLR_=XNDJJ&KWUN:)&0@QRT6%1PP:.=A]<@N
M5ONX<Q[DJW/,UPFWQG/AJ!--]AH0B_[TQ'FO0)W'GS;[<F.P0SL/Q?"GY$@D
M_L ^?5!/=G\^K^99W--,E)W-B^FL+/')&VW^D]I8O:D*&0K^Y#N3-G=._H9$
M"V4KF !<\7Y]SOLWL1[<;0*R6CWC@_%<2,WY:$\-#^:'H&77.>_7/PR+$/1%
M _FVH_L/5:>^/D;\A>S15+V3WQW-V$M;'4Q5B[X[0WONP5<58--7'5#/9RO$
M\=4IM('N''ZK^Y'LN6N7-N8/M^WVT!4@@QP1(01P(TJ*4\NB&7<=PG!6>>1P
M>(9V-:_:>@9]G?2/H2=D]R]P=:^(]<]K=D[ ,#2-!_<G?.Z-J^%IIHZB5HOX
M%E*#QM+40H[$6U.@8\@'V5WVQ[+N;%MRLX+@GB98HY#C ^)3TJAOKVW&FWF>
M,#R5V7_ 1T?SIO\ G/?S*NE'Q\6$^46]=ZXBA>\F"[>AQ/:]-D(+6%)5YG>]
M!E]W0P"PTFER5/(MK*X4D$![Q[->W&\AVEVU(';\=N6A*GU"(1'^U"/ET<VO
M-F_6M LY=1Y. U?M)&K^?5T/QM_X5&9J!Z##?+7X[4&1@]25N_\ H;*2XZK0
M?<*L#/UKOC(UM-5/]HY::6/<=./)'Z*<+)ICAWF/[LJ4:;E3<"/2*Z6OEG]:
M(#SX#PN!RV,BFP]P>";E!]K1GYX[&/I_2_+K8X^*O\Q7X<?,^E0="=V;9W!N
M80O-6]=YQI]H]DX](1%]S))LK<<>/S.0H:9IT5ZVA2KH"[:5G8^\>N9^0>;>
M3WIOUD\49P)11X37@!*FI:X^$D-ZCH<;?O.V;HM;*4.?->##[5-#^?#H[7L'
M=&G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]T4#Y,_.[XP?$JC<=P]E8ZDW.U,:F@Z\VVO]Y>P
M<FK1/+3^/;>/D,F*IZSQE8JO)24-"S\&<>QYR=[:\Y<]24Y?LV>$&C3O^G O
M"M9&P2*U*IJ:GX>@1S=[B\G\CQ:N8+Q8Y"*K"O?,WI2-:D \-3:5KQ8=4$]]
M?\*"^S,W-78GXX]0[>V+BO*8J7=_9E1)NW=%12F$_P"4P;8P\^,VY@*]:A@
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M32GAPQI2G"FE1PZBO<.:N:-V!7==RNKD-4$2W$TE0>(.MS6OGTAO9OT0=*C
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5$/\
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MD4LL$JSP,4="&5E)#*P-001D$'((R#U9G\=/YG_<G5;T.W^TS4=P;)B,%/\
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MS4U4\:5 ('_('N5S1[<;G]?L$U8G(\:W>I@F']-:BC#\+K1APKI)4[*_Q?\
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M;&STU=05<+?IDB=6'];'VFO+*TW&U>QOXEFAE&ET=0RL#Y,IJ#TY#-+;RK-
MQ1U-00:$?8>MPC^6A_PHHQ&Y/X#TM\_)Z+;N>*T6)V]\D<91Q4>V\S)H2GC3
MMO!444<&V:^21 SYK'Q_PV1I?\HI:)(WJ),1?<C[OL]GKWGD0-+%EGM":R(.
M/Z#'+C^@W>*89R:"4-AYVCFTVF\41L 2\%/^G'X3\QC[.MKW$9C$[@Q6.SN!
MRF.S>$S%%39+$YC$5M-DL5E,=61+/1U^.R%%+-25M%50.KQRQ.R.A!4D'WB[
M)%)#(T4RE'4D%2""".((.01U(:L& 934'S'3C[IUOKWOW7NJ7/YH'9'<_=^6
MP_\ +S^*%!49CLGLG$TNY.]]PT]7+CL'UWU)53M!1XK=FX(HGBPE+O"H0RUL
M89ZN;%PBF2GJ!DHT;(/V:VGE[ER&3W5YX8)9V;&.RC(#/<70%2T49/<8P>TX
M4.=19?#/4"^\&Y<Q<Q,GM?R2NN\O$#WDE2L=O:,2H$D@';XI!J!5B@("G6.G
M7X?_ ,F'XU_'ZAQFY.W,;C_D%VJD<-155V[,<LO76"K 5E:GVWL6J,]#D4IY
M %^[RXK)I"@DBBI=1B#//OW@^<.:Y'M-C=MJL34!8FI.XX5DF%"*_P *:1Y$
MM2O3G(?L#R=RG&EWN\:[I?"A+S*#"AP?TH35<$89]3>8TUIU</2TM+0TU/14
M5-3T='2PQT]+24L,=/34U/"H2*"G@A5(H88D4!54!5 L![@1W>1S)(2S$U))
MJ23YDGJ=5544*HH!@ <!UG]UZWU[W[KW7O?NO=>]^Z]T"_;'QSZ%[TI32]P=
M0=>=BVC\<-9NC:V)R.7HU\;1 XW.24PS.,D6-R ]//$R@\$>Q!LG-?,O+<GB
M;!?SVA/$12LJGS[D!TM]A!Z(]YY9Y=YBC\+?;&"[ X>+$CD&E*JQ!(-#Q!!Z
MJ)[Y_D'_ !GWTE;D^C]W[RZ0SDJR/2X>JGD[#V&LA?R*GV&=JX-WTP>Y0N,S
M,B+8B(E2&G?EC[SW.6V%8>8X(MRB'%J"":G^F0&,^O\ 9U/KU!?,WW9N2MT#
M3<ORR[;*:T4$S0UK7*2'7\L2 #TZHL^2/\I?YF_'"*OS55L!>UMCT1GE?>74
M3UN[8:6CB9B*G,;9^QI-X8A(J8"2>9J!Z* :KU#!2WO);E'WU]O>;66W6Z^@
MN6I^E=4BJ?1)=1C;. -08_P^76-G-OL1[@<JAKA;8;A;+7]2UU2$"N"\5!(,
M9-%95S5J"O5:3H\;M'(K)(C,CHZE71U)5E96 965A8@\@^YB!# ,IJ#U#;*R
M,584(P0>(/H>N/O?6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z-Q
M\2?FSWO\,]Z+N;J;<KMM_(54,N\.N<XTU;L?>=-&$1DRF+$B-0Y5(4"P9&C:
M"N@L%$C0M)%( ^>_;CEGW"V_Z3?(:3("(KA*":(\>UO-:\4:JGC0-0@?<A^Y
M',WM[?BYV:75 [ RV[YAE' U'X6IP=:,* &JU4[COPE_F2]!?-3$4V-V]DH]
MB=P4U&9\]U#N:O@&<7PHS55?M+(&.EI=Z8.,1L[2TJ+54R6-53P!DU\__<7V
MCYH]N[@RWB?4V#&B748.@UX+(,F-ODV"?A9J'K/SV]]V.5_<.W"6$G@7JBLE
MK(0)!3BR' D3^DN0"-04FG5A?N*^I.Z][]U[H(^].X-O]$]7[G[*W"KU46%I
M4AQ&'@/^7;BW'D)!1X';^/C :22IR>1E1"55C%"'E(TQM[$?*7+5[S=O]OL5
MEVF4U=S\,<:C5)(Q]%4$_,T'$CH+<Y\UV')7+=SS%N ++"M$C7XY96.F*)!Y
ML[$#Y"I. >JDNF/Y>6__ )![LRG?WS RN5PM7O?)-N.3KW&L<?N6NBJ%7[*F
MS]3)YWVCB*2ACAIX,;%JKX:5%B=Z22/3[R0YH]ZMGY,VV/DWVSC25+1?#^I;
MNC!'Q&,8\1B22TA["Q) <&O6*O*'L#O?/N[2\^^[LCQ27K^+](E4E(--"RMD
MQ(% 58U/B*H 9D8$=7$=<]4=;=1X2/;O6FRMO;-Q*+&)8<+CXJ>HKGC0(M3E
MLBPDR69K="@&>KFFF8 78^\9=[YBWSF2[-]OMU)=2G@9&)"U\D7X5'R4 ?+K
M+;8.6>7^5;(;=R[9Q6<(IVQ(%+$"FIV^)VQEF)8^9Z$'V3='O7O?NO=>]^Z]
MU[W[KW39E\+A]P4,V+SV)QF;QE0+5&.R]!2Y*AG%B+34E9%-3RBS$>I3P?;]
MO=7-G*+BTD:*1>#(Q5A]A4@],7-K;7D)M[R-98VXJZAE/VJP(/1)>T?Y</Q6
M[+CJ9Z;8K==9F:.18\MUQ5G;\,+L2\;?W<>.LVJ4C<FX2BC=D.G4+*5E7E_W
MP]P]A95>\^MB!RER/%)_YN5$G_&_G3CU#/,WW>_:[F16=; ;?,00)+0^"!Z'
MP@#%_P 8K3%>%*P^X_Y2G<&TUJLIU%N?"=I8N(22IA*\1;0W@J:@4AIXZZKJ
M-N9,Q1WU2&NI'<@:(26TB?>6/O(<M;B5M^9;=]OD-!XBUFA^9.D"1?D-#T\V
MZQJYO^ZCS5M@>ZY1NH]RC%2(GI!/3R"ZB8W\ZDO'PPN:"L/>>Q=Y]=YRIVUO
MO:V>VCGJ4MY<5N'%U>+JS&LCQ"H@CJXHQ54<KQMXYXB\,H%T9AS[G[:]XVK?
M+1;_ &>XCN86X/&X<<*T-":'.0:$>8ZQGWK8=ZY<OFVW?K66TG6O9*C(2 2-
M2U U*2,,M5/$$CI*>S'HIZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[ITPF<S.VLMC\_MW+9+!9S$U,=;B\QB*VIQV3Q]7$;QU-%74DD-333H?HR,#
M[3W=I:W]L]G?1K-#(-+HZAE8'R92""/MZ5V-_>[9=Q[AMLSP3Q'4DD;%'1O5
M64@@_9U>=\2_YI=%E#C-@_)>2#&9 B&CQO;%)3I#BZV2VB-=ZXNDA2/$S.0
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ML"[QHN'^^KIT\D]1!)2&UEO-WMUA<6-D?#-V DK@]S1 AO!!\E9@&<?BTJ,
M$,FEM8YYDEE&KPS50> ;AJ^T T'I4]#=[*>E/7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]TA>Q^L.N.X-IY/8?:VQ-I=C;+S,1BR>U]ZX#&;
MDPE6-)"2/C\K355.M3"6U12JJRQ/9D96 (66&XW^U72WVV3/;S(:J\;,C#[&
M4@]-30PW$9BG4.K<0P!!_(]:W?S2_P"$T_278ZYO>GPWWK/T=O.<U%=#UCO6
MHR6Y^H<E5,M1(*'%Y@+7;XV&E352J3*6SE+#&GCAHXE(*Y#\F_>,WS;"EES=
M#]= *#QDHEPHP*D822@!P=#$FI<] ?=>1+.YK+MC>"_'2:F,\?S7^8 X+UJ6
M?*7X5_)KX9;PDV=\A^J=Q;'DEJI:?!;G,(RNP]W1Q^1XZG:>]<8:G;V9$M-'
MY6ITG6MID8+4P0R!D&5G*_.O+/.5K]5R_=),0*M'\,L?"H>,T84)I6A4GX6(
MSU&VX[1N&U2>'>QE17#<5;[&&/+AQ]0.BL>Q3T6]>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U:7_+^_FX_*;X 92BPFULT>SNC'JY9\WT5O?(U#;<
M_P ID1ZJNV1G!!797KW-O9V#T:RX^:60R55%5,$*Q=S[[2\L<]QM<3I]+?4&
MFYC4:C3RE2H$@^VC"@ <#!$>R\S[CLQ$:GQ8?]]L<?[4Y*_X/E7K>7^#/\T7
MXG_/G"P1=4[TCV[VC3X\UNXNDM\2TF&[%Q"PB,5M7BZ(SM1[RP-+)*NK(8J2
MIBB62,5*T\KB(83\Z^VO-7(LQ_>\&NV)HEQ'5H6K6@+4[6-#VN <&E1GJ6]I
MW[;=X3_%7H]*E&PX_+S&>(J.K%O8 Z.N@IZLZBVSU73[GK,<@R>\>P=Q56\N
MRM[U<*KF]Z[JK%$7WE8YDG>DP^&HD2AQ&.21J?%XV&*GBN%9W.=XWR\WEH8Y
MCI@M8Q%!$#V11C- ,59B2SM2KN2QXX*MKVBTVL320BLURYEFD([I9" *L<FB
M@!46M$0*HP.A6]DW1KU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=$1^4/\M_XG_+&&OR&_\ KNEV]OVKB<1=H; ^WVMO:.I*E8ZK)U--32XG
M=31W "Y:DKM*BR%#8B2^2_=OGCD9ECVF[,MLIS;3UDA(\PH)JE?6-E/K7J.N
M<O:KDKGE&?>+0)<D4%Q#2.<&A )8"CTK@2!A\NM9_P"6G\E;Y-] C*;JZLC'
MR#ZVHQ/5-5;2Q\E)V)AJ&,22DYG81FJZK)B")0IEQ$U>SV+O# O S"Y%^\3R
M=S/HLM\_W57C4%)6K;NV!VS4 6OI(% X:F/6('//W=N;N6]=]R__ +M;1:FB
M#3<(N3W0U.N@ %8R23^ #JG&6*6"66">*2&>&1XIH94:.6*6-BDD4L;@/')&
MX(92 018^\@E974.AJ#D$9!!X$'K'UT>-S'("K*2""*$$8((/GUC][ZKU[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TXXC,9;;^5QV=P.4R.$S>(K:;)8G,8
MBMJ<;E<7D:.59Z2OQV0HI8:NBK:6=%>.6)U=' *D$>V;BWM[N![6Z198I 59
M'4,K*10JRD$$$<0<'I^VN;FSN$N[.1HI8R&1T8JZL.#*RD$$>1!KUL5?![^>
MEG]KIB>N/F53UN[,#$(:'']UX#'B?=F+@1?'$=][=H41=TT\2A0]?0HF1TJ6
MD@K)F9_>)GN1]VFWNR^[>WQ$,AJ6LY&I&Q_X1(WP'^BYT^C( !UEG[<_>4EM
MU3:O<$&1!A;R-:N!3_1XU'=_ID&KU1C5NMF_KOLG8';>TL5OSK+>&WM];/S4
M7EQNX=LY.FRF-G*A?+3O-3.YIJZE9M$]/*$G@D!21%<$##G==IW/8[Y]LWBW
M>VN(S1HY%*L/0T/$'R(P1D$CK,#;=SV[>;)-QVJ=+B"0562-@ZG["">'F.(.
M#U"W)UM@=X[OVGNG=$<>:I]B--DMI8"KIUDQ>-W=4L8FWE/%([QUN;QN.7[?
M&NR+]@)ZF12TDR-"HL=\O-LVZXL+ F(W=$FD4T9H1GP01P1F[G%>^B T"G4A
MO]@L=UW.UW'<5$PLB7@C8 HDYQX]#6KJO;&:#1J<BI8:1#]DW1YU[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=(;L#K+K[M7!OMOL?9VW]YX5
MS(T=%GL;3UWVDTD9B:KQM2Z_=XNN$9LM13213)_98>S;9M^WGEZ[%]LEU):R
MC\4;%:CC1@,,/DP(/F.B;?.7=BYFL3MO,%I%>0'.B5 X!I34I(JK>C*01Y'J
MH+O[^4=C:E*O/_'7=3XVI&N8]?[YJY:G'R?0^# [MCADKJ,JBD1PY"*J\DC>
MNKB4>\EN3?O)7$96SYWM_$7A]1  &'SDAJ%/S*%:#@A/6)G/GW4+.</?^WUU
MX+\?I;EBT9X8CGH67%:"0/4G+J.J8NQ>KNP^I-PS[6[)V?G-G9V$N11YFC:&
M.KBC;0U5BZZ,RX_+T!;A:BEEF@;\.?>4>Q\P[)S+9#<-BNH[J(^:-4J3Y.IH
MRG^BP!^76'7,7*W,/*5^=LYDLY+.85H)%H& \T<55U_I(6'SZ07LYZ(.O>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z.'\9OFUW%\9JN''X.N&[.O9*
MGS9'KO<-3.V*(D8FHGV_7!9ZK;&0EU%C) KT\DEFF@FL![C'GWVHY8Y\C,]T
MGTUZ!1;F,#7\A(N!(/D:,!A67J8/;;WJYN]MY%MK5_K-OK5K25CH%>)A?)B8
M_(%2<LC'K8G^.?S!Z9^2V-C&S<X,3O"*G,N5Z^W#)!1;GH3&FJHFHH1(8,]C
M8P+_ '-&TJHI'E6)SH&$W._MIS1R).?WK#XEL31+B.K1-Z FE4;^BU#Z5&>N
M@OM][L<G^X]L&V6?P[I162UEHLZ4XD+6CK_20D>M#CHTWN/NI+Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I$]B=;=?=N;/S/7
M_:6RMK]A;'W# *;-;3WC@\=N' Y*)'$D1J<9E*>II7FIIE62&32)(955T974
M,%EAN%]M=VE]MLSP31FJO&Q1U/R92#TW-#%<1F&=0Z-Q# $'[0>M4KY_?\)K
MZ"I3-=F? 3.G'U0\M=5_'??V;DFQ\RK"NJFZS["RTLE723L\=TQ^X)IHW>5R
M,G"BQTYRAY#^\7-%HVWGN/Q%X"[B4!AGC-$* \?BC ( ^!B2>H[WGD2-ZW&S
MMI/'PV./]JW$?8:_:!UJ6]E]8=B]-[USG7/:VR=S=>;ZVW5&DS>U=W8>MPF:
MH);:HI)*.NBB>6DJXB)*>>/7!40LLD3O&RL<K-LW3;MYLDW':9TN()!57C8,
MI^51P(\P<@X(!ZC:YMKBSF,%TAC=>((H?^*^? ](3VOZ8Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z=]O[AS^T\WB]R[6SF8VUN/!UU/D\)N#;^2K<-F\/
MDJ1Q+2Y#%Y7'34U?CZZFE4-'+#(DB,+@@^V;BVM[R![6[C66*049'4,K \0R
ML""/D>KQR20N)8F*LN002"/L(ZV8_@;_ ,*0NWNJ8\/UY\T\#D>\]CT_CI*?
MMC;,.-HNXL+2@Z(SGL?--BMM]A4]-&%7RN^.R9 :2:IK)2![QLYY^[MM>Y%]
MPY+D%G,<FWD+&!C_ $&[F0GT[E\@$'0_V?GJ>&D&[@RK_&H&H?:, _;@_:>M
MNCXT?,+XV?,#9\>]?CQVSM?L3')#')EL30U3T&[]LR.57[7=>S,K'1;GVY.)
M#I0U5+''.+/"\D95SBCS%RIS#RG>&QY@M7MG\BPJCCU21:JP_P!*33@<]238
M[C9;E%XUE()%\Z<1\B#D?F.C+>P]TMZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NB>]^_,?KOISM/IOXZX:JQ^]/D?WUNK&8/8W5E#D8AD<1
MM8FLR&[NT]ZK!YJG";(V=M?#9&N!9!/E9J,TM*+^::G%.R\J;CNVV7F_NIBV
M^Q0M+,0=)?"QPIZN[,J_T0=38H"7W6XP6]Q%95#33&BK7-!4LQ]  "?GP'1P
MO86Z,.J\OF#_ "R_C+\PZ:OS&YMN?W"[4GCO2=L[%IZ3'[BFJ$7]I=TX]H_X
M3O*B8JJN*R/[Q8AH@JH+EO<J<A>\/./(#K!8S?4V0XVLQ+1T\_#-=49_TITU
MRRMPZC#GOVDY/Y^C:7<8? O/PW,("RXX!\%9!Y48$@?"5.>M3WYD_P LKY)?
M#:HK<WN/"#L'J9*C11=M;)HZRJP5/#+($IDW?C&67([*KI"Z(15:Z)IG$<%7
M.WO./V^]Y>4/<!5M;:3Z2_(S;3$!R?/PFP)!]E&IDH!UA#[@>S/-O():[F3Z
MRP!Q<PJ2%'_#DR8_M)*5H Y..J[O<L]1)U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW1C/CC\L.^OBCNP;MZ2W]D]L25$D)SFW9F.2V=NF"%D(IMR;
M8JV;&9'T*42<*E93JS>":(DGV$>;^1>5^>;'Z'F.U6:E=$@[9HR?..09'K3*
MG\2GH8<G\^<T<C7OUG+MRT8;XXF[H9.'QQDT)Q34*.!P85ZV@?B#_/(Z*[>A
MQFTOD=24O0O84BT]*=RF:JKNIL_5F,"2I3,2K+D-B^696/ARAEHX$M?(.QTC
M#'GW[MW,^P,]]RF3NEH*GPP +I!7 *#$GVIW'_?8'69?(GWC>5N852RYI VN
M[-!J8DVSFAJ1(?[/APDP*@!V/5X>)R^*SV-H<U@\GC\UA\G315F-RV)K:;(X
MW(4<ZAX:NAKZ.2:EJZ:9#=9(W96'(/O'":":VE:WN$:.1"0RL"K*1Q!!H0?D
M>LB8I8IXUFA8.C"H92""#P((P1TX>VNG.O>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>ZPU%1!203U55/#34M-#)45-342)#!3P0HTDT\\TC+'%#%&I9
MF8A54$DV]V56=@B DDT &22>  ZTS!068T R2?+HM_0OR:V9\E,]V?/U.Z;@
MZRZQW#%L&3L6(RG%;R[!IX?XAN6@VD^A:>NVYM;&U5"#D5>2/(SUY\ 6&!9J
MH6<S<H;CRC;V:;X/"O+R/Q_ --44!.F-I?,.Y#=A *!>[+44,\N\U;;S3-=O
MLK>-;6DG@&85TR3**R+&:494!7O!(8D@86K"QV/U;UYV[MNHVEV3M'"[OP-0
M)"*3+4BRRT4\D;1?>XJOC,>0P^22-R$J:66&= ?2X]E.R<P;URW?+N6Q7+VT
MR_B0TJ*UTNN0R^JL"#YCI7S!RUL/-6W-M7,5I'=P-7MD4'22*:D;XD85PRD,
M/(CJCWY+?RH]T;:_B&[/CKD:C>6$#RU,W7F<J*:'=>-B+-(T> S$AI:#<5+
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M15"J@4 "7-FY>V+EZ#Z;8[2*U2@!\-%4M3AJ8"K'YL2>@Q=W][?OKO)6D/\
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M2ND:,P+-YWG;>7]LFW?=I1#;P*69C_( >;$X4#)) &>E-G:7%_<K:VJZG<T
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M[_F@=!?S(O\ 2W_H.VCW!M7_ $,_W"_O1_I7P&R\']__ *1/[Z?P3^ _W0[
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M0)%-).*$>G6N-_T$R_S#/^>1^,7_ *+???\ ]M?WD/\ \#;R#_O^]_YRP_\
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M4SUE=75D\M565E952M/4U554SL\U14U$SL[N[%G8DDDGW+4<<<4:Q1*%50
M!0 #   X >0Z"[,SL68U)R2>)/J>HWN_6NO>_=>Z&7IOY$=[_'G.Q[DZ-[?[
M%ZIRZ5<%9-/L?=F9P%-D9J:XC3-8VAJX\9G:0H2CP5L,\$D9*.C*2"2[SRYL
M/,,/T^^6<-TM"!XB*S*#_"Q&I3\U(/2RTW"^L&UV<K1YKVD@'[1P/YCK9M^
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M(IV:GZFG3**"@I,FEQ3TU4^71G8[SN>VD?1S,@'X:U3.3VFH_E7K;3_ER_\
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MS/ON[V6^3VUK.R1KHH!2@K&A/EZGJL+_ (=<_F0?]YF]\?\ H:5?_1GN2?\
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MTU-!4J048TRRGJ>]AW1=WVR.[QK^%P/)QQ\SQXCY$=6%^P'T<]>]^Z]U2_\
M\*!/^W6'?O\ X<72W_OYMB^Y@]A_^GH;?_I;C_M&EZ"_.7_*NS_;'_U<7KYT
M_OH1U!_7O?NO=?1Z_D*_]NGOBG_Y7/\ ^"2[B]\\??/_ *>GNG_4-_VB6_4Y
M<G?\JY;?\W/^KK]6_>XEZ$W7O?NO=?.%_GU?]O8?E9_Y0S_X&WIWWT.]C/\
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M.BAA:_VA2--2\=2<>92N<>:^G#A0ZF'O*WJ->O>_=>ZVFO\ A+OWU6X'O7Y
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M,'2!/--4$-#C<%3)(SU-3)*S-=FED=R2S,3"-YS%O^XRF>_OKB=SQ:2:1SP
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MU_O<S_E+C_[)X?\ H#J5/ZE\O?[Y/^]O_P!!=>_Z!W/Y8W_/N.R?_1O[S_\
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MD0J!QJN3?;OO(\\6K_X_!:W2$U-4>-J>@9)*#\U/59^0MGD'Z+21GY,"/S#
MG^8ZV+\/0?PK$XO%^7[C^&XZBH//X_%YOLZ:*G\OBUR>/R>.^G4UKVN?K[Q^
MD?Q)&DX:B3^T]#8"@ ].G'W3K?7O?NO=>]^Z]U[W[KW7R!_?6CK&?KWOW7NA
M\^+?Q_W3\I_D-U#\>]FL8,[VKO7%[:7(>$U,>#Q#&2NW-N6HIU9&GI-L;:HJ
MO(S(""T5*P'/L@YIW^VY6Y=N^8+L52UC+TX:F^%$KY:F*K7Y]+MML7W*_BL8
M\&1J5]!Q8_D 3U]2_ICJ#870/5.P.E^K\)!MW8/6NV,9M3;.*AN[QT&-@"-5
MUU0W[U?E\I5&2JK:J4M/5UDTLTK-)(S'F/NVZWV^;G/N^Y.9)[EVD=O5F-<
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M/0V]$+(Q4E):1(I4)4@E)(W*L/H5)!X/L=>V0!]PMFK_ ,I</_'QT4;_ /\
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M4[+VL[!0 K';>WJ6ZB^D\:FMJ/3+VWVQ=HY"VFQ7B+:)V_T\J^*__&G/6/\
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M]UN//'[\52(-OBD+-3!DF1HD2OJ59F^Q3Z] OGF]C@V8VA/?.R@#Y*0Q/V8
M_,=:$_O.OJ&^O>_=>Z^BQ_PG[_[=8=!?^'%W3_[^;?7OGO[\?]/0W#_2V_\
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MQQLRAQ/<,5)'F P-/0CJ4>2=SVZRVJ2*[G2-C*Q 9@#31&*T/V'J]K_AU_\
MEO?]YF=$_P#H8T__ %Z]P=_K8^X7_1FN_P#G"W^;H8?O_9/^4N+_ 'M?\_7O
M^'7_ .6]_P!YF=$_^AC3_P#7KW[_ %L?<+_HS7?_ #A;_-U[]_[)_P I<7^]
MK_GZ]_PZ_P#RWO\ O,SHG_T,:?\ Z]>_?ZV/N%_T9KO_ )PM_FZ]^_\ 9/\
ME+B_WM?\_7O^'7_Y;W_>9G1/_H8T_P#UZ]^_UL?<+_HS7?\ SA;_ #=>_?\
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MG>(VT4(\RU /GT8;5;_5[G;VQ&H/(@(^6H:OY5ZVC?\ A5!U=+-@OB+W32P
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MRQ*&!'J"*'J"]R=)-PGDC-5:1R".!!8D$= ][.^D76UG_P )7_\ F;_RZ_\
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MI=H3U\M/!W#TMV5L>GHO*HIJ_*X083LVE+PNZHU52X[8588G4&55>119'DO
MWWB]M-Y[?B\5:FTN8I"U,JK!X3GT+2+7RK3T'0TY$G$6]&(FGB1L /4@AO\
M #_/KZ ?O!#J9.J%_P#A1WV3!LC^6WG-IM,5J.XNX>K=@PP)*5>6/"Y#(=JS
MR21*&,M+"W7"!BUD65X[G45#3A]WK;GO?<:*Z48LX)Y3_ME\ ?G6;]E>@ASO
M.L6PO&>,KHH_(Z_^?>OGW^\^.H6ZN<_D#=7R=D_S.>E<@\;2XWJS ]C]H99%
MA$H\>*V9E-LX61G8Z:=8-V;LQTFO2Q)70-+,'6&_?K<QMWMM=Q?BNWAA7-*5
MD$C?;VQL/SK\B*^2[<S[_&_E$KN?V:1_-AUM$?\ "BGJZ'L#^6IO'='V35=;
MTSVAU?V1121"8STJU^;EZPR$VF!E,E,F.[&E:57#1*J>0@&-77&?[O\ N;;?
M[D06X;2MY#-"U:9HGC*,^>J(4IGR\Z&0>=;<3[#(]*F)D<?+.DG]C'KY[?O/
MSJ$^K3OY*?8XZR_F=?%/+35PHJ'<N\,[UQ7(\QA@KSV3LK<NR\10SVXE,FX\
MS1/"A^M1''^0/<6^].W_ +Q]M-S0+J:)$E7%2OA2H[,/]H&K\B>A)RE.8.8+
M<UH&+*?GJ4@#]M.OI5>^=/4Z=5>?SH.SEZI_EE?+#-J2:O<NQ,?UC10KP]0W
M:FZ<#U]D A/I'VV%W#55#7(ND+ 78@&2?:#;#NON1M,' 1S>,3_S01IA^TH!
M^?1#S/<"VV&Y<_B31_O9"?\ /W7S2O?1_J!>O>_=>Z^L#\6^LQTQ\:/CYU&$
MG1^LNE.K]B5 JS$U6]9M;96%PU;-6- D4#5D]91N\I150R,=( L/?+'F/<FW
MGF&^W=J5NKB:7'#]21FH*UQG'61UC;BTLH;5>$:*N>/:H&?V=#O[)>E77O?N
MO=>]^Z]U[W[KW39FLWAMMXG(9[<67QF!P6(I)J_+9K-5]+B\3C*&G0R5%;D,
MC72P4=%20("SR2.J*.21[<BBEGD6&%2[L:!5!))/  #)/6F95!9C0#S/6O;\
MTO\ A1C\5>A9<GL[XWXJ7Y1]A4IFI9,YA\F^W>G,-5*%42/O22AK:[>9A:0.
MJ8:EDH:E5*C(Q-R)ZY.^[[S5OP6[Y@;]UVYS1UU7##/"*HT</QD$5KI/0,W7
MG;;;*L5E_C,G]$T0?[;-?R!'E4=:F7S$_FA?,WYPSST7=':=51[">834W477
MT51LWK"F*/'+%]U@*6MJJW<\M-/&'AGS=9E*F!B?'(H-O>5/*'MAR=R527:+
M;7<#_1YJ23?DU $]#H5:^=>HWW3F/==V[;F32G\"=J_F*DG\R>J^?<@]$?6>
M*EJ:B.JE@IYYHJ*!:JMDBBDDCI*9ZFGHDJ*IT5EIX&K*N*(.Y"F65%OJ8 U9
MT4JK$ L:"IXFA-!ZF@)^P$^76PI() K3)^7EG]O6#W;K77O?NO=?18_X3]_]
MNL.@O_#B[I_]_-OKWSW]^/\ IZ&X?Z6W_P"T:+J<.3?^5=@^V3_JXW5T'N'^
MA1U[W[KW7O?NO=?-C_GA?]O3_EK_ .'%UW_[YGKCWT4]D_\ IU^U?Z6;_M)F
MZ@OF[_E8KG[4_P"K:=51^Y4Z#?5KG\CW_MZ?\2O_  XNQ/\ WS/8_N*_>S_I
MU^Z_Z6'_ +28>A)RC_RL5M]K_P#5M^OI.>^=?4Z=>]^Z]U[W[KW7O?NO=4$_
M\*2/^W;\O_B>.K?_ '$W9[G'[O7_ $\>/_GGG_P#H(\[_P#) ?\ TZ?X>OG^
M^\]^H5Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NMK/_ (2O
M_P#,W_EU_P"(VZR_]ZC<OO%C[T'_ "3MG_YJ7'_'8NI(]N_[6[^R/_"_6Z+[
MP^ZE#KWOW7NOG"_SZO\ M[#\K/\ RAG_ ,#;T[[Z'>QG_3K-K_ZB?^TNXZ@W
MG'_E8[G_ )M_]6DZJ!]RUT&>K7/Y'O\ V]/^)7_AQ=B?^^9[']Q7[V?].OW7
M_2P_]I,/0DY1_P"5BMOM?_JV_7TG/?.OJ=.O>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KY _OK1UC/U[W[KW6WY_PE+_ .Y\_P#RUW_YXKWB
M7]Z/_EA?]1O_ &J=29[=?\3/^;7_ %EZV_/>)?4F=>]^Z]U[W[KW7O?NO=?/
M[_X4C?\ ;R&H_P#$$]6_^Y&Z?>=WW<_^G>M_SUS?\=BZASGS_DMK_P TE_X\
M_5!?N>N@5U8-_*C_ .WD'PR_\3QLO_W+?W'GNQ_T[C=_^>=O\*]'W+'_ "7[
M7_3_ .0]?3R]\VNIZZ][]U[JE_\ X4"?]NL._?\ PXNEO_?S;%]S![#_ /3T
M-O\ ]+<?]HTO07YR_P"5=G^V/_JXO7SI_?0CJ#^O>_=>Z^CU_(5_[=/?%/\
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M^[?\HLW_ #C?_H'KW^R2_,W_ +Q&^3O_ *(3M7_[%/?OZ[<F?]'>R_[*H/\
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M[V,_Z=9M?_43_P!I=QU!O./_ "L=S_S;_P"K2=5 ^Y:Z#/5FO\FO_MYS\/\
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M&NKJ1@U/B1%CC'Y!E?\ ,GJ(>?9S)O"0@U$<:X]"2Q/\J=:^7N?^@1UOD?\
M"9GJZ3:/P4WSV+64\25?;G?&Z*['U*JPDGVQLO;VVMIT$<K,;-X-RTV9TV%@
M'^M[@8+_ 'C]S6\YZBL$K2SMHU(_IR,\I(_VK)^SJ8^0[<Q;*9C_ *+(Q'V
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M8=!?^'%W3_[^;?7OGO[\?]/0W#_2V_\ VC1=3AR;_P J[!]LG_5QNKH/</\
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M"6;A%146R*H'-CW5W-MV]Q-WNF.K3<-$.%-,%(5I3Y1_GQ.>I^Y<MQ:[':Q
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MNO=;W?\ PE__ .R!>W?_ !;_ ']_[YCH#W@]]Y?_ )7NT_YX(O\ M(NNI?\
M;_\ Y(TO_-9O^.1];'OO'CH<]>]^Z]U[W[KW7O?NO=:\W\Q'^?/_ +(1\G=R
M_''_ &53_2O_ '>VWL_<']\O].7]Q?O/[UX2#,?:?W>_T/;Q^W^P\WC\GWS^
M6VK2GZ?<^>WOL?\ U\Y;7F#]Z?2:I'3P_IO%IH-*Z_'CX^FG'0+WWF_]RW_T
M7T_B]H;5XFGC7%-#?X>B.?\ 05I_X 9_[-%_^KK[''_ N?\ 2=_[,O\ M[Z)
M_P#7%_Y<_P#JK_URZ-_\"O\ A0/_ +.]\L.J?B__ +*3_HQ_TG?WY_W_ !_I
MZ_OI_!/[E];;Q["_X]G_ $,;3_B7\2_NG]G_ ,7"G\/W'E]>CQN$N>O87^I?
M*MUS-^]?J?IO"_3^E\/5XDT<7Q_4/2FNOPFM*8K4&>S\Z?O;<H]O^F\/Q-7=
MXFJFE6;AH'I3CUL>^\>.ASU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW10?Y@/6TW;WP?^6775)3Q5>3W'\?\ M*/!4\RNT4NY<;M+)YC;(<1I)(MM
MP8ZF.I5=E(U!6( (IY'W%=HYRVO<I"0D5U 7(XZ/$4/Z?A)Z+]V@:ZVNXMUX
MO&X'VZ33^?7RQ??3_K'?KWOW7NMZC_A-IW132?R_.X-O[@J:=*7HKN7>V4M#
MK$]-LS/[*VYO(2U*/(ZM*V<@S)5UT(R*%TZE9WP>^\7M'A\_6UQ #6]MXJUX
M&17>*@Q_"$]<_L$P\BW)?9'C?_09& ^P@-G\R>M(#?.[LIO_ 'MO#?F;,9S6
M]MT[@W=ES%?Q'*;DRU7F<@8]1+>,U=:]K\V]YJ[?91;;80;=!\$$:1K7CI10
MH_D.HDN)FN+A[A^,C,Q^UB2?\/4;:6V<KO7=6V=FX*))\YNW<&&VSAH9#($F
MRN>R--BL=$YBCFE"25=6@.E&:QX!/'N][=PV%G+?7&(X4:1J<=**6/&GD.JP
MQ//,D$?Q.P4?:30=?6TV;M?'[(V?M39>)54Q6T=MX+:^,1(Q"B8_ 8NEQ5$J
MQ!G$2K34B@+<Z1Q<^^4]S.]U<R74GQ2,S'[6))_P]9)(H1 B\  /V=*3VQU;
MK2+_ .%1_6$>#^2WQO[?A69!V+TQG=C5 NOVTM;U9O&?+/4HOC$@JFH>TJ>.
M0ERICBBLJG47S.^[)N;3<O[EM!I2WN$E'K^O'IIQX?H8QYGCY13[A6X6]M[H
M<71E_P!X:O\ S_UJ]^\FNH]ZW0_^$L7929#J/Y9=/.TRR;2['Z_[*IU=8A3S
M)V'MG+;7K&IW5S.TU.W6$'F#JJ*LL6DL2X7#C[SNVM'O.U[OBDT,D/G4&%P^
M?*A\?'V'Y5E7V]N UG<6OFCJ_P#O:T_Y\ZU/OEGV8G<WRC^1G;,-=)DJ+L?O
M#M/>>+JY*LUP;"[AWMFLEA(*>IU.CT-)B*B"&G"'QI!&BH @4#*;E';3L_*V
MV[6R:&M[:!&%*=ZQJ'J/4M4GSJ23GJ.=UG^JW.XN =0>1R#6N"QI^5*4^71?
M?8AZ0=;UO_"8CKB?;?PJ[9[%K*3[>?LOO_,4V-G*IJKMN;'V;M/&4E0) -9C
MCW'D\M"%/"M$Q'ZC[P>^\GN*7/.UM81FOTUJ@8>CR22.1_O.@_GU,'(4#1[.
M\S#^TD)'V *O^$'K9+]X\=#CKWOW7NM>+_A2KW76=>? _;W5N*JDAK.^NX-L
M[=S$/W#Q3S;-V/25V_\ *-%'&RM.J;IPV#20->,)*;\E?<^?=TV9-QY[;<91
MBQMY)%Q4>)(1$M?]J[D?,= SGJ[:#9?!7C,ZJ?L%6/\ -0/SZT)/>=G4-=>]
M^Z]U](C^27\3<3\6/@-U'+48J&E[&[SPF-[O['R+T<E)E)Y]\4,66V9@<A'4
MN]53':6QZNAHWIFT+'7?=2>-'FD'OG7[R<TR\T<]WC*];>S8VT(J"NF(Z792
M,'6X9@?0@5( ZG;E;;EV[9HE(H\H$CXH:MD _8*#\NK</<5]"+KWOW7NO>_=
M>ZIU_GYUL-+_ "I/DY!*'UY.LZ/HJ;2H*B:/Y!]5Y%C(2PTI]OCY.1?U6%N;
MB7/8I2WNEMA'X1<D_P#9)./\O08YQ-.7+CY^'_U=3KYR/OH9U!W7O?NO=?18
M_P"$_?\ VZPZ"_\ #B[I_P#?S;Z]\]_?C_IZ&X?Z6W_[1HNIPY-_Y5V#[9/^
MKC=70>X?Z%'7O?NO=>]^Z]U\V/\ GA?]O3_EK_X<77?_ +YGKCWT4]D_^G7[
M5_I9O^TF;J"^;O\ E8KG[4_ZMIU5'[E3H-]6N?R/?^WI_P 2O_#B[$_]\SV/
M[BOWL_Z=?NO^EA_[28>A)RC_ ,K%;?:__5M^OI.>^=?4Z=>]^Z]U[W[KW7O?
MNO=4$_\ "DC_ +=OR_\ B>.K?_<3=GN<?N]?]/'C_P">>?\ P#H(\[_\D!_]
M.G^'KY_OO/?J%>O>_=>Z^GA_*@_[=O?#/_Q!.SO_ ''E]\T?<[_IX6\_\]<W
M_'CUD#L'_)$M/^:2?\='5A'L"]&_7O?NO=>]^Z]U[W[KW6JEW;_PIM_T.=S]
MN=1?[)+_ 'C_ -%?9^_NN/[P_P"S)?PC^._W'W5EML?QG^$_Z \I_"_XI_"_
M/]O]S4>#7H\LFG6<H=D^[=^^=FM-W_?7A_5013:/I-6GQ8U?3J^J6M-5*T%>
M-!U'=YS[])=RVOTFKPG9*^+2NEB*T\,TK3UZ##_H*T_\ ,_]FB__ %=?9G_P
M+G_2=_[,O^WOI/\ ZXO_ "Y_]5?^N75K7\J_^;W_ ,.8[P[=VI_LO7^A3_17
MMK;.X?O_ /2S_I'_ (]_>/*9+&_9_:_Z,]A?PO[/^':_)Y*CR:[:5M<Q9[H>
MU'^MO;V=Q]?];]6TBT\#P=.@*:U\:6M=7RI3SZ$G+O,G[_>5?!\+P@I^/575
M7^BM.'5T7N'NA1U[W[KW7SA?Y]7_ &]A^5G_ )0S_P"!MZ=]]#O8S_IUFU_]
M1/\ VEW'4&\X_P#*QW/_ #;_ .K2=5 ^Y:Z#/5KG\CW_ +>G_$K_ ,.+L3_W
MS/8_N*_>S_IU^Z_Z6'_M)AZ$G*/_ "L5M]K_ /5M^OI.>^=?4Z=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7R!_?6CK&?KWOW7NMD7_ (3(
M=NTVS_FGV;U1D*F*GI^Y.DLH^(C<H):[=G76?Q6X**CA!36UMI5V<G:S#B#D
M'ZKCG]Y3:6N^4;3=D!)M+@!O0),A!)_VR(/SZ'O(%SX>Y2VIX2I7\T/#]C']
MG6]G[PCZEOKWOW7NO>_=>Z][]U[KY\7_  HRSM#EOYE^ZZ"D=7J-K]1=38+)
MJ)89#%75&&K-RQHRQ2.\+'&[BIVTR!'(8,!H96.>GW=X)(O;I9'&);F=E^8&
MA/\ "AX=0USVX;?*#\,: _M8_P"7JB3W.G0,ZL6_E'XRHRW\RGX;4M*8A+%W
M1@LFQE8HOV^%I,AF*P JKDRFDH'""UF>P) -Q'/NY(L7MMN[-YP4_-G11_,]
M'_*REN8+8#^(G]BD]?3B]\W>IYZ][]U[JE__ (4"?]NL._?_  XNEO\ W\VQ
M?<P>P_\ T]#;_P#2W'_:-+T%^<O^5=G^V/\ ZN+U\Z?WT(Z@_KWOW7NOH]?R
M%?\ MT]\4_\ RN?_ ,$EW%[YX^^?_3T]T_ZAO^T2WZG+D[_E7+;_ )N?]77Z
MM^]Q+T)NO>_=>Z^<K_/VQ5?C_P":Q\EJNLIF@I\YC^D<KBI2\;"LH(>@NL,)
M)4H$=FC5<IAZF&SA6O$3;25)Z$^Q$T4OM?MR1FIC:Y5ODQN9GI_O+@X]>H/Y
MS1DYBG9A0,(R/F/#4?X0>J<?<O\ 07ZL6_E(;CQVUOYE/PVR>4ECAIJKNC [
M<B>6:.!3D=X4N0VCB(@\I"M)/ELW B(/5([!5]1'N.O=NVENO;?=XH021 7P
M*]L;+(Q_)5)/H,]'_*\BQ;_:LYH"U/S92H_F>OIQ>^;G4\]>]^Z]U[W[KW7O
M?NO=:(?_  IK[8@WA\W>N^KZ"HAFINGNCL''E8T?5-2;JW]G\WN6NIYE#%8P
MVU8L)*H(#$2DFX*^\WONU[4;3D^ZW5P0;NY('H4A15!'^V9Q^741\_W/B;G%
M;#A''7\W)K_(#K7#]Y%= /KWOW7NOK\>^2_63'7O?NO=$V_F)X2NW%\!_FCA
M\9!/59&J^+G>KT5'2T\U755M32=:[CK8J&DI:=7GJ*NM>G$42(I9I'  /L7<
M@31V_/.SS3$*JWMK4D@ #QDJ23@ <3T6;TC2;/=(@J3#)0#))T' Z^6A[Z==
M8]=>]^Z]UO+_ /"77<5-4_#7OK::S4[5>%^3>3W%/3J&^ZBIMT=5]9XVEFF)
M<I]O/+M"98[*#JC>Y/ &$OWF867G*QN"#1K)5KY56><G_CX_EU+OM^P.TRIZ
M3$_M1/\ -ULP^\<>AWU[W[KW7O?NO=>]^Z]U\Z/^?]NNCW-_-([YI**,A-H8
M'J/:D]1Y-:5=9!U5M'-5<B+XT,/VL^<-*RG5=Z=F!LP Z!^PEH]K[9V<CFOC
MR3R >@\9T _XQ7\^H3YUE$G,$BC\"HOV]H;_ )^ZIC]S+T$^KT/^$ZNV/X__
M #-=B97[2FJ?[D=6]N;G\T\3R2X_[O;#;,^[HG6&58*E_P"]W@+LT8,,\BZB
M6"-!WWAKHV_MQ)$&(\>X@0@'XJ$R4/J/TZ_: >ACR-&'WT,171&Y^S@M1_O5
M.OH4>\".IGZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K#4T\%93ST
ME3&LU-50RT]1"_*2P3HT4L; 6.EXV(/^!][4E2&7!'7CG!Z^2YW=UW+U!W1V
M[U-,]1)-U?V?O[KN62K,;5<DNR=UY;;4CU31101&H9L82Y5$75>R@<>^J6Q;
MC^]]DL]V( ^J@BFH.'ZD:OBI..[U/6.%[ +6\FMAD1NRY_HL1_DZ##V:])NK
MN?Y57R7AZ1^*O\V[:4F<.)KMX?$*CSNW6DJUI%ILR,[D>DZ6LH)I05ARCYKO
MW&QQ*A62>41*+LJ%81]U>7&WKFGE.Y$7B)'?%),5JM$N"#3RTVSD^0%3Z]##
MEJ_%IMNY1E]),.I<^>4J/G5U'SQU2-[F[H']6'?RFNLHNW?YD'P^V?.DDM/3
M=QX7?E1%$&8RTW4U'D>U:B*0*&/VTL.RV67Z?M%KD#D1[[K[D^T^W6[W:<3
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M8'=N#R-<DCT,<54<FD)45%-$Y ;GSSK[/<X<IW\HM[62]L@28YX4,G9Y>*J
ME& ^*HTUKI8C/4W[3S1M>YPKJD6*7%4<@&O]$FFH>E,^H'5E=?W]T1BL>V6R
M?=?4F-Q2)'*^3K^Q]G4>/2.73XI&K:C,QTRI+J&DEK-<6]QPFT;M))X4=K,S
M>@C<G]@7H^-Q JZF=0/6HI_AZ+9MW^9G\&-[]W;"^._7/R*V-VCVOV17Y>@V
MQA>L9ZS?N%D?!8+)[CR<U?O?;-)D=CXZ&'%XF9D$N1$D["T2/S827'MUSM9;
M-/O^X;=+;6ML%+M,!$PUL$6D<A5VRPX*:>=.B]-]VF6Z2R@G6222ND(=0P*F
MI6H&!YG/ET>[V"NC;K%/!!5034M5#%4TU3%)!44\\:303P3(8YH9H9 T<L4L
M;%65@0P-CQ[V"5(930CKW7R[/YC7Q0RGPN^8O<W1D]%/3;7QNY*C<W6-7(DO
MARO5N[)9<QLJIIYY7D-6^-QTQQM7(&8#(4%0GU0@=+_;GFJ/G'D^SWH-64H(
MYQYB:,!9*\*:OC _A8=0!O\ MK;5NLMK2B5U)_I&R/V</M'1'_8XZ)NAS^-W
MR-[8^)_<NS.]NE=PG;N_-DUYJ*1YXFJ\/FL94H:;,;9W+C!+"N6VWG\>[T]7
M!KC?0VN*2*=(I4(N9.7-IYKV>;8]YC\2"8>6&1AE71LT93D'(\B"I(*W;[^Y
MVRZ6\M&TNO["/-6'F#_LBAH>M[[X:_S\_A#\DMN8?']L[UQGQA[;%%$,_M?M
M&O\ X=L&>MC-/#55FUNTZF&GVK+B9)JA3'%EI<7D -?[$D<33G!SF_V,YVY<
MN'?;8&W.UKV20+JDH:T#P"K@XR5#+P[JFG4P;9SAM%^@$[BWDIE7-%_)S0'Y
M5H?EU;9B^_\ HC-XZ',87NOJ3+XFIC,M/E,7V1LZOQT\2WU2PUM)F9::6,6Y
M96(]Q1+L^[0R&&:UF1Q@JT;@C[05KT)5N(&74KJ1Z@BG^'HH'R$_FS_R_/C9
MA,GDMY_)3KO=F;QT):+874FX,3VEOK(59C66GQJX;:-=D*;"U57&ZLDF6J<=
M2A6#/,JD$B[8/:[GOF.9([';ID1_]%F1H8@*T)UR 5IZ+J/D 3T67O,&SV"D
MSW"$C\*D,WV:5K_.G6D)_-._FI]B_P Q[?N'I8L/5==]!=?5U94]<];-7M5U
M]9DJF)Z27?&^YZ>4XW(;NJ*%WA@C@4T^+I99((7D:2HJ*C-+VN]K;#V\LGED
M<7%_< "64"BJH-?#BJ*A:T))RQ ) H (FYCYCEWR4(@*0(:JIXD\-34Q7T],
M]5.>Y7Z#/2KV)LC='9F]MH==;(Q-1GMX[[W-@]H;5PE)I^YRNX=QY*FQ&'Q\
M)<JB/55]7&FIB%6]V( )]I-PO[7:[&;<KY]$-NC2.Q\D0%F/[!T[!!)<SI;P
MBKN0H'S)H.OJB?$GX_83XK?&GI3X]8!X*BCZKV#A=MUV0IX13Q9O<GB;(;OW
M&( !XGW+NRNK:]UY(>I-R3S[Y@<T;[/S-S#>;_<8:ZE9P*UTJ31$K_14!1\A
MUD/M]FEA9164?"-0OVD<3^9ST8GV0]+.O>_=>Z^<+_/J_P"WL/RL_P#*&?\
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M'K^0K_VZ>^*?_E<__@DNXO?/'WS_ .GI[I_U#?\ :);]3ER=_P JY;?\W/\
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M4>@VGMQ5CJHV_P MK("5=; W%PWS%SARURG!]1S!>1V^*A2:R,,_!&M7;@>
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M,*JJ!]+GFY]XFW=W<WUS)>WLC2S2L7=W)9F9C4LQ.22>I*CCCAC6*)0JJ
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MY?\ _I-/<_\ ]A7N9OZ_<B?]'JP_[++?_K9T$_W+O/\ RB3?\XG_ .@>O?\
M#>WSZ_[P>^7_ /Z33W/_ /85[]_7[D3_ */5A_V66_\ ULZ]^Y=Y_P"42;_G
M$_\ T#ULY?\ ";'X@=X]);X^5'9G>W1O:G3>0J=J=:;%V0_:W7FZ^OJ_/T>5
MR^ZL_O)<%2;LQ&)K*^CQT^W<,:F2)3$KS1+<L"%QI^\7S9LF]6NU[=L=]#>*
MK3R2>!*DH4@1K'J*,P!.IZ#CQZD#D3;;RT>YFO(7B)"*NM2I/Q%J @?+K;']
MXM=2+U[W[KW7O?NO=>]^Z]U7-_,:_EJ=)_S%^L(=L[Z+;-[1VG3U\G5G<6'Q
M\-9G=GUU6H>3&9:A>:D&Z-E9*IC1JW&23PL2ODIYZ:>TON0/;[W$WKV^W3ZN
MP_5MI2!/;L:)(H\P:'2XJ=+@&G AEJ"2[WL=IO=MX4_:ZUT.!E3_ )0?,?X#
M0]:&7S+_ )6OS'^$69S![0ZOR^X>N,?-,:#NCK^AR.Y^L\ACE=A!6Y#,4M&*
MC:%1*@YI<S#0SA@= D0!VSDY/]T>3^=(D&WW*PW+4K;RD)*&]%!-'^10GYT.
M.H?W7EO=-I8F:,O&/QJ"5IZGT_/^?5=ON1.B'KWOW7NE;LG8.^NS-PTFT>N-
ME;M[ W7D [4&V-D[<S&Z]PUJQZ?(:3"X*CK\E4B/4-6B)K7%_:.^W"PVRW-W
MN4\=O$,%Y76- 3PJSD#^?3L,$]R_A6Z-(WHH+']@KULR?R[O^$YG:._<YA.S
M?G?$_676U'/39&GZ.P^:CG[*WPL4S2?8;QS.!JI*/KW;E9$L?E2DJYL[+&\D
M6G&RJD_O&WW ^\-MUG ^V\BGZBX-0;EEI%'CC&CBLC#.64(* ]X-.A_LG(T\
MCBXWGL0?Z&#W-_IB. ^PU^SK="V;LW:G7>U-N[%V+MW#[1V;M'#T&W]L;8V_
M04^,PN"PN,ITI:#&XV@I4CIZ6DI:>,*JJ!]+GFY]X>W=W<WUS)>WLC2S2L7=
MW)9F9C4LQ.22>I1CCCAC6*)0JJ   *  < !UH6?SEO@'\L\]_,9^0N]NI/C+
MWYVGU]V%6[,WK@MV]9=-=C;XV[/4Y786V8-QT,N9VQMO*8I,G0;JH:Y)81,T
M@30[!2^D9R>SG/?*MO[>6%CNNY6UK<6_BQLDUQ#$U!*[(0KN#0JRT-.-1Y=0
M_P U[-N4F^33VT$DB2:6!1&8?" 02 16H/57W_#>WSZ_[P>^7_\ Z33W/_\
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MZ][]U[KWOW7NO>_=>Z][]U[J)7T%#E*.HQV3HJ3(X^LB:"KH:^FAJZ.JA?\
M5#44U0DD,\3?E64@^[*[(P="01P(P1^?6B 10]$SW?\ RW?@'ONOJ,KN?X<?
M'*MRE94FLK<E1]3;/PE?75;>8R5-=68+%XRIK9IFG8R-*SF1K%KE5(%UI[@\
M\V,8AM=WO%110+]1*5 ] "Q _+HMDV7:)F+RVL18\3H6I^TTZ8\/_*Y_ETX.
MK%;1?"WXZ3S+I 3,=8[;W#2>EU<7H,_1Y.A8ZEYO&;BX/!(]O2>Y/N!*NEMY
MO /E<2*?VJP/5!L.RJ:BTB_YQJ?\(Z.?M39NS]B8>#;VQ]J;;V;@*8WIL'M3
M!8O;N'ISI5;P8S$4M'11'2H'I0< >PA<75S=RF>[D:5SQ9V+,?M))/1FB)&N
MF,!1Z 4'\NE)[8ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]T#G9OQVZ [KB,/<71_47:J:/&O^D7KC9^\WB6X(,$NXL/D9:=T90R
MLC*RLH(((!]FNV[[O>S/XFT7D]J?6*62/_CC#I//:6ETNFYB20>C*&_P@]%C
MJ_Y57\N.MJ):J;X8= )+,076DV%C*"G!550>*CH%IJ2 67D(B@FY/))]B-?<
MSW!5=(WF[_.=R?VDD](#L.R'/TD7^\+_ )NE+M;^6Q_+^V95TU?M_P"&?QL@
MKZ*I2MHJ[(=0[+SU;15D4L,\%51U6?Q.3J*6IIIH$>)XV5HF%T*DF[%S[A<]
MW:&*XWB\96!!'U$H!!%""%8 @UR#QZNFR;/&P9+6($9!\-:@^HQT</![?P.V
M,;!AMM83$;>P]*"*7%8/&T>)QM,#:X@H:"&GI80;?V5'L)2S2SN99V+L>)8D
MD_:3T9JJJ-*B@^73O[;ZWU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7%T21&CD57C=61T=0R.C JRLK JRLIL0>"/?@:9'7NBB]A_ #X/]KY&?,]@_
M$OX^;ES=40:O/5756SJ;/U9$@F!J\[C\51Y:J/DN?W)FX9A]&8$4[?SQSEM4
M0@V[=;J&,<$6>30/L753^71?/M.UW+^)<6\;MZE%)_;3I 8_^5A_+EQE2M73
M?"_X^22H"H3(=>8;+4Q#6OJHLK#6T;GC@F,D?CVO?W+]P)%TMO-Y^4\@/[00
M>F1L.R U^DB_WA?\W1ONO^JNK^I\2F ZLZWV%UI@HHXXH\+U_L_;VS<3'%$H
M6*),;MW'8VC2.)0 JA+*!Q["E]N6X[G,;C<IY+B0FI:5VD8D\268D]&,4$-N
M@C@144< H '[!TO?:+IWKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[I#[\ZRZV[4PTVW.S^O=C]C[>J(IH*C [\VG@=WX:>&HC,51#-
MB]PT&1H98IXB5=60AE-C<>U=EN%_MLXN=NGDMY%((>-V1@1D$,I!%.FY889T
M,<Z!U."& (/V@]%!RO\ *U_ET9BK-95_"[X[PS,I4IBNM<!@J2QDDE-J#"4V
M/H5;5*1<1@A0%_2J@"R/W*]P(UTKO-X1\YY&/[68GHM.P[(<FTB_YQK_ )NI
MVW_Y8W\O';-4M9B_A=\;GJ$D65'S'5&TMR)'(BNB/%#N/'96&-D\A(TJ+.%;
M]2J12;W&Y^N%T2[S>4.,7$J_\=8=;78]F0U6UBJ/^%K_ )1T<S;FV-M;/Q--
M@-H[>P>UL%1+IH\+MS$T&$Q-(NE5TTV.QE/2T<"Z4 LJ#@#^GL(33SW,AFN'
M:1SQ9B6)^TFIZ,U54&E  /08Z?/;75NO>_=>Z][]U[KWOW7NO>_=>Z+IV7\0
M/BAW-6+DNV?C3T/V/E8S*8LQO3J;8NXLU"9Y(I:CP9G)X.HRD J9($,H251)
MI&JX'L^VWFKF;9E,>T[C<VRFE5BGD132M*JK &E33&.D=QMVWW9!NH(Y".!9
M%8C\R.@#;^5%_+?9BQ^&71%V))T[,I56Y-S95D"J/\  ![//]<WW"_Z/-W_S
MF?\ S])/W!LG_*)%_O"_YNA/V+\!/@_UG6TV4V+\1OCEMS+T:Q+29NCZ>V)+
MGJ;PE61H,[5X.IR\4FM%9F68,[*&8D@$%M]SOSEN<9AO]UNY4/%6N)2I_P!K
MJI_+I^':=KMVUP6T2-ZA%!_;2O1LJ:FIZ.GAI:2"&EI:>-(:>FIHD@IX(8U"
MQQ0PQ*L<4:*+!5  'T]A@DL=3&I/1A2F!UF]ZZ]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4:_S,_DGWGT[WQM+;/679.?V=
M@:[J/ YVKQF*^P^WGR]5O+?N/GKW^ZHZB3S2T>,IXS9@-,0XO>^6GL-R)RCS
M/RA<W^_V,=U,EY)&&?54((;=@O:PQ5V/Y]84_>/]R>>.3N>+7;.6=QDM()+&
M*5D18R#(UQ<H6[D8U*HHXTQT"/PJ^6WR/[$^3_4^S-[=M;FW%M?.9/.PY;#5
MW\-^TKHJ7:.X*^G2;P4$,MHJRECD%F'*#\>Q7[J^VW(VQ\@;CNNT[;%!<0K&
M4===5)FC4TJQ' D?GT#O9GW:]Q>8_<O:]EWO=9;BUG:821LL8#!;>9UJ50'#
M*#@^76QQ[P@ZZ#]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=:XO\ -^_[*5V/_P"(-VU_[WW9GO.'[M'_
M "HEW_SWR_\ :/:]<\?O:_\ 3Q[+_I6P_P#:5>=%V_E[?]EC=)?]K?<O_O#;
MH]C7WJ_Z=ANO^DB_[2(>@#]W[_I[^S?Z>?\ [19^ML/WSIZZF=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO= SV)\>.D>VLW2[C[)ZTVMO+.T6+@PE)E,W0FIJX,335==7P4$<@D2U/%69
M*>0"WZI6_K[$^R\Z<U\N6K6.Q7\UK"[ERD;4!<A5+$>M% _(=!+?N0^3>:+Q
M=PYBVVWO)T01J\L89@@9F"@GR!=C3U)Z9]H?%CX[[ W'B]W[,ZBV;MS<V%DF
MFQ6:QF.:"NH9:BEGHIWIY?,VAI:2IDC/'*N1[5;E[@\Z[Q8R;;NFYSSP2T#Q
MN]58 AA4?(@'\NDFU>VO(.Q[A'NNS[3;6US"24DCC"NI*E30CU#$'Y'H?O8.
MZ''7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5*G8_P#-
MDW5UUV#O?8.0Z#Q<M9LK=NX=K5$\G8%;3M4O@LK58W[L0_W/D"1U:TPE2S,I
M5P02+$Y3[']W.PWS9;3>8=Y8+=PQR@?3*:>(@;37QQPK0_,=8<\Q_>HW#ESF
M"^V"?859[*>6$DW;+J\-V0-3Z8T# 5&3@X)X]&G^%GSC;Y99K?F R.Q*/8F1
MVCB\)F*"*EW)+GSEZ*OJZ^BR<CB;#XAJ48V>.E *B0/]SSITC5'ONG[3?ZW-
MK9W<-X;Q+EI$8F(1Z&4*RC#O74"WI33YUQ)WLY[U?ZZMU?V<U@MC)9I$Z@3>
M+XBN75CF..FDJOK75Y4S8)[AKJ>.O>_=>Z*'\R?E.GQ1Z_V[N^#:T&\\IN3=
ML.VZ/!U&9;!HM*,3E,G790U<>/R<C+1M10Q:!%RU0"6%N9)]L/;YO<7>IML:
MX-K'!"96D">)G6B*FG4G'436OX>HH]WO<Y?:WE^#>!:B\DN)Q"L9D\+&AW9R
MVA^&@"E.+#JOS:?\W3=>\-U;:VEC>@,/_$=T;@PVW:"_8E:X^]S>1IL92W4;
M.4L//4KQ<7_K[F;<ONV;?MFW7&Y3[R^BWC>5O\67X8U+G_1_0=0/L_WK]PWG
M=[79[?8$$EW-%"I^L)HTKJ@_XC#S;J[_ -XH=9G]>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW5=WR>_F-]2_'_*5NS-O44W:/8M"9X,EAL/D
M8:# ;;K(CXS2;BW$8*T+DHY+ZZ2E@J)8RC+,T#%;S5R#[(<R<YVZ;I>,-OL7
MH5D=2TDJGSBBJO;_ $F*@UJNK-(!]R_O!\I\@7+[/9H=RW%*AHHV"QQ-_#-+
M1J-_05684[M-16L/<'\VKY,9.MDEPN'ZRVU0>1C3T=/MW*9.81&VA:JLRF?G
M$\JVY:.*!23^D>Y]LONW\B01!;N6ZG?S8R(@K\E6,4_,G[>L:K[[UWN+<3EK
M*WLK>.O:OA2.P'])FFR?F%7[.HV'_FS?*+'UD<^0H>L,]2AE\M#7;5R5(CQW
M(?QSXG<-!/%*5/I8EU# $JPN"Y<_=QY FB*0O=PMY,LJ'/S#Q,"/V?;TW:_>
ML]RH90]Q#93)454PR+4>="LPH?GFGH>'5E/QC_F7]7]YYS&[%WMAI>J]^Y>>
M.BPL=7DDRVTMQ5\ITP4%!G32T$V-RM8XM#35<*1R.5BCGEF=$:"N?O8CF#E&
MTDW?:Y1N-G&-3E5T31J.+-'5@RCS922!4E54$]9&>VOWC>5^>+V/9-VB.UW\
MITQJS^)!*QX*DNE*.?)74 DA59F('5EON">LB^O>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7N@6[Q^0/5OQWVF=V]F[A3&03&6+#86C5
M*W<FY*R((7HL!A_+%+6R1^5/+*S1TU.'4S2QJ0?8IY3Y-Y@YUW']V[! 9&%"
M[GMBB4_BD>A X&@RS4HH)Z!_.G/?+/(&U'=N9;@1(:A$'=+*P_#%'4%CD5.%
M6M6(&>J8^ROYP/9.1K:BGZFZVVIM?#B26.#(;TER.Y\[40 VAJ?M<96X+$XN
M=QRT+??HM["1K:CE%L7W9]DAB5^8[^:>6@JL 6*,'S&IUD9A\^P_(=8?<R?>
MWW^>=H^4]MAMX@31[DO-(P\CHC:)4/J*R#YGCT#:_P UGY7JRL:KKQPK E&V
M;97 -RK%,HCA6^AL0?Z$>Q.?N[>W9%*7(_YO#_H#H(C[T_N@#4BS/_-AO^MO
M1D>HOYP67&0I<?WEUMBY,9*RQ3[FZV>LI*NB%PHJ)]L;@R60BR"D'5*8LA3E
M;$I&UP@ W,OW9[?P6GY2OF\09$5UI(;Y"6-5I\JH?FPX]2'RE][><SI;\[[<
MGAG!FM"P*YP3!*S5'J1(#Z*>'5TO7_86S.T]I8G?.P-P4&YMKYN$S4&4Q[L4
M9D8QSTM3!*L=30U]',ICGIYDCFAD4JZJP(]XM;SLNZ<O[C)M.\PM;W$1HR,,
M^H((P01D,"01D$CK,78M^VCF;:H=[V*=;FUG%4=#@T-""#0A@11E(#*000".
MEG[*^C?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z3V[-V[9
MV+MW+;MWCG,;MO;6#I'K<MF<M4QTE#1TZE5!DED(URS2NL<4:!I)I65$5G95
M*W;MNO\ =[V/;=LB:>>8Z41 69C\@/3B3P J30#I!N>Y[=LUA+NF[3);V\*Z
MGDD8*J@>9)_8!Q)H!4GJFGN?^;[14-?68GH;KVGS=/ SQ0[R[">MI:&L='*F
M6AVCB:BBR344BC5')4U]-,01KIT((.3_ "M]VF::%;GG"],).3!;Z68#T:9P
MRU]0J,/1CUB%SC][2UMYGM.1K 7 6H%Q=%E0FO%8$*N5]"SHWJHZ*?-_-:^5
MLDLDB3]=4Z.Q98(=G.T40)X2,SY>>8JOXU.S?U)]R*OW=?;M5 /U34\S,*G]
MD8'\NHM;[U'N>S$A;):^0@>@_;,3_/H2^OOYOO<F(KH8^R.O]C;SPVM!/)M\
M97:&?56(621*J6LS^'G\:^I8_LHM37!D4$%2+>?NT<LW$);8KVXM9?(2Z)H_
MD*!8V'VZC]GJ(MA^]MS9;3A>8]NMKN'%3#XD$H]35FF4_(:5S^(>5ROQY^3_
M %1\F=MSYSKK+3+D<8(5W%M'-1PT6Z-NRU&H0&OH8IZF&>AJ3&WAJJ>2:FD*
ME=8D5T7%_G3D'F+D.^%GOD0T25\.9*M%*!QTL0""/-6 88-*$$Y?<@^Y/*WN
M/MK7_+LQUQT\6"0!9H2U::U!(H:&C*64T(!J" 8?V"^A]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5J?,CY_9/XJ]G8+KVBZPH=ZQ9G8>,
MWFV5JMV5&"DIY,CN#=&#./%)%M_*K(D2[=$GD\BDF4KI&FYG;VP]FH/</8)M
MZDW!K0Q7#P:!")*Z8XI-6HR)Q\2E*>7'/6.?N][\S^UW,L'+\>UK>B:V2XUF
MX,5-<LT>C2(9*T\*M:^=*8R&_P =/YG>8[V[HV-U/4=.XW;4.\:S)TLF<AWM
M5966@&/P.5S0=*"3;% E096QHCL9DTA]7-K$[YW]@[?E#E:[YC3=&N#:A#X9
M@"!M4B1_%XK4IJKP/"G0?]O/O*W'/7.-ERH^SK;"[,@\47)D*Z(I)?@\!*UT
M4^(<:_+JW/WC=UE9U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=4N=I_S9,UUQV=V-U[%TAB\M%L/?F[]F1Y63?M71R9./:^X,C@TR#TB[3J5
MI7K%H1(8Q)($+:=36N<I>7ONY6V^;!8[TV[-&;RWAG*?3AM/BQK)IU>,*TU4
MK05]!UAWS/\ >IN>7>9=PY?79%E%C<SVX?ZLKK\&5X]>GZ=J:M-:5-*TJ>CQ
M?&OY9X;NOH?/=Z[UQ^'ZQP>V<[G\7FQ/GSE,?C:+!T>+K&KJG(38_&R":H7)
MJ$@$)=F**FIG4>XEYZ]N;KE7F^+E':W>_FGCC:.D>AF:0L-(4,_#3QK3C6E.
MIM]NO=&SYTY'EYWW:./;8())5D#2ZU18@I+,Y1.(;A2O"E:]5V=V?S>LFF6K
ML/T'L3$OB:6H:&#>F_UR%1-EHT(#5./VICJG%-BX'928GJJN:1XV!>")[H)L
MY4^[5"ULEUSC>.)&%3!;Z1H/HTS!]1]0J@ \&89ZQ\YT^]G,EU)9\B6*/$IH
M+FZUG6!Q*0(8RH/D6>I'%%..BV0_S6OE;'+'(\_750B,&:";9SK%* >4D,&7
M@F"M^=+JW]"/8Z;[NOMVRD#ZI:^8F%1^V,C^74=K]ZCW/5@2MDU/(P/0_LF!
M_GT>[XT?S5=L]BY_%[([PVWB^N\UEYJ>BQV],+6U#;(J,E/:-*?+T65EGR.U
MH)I[+'.]770 O^\\**9#$7/GW>=PV.SDW;E2=KZ*,%F@=1XX49JA0!9"!Q 5
M#CM#$T$X>V_WG]KYDOHMDYRMTVZXE*JEQ&Q-LSG%'#]T53\)+2+GN9:5-O (
M(!!!! ((-P0>001P01[QKZRNZ[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO= !W_ /)GJ7XV;<CSW9.=:&MKTG_N_M3$)#7[KW)+3@&5
M<5BWGIU6FB9E62JJ)(*.%G57E5G16&7)O(?,?/5\;/8H:JE/$F>JPQ \-;T.
M3Y*H+&AHI /0%Y[]QN5?;K;1N',<^EGKX4*4:>8KQ$:5&!4 LQ5%)&IA45IL
M[#_F_P#;.4K)X>LNN=E[0Q.N=(*G=$F4W;G9(O6E/4:J2JV]B:*5E(=HC!5*
MC^GR.H);)[9?NS\NV\0;?[Z>YDQ40A(8P?,=PE8CRK5:C-!Y8@\P?>WYFN)B
MG+.VV]K$"0&G+SR$?A-$:%5/F11P#BI&2%*?S6?E<CH[5/7<JJZLT3[-(20*
M02CF+*QR!' L=+*UOH0>?8B/W=O;L@@"Y'S\88_:AZ# ^]/[H @D69^7@-_D
MEZ,SU!_.!K7KJ/&]Y];8^.AF=8JC=77$M9"]%JG1%GJ-J9VMR#U4,<#%YFAR
M*O=#XX6U!% ?,WW9XUB>?E*^8N,B&Y"G5C@)HU6AK@ I3.6%*F1^4?O;,\R6
MW.^W*J-AI[0M1:L "8)&8T -6*R$X[4-:"YW8'8.S.TMJ8G?&P-PX_=&ULW"
M9L?EL;(S1N5.B>FJ8)4BJJ"OI)08YZ:=(YX) 4D16!'O%S>-FW3E_<9-IWF!
MK>XB-&1AGY$$5!!&0P)!&02.LPMCWW:.9=KBWK8KA+FUG%4D0U!\B"#0A@<,
MK ,I!! (ITLO99T;=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW09]L]P==]'[/K-\]E[DI-N8&E<4\+2AYZ_*Y"2.22GQ.%QL"O693)U*Q,5
MBB4Z45I'*1H[J?<N<M;WS9N:[1L,#3S-DTPJ*.+NQPJBO$GC0"I(!#O-'->P
M<F;2^]\QW*VUNF 34L[$$A(T%69C0T !- 2: $BECM'^<)O2LKJBEZ;ZRV_@
M\2DY6#,]A35N=S-;2Z;K-_!,#D<1C<+5&0@%#5Y) H/JNWIRFY?^[-M<<0DY
MHW"260C*6P6-%/IXDBNSC_:(?V9PWYG^]QNLLS1<G;9'#$#B2[+2.RT_WU$Z
M*AK_ ,,D%/MP!*_S6?E>K*QJNO'"L"4;9ME< W*L4RB.%;Z&Q!_H1[%Q^[M[
M=D4I<C_F\/\ H#H%#[T_N@#4BS/_ #8;_K;T:3I?^;\]17TF)[[Z^H:&CG<1
M2[PZY^^,5%JD")-7;2S-=D*J:G2-M4TE-7M(-)\=.UP@C_FG[M/APM<\G7K.
MPR(;G35L<%F15%?0,@'JPX]29R;][1)9DM.>K!8E8T-Q::BJU."T$C,U /B*
MR,<80UH+HMH[OVQOW;>(W?LW.8_<>V<]2+6XG,XN=:BCK*=F9"486:.6&5&C
MEC<+)%*K(ZJZD#%O<MMO]HOI-MW.)H)X3I='%&4_[/$$8(H02#UF)M>Z;=O6
MWQ;KM,R7%O.NI)$.I6!]"/V$<0:@T(Z4?M#TOZ][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NM6S^9EL4[*^6N]*Q(A#1;]PVV=]4"!0H(K<=_
M <G+< !C/N#;M8Y/]6YN??0/V%W?]Z>V]K$35K.26W;_ &K>(O[$E4=<ROO*
M;)^Y_=:[G&%OXH;E1]J>"W[7A8_GU-_E@[X&S_EGM?&2R^&D[ VWNK950[-I
MB\CX\;GQRN+C4U1E=LP0IP3KE'T%R&O?[:?WG[<SW"BK64L,X]::O":GV+*2
M?D.G_NR[T-I]U+>T<T7<()[<^@.D3K7[3 %'S/6T-[P!ZZ7=>]^Z]U0%_.*W
MN*[L/J'KN&=BNV]HYO=M9 C.(C4;NRT6*I#. ?')/!!M!RE[M&DQM82<YD?=
MCVGPMFW/>V7^WFCA4^=(4+M3Y$S"OJ1\NL$?O=[T)M\VCEY&/^+P2W#+FE9W
M$:$^1($#4\P"?7HH_P#+NV&=^?+;JZ.6G$^.VC4Y3?F28J'^W&U\94U6&J K
M BXW1)0*#P5U:AR #)/O;O V?VWW JU'N0ENGS\5P''_ #C#_P"#J*/N];&=
M\]U]MU*&CL_$N7KY>$A\,CYB5H_LX\1UM:^^=W747KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NB._S ?D-D?CYT+D*[:]6M'OS?>079FTZH7:?$FK
MI:BIS>X8%! $^)Q4#K3N3:.LG@8JR@J98]F^2H.=.<$@OUU6=HOCS#R<*0$C
M/R9B*CS4,,'/4+^^_/\ <<@<B2W6VOHOKUA;V[<2A8$R2CYH@.D\ Y6H(QUJ
MJRRRSRR33223332/+++*[22RRR,7DDDD<EGD=B22222??0]55%"(* 8 &  .
M  ZY<N[R.9)"69B2234DG)))XD]6=='_ ,K'NGM+;-!N[>>X<-U-B\S20UV(
MQ>8QE=FMV34M0AD@J<E@89\7!AHJB(HR1S5?W0#'R0QD & >;/O"\K<OW[[;
MM4#[E)$Q5W1UCA!&"$D(<O0UJ0NGT8]9,\E?=>YPYEVU-UWNYCVE)E#1QO&T
ML]#D&2,-&$J*$ L7%:,JD4ZY]X?RL.Y.K-IY+>6SMRX;M;'82EEKLOB,3BJ_
M";JCH:=!+4U>-PTU1E*?+I2QJ[O%%5"I95_;BD8Z1KE/[PO+',&XQ[9NEN^W
M/*0J.[K)#J. '<!"M< $KI]2!GK?.OW7N;>6MJDW?9;I-U2%2TD:1M%/I&28
MXRT@>@J2H8,:=JL33JK]696#*2K*0RLI(96!N"".00?<_D BAR#UC("5(930
MCK:=_EV]_93O?X_T']Z*V7(;VZZR+;)W%D*AWDJLQ2TU+!5[>SE5)(TDDM56
M8F=8)Y78O/54LLIMKM[Y[>]?)MORASFXV]-%I>KX\2C@A)(DC'"@# E1Y*RC
MRZZ@>P'/=USSR#')N;F2]L'-M,QXR:5#12&I))9& 8GXG5CY]'R]Q#U-_7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=0LED:'#X[(9?)U,=%C<7156
M1R%9,2(:2AH8)*FKJ92H8B."GB9FL";#V[!#+<S);P*6>1@J@<2S&@ ^TGIJ
M>:*VA>XG8*D:EF8\ JBI)^P#K3_^3O?VXOD?VYN+L+,S5,6):>3%[,P<SWBV
M[M*CGE_A6/CB#-&E5.KM4U;*2)*N:1AZ=('2[D#DVRY&Y:@V6V ,M-<\@XR3
M,!K:OH/A7T4#SKUR5]SN?;_W%YLN-^NF80 E+:,\(H%)T+3^(_$Y\V)\J 8.
M@OC3VS\D]Q56W^LL'!4PXM89,_N3,5+8W;&W8JH3FD;+9%8:F<S5C4[K%!30
MU%3)I9EC*([*YSESYRYR+9+>;]*5,E?#B0:I9"*5T+4"@KDL54<*U(!;Y"]M
MN:_<>_>RY;A!6*GBS2-HABJ#IUL QJ:4"JK,>-* D6"UG\G;MR/%//0]L==U
M6:6'4N-J*#<E'CGG"DF$9=**KJ%C+<!S1_ZZCW"\7WF^7&N0DVVW*Q5^(-$S
M4]=%5'Y:_P ^I^F^Z)S,MH7M]WMGGIA&CE5"?3Q!J-/GH_+JM3N+I7L?H;>-
M3L;LS;\V#S442U='*LB5>*S.-D=XX,KA<E 33Y"@F:-EU*0\;JT<BI(K()WY
M8YKV/G#:UW;89A+$31A2CHWFCJ<J1^PC()!!ZQOYQY*YBY$W=MEYD@,,H&I6
M!U1R)6@>-QAE/Y$'# ''1OOY;WR0RO3?=^&V%E,C*>NNVLI1;;RM!/._V6*W
M57$46V-QTL37BIZF7(/%0U;WC5Z2;7(6^WB"QG[Y\C6_,_*DN\VZ#Z[;4:5&
M [GA7NEC8\2 M77C1A0?&>I;^[I[BW7*/.<7+UU(?W=NSK$ZDG3'.W;#*HR
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M;)[<[K?V;%9/"6,$<0)Y8X&(]"!(:'B#D9Z@[V0V:SW[W5V;;K]=<7BO*5/
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M\0U(?>]+,R"WUJ(C&&)/^ZEM^?>+_P!Z&WCT[+= =_\ C2$^H_0(_8:_MZS
M^Y]<RG]_V9-4'T;@>C'ZE2?S '[!U>=[Q*ZS8Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[JO?^9]NJIVW\1]VT5+)+#)O#<FT-JR21,%84TF67/U<
M;,75A%4TV >)PMRR2%2-))$S^P>WQWWN3:RR $6T<TM#ZA#&I_(R CYCUZ@;
M[R>YR;=[3WL<1*FZD@AJ,8,H=A]A6,J?4&G"O6KO[Z ]<R.MP?XF];8[JCXZ
M]2;0H*:.FG79F&SF=91ZZK<VY*.+.[@J)7(UR?[DZ^1(RW*PHB"P4 <S/<7?
M9^8^=MRW.9BP,[I'\HHV,<8'^U45^9)\^NN?MARY!RIR#M6S0J%9+>-Y*><T
MJB29OS=C3T%!P'1B?8*Z'O57_P#-?ZTQ.Z/CE!V$]+&N?ZPW3AJFDR*PAJC^
M![KKJ;;66Q32@7CI:K(UE!4&_P#NRE0#]1O/WW==]N=OYX.RACX.X1.&6N-<
M*F5'IZA5=?L8]8U?>DY<M-T]NOW\ZCQ]LFC97IGPYW6&1*^2DLC'YH.M;.*6
M6"6.:&22&:&1)8I8G:.6*6-@\<D<B$,DB, 00001[SI95=2CBH."#D$'B".N
M<R.\;B2,E64@@@T((R"".!'6ZGU?NG^_/6G7>]M0?^^&Q=I;IUA&C#_W@P&/
MRVH1ND;H&^[O8JI'Y ^GOE=OVWG:-]O=J(I]+/-%Z_V<C)Q%?3KLKR[N:[WR
M_8;RAJMW;PS T(J)8U<&A _B]!TN?93T<]>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=)W=^1J,1M/=&6I"!58O;N;R-,3>PJ*+&U-3"38@V$D0^GM9MT*7.
MX06\GPR2(I^QF /^'I'N,SVVWSW$?Q1QNP^U5)'^#K229F9BS$LS$LS,269B
M;DDGDDGWU;  %!@#KBX26)9C4GK91_E-[3Q.&^,]=N6EBC;+[RW_ +@J,M5:
M%$_@P<5%AL9CS("2]-2+#-.@-M+U<G];^\%/O&;C<W7/JV,A_3M;>,(/*LFJ
M1FIZFH!^2CKH[]UG:;2R]M#N,0K+>W,S2'S_ $Z1(M?0!21\V/5GWN ^LDNJ
M@_YP^U<94].=7;V>"+^,X7LP[5IJK2!,,9NC:V?R]= 7 NT1JMH4[ $\$&WU
M/O);[LNX7$?-&X;4&/A2VOBD>6N*:-%/[)FZQ-^]SMMM)R;MF[LH\:&]\%6\
MPDT$KN/L)@4_EU1?U#G9MK]L=8[EIVE2;;_86S,U&T/,H;&;CQU: @\D.ICX
M;6UJ#]+CZ^\MN9[1;_EO<+%Z$36TZ9X=T3#T/KZ=82\FWK;=S?M6X(2#!>6S
MXX]LR-C(]/7K=,]\L^NQG7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]T0K^95L0;W^)._*B*F2IR&QLCMW?>.# %H3B\G'C,Q4QL?T/!MG-5Q
MO]2MU_/N7_8K=_W3[D6:,VE+M9+=OGK4L@/VR(G^'J#_ +Q6Q?OOVIW!D0/)
M9&*Z2OX?#<+(P]"(GD_*H\^M63WT)ZY?];B/Q5WT.R?CCTQO%IEJ*K([ P-'
ME)EOIDSF!IAM[/, 68C_ '-8J<6))'T]\R/<+:/W%SONFU@:5CN)"@](Y#XD
M?_&''77?VSWS^L?M_L^\LP9YK6(.1P\5%\.7U_&C=#7G,Q1;>PN8S^2D$..P
M>+R&8KY25 BHL9235M5(2Q50$@@8W) X]A6UMI;RZCM(!5Y65%'JS$*!^T]#
M&[N8K*UEO)S2.)&=CZ*H+$_L'6D_N?/UVZ]R[AW3DR&R6Y<YEL_D&!N&KLS7
MU&1JR#87!GJ6_'OJKM]E%MNWP;=!\%O&D:_Z5%"C^0ZXS[MN,V[[I<[M<_VE
MU+),W^FD<NW\VZV6_P"5KL0;1^*>&SDD+1UG8N[=T;OF,B@2_;4U7%M''J/[
M0IWIML":,'C]\L.&]X(_>!W?]Y^XDMJIJMC#%"*<*D&9OSK+0_93RZZ/?=FV
M,;1[66]XRE7W"::X:O&@;P$I\BL(8?;7SZL9]PCUD%U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW0'=I?&SH_NO+8[.=I=>XK>&6Q&..)QU;D*O,4\
ME+CS4S5AI47'9*BB*&IG=[LI:[?6UO8KY?YXYKY5MWM>7[U[6.5M;*H0U:@%
M3J4^0Z!O,OM]R9SC<QW?,VWQWDD*Z$9]=54G40-+#S->F#8/Q$^.'5^[,3OK
M875>$VWNS!_??PG-4==GIJBB_B>-K,/7>..MRU53-]QC<A-$=2-99"18V(6[
MQ[D<\;_MTFT[QN,D]M+IUHP0!M+*ZUH@.&4'CY=(-C]J_;WEO=(MZV/:H;:Z
MAU:)%UZEUHT;4JY&58CAP/1D/8'ZD'I,;RWIM3KW;>4W?O;/8S;6VL+3M4Y'
M+Y:JCI*2!!PD8:0@S5-0Y"10H&EFD8(BLQ *_;-KW#>;Z/;=JA:>>4T5$!+$
M_EY#B2< 9)IT7;KNVV;%M\NZ[Q.EM;PC4\DC!54?:?,\ .).!4]:>_R![(I^
MW^[.SNRJ*GDI<=N[=^6R>)IYD"5$>&$WVN&%4@9E2L;%T\)F ) E+6X]],N2
M]BDY9Y4L-BF;5);0HKD<-=-3T^6HFGRIUR1]P>9(N;^=MSYD@73%=3NT8.#X
M8HD>H>I103\Z]6,_R=_^9S=J?^(QB_\ >JPON#_O-_\ *L[=_P ]1_ZM/UD/
M]T3_ )6K=O\ GD3_ *O+UL+>\+NL^.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z()_,V_[(Y['_[6^P?_ 'N<![F+V%_Z>?8?Z2X_[1Y>H+^\C_TZ
M#<_]/:_]I4/6K5[Z#=<P^MP?XC?]DO?'_P#\1)L7_P!Y^B]\S/<C_E?]Y_Y[
M+C_JZW77+VK_ .G:;!_SP6O_ %93HQ/L%=#[HKGS*Z;W;WY\?MW=8;(FPU/N
M/.5^UZFCES]944&+6/#;EQ>7J_/4TE%D)T9J6B<(!$UW(!L.1('MAS/MW)W.
M=MS!NH=H(5E#"-0S]\3H*!F4<6%<\.HT]W>4-TYZY"O.6-F:-;BX:$J9694'
MASQR-4JKG@II@YI]O5*/_#2?RA_YW'4G_H5[@_\ L.]Y4_\ !(<@?[ZO/^<,
M7_6_K#3_ (%#W+_Y2+#_ )SS?]LW6P]UQ@*[:G7NP]KY-J=LEMO9FU\!D&I)
M'EI6KL/@Z''5;4TKQPO)3FHIFT,44E;$@?3WA3O5Y%N&\W=_!4)/-+(M<'2[
MLPJ*G-#GKH#L5E-MNR6>W7%#);P11MI-1J2-5-"0,5&,#I9^RSHUZ][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z:-P?\6'-_]JC)?^X<WM1:?[E1?Z=?\(Z3
MW?\ N++_ *1O\!ZTAO?6#KBOUL1_R>_^9$=E?^);JO\ WCMI^\)OO,_\KA8_
M\\:_]7YNN@WW2/\ E0]P_P">]_\ M'M^K;?>.'6574#*TTE;B\E1PZ?+5T%9
M31:R53R3T\D2:B 2%U,+FQX]NP.(YTD;@K G\C7IJ=#) \:\64@?F*=:WO\
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MUBN8TE7_ $KJ&'YYS\^N-&][3=;#O-WLEZ*36DTD+X([HW*$BOD:5'RZM?\
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MM?\ M*AZU:O?0;KF'UN#_$;_ +)>^/\ _P"(DV+_ .\_1>^9GN1_RO\ O/\
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ML_[Z=\@_\J)LO_/!9_\ :/'UR%]R_P#IX_,'_2ROO^TJ7JS_ /DT?\7[O_\
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M:7D:RQ2 JR. RLIXAE-01U&UG>7>W74=]82M#-$P9'1BKJPX%6!!!^SK8J^
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M9ZB>5FDFFD9Y9I7:21F=F8\X-SW._P!YOY=TW25IKB9BSNQJ23_@ X # %
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MFU3^?7'GG+?/ZS<V;ES *Z;RYFE4$4(1Y&,:G[%H/RSGJS+^3O\ \SF[4_\
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MZRZZ0O:&YL=LOK;?^[LM*D.-VULS<V<K7=M ,&,PU95O&IY)DF\6A% +,[
M$D#V;;#83[IO=GMML*R3S11K]KNJC_#T3\P[E;;/L-[NUVVF*V@EE8G^%$9C
M_@ZTJ??5+KC/UL\_RL\+/B_B1M^NE618]Q[SWMFJ8N %>"#*+MYFA(_5&*G
MR D_VPP_'O 3[P5TMQ[DSQ+Q@A@0_:4\3/Y2#KIA]V6T:V]IK69JTN)[F0?8
M)3%C\XS^?5B_N$NL@.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUQ
M?YOW_92NQ_\ Q!NVO_>^[,]YP_=H_P"5$N_^>^7_ +1[7KGC][7_ *>/9?\
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M*2PR%3_@?;D,LD$JSQ'2R$,#Z$&H/[>FYHH[B%H)AJ1P58>H(H1^P]:;W?\
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G=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>timage_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M_G1?^M.L_P#JCW[6>O:!U[_1;L3_ )T7_K3K/_JCW[6>O:!U[_1;L3_G1?\
MK3K/_JCW[6>O:!U[_1;L3_G1?^M.L_\ JCW[6>O:!U[_ $6[$_YT7_K3K/\
MZH]^UGKV@=>_T6[$_P"=%_ZTZS_ZH]^UGKV@=>_T6[$_YT7_ *TZS_ZH]^UG
MKV@=>_T6[$_YT7_K3K/_ *H]^UGKV@=>_P!%NQ/^=%_ZTZS_ .J/?M9Z]H'7
MO]%NQ/\ G1?^M.L_^J/?M9Z]H'7O]%NQ/^=%_P"M.L_^J/?M9Z]H'7O]%NQ/
M^=%_ZTZS_P"J/?M9Z]H'7O\ 1;L3_G1?^M.L_P#JCW[6>O:!U[_1;L3_ )T7
M_K3K/_JCW[6>O:!U[_1;L3_G1?\ K3K/_JCW[6>O:!U[_1;L3_G1?^M.L_\
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M[$_YT7_K3K/_ *H]^UGKV@=>_P!%NQ/^=%_ZTZS_ .J/?M9Z]H'7O]%NQ/\
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB__P#-=O\
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MZ*3=F/>:A;144[5%'+*L553R K+#)IEB;TR(IX]^Z]T6;X1_S-_@_P#S&O\
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M")0AB8.?=>ZM0FS>%IL++N2HR^+I]O4^+DS<^>FKXHJ)***(SM6/5,X@6E6
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MP+<WRV^9G67RY[=_TRU2[[V9V%AYZ#'5>R-W;GV;0SHM1@3N:H\N-P\'W/\
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M=@/L2K@Q\N3.QUZ[7%>>>2"695HAFLGH6.1 3.6<,R1E/=>Z$!/Y'7\ZGJ+
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M;>&Z&@$YIO,-O_Q'^+&+[E6BUBDT^4&.^H6]^Z]T/'OW7N@)WK\I/C+UMOK
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M],;-FS5:^1JOX/U3W3L+ 8E)YI"S2/%CL=3)<GZ* +  >_=>Z+O\&?@]U?\
MS%?^%#'\TWXV_(.NW9D_CQMSY'?-?Y%]B=6;>W;7;.IMU5W6G:]9MO!4F2JL
M9)3UZP4,V^:NI!IZNFF&EE2=0[!O=>ZW+?F;L[^4S\$?Y?N/ZF^5NP^K>O\
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MW/OK9ZXS#9>EKJW!>&OCS<N9R>85Y8YTGI:##RT,$T#SU33>Z]T"WS3^0?\
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MM)]W7@>J-Q'0@>Z=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM#/^>[_P!Q/?\
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MP_\ CW?X_P#W4_X]3_(?^+%_TT_\#/\ */?NO=)?^9SU#_PF#Z9^5_;W9/\
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MNO=:5O\ LJWR?_Z#$O\ 9G/]EP[Z_P!EL_[R$_T0;A_N/_V2Y_=__C[/X=_
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MQCUL<]-3MM>A>KD--!)/1B?S)[KW1X_^$Y?\I_>_\OKX2=DT'R:VOB<;W?\
M+'<4.X>T-BF*FJI\1MO#X^;&8/;.4KJ6:=:VIB2NS59,L<_BIGR<E*B^2*::
M;W7NM-.L^,G>..^:V_\ _A.?BER&-ZHWM_,\V;VS19O%YV1:ZDVMBMO98/DI
MUFIZB*N\O6V1Q&9'E0B"JQ@UQ532(U/[KW7T@?G7\*=L?+GX!=X_"#!C;^SL
M-O[IZ'K[KV7(XG^(XW"UVSOM*O:M0U*A5OM\3E,7BY5\9#QB%7C]:*/?NO=:
M/_PW[_\ BS_*;Z;R/Q5_G+?R,DWGOGI_=VYZ/$_*"C^'77G<DFX:+=63J,C
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M?SW?^XGO^37_ .8\?_@A-W^_=>ZOF_X4W_\ ;C[YM_\ EMO_ +]W8/OW7NJ
M*+X^_)7Y)?\ ".KXV;&^,N#SF\LY@^Q^S.PNR^N]KXHYO*;@VELGN'LFKK:+
M'4J2+/45-!E?X-E?%!%//-'CI(88)))%M[KW6;XP?S0]F]L?RD\Y_*R^#O\
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M7^(97;%-3I5R"&MRJ[KSU3GIJRAB>@Q\<,-&DTU8J54WNO=(;^>[_P!Q/?\
M)K_\QX__  0F[_?NO=>_GN_]Q/?\FO\ \QX__!";O]^Z]U[_ (6X_P#=,K_R
M\_\ ^9/[]U[K;9_FH_\ ;L+^8]_XH9\O_P#WWNX??NO=:H7_  GM^)\?SD_X
M3N_S$/BFM1AZ+*=Q?*3N3"[3R&?I/OJ.ES^&V%U1EMNUE0@.H1T>>Q^.F,BW
M>(QB5 710?=>Z1O\IC^<=V7_ ">^F<9_+#^?GP2^8$O9>P=]]@+\?L5TQUK1
M[IRF6I=UU]1GLEBQ1Y+.8RGS"TV:R.1J8<CA*JMIY:6JC7P:H#457NO=%_\
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M*83%[LV7B?Y8O4^X7PS9K4RR5D.&DRN>T+"CRJ@V]YYHDD,4+LH5O=>Z!?\
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M7R\_X3N5/7WRIKL(U%F-@;'_ );G5=?2Y7*8.G+5\^*I]PIMG.I3OI$\D/\
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MZ":OI\=0XC;N#QF,QD+9*>LJ(Y:B>N2!XHFJO=>ZVPO?NO=!_O#_ (OVPO\
MPX)?^M)]W7@>J-Q'0@>Z=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[IORW_%JR?_:OK?\
MK6WO8X]:/#I/[ _X\W;W_:O3_H9O>WX]:3ATL/=>K=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]T7_\ YKM_OO\ G3^W/P_ZO7IO\7^KTZ$#JW_CQ,%_Y$__ ',J/=7X]63A
MT('NO5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[H/]@?\QK_ .) W)_UQ]V;R^SJJ^?V]"![KU;KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7N@_R/_,Q]N?^&_E_^AU]W'P]4/Q="![IU?KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
M@_[2_P"/$SO_ )#/_<RG]V3CU5^'0@>Z]6Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7N@_V?\ \7[?O_AP1?\ 6D>[MP'5%XGH0/=.K]>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T
M'^\/^+]L+_PX)?\ K2?=UX'JC<1T('NG5^O>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z;\M_
MQ:LG_P!J^M_ZUM[V./6CPZ3^P/\ CS=O?]J]/^AF][?CUI.'2P]UZMU[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW1?\ _FNW^^_YT_MS\/\ J]>F_P 7^KTZ$#JW_CQ,%_Y$
M_P#W,J/=7X]63AT('NO5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[H/]@?\ ,:_^) W)_P!<?=F\OLZJOG]O0@>Z]6Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[H/\ (_\ ,Q]N?^&_E_\ H=?=Q\/5#\70@>Z=7Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[H/^TO^/$SO_D,_P#<RG]V3CU5^'0@>Z]6Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7N@_V?_P 7[?O_ (<$7_6D>[MP'5%XGH0/=.K]>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]T'^\/\ B_;"_P##@E_ZTGW=>!ZHW$="![IU?KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NF_+?\6K)_]J^M_P"M;>]CCUH\.D_L#_CS=O?]J]/^AF][
M?CUI.'2P]UZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1?_P#FNW^^_P"=/[<_#_J]>F_Q
M?ZO3H0.K?^/$P7_D3_\ <RH]U?CU9.'0@>Z]6Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@_V!_S&O\ XD#<G_7'W9O+
M[.JKY_;T('NO5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#_(_\S'VY_X;^7_Z'7W<?#U0
M_%T('NG5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#_M+_ (\3._\ D,_]S*?W9./57X="
M![KU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#_9_P#Q?M^_^'!%_P!:1[NW =47
MB>A ]TZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0?[P_XOVPO_#@E_P"M)]W7@>J-Q'0@
M>Z=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[IORW_%JR?_ &KZW_K6WO8X]:/#I/[ _P"/
M-V]_VKT_Z&;WM^/6DX=+#W7JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%_P#^:[?[[_G3
M^W/P_P"KUZ;_ !?ZO3H0.K?^/$P7_D3_ /<RH]U?CU9.'0@>Z]6Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@_V!_P Q
MK_XD#<G_ %Q]V;R^SJJ^?V]"![KU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@_P C_P S
M'VY_X;^7_P"AU]W'P]4/Q="![IU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@_[2_X\3._
M^0S_ -S*?W9./57X="![KU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#_9__ !?M
M^_\ AP1?]:1[NW =47B>A ]TZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0?[P_P"+]L+_
M ,."7_K2?=UX'JC<1T('NG5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z;\M_Q:LG_VKZW_
M *UM[V./6CPZ3^P/^/-V]_VKT_Z&;WM^/6DX=+#W7JW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=%__ .:[?[[_ )T_MS\/^KUZ;_%_J].A ZM_X\3!?^1/_P!S*CW5^/5D
MX="![KU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z#_8'_,:_P#B0-R?]<?=F\OLZJOG]O0@>Z]6Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[H/\C_S,?;G_AOY?_H=?=Q\/5#\70@>Z=7Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[H/^TO\ CQ,[_P"0S_W,I_=DX]5?AT('NO5NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[H/]G_ /%^W[_X<$7_ %I'N[<!U1>)Z$#W3J_7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=!_O#_B_;"_\."7_ *TGW=>!ZHW$="![IU?KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NF_+
M?\6K)_\ :OK?^M;>]CCUH\.D_L#_ (\W;W_:O3_H9O>WX]:3ATL/=>K=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]T7_ /YKM_OO^=/[<_#_ *O7IO\ %_J].A ZM_X\3!?^
M1/\ ]S*CW5^/5DX="![KU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z#_8'_ #&O_B0-R?\ 7'W9O+[.JKY_;T('NO5N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z#_ "/_ #,?;G_AOY?_ *'7W<?#U0_%T('NG5^O
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z#_M+_CQ,[_Y#/\ W,I_=DX]5?AT('NO5NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[H/]G_\ %^W[_P"'!%_UI'N[<!U1>)Z$#W3J_7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=!_O#_ (OVPO\ PX)?^M)]W7@>J-Q'0@>Z=7Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[IORW_%JR?_:OK?\ K6WO8X]:/#I/[ _X\W;W_:O3_H9O
M>WX]:3ATL/=>K=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T7_\ YKM_OO\ G3^W/P_ZO7IO
M\7^KTZ #^\>1H/\ )(&(BB_2/NJF/_.>H^F.=$')/T4?X\W/N1]BY7MMQM4F
MD+ZFU5HP P[+_"?(=1CS!S;=;9=R01B/2NFFI23W(K'@P\SU[^]^6_U9_P#.
MZL_^JO9M_4FS]9/]Z'_0/1-_7R]](O\ >6_Z#Z]_>_+?ZL_^=U9_]5>_?U)L
M_63_ 'H?] ]>_KY>^D7^\M_T'U[^]^6_U9_\[JS_ .JO?OZDV?K)_O0_Z!Z]
M_7R]](O]Y;_H/KW][\M_JS_YW5G_ -5>_?U)L_63_>A_T#U[^OE[Z1?[RW_0
M?7O[WY;_ %9_\[JS_P"JO?OZDV?K)_O0_P"@>O?U\O?2+_>6_P"@^O?WORW^
MK/\ YW5G_P!5>_?U)L_63_>A_P! ]>_KY>^D7^\M_P!!]>_O?EO]6?\ SNK/
M_JKW[^I-GZR?[T/^@>O?U\O?2+_>6_Z#Z]_>_+?ZL_\ G=6?_57OW]2;/UD_
MWH?] ]>_KY>^D7^\M_T'U[^]^6_U9_\ .ZL_^JO?OZDV?K)_O0_Z!Z]_7R]]
M(O\ >6_Z#Z]_>_+?ZL_^=U9_]5>_?U)L_63_ 'H?] ]>_KY>^D7^\M_T'U[^
M]^6_U9_\[JS_ .JO?OZDV?K)_O0_Z!Z]_7R]](O]Y;_H/KW][\M_JS_YW5G_
M -5>_?U)L_63_>A_T#U[^OE[Z1?[RW_0?7O[WY;_ %9_\[JS_P"JO?OZDV?K
M)_O0_P"@>O?U\O?2+_>6_P"@^O?WORW^K/\ YW5G_P!5>_?U)L_63_>A_P!
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MORW^K/\ YW5G_P!5>_?U)L_63_>A_P! ]>_KY>^D7^\M_P!!]>_O?EO]6?\
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M9WMUA$5);6*9M2D][EZT[ACM%!_/JO[_ (>A^;?_ #O-@_\ H)S?_5_N3?\
M@>.7O^7G_G,/^@.@Q_KI;GZ0_P"\-_T'U[_AZ'YM_P#.\V#_ .@G-_\ 5_OW
M_ \<O?\ +S_SF'_0'7O]=+<_2'_>&_Z#Z]_P]#\V_P#G>;!_]!.;_P"K_?O^
M!XY>_P"7G_G,/^@.O?ZZ6Y^D/^\-_P!!]>_X>A^;?_.\V#_Z"<W_ -7^_?\
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M #F'_0'7O]=+<_2'_>&_Z#Z]_P /0_-O_G>;!_\ 03F_^K_?O^!XY>_Y>?\
MG,/^@.O?ZZ6Y^D/^\-_T'U[_ (>A^;?_ #O-@_\ H)S?_5_OW_ \<O?\O/\
MSF'_ $!U[_72W/TA_P!X;_H/KW_#T/S;_P"=YL'_ -!.;_ZO]^_X'CE[_EY_
MYS#_ * Z]_KI;GZ0_P"\-_T'U[_AZ'YM_P#.\V#_ .@G-_\ 5_OW_ \<O?\
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MG-_]7^_?\#QR]_R\_P#.8?\ 0'7O]=+<_2'_ 'AO^@^O?\/0_-O_ )WFP?\
MT$YO_J_W[_@>.7O^7G_G,/\ H#KW^NEN?I#_ +PW_0?7O^'H?FW_ ,[S8/\
MZ"<W_P!7^_?\#QR]_P O/_.8?] =>_UTMS](?]X;_H/KW_#T/S;_ .=YL'_T
M$YO_ *O]^_X'CE[_ )>?^<P_Z Z]_KI;GZ0_[PW_ $'U[_AZ'YM_\[S8/_H)
MS?\ U?[]_P #QR]_R\_\YA_T!U[_ %TMS](?]X;_ *#Z]_P]#\V_^=YL'_T$
MYO\ ZO\ ?O\ @>.7O^7G_G,/^@.O?ZZ6Y^D/^\-_T'U[_AZ'YM_\[S8/_H)S
M?_5_OW_ \<O?\O/_ #F'_0'7O]=+<_2'_>&_Z#Z]_P /0_-O_G>;!_\ 03F_
M^K_?O^!XY>_Y>?\ G,/^@.O?ZZ6Y^D/^\-_T'TK-A_SKOE9CM[;1K^P6VEN+
M8=)N3"S[TP6&P,V+K:O%1U$9R$%%4_Q!13UDE)Y1!(UT270SJZ!E*/</NZ[)
M)!(MLUPDI1O"9Y0462ATEAX>5K34!FE:9Z?MO=._613*L134-85"&*US2KTK
M3A7%>/6[!LS8G578.T-K[\V=GLUGMI;TV]AMU;8S=#N6>6&KH,_3QU5)4Q,#
MRDT$L;C_  //O"*\MI=OF>"92DD;LCJ10JZ$J0?F"*=9!0.ERBR1G4K*&5@:
M@JPJ"/M!Z4O^A39W_*QN7_T(9_\ BOM-K/3N@=>_T*;._P"5C<O_ *$,_P#Q
M7W[6>O:!U[_0IL[_ )6-R_\ H0S_ /%??M9Z]H'7O]"FSO\ E8W+_P"A#/\
M\5]^UGKV@=!]VGU?MK;NP\[F<?-G'JZ/^&>%:S,S5<?^45E/$VJ-CI;TNUK_
M $-C^/=E8D]:9*#H0?\ 0IL[_E8W+_Z$,_\ Q7W76>MZ!U[_ $*;._Y6-R_^
MA#/_ ,5]^UGKV@=>_P!"FSO^5C<O_H0S_P#%??M9Z]H'7O\ 0IL[_E8W+_Z$
M,_\ Q7W[6>O:!U[_ $*;._Y6-R_^A#/_ ,5]^UGKV@=>_P!"FSO^5C<O_H0S
M_P#%??M9Z]H'7O\ 0IL[_E8W+_Z$,_\ Q7W[6>O:!U[_ $*;._Y6-R_^A#/_
M ,5]^UGKV@=>_P!"FSO^5C<O_H0S_P#%??M9Z]H'7O\ 0IL[_E8W+_Z$,_\
MQ7W[6>O:!U[_ $*;._Y6-R_^A#/_ ,5]^UGKV@=>_P!"FSO^5C<O_H0S_P#%
M??M9Z]H'7O\ 0IL[_E8W+_Z$,_\ Q7W[6>O:!U[_ $*;._Y6-R_^A#/_ ,5]
M^UGKV@=>_P!"FSO^5C<O_H0S_P#%??M9Z]H'7O\ 0IL[_E8W+_Z$,_\ Q7W[
M6>O:!U[_ $*;._Y6-R_^A#/_ ,5]^UGKV@=>_P!"FSO^5C<O_H0S_P#%??M9
MZ]H'7O\ 0IL[_E8W+_Z$,_\ Q7W[6>O:!U[_ $*;._Y6-R_^A#/_ ,5]^UGK
MV@=>_P!"FSO^5C<O_H0S_P#%??M9Z]H'7O\ 0IL[_E8W+_Z$,_\ Q7W[6>O:
M!U[_ $*;._Y6-R_^A#/_ ,5]^UGKV@=>_P!"FSO^5C<O_H0S_P#%??M9Z]H'
M7O\ 0IL[_E8W+_Z$,_\ Q7W[6>O:!U[_ $*;._Y6-R_^A#/_ ,5]^UGKV@=>
M_P!"FSO^5C<O_H0S_P#%??M9Z]H'0?[/ZNVUE,[OVCJ9\X(<-N"&BHS!F986
M*- KDR,IO(US]3S;CWLL>JA:UZ$#_0IL[_E8W+_Z$,__ !7WK6>K:!U[_0IL
M[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8
MW+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z
M$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__
M !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W
M[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O
M:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[
M_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL
M[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8
MW+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z
M$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__
M !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!U[_0IL[_E8W+_Z$,__ !7W
M[6>O:!U[_0IL[_E8W+_Z$,__ !7W[6>O:!T'^\.KMM8O.["HZ:?.&',[@FHJ
MPSYF69@BP,X,;,;QM<?4<VX][#'JI6E.A _T*;._Y6-R_P#H0S_\5]ZUGJV@
M=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T
M*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._
MY6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R
M_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H
M0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\
M5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^U
MGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@
M=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T
M*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._
MY6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R
M_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=>_T*;._Y6-R_P#H
M0S_\5]^UGKV@=>_T*;._Y6-R_P#H0S_\5]^UGKV@=-^6Z:VC38O)5$=1N,R0
M8^LF37GYW%XHV87!-B+CD?GW[6>M% .D_L#JC:^:V9MW*UD^>6JKL='/,M-F
MYJ>,,Q;]**=*CCZ#WLL>O*E1TL/]"FSO^5C<O_H0S_\ %?>M9ZWH'7O]"FSO
M^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<
MO_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0
MS_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\
M%??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M
M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H
M'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]
M"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO
M^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<
MO_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0
MS_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\ %??M9Z]H'7O]"FSO^5C<O_H0S_\
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MZ][]U[JQ[K/_ +=B_)7_ ,6"ZL_ZU4ON&]Z_Y7?;O^>"Y_PR=2!MW_*N7?\
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUF/YUG_94?77_BO&T?\
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M#\P10]9;1R+*H92"" 01P(.0>GCVUU?KWOW7NO>_=>Z"?O'_ )E=NC_R"_\
MNQI/=DX]5?AT+'NO5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H*>OO\ CZ.T_P#P
M[*?_ -QD][/5%XGH5O>NK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T%/8/_'T=6?\ AV5'
M_N,_O8ZHW$="M[UU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NFK._\63,_]JK(?]:7]^ZT
M>'23ZI_YEUM'_M41?]#-[V>/6DX="#[UU;KWOW7NO>_=>Z][]U[KWOW7NM33
M^=_E/YD/1W:?PX[OE^<N<V!T1V%_->^)'Q]ZT^.'QNQF0ZB$^U-Z1;DR&6J>
MP]SP9-LQNJMKSAX:4XM)(,$*=Y)9J*>H:(TONO=7F?S8O^W67\RS_P 4 ^9'
M_ONMQ^_=>Z#3^2+_ -NB?Y='_BI?3_\ [JX??NO=$ ^?7_<1S_(0_P#$:?S&
MO_?99GW[KW1Y/EY_+V^4'S#[8W=7UO\ ,]^5GQ9^.QP&RL=UUTW\+CB>D\Y3
M9'%"2;-9;/;]>DR6?R9R=4T"PT=,:*EIJ:'QL)VGF+>Z]T4O^6EW%\N.@?YD
MGRU_E-_*7Y![I^7>U>N^@NNOEC\6N_M_X6GCW;'M+.U]+MW*[>WEE*&GIJ;(
M9*#+U,+4<LL<M54I#6U;U)BFCHL?[KW0Y?(#^5[\L/E+V?V+OGL+^;Q\V^D=
MH3]A56<Z+ZC^%^0PWQVQ.V<%24T4%!C<]704.0S.]:QIA45-9+75\=-,\PAC
MI(XX8B/=>Z0_\FKY2_)[<.Z?YAOPD^;/:-#W5VW_ "YN^<%L^F^2#[<I]G+N
M?8_:N-K<WM:LS?VT=-C1GZ"AQ]5_$/%"@@ADI(ZB2KF63(5?NO=6W?'OY+]
M_+#KX=K_ !L[=V+W7UN<]F=K_P!\^O<[%N"@&0V^ZI64AFB)"S0^2)BI U1R
M1RIJBDC=O=>Z37</S"^-_0/<'0/0W<'9M%L;M+Y0)VS+TA@,E@,O54^7CZ,Q
M5-G-URSY>EQ]1A<)#A\55T]0\F5R-%'*K%:=IG1U7W7NB;==_P \[^4AVOW3
M1_'S8/SNZ0SW:.4K\3B,'CVK\AB<5DZW/3K2T5!B=SUU!3;7RV0JZEXXHJ6C
MS,]1)(Z(L99U!]U[H]W;GR2Z2Z'W-TSM#MO?='LO/_(+?]9U?U'35^*R%9#E
M<[08C(9V6A>LI*2HH\8%Q>+KIA/7U%+3L8Q"LQGDBC?W7N@[^-'SM^(GS%P'
M:^[OC+WMLSM_9O2.\*K8G96]]M&KBP=#D:''T^5F6GS592TV+RM''CZJ&9J[
M'U=50@%E^XUQR*ONO=%\VY_.9_E>[MWYMOKS;_S,ZGK\MO/+TNW=F;E+9.CV
MGF<G75<U#%B<1OF?'Q;+R>7>J@=!0TV?EJ[&-S#XY8F?W7NK./?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%/\ ^YH_]]_SSOMS\/\ J]>F_P 7^KTZ
M)C6_\"9?^0/^A1[FKE/_ ))\7^W_ .KC]03SC_R4IO\ FW_U:3J+[$709Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM9
MC^=9_P!E1]=?^*\;1_\ >BW7[F7V#_Y)M]_TM+G_ *M6_5^??[6S_P">"W_P
MR=4_>YSZ G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6/=9_P#;L7Y*_P#BP75G_6JE]PWO
M7_*[[=_SP7/^&3J0-N_Y5R[_ .>F/_K'U7#[F3J/^O>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NMV/_ (3Z?,"7N+XZYWXU
M;OR+5.]_CI+2G:TM5+KEJ]H[DEE:B12Q+R'"5RU%(WT2*EEQT2C@^\'/O#<F
MC9-S7<H12*\J7IP6X0#5_O8(;YMK/617MAOW[QLS:R'OMZ ?.(UT_P"\T*_(
M:>M@WWCUU)W7O?NO=>]^Z]T$_>/_ #*[='_D%_\ =C2>[)QZJ_#H6/=>K=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW04]??\ 'T=I_P#AV4__ +C)[V>J+Q/0K>]=
M7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[H*>P?^/HZL_\ #LJ/_<9_>QU1N(Z%;WKJ_7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=-6=_XLF9_[560_P"M+^_=:/#I)]4_\RZVC_VJ(O\
MH9O>SQZTG#H0?>NK=>]^Z]U[W[KW7O?NO=>]^Z]UK;?\*7/^9._RK_\ QMG\
M'_\ W5[\]^Z]U:5_-B_[=9?S+/\ Q0#YD?\ ONMQ^_=>ZUY_Y7G\BW:??/\
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MM=/[OE]^Z]T<GW[KW7O?NO=>]^Z]U[W[KW7O?NO=%/\ ^YH_]]_SSOMS\/\
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M(!*K6V>\E2&,5>1E1!4"K,0H%20!4GB2!Z]&UU<I91/-*=*1JSN:$T506)H
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NBG_P#<T?\
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M<(ZR_4K&+>69#J9U7NT#_0A53CB#U(^^\AV.U;7)>0SO+)&44D%/"+&5(V%
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M;]7Y]_M;/_G@M_\ #)U3][G/H"=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6Y_\
M);=_P<V?_+'_ ):M7\YNK.V>U-FU?2715/LG&=2Y 8ZJI<FO7V+::>K8[CVW
MJ@:E#HH^XF]9!\8_4,)>6;/?;WFK>5V&>"WE%S=F1IQJ5H_JWP/T9LZJ'@,>
M?60N[7&W6^RV!W**25#% %$9H0_@#)_4CQ2OF?LZ"#YQ;?V9\F?Y4&/W/_+E
MW3MO:/Q!Z.R-?E^RNBX]FU6#S$\NU:B*LJ_OLG65\\S5&):M&4J()8I6R!=*
MXU\\B0I(;<B7,_*_-QCYDCDDW"Y 6&Y,JM&OB*572JK2CZ?#4@@)E- %:).9
M(8]XV/5M+HMM%5GB"%68(=1!)-05^,@@EC0ZO4)NNJ3+_,C_ (3\Y/K_  VC
M<O8_QT[:Q.V,+253""4/C=R4%32('<*H2';&ZY((I!Z"L1B+:UD(-MTDCY(]
MPQ<R=D%W TC$9J'@=6-*^<T-2..:TI3I%8H_,G+'@IW20N$%<4*R*0.'E&X
M/Y5K7JT3;7<NWNMOYHG1OP.Q<F/AZ\V=\ :OK6@P)D2*.?+QRT&3B@CA*EO\
MGVKMC4%5@6CGF9U(BC;W%=SL<FY\K7._OJ,TFZB1GR2(]+J237\4LX%3P*@
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MHS>]MYS;6R6"RVXLQG8\ECVI::>HCI\;%+5TI^]'@DA]U[JXC:/PF^$'\O\
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MG\XNLW-,]1VL_P#.C^85-OB:OF^XKA34-/MV+'0U#LSN88*M<PD*ZBJ6D5+
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M.Q=*9#,]M322RRN>9)ZB9Y)97L-<CLUA>WN+]QW"7=9WN)SJ=SJ8_P J#T
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M( &<<3TS/((5+M@*"2?0#)ZJY_Z"5OY//_>2FY?_ $0F_?\ ['/8E_J1N?\
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MY[]_4C<_]]#_ )R1_P#0?7OZQ6?\?_&'_P"@>O?]!*W\GG_O)3<O_HA-^_\
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T%/7W_ !]':?\
MX=E/_P"XR>]GJB\3T*WO75^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJJ_G.?]N\_E3_XK
M=\B/_>/ROLWV#_<ZW_YK1?\ 5Q>B_=/]QY/^:;_\=/7R9/>2/43]'?\ AA\:
M=L]O5O8'<'= W72_&CX_XS'9OLU=C0?<Y_<N6SRU1VWL':\8CG8Y[=$U!6O)
M4F!X,3B*+*9>I]%$L4Q'O6YFS"Q1%?&E-$UFBHH^)VKBBUP.+,0 #T9[=9"X
M)=PWAIEM(J6/DH^9\_09)''K9=H<-VQ79O8V\_CAW=U[CNL]C9"HWS\)>[>E
MDW'UCUGA=D=;9G8^([!ZS['VI5F.&HV9NS-E9<57TK9W<>YLQCLIBJ\Y+*U%
M7C<;&SO'&K+/&QD;MG22AE,CB5DE1N-57X@0J@%3Z-T,%1Y&!B8:1F)D^#2I
M0,C#A0GA2IP?2G56W;6[OBILSK3'=>]>_%7YA?*/XT]E?)_N3LWI89[+'X\;
M)BW!B8Z*ES6&V/34VUMQ;ZSU#C,.U#CZJ6IW!B'E^S%348B&M5EH!-:17,LA
MEDN(()4AC1R )7*$X:0EP@)(!%-7$"M*5)IWB1-"122HTCLM:HH8>2@*6H 2
M,TX'YT7'Q8^876VS=D?(C&]>_%_Y8?%K9>7VW@>R-]]U[.JZ7YAXC8-;V#0U
M^U\!V*^&W?M[;V>Q60EQ^Z<E%1Y6B[#@DGBJY9Z>DJYX*66F9W/:'E>(O/#,
M0QC$9 @,@0ZC$#&67B.!44-!45RY9WZHKA8I(P1J+YD"EL!SJ /G7!-17'0J
M_(ONKY8[%W=TCM;JG ;)P?QRH.MZ7IKX)]5=-=5YOY ;1[MQVX<KMW'5?5W9
ML&ZZ[$9.DS<V&JVK,WC\AM7&5AKXY*U<9%DZZDS#I]OM;6=7>0LTNHO<.\BQ
MM 1J;Q(O##!AJPI#$?#^&HZ=NIIXBJ( $H%B4(7$@-!H?400:9((&*\2*]5H
M?S(?A!/T"-B_(+8W66Y.I.HNYZF;&YKIW<^9&Z*SKS>4-.*ZNVLF9C4P9_;%
M=2,:[;&9CGE_B&/2HIIW-?BZTD2<N;V+_5;NX=X\K(!02QUH&H<A@<,#P)!%
M:]$^[[<;6DJKI5N*UKH>E2,<1Z'[>'55WL4]$G1WJ?H+8$G\MS+?*1ES/^E*
MC^;^W>@H7&2 Q_\  ,GL/*;BE!H_'<UO\1I(;3>7B*Z:.=7LF^MD_>/T]1H^
MG,E*9U>*%X_9Y=&'TZ_2>+3N\;16OX=%?\/5@'3OP%^*N=^=7P$Z4[-E[$HN
MCN^/Y>>)^5/>-7@-P*<O%E%ZGWIO;(SXB4TDHA@CK]OTKQ4Q@EO&&A);7<$=
MUO-REE=3(1KBN3%'@4TB6- #ZX8YZ,H=OB:X@C(.EX0[9/'0YK^T#H%^\OY<
ME#\:>I/YAE1V'59#<&]_C7W+\,\+T5O_  =::?!;GV5\E8.P:^#<E/'XWCKZ
M;,XO 8.:GDBJ"M+-]U3,SR)(%56F_G<);3PZ!95G\5<55X@F/44)/V@@]-3[
M6+5)]524,>ALT*N6S\Z@?D0>C"X?^7)\;]U=S]7?'+!Q;SA[.^1G\G7J[Y7=
M&O4;MNM5W-G-EKO6?%.AI"CX?-TN.S--!2DAX96@\<KL CH)=]N88WG)!2*^
M>&0!1_8!@O[149\ZYZ41[;#(RQ =SVRNI+'^TH3_ #_E3HK'7/Q#Z:'QO^!.
M\.R3GY>V_F]\VZS:>W*7";A^WIZ?J78&1Q>TLU43TIICX<OE-XY"OBHZCRNB
M0XN8*KLTBQ&5UNDWU%RL>$M[:IJ!_;L"ZT\R HR/7\NDD-E'X4)?XI9J"A/]
MF"%/RK7H5?YJ'PJQOQ,BW#0;=_E\_('XX;,Q7R"W#UYL?Y(=I=WS=A8C>&*P
M0SJ44=%AWVQB4HZC.4E)3Y2*49.<PPP20!)1*943\M;JVXD:KI96,09HA$$*
M$Z:]U<Z2=/SK7IW>+(6H[83&-= YDU:AGR\JTK\N'1Q/YE/\KGXS_'3HCYF[
MVVG\?_D5\9\Q\9N[NOMA]%=D=Q=J1[JP'=&.W7ETQF27;N*K=NX?(0U6)HY6
MR+3TM5649@II/\J9G\495R_S%<WMQ CRI*)4<R(J:6A*@D5(P:T_GPX$KMUV
MJ&WBD949"C*%8M42 D X.<5_EQXCHO/R@^(7Q5Z#^$W5'9FS/B]WKW=M;M?X
M]; WAC/YANQN]Z>IP&-[)W3%2U&3VCN39E-A,ACMNT&&K:AL:U'7U]/EIV11
M#4O/Y)56[=NMU?7;1M-'&R2LIM63)B7\2O6K-YXQY_#CI/=V,%M &$;.&0$3
M!OQGR*\ /+U\N.>@#[EZ.^*7Q<ZS_EV]O[VZCW]W-C/DS\4]U]E=G;-HNYFZ
MR9MPTVZ\EB:.LH,E'@<RU)1T]%1*'I/LW\KMK\R6LRJRO+O=);J))1'X4P5&
M\,/V4:HH2/EGIFYMX+)()&0OKC)8:RO=VYQ7U..C.?*'I'^5M\>OYDN'^%N[
MND.X=B]/[;[#ZYVUVCWU5?)09J>#%]M;1H*^')_PF?;5%3X^GVYE\_05=7*<
MG4>:@H*E%A$E0HB16%QN5[8&[296<JQ6/P5R4<BE0222%( IQ(^WI^YCL[>Y
M\!HR%!4%_$/XE!X&E*$BIKP'1<?GQ_+[V;_+DZ:VSUIW9D*O<7S8[+[E[#SV
MVX-M;DI7P6*ZBZ_JZK X;<%701/+4M7=AYBGJJ[%:Y;0XNDD6H2&K)C]F.S;
MS)OLYDB[;=(U# C+3,-1 ) PE:'YT.0>DFX6";;&$?,K,2#7"Q@T!(!/Q<1^
M?F.D%\._CS\=*+XT=]?.WY>8?>N_NI^H^P>O^C.JNC=@[SCZYJ=\;[[#HLCE
M319+<!H,E48G"X7!8VHKJAJ6E-5.2BQ.HC=)GMVO[AKF.RM2%=U,CR,NH1QJ
M0*@5H23C..'K4-V-K$(7N)ZLJD*J TU,17)XT''&>/I0C%O/XC?%/N7;?PA^
M5?QIPO877'2'R(^6N,^('?\ T%O3>G]]*[9^[,=+MZNF7;6Z'QU!49C"9O;.
M;CJXY:FC,]!5:HGEG#B*E21[I=69N+:X*M)' T\4JJ '3N%66I (84H,$#\R
M^UG!<>%-$"$>18W0DG2V.!ID$9K7S_(/'\V/X187X@5F\<+M+X!]_P#Q^V#@
M/DANSK3K[Y.]G]WR]@X;>N&VV^>BQYH,.VV<5'13[@HJ*ERT4@RE1X8(9( L
MHE\R:Y:W5MR(UW2RL8@S1"((48Z:]U<Z2=/#-:]6WBR%H.V$H-= YDU:AFF/
M*M*_+AU23[&'0?Z][]U[KWOW7NO>_=>Z,#\3/^RJ?C/_ .+ ]-?^]'C?9=O'
M^XD__-&3_CC=*[#^WC_YJ)_QX=?8NZI_YEUM'_M41?\ 0S>\:3QZEM.'0@^]
M=6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[HI__ '-'_OO^>=]N?A_U>O3?XO\ 5Z=$QK?^
M!,O_ "!_T*/<U<I_\D^+_;_]7'Z@GG'_ )*4W_-O_JTG47V(N@SU[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:S'\ZS_L
MJ/KK_P 5XVC_ .]%NOW,OL'_ ,DV^_Z6ES_U:M^K\^_VMG_SP6_^&3JG[W.?
M0$Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[JQ[K/_MV+\E?_%@NK/\ K52^X;WK_E=]N_YX
M+G_#)U(&W?\ *N7?_/3'_P!8^JX?<R=1_P!>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6X]_PG>^'']P^J=W?,#>>*\6Z>W_ +G9
M?5_W<&F2FVQ@:D??UL>I0Z?QK+TX0?U@Q\4B$I4&^%WWC.=/WC>1[/ U8[:D
MDU#AIW7 -#0^&A_)G8'AU/\ [5[!]);M?2#OF[8ZC(B4Y/#\3#\PJGSZV4O>
M-'4L]>]^Z]U[W[KW7O?NO=!/WC_S*[='_D%_]V-)[LG'JK\.A8]UZMU[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=!3U]_Q]':?_AV4_P#[C)[V>J+Q/0K>]=7Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[JJK^<Y_V[S^5/\ XK=\B/\ WC\K[-]@_P!SK?\ YK1?
M]7%Z+]T_W'D_YIO_ ,=/7R9/>2/43];?OP$ER/Q;Z5^'^W>FOE;\7ND>[5VM
MMCY+=D=4_(W)8K"X[>L?RLR:E:R:HRF6PE;3':>P<#L^2E?$9"7(205&XZ:.
MAF3(K292)-\;]XSW#RPRO&&,2NFK],Q"GDK"C,Q)! _#W"E>AYMJBUBB59$5
MB Y5J=X?/ D&H  !!]<'HHOS)J/D]\A?D_C_ (>_#+9^)V]V#TG%M+Y>]R[<
MVODMG=42Y#LW+KA:BG\$P&U\/E3UAB<YMS;&)@^PBKI)Z#+Y%XZNIKZB=S;9
MTM;&U^KNS59=4"$ZV"Q ,#CN8&0JS-0D9 %!CI!N#37$_@0?$E)6^$$OVTS@
M$*"H%:'!K4]7R?(GM_YE]R?%?>_4>PNK_AKLWMK?6S.T\9MR#"?S&-H[@SU%
MG?D/2Y;^]E/A-FKU;M_*Q[ES*9/<4-+0KNB*J@JY74SU#0RI*#K*&SMYTE=Y
MV564D&VHI5"*5/C,-.!7M./+H_N'N)8V15C!((!$IJ"0> \,9_/H,/Y;.^?E
MOL/X<].] ;UZS^)N_=X;DZ_V/U73;=W]_,+VAT[O"JP53D*_<6R=H[@V55]6
M[QRE)E\92[N$$&/FR?W?V\]/3RT<,K/&RK?8[2XNI)4>95U,W;!K35\+,K>,
MM02I-:4Z8VUKB*%$94)T@=TFEJ<0"/#-" 0./5%'Q%^3WR4VG_,4[-Z<^0N1
M38^[OG#V/#OBCI]VPT'8..V=VMWW0?QKJ[?%/2%:ZA,1?<U!B<G$DD$<^U\Q
MD*&M\8BC6F&&Z;9;W&WI-!W"!*$K5#)%&:2+FE,J6!(-&%16N2*RO)8;MHY>
MTR,30G4$=Q5#CCQ"X(P<TI@Y/8V6^-/?G7/>_P 8]J=Q9[LSNGMWXXKN"AZ.
MQ'4<'5>VNJY_C;LBJ[%ZXV7B8,&^<VK29_ U=#NO;V<E.X(IY<CNJMH*N$5]
M-72TY';K<;?)#=.JI&LIK*7U-,)7$<C]U'(8$,O;@*&'')G*8KM)(5)+E!1
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M7_J6?^*>S[]\6G^_X?\ G(G_ $%T'OW+>?[XF_YQ/_T#U[P3_P#'&7_J6?\
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M?^<B?]!=>_<MY_OB;_G$_P#T#U[P3_\ '&7_ *EG_BGOW[XM/]_P_P#.1/\
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MB;_G$_\ T#U[P3_\<9?^I9_XI[]^^+3_ '_#_P Y$_Z"Z]^Y;S_?$W_.)_\
MH'KW@G_XXR_]2S_Q3W[]\6G^_P"'_G(G_077OW+>?[XF_P"<3_\ 0/7O!/\
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MMOOW]?=B_P"CC8?]EEO_ -;.O?U;W'_E%N?^<$O_ $#U[_92_E5_WC-\@O\
MT3.X_P#ZV^_?U]V+_HXV'_99;_\ 6SKW]6]Q_P"46Y_YP2_] ]>_V4OY5?\
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M;.O?U;W'_E%N?^<$O_0/7O\ 92_E5_WC-\@O_1,[C_\ K;[]_7W8O^CC8?\
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M]Q_Y1;G_ )P2_P#0/7O]E+^57_>,WR"_]$SN/_ZV^_?U]V+_ *.-A_V66_\
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M -".C_Z_>_4/7JCKW]_=C?\ /:;3_P#0CH_^OWOU#UZHZ]_?W8W_ #VFT_\
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M!KEF#RO:&G2:=DB8NW/=H-GC\2=M(X <68TK0 <?\ \R.E=G8RW[:(A7U/
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M #VFT_\ T(Z/_K][]0]>J.O?W]V-_P ]IM/_ -".C_Z_>_4/7JCKW]_=C?\
M/:;3_P#0CH_^OWOU#UZHZ]_?W8W_ #VFT_\ T(Z/_K][]0]>J.O?W]V-_P ]
MIM/_ -".C_Z_>_4/7JCKW]_=C?\ /:;3_P#0CH_^OWOU#UZHZ]_?W8W_ #VF
MT_\ T(Z/_K][]0]>J.O?W]V-_P ]IM/_ -".C_Z_>_4/7JCKW]_=C?\ /:;3
M_P#0CH_^OWOU#UZHZ]_?W8W_ #VFT_\ T(Z/_K][]0]>J.O?W]V-_P ]IM/_
M -".C_Z_>_4/7JCKW]_=C?\ /:;3_P#0CH_^OWOU#UZHZ]_?W8W_ #VFT_\
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MW_.5_P#H+KWGG_X[2_\ 4P_\5]^_<]I_OB'_ )QI_P! ]>_?5Y_O^;_G*_\
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M.?<?_P!<O?OZB[)_T;['_LDM_P#K7U[^L>X?\I5Q_P YY?\ H+KW^S;?*O\
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M<O?OZB[)_P!&^Q_[)+?_ *U]>_K'N'_*5<?\YY?^@NO?[-M\J_\ O)KY!_\
MHY]Q_P#UR]^_J+LG_1OL?^R2W_ZU]>_K'N'_ "E7'_.>7_H+KW^S;?*O_O)K
MY!_^CGW'_P#7+W[^HNR?]&^Q_P"R2W_ZU]>_K'N'_*5<?\YY?^@NO?[-M\J_
M^\FOD'_Z.?<?_P!<O?OZB[)_T;['_LDM_P#K7U[^L>X?\I5Q_P YY?\ H+KW
M^S;?*O\ [R:^0?\ Z.?<?_UR]^_J+LG_ $;['_LDM_\ K7U[^L>X?\I5Q_SG
ME_Z"Z]_LVWRK_P"\FOD'_P"CGW'_ /7+W[^HNR?]&^Q_[)+?_K7U[^L>X?\
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M()_LVWRK_P"\FOD'_P"CGW'_ /7+W*G]1=D_Z-]C_P!DEO\ ]:^@5_6/</\
ME*N/^<\O_077O]FV^5?_ 'DU\@__ $<^X_\ ZY>_?U%V3_HWV/\ V26__6OK
MW]8]P_Y2KC_G/+_T%U[_ &;;Y5_]Y-?(/_T<^X__ *Y>_?U%V3_HWV/_ &26
M_P#UKZ]_6/</^4JX_P"<\O\ T%U[_9MOE7_WDU\@_P#T<^X__KE[]_479/\
MHWV/_9);_P#6OKW]8]P_Y2KC_G/+_P!!=>_V;;Y5_P#>37R#_P#1S[C_ /KE
M[]_479/^C?8_]DEO_P!:^O?UCW#_ )2KC_G/+_T%U[_9MOE7_P!Y-?(/_P!'
M/N/_ .N7OW]1=D_Z-]C_ -DEO_UKZ]_6/</^4JX_YSR_]!=>_P!FV^5?_>37
MR#_]'/N/_P"N7OW]1=D_Z-]C_P!DEO\ ]:^O?UCW#_E*N/\ G/+_ -!=>_V;
M;Y5_]Y-?(/\ ]'/N/_ZY>_?U%V3_ *-]C_V26_\ UKZ]_6/</^4JX_YSR_\
M077O]FV^5?\ WDU\@_\ T<^X_P#ZY>_?U%V3_HWV/_9);_\ 6OKW]8]P_P"4
MJX_YSR_]!=>_V;;Y5_\ >37R#_\ 1S[C_P#KE[]_479/^C?8_P#9);_]:^O?
MUCW#_E*N/^<\O_077O\ 9MOE7_WDU\@__1S[C_\ KE[]_479/^C?8_\ 9);_
M /6OKW]8]P_Y2KC_ )SR_P#077O]FV^5?_>37R#_ /1S[C_^N7OW]1=D_P"C
M?8_]DEO_ -:^O?UCW#_E*N/^<\O_ $%U[_9MOE7_ -Y-?(/_ -'/N/\ ^N7O
MW]1=D_Z-]C_V26__ %KZ]_6/</\ E*N/^<\O_077O]FV^5?_ 'DU\@__ $<^
MX_\ ZY>_?U%V3_HWV/\ V26__6OKW]8]P_Y2KC_G/+_T%U[_ &;;Y5_]Y-?(
M/_T<^X__ *Y>_?U%V3_HWV/_ &26_P#UKZ]_6/</^4JX_P"<\O\ T%U[_9MO
ME7_WDU\@_P#T<^X__KE[]_479/\ HWV/_9);_P#6OKW]8]P_Y2KC_G/+_P!!
M=>_V;;Y5_P#>37R#_P#1S[C_ /KE[]_479/^C?8_]DEO_P!:^O?UCW#_ )2K
MC_G/+_T%U[_9MOE7_P!Y-?(/_P!'/N/_ .N7OW]1=D_Z-]C_ -DEO_UKZ]_6
M/</^4JX_YSR_]!=>_P!FV^5?_>37R#_]'/N/_P"N7OW]1=D_Z-]C_P!DEO\
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MY5_]Y-?(/_T<^X__ *Y>_?U%V3_HWV/_ &26_P#UKZ]_6/</^4JX_P"<\O\
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M /0<H_\ KS[]4]>H.O?W"V-_SQ>T_P#T'*/_ *\^_5/7J#KW]PMC?\\7M/\
M]!RC_P"O/OU3UZ@Z]_<+8W_/%[3_ /0<H_\ KS[]4]>H.@TV-M':E7N/LF"K
MVQMZJ@H=SP4]##486FF6&,TZ,4B5HB(T+&]E %^;>]DGJBC)Z$O^X6QO^>+V
MG_Z#E'_UY]ZJ>KT'7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_
M]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ
M]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A
M;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+V
MG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_
M]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ
M]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A
M;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+V
MG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_
M]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ
M]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A
M;&_YXO:?_H.4?_7GWZIZ]0=5=_SC-L[;Q/\ +U^5KXK;^$QCS?&[Y""5\?B8
M*(MX-I91TU&.-2VAP&6_T8 CD>S?8"?KK?\ YK1?]7%Z+]T'^+R?\TW_ ..G
MKY/_ +R0ZBCK:A_E9?+WL/(_$C'[.ZWSNVZ#L+HM*WX\]K1[TVWOON&)>L.Z
M\[7Y/:VZ,;L+9^1H)MW;AQ&[L]N#:-/'4-]M01;EQ*5%30XR:LE6+^9]K2*[
M+R Z)1XBZ3''^JB@,I=P=(*@.33N(( )R!ILUZSP!5(U(=)J';L8D@Z5I7)T
MTK@9J!CJ3WELK?&]>R:#%_RX?D#N[&_S&?C'T=M;9W:^P^N:S =7YG<VP=MY
M*DRD>V()-D92OV14[KZDJ:'$X[,8/'Y=Z&7 T>.HX?N:O!Y"C?6WRK;H?WA'
M6UFD9D=@[ 2E2-7> ^F0$E6(KJSBM1NZ0RL/I&I-&H#*"H.@-73CMJA ! -*
M8SPZ4OP2Q'\UCOOO6JZ&^3WRM^7GQRW]-C^O>S^ML-N#J^#=N,WQM#&;AQ=!
MV F(EJ<75XS*UF(PV9HZV'Q19&B8PU=)7TS>H1UWG]VVD(FMH8I4.I'_ %'#
M(Y4E*C6" 2K5J 2*4(ZMMYO)W,<TCHPTLO8A#*"-5#I()%1P./,'J/\ SE.S
M_E__ "\>P,-B]A?/KO;(9#M_L#L?<O7_ %9_H^Q/4M)MCKW!1XN/!M48^EQ&
M)A-77Y&LR-+!]GAZ.D6+%SEHEG=HX[<J65KO:G7;H!&JAFUR$O(2<_%0"@R*
MDU.,=5WNYFVTC3*U68D#2E%44Q\-:U./E\^@O^#/2/9%/\A]T_(KYS=@;CB^
M;G;?2&]=Z=8[&W;M;,]A[VQ&T<9MX8S-;_SFU]NST6Z(LI4;6C?$;7QE'HS4
M4,U;NM*1:7 TGW[N^7B-;K;62CZ=) K.&"HTA)8(&>JD!NYV/;P6HKU3;+=A
M*9KD_JLA95I5@H !8A:&M,*!GB:&G0F_S%>Y:/IKI/N?=?9/Q%Z3^.GRNW'@
M]S_!O8N_NKMT/O"7?F-W;B]O2;YWBE568S#9FJPF$V'%18!ZC,RY'-C/;JKL
M=7?PZ3!5.+I&>7[(W<T2QS220H1.RL-(C*LVA:!G 8O5J"@**&!.KJ^Z7(@C
M=FC5)&_2!!J6! U&I"DJ%H*Y(8T(%.M3OW*70*ZW5,/MZ7^7%_PE\J^S^I=6
M [O^<M=MENP>Q<5(T=<E!VUDZFEIZ:"I699J6&FV/0FCC2-R(:RMJZI(TEGD
M81,[C?=_$<N4A+*JFE/T@3Z9J^37RQ7 Z'*J=MVPNGQ. 2<_C('KQ"F@IYYZ
MTJ_<L] ;K=-_EN;?G_F*_P#"=KYF?'GM^F&\,Y\1\KV=FOCEN#*S&6KQ4NS=
MLT^\-NTD%=4RR20)#DGR^.8KXXH\/6+1*GBC(]Q1O[C8MZBGC[1($,@ %"&8
MHV!3B!7UU9K7H;[6IW+;WB?)74$)KY ,N?D33[,=47_R:_YI6\OY9/R8H=PY
M&:OSOQO[3J<3MCY";"A#U1;'I(RT^X<9"&T_QO &:66)=)%73-4T+%#415%.
M,.:>7EWV Z125 3&W"OJI^1_D:'A6I#LNZG;9,G]-CW#C3YCYC^8_*E_'S1^
M%?P]_EB=G;U_G3]5T.$[FZC['QFS=Z?!GIG!XJKS>UJ/M'N>#(Y.+<N3JZ:$
M4%/L;$4429G#4WW41DJZE:"E%,**B,@)VW<KK?HTVESH925F<T#^%'0::'):
MN#BM!4_B/0BNK2#;6:^7N! ,:C*ZVKFH\O,5QG&=(ZTR.T^TNPN[>QMY]M]L
M;MR^^NR.PMP9#=.\MVYV<3U-=791R\LKZ52*)!PD4,4:0P1*D,,<<4:(LK6U
MM'9QK%$H55%% X ?ZN).2<G/0(FF:X8NY)8FI)_U?\5UMO?\)\=E[J[(_E,_
MSJNN]B8+(;IWOOWJ/?VR]F[8Q$/W%7D<KNGK7=5#CJ"ECN/)45E7/#%&MQJ=
MU'Y]QKSC,MONEG(YHJF-F/H!-4G\@.AAL,9ELIU45)U@#U)C '57?QM_E/\
M\R#XXP=M_.3>FR=^_$(_!?KR7Y*;%W9OO:<%:^?W)L2OHI\=MF#'ME:.=Z3(
M4XKWKJEH*JDCIX3255/+]]&C'U_S+8[AHM$(F\=Q$P%5T*V-52IR#2@XUS44
MZ++79[FTU3M^GX2EQ6AU$9IAN!%:_+'GU;O_ "&4I>N/@U_-E_G"Y?#8G=?R
M4Q3=^4.VJ^KQU-!#0U.S=JP;]R(HE6(M1T^?S>XL:*U5++X,?3I$@M()0[S<
MAENK/;%)$5(QYDG4YB!/D2H7'#B?7HUV)@D,]X15ZN?EA==!YBI.?L'IUIE;
MDW)G]X[BS^[MUYG);BW3NK-97<FY=P9FK?(5E?D,Y/)55E953R%I)ZFJJ)9)
M)9&8L[LS,22?<I11K"H1!15   X  4 Z!;N9"68U)))/J3GK;9_X2R;]QW>$
MWS>_EO=Q4TV^.A^X.CJKM=]C94">BI7H*_';6W#+2Z@?MJK)P9_!-K7U)+C:
M>:+1)&6:-O<&V-L8+V+M=7T%Q@UIJ3]FEOVT].A=RM-XHDMWRI74%/"GPM^V
MHQ_L]%W_ .$^?651TK_/6S/3=76'(U?4L'RNZRJL@R+$9Y-AI7XIYBJ/(BF5
MJ0M99&47L&(Y*KG.X^KVF.6E-9A>GIJ0G_+TSR_%X%\Z#\(=?V,!T#W<?\M_
MY_=X_P XOY'9'J?H#OK9&)S'\P3N_?\ @?D%E>N,IM';F$Q*]C9+(P;QCW'E
M*6EPTE'0TA3(4SQU<C52H@I$G>2-&61;Y9VNUQK))&Q^F1#&&#,S>$!I(4DB
MIP>%/,CI.VVW$UZQ57 \9FUTH -=:@M@^H]>AX_X5,_+?X^_)'Y<].[$Z.W-
MMOL+)_'[KG<VU.S=_P"TJR#,4#93<646H3;\>0@=XJR7 K2RO/XG>*"HKI:?
M7]Q%4QQ)/;[;IK."224%1(5**:@T4'NH?(ZA3UIZ4J_S3=QSR(B&I0-J(R*D
MC'VBF?MZ,)_PDB_X_?\ F$?^(-ZZ_P#<O/\ M%[D<+;_ $TG_/G2CE+C+]B?
M\_=:?/N3N@=UNA?#NBA_F%_\)G?E?L;O&*+<NY/@/4]O9OHK>>6(R.1Q5'TG
MM7'[WQ<%-4RAYH%2@K<O@EC4B-<4T-,EEC41Q7N8.S;[$\)H)S'K4<#XCE&K
MZU(U?Z;/ET-;,C<-M<2"OA!M)\^Q=0^RE:?9]O6E[[E3H%=#_P#$]$D^4WQJ
MCD571^_^FT='4,"&W%C000>""/J/9=N_^XD__-&3_CC=*[#^WC_YJ)_QX=?8
M,ZTV;M"OV'M>LKMJ[;K:NHQ<4E155>#I:B1V+-ZG=XBS'_$DGWC42:]2THQT
MN?[A;&_YXO:?_H.4?_7GWJIZM0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO
M^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^
M@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7G
MWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'
M7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO
M^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^
M@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7G
MWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'
M7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!U[^X6QO
M^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7GWZIZ]0=>_N%L;_GB]I_^
M@Y1_]>??JGKU!U[^X6QO^>+VG_Z#E'_UY]^J>O4'7O[A;&_YXO:?_H.4?_7G
MWZIZ]0=>_N%L;_GB]I_^@Y1_]>??JGKU!T67^ 8+_9COX'_!<3_!/^=/_#H?
MM?\ BQ>;_@/H\/\ G?7^C]?J_5S[<KV]-T[NBCUO_ F7_D#_ *%'N:>4_P#D
MGQ?[?_JX_4%<X_\ )2F_YM_]6DZB^Q%T&>O>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K63_G8?]E2]<_^*[[0_P#>BW7[
MEOV*_P"2?>_]+2Y_ZM6_2CGG^TL_^>"W_P ,G5/?N;>@/U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW5C_6?_;L3Y+?^+!]5_P#6FF]P_O/_ "NFW_\ /#<?X9.A[M__ "KU
MU_ST1_\ 6/JN#W,'0"Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JP;^5?\ ]EY=$_\ E3__
M 'C=P^XK][/^58O?^H?_ +2X.AE[?_\ )7M_^;O_ %9DZKY]RIT#>O>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NG; 9[-;5SN%W/MO*5V$W%MS+8[/8'-8RH:DJ:.MP\R
M5%+54\J$/%/3SQQR1NI!5E!'(]LW%NEW&T4JAD=61U85#*P(((\P0:'IR&5H
M'5T)#*0RD<00:@C[#U](?^7K\O<)\V?BUU_W122T,.[OMVVGVI@J)U_W';EV
M^D:Y"'QJ288:Q)(*ZF4FXI*J#5ZK@<X?<#E&3DK=);)JE*ZX'/XX7)TGYD4*
MM_24]97<M;VG,%FEPM-1[9%'X9!2H_RCY$'H[?L%]'W7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T%/7W_'T=I_^'93_ /N,GO9ZHO$]"M[U
MU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NJJOYSG_;O/Y4_P#BMWR(_P#>/ROLWV#_ '.M
M_P#FM%_U<7HOW3_<>3_FF_\ QT]?)D]Y(]1/T-GQ[^0'8OQE[2P?;'6=5B3F
M,9393"YO;FY\4FXL%N#";D@>CS.W-Q8J8B#*X'-T$LU+64SE2T;ZXI(:B.&:
M-'?V$>Y1&*4&AR"#1E8<&4^3#R/Y&H)'2BUNGLW#IQX$'(8'B"/,'_9&>MP3
M^65V7\6X?AUWQNWXB='=@;YBWWV;N7<O97QFH\AAZ_?&PLQG*3845!@>M\MF
M:3*4>\PM#C=[Y[;$>4QT,F2J<)1T,].^9Q4%7-$W,5O<"ZC2Z=1I0*LQ!T2*
M#(=3A<J:D*]*TJ2*@]#G:98C S0*<L2T>-2FBX6N#PJOKPQY$+P'\U;9%1V!
MWW\9/ES\>\#\W/AYU?OK-]I[7J/EK1;6^-O<]&^VY8\0TLA@EQ-%NC=4<.2G
M#8G3#FJZCCFTS0)$]'$>'EMUCBN+60PS2 (P@+R0YSQ&IE7MRW<H:GEGHN&[
MJ7>*91)&O</$"I)C' T!.<#!I\\=8%[)^/6&^/?6&]/@5V1\+?AOO;=?:?9.
M&I>^>Z_B=V!UCN6CQNRL/MNIAV[@=WYBE[[QD&Y<?/EZB?,9*B[ I*MHIL.M
M BM+7:M&WF>=TOEN)U55)BCF212S%N\JI@(7':N@TSJ-*5\)46)6MC%&22 [
MHR$  =NIA("<Y.K/D.-"UUGP8VY\9*#$?.OYL_.Z+<C9W<D^YNN=J_'O*;[@
M[0[/R!B,CUF#W-OC;VU)J/"-+/3_ ,0W73IEJ2"&26"&2;*&*C8Q&]'<P;.R
MMJ"E&,H3PHL^:H7%<&BFAKY4Z2G;Q9'ZBYFS6H"%M;X\F;2?M(KCS'56WRL^
M46]?E?V<F^]S8W%[1VSMS 8W8G5'5NVIZF;#;2VQ@#(<?@\7]W+/4RJKS3U-
M753RO45]?455=4NT]0Y]B;:MKCVF+PTR2=3N:5=CQ)IP] /(8^?1-?7S7[ZF
MP!A5'!1Z?YSYG]G19_9GTBZW+/B%V#A?YM'\A_?_ /+2VGN#'O\ -[XH8RDW
MIU7UUF,A#C:O=>&V%FY<MB&P_P!S400U7^XFJJ]O2?NJE!5''U%;XH*N!Y(L
MW*W/+>[K?,#X$K'4PJ=)=2&K0$X/>!3(J!D&@UM)ANUB;93^HBBB^H4@BE3Y
MT"D^1X\173[R^Q]Z[?W?5]>Y[:&Z,)OZ@S0VU7;'R^WZO&YB'(M((1CY<9-"
ME;'6F9E3P- )=9"Z=1M[DY;B-T\164I2NH$%:#SK6E/GT#FB96T$$-6FD@UJ
M?*G'K</VYG(_Y*?\A3L[JSM^O;;?S:_F+C?=;M;IB>I;$Y_;V%['Q-#MB2LR
M,*JU5C3A-N0U%<SR11RQY:NAQNJ.:*22"+W']:]X62,5@M](+TJK:"7IDT.I
MC0?T<TX]#)3^Y+ JYI)+6BUH06 'D/PC)^>*Y'5*/\N'X2["RNRM^_S$?FYA
M<KBO@;\:A%DOX)(C8ZK[8W@LYBPW7^VS(JK54U9D(Q'EJI'\=-$&A=XU-54T
M(JY@W=PZV%H?\8E-"1_H2$5+&G TR/.F?2I+M=@I4W,X_23-/XVK@#U%<>E<
M>M+L_P"5A_-YPW\Q#LOY _R[/YD=!MG*],?-C)5U#T+B*2G3!X[:E?50QTV.
MV'B)54#'T<=/1XUMMSKHGI<S2#2\U5DHO$%.8.6#L4<5Y9$ZX:>(>);-==#7
MS)##(TTQ0$]'6U[P-R=X+@#3)70/3'PU'RR#ZU^0ZUU?YF7\N?N#^6S\E-V=
M-;^QF9RO7U5D*O*=+]M28QX,?NC 5#%Z6>.=5^WCRU'&RP9*C#:Z:J1RH>EE
MIJB<<[!OL>^0"12 X'ZB Y5OL.:'B#^5:@]!O=-M?;9"I!TU[6\B/\X\_P!O
M"G5_O\A;;FX<S_)L_G?4^(P.:RL^Y.E>W=N;=@QN+GKGK\B.J]S*:"B6*-FJ
MJW56T8\$0:6\\(T_NIJ!G-TBQ[M9%B  8B230 >-Q/H,<>A#L:E[&< $DZP
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M9-KB.DD4K0'%0?,'TZ,YW7_-M_F+?(SK?<?47=WRCWGV-UQNRGBI<_M7/X+
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M^W8GR6_\6#ZK_P"M--[A_>?^5TV__GAN/\,G0]V__E7KK_GHC_ZQ]5P>Y@Z
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M%(,1NW>6<J,74JA8V@R%)XZR$V >&H20"SW/NO=;!_OW7NBG_P#<T?\ OO\
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M[)VAMVA3&4&+Q.V*6*BQ^/HJ>,"."EHZ2&**)%%E10!]/?NO=*SW[KW13_\
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M'Q[P_?'7^Q-\[;QV\NKX!"C[VPE)FQC4R%;O3$I555)#5%7T4RZ@AD"J#I$
M77O7=MN-UM]CM,UVUK++$YBG8DB*5H]6E;:2@)'F<5I7J3H/;V#Z6&ZN+U(1
M,B. \8 != ^FK3+4@'T\J]%J^;O\I?L#XE]1X'Y';$[CZ]^2GQTSU3B*2+LS
M8*#'M#_'W>.BJI*6.MRE%/C:J4)#'4TN7J!YW6.1$#(SB/DCW;M^;+QMMN+>
M6SNUU'P93JKH%66I6-@X%259!@5KY=%7,/(\NR6XNXI4G@.GO44IJP#34P*G
M J&.3P\^F?\ F!?RS!\(^K?CUW%MSN^+N_9'?M)6U5'D4Z[&P/X>),=CLIC+
M:<_GEKER-)65+:@\(B^W%O*);QO>WWN=_7>ZNK.2V-M+;4J/&\771V1_]"BT
MZ2!ZUU>5,TYHY./+L,4ZS>,DII71HI50R_C>M17TI3SK@2^L?Y/&Y^Q?Y=6X
M/GQ)W(^ J,3U_P!G=E8_IZ?K!ZMZK&=9U>0AEF;-MGJ=H!64V,J:J)OX+(OB
M,;*75PX+MS]XHMNYB781;ZPTT$!N!. %>8(::/"-=)<*1K&0>%*=*K/D-[K:
MSN1ETD1R2"(Q\5C+?BUCX@M0=/ CCT"W\MK^7)-_,%S'<L59W!%TKM?I?:V
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MQX+JCDD )\M5 3BM2!T?[I[<[CM<)F/AR!15A$S%@!Q-&1*T^53\NJ=_<Q=
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M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW35G?\
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M7GR:8?-[DV%]X(Y$@A[)H'AIS3!B0%Q&YL53UK:D $M:K*[7(CK[TPMRKO\
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M4_\ [FC_ -]_SSOMS\/^KUZ;_%_J].B8UO\ P)E_Y _Z%'N:N4_^2?%_M_\
MJX_4$\X_\E*;_FW_ -6DZB^Q%T&>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>ZI3^%O\ V\8^67_E=_\ WNL5[G#G?_E6MO\
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M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6LG_.P_[*EZY_\
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M $_YR0?];NO?ZS>_?\H[_P#.*X_ZT]>\>/\ ^=]A/_.I_P#KW[]_KL[)_O\
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M ,XKC_K3U[QX_P#YWV$_\ZG_ .O?OW^NSLG^_P!/^<D'_6[KW^LWOW_*._\
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M /G?83_SJ?\ Z]^_?Z[.R?[_ $_YR0?];NO?ZS>_?\H[_P#.*X_ZT]>\>/\
M^=]A/_.I_P#KW[]_KL[)_O\ 3_G)!_UNZ]_K-[]_RCO_ ,XKC_K3U[QX_P#Y
MWV$_\ZG_ .O?OW^NSLG^_P!/^<D'_6[KW^LWOW_*._\ SBN/^M/7O'C_ /G?
M83_SJ?\ Z]^_?Z[.R?[_ $_YR0?];NO?ZS>_?\H[_P#.*X_ZT]>\>/\ ^=]A
M/_.I_P#KW[]_KL[)_O\ 3_G)!_UNZ]_K-[]_RCO_ ,XKC_K3U[QX_P#YWV$_
M\ZG_ .O?OW^NSLG^_P!/^<D'_6[KW^LWOW_*._\ SBN/^M/7O'C_ /G?83_S
MJ?\ Z]^_?Z[.R?[_ $_YR0?];NO?ZS>_?\H[_P#.*X_ZT]>\>/\ ^=]A/_.I
M_P#KW[]_KL[)_O\ 3_G)!_UNZ]_K-[]_RCO_ ,XKC_K3U[QX_P#YWV$_\ZG_
M .O?OW^NSLG^_P!/^<D'_6[KW^LWOW_*._\ SBN/^M/7O'C_ /G?83_SJ?\
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M_9->?]LW7O\ AI_OK_GZWQE_]&O-_P#6GW[_ (+7DS_E)/\ O=K_ -M77O\
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M'F>B<_\ #3_?7_/UOC+_ .C7F_\ K3[&O_!:\F?\I)_WNU_[:NB3_@;.</\
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M_6GW[_@M>3/^4D_[W:_]M77O^!LYP_Z-]Q_V37G_ &S=>_X:?[Z_Y^M\9?\
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M]A_^@G)_T?[]3KVL=>_TN8S_ )Y'L/\ ]!.3_H_WZG7M8Z]_I<QG_/(]A_\
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M )Y'L/\ ]!.3_H_WZG7M8Z+W_>ZE_P!/7]ZOX1N+[;_G5?PEOO\ _BS?;?\
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M+-)3@EZN9/6GB@B4>K>+3 ZM1]Y0=8>]>]^Z]U[W[KW04]??\?1VG_X=E/\
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M +FC_P!]_P \[[<_#_J]>F_Q?ZO3JM?>?_'RY+_JC_\ <>+WAC[M?\K!=_\
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M6Q-U_#OI:@V^NQ=TR[L[QW-BWSF^*<&EFJ*_<M5ONNEGW.^5A<2UDE4V3OY
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M[IKKWOW7NO>_=>Z(5_LTG8'^SQ?[+/\ P?9W]Q/^=M_#ZW^+_P#'H?Q__/\
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MJJ)NK/CQV=V+MO'UDE+DMP1%Z 1K$5+.L5'099+F-E<)+/"UF75HOP_X%.)
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M+_!T,O<'V=CO_<6?E/EZ(01%[41JSRRI!&UC;W$TC-*\CD L[T+$DD(M.T=
MALC?'\P'Y"XB'LG8&1ZQZFV16ULL^W<1GZ 3OD*:D<KP\V+RU3)#(RLAF_R/
MR%2\(2,J38K'&:&I/RZDOF7EGVG]I+AMFW:/<MTO40+<2P/I6"1A7@ES:H&
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M '+N,7,MJM(;TB&Z &$NT3M?   FC7\WC=B:OU<-[R[ZP>Z"GK[_ (^CM/\
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MU9#&U;0:O)3-#*%<>Z]U[Y9?$3X\?.3I//\ QU^4O7O^E#IS=&3V]F,[L_\
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M&Y7+=?\ 4VYL34/6;5QNX]P4V5:BC^[@,^:IZ8T%0\Z:D146EK(UYLQEM>X
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*?\ ]S1_[[_GG?;GX?\
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MOX.GD:H>& M-)//(JJ]14SR,\M142*BAG=R;!5%E55##,6-3UBWSESMN?/\
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M#4-%%+64E#.SP>81R7IE E5U4LH#%CG/E2?D?<IMKN9(998"HD:!G:/4R*]
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M=*L*Y!L/625-+74D<DM.)WH<C5"E^XI34^$55/Y/=>ZKM_E,?]OK_P#A1_\
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M?NO=>]^Z]U[W[KW7O?NO=&<VM_V2GVE_XDC:'_0D?O(;ES_IVV[_ /2SM/\
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M[<AA>X=8XU+,Q"JJ@LS,QH  *DDDT &2>FYIDMT:21@JJ"S,Q 55 J22:
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M+(-)(L1A:!5=']U[IC^(?\NOI/X7=;?)_JWJW=':>>V_\L?D/W5\E^Q:S?\
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MHR'Q&_[*%Z^_\FO_ -T>2]SI]VK_ )7;;O\ J,_[0+KK'?[UW_*@;I_U _\
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MP3!GIL2^5B)%34W*50_SLG_'1K^Z]T9Q$2)$CC18XXU5(XT4(JJ@L  .  .
M![]U[KE[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*?\ ]S1_[[_GG?;GX?\
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M_%_J].JU]Y_\?+DO^J/_ -QXO>&/NU_RL%W_ ,V/^T:'K-KV@_Y5VT_YO_\
M:3-TE_<<]25U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=$C^:O_,Q-B?^(CVQ_P"YV5]A+[R7^Y^T?]*"P_ZN774H_=/_
M .27O7_BQ[C_ -6;/HG?O'3K*?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NC.;6_P"R4^TO
M_$D;0_Z$C]Y#<N?].VW?_I9VG^"'K&_F;_IZ&S?]*B__ ./GHL?O'GK)#KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NC(?$;_LH7K[_R:_\ W1Y+W.GW:O\ E=MN_P"HS_M
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M>:>18XU'FSF@^P#B3P !)P.BS>=XMN7[2:^NW$<$$;RRNW!412Q/S-!@#)-
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M5/\ _7#V%?\ 6CL_^CHG_9,?^M_0B_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
MYQ4__P!</?O]:.S_ .CHG_9,?^M_7O\ @E;?_E#'_95_V[]>_P!%4?\ ST*_
M^<5/_P#7#W[_ %H[/_HZ)_V3'_K?U[_@E;?_ )0Q_P!E7_;OU[_15'_ST*_^
M<5/_ /7#W[_6CL_^CHG_ &3'_K?U[_@E;?\ Y0Q_V5?]N_7O]%4?_/0K_P"<
M5/\ _7#W[_6CL_\ HZ)_V3'_ *W]>_X)6W_Y0Q_V5?\ ;OU[_15'_P ]"O\
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M;^O?\G.N6O\ E!/_ &6'_MBZ]_H:Z:_[R7VW_P"@-D?^O_OW^L)LG_326_\
MV0R_];^O?\G.N6O^4$_]EA_[8NO?Z&NFO^\E]M_^@-D?^O\ []_K";)_TTEO
M_P!D,O\ UOZ]_P G.N6O^4$_]EA_[8NO?Z&NFO\ O)?;?_H#9'_K_P"_?ZPF
MR?\ 326__9#+_P!;^O?\G.N6O^4$_P#98?\ MBZ]_H:Z:_[R7VW_ .@-D?\
MK_[]_K";)_TTEO\ ]D,O_6_KW_)SKEK_ )03_P!EA_[8NO?Z&NFO^\E]M_\
MH#9'_K_[]_K";)_TTEO_ -D,O_6_KW_)SKEK_E!/_98?^V+KW^AKIK_O)?;?
M_H#9'_K_ ._?ZPFR?]-);_\ 9#+_ -;^O?\ )SKEK_E!/_98?^V+KW^AKIK_
M +R7VW_Z V1_Z_\ OW^L)LG_ $TEO_V0R_\ 6_KW_)SKEK_E!/\ V6'_ +8N
MO?Z&NFO^\E]M_P#H#9'_ *_^_?ZPFR?]-);_ /9#+_UOZ]_R<ZY:_P"4$_\
M98?^V+KW^AKIK_O)?;?_ * V1_Z_^_?ZPFR?]-);_P#9#+_UOZ]_R<ZY:_Y0
M3_V6'_MBZ]_H:Z:_[R7VW_Z V1_Z_P#OW^L)LG_326__ &0R_P#6_KW_ "<Z
MY:_Y03_V6'_MBZ]_H:Z:_P"\E]M_^@-D?^O_ +]_K";)_P!-);_]D,O_ %OZ
M]_R<ZY:_Y03_ -EA_P"V+KW^AKIK_O)?;?\ Z V1_P"O_OW^L)LG_326_P#V
M0R_];^O?\G.N6O\ E!/_ &6'_MBZ]_H:Z:_[R7VW_P"@-D?^O_OW^L)LG_32
M6_\ V0R_];^O?\G.N6O^4$_]EA_[8NO?Z&NFO^\E]M_^@-D?^O\ []_K";)_
MTTEO_P!D,O\ UOZ]_P G.N6O^4$_]EA_[8NO?Z&NFO\ O)?;?_H#9'_K_P"_
M?ZPFR?\ 326__9#+_P!;^O?\G.N6O^4$_P#98?\ MBZ]_H:Z:_[R7VW_ .@-
MD?\ K_[]_K";)_TTEO\ ]D,O_6_KW_)SKEK_ )03_P!EA_[8NO?Z&NFO^\E]
MM_\ H#9'_K_[]_K";)_TTEO_ -D,O_6_KW_)SKEK_E!/_98?^V+KW^AKIK_O
M)?;?_H#9'_K_ ._?ZPFR?]-);_\ 9#+_ -;^O?\ )SKEK_E!/_98?^V+KW^A
MKIK_ +R7VW_Z V1_Z_\ OW^L)LG_ $TEO_V0R_\ 6_KW_)SKEK_E!/\ V6'_
M +8NAQP/6_6M/T%OS 0=W86KP-?O7;E;7;M3:M9'%234Z+XZ9Z<RF61I@MPP
M8!;\CW*^T>U.V6O)]_M:[S"\,U[;RO=BUD"1,@2B%/%)8MIXAA2O#H!;A]^?
M9-VYBM.;DM"(+"UGLGC^I)U/<FJG7],*4KPT&OJ.@._T-=-?]Y+[;_\ 0&R/
M_7_W%'^L)LG_ $TEO_V0R_\ 6_H>_P#)SKEK_E!/_98?^V+KW^AKIK_O)?;?
M_H#9'_K_ ._?ZPFR?]-);_\ 9#+_ -;^O?\ )SKEK_E!/_98?^V+KW^AKIK_
M +R7VW_Z V1_Z_\ OW^L)LG_ $TEO_V0R_\ 6_KW_)SKEK_E!/\ V6'_ +8N
MO?Z&NFO^\E]M_P#H#9'_ *_^_?ZPFR?]-);_ /9#+_UOZ]_R<ZY:_P"4$_\
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M?@_^O'OW_ 92_P#1W3_LB;_MJZ]_P>-O_P!&67_LN7_MEZ]_PTSV]_STT?\
MZ#\'_P!>/?O^ RE_Z.Z?]D3?]M77O^#QM_\ HRR_]ER_]LO7O^&F>WO^>FC_
M /0?@_\ KQ[]_P !E+_T=T_[(F_[:NO?\'C;_P#1EE_[+E_[9>O?\-,]O?\
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M -"6B_XI[/Z=!?4?3KW]]]_?\^ERO_H2T7_%/?J=>U'TZ]_???W_ #Z7*_\
MH2T7_%/?J=>U'TZ#[9VZMW4N>W_-1]=Y#(SUNX89Z^ECSE+ :200*HA9G&F0
ME1JU+QS;WLCJH-*XZ$'^^^_O^?2Y7_T):+_BGO5.K:CZ=>_OOO[_ )]+E?\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H*>P?\ CZ.K/_#LJ/\
MW&?WL=4;B.A6]ZZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW35G?\ BR9G_M59#_K2_OW6
MCPZ2?5/_ #+K:/\ VJ(O^AF][/'K2<.A!]ZZMU[W[KW7O?NO=>]^Z]U[W[KW
M5 '_  J-51_(I^<Y  +'XRLQ M<_Z8>O1<_U-@!_K#W[KW5VG2__ #)WJ?\
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MS'W7NA%]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%/\ ^YH_]]_SSOMS\/\
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MQJ+:F!*@R#O6]V^PP^-<$@5HJ@59FI6@&/VD@#S/0AO;Z.P37(?D .)/H/\
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ME18O<BZV9K;.<EW6&ZN$A8);Q^(NIJ&4:9#3"D+_ &=.+<?EU2UWD7:2R*A
MC74*GXL,?3'P_/I8=*=K_P"F':N0W-_ /[N_8[@JL%]E_%/XOJ^VIJ2H\OD^
MVI=.K[K3I\9MIOJ.JP,>5^8?ZR6[3^'X>F0QZ=>NM%1JUTK_ !4I3RX]*=KW
M#]Y1F33IHQ6E:\ #Z#UZ3_\ IT_XSM_H4_NM_P"3-_&_^K/_ !;_ (!?9_\
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MHK:=Z2=U$:S0U\P\K!'5+J6#W.7M;/RO:+N$%Q%=VK%1XL8TTUFBF@9U*DT
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M1Q.S2 <>#(H)IF@))\@30=$AZ_ZYWQVKNBAV9UWMG*;MW/D1(]-B<3")'T0
M&265V*Q001@C7++(D:7&IA<>XRVC9KK?IQ;6<;2R-4A5]!Q))H !YDD >O4>
M;7M5SO4PM[6-I)&X*H\AQ))H !YDD >O1EOD!\&.Y?C7US@.RNR,CL3^';@W
M+CMJ1X+ 9NKRF0IJO)4==6J*D-CX:'QI%CYE=H:^;UE H92S*,^;/;#<>3+-
M+R\:#2\BQ:(W=G5F1WS6-5H!&:D,<TI49Z%G,WMU?\IVJ7=VT.EY%CT([,ZL
MRN^:H%H AK1CFE*\>B:>XYZ ?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T9?:_\
MV2QVA_XD?:'_ %K7W+6S_P#*G7__ #VV_P#@3J2=L_Y5>]_YZX/\"]%H]Q+U
M&W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7)'>)TDC=HY(V5XY$8HRLAN"".00>01[VK%348(R"/+K8)4U'6W=\,>]8_D
M'\?ME;UJJN.IW7CJ8[3WW&) [KEMOJD<TL@'Z37P-3UBC^RM0J_4'WT ]O.9
MQS;M,-T2#(!X4X\Q+'0&OIJ%' ]&'6;_ ")S$.9]LBN":R >'-ZB5* D_P"F
M%''R8=&H]C?H8=>]^Z]T$_>/_,KMT?\ D%_]V-)[LG'JK\.A8]UZMU[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=!3U]_Q]':?_ (=E/_[C)[V>J+Q/0K>]=7Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[H*>P?^/HZL_\.RH_]QG]['5&XCH5O>NK]>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]TU9W_BR9G_ +560_ZTO[]UH\.DGU3_ ,RZVC_VJ(O^AF][/'K2
M<.A!]ZZMU[W[KW7O?NO=>]^Z]U[W[KW58'\YCYJ]I_R[?Y;/R/\ F+TI@.O]
MT=F]/_Z'_P"[6"[2Q61S>"G_ -(&_=K;6K?OJ7$Y7"9"7Q8_-U<D/BRD.FH2
M)W\D:O%)[KW2R^6?S-[D^-GQNZ/[KZP^'';WS.WCVCOSI'9FY.L>@Y8**LPU
M%VA&KY'<<GWJU>G'8MK1HLS1TQJ)Z9,ADL;1FHR-/[KW5AOOW7NO>_=>Z)#\
MG_E;VOT'WG\-NIM@_#SN?Y%;3^3G:F9Z^[,[@ZVJ*:'#]78_&4D4Z9_<HFBD
MUT<K2R2%9*BB0TM)6FFJ*K)+18JO]U[H[WOW7NO>_=>Z][]U[JI'^=[\]>X/
MY:O\O+L[Y:=%[;ZVW7V-LK=_5F Q>%[9P^4SN$DAWQGJ+%U;5%-A\Q@:]Y8Z
M>I=H2F215D"EUD4%#[KW5MWOW7NJ2_G+_->[W^//S=V)_+Z^)'\O[<'SB^1>
M]/CG0?*-\6/DKM?XU8NDVO)GMP[=K&.4W+05U/-74=?A:8^#]OS15@9'UP,D
MGNO=-W4W\XW>VW.]NC_C1_,A^!?</\N/M+Y(9VNV=TINS<G:6U?D)UQG=Q)*
MBT&V(-^;7F@IX-P96.>F%+2U&+B$E2_VHE+M T_NO='!^=G\QWICX(P]6[7W
M'MCLCN_Y!=^[E;:/Q]^+?0^!AW?OC=]72E&KJBBH9ZJCI:+#8>!_N,CDJRK@
MI::%6(:273"WNO=5][L_G%?-GXYX?</;GSF_DL?([X]?%K 5E/4Y3O#JSY'=
M>_*VOPN$GG*2Y_=FS]LS4F5P-!CZ9Z>HKC'45XI4^Y!:0TX,WNO=7?=6]Q=8
M=U]5;.[OZLWO@-Z=3[_VI0[WVEOO$5RO05>+R$/G2K$KZ/$J)J\JR!'A9725
M4=&4>Z]U25F_YX^[N[\[O_"?RLOY=OR'_F28+KG.-MC+=Z8;>&#^.'5N0R-#
M53T]?2[>WQNA*E-PFB%+,3+0XF6GE)@:*9J:J@J7]U[JP[X/?*7Y*_)'&;YI
MODY\!^VO@OO78\&SI5Q6^^R=K]N87.-NA<B:A-NY_;E2#6_PAJ",59J,91D"
MKI2BL6D6+W7NCX^_=>Z][]U[KWOW7NO>_=>Z*?\ ]S1_[[_GG?;GX?\ 5Z]-
M_B_U>G13_<.\V?\ )0E_VG_5M.@7NO\ ;M_M?^.CKWL.]%_7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO= E\CO^9)[_P#^U91_^YE-[#'.?_)+N/\
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M\Z(3]I=2?\W3EUI_V1KDO_$?]L_];\S[>V/_ )5EO^>>[_X]-U>Q_P"28?\
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M78@&PN0->9MKDWJQEMHBH9]%"Y(7MD1S6@8\%/EQZ.]SM6O8&B2@+::5K3#
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M-'-6B*..-(T$AE'A'VI!,2B]*?4;J/9S+LTMQNEN?#TVUI%^F:K0R4   K7
MTTP,IQX=*WLGDNH^VD42=N1EJ4]:XQ^SH=-[X2JW+LO=^W*&2GBKMP;7S^$H
MY:MVCB67*TDT$;2LB2.L:O("Q5&(%[*3Q[%&ZVK7UK- E TD4B*36@+H5%:
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MPF'@I72*>5.'[*#HNW5G0G9^S:FLVUN7>V*RO5M;CMQX^JVYCZJI\DHSM/)
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MT+*"7(K0NQJ:5 -/(8& .EVVV?T,*QXJ,L1YDY/I]GV=!7_H4W5_LRG^F/\
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MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NFK._\
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MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T9?:_\
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MX#$8O!8:C@Q^(PN.H<1BJ"F011P4V-B6&"&-1PJ11(JJ!P  /?0Z"!+9%CC
M544*JC 55% !\@!3K.R"%;9%C0!550J@8 510 ?8!TX^W>G>O>_=>Z"?O'_F
M5VZ/_(+_ .[&D]V3CU5^'0L>Z]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@IZ^_
MX^CM/_P[*?\ ]QD][/5%XGH5O>NK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T%/8/_ !]'
M5G_AV5'_ +C/[V.J-Q'0K>]=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[IJSO_ !9,S_VJ
MLA_UI?W[K1X=)/JG_F76T?\ M41?]#-[V>/6DX="#[UU;KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NBG_\ <T?^^_YYWVY^'_5Z]-_B_P!7IT4_W#O-G_)0E_VG_5M.@7NO
M]NW^U_XZ.O>P[T7]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW53GSN_YF[MS_ ,1QB/\ W9YCW%WO=_N?9?\ 2LMO^KD_
M4)>\?_)0M_\ GAA_ZNS]$J]PQU$G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=&7VO\ ]DL=
MH?\ B1]H?]:U]RUL_P#RIU__ ,]MO_@3J2=L_P"57O?^>N#_  +T6CW$O4;=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=7
MU_RA^BOX?@=Y?(+-T2BJW!)-L;8TDR D46.D23*U<?)XJ*Q(:=6LK*:6=?TR
M<Y5>P'*_@02[M*.Z4F&&O^^U-78?Z9P%]>P^1ZR3]D.7?!BEW.09D)ABK_ I
M!=A]K +Z]I\CU=;[R.ZGWKWOW7NO>_=>Z"?O'_F5VZ/_ ""_^[&D]V3CU5^'
M0L>Z]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@IZ^_X^CM/_P .RG_]QD][/5%X
MGH5O>NK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T%/8/\ Q]'5G_AV5'_N,_O8ZHW$="M[
MUU?H)NV^Y]D]-8+^+[JK6>LJED7#;?H2LM96R)]1%&2 D2$C7*Y"(.+ERJ-'
MGN-[G;5[86?U6XR=S5$-NE#/.P\D4D8%>YV(5<5-2 4EW>I9K5N/D!Q/4OJ'
MM+!]P;(QN\L*GVAJ&DI,MB'J!4R45736\M-(X2/78,CH_C77&Z/I6^D*/;?G
M^T]RMIBW2T[==5EB+:F@F6FJ-C1:TJ"IH-2E6H*TZM:72W:!U_,>AZ$[V.^E
M/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=-6=_XLF9_[560_ZTO[]UH\.DGU3_S+K:/_ &J(O^AF][/'K2<.A!]Z
MZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW13_^YH_]]_SSOMS\/^KUZ;_%_J].BG^X=YL_
MY*$O^T_ZMIT"]U_MV_VO_'1U[V'>B_KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ<^=W_,W=N?\ B.,1_P"[/,>XN][O
M]S[+_I66W_5R?J$O>/\ Y*%O_P \,/\ U=GZ)5[ACJ).O>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z,OM?\ [)8[0_\ $C[0_P"M:^Y:V?\ Y4Z__P">VW_P)U).V?\ *KWO
M_/7!_@7HM'N)>HVZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NE1LC9^<[!WCMC8VVJ5JS/[MSN+V]B:< V,^5F2%"Y .B)"^IW/"
M(&9B%!/M?M6VR[Q<Q6L(J\LBQJ/FQ J?D.)/D 3TMVZPDW2XCMH15Y75%'S8
M@9^0XD^0SUN9=6=>87J;KG9?6VWEMB-F;>QV"II2FAIFI(P)JF07/[M5.99I
M.?UNWOHMLNU1;':0V</P0QK&/4Z10D_,FI/S/6>.T;9'LUK%:Q?#$BH/G09)
M^9-2?F>E][,^C+KWOW7NO>_=>Z"?O'_F5VZ/_(+_ .[&D]V3CU5^'0L>Z]6Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7N@IZ^_X^CM/_P[*?\ ]QD][/5%XGH5O>NK
M]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]T%/8/_ !]'5G_AV5'_ +C/[V.J-Q'7/N/MG;73
M&QLAO+<=33J5DCQF"QLM2E*]?D:Q7--1PECR\FAW:P8K$DDFEM-B"O<#G6W]
MO]JFW*=6D*#3%"E2\TS5"1K0$Y.6-#I4,U#3I'N.XQ;9'KE95J=*ZF"ZF-:
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M>=.K'/;/3W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW35G?^+)F?^U5D/\
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MGOW]:YO]]6__ #C/_077OWH_\,?^\_[/7OXA4_\ '23_ ,Z)O^OGOW]:YO\
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M ,XS_P!!=>_>C_PQ_P"\_P"SU[^(5/\ QTD_\Z)O^OGOW]:YO]]6_P#SC/\
MT%U[]Z/_  Q_[S_L]>_B%3_QTD_\Z)O^OGOW]:YO]]6__.,_]!=>_>C_ ,,?
M^\_[/7OXA4_\=)/_ #HF_P"OGOW]:YO]]6__ #C/_077OWH_\,?^\_[/7OXA
M4_\ '23_ ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ_P"\_P"SU[^(5/\
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M/7OXA4_\=)/_ #HF_P"OGOW]:YO]]6__ #C/_077OWH_\,?^\_[/7OXA4_\
M'23_ ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ_P"\_P"SU[^(5/\ QTD_
M\Z)O^OGOW]:YO]]6_P#SC/\ T%U[]Z/_  Q_[S_L]>_B%3_QTD_\Z)O^OGOW
M]:YO]]6__.,_]!=>_>C_ ,,?^\_[/7OXA4_\=)/_ #HF_P"OGOW]:YO]]6__
M #C/_077OWH_\,?^\_[/7OXA4_\ '23_ ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!
M=>_>C_PQ_P"\_P"SU[^(5/\ QTD_\Z)O^OGOW]:YO]]6_P#SC/\ T%U[]Z/_
M  Q_[S_L]>_B%3_QTD_\Z)O^OGOW]:YO]]6__.,_]!=>_>C_ ,,?^\_[/7OX
MA4_\=)/_ #HF_P"OGOW]:YO]]6__ #C/_077OWH_\,?^\_[/7OXA4_\ '23_
M ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ_P"\_P"SU[^(5/\ QTD_\Z)O
M^OGOW]:YO]]6_P#SC/\ T%U[]Z/_  Q_[S_L]>_B%3_QTD_\Z)O^OGOW]:YO
M]]6__.,_]!=>_>C_ ,,?^\_[/7OXA4_\=)/_ #HF_P"OGOW]:YO]]6__ #C/
M_077OWH_\,?^\_[/7OXA4_\ '23_ ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!=>_>
MC_PQ_P"\_P"SU[^(5/\ QTD_\Z)O^OGOW]:YO]]6_P#SC/\ T%U[]Z/_  Q_
M[S_L]>_B%3_QTD_\Z)O^OGOW]:YO]]6__.,_]!=>_>C_ ,,?^\_[/7OXA4_\
M=)/_ #HF_P"OGOW]:YO]]6__ #C/_077OWH_\,?^\_[/7OXA4_\ '23_ ,Z)
MO^OGOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ_P"\_P"SU[^(5/\ QTD_\Z)O^OGO
MW]:YO]]6_P#SC/\ T%U[]Z/_  Q_[S_L]>_B%3_QTD_\Z)O^OGOW]:YO]]6_
M_.,_]!=>_>C_ ,,?^\_[/7OXA4_\=)/_ #HF_P"OGOW]:YO]]6__ #C/_077
MOWH_\,?^\_[/7OXA4_\ '23_ ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ
M_P"\_P"SU[^(5/\ QTD_\Z)O^OGOW]:YO]]6_P#SC/\ T%U[]Z/_  Q_[S_L
M]>_B%3_QTD_\Z)O^OGOW]:YO]]6__.,_]!=>_>C_ ,,?^\_[/7OXA4_\=)/_
M #HF_P"OGOW]:YO]]6__ #C/_077OWH_\,?^\_[/7OXA4_\ '23_ ,Z)O^OG
MOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ_P"\_P"SU[^(5/\ QTD_\Z)O^OGOW]:Y
MO]]6_P#SC/\ T%U[]Z/_  Q_[S_L]>_B%3_QTD_\Z)O^OGOW]:YO]]6__.,_
M]!=>_>C_ ,,?^\_[/7OXA4_\=)/_ #HF_P"OGOW]:YO]]6__ #C/_077OWH_
M\,?^\_[/7OXA4_\ '23_ ,Z)O^OGOW]:YO\ ?5O_ ,XS_P!!=>_>C_PQ_P"\
M_P"SU[^(5/\ QTD_\Z)O^OGOW]:YO]]6_P#SC/\ T%U[]Z/_  Q_[S_L]>_B
M%3_QTD_\Z)O^OGOW]:YO]]6__.,_]!=>_>C_ ,,?^\_[/5=ORR[ES&P.Q\1B
M*':?7V?BK-F8_+25F[=KKG:E7J*_)1&-)GF1A"!"&"V-F9VOZO8"]T/<"XY?
MN[:..VLI1)8PS$SV_B,I=Y054ZQ1!IP/(DYSU%WN3SE-L=Y#&D%I('M8Y"9H
M?$8%GE% =0HHTX'J3Z]%@_V9[<O_ #[CI;_T7L?_ -4>XT_UWKS_ )0ML_[(
M_P#KIU'G^N7<_P#*)M__ &2C_H/KW^S/;E_Y]QTM_P"B]C_^J/?O]=Z\_P"4
M+;/^R/\ ZZ=>_P!<NY_Y1-O_ .R4?]!]>_V9[<O_ #[CI;_T7L?_ -4>_?Z[
MUY_RA;9_V1_]=.O?ZY=S_P HFW_]DH_Z#Z]_LSVY?^?<=+?^B]C_ /JCW[_7
M>O/^4+;/^R/_ *Z=>_UR[G_E$V__ +)1_P!!]>_V9[<O_/N.EO\ T7L?_P!4
M>_?Z[UY_RA;9_P!D?_73KW^N7<_\HFW_ /9*/^@^O?[,]N7_ )]QTM_Z+V/_
M .J/?O\ 7>O/^4+;/^R/_KIU[_7+N?\ E$V__LE'_0?7O]F>W+_S[CI;_P!%
M['_]4>_?Z[UY_P H6V?]D?\ UTZ]_KEW/_*)M_\ V2C_ *#Z]_LSVY?^?<=+
M?^B]C_\ JCW[_7>O/^4+;/\ LC_ZZ=>_UR[G_E$V_P#[)1_T'U[_ &9[<O\
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M /9*/^@^O?[,]N7_ )]QTM_Z+V/_ .J/?O\ 7>O/^4+;/^R/_KIU[_7+N?\
ME$V__LE'_0?7O]F>W+_S[CI;_P!%['_]4>_?Z[UY_P H6V?]D?\ UTZ]_KEW
M/_*)M_\ V2C_ *#Z]_LSVY?^?<=+?^B]C_\ JCW[_7>O/^4+;/\ LC_ZZ=>_
MUR[G_E$V_P#[)1_T'U[_ &9[<O\ S[CI;_T7L?\ ]4>_?Z[UY_RA;9_V1_\
M73KW^N7<_P#*)M__ &2C_H/KW^S/;E_Y]QTM_P"B]C_^J/?O]=Z\_P"4+;/^
MR/\ ZZ=>_P!<NY_Y1-O_ .R4?]!]>_V9[<O_ #[CI;_T7L?_ -4>_?Z[UY_R
MA;9_V1_]=.O?ZY=S_P HFW_]DH_Z#Z]_LSVY?^?<=+?^B]C_ /JCW[_7>O/^
M4+;/^R/_ *Z=>_UR[G_E$V__ +)1_P!!]>_V9[<O_/N.EO\ T7L?_P!4>_?Z
M[UY_RA;9_P!D?_73KW^N7<_\HFW_ /9*/^@^O?[,]N7_ )]QTM_Z+V/_ .J/
M?O\ 7>O/^4+;/^R/_KIU[_7+N?\ E$V__LE'_0?7O]F>W+_S[CI;_P!%['_]
M4>_?Z[UY_P H6V?]D?\ UTZ]_KEW/_*)M_\ V2C_ *#Z]_LSVY?^?<=+?^B]
MC_\ JCW[_7>O/^4+;/\ LC_ZZ=>_UR[G_E$V_P#[)1_T'U[_ &9[<O\ S[CI
M;_T7L?\ ]4>_?Z[UY_RA;9_V1_\ 73KW^N7<_P#*)M__ &2C_H/KW^S/;E_Y
M]QTM_P"B]C_^J/?O]=Z\_P"4+;/^R/\ ZZ=>_P!<NY_Y1-O_ .R4?]!]#?@N
M\\W5]"[[W>^R^LHJO$[TVYBXL5!LY(J"5:U 3)/3>8B6=+^A]8T_T]R#MWN'
M<3\N7=^;:Q#Q74,8C%O2%@P7+)KRPK@UQT-;'G::;8KF\-O9AH[B) @@ B8,
M!EEU985P:XZ!#_9GMR_\^XZ6_P#1>Q__ %1[C[_7>O/^4+;/^R/_ *Z= K_7
M+N?^43;_ /LE'_0?7O\ 9GMR_P#/N.EO_1>Q_P#U1[]_KO7G_*%MG_9'_P!=
M.O?ZY=S_ ,HFW_\ 9*/^@^O?[,]N7_GW'2W_ *+V/_ZH]^_UWKS_ )0ML_[(
M_P#KIU[_ %R[G_E$V_\ [)1_T'U[_9GMR_\ /N.EO_1>Q_\ U1[]_KO7G_*%
MMG_9'_UTZ]_KEW/_ "B;?_V2C_H/KW^S/;E_Y]QTM_Z+V/\ ^J/?O]=Z\_Y0
MML_[(_\ KIU[_7+N?^43;_\ LE'_ $'U[_9GMR_\^XZ6_P#1>Q__ %1[]_KO
M7G_*%MG_ &1_]=.O?ZY=S_RB;?\ ]DH_Z#Z]_LSVY?\ GW'2W_HO8_\ ZH]^
M_P!=Z\_Y0ML_[(_^NG7O]<NY_P"43;_^R4?]!]>_V9[<O_/N.EO_ $7L?_U1
M[]_KO7G_ "A;9_V1_P#73KW^N7<_\HFW_P#9*/\ H/KW^S/;E_Y]QTM_Z+V/
M_P"J/?O]=Z\_Y0ML_P"R/_KIU[_7+N?^43;_ /LE'_0?7O\ 9GMR_P#/N.EO
M_1>Q_P#U1[]_KO7G_*%MG_9'_P!=.O?ZY=S_ ,HFW_\ 9*/^@^O?[,]N7_GW
M'2W_ *+V/_ZH]^_UWKS_ )0ML_[(_P#KIU[_ %R[G_E$V_\ [)1_T'U[_9GM
MR_\ /N.EO_1>Q_\ U1[]_KO7G_*%MG_9'_UTZ]_KEW/_ "B;?_V2C_H/KW^S
M/;E_Y]QTM_Z+V/\ ^J/?O]=Z\_Y0ML_[(_\ KIU[_7+N?^43;_\ LE'_ $'U
M[_9GMR_\^XZ6_P#1>Q__ %1[]_KO7G_*%MG_ &1_]=.O?ZY=S_RB;?\ ]DH_
MZ#Z]_LSVY?\ GW'2W_HO8_\ ZH]^_P!=Z\_Y0ML_[(_^NG7O]<NY_P"43;_^
MR4?]!]>_V9[<O_/N.EO_ $7L?_U1[]_KO7G_ "A;9_V1_P#73KW^N7<_\HFW
M_P#9*/\ H/KW^S/;E_Y]QTM_Z+V/_P"J/?O]=Z\_Y0ML_P"R/_KIU[_7+N?^
M43;_ /LE'_0?7O\ 9GMR_P#/N.EO_1>Q_P#U1[]_KO7G_*%MG_9'_P!=.O?Z
MY=S_ ,HFW_\ 9*/^@^O?[,]N7_GW'2W_ *+V/_ZH]^_UWKS_ )0ML_[(_P#K
MIU[_ %R[G_E$V_\ [)1_T'U[_9GMR_\ /N.EO_1>Q_\ U1[]_KO7G_*%MG_9
M'_UTZ]_KEW/_ "B;?_V2C_H/KW^S/;E_Y]QTM_Z+V/\ ^J/?O]=Z\_Y0ML_[
M(_\ KIU[_7+N?^43;_\ LE'_ $'U>=\ ,AM;O#H6'.0562V?N/![GS>"WA@-
MBUYVSCQ5 I44]5!1HK:!4X^>DU.7;5-'* P"Z%R9]K.9TYHVH3".**1)'CFC
MAC$<8<$,"%SQ1EJ:G-?2@R&]MM^3F/;1*$CCD21TE2)-"!L,"%SQ4K4U.:^E
M.CO?Z(\9_P ]=V'_ .A9)_T9[DBO4@:!U[_1'C/^>N[#_P#0LD_Z,]^KU[0.
MO?Z(\9_SUW8?_H62?]&>_5Z]H'7O]$>,_P">N[#_ /0LD_Z,]^KU[0.@][5Z
MZH<%L+/96'<>\J^2E_A>FDRNX7KJ=_/6T\9\D10!M(<E>>& /X]V4YZTR4'0
MA?Z(\9_SUW8?_H62?]&>ZUZWH'7O]$>,_P">N[#_ /0LD_Z,]^KU[0.O?Z(\
M9_SUW8?_ *%DG_1GOU>O:!U[_1'C/^>N[#_]"R3_ *,]^KU[0.O?Z(\9_P ]
M=V'_ .A9)_T9[]7KV@=>_P!$>,_YZ[L/_P!"R3_HSWZO7M Z]_HCQG_/7=A_
M^A9)_P!&>_5Z]H'7O]$>,_YZ[L/_ -"R3_HSWZO7M Z]_HCQG_/7=A_^A9)_
MT9[]7KV@=>_T1XS_ )Z[L/\ ]"R3_HSWZO7M Z]_HCQG_/7=A_\ H62?]&>_
M5Z]H'7O]$>,_YZ[L/_T+)/\ HSWZO7M Z]_HCQG_ #UW8?\ Z%DG_1GOU>O:
M!U[_ $1XS_GKNP__ $+)/^C/?J]>T#KW^B/&?\]=V'_Z%DG_ $9[]7KV@=>_
MT1XS_GKNP_\ T+)/^C/?J]>T#KW^B/&?\]=V'_Z%DG_1GOU>O:!U[_1'C/\
MGKNP_P#T+)/^C/?J]>T#KW^B/&?\]=V'_P"A9)_T9[]7KV@=>_T1XS_GKNP_
M_0LD_P"C/?J]>T#KW^B/&?\ /7=A_P#H62?]&>_5Z]H'7O\ 1'C/^>N[#_\
M0LD_Z,]^KU[0.O?Z(\9_SUW8?_H62?\ 1GOU>O:!U[_1'C/^>N[#_P#0LD_Z
M,]^KU[0.O?Z(\9_SUW8?_H62?]&>_5Z]H'7O]$>,_P">N[#_ /0LD_Z,]^KU
M[0.O?Z(\9_SUW8?_ *%DG_1GOU>O:!T'VSNNJ#(Y[?\ 2ON/>5,N)W##21RT
M6X7IY)@T"OKJ'"$RR7-M1MQQ[V6ZJ%K7H0?]$>,_YZ[L/_T+)/\ HSWJO5M
MZ]_HCQG_ #UW8?\ Z%DG_1GOU>O:!U[_ $1XS_GKNP__ $+)/^C/?J]>T#KW
M^B/&?\]=V'_Z%DG_ $9[]7KV@=>_T1XS_GKNP_\ T+)/^C/?J]>T#KW^B/&?
M\]=V'_Z%DG_1GOU>O:!U[_1'C/\ GKNP_P#T+)/^C/?J]>T#KW^B/&?\]=V'
M_P"A9)_T9[]7KV@=>_T1XS_GKNP__0LD_P"C/?J]>T#KW^B/&?\ /7=A_P#H
M62?]&>_5Z]H'7O\ 1'C/^>N[#_\ 0LD_Z,]^KU[0.O?Z(\9_SUW8?_H62?\
M1GOU>O:!U[_1'C/^>N[#_P#0LD_Z,]^KU[0.O?Z(\9_SUW8?_H62?]&>_5Z]
MH'7O]$>,_P">N[#_ /0LD_Z,]^KU[0.O?Z(\9_SUW8?_ *%DG_1GOU>O:!U[
M_1'C/^>N[#_]"R3_ *,]^KU[0.O?Z(\9_P ]=V'_ .A9)_T9[]7KV@=>_P!$
M>,_YZ[L/_P!"R3_HSWZO7M Z]_HCQG_/7=A_^A9)_P!&>_5Z]H'7O]$>,_YZ
M[L/_ -"R3_HSWZO7M Z]_HCQG_/7=A_^A9)_T9[]7KV@=>_T1XS_ )Z[L/\
M]"R3_HSWZO7M Z]_HCQG_/7=A_\ H62?]&>_5Z]H'7O]$>,_YZ[L/_T+)/\
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M@?\ #8P67]JZQ\S3Y=;)7O,3K*SKWOW7NO>_=>Z][]U[H)^\?^97;H_\@O\
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M%;',C[*V-4RUT/\ !I)FJ6:;$Y.&LCS&.J#]Y4CS4^0CET2,FO0=/NRS,IU
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MT9?:_P#V2QVA_P")'VA_UK7W+6S_ /*G7_\ SVV_^!.I)VS_ )5>]_YZX/\
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ME@ZV U6-W#09#&Y^MKZK"YBF-/+15"8LEXJB&22.)"[)[KW5D?PL_F-_#?\
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MCHTJ6VSB\3#+59$2ZJ.*:*AFD"S1T\L?NO=;">_.C^F^TMT=>;V[*ZMV#O\
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M5_C'NO=4H?R\/^X-OY-?^(6^<O\ [O<W[]U[K:4_E._]NLOY:?\ XH!\-_\
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MY47[7N+[7,)4\L,.&I3Q'^;T-#T.?;[GBY]O]SCW"W[E'9-%6@FA8@LA.:'
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M5;X3QZW=6YEHRX8<.BK87Y\_S_H]HQ=8U7\L_ Y;N6FI5Q3]MY&)\9A)I %
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MJZJ=Q%''%3*7DD=C8*B(I))-@!?W2218E+L0 H)).  !4D_9U5F" DX R3Z
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MMN.KAKUV_/N-:49B7"+7T\%2*%JPTHGCCF\7D16'NO=+#<6W-O;OP>4VQNS
MX;=&VLY138[-[>W%BX,U0UE/4"TD%525*2T]1#(.&22-E8?4'W[KW2%Z>Z,Z
M3^/.SDZ[Z!Z>ZLZ-Z_3)UV:38W3W7V)ZSPXK,GH^YJQC,+245$*FH\<?EE\&
MN32NMCI%O=>ZE=@]-=/]M5FP\CVKU3UMV;D.J][8?LOK"N[!V-B]YS;<W)MU
M_)C]P8&7)4M2^'S="_JIZZD:&JA;F.53[]U[KV?Z:Z?W7V/L'N/=/5/6VY>W
M>J:;<=%U=VIG]C8O,[DVW#O&E>BR\. SE12R9/#Q96BDDIZQ:2JA6IA9HI@Z
M,5/NO="!6T5'DJ.KQV1I*:OQ]?33T5=0UL"54,T-4ACEAFBD#))%(C,K*RE6
M4D$$'W[KW01;-^./QYZZZIGZ'Z^Z&Z8V)T=51Y>&JZ:V;U=@]L;4D3/RM/7K
M)MVAH8,0ZUL[O)4 T9$TC,\FIB3[]U[H%=D?RWOY=_6>>AW3UO\  KX7=?;G
MIXF@I]Q[(^+>Q]J5Z([(Y1*R@P5/4*I>.-B!(!J53]5%O=>Z.534U/1T\%'1
MP0TM)2PQ4U+2TT2P1QQP*%2.-% 5$10 J@    "WOW7NLWOW7NO>_=>Z*?\
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M(J>GEHZ&>K,<4:Q2&H4O T.LRQ*6N\?D0 M>RYUAW*^2S@1F!U:I:T52$9Z
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5.?.[_F;NW/\
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MIGZ;Z [<^0&5S&$ZCV@^[<E@,?%E,O ,WC<$L,$\@A1S+DZRBA8M(;!%D9R
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M4B_\=?I"]_?]DL=*_P#E./\ WG*SV4\W_P#) LO^H;_M&?I)O'_)/@_YM_\
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M[*ONR]]93L[L+>O8>:9SD]Z;GS6XZE))/+X_XK.\J0*; >.GC98T 4 (B@
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MEI':2)I<520P2-$SI&[1L\9*ED4D6NH/'L6[5:M8VL,#T+1Q1HQ%:$H@4TJ
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M=8"ZB/R"FEHY8HY_$B*7BKHRVE3Q86(;#D_==G9HK2[1(&8ME-3Y%*Z2A%:
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M:8:NA/SI>-)MMFL3)$',-L H4(P&L !.ZK#@"?3JT/\ E[3_ ##SN^=XX'Y
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M -\XG+83)9N"3,9..@IL[CZO%5J[:H*[*56.V?)5XZOJX)I<%28Z61)&U.2
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MKIW_ $)_&CKO;592_:[BSU"=];N5D"/_ !#=BI/XI0&8>2CHQ1TC$&Q^WO\
MGWGY[:<N_P!6=FMX&%)&7QI?7Q)>X@T\U&E*_P!'K-OV]V+^KVTP0L*.Z^++
MZZY*-0_-1I3_ &O1N?8\Z&O7O?NO=>]^Z]T$_>/_ #*[='_D%_\ =C2>[)QZ
MJ_#H6/=>K=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW04]??\ 'T=I_P#AV4__ +C)
M[V>J+Q/0K>]=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H*>P?^/HZL_\ #LJ/_<9_>QU1
MN(Z%;WKJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-6=_XLF9_[560_P"M+^_=:/#I)]4_
M\RZVC_VJ(O\ H9O>SQZTG#H0?>NK=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4_P#[FC_W
MW_/.^W/P_P"KUZ;_ !?ZO3HI_N'>;/\ DH2_[3_JVG0+W7^W;_:_\='7O8=Z
M+^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[JISYW?\S=VY_XCC$?^[/,>XN][O]S[+_I66W_5R?J$O>/_ )*%O_SPP_\
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*?\
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M[_=%_2_ZJ]>_Q#Y_\;Z]]MLG_G<U7_H,S?\ UV]^_P!T7]+_ *J]>_Q#Y_\
M&^O?;;)_YW-5_P"@S-_]=O?O]T7]+_JKU[_$/G_QOKWVVR?^=S5?^@S-_P#7
M;W[_ '1?TO\ JKU[_$/G_P ;Z]]MLG_G<U7_ *#,W_UV]^_W1?TO^JO7O\0^
M?_&^O?;;)_YW-5_Z#,W_ -=O?O\ =%_2_P"JO7O\0^?_ !OKWVVR?^=S5?\
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M !OKWVVR?^=S5?\ H,S?_7;W[_=%_2_ZJ]>_Q#Y_\;Z]]MLG_G<U7_H,S?\
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MLG_G<U7_ *#,W_UV]^_W1?TO^JO7O\0^?_&^O?;;)_YW-5_Z#,W_ -=O?O\
M=%_2_P"JO7O\0^?_ !OKWVVR?^=S5?\ H,S?_7;W[_=%_2_ZJ]>_Q#Y_\;Z]
M]MLG_G<U7_H,S?\ UV]^_P!T7]+_ *J]>_Q#Y_\ &^O?;;)_YW-5_P"@S-_]
M=O?O]T7]+_JKU[_$/G_QOKWVVR?^=S5?^@S-_P#7;W[_ '1?TO\ JKU[_$/G
M_P ;Z]]MLG_G<U7_ *#,W_UV]^_W1?TO^JO7O\0^?_&^O?;;)_YW-5_Z#,W_
M -=O?O\ =%_2_P"JO7O\0^?_ !OKWVVR?^=S5?\ H,S?_7;W[_=%_2_ZJ]>_
MQ#Y_\;Z]]MLG_G<U7_H,S?\ UV]^_P!T7]+_ *J]>_Q#Y_\ &^O?;;)_YW-5
M_P"@S-_]=O?O]T7]+_JKU[_$/G_QOKWVVR?^=S5?^@S-_P#7;W[_ '1?TO\
MJKU[_$/G_P ;Z]]MLG_G<U7_ *#,W_UV]^_W1?TO^JO7O\0^?_&^O?;;)_YW
M-5_Z#,W_ -=O?O\ =%_2_P"JO7O\0^?_ !OKWVVR?^=S5?\ H,S?_7;W[_=%
M_2_ZJ]>_Q#Y_\;Z]]MLG_G<U7_H,S?\ UV]^_P!T7]+_ *J]>_Q#Y_\ &^O?
M;;)_YW-5_P"@S-_]=O?O]T7]+_JKU[_$/G_QOKWVVR?^=S5?^@S-_P#7;W[_
M '1?TO\ JKU[_$/G_P ;Z]]MLG_G<U7_ *#,W_UV]^_W1?TO^JO7O\0^?_&^
MO?;;)_YW-5_Z#,W_ -=O?O\ =%_2_P"JO7O\0^?_ !OKWVVR?^=S5?\ H,S?
M_7;W[_=%_2_ZJ]>_Q#Y_\;Z]]MLG_G<U7_H,S?\ UV]^_P!T7]+_ *J]>_Q#
MY_\ &^B*?)6F^(O]_,;_ *7LSV)_>/\ NM1_P_\ @.V6\'V'WE?XOT9;]?G^
MY_5ZM.F_L%^X7]4_J;?][>-XGTD7@^'XM/I]<FBNGSKJK7/"O4=<^?U;^JB_
M>GC>)].GA^'XE/!UR:?A\ZZN.>'1>OMOY>'_ #N>WO\ T&9?_KM[ /\ S#[_
M )>O^SCH$?\ ((_Y>?\ JKU[[;^7A_SN>WO_ $&9?_KM[]_S#[_EZ_[..O?\
M@C_EY_ZJ]>^V_EX?\[GM[_T&9?\ Z[>_?\P^_P"7K_LXZ]_R"/\ EY_ZJ]>^
MV_EX?\[GM[_T&9?_ *[>_?\ ,/O^7K_LXZ]_R"/^7G_JKU[[;^7A_P [GM[_
M -!F7_Z[>_?\P^_Y>O\ LXZ]_P @C_EY_P"JO7OMOY>'_.Y[>_\ 09E_^NWO
MW_,/O^7K_LXZ]_R"/^7G_JKU[[;^7A_SN>WO_09E_P#KM[]_S#[_ )>O^SCK
MW_((_P"7G_JKU[[;^7A_SN>WO_09E_\ KM[]_P P^_Y>O^SCKW_((_Y>?^JO
M7OMOY>'_ #N>WO\ T&9?_KM[]_S#[_EZ_P"SCKW_ ""/^7G_ *J]>^V_EX?\
M[GM[_P!!F7_Z[>_?\P^_Y>O^SCKW_((_Y>?^JO7OMOY>'_.Y[>_]!F7_ .NW
MOW_,/O\ EZ_[..O?\@C_ )>?^JO7OMOY>'_.Y[>_]!F7_P"NWOW_ ##[_EZ_
M[..O?\@C_EY_ZJ]>^V_EX?\ .Y[>_P#09E_^NWOW_,/O^7K_ +..O?\ ((_Y
M>?\ JKU[[;^7A_SN>WO_ $&9?_KM[]_S#[_EZ_[..O?\@C_EY_ZJ]>^V_EX?
M\[GM[_T&9?\ Z[>_?\P^_P"7K_LXZ]_R"/\ EY_ZJ]>^V_EX?\[GM[_T&9?_
M *[>_?\ ,/O^7K_LXZ]_R"/^7G_JKU[[;^7A_P [GM[_ -!F7_Z[>_?\P^_Y
M>O\ LXZ]_P @C_EY_P"JO7OMOY>'_.Y[>_\ 09E_^NWOW_,/O^7K_LXZ]_R"
M/^7G_JKU[[;^7A_SN>WO_09E_P#KM[]_S#[_ )>O^SCKW_((_P"7G_JKU[[;
M^7A_SN>WO_09E_\ KM[]_P P^_Y>O^SCKW_((_Y>?^JO7OMOY>'_ #N>WO\
MT&9?_KM[]_S#[_EZ_P"SCKW_ ""/^7G_ *J]>^V_EX?\[GM[_P!!F7_Z[>_?
M\P^_Y>O^SCKW_((_Y>?^JO7OMOY>'_.Y[>_]!F7_ .NWOW_,/O\ EZ_[..O?
M\@C_ )>?^JO7OMOY>'_.Y[>_]!F7_P"NWOW_ ##[_EZ_[..O?\@C_EY_ZJ]>
M^V_EX?\ .Y[>_P#09E_^NWOW_,/O^7K_ +..O?\ ((_Y>?\ JKU[[;^7A_SN
M>WO_ $&9?_KM[]_S#[_EZ_[..O?\@C_EY_ZJ]"WAZ;X7?Z&MX?P_,]G?Z._[
MUX+^\'DVR?N?OM ^V\=\MY/'IMJMQ_7V-;'^J/[BN?"\?Z'ZB+QJ^+K\6@TT
MKW4X5ICH5VG]5_W/<>'X_P!)X\?BU\35XE!IIYTX5ICH)/MOY>'_ #N>WO\
MT&9?_KM[!7_,/O\ EZ_[..@I_P @C_EY_P"JO7OMOY>'_.Y[>_\ 09E_^NWO
MW_,/O^7K_LXZ]_R"/^7G_JKU[[;^7A_SN>WO_09E_P#KM[]_S#[_ )>O^SCK
MW_((_P"7G_JKU[[;^7A_SN>WO_09E_\ KM[]_P P^_Y>O^SCKW_((_Y>?^JO
M7OMOY>'_ #N>WO\ T&9?_KM[]_S#[_EZ_P"SCKW_ ""/^7G_ *J]>^V_EX?\
M[GM[_P!!F7_Z[>_?\P^_Y>O^SCKW_((_Y>?^JO7OMOY>'_.Y[>_]!F7_ .NW
MOW_,/O\ EZ_[..O?\@C_ )>?^JO7OMOY>'_.Y[>_]!F7_P"NWOW_ ##[_EZ_
M[..O?\@C_EY_ZJ]>^V_EX?\ .Y[>_P#09E_^NWOW_,/O^7K_ +..O?\ ((_Y
M>?\ JKU[[;^7A_SN>WO_ $&9?_KM[]_S#[_EZ_[..O?\@C_EY_ZJ]>^V_EX?
M\[GM[_T&9?\ Z[>_?\P^_P"7K_LXZ]_R"/\ EY_ZJ]>^V_EX?\[GM[_T&9?_
M *[>_?\ ,/O^7K_LXZ]_R"/^7G_JKU[[;^7A_P [GM[_ -!F7_Z[>_?\P^_Y
M>O\ LXZ]_P @C_EY_P"JO7OMOY>'_.Y[>_\ 09E_^NWOW_,/O^7K_LXZ]_R"
M/^7G_JKU[[;^7A_SN>WO_09E_P#KM[]_S#[_ )>O^SCKW_((_P"7G_JKU[[;
M^7A_SN>WO_09E_\ KM[]_P P^_Y>O^SCKW_((_Y>?^JO7OMOY>'_ #N>WO\
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M!FC_ /KM[]CKV?\ 53KWVW<'_.YH?_09H_\ Z[>_8Z]G_53KWVW<'_.YH?\
MT&:/_P"NWOV.O9_U4Z]]MW!_SN:'_P!!FC_^NWOV.O9_U4Z]]MW!_P [FA_]
M!FC_ /KM[]CKV?\ 53KWVW<'_.YH?_09H_\ Z[>_8Z]G_53KWVW<'_.YH?\
MT&:/_P"NWOV.O9_U4Z]]MW!_SN:'_P!!FC_^NWOV.O9_U4Z]]MW!_P [FA_]
M!FC_ /KM[]CKV?\ 53KWVW<'_.YH?_09H_\ Z[>_8Z]G_53KWVW<'_.YH?\
MT&:/_P"NWOV.O9_U4Z]]MW!_SN:'_P!!FC_^NWOV.O9_U4Z]]MW!_P [FA_]
M!FC_ /KM[]CKV?\ 53KWVW<'_.YH?_09H_\ Z[>_8Z]G_53KWVW<'_.YH?\
MT&:/_P"NWOV.O9_U4Z]]MW!_SN:'_P!!FC_^NWOV.O9_U4Z]]MW!_P [FA_]
M!FC_ /KM[]CKV?\ 53KWVW<'_.YH?_09H_\ Z[>_8Z]G_53KWVW<'_.YH?\
MT&:/_P"NWOV.O9_U4Z]]MW!_SN:'_P!!FC_^NWOV.O9_U4Z]]MW!_P [FA_]
M!FC_ /KM[]CKV?\ 53KWVW<'_.YH?_09H_\ Z[>_8Z]G_53KWVW<'_.YH?\
MT&:/_P"NWOV.O9_U4Z]]MW!_SN:'_P!!FC_^NWOV.O9_U4Z]]MW!_P [FA_]
M!FC_ /KM[]CKV?\ 53H$/MLW_IG_ .+S4_Z0/_#9I?M/^+5_VMM/_ +_ )/]
(W\NJ^?SZ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>timage_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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MCOETV^N[Z/N7ICH_OW;G4?2'>?:.R=O_ !^^0.]Z=>H=D;F["I>^>B*7:O6
MZSS>%[ R]=3X1JK:VUJK-8E15#&1P"&>H]U[K!_,_P"T_E5\7^O:_P"6?2?R
MRH-+]A=!]<]#_#O(]0]99KKGY![R[7W]L'8M)UMF>PCA,OW7/N_L"MRU?+BL
MMM[+XN@P='(:BJQU?#22RGW7NI?\RSM'Y>?%:CVE\@.FOD1'N6MW7\D/C;TE
MU1\**WJ7KJ3:O<$/;O9W6&R=[[?R.^SALMW//OG#;6;=.XZ+)8;)XW'8W'PM
M]YC:Q:0SM[KW06=T?*'>^,_F4[^ZA[0^<?R#^%72VV#\6=O]([?HOC5U%D/C
M]\A]];^:NR&_MM97Y,=L_%WLK%8?.YW+9_;^W8<13[UP.4,LDQH8?*&G3W7N
MK!.K._MV57SG^4WQ+WK5MDZ?9O4WQ]^3'462_A>-H7I.M.X:[L_K#<&SZVJQ
MR4S92?;79O1N3K8*B>$U#4F:CA>67[<'W[KW1W??NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U55V5_+*_P!(>[_YN.ZO]-G\'_X=/^*W6WQF^P_T
M;?Q#_03_ */.C^[^F?[[?=?W^HO])_\ %_\ 3)_$OX;X]O?;_P -^W^ZD^X\
M\'NO=%3^2?\ (N_V87:&^MJ_[-'_ '0_OI_*J^/'\LK[_P#T)?Q_^&_Z!.\#
MW-_IL^U_TNX3[S^]=_X;_=OR1?8_\"/XK4?YCW[KW0]?.+^5WU]\H.T/EGWS
MVGOC>N2V)W;_ "SX_A!G.H.MNO8,UV)0-LSN3?G?^*[1V%N&ISM=39_>:9K<
M=-2XO;TF!\;UU#%*U8ZS&"/W7NB=?&GXO=W?+KYL]L]O_*6L[C[$Z-KOY87:
MG\OO=.Y^W?B9/\,F[&;NSO6@S>YL1MCJ[?&X]S]GY*NV_L+8+IG]Q5JMMG.U
MV9@J<'!24FN*;W7NC]?R\?Y7VP_@)DLK787'?%?/9*#8.*ZMVIV3U;\'.GOC
M7W[7['H),'5Y&F[J[>ZTS%0>WLQN;*[<HJW(RP8G;N/JJRCIZAZ(U$1F?W7N
MFNL^(ORBP>=_F8[!^//<$?QNC^9/877_ ,B.J_E%5;'VQW')U?V#NCJ'KOHC
MN_:F-ZO;?_6^?;=V,PO1&,S&%RM9/+B*>3<:.OW%103T\GNO="M_+K^'G<OP
MDZK/2N^>[.E^V.O,)24TFRX.LOC5O+H_=?\ >O)Y/,YOL;?_ &IO+>OR@^1F
M8[<WOV5G,HN0R.3J305LF0-1/-+4FH"P^Z]T7S9'\H/!;7_E[=(?!S)=^;AK
MMP?'GY,3_*_K7N[ ;'H]O1P=HXSY8[Z^5.R8-R=79/=6Z\5N;:6#R>]/X/D,
M?4933DX:;[N-Z*<PBG]U[H8.L?Y9O6%=D/D'O3YK+U=\X>Q?D_N+I[<?:5#V
M-T'LV@Z Q]3T/LK)[)ZU3KCX_;PRO;&*VO6XJDW'EJBHRV0R^;SU9+D/%+7F
MEIJ."#W7N@+[=_EF_*#<WRMZW[]Z<^7/QOZPZF^.6PL9U]\/?BQN_P"!F<[!
MZH^+]%3[6H]I93=FQ\=LKYC=*;:KNPZW 0RXB@RDF#@7;VW'&,Q4%'&]7+5^
MZ]TY=P_R]OF_V'\UJ3YB[<^>G25"FQ-GR;,Z ZA[0^$.]>S]F]#Q9S&TU'V#
MN_; V_\ -[JK&9WLKL*2)XJO/Y'&35M'BBN/H330&I^Y]U[H7_E;\$.XOF9E
M\EUMW1\HL#)\+LKV#U1V1DOC_M3X]8W#]IY7(]/]B[)[1V[M'+?(;)=GYW'2
M]>Y+=>QZ=\A3TVR:3-S0RO%'E8D]/OW7NA2ZGZ+WD/G9\K/EAOC#5.WJ'<G4
M_P >_BWT[05&3V[7OGNM^GJ_M+MO<G8;0X"LKY\5!N;LOO[(8JFH\D\61CBV
MV:AXDAJX%'NO='D]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5I?-K^<)_+B_ET;]VEU?\ ,CY*8[J#
ML'?&T?[^[;VG%UOW'V/EZK9SYG);>I]PUT/4_7>^EP>.K\WA:VFI6KVIC5RT
M50(1)X)='NO=&T^,OR<Z*^8_2.R/D=\:^P:'M#ICL:#+S[/WI08K<.!CR8P&
M>RFU\U!48+=N(P&Y\-78O/X6JI9Z:NHJ:HCDA-TL03[KW0\^_=>Z][]U[K5
M_G<_ST_FA_+I^='7?Q-^,72_QO['PN[?BEM7Y!Y3,]SQ=C#-TN6S7;?;?7>0
MQE#5;1WYMC&_PF"AV)02Q(],\_FGG+2E-"H7;E?)MT0N)3120OPEC4U/\2^G
M0,YXYTVOD/:DWK>G*6[R+$-$1D;6RNPP'3%$/^H]53_]!2'\WK_O%;X$?]3>
M[_\ [;GLE_K39?Q'_G&?^MG44_\ !*>WW^_YO^R1O^M_7O\ H*0_F]?]XK?
MC_J;W?\ _;<]^_K39?Q'_G&?^MG7O^"4]OO]_P W_9(W_6_KW_04A_-Z_P"\
M5O@1_P!3>[__ +;GOW]:;+^(_P#.,_\ 6SKW_!*>WW^_YO\ LD;_ *W]>_Z"
MD/YO7_>*WP(_ZF]W_P#VW/?OZTV7\1_YQG_K9U[_ ()3V^_W_-_V2-_UOZ]_
MT%(?S>O^\5O@1_U-[O\ _MN>_?UILOXC_P XS_ULZ]_P2GM]_O\ F_[)&_ZW
M]>_Z"D/YO7_>*WP(_P"IO=__ -MSW[^M-E_$?^<9_P"MG7O^"4]OO]_S?]DC
M?];^O?\ 04A_-Z_[Q6^!'_4WN_\ ^VY[]_6FR_B/_.,_];.O?\$I[??[_F_[
M)&_ZW]>_Z"D/YO7_ 'BM\"/^IO=__P!MSW[^M-E_$?\ G&?^MG7O^"4]OO\
M?\W_ &2-_P!;^O?]!2'\WK_O%;X$?]3>[_\ [;GOW]:;+^(_\XS_ -;.O?\
M!*>WW^_YO^R1O^M_7O\ H*0_F]?]XK? C_J;W?\ _;<]^_K39?Q'_G&?^MG7
MO^"4]OO]_P W_9(W_6_KW_04A_-Z_P"\5O@1_P!3>[__ +;GOW]:;+^(_P#.
M,_\ 6SKW_!*>WW^_YO\ LD;_ *W]>_Z"D/YO7_>*WP(_ZF]W_P#VW/?OZTV7
M\1_YQG_K9U[_ ()3V^_W_-_V2-_UOZ]_T%(?S>O^\5O@1_U-[O\ _MN>_?UI
MLOXC_P XS_ULZ]_P2GM]_O\ F_[)&_ZW]>_Z"D/YO7_>*WP(_P"IO=__ -MS
MW[^M-E_$?^<9_P"MG7O^"4]OO]_S?]DC?];^O?\ 04A_-Z_[Q6^!'_4WN_\
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M:OXF_P"<9_Z"Z]_T%G_S:?\ O%;X(_\ G'W9_P#;Q]^_UG^9O]]Q_P#90/\
MK3U[^M^U?Q-_SC/_ $%U[_H+/_FT_P#>*WP1_P#./NS_ .WC[]_K/\S?[[C_
M .R@?]:>O?UOVK^)O^<9_P"@NO?]!9_\VG_O%;X(_P#G'W9_]O'W[_6?YF_W
MW'_V4#_K3U[^M^U?Q-_SC/\ T%U[_H+/_FT_]XK?!'_SC[L_^WC[]_K/\S?[
M[C_[*!_UIZ]_6_:OXF_YQG_H+KW_ $%G_P VG_O%;X(_^<?=G_V\??O]9_F;
M_?<?_90/^M/7OZW[5_$W_.,_]!=>_P"@L_\ FT_]XK?!'_SC[L_^WC[]_K/\
MS?[[C_[*!_UIZ]_6_:OXF_YQG_H+KW_06?\ S:?^\5O@C_YQ]V?_ &\??O\
M6?YF_P!]Q_\ 90/^M/7OZW[5_$W_ #C/_077O^@L_P#FT_\ >*WP1_\ ./NS
M_P"WC[]_K/\ ,W^^X_\ LH'_ %IZ]_6_:OXF_P"<9_Z"Z]_T%G_S:?\ O%;X
M(_\ G'W9_P#;Q]^_UG^9O]]Q_P#90/\ K3U[^M^U?Q-_SC/_ $%U[_H+/_FT
M_P#>*WP1_P#./NS_ .WC[]_K/\S?[[C_ .R@?]:>O?UOVK^)O^<9_P"@NO?]
M!9_\VG_O%;X(_P#G'W9_]O'W[_6?YF_WW'_V4#_K3U[^M^U?Q-_SC/\ T%U[
M_H+/_FT_]XK?!'_SC[L_^WC[]_K/\S?[[C_[*!_UIZ]_6_:OXF_YQG_H+KW_
M $%G_P VG_O%;X(_^<?=G_V\??O]9_F;_?<?_90/^M/7OZW[5_$W_.,_]!=>
M_P"@L_\ FT_]XK?!'_SC[L_^WC[]_K/\S?[[C_[*!_UIZ]_6_:OXF_YQG_H+
MKW_06?\ S:?^\5O@C_YQ]V?_ &\??O\ 6?YF_P!]Q_\ 90/^M/7OZW[5_$W_
M #C/_077O^@L_P#FT_\ >*WP1_\ ./NS_P"WC[]_K/\ ,W^^X_\ LH'_ %IZ
M]_6_:OXF_P"<9_Z"Z]_T%G_S:?\ O%;X(_\ G'W9_P#;Q]^_UG^9O]]Q_P#9
M0/\ K3U[^M^U?Q-_SC/_ $%U[_H+/_FT_P#>*WP1_P#./NS_ .WC[]_K/\S?
M[[C_ .R@?]:>O?UOVK^)O^<9_P"@NO?]!9_\VG_O%;X(_P#G'W9_]O'W[_6?
MYF_WW'_V4#_K3U[^M^U?Q-_SC/\ T%U[_H+/_FT_]XK?!'_SC[L_^WC[]_K/
M\S?[[C_[*!_UIZ]_6_:OXF_YQG_H+KW_ $%G_P VG_O%;X(_^<?=G_V\??O]
M9_F;_?<?_90/^M/7OZW[5_$W_.,_]!=>_P"@L_\ FT_]XK?!'_SC[L_^WC[]
M_K/\S?[[C_[*!_UIZ]_6_:OXF_YQG_H+KW_06?\ S:?^\5O@C_YQ]V?_ &\?
M?O\ 6?YF_P!]Q_\ 90/^M/7OZW[5_$W_ #C/_077O^@L_P#FT_\ >*WP1_\
M./NS_P"WC[]_K/\ ,W^^X_\ LH'_ %IZ]_6_:OXF_P"<9_Z"Z]_T%G_S:?\
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M0OF-_P!X#_/3_P!)=WE_]CWOW^MZ?XHO][D_S=>_X$SGK_H[6'[9O^M'7O\
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M $F_L+_[#O8I_P!?C8?^4:Z_YQP_];>BC_6^O?\ ?T7[7_Z!ZNMZP_FS?)#
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MM_FO_P!X%_-G_P!)O["_^P[W[_7XV'_E&NO^<</_ %MZ]_K?7O\ OZ+]K_\
M0/7OM_FO_P!X%_-G_P!)O["_^P[W[_7XV'_E&NO^<</_ %MZ]_K?7O\ OZ+]
MK_\ 0/7OM_FO_P!X%_-G_P!)O["_^P[W[_7XV'_E&NO^<</_ %MZ]_K?7O\
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M<ONW)U>XLGM3:VRMO5,E'+EA14OVV+I0E!2P+)Y)5DFD]U[H@OS_ /\ A/\
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MRQW-_P"DX?)'_P"U3[]U[KW_ $%5_P CS_O+'<W_ *3A\D?_ +5/OW7NO?\
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M'<-1NOKO;T>X**.2AQ^ P-;EUQICR=96TU7/3'W7NB]_\,^?[]+^ZW^S$?\
M=:O_ (>#^^_T2?\ ?[/],7^R[_:_Z3?_ "'?WM\G_31_!?\ ='OW7NGG9_\
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MGV']T?\ G(CR_P!U?YU?8O\ .#_YE)H^_P#[_P#^E'_G'?\ YF:_VO\ "?\
M25_Q]O[GG^R_XLL?F_:]U[H"^[_Y<$?QEK-X_*O:?</<-?WK_P .7_('YZ=.
M[LZ?^&^Z_DI+U5_LR/QIQ'0_8'4O871&P=ZU6_NX.N*K:6RG^ZR6#K]NY6HR
M%911P00F,M+[KW1J_P"3WT1W!T_UG\P-_=U46]L7N3Y8?/[O[Y0X/&]D[0VQ
ML#?D.S-U;=ZPZXV]D-R['VGD,CCMHS;GCZKDS%)C)W&3H,;D*:"O,M;'//-[
MKW0.2_RZ_EYOC^7#B/Y>VTOD1A_AYB^M>S^P^LY=_8;KN'MN3O+X=XS?.X\G
MU3M/%+UOVU\>,_T_#NWK+,XK![G%'4T>:ADQM?3T<R05$.1F]U[J;WM_+&^;
M'?7QKZJ^+69^=GQLV=U+L'=U+4;PZYV!_+\WQMKJON'J':N$VA0]<= [YV?2
M?/;^\0ZTP>6PN1JLY24N?BI]U4U524%9"E'25<63]U[HRN^?@OW/V+B?B[V7
MG/D?UK@?FE\1:_MP=4][;#^+L.#Z9EVEW#MF79>Y.N=P_&_/]U[OS1V75;:Q
MV#-0N*W]B<A)D,#3ST]720O)2'W7NI73'\JCXB[(Z]@VUWCU%T_\N-]S=\]]
M_)S*]H]_=']6;RS%-W;\E.PH^R.U-S["QF?V[G8>N*#(Y?'8RFIZ:@G:=:'"
MT"5%34RTRS'W7NH.\O@AW+WIWQTSV3\GOE)M[L_JSXQ]^I\DOCUU!L7X\8[J
MK*8SLK&;3[ V=M&J[?[*JNTNP:CLG&[)QO8,\M!!A<1L[RU5/%)6&JL1[]U[
MI]VA\)NY,S\DND_D7\FOE=+WA6_&6D[0@Z*VALOI?#]%XN#(]N;)Q^P=U;J[
M>K<-OC>,G9^Y8]O)714D%)#MW;D#5J3_ ,):MHZ:K3W7N@CZB_E20=:]@])1
M9[Y$[H["^-'Q7[X[/^2OQ?\ C_F-C8K&YKK?M/M,]NQ5%'N?MJCW#--O[K;K
M;']S96#9N&&"Q55AET+4U^0ACA@A]U[HT?P>Z7WMU5LWNO>/:& H]J=G_)3Y
M.=R?(O>>UZ6KV_E)MLTVZ:_%;)ZRVWELYM=I<)G\_M[I/KW;%#7U<$DT;U=/
M(BRS(BRO[KW1U??NO=>]^Z]U$K:"AR5.])D:.DKZ20HTE+6T\-53N8V#H7AG
M22-BCJ"+C@B_OW7NF3^Y6S?^>2VS_P">'%?_ %+[]U[KW]RMF_\ /);9_P#/
M#BO_ *E]^Z]U[^Y6S?\ GDML_P#GAQ7_ -2^_=>ZI]_G];5VO1?R;_Y@-71;
M;P%)50=&5+PU-+A\=3U$+_WIVT-44T5.DD;6-K@@^_=>ZL>^('_9)?Q=_P#%
M=>D__?:;9]^Z]T8KW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T5^I^'W1M7\R
M,?\ /*; Y<_(_&?'=_BS2[F7<>77!KTY)V#7=GM@WVF*C^!/DO[X9"2?[_Q?
M=^,B+7XQI]^Z]T:#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW11/DM\(NB_ECV%\6^SNW:+<]5NGX?=RT'>_34N W%
M-A*&DW]COL333;BHXJ>9<[B0<;$33,8P;'U<GW[KW1N_?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= 7\F/CGU=\M^B.R_C?W7B\
MEFNJNW-O_P!U][XG$9FOV_D<AAC7T61>FI<UC)(<ACGDJ*".\D+K(%N 1>_O
MW7NA*V+LW!]=;(V=U]MB*>#;>Q-J[>V;MZ"JJ)*RJAP>V,11X3$Q5-7+^[53
MQT%#&'D;U.P+'D^_=>Z57OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZIM_G6_*SOSXD?'KJ_?/Q[WY_H_W3N+N:BVGF<I_=?9FZ_O,!+LC>>8DH/LM
M[[=W)CJ?5D<33R>6*%)QX](?2S*9F]DN4]@YOYCNK#F*W^HBCMC(JZY(Z.)8
MEK6)T/!B*$TSPZ#G,U_=[?9)+9OH8N 30'&EC^('TZN2]PST(^O>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUY_^%'?_ &2;TI_XL1CO_?:]
MA^\B/NV_\K?>_P#/&W_5Z'H(<Y_\DZ/_ )J#_CK=;#'O'?H7]>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW5;?7G\W_P#EI]M?)R#X<=8?+OK+?_R,JZO(XZ@V#M&/
M=.=I,IE</!F:K,X;#[[QVW9^N<QF\-2[>K)JRBI<O+54D,#/+&B%2?=>ZLD]
M^Z]T4_9WSD^*F^^QOECU3M[M_$_WV^#5-M&M^5M)G\%N_9^#Z>H-\[9W'O+;
M62S&]-W[>P6RLWBZK;&TLC63U.(R&0@H(J5ONG@9D5O=>Z=OBI\Q?CE\V^O\
M_P!J?%_L-^T>NMM[]SG6M=N^'9V_=I86OW5MW'8/+Y+^Z]3OS:VUO[Z[9;';
MCHY:7/885^"KQ*PI:R9HI0GNO=&:]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=%M^)OR[^/'SDZ3P'R*^+787^E#IS=&3W#A\%O#^Z>^-D_?9':N8J\!GZ?\
MN_V)MK:6Z:;[#+44L6N:ACCETZHV="&/NO=>V!\N_CQVA\CN_/B3L7L+^.?(
M/XP8SKC,=Y=?_P!T]\8S^X^.[:VQ1;QZ^J/[UYC;6/V3N7^\&V\A#4Z,/DLA
M)2:_'4K#*&0>Z]T9+W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]TC.QGWY'U]OF3JV';U1V9'M#<C]>T^[7JXMJS[W7#UC;6AW
M))0$5T>"ES@@6K:$B00%BO-O:S;A8G<(!NA<6WB)XICIX@BU#Q-%<:M-=-<5
MI7IN7Q?";P::Z'37AJIBM/*O'JMC^7%_,5R'RJEWSTAW]MG$]3?+WJ#*9JAW
MYUU24U?A\?G,7BLH^/GSFVL7F,EF,A3U&"J'CI,K2&LJO',4J8G^WJ5CADKW
M(]NH^5!!OG+\K7>SWJJ89B0Q5F6NB0JJC.2ITBHJI&I34FV?>#?Z[6[41W,9
M.I>%17B*D_GD^O ]%!_X4=_]DF]*?^+$8[_WVO8?L9?=M_Y6^]_YXV_ZO0]%
MO.?_ "3H_P#FH/\ CK=;#'O'?H7]4X5G\R7L'NSYV[-^*'PQV1MGL?K[86Y0
MWRF[DW!#F)MO8';F-R4=-N6CV+EL560XZ&KQJ4]124M9515<.8R[QP4RQTT<
ME:\Q)[;[?LG(<W-O.D[VUQ<)_B%LFG6[D51I585H:@D @HG<:L0G0>.\RW.Z
M+M^VH'5#^JYK0#S"D>?^$XX5/5Q_N'>A#U[W[KW7O?NO=,FYL3CL]MO<&#R\
M\E-B<UA,MB<I4PU"TDM/CLC05%'6SQ53ADII(J:9F60@A"+GZ>_=>ZU&?B/-
M\J/Y$'=/P>_E^;TK_C]\N?Y<ORH^1>Z>L/B?VUL3%3X;Y3]4[S[3SFXMSTV:
M[#P.)I<A@=Z[<ILAN62'*9JC,T5'BY99GKJ*E@AQI]U[I T_\XG^:_WO\COE
M#O#XK_'KY!]D]=_%?YR[D^,L7QKZU^./1^\^F]X=3]7[GVQA^R,OV]\@MT]M
M[9^0&R?D5G,"<ED,)C\)@O[K8V6:EIZJ3(WGEI?=>Z+S\B,'NW/;P_X6:Q;0
MW]6]?5&-V1\+,YGJV@P&!W!-N;:6'Z+[VK-R[!ECW!35=/B:+>V,C>@J,A3*
M*^C@E=Z9XYM$B^Z]U=K_ "_OD;VC\+?Y57\L/"Y3X]?-?Y]5'97P^Z;WMB\Y
M\7^EN@G@Z>VAE.J>N,_M#K#>4.8[5Z5HJI-NXC<PQF)RBPY'*YFGQ4U5E9FK
M&::I]U[JK'YX?SN/F1TGO;Y"?+KXF=@]J]V?#+XD?,+&_%SNS;6^.@/BALGX
MUUF?Q^:P\.^^MMD;YK>TZ#YJ;L[*Q,6YJ:FIMQT>(7;=XQ(^/>E/\2D]U[H^
M_P B_G=\W.@/YM^W^NOE'V;V!\2?Y?F^NX>@>K/ASO#8/QFZW[MZ*^56[=ZT
M&!B[#ZF^1?>%=49OM'HCL?,[BJ*^GVN<=!@::"FQ^0K:P5%#C/N:[W7NGX_.
M3YH=9?S9Y.FOFUV;N_XH_&_LOY 4_47P=VMMSX^===C?&/Y9;=S&*\6U,)NO
MY75(?LGK/Y+;FS2H\>W7BQV/BF>3'0+7N8:P^Z]U75UC_.,_F]?)O*YKY,_&
M?XY?*3L#K[:_RAW-UXGQ9VY\/.C:KHC)=%;-W]38#=.'WMW]N3Y 87Y/[2^5
M6.VK3SU1']WZ3;E'E76BGQ4L+"NB]U[H2ODS_,1_FJIW%_/;_P! 'R<ZAZ]Z
MS_E09+I3MS;6S]__ !RVOV%G]_;*W]U14[HK>G,=NV@RNTEVQM]*OKG.5M5E
M<C1;ASE549:&FIJO'P0!U]U[HP/Q$_F/?S!)OG?_ "O=F_)KL[ICLKHK^;_\
M.=X_(_K?K#K/I9^N:_XN;DVYTPGR#Q^U9=[9+>>Z=P]F4!V7.F,J\E621?=Y
M!M<-!11Q%Y_=>ZI0_ED_+;YM_P O_P#D6_%OYC]1]S]7;OZ:VI\S\GU-G_A9
M#TO2YOL3N#;/9/=<V-W/B<#V,V\)]V5/>,E=7U%7@,?BJ+'4$6(D22I@KI(R
MTGNO=6#]B?+K/_ [^9__ ,*C_EKM/9LV_MU],_&[^71FMK;83'9+*453N7.=
M ]:;0P&2W!28@KD/[G[<R^XH<EFY8WB%/B*2IE:2)$:1?=>ZL._E#?+W^9YW
M7WID=L?*KJKOK<_QBW[\<L3W)LOY(]U_'OI/X[38'NRMW-BWR?4>P<%T3VAV
MKMW>?1^:V1N..OVOF,Q7C<R#&RQ5[59D6I/NO=;%OOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JD?^:7\&-[[DS&WOGA\1/O]
MN?+3HLTV>KZ/;%,6R':VU\'3F)Z8T-/9\SNO#842TJ4VF1LWB))<;(DW^2QK
M-OM9SU8VL,O(?-])-GW"J N<6\C'# G@A:A)_ X$@([JAK?-KED==UV_%Q#G
M'XP/+[:?M&/3JJ?^9?\ /#8?SP_EP]%;WPXH\#V9M;Y#8#"]N]?).S3;9W)+
MU?V,8<GC%G)J*K:.YUIY*C&U!+Z0LE-(YGIYK2S[8<A[AR%[EW]A<5DMI;-V
MMYJ8D3QX<&G!UK1A]C#M8=$&^;K#NNR13)AUD =?0Z&_D?+_ #@]6 _S$?F]
MVE\@.UQ_+6^!#39[L[=TTF#[P[9P61>+%=>8".58MT[;I<_CV<8E<32N5W)D
MPQ-&C?PRF2;(3M'!'GMWR/M6P;1_KF<_]EI#W6MNP[IWI5'*'C4_V:_B_M&(
MC6K&^\;G<75Q^Y=IS(V'<<$'F*^7S/EP&3BTKX0_"WK#X/=+XOJ[8$$.2SU:
MM)E.R.P)J,4N9[!W:E/XILK6(T]6]!B:/6\6.QZRO%14Y(N\LDTTL6\[\Z;I
MSSO;[MN)*H*K#$#588ZX48%2>+-2K'Y  'NV;;!MEL+>$9XLWFQ]3_D'ET<7
MV#NC#KWOW7NO>_=>Z;\MBL?G,5D\)EJ9*W%9C'UF*R5'(76.KQ^0II*2LII&
MB9)%2>GF9"58, >"#[]U[JMWXX?R;?Y87Q([</?'QY^&O4W7?;D5=6Y+$;WA
MCW'N7)[2K<EAFV_7R[!@WCG]PXWKM:O"RRT\B8*#'(T=1/<7GF+^Z]TNMY?R
MO/@1OWY!5'RGW'\;MHGOC(Y/#9O/[[P.8WIL\[QSNW*_!93;N?W_ +9VAN?!
M;.["S^W\AMJCEH*[.8_(5=&\;^&1/--Y/=>Z<\K_ "VOA9FZ[YJY+)],?<UO
M\Q+"[5V[\Q9O](O;$/\ I@P^R=NY_:>V*/QT^^HHNO\ ^&;?W174_DVLN$EF
M\^N5I)$C=/=>Z-+U/U;L3H[JSK3I3JW!?W7ZRZ?Z_P!F]6]=;:_B>8S?]W=B
M=?[<QNT]HX+^,[BR&7W!E_X1M_$4]/\ =5U755E1X]<TLDC,Y]U[JMGMK^1=
M_*@[RRG<F8[-^'.S,Y7=^[OHNPNT#CMZ=M;1I,KV!29.HR\^_-O8[9O8&W\=
MU]O7/5E9,,QEMNQ8JOSE//+!D9:J"1XV]U[H:-S?RM_@9O7Y(4?RTWG\?,1N
M_O/'[NQ785!GMT[T[,W%L^A[%P7VO\#['H^H,QO6LZ<I>Q<(E# E'GX\ N7I
M8X(TBJ$5$ ]U[J3A?Y8?P4P/R/;Y:T?0.)J^^UW=GNP<?N[<&\>R=U8;;W8&
MZ:S(9#<>_=H=<[GWGE^L=F;WS==E:B:IR^)PU%D9I)69IB;$>Z]TQYO^4[_+
MQSW?%7\F)_C#L_$]T97<E%O+<6Z-H9[?FQ,9O'=^,R]%N#%[JW[L;96[-O\
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M"ON?-W\7,5C 2MO#Y!:_VC@$C6PXTPHHHJ!4B+9]HBVJWT_%*V7;U/H/D/\
M9ZL>]QQT<=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0WNC^8-
M\8NCJ^?"[J[ QM?F:7]FJQ6%FI*NJI)^"PT"]C_KCW(W+?M5SES-#]1MMJ$C
M'XF-!_@ZCW?_ ',Y5Y<F^GW.X:20_@4%C^5.@KZ\_FU_#OL+-?P%-]MMF:6;
MPK5;@CIZ"E=@+:=1^JL!;\^S7>/8_GS:;4W3VZRD?P$$_:>/^'IO;/=;D[=@
M&29H@?)U(_F?]7^#JR#;^;Q&X\12YK!UU-E,5D*7ST60QU0M5255.R<-25"O
MRK@7!!'/N)98?IB5;MH<CU_/J08IOJ!J&:^?^QTIO>NG>O>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZBR3
MI!%+)+(8HX#^Y+*I/'I.J_ (NUOH?=/+[.M@$X'58/RT_FC?';XL++@:K,IO
M#?DM-KIL)A%^]IE_ZC*RD6T2A_I[F+DKV9YJYPB^J>);6T)XN:?D ?\ -U%7
M-/NKL.PR?2;:QO[L#*H 0/M;_9ZHR[(_GK]_[FK*N7:6TL7L['&FGI\<L56T
ME:.?35MH0*K*/H!?_7]Y';;]W7DZPA5;V1[E_P 3 :1GTX_Y.H0/N]SQNK&5
MQ#:MY)4N?]L010_M^WJL#=_\W'YTP967 Y+N_-T^,W!,8A41I&#24E1932HS
M(2% ;^GL?V/L[[<P 7$6V1EE\B6H3^WY=*;O?>;][LKB!-QFTN"6 H"HQD$J
M<9\QT8OIW8.R)MN2]D]ES5VY]Q;F=\M)55]::EZPU8"?>2,"3J*K_2WL]OKJ
MY1XK/:551%B@6@6F: =8\3AFN[Z+='>W@D-=1;N8D4))&> Z)9\D,=M>>OR(
MP<)IL8")E$=4'"J3<A;D64?[#V?V32K"KR&K^>//H_Y1GD:\:R<'37%37'V=
M8?CE_,4^;O5^+BZTZ][9W&NP,8AI\31UU0E:N*I>0%A=CJ86Y]7U_/L*;[[7
M\@[W<B_W3;XVE(\@17J9[K>MRY;V [=ME[)'&*\2#]E#_GSU87U7_.6^:/4.
M5:OW)5P]Q8Z4A9\5G6:$_P!H#2Z"W!^GT]@7?O83D#>[?Z>TC^A8_B3/\NDV
MT^Z'.>WCQ8IEE%<B3%?SX?X.KN/CC_/-^/7:M3MS;G:F-J^M-W9^JIJ*&)@U
M9A8*NH *!:[TV!TW^GN >;/NY\T[.'N]CD%[$@J5X,,^G^JG4F[5[];!0?O^
M)K%6- V2I.3_ *JTZNRP>X<)N;%PY7;F4QV6H*A-<5=CZCS4S@WNRO2MHE!O
M_7WCW<0W=I<FUO%TD_M!^?4Y6\UM=+JM2& Z5OO73O7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U'GFABA,LLWBB]/[@_VK]-O2WZO];W4D4X]
M; K@=$6[\_F-?$/XR9:CP';_ &UAL#F*M-4-+3H<JW 'ZA1>4C2O^/T]R#R_
M[4<]\VV?UNQVE4X5:@'\^@3O'N'RCL%V+*_NJMQHH)(_9U4[\^/YUOQ@ROQ]
MS6V_C=V]%G^PMW--@8HJ2CFAJZ&BK0JM*2RDJJV(!;C_ !Y/N7/;3V5Y@L><
M(+GFRU"VZ!B 2*$@$@<?]GH!<Z^X>V[ORU<6O+MPWCL5K13A6-"3Q\N'EUK6
MX7+X_,**O<]369;*5E29ZO(UM9]U)_E!YYJ1_3WFGV+'54"JHH !3A\NL.[_
M &_<[2\-K8W#=YJ23G/SZ$;=M)U1C-H+70YE),J8N8%0GDW_ -XO[3QS3M,5
M=.SR->DFV;?OTTY,#_J^8IU4W\G=ZX2':]9D\++JDHM$FJ*Q!,$A3CZ$$LP]
MEO-%S+MG+MQ<L=.@+]OQ*?\  .LH_;':;D[CXESG4":?E3JSOX#_ "-Q/R;Z
M!P&#K]./W)M:E&(2E6LO4UE)&6TUQN;W+ _T^E^/I["'*F^1<U;#%S19II65
MB'!&%=:</D0?\/4)^Z%F_*7.DVVRFOBJKQ^I1BPS\P5(^P"H'#HPG?G0^'V?
MU!N7>^Y\NF(#4LT.)C:Q%95 @?:_0\E;V]B^PW%[J\%K;KJ*D5^0]>@1LVY/
M!NUL92 LAP.-:<!U5;T5NN@Q>3CH\X1 ):T0F:;@<U/%PP O[$=S"SFJ^G =
M37SG87!VTRVF309_/HXO8B;<QT=#E<3DHZR.L_SM*!?[4\\$V-^![+X&<DK,
MM".HOVN.XN#]/#4UZ"^LW=AH*1V'B28Q?YR(_N_[2+6^G^/M0 2E,]&4.SW9
MW+74E:^?#JU_^37_ #/I^D>S]Q]+=W[]>FZ5EP>0SV(RV;K'J5P63C"ZHRU3
MJ/BDO>W/((^GO'_WP]K5YIVU-\V.W!W%2 :8U+G_  4_P?/K([D/?TY-M3:7
M@(L6U4'\!Q6G#C7\NMGCJ+^9I\+N\MTP[&ZW[GPN6W'.@\%!61R8P,.02L^0
M' )'%K^\4=^]I>?=@L?WCNVVU0<2"K?EBO4I[;S_ ,I;E>_N^UN=+G(#5&/E
M6G1\L?D,?6QZZ2LIJV/\205-+46TC\&F)7W'4D+/]OV]#(R#C7_#T\>W.M]>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]T6SOSY)=5_&K9U7O#L_<M+B8HHF^RQ\TRI/DZH*JK
M2T<8!UR,>#:WL2\J\G[WSA>?0;#:ECYG H*?/H(<W\Z;'R18_7[[<A?0 &K&
MOR'[*]41]D?\* L5-6U6)ZJZAR[(B_;KFLO+ X()!(5(^3I_UOI[R2V?[L/A
M1^)ONY!SYJBG_+2G4+77OUN$S4VW;!&#P+NM/V+7_!U7O\COYPGRQ[-Z\SNT
ML9)C-B4V>A,+Y/'#PY.E@:X;2= %V_J;\>Y*Y9]A>3M@O1=W'B7+C@'P,_9T
M!I?=WFKF%/I4N8A'7/AG4:^E>&>J&L-VT*?=V;@[IGRN^#F+?;9[*5LE744-
M1_9F E\EX_ZA?H1Q];B;0D,(BM8?T(S720!IKYJ:4H?0GCYGI#S!R[N<MD^\
M\LP++=8$JZF#MZ.-5:C^B/\ :](7M7 TN/S5#N##+?'5+B:*6'F)HP?0;_U_
M'M7 H)4/\2>O\P?\/0AY<W 7^W7%K='N?%/.OX?\W[.A8Q.>J<AC87I_-J,5
M[G_'Z"WMEU$;$'H.R[;$;@,:=![GL'N[=%4$BJ*LPG_=))M>_P!.+?6WM1&T
M,8J1GHWM[VPVZ$4IT#W:O3.<EVEDZ>LBE$%33LFL"VDOP'^OUUV/^M[)^8[!
M=]V6:Q7XG&!ZD>7[.A;RCSI8Q;J;0D47!^5?/HEOQ1^0N2^)/<=10YR:>/"+
M4N\T<'JLU[,18,Y1U*D *68!?Q<'$+V^YL'M;S-><F\R,1924*M3X6&0U*@?
M(U-,GB:=2#[F<C1<_P"Q++:@&X0DYP"&XJ2 Q (H< FH7RKU=OV)\Z,)\P\'
M@^L=MRM58RBEIJRH1#&"M<B-+'(=$FI%T1$\"U_>5/*N^<L[D9IN7KI+@HM6
M*!J:20M.Y1G/6'W^M;O/*6Z1;US-;,5=RJ!V0E7"EPU4<TJ%Z0N6ZJK:;&?<
MTJ%&/T(_U^;<WOSS[$XD-=?$=#*RYSMI9?W?.<] 3N*OW713F">IK!'&>?+_
M (7'T)X ]JXDA8<!4]#&T-E)'J2A ZAU.>K4H6J9WF))%K\?3^OT' ]ZT*&T
MGRZ76UI'+*)( *MT'?7;Y3=O9<.)I7D0IXY9W%[B*Y,AXO\ 2)"/]?V&K7<K
MBYWZ2W&(HT-01^0_F1T).>(K;9.2]>D%W957_3'B?V5_P='L-;2P5<&/VY25
M.WJ^D!*Y?%,<?4*1S85=$UU_K]?9R\:R0'Q&#ZN*MD?L/6/UO->V^YBYN$I$
MO"AX'TQPZL'^)GS+^6'QTD^XVEV%F]W81O\ @9B-S5%9F4--8W DJW+*MS_:
M#>XXYQ]M.3><2!NEOX<PX-$0M?M%#_+I5M_/',7+%Q]9R[=^#;GXHY%++^3
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MP;HJ)\MDWK\MFJ]YJ^KF75)5U=22Q8EB!JO_ + #V)9]LVSPP&CJM!0 T%
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MH/F,="'?-OALY8C9$/#ED<?B7@?S[:$>1Z54^]9-K_N5PG4+PR7&JX_%[V)
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M[&>QWMH>7_;&QVSFI-%VJEFH>YJY)\_.O677W:/=/F_:MA?:[VW/THE;PR2
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M+[M%?R;BTN:5Z!-B;*SLO"?XC_J_P]5=_,[ -B\N]33A?M9X X,/T!!]1/\
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M^Q_NR_/T/]/Z^U$*AFH,='&P;+;)+K _9U7SO+>]%1U4DM9)ZFE+?@FYN/\
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M<FX_&._N5[.7G-%VVZ;3<-*R@_XN] /,]K5R?V'ACJ3MO]]X;;9!-?(OC]M
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M^GYPW(R273JEJU&B.=#?$5/H1JR!TB.Z=@R[B_CVZ\&HPVYLA1^$9"%VCJ/
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M@Y:GY9Y62XD/^,7?>W]%02*?F03]@'1%[Q;]+O?-,6QR+2VM, G\4CJIK\J
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MQ6(DQLM33SS^&NUQS),8@"5DLNF2,<\J22%Y]S;[/[O[C<R[BNU;"LM[!^,
M!E3'\1Q7_53J"]O]V(.5]HN[S9KQ[20"H0,X5E_BT@57UH:FF:]&CR_P>ZDV
M5UGN?L+*XJGR"8/%SUBX^L=[M+"Y 0P*T;:PH)%[J?>>&Y>VMVFS70FDC,Y4
ME5%*T R=7<*?SZCFR]_O?OG+?;;;V>:*SN9%1G(*C4YHJZ!H-?/TZJFH.FY-
MYX&O[:@D78^(IYI*G%!V\.DTTMM)(95)8>AA:P+ $\@'G+M?.^];3SW&^VR2
M,?J!1"3J(+::4X#_ &,<.LYE]R;7D5K+DNW/[TW?0K%URO<2:$@BIIVFG"HJ
M:D=&WZAD.$-+.I])G*Q/];'2O-['WUWMT7Z"+2:C0#^1)Z%'-ES^])6!7);_
M )]7JV;KKY>2[2VVV#KIZ>II8Z<P(]0#^;W'Y]DUSL5K.?J02'KP!Z@R_P!N
MYBEW(V44*F*G$CH@O:/<4&ZMWY 8UPS5%5YF\7I'XX^GL\MK?PT!(P.I(VCE
M)[7: +DBOGT%6_\ ?LM-A/X:K_Y3DH-$J6N1%-];W/U-N/\ 'WJ5DME,[^M%
M^;>71]RQL;7EZ"H[8?B_TO\ J'4GJC+TVUL.^.DGTUU4XF-B+A)5" 7_ *N!
M[LELT,"6ISI%"?Z1R?\ -T6<T1/NVXOS&N(OP_Z48_GT.6/G6N=7,EY)#<\_
MZ]OZ\_CWYJ &G0,> PD(W = SVON&3 0BE59:JNJ/134T?[TLLH*@G@78\V%
MK\\?U]LSW:6D#3N"0, #B2> 'VT/^JG0WY/V(;M,#-0#BQ. !_J_U<>KJ/Y3
M/\D#M'O7?G7WRE^2T2[3ZHQE32;GVWLNJ8TVY,QE*-UK<=+D:1E'V\09-6GD
MBP)(^GO$3W6]XHU:?;=J;7<!-(_ACQD YU'-*_;]O64G+>SVL%IH040'CYL>
M.0>'V?X.'6]I24U/CZ6CH:0K%!1T]-3Q@VTFFI;4^FQX4V;_ &_O$BM#3T_S
MTZ&?'/KTZ>[]>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>ZI=_F0?RD^G_F/LK+[BV=@\5U]WKCHJJLP.\\52+1'+5!L%H\
MWH\6J.4\6Y)'/UY]R[[>>\7,')$OTUU-XEFU:JV=/H17T\_\%.@-S;R-M_,*
M_4VQ*72Y#9SZ@T/ _P"K-"-4K>?\B+^;)F)/X)A]J;!">?Q#+5VYHQ3_ &W
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M::LIS3U.B8"W[52H/Z'O]!?ZCVJ@DAN(Q<VRT# $@_B)'K]H/0;B,@L_W?S
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M+X-MW9"*/)?9C)/23+323O3PP11^\-OE^T?Y^O5'0B?\/<_RBO\ O8O\2O\
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MY_E%?][%_B5_Z.+:W_U9[]X;?+]H_P _7JCKW_#W/\HK_O8O\2O_ $<6UO\
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M_P#FZ]_KM>Z__1UO_P#LND_Z"Z]_LF/7W_/J-A?^@SMC_K_[]_6ZZ_Y2I/\
M>G_S=>_UVO=?_HZW_P#V72?]!=>_V3'K[_GU&PO_ $&=L?\ 7_W[^MUU_P I
M4G^]/_FZ]_KM>Z__ $=;_P#[+I/^@NO?[)CU]_SZC87_ *#.V/\ K_[]_6ZZ
M_P"4J3_>G_S=>_UVO=?_ *.M_P#]ETG_ $%U[_9,>OO^?4;"_P#09VQ_U_\
M?OZW77_*5)_O3_YNO?Z[7NO_ -'6_P#^RZ3_ *"Z]_LF/7W_ #ZC87_H,[8_
MZ_\ OW];KK_E*D_WI_\ -U[_ %VO=?\ Z.M__P!ETG_072]^#WQ/V7N_X=_S
MU]T5FQ=KU-7\?-CYVJVS43;?Q-1+M1Z7K3N')(V!G:GJ&Q!BEPL;@T[I9HU(
M-P"!C<6MWNUQLFY1ROICTN]&8!ZLA[ABO#SZSTY7L-TYHV#D_F#<)I7GB@AE
ME8R,Q=F9&8R-7N)TYK7JNWJKXW;0W#UIL+.U>TMO555F-HX#)5%3/BL?+//-
M68VGGDFEDDJU=Y)&<DD@$D^^C'*'(_+][RMMUW/86SO+;0LS-!$S,3&I))(J
M2?,GHVWCF*^@W6Y@2XD4)(X #L  &(H .E]_LJVR/^>+VS_YYL;_ /5OL1?Z
MWW+7_1MM?^R>'_-T6_UGW#_E)E_WM^O?[*MLC_GB]L_^>;&__5OOW^M]RU_T
M;;7_ +)X?\W7OZS[A_RDR_[V_7O]E6V1_P \7MG_ ,\V-_\ JWW[_6^Y:_Z-
MMK_V3P_YNO?UGW#_ )29?][?KW^RK;(_YXO;/_GFQO\ ]6^_?ZWW+7_1MM?^
MR>'_ #=>_K/N'_*3+_O;]>_V5;9'_/%[9_\ /-C?_JWW[_6^Y:_Z-MK_ -D\
M/^;KW]9]P_Y29?\ >WZ]_LJVR/\ GB]L_P#GFQO_ -6^_?ZWW+7_ $;;7_LG
MA_S=>_K/N'_*3+_O;]>_V5;9'_/%[9_\\V-_^K??O];[EK_HVVO_ &3P_P";
MKW]9]P_Y29?][?KW^RK;(_YXO;/_ )YL;_\ 5OOW^M]RU_T;;7_LGA_S=>_K
M/N'_ "DR_P"]OU[_ &5;9'_/%[9_\\V-_P#JWW[_ %ON6O\ HVVO_9/#_FZ]
M_6?</^4F7_>WZ]_LJVR/^>+VS_YYL;_]6^_?ZWW+7_1MM?\ LGA_S=>_K/N'
M_*3+_O;]6D_ 3^5C\'>W^B/FG\A_E=@>V(=H?%3&]'9&@VW\?1U7AMT;F';&
MX-];:K8YZGL7;NZ<06QE?@J"2.S4H$+U%S(QC"@#G#8K3:=XVK9-CVK;C+N3
M3KJGMU*KX*QM_H=#D,?7R^?0BV7<Y+VSN[Z^NK@):A#2.0U.LL/Q#Y#I,_/G
M^4_\6NAMH?%OO3XU3;@W;T9\K]@;HW9M/#]Q;5VA0]I;+S.Q\KA\7N?!;GFV
MNU!MS)QQS[@ITAJ*.%87DBF\;S1>.9W.3MFVO>[S<MGWG:+&.ZVV1$<PP1F)
MQ(&*E=8K^ \36A%0#4=5WO<;BP@M;VSO)VBNE+*'=M0TTK6F/Q#_ #GH-OA5
M_*7@^2?=?2&)W1T#V))\>]]]O;/Z]W]VOL'KN6/$;<QN?SM+A\E+3;^K-N[H
MV9B,M1"INOWD,Z*XLT9O[6\U[3R7R_MEU)';;:+V&)I$ADCM]34%1^F&5R"/
M3IG9[[>MRNHE:2Y\"1@ID4R:1Y?&5*\?7IG[:_E.9&F^2GR<Z?\ CO\ 'KL'
MN3:71/=W;/7-)E-M=75V_P#.4VV=B[ZW'MS"9+>%3LK#)CZ7)UF(PJS5$HI:
M.!Y-;)%&GI5ZPV?D8['8;GO5OMUH]Y!#+1TMXP3)&K$()""0"U!DGUZ;GW#?
M?KKBUL7N9E@D=*J9'/:Q KI%*XZ ?:?\N_=6_3N-=B_'/<F]&V?DL-AMVKM/
MJS+;C.ULON/)U&%V]BMQC#T]8<)DL[F*26DHH*GQ2U53$\42LZE0;W7*W(=D
M(VO;?;X1,&:,NELFM5 9F3534 ""2*@ @G'2.'>=^N"RP/<.4(#:3*=))H U
M :$D4%?/I05/\L/M2C;>Z5?Q.[$I7ZR@6J[(6IZ3W/ W7U,U#'DUJ-[K+CE.
MU(&QLJU >O\ MU,#"2^D@^TZ[![<MX6E-M/U!I%06OZAKII'GNSC%<XZ=.Y\
MR#74W0\/XL2]N*]V,8SGRZ:=M_RX=[[QV7FNR-H?&?=VZNN]N1U<VX=^[;ZD
MS><V7@8L?&TU?+FMTXRDJL'BXZ*%2\S3SQB-02UA[=N.6>0+2[7;[N';HIWI
MIC=+99&KPHA(8U\J#/3<6\;_ #0FYA>X>,5JR^*5%.-6 ICH<*'^6!UCN;XK
M];]K[!V/V5O7O#?OR'RG3D'7&%^.6Y:[KRNQO]U&S.!@V?VCCHJ[ ;N[(K\C
M3,IV_23/E&IY6?[2..F\]64OR_RY;\Q7&VWVW[;#:06PF,C?2B0'6%)>(D,D
M=#\9&FH'<2U L7==PEVR.ZM[BY>:24H% E*$4) 5P"&;' &O'&*D$-X_RX=[
M]=[>H]W=@?&?=^Q=J9')U&$Q^Y]X]29S;&WJ[,TC3K58FCS6;I*'&U63IFII
M!)3I*TJ&-KJ-)L;6G+/(&X3FUL(=NGE U%(TMG8+_$54DTSQI3I'-O&_VT?B
MW#7,:5IJ;Q5%?2I %>@J_P!E6V1_SQ>V?_/-C?\ ZM]FG^M]RU_T;;7_ +)X
M?\W23^L^X?\ *3+_ +V_7O\ 95MD?\\7MG_SS8W_ .K??O\ 6^Y:_P"C;:_]
MD\/^;KW]9]P_Y29?][?KW^RK;(_YXO;/_GFQO_U;[]_K?<M?]&VU_P"R>'_-
MU[^L^X?\I,O^]OU[_95MD?\ /%[9_P#/-C?_ *M]^_UON6O^C;:_]D\/^;KW
M]9]P_P"4F7_>WZ]_LJVR/^>+VS_YYL;_ /5OOW^M]RU_T;;7_LGA_P W7OZS
M[A_RDR_[V_7O]E6V1_SQ>V?_ #S8W_ZM]^_UON6O^C;:_P#9/#_FZ]_6?</^
M4F7_ 'M^O?[*MLC_ )XO;/\ YYL;_P#5OOW^M]RU_P!&VU_[)X?\W7OZS[A_
MRDR_[V_7O]E6V1_SQ>V?_/-C?_JWW[_6^Y:_Z-MK_P!D\/\ FZ]_6?</^4F7
M_>WZ]_LJVR/^>+VS_P">;&__ %;[]_K?<M?]&VU_[)X?\W7OZS[A_P I,O\
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MG^#_ #]>_P!+V#_XZ_\ )E7_ /6SW[]ZQ_ZJ_P";KW[MD]/\'^?KW^E[!_\
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M$&,*-1]!Y^76P[TI\L^H]W5?\LGN/K/^8KT?\<.ANA^L>K.L>_?B]O#MC*[
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MZ]_I>P?_ !U_Y,J__K9[]^]8_P#57_-U[]VR>G^#_/U[_2]@_P#CK_R95_\
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M^TK[]^[[;^$?[Q'_ - =>_JKR_\ \H<'_9/!_P!:NO?] @/\LO\ Y_5\^/\
MT?NQ/_M*^_?N^V_A'^\1_P#0'7OZJ\O_ /*'!_V3P?\ 6KKW_0(#_++_ .?U
M?/C_ -'[L3_[2OOW[OMOX1_O$?\ T!U[^JO+_P#RAP?]D\'_ %JZ]_T" _RR
M_P#G]7SX_P#1^[$_^TK[]^[[;^$?[Q'_ - =>_JKR_\ \H<'_9/!_P!:NO?]
M @/\LO\ Y_5\^/\ T?NQ/_M*^_?N^V_A'^\1_P#0'7OZJ\O_ /*'!_V3P?\
M6KKW_0(#_++_ .?U?/C_ -'[L3_[2OOW[OMOX1_O$?\ T!U[^JO+_P#RAP?]
MD\'_ %JZ]_T" _RR_P#G]7SX_P#1^[$_^TK[]^[[;^$?[Q'_ - =>_JKR_\
M\H<'_9/!_P!:NO?] @/\LO\ Y_5\^/\ T?NQ/_M*^_?N^V_A'^\1_P#0'7OZ
MJ\O_ /*'!_V3P?\ 6KKW_0(#_++_ .?U?/C_ -'[L3_[2OOW[OMOX1_O$?\
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M?OZP;O\ \I$O_.:;_K9U[Z*V_@7_ 'E?^@>O?] <O\KC_G[_ ,[?_1W=9_\
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M_K9U[Z*V_@7_ 'E?^@>O?] <O\KC_G[_ ,[?_1W=9_\ VB??OZP;O_RD2_\
M.:;_ *V=>^BMOX%_WE?^@>O?] <O\KC_ )^_\[?_ $=W6?\ ]HGW[^L&[_\
M*1+_ ,YIO^MG7OHK;^!?]Y7_ *!Z]_T!R_RN/^?O_.W_ -'=UG_]HGW[^L&[
M_P#*1+_SFF_ZV=>^BMOX%_WE?^@>O?\ 0'+_ "N/^?O_ #M_]'=UG_\ :)]^
M_K!N_P#RD2_\YIO^MG7OHK;^!?\ >5_Z!Z]_T!R_RN/^?O\ SM_]'=UG_P#:
M)]^_K!N__*1+_P YIO\ K9U[Z*V_@7_>5_Z!Z]_T!R_RN/\ G[_SM_\ 1W=9
M_P#VB??OZP;O_P I$O\ SFF_ZV=>^BMOX%_WE?\ H'KW_0'+_*X_Y^_\[?\
MT=W6?_VB??OZP;O_ ,I$O_.:;_K9U[Z*V_@7_>5_Z!Z]_P! <O\ *X_Y^_\
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M]A[OZZZNS7RUW#E^R<!25-2=LXH9*V<RTL+54=#CZ6HG?W7N@5^=70F$S?\
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M<D\_+]&CG;;D4/AR44UXD"E?(^IQU:Q25M)D*:&MH9H*FFJ*<2PU<%IZ>>E
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MD;G_ !)N/Q]+'F_ /N3MJWPV5]0]!J^M]:XX].-5#E,D/%!(8XY "PYN#?\
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M;A?H1;3]+DZCS_3V/HH+.S8JXQT3O<78B$T#T8?E3J3_ !-*F04\$9+#45N
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M7T\_4?LZ/;+=+:+<$>_B\2-2=5<Z3Y-3Y-_AKTK=SYVHW=DJ>'$X_26#T]-
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M&2C4%,DU%#]G6JYVS\Z>X\QG:_']P5&X.P\_!&*./,96:?4%4E2K-J12"1^
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M[#UW;7MU.TBOH3BH&/V]$LT=W>SG6@*1\*GCT!G8E51Y++>7!(T*5A)B5OJ
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MR<?['7T'?Y5V^J;?OPQZWR,>7.3JZ."?'5?DK!-+ :,K&VL ZK@@_2Y;V?\
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MM8M-J5(8HA0**#Y?GUBONT,L\B2S73-+(:LS=QK_ ).A"[+^(NT]\;:V_O\
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M/H.JWL >V._7VY65Q=;DWB>"U*^? '/S'1OS1MJ6-VEE$6 9>/K45^6,_/\
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MBZ>.1I4'Z8."JT( *XJ*"@KP'Y=!.P&\6B?OHI(IC<BK?$"W%F5O+.>KN_\
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M/N7.>IN4MSWRSM-X9EH*$K7 .,G/6-W+YW*,LVW&C#CFGGZXZ?&H#-!$0/\
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M5.0U*K%9&L6LQ_01,+K<\_7Z?Z]KA?R3[2M=D[IS*I\)<K"IR0/XB/\  /\
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MQ[SG=;7RM$O*?+9831M^O+7.1\(/J<5/D/MZ _+&SW_,]VU]>ACZ>@J>-?\
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M:[?Q+GN;@ /B)IP"^1_D//.>IJ]L?;.[A8;_ +P-=U(7\&)"K,7+:032I*4
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M\_V\1Y4/SZYR53A6#U0LNI0"5(N3^+?U(_U_>@#447I3#MVV2LSU%!7TX?\
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MNJ]D;)9C_*@'#JP7ICX=?'/X_P!!/0]6]7;=V_#/4//,ZT\%8?N.!;R5@-W
M (%C;V?;=R]MNS.9;>$L[<78EW],DEORSCH:;!R%RARV"NQV:J#^?#AD]&PC
MCBIHA'&/%%%SS^G3^H\M>][_ .P]B# 'I3H79)ZS^[=:Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I)[@V_C]T8>OP.4A$V/RE+40U<+$
M*2*@>IO5;E@Q]WL[JYVN]6_LS4@\?0^O2.]M+7=;-[&]%0PX?+HH?QS^"G1/
MQGW7O'>NP=MT\.YM[3#^,9&HB#*44_=E560D)#Y&Y4?D@?6X]CWG+W-YDYTL
MH+#<)0D<)!HOF0 *G_-Z?ET$N5?;_9^5&#PLTK*I +&M,UH/+\^AP_V7GI;^
M^O\ I%_N!@?[Y:=/\6_A]+]U;3IOJTWM_M5_9+_7/FO]U?N3ZQOI^--6/LIQ
MKTO_ *G\M?O?]^?1K]3PU4S7U].AX]AGH5=>]^Z]UA\"?U;_ &X_XI[IH'7N
MLWN_7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7N@1KODE\;\7VG1='9/OSI''=VY6-:G'=/UW:>PZ
M/M/(P_=4E"E11=?U&=CW;61_>U\$(=*1AY9HTOJ=0=4'7NAL"(#J"J#]+A0#
M;^E[7]^H.O=<O>^O=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TWPY
M;%U.1K<13Y+'SY;&PTE1D<7#64\N1Q\%>)30SUM$DC5-+#6B"3Q-(JK)H;23
M8^_=>Z1O:7:W5/1VQ,[VEW7V3U[T_P!9;7_AG]Y>Q>TMX[;Z_P!B;=_C>8Q^
MW<-_'=W;LR.(V_B/XON#+TE#2_<5$?W%9510IJDD13J@].O=+>BJZ#)45)D,
M=4TE?CJ^EIJVAK:*:&JHJVBJ(DGI*NDJ8&D@J:6>!U>.1&9&0@J2"/?J#KW4
MOWOKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=1ZNKI:"EJ:ZNJ:>BHJ*GFJZRLJYHZ:EI*6FC::HJ:
MFHF9(8*>"%"[NY"JH)) 'OW7NB\]6_+WXB]W[NS_ %_TI\H?CAV]OS:-3+1;
MHV3U;W7UEO\ W=MBL@GKJ:>DS^V]I[FRV9PM3#4XNIC>.HAB=7IY5(O&X&J#
MTZ]T8ZPO>W/TO^;?TO[WU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NN.A/\ 4K^K7^D?K_U7T_5_C]?>J#KW3?%D\15Y&MQ$.0QU1EL9'1U61QD-
M932Y''Q5HF./J*VB21JFEBJQ!(86D55DT-I)L;>H.O=)#M'M;JKHW8N>[3[J
M[)Z^Z?ZTVS_"O[S]C]H[QVYU_L7;_P#&<QC]NX3^/;OW9D<1@,3_ !7<&7I:
M&E^XJ(_/6544,>J21%;=.O=+:BJJ#)4=)D<=4TF0Q^0IH:VAKJ*:&JHZVCK8
MDG@JZ2J@:2"IIJN!U=)$9DD0@@D'WJ@Z]U+][Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UI%?'/J<?R6?EEUMUY_,:^
M O17R V3\A_G#DH_C=_.0V_B-B[J^1#]Y]U[DR^Y^OMN]QT.4Q-1V9@]SS5U
M/7RUE9BI\3BH("[04V0$=5-[]U[J^_\ FV_S!.^O@A5?!+$?'_K?JWM'=?R\
M^8VSOBDVV^T\CN;;V-;)]F;>SU#L6:AWAMNLD;9L8[#.+&2R,^)SZP8DU/BH
M)9_&5]U[HK'3W\Y?M?&=6?S3,'\U:#XG_'#Y%_RQ=Z=<83?6ZZ'=/;^Y/C!G
M]O=V45=E>I\I154&UJOM[-9;-IA:V@CQ>,QE1F<CD#2I#0135(I4]U[HNG1'
M\^;Y09VB_F/=2=T=.]=TG?\ \3?Y<'<O\PGH3?U-T%\J_CIUQVMM?K;:\[08
M[>G0/R6J,+W#C,(F]LGBHHLACMP/2Y['?<O33T<R,L/NO=+;XD?SHOG)O3NW
M^5!MGY6_'/XT;7Z;_FN].[PW#U)NCI+?78F4[#VSOWJOK?;V\MZYC>^U]WTK
MX#;>S]TU^Y*,X?#TF2SE=04%6OW63GJ89HA[KW2'W)_/B^8,WQ%W]_-MZ[^/
MOQSW#_+ ZW[Z'5TVSLMNCLC&_,'L+JUNWMO])IWCM;*2BEZRVO53[WW! D&T
M<KB'K)*>1I9<A3K%:;W7NC:=P_S)_GANG^9KOC^7U\*>J/BIO"GB_E];;^:V
MR=[_ "!SG:VSZFCJ:W=$^U)=O9N'9CYJ#=%-NG/[DVU1TE.D6WWP\,U=6SUE
M;XHJ)O=>Z 2A_GW;J[N_E_\ PO\ DCTE'TGT]\C?EKN?M#8V&Z#[,ZI^3?RP
MWAN/=?3&6J\?OH=+]-?%"AINT=_X"*FQ$U5+D:ZHP]%B8*ZF%1-)4!::I]U[
MH(*K_A1-\C,[_+^^.'R@V/\ &;KN'OK+?S=MF?RR/D7TIND=B8S$5]7)L[=&
M]=TR=3UNZJKKK=?6^\]PX],'3T$F[:"OCV]6U-7#D<=5-!Z?=>Z:_GYWK_.F
MVY\Z/Y'75U7VA\5.C>R_D%N'YD3[GZCZ]K?D/N?XZ;AWUUQD:K([:H>]9,?O
MG8&Y>Y-@[?Z'W7M!L;10Q8C[??R9S(.KT;XJGH?=>Z$O=W\RO97PO_F!?S_^
MY^R^@^H8W^&GQV^ V2K^P.OEW[@^V>_-P=B]5;238FPNP,[N;?FY]@TN+I>Q
M^R(,-B:O$[:Q=53XV:+[TY"2!"?=>Z#7^=!O?Y\]G?\ ">_YR=E_-3:GQ9Z^
MQ_8.V/ASO/K+KWX_97LS<VZ=CT.X?EK\?Z^JVWVCO#>DD.VMU9FDH6I9_O,'
M24=()ZN6D6.5*-*^O]U[H3?E9_/2W9\=^ZJ;X5_'VBZ:Q>\N@OC%T7V)V=O3
MNWJ;YB]VXK<F\>P-B8+=NU^D-K[5^'W6.]\QL3(9;8M=15T^[MPU)Q]"V2B6
M'&9%H9HQ[KW5\WP$^551\V_AYT1\HZ_K7<O3N:[8VE4U^Y^KMVTF7I,WL;>.
MW=P9G9F\]O/_ !["[=RM=C*'=6W*P8^MEH:7^(8\PU*QJDR^_=>Z.![]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[H-.Z/^9.]L?^(TWW_[RV5]^Z]U\\O^6CT3O/Y??![^1[L7XE_"CM?;
M'R!^,GSDRG?'?G\P_(=/0=3]8T/0&"^1W?&0W3LK:_R)R!P^4[WFR^,RN,HZ
MO#X9LJM#6[;;&U0@-E/NO=;?/\VW^8)WU\$*KX)8CX_];]6]H[K^7GS&V=\4
MFVWVGD=S;>QK9/LS;V>H=BS4.\-MUDC;-C'89Q8R61GQ.?6#$FI\5!+/XRON
MO=%8Z>_G+]KXSJS^:9@_FK0?$_XX?(O^6+O3KC";ZW70[I[?W)\8,_M[NRBK
MLKU/E**J@VM5]O9K+9M,+6T$>+QF,J,SD<@:5(:"*:I%*GNO=%TZ(_GS?*#.
MT7\Q[J3NCIWKND[_ /B;_+@[E_F$]";^IN@OE7\=.N.UMK];;7G:#';TZ!^2
MU1A>X<9A$WMD\5%%D,=N!Z7/8[[EZ:>CF1EA]U[I;?$C^=%\Y-Z=V_RH-L_*
MWXY_&C:_3?\ -=Z=WAN'J3='26^NQ,IV'MG?O5?6^WMY;US&]]K[OI7P&V]G
M[IK]R49P^'I,EG*Z@H*M?NLG/4PS1#W7NL&^?YS_ ,[=X["_F _,CXM?'KXQ
M9OX2_P MOOSL_HCLG9W<6\.R,-\E/D!6=)8O;U=VQNKKO<>VFDZZZ@Q&WJ7<
M])D,=#EL1N:JS-&[PZ*.JCT/[KW0CUW\VOYH_(;YT4/Q2_E_=5?%O>>S^ROY
M7W5O\QGJ3?7R+RW;>QLE2XGL*HIH,7@=QT.TQE/[PKNNNWOM:CIZ3[?;LN$C
MFKZRIJJPQ14+>Z]T@*'^?=NKN[^7_P#"_P"2/24?2?3WR-^6NY^T-C8;H/LS
MJGY-_+#>&X]U],9:KQ^^ATOTU\4*&F[1W_@(J;$354N1KJC#T6)@KJ85$TE0
M%IJGW7N@@JO^%$WR,SO\O[XX?*#8_P 9NNX>^LM_-VV9_+(^1?2FZ1V)C,17
MU<FSMT;UW3)U/6[JJNNMU];[SW#CTP=/02;MH*^/;U;4U<.1QU4T'I]U[IK^
M?G>O\Z;;GSH_D==75?:'Q4Z-[+^06X?F1/N?J/KVM^0^Y_CIN'?77&1JLCMJ
MA[UDQ^^=@;E[DV#M_H?=>T&QM%#%B/M]_)G,@ZO1OBJ>A]U[H2]W?S*]E?"_
M^8%_/_[G[+Z#ZAC?X:?';X#9*O[ Z^7?N#[9[\W!V+U5M)-B;"[ SNYM^;GV
M#2XNE['[(@PV)J\3MK%U5/C9HOO3D)($)]U[H-?YT&]_GSV=_P )[_G)V7\U
M-J?%GK[']@[8^'.\^LNO?C]E>S-S;IV/0[A^6OQ_KZK;?:.\-Z20[:W5F:2A
M:EG^\P=)1T@GJY:18Y4HTKZ_W7NA-^5G\]+=GQW[JIOA7\?:+IK%[RZ"^,71
M?8G9V].[>IOF+W;BMR;Q[ V)@MV[7Z0VOM7X?=8[WS&Q,AEMBUU%73[NW#4G
M'T+9*)8<9D6AFC'NO=7S? 3Y55'S;^'G1'RCK^M=R].YKMC:537[GZNW;29>
MDS>QMX[=W!F=F;SV\_\ 'L+MW*UV,H=U;<K!CZV6AI?XACS#4K&J3+[]U[HX
M'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZZ8$J0&*
MD@@,NG4I(L&&H,MQ_B"/?NO=4O;+_D6_%/!=V[,[E[([K^</R8Q_5'9& [>Z
M0Z,^3ORMWUV_\?.C^R]MI4G&[PZZZWRL-($RL595&H3^+UF6BIY55:=(808C
M[KW1Q_F'\"NG_FUN7XE;I[5W)V3M_(?#7Y1];?+;K"'K[,;7Q5'G>Q^K:]<C
MM_"[\CW'L[=<^4V363K:LIL?)BZ^1.(ZR(\^_=>Z*?VK_(Y^%O=U=_,7JNT,
MAW/NBE_F:YOX_P"YN\,2^]-NXFAV)N3XTT^:CZQS72]1@MD8S,[=JH*K-O45
MR9NKW#3UDD21M&M.TT$ONO=)O"_R*/C+0=A?(?MC<G?OS0[/[+^4GP#W_P#R
M[>X=[=L=T;8W_GLSU1V1!@Z3/]@XFHSG64T6VNV*>BVY21T@H4AVA 4DE_@#
M3SSRR^Z]T+& _E ?&K;F5_E?YBAWQWE+4_RFML=@;3^.B56Y=@O!O3'=C[,V
MAL;.3=UK#UG!)N.MI<3LNEDI&P3;<C2IDE:1)49(T]U[H.-U_P A[X+[QW;N
M*7*U?R"BZ&WMV^_?_8'PJH.[MQTWPYW_ -S29W';D;?.ZNGVIY:FJ$V:QWGG
MPL&4I]M5DDI:IQTS14K0>Z]T4WOG^5!V_P#)K^=]V1\B]VU'>O2WQ)S'\LVC
MZ&V[WQ\<?D%A>G][S=OMVUA#ENLI<+MK<E3ORJVWD>K\GF))#D<!+@HZB*GJ
M()XLI2T$T/NO=')W#_(Y^$3X#X5X;J-^Z_C%D_@*^]H/CWO;X[=I56S-]X[!
M=IS/-VWMW=&XL_B=W2[BI.TS558S%<R0YHC(57VM=3&=R?=>Z#3;/_"?3X6[
M0Z1V_P! X7L?Y2?W&VQ_,KQ/\TO$UF8[+V5N;=_^GO"[2I]ET&RLINO<O5V7
MRVX.I/X13(\\>0:JW75U6J:?/2.S$^Z]T<OY[?RUNAOYA=/TQ7]H[J[KZG[*
M^/&\LAO?I+O7XW]CR=2]W]:9//QXBEW?1;3W[!B,U4XK%;TQN"I:7)1QPB1X
MX8Y(I(:B&":/W7ND75_RD_BAG^Y_GSW-O]^S.RYOYD/575'3GR-Z^WCNO%KL
M,[/Z@ZUQO5VWWV)-M?;6V>P=MY_)X/%155;D)L_6U*Y/_**-J0JBI[KW0*;A
M_D<] ;M^&G=WP,W7\H/GAN[XY]S8WJW X[;6^._<#V!DND]K]/\ 8VT>SMH;
M6Z2R6_.M-RIMS"1Y[9T%-,N4AS4_\*E-'%+#!3T"T?NO=#;W5_*FZ([9[0V=
MWOM'M?Y0_&;O[:?7&TNHJ[NCXO\ <\_6.[>P^M=E.C8+:':F#K,!N;K?L#&T
MT;3)&U?@I)Z;[@R4TD$T-+)3^Z]U8'UMLB'K786TM@T^Y][;T@VC@J#!1;L[
M)W/7;TW[N%*"$0C*[MW9D_\ <AN#.U=M4]5-ZY7-S[]U[I;>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M8]SX"CW9MK<.ULC+4PX_<N#RV KIJ)XHZR*CS-!48ZJEI))X:F".IC@J6,;/
M'(@< E6'!]U[HKGP*^%75G\NWXG=4_#KI3/]@;HZRZ?_ +\_W:SO:65VYF]]
MUW^D#LG>/:69_CN3VGM79.WZG[;<&]JN&E^WQ=+HHXXD?R2*\LGNO=,?S#^!
M73_S:W+\2MT]J[D[)V_D/AK\H^MOEMUA#U]F-KXJCSO8_5M>N1V_A=^1[CV=
MNN?*;)K)UM64V/DQ=?(G$=9$>??NO=%/[5_D<_"WNZN_F+U7:&0[GW12_P S
M7-_'_<W>&)?>FW<30[$W)\::?-1]8YKI>HP6R,9F=NU4%5FWJ*Y,W5[AIZR2
M)(VC6G::"7W7NDWA?Y%'QEH.POD/VQN3OWYH=G]E_*3X![__ )=O<.]NV.Z-
ML;_SV9ZH[(@P=)G^P<349SK*:+;7;%/1;<I(Z04*0[0@*22_P!IYYY9?=>Z%
MC ?R@/C5MS*_RO\ ,4.^.\I:G^4UMCL#:?QT2JW+L%X-Z8[L?9FT-C9R;NM8
M>LX)-QUM+B=ETLE(V";;D:5,DK2)*C)&GNO=(7M'^1A\)NTNP.XMSU&7^16Q
M.M/DEOL=H_)GXO\ 5W>FYMC?&3Y"]D_?8O)3;V[)ZVQD#5JYG)UN+\N23"Y/
M#TF8EF:3(0U4D=.\'NO=$S[G_E'=H?('^=;OGO/+Q]V]#?#5_P"6!B/CILON
MCXR]^X+IC=E/VA1]IX"GJNIHMO;6W'/OB3:4_4]=E217[?DP$,T%-/3SQ9.D
MH)8?=>Z.MN'^1S\(GP'PKPW4;]U_&+)_ 5][0?'O>WQV[2JMF;[QV"[3F>;M
MO;NZ-Q9_$[NEW%2=IFJJQF*YDAS1&0JOM:ZF,[D^Z]T&FV?^$^GPMVATCM_H
M'"]C_*3^XVV/YE>)_FEXFLS'9>RMS;O_ -/>%VE3[+H-E93=>Y>KLOEMP=2?
MPBF1YX\@U5NNKJM4T^>D=F)]U[HY?SV_EK=#?S"Z?IBO[1W5W7U/V5\>-Y9#
M>_27>OQO['DZE[OZTR>?CQ%+N^BVGOV#$9JIQ6*WIC<%2TN2CCA$CQPQR120
MU$,$T?NO=(NK_E)_%#/]S_/GN;?[]F=ES?S(>JNJ.G/D;U]O'=>+789V?U!U
MKC>KMOOL2;:^VML]@[;S^3P>*BJJW(39^MJ5R?\ E%&U(514]U[H%-P_R.>@
M-V_#3N[X&;K^4'SPW=\<^YL;U;@<=MK?'?N![ R72>U^G^QMH]G;0VMTEDM^
M=:;E3;F$CSVSH*:9<I#FI_X5*:.*6&"GH%H_=>Z&WNK^5-T1VSVAL[O?:/:_
MRA^,W?VT^N-I=15W='Q?[GGZQW;V'UKLIT;!;0[4P=9@-S=;]@8VFC:9(VK\
M%)/3?<&2FD@FAI9*?W7NK ^MMD0]:["VEL&GW/O;>D&T<%08*+=G9.YZ[>F_
M=PI00B$97=N[,G_N0W!G:NVJ>JF]<KFY]^Z]TMO?NO=>]^Z]U[W[KW7O?NO=
8>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ttable_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ttable_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M_6_9M+CIL12]B["V?ONFQ-14)53XN#=VWL=N"''3U4<<*R/ N0$32*BABI(
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M;Q-;E?[H; I,+6[MS@H:::J>BPL&X\]MB@\SB$JAJ\A21 D:Y4'(]U[HH/\
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M9Q(:',8:2++4<2Y.DJ@L54M+$M3&++((U#A@HM[KW6A5_P (;O\ C]/YDO\
MX:_Q5_\ =M\@??NO=?0D]^Z]U[W[KW6K/_.HC^97P6^?7QE_G/\ QXZ?S?RB
MZ3Z=^.>Z?C!\I.D<'4Y";-[.ZSS.^\MOFJ[2VSCZ"CR,M,\\F>A&2R\--51T
MR[=I!7QK0O+40>Z]T>_XQ?S'?Y<W\\7H?)]?].=FX27>HJ-A[VSW1G:N!HL9
MW#UIO#K[=&V.S-K[A&QLG7I%EDPN6V_15$6;V[79*ACJ*<!:Q9D9%]U[H3_Y
MOO\ ,<[!_E9?%?(_+3!_'/;'R(V)MC=>R]L;SP5;WOD.F]SXE=[Y>?;^.RN&
MA3I+M2FKXXZV>@BEC>HHGTU4D@!$%I/=>Z4'\VK^8+O#^6%\/]Y_,+#]#[>[
M^VKUYF]BXK=FTJ_N7(=0YY(=^;SQ&QL=6X.JAZ?[3IZKPUF?I&FBF-&?&TC*
MQ*!7]U[H)_YD'\U7=7P(ROPCHZ7XRYGL7;WS"^2W4'Q^DWT^^L91X_8Y['EQ
M=3DLAAMF;<QFZ=P9^O@I:R=:&A6@QBSS4DJF92:9*OW7N@I^8/\ -K^3'P0[
M@^.&>^2WPAPFU/A)\E.]]H?';"]M;>[YI=X]_==;VWWA<CD]LY#LOI7#;$;$
MQI*<+D)9<?@MU9YTI,?/*M4]9X,?/[KW4KYR?S7_ )/_  ).TOD3W/\ !O&X
MO^7E6=D;.V#O_N$]XT\_R-Z]PF^,K58/#=H;A^/-!L:JAAQYJ&I)!AH,_794
M1U*1U5/15AEI:?W7NC ?S?\ ^91NC^5[\/MS_*K;'QZJN_\ '8++;)P;Z^Q]
MM["VIC*C?FX8=O8O(9.O:#<>6J8HI)XV:+'XB82&H@431QM43TONO=%Z_F"_
MS6OEG\%NG\?\R*GX(8C>/P@VOE.MJ/M[=F7[WBV;\C<5A.P]Y8G94&]]K]'S
M[!R="F--5N#')C:7+[EHLG42U\460H,.JS31>Z]TJOFO_,U^6GQYZ2R?S'Z-
M^#&)[G^&/7VV<3V+V+O?>_>D'4?=.>ZOG;"5F>WUU?TW7;%SFK'T-#D*BIB?
M/97%U=6*5Y8,>:1Z:IJO=>Z&7Y0_S6>INC?BC\1_DKUQM;(]P5OS[WY\=^K?
MB+LVMR%;L#&;OWM\G<13[@ZYD['W4^W-U3[:Q5-0RO4YFH_A&3JX/$8(J&><
M^,>Z]TT[V_F']H?'?Y^?$+X0?)3I_9C8SYR[=[2DZ0[KZ@WEGLEC,-V'TU@E
MW/O?8O86RMX;9P\T=*U%DL8,?F<=D:MI*C()'/CZ:)&J![KW0??,/^;-OWXK
M_P PCX<_!JG^(FZM[4?RVI^UZC;/9--V!MS^*92MZZVKEJ_&8#:FQ,/39D(<
MADX:&"JRNX,IA*7'4=8*VJ BBJC2>Z]TE=V?S&_YF_3_ ,,_E3\H>Z/Y3V#P
MN]OC+OW/2/TMAOF+AJF7LGH/;^,Q63SO</7.]<1TMN^/(C%PU%;5U5#5X[$3
M5%)0R/2QM6_[C_?NO=6,?#+Y0UWRX^&G2/RV;:>S]B#N_IW;/;N,V?1=E5^\
M<#M>'<VV*3/';>Y-_P!9UULIDJ,;4338_+31862.&6EE:/SJ!?W7NN_@Y\BN
MQ/EC\<]B_(7?O4^T.H*#M.CDW9UO@MH=NU_<E-G^L,E/+)L??57N*LZKZI2G
M_CN/$&6I*."EK%2EK(2]09&>-/=>Z<_F+\NNM?A;T^O:O8=+F=PY#<6]-F]3
M]3]:[5_AAWMW%W3V7F8=M];=5;+7-Y#$T2U^6KZA4-37U=)24L$<U75314\$
MCK[KW1,/F3_,!^1_\O;KO9WR4^3'QNV'NCXLIGMMX'Y%;H^/O9FZ=Y]C?&*G
MWAD\9@L-OJLVINSKC:$6\]M4V0R*4.5K,9+A\A"T]/+#BZF)YC3^Z]TZ_P U
M_MKM;(_RKOEAVE\5L=U;V%LO=WP=^2>],GV9E^\MY=597:O665^.N[\_B>T.
MF1LWI3M<;CS$=+4??XS&5F2V=#))'"#EZ;698O=>Z"+^0EN'Y-5W\N+X-8?L
M/J+HG:_1E#\0NM7Z][%V9\B^P-^]L;HK(<;@(<%!O+I?.?%OKC#X&*IH):VI
MJYJ'?NXVIIZ>"FCCJHZB2JIO=>ZMJ[O[#W#U1U;O3L+:_7&:[6R^TMO9G<$.
MRL%G=L[:K<K%A<379>>/^,[LR6-I80ZT)B0CS/Y)8QX]&N2/W7NJ1OCK_-L^
M;OS6_EU[!^:_Q'_EX;;W=NO<>%[;W3N?978_R.I>O]D4]'UOVCVMLBBV+U1N
MZHZ]JJ_=FXJBCZ]HZFKFK<3M3#0399($RDU1!5TU-[KW5AOP5_F)]-?-WX$[
M ^?V/5^J^L]P;)WENK?^/WCD89!U=5]8Y+/X3LRBS.:2FHXYZ3&5&UZV6*O$
M,(GI!%4>*(R>-?=>Z#';OS-^6O>WQ;/S'^*/Q<V%O_KC<>#JNP^CNI>QNVLQ
ML+NSO_J*GD:JPN[,2^.V'N;";9RNY\=3ODMIX'*U5898:O'KF*S"5-15TV/]
MU[I4?''^9CUC\P_@Q/\ -OXP; WIV;38W%;LCW-TO79#:VQNQ=C;^V%C*FOW
MGUOO:7=&7I*.CKJ)J=(TDADJTG6KI:B$-33>5/=>ZKF^)G\YGYS_ #@^-?Q0
M^3OQJ_E@OV#L/M[O'.=;]_S+\A\)M[_0IM;'=I979R[@V3'NW9NWI]XQ46'Q
MZ93-96"#&T=-531T$*5,J9!L;[KW5GFV/F/NOY#]T?(3I_XC[5V)NS$?%C<E
M-UAW)W-V5NK,8C8Z=]3XFDW%D>E-BX#:>#SF0RE7@L?D:.7=.7J9<92T,V1I
M:.C7*U*Y!,=[KW0>?"?^9,OR8[?^2'P][?ZD_P!EW^=GQ2EI)NRNCZ_>9W?L
M;>>S,[34=5LKN/ISM"GVSAYLOM/+IE**3S56#H<A0BN@2LH$ED5&]U[I"_#/
M^9AW+\C_ )Y?,;X&]Q_%'9WQYWK\/\9L;<61W'0_([-]I?Z5MG]CPY&KVMO3
MKO;U=\<^KO)C#"F/:MGJ*Z,T\F22#1)+'(OOW7NCJIWMVCD/EYD?CK@.J]@Y
M;KO:O4. [2[ [9;N'<5+NO:-5O/=&X-M[&VBW5D?2E;0U%3E5V=F:V*0[OIV
MC@QS-+"HFIS+[KW17.C?YBV^.W?YB7RE^"6?^,V=ZR;XU="]>]STNY\MV%LW
M<NY>T&[)K:<8;'XC!;>JI,3BXHHF>G9JO.SL]4KAOMZ>-9I_=>Z)7@OYS7RR
M[9^17\R#XH?'_P#EQUF_._?@U1]:MM/8N;[_ -M8"A[*CW=09[+Y_-[IWZ-K
MU&#P;+34= NW<%3UF4K,K-7 /+0P09"HQWNO=#!WG_-6^27QAIOY6@[S^#&
MVODOYAW??1GQF[ P3_)GQ;S^-/:O;^2VQC:M*_:]#T?N"@W%24 R.3J$%/N'
M'._V$4$QIY*AF@]U[H=OYC?\Q?>'\O[=_P ,:!N@=O=M;%^7?RZZE^(QW.O=
M60V)N?KO<?;%9+'1;L;9C=.;PILM24L&.K97@&<QSN\44>I!*TD7NO=#]WU\
MKINO?D+\?_B1UUB-K9WO?Y#;8[6["P7]^\_E-N;.VOUMTQ'M5=Y[AK),/@\W
M59/(RU.]*"FQF%IA2F915U,M53PT;"7W7NNN@.]/D7N_Y%_(_H'OKHW9O7N/
MZ9V%\?\ ?_6W;?7G8.Y=\;3[OP?=.9[YPN588S<77.R6V]D<#4=,)#7X05V>
M=!D8:@U9@J*8R>Z]T;;<>2R>(P>2R6%V]7;KRM+3EZ#;N.K<1C:O*5+.D<<"
M5^>K\92PJ"^N6268:45BBR/IC?W7NJ)_A]_-L^5_SSZG^3>;^.OP%QD';_0_
MRT[B^-:;7[1^0E!M7J;#T/4F%ZRJ7RN_.U\5U_GZF;<63JMZ9!:;;VV\!F*6
M&/%EJ[,4D=113UGNO="_\+OYP>Q/D-\%_D_\N>\>K=P?'W=WP5W-WEU_\P>G
M*/*4O8]?L+??Q\P"[DWO0;-SN(AHH<U3STLBBBEC")]P):<RND/W,GNO= QW
M%_.![VZ+_ES=7?S7=Z?%S864^+N^8>IM\[IZTVCV_GLAWKL3HWO/<.+V_P!;
M;YBK\OUOA-OY3.NV[< ^3VX9<;34\F2E@AS54M*M14^Z]T8;^;9_,_W%_+5^
M%];\O]D?':O^0>W%FV#313U/8>!ZYVUB!V1EJ3%;?R&8EFHMR9B95-9&TD%'
MB&#-/!&9XU:>6F]U[H'?G_\ S7?DW\#-O8+Y/;O^"0K_ (!8KL+:6RNUNTLO
MW=BL)\CMJ[?WEN>3:&+[2H_CW3[3RE.N&DJZF@:AH*G<G\9G7(P1U^-P\@J!
M3^Z]U9%\M/F5U3\0ND,?W3O)<KNW^^FZ=B=;],[ V><:^\>[.W.U\G383JSK
M+8PS=?B*):W,U=9&!55]524E+3K-5U<T5/!*Z^Z]T3SYD_S ?D?_ "]NN]G?
M)3Y,?&[8>Z/BRF>VW@?D5NCX^]F;IWGV-\8J?>&3QF"PV^JS:F[.N-H1;SVU
M39#(I0Y6LQDN'R$+3T\L.+J8GF-/[KW29_FT?S<F_EP_"S;GS+ZOZ$J?E+L'
M?-9U[1[3W7BNR]K;*Z[CI>T*.LR>TMQ9#)/'N'-55'-240F08_"2K(]921^>
M)9*B:E]U[HNGSD_G+?,[X0)0?(W=W\K/?V>_EU4FYH<1NWO*F[GV73=]X/:=
M5G8<#ANRLG\>#1R38>AS7WD-5A*#-Y.BJ!&\<.=; 5TXI(_=>Z/?\Q/YH'4_
MQJ^.7QE[TZZP\/?.0^;O:O1G2GQ(PF,W#)MC9W8F^/D33#)==Y;=G8-+M_=Q
MPFWUH5>NR&1AQ65J$C41P451,P0>Z]TC][?S#^T/CO\ /SXA?"#Y*=/[,;&?
M.7;O:4G2'=?4&\L]DL9ANP^FL$NY][[%["V5O#;.'FCI6HLEC!C\SCLC5M)4
M9!(Y\?31(U0/=>Z#[YA_S9M^_%?^81\.?@U3_$3=6]J/Y;4_:]1MGLFF[ VY
M_%,I6]=;5RU?C,!M38F'ILR$.0R<-#!597<&4PE+CJ.L%;5 1151I/=>ZJ#_
M )TGSR_F_4'\I'Y8;EW_ /$?K7X&K3]P-T!V)N6+Y%2=M;ZW=T9OVOV3MK$9
M?H [7ZTIZ"I3<$FXLIB<YE\S6[>GHL?'KQU')7U3'%>Z]ULE;O[^^4_3WQH[
M@[M[E^+/764[ ZSPV\-W8KJ;XW_)JJ[3QFX]F;0V55;JJ,GD^Q>[.AOBQ_#J
MV6?&55"N/IL+EP"U-,)V66=*3W7NF#X8_.K;GR/_ )>'5G\P/MC';=Z)V9O/
MIS/]W[YHLANC^*[;ZQV=M^7<-;EI\IN_(8[!">"@Q^#:>JK7I*16T.XBC6R#
MW7NBX]V?S%/D?L/X.[J_F.[!^+^TMP?'O;.P,7WKCNK=^=E;DV/\B-V_':6E
MH<WENQ*S&TO7>X<-M[+KAJJ3.4>V:NJR3-1Q(*RNH:Z66AI?=>Z!?^;3WYLK
MY3_\)Z/E!\D>N(,U2[#[R^'> [0VG2[CH/X7GJ3![RJ=I9N@I<O0K+.L=1&E
M6$E\<DL9*EHW>,JY]U[H]^S/D+M?X^?#'X7U.5H*O<^]^V-@_'3ISIKKK$U5
M'1YSLGM'=75^.R.-VYCZJO=(::GI<=@<GF\Q7RZDHL7B:VL=7$'C?W7NBP_)
MS^9KW-\ >Z/C-B/FSTEU)A_C1\J.Q\3T=@.^>DNW-V[NR?47=VXX:VNV[MGL
MK8N]NK=CFKP-7!1RZ=RXVMC>,4L\M1C*= BM[KW1OMW?*[/9OY<9SX6]'8C8
M>2[1V#T?M;Y =I9_LG/Y[%8;;6S]_;MW)LS8N&VWM[;V#KZG,5]94[1KY\A*
M:S'P8^ 4I9JF6L2*/W7NE)\1^].\NYG^2& ^071NW^C-[]!?(JMZ4Q])M#L'
M-]G;.[+VDO2_2G;>W^V=J[LSW7/5\S4F37MJ2E:B_ATAHI\=-22U$M1#-I]U
M[H8?D!W=L?XU=&=P?(7LR;)0=>](]:[T[4WK)AZ"3*Y<;9V+M^OW)F$Q6-B9
M#/4O!CG2"+4@9V4,RK=A[KW5,7<7\X'O;HO^7-U=_-=WI\7-A93XN[YAZFWS
MNGK3:/;^>R'>NQ.C>\]PXO;_ %MOF*OR_6^$V_E,Z[;MP#Y/;AEQM-3R9*6"
M'-52TJU%3[KW1AOYMG\S_<7\M7X7UOR_V1\=J_Y![<6;8--%/4]AX'KG;6('
M9&6I,5M_(9B6:BW)F)E4UD;204>(8,T\$9GC5IY:;W7N@=^?_P#-=^3?P,V]
M@OD]N_X)"O\ @%BNPMI;*[6[2R_=V*PGR.VKM_>6YY-H8OM*C^/=/M/*4ZX:
M2KJ:!J&@J=R?QF=<C!'7XW#R"H%/[KW5D'RY^9G4_P />B(>\][?Q3=<6Z-P
M['V!U!L#9[8V7>O=G:_:F4I,%U?UEU_3YFOQ-,]?F:NOC"S5513T]+3)/654
ML5-3S2+[KW5 /_"E_L+Y:T/\ESY'X[MWIGJ.DVEV;/T%BMR5G5W:>XMRYKI;
M/T/R2Z@WIAH=P#=6Q-I0;AQE4-MOAY\EC1CYH*^JI2M!/1RS5-+[KW6S5TO_
M ,R=ZG_\1IL3_P!Y;%>_=>ZK/_G,_P T/=/\J#XM2_(_"?&C,]_4<F[=K['^
MX;L/;&P-H;<S6[I<JF.J=Q5,L>X<W-%&N'?4E!A95>6HI8O/&DE1-2^Z]T5'
MYR?SEOF=\($H/D;N[^5GO[/?RZJ3<T.(W;WE3=S[+IN^\'M.JSL.!PW963^/
M!HY)L/0YK[R&JPE!F\G15 C>.'.M@*Z<4D?NO=65=R_S#.H]D[*^*61ZC%%W
MMV+\\,IM_%?#W86"W'1X#']HT>;VE'V'E.P<YNZHI,LN(VGM[;C/GMPY:.BR
M53%3HL%#05^1J*6AG]U[H ?DS_,E[&^ /;/0]%\V^H-E8;XL_(?>N+ZCP_RN
MZ=WMG\_@^F>Y\['65&W-H]Z[!W9M/!U5'A<M%22''[JQ=?7Q(U)4_?T5!&D4
MDWNO=%R_X4ELK? [IME(96^?WPJ964@JRGM>G(((^H/OW7NC1?S?OYC'=G\K
MSXXCY3[%^']!\KNJ]MYW#X?MS[/OR7J#<_65!N*L.*PF[Y,-+TMV;'DL0U?-
M1X^KF@JH:BGFR$#M3-2BHJ(/=>Z.9VS\AVZE^(O8/RFR]!UY5TW7W26XN[*N
M@/9F2QW761PFW]K56\-%+VA6]="I2EJJ*G#4];)MH,6D133\W]^Z]U7'_,+_
M )J??O\ +W_ERXOYM]B_"B@RF_*BCZW&[>JL-\@\57;,ZQR_9V7I,3C,5N#L
M#)]=;6S.3J,>];%'7PXW:(C^XECBCJ3!YZRG]U[I*?S!?YK7RS^"W3^/^9%3
M\$,1O'X0;7RG6U'V]NS+][Q;-^1N*PG8>\L3LJ#>^U^CY]@Y.A3&FJW!CDQM
M+E]RT63J):^*+(4&'59IHO=>Z57S7_F:_+3X\])9/YC]&_!C$]S_  QZ^VSB
M>Q>Q=[[W[T@ZC[ISW5\[82LSV^NK^FZ[8N<U8^AH<A45,3Y[*XNKJQ2O+!CS
M2/35-5[KW1Z<K\YNGV^._P <?D)L@9/?5#\PTZDH_C!LJE$.#W3VGN3NS:1W
MYLS!"#,&$8[[7"4U=F\_/5+_ +C<?B:^HFC8TQB;W7NB7?)S^9KW-\ >Z/C-
MB/FSTEU)A_C1\J.Q\3T=@.^>DNW-V[NR?47=VXX:VNV[MGLK8N]NK=CFKP-7
M!1RZ=RXVMC>,4L\M1C*= BM[KW47YA_S9M^_%?\ F$?#GX-4_P 1-U;VH_EM
M3]KU&V>R:;L#;G\4RE;UUM7+5^,P&U-B8>FS(0Y#)PT,%5E=P93"4N.HZP5M
M4!%%5&D]U[KO8_\ ,E^7&W<%@-J?,+X/[<^+GR([J^9$7Q/^+NQJOY!XO?W6
M?:%)4[%S'8,_:>2[+VULN2HI<50T&ULFJ)_!5J,C4BCI(8*::IE^U]U[HXVS
M>]/E'0?,+;OQK[?Z-ZZ@ZQW?\=>U>Z]K_(SK/L'=^9H:K=O6'8O16R<AU-NG
MKG<77.*3"5<E/W(V3H:W^\N3%?#02^&GA-/5"+W7NCR>_=>ZJ_PWSZW=WA\X
M_D]\'OC)L'9==G/AGLGJS.=_]H]O;EW1@<+3;X[KQ-1N7KKKS8&S]L[3RL^4
MC.*Q]369C.5.4QT=)((::FI,@9)9:;W7N@J^+7\X78O;_P 2?G'\CN\NJ\ST
M9NC^7#V9WST_\I^OL/GE[%Q\>\_C[AURNYJGJ[<G\&VK492AR+%J3'?Q#&8F
MH%3&\<T*1A)Y/=>Z%S>/RJ^9>SMA?&[N2E^.'2O8G6_>W<?Q>V+O7&;#[KWQ
M5[UZ1Z]^2W:W7G7E+V;2D]-UE!O2'"0[_AJLM%3OMF*&.-ZM:B6CAFD7W7NK
M.??NO=4__P S[^9?W'_+BW'\9\C%\4MG]P]%?(;OGK[X\Y?N6N^1F;ZR?IO>
M?8F2BI,3FNP-I0_'7L:$840Q5DXKX<SJ9J,PM#&\L6OW7NCO_*GO/L'X_=&5
M'9.S.M=F]F]CR9SKW9VW>KL[VEF^O,7NS?G9.\=N[#V[M/![XQO4O8]2TD^3
MW)#%#-)@(U\:F:<4\2R-'[KW18=_?/\ W=3_ #FZL_EP]9]9;+RGR4W)\;\S
M\J^W\]NG?6Z(.I>I.J,=N<;!Q<>V\I0=<P9'=N7R6>ECI8J)J3;4,%()*R:I
M$JQ4,_NO=8_A1_,.SOR-^4_S@^$7;O4='U7\A/@UN#K==U5^T]V5&\^L^S.O
M^Y,!5[NZUWMM"ORV VMDZ&IEQ:TD^4Q-=12+3/71)3UM:HD>/W7NA*VU\M-]
M_(K??>FSOA_M/KO=>V_CEO[/],=B]P=K;MW!@]D9KOC;6)Q.3W'U9UQC=E;:
MW14Y./ OF8L?NK.U%10QX[(*^/IJ3)U$-;]C[KW0.? '^:MUU\Q/C;\BN\>T
M]ER_%_._#+LOMGJ'Y:;=W?N:GSNR^M-W=)8P9K?^8PW8SXK;D60PM/1ZJDU4
M]#031!'2:!0J22^Z]TD>[/YBGR/V'\'=U?S'=@_%_:6X/CWMG8&+[UQW5N_.
MRMR;'^1&[?CM+2T.;RW8E9C:7KO<.&V]EUPU5)G*/;-759)FHXD%974-=++0
MTONO=*#Y-?S4*/J+^6!1?S/.EOCWO;O?KO,]';5[VQVT<ANO:O5>0PNU=XQ[
M9.+;>%9G)<Q4QM"=SK+4KB,=F"8:*H>+633+4>Z]T(_RC^>&[_C9_+JR/SMQ
MG060[AJ]O?';$=\[DV!@]];>V1B<52UFS</N>OIJO<VXDR%4*:%LJWKHL5DY
MO!32MX6E$44WNO=$;[2_FU_-+!_ #K#^8EU%_+UP>^^DH?C?U3\D^_$WM\AZ
M'K3=E+M7=G7.R^Q.Q).A=I2;%W'-G,5MV#<.11LQN&HVU/6##RRX[%U]--25
M%1[KW5GM-\ZNB)OA3L7YX/D<S%TSV1UCUAV1LVA&/1]Z;@JNY!MNAZUZZQ6!
M-2@FW'E\ON['8"BQXF DR%4D/D .L>Z]T2SYS_S'/DW_ "ZNN-I_*CY$_&7J
MS*?$==Z[7VMWC5=7]V;CW!WKT+B=^Y_&[9VANU]K9;JO#8/=4<=9DH(,S1XW
M+T#T\U0D='+D85-4WNO=7 ;6W-@MZ[8VYO+:^2I\SMG=N!Q&YMNY>D;7297!
M9['T^5Q&2I7(%XYZ>KCE0_D,/?NO=%F^2GRPP70^[>D.FMO;>_TD_(WY-[BW
M3MCHGJ>/.1[;I<N-B[:FW;O_ + W[N88[/S83:&W*%(9,YFH,7EIHY:ZBI*6
MBJZVMIJ>3W7NBB;A_F.]B]#?S#?C;\!_D]TYM>D_V<?9&]=P?'GN[IK=>XMQ
M[?GWIUECJO,;_P"N>PME[HVIAJJ@--1Q05-+F:.OKHI!60K-34UY'B]U[K!U
M)_,1[E^8.7^<3_"_IKK;<>T_A5W%OOXW1Y+N7?\ O/:.>[Q^0'5V"BRV_=J[
M?P.V>NMP+M_!P5&2Q^.QV?JZG+SUDM1-*V*IH:>)JOW7NE;\//YG.*^;7\N#
M;G\P3IOH;?.2ES. [$K*_H^HW5LO'[AQ6XNK<MN?";IQ(WCFLAB<?-22S;7=
M\=6)&)98JRF:6DIW,Z4_NO=$[^.O\VSYN_-;^77L'YK_ !'_ )>&V]W;KW'A
M>V]T[GV5V/\ (ZEZ_P!D4]'UOVCVMLBBV+U1NZHZ]JJ_=FXJBCZ]HZFKFK<3
MM3#0399($RDU1!5TU-[KW5B'P1_F(=-_.+X&]>_/G&#_ $5=:[DV9N_<V_:#
M>N5I5BZMK>M,IGL'V71YW<#0T$,M'C*G;%;+'D3%3K-2".I,<7D,:^Z]T'G5
M_P T_D?\A?CW_LXG1'QTV=DN@<[BJS??4&S-_=D93:W?'=_3V/DJYZ?L'%8R
MEVCD\'MNJS]!2');4P>7R%0]3!/2#*U6$FJ)HJ+W7NJU?^$LF7S6"_D7=+9;
M;NU,AO?-TG8GR!;&[6Q>2P>'K<O4R]T;E@6),GN3(XJC@2,2F::268$1QOXT
MEET1/[KW5H_\K3Y]9C^8W\;MS_(//=/MT/48;O;M_J!>NJS=U+O;*XB#JK-T
M^WY:G/[BH,;BJ1ZV:83/41T<<E/";1QSU"K]Q)[KW4?ISYJ=L?,;']J=B?#'
MKGJS='0_7>^MZ]7;([5[:[%S^W*/Y%;[ZVRDNW]\U/6=#LG9N\3CMITN6H:O
M"TFZLB]3+6U-)434V):@2GJZWW7NJ4?Y%WR7VSU%U5_PH&^7?<VW-Q=?[5V#
M_,U^9W?O96SE2CW/NS9V,PN+FWUN?:8&$GEIJ[(T*Q2T.JFF\,LT=UD$;:Q[
MKW1X.XOYP/>W1?\ +FZN_FN[T^+FPLI\7=\P]3;YW3UIM'M_/9#O78G1O>>X
M<7M_K;?,5?E^M\)M_*9UVW;@'R>W#+C::GDR4L$.:JEI5J*GW7N@B_X4X_);
MY8=0?RINP=]_%S(==;9ZH[-Q6TME=Q=H9+=VZ<=W1CMB=N9S [:I]M=2;)I.
MOLEBY/XY2YV6DS.9R&XL944-%+,M#2RU<L552>Z]U<=E/DGV)T/T#O\ [O\
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MO#/?WH[5WWAMIYZ@VIA(QA*".EI\5%N[+5"U_D3'DP5L=%[KW3;\4OYN??\
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M3;CQ4^[.O-[8N.6=(<A02S(=<4DD4\$T-3"[13(3[KW1TO?NO=?,$_X14_\
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M>P&W]L]M_$VHZ\QV[MRXEHWIS3XY<E73QRS%&\H2" F>H16]U[K8([.Z&_E
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M2PCS^"2(?R"(-/F\;1BJB_EZQ_;6UW'D69$T?D.!;U >_=>ZI=_F&T'9\O\
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M]U'\I>EOE%@-^;)[N^,O<5?UMUK\I.S_ (S;TZOP'R6Z>K\WN.BV+W1CNO\
M/8OK7&5.5J*7:-8<A38>6*GIONL?4U%*@J!!/[KW2O\ Y#_R4^17RI^&F_\
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MS_Y_L5_]5>_=>Z]_?79O_/6[9_\ /]BO_JKW[KW7O[Z[-_YZW;/_ )_L5_\
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M ,];MG_S_8K_ .JO?NO=>_OKLW_GK=L_^?[%?_57OW7NO?WUV;_SUNV?_/\
M8K_ZJ]^Z]U[^^NS?^>MVS_Y_L5_]5>_=>Z]_?79O_/6[9_\ /]BO_JKW[KW7
MO[Z[-_YZW;/_ )_L5_\ 57OW7NO?WUV;_P ];MG_ ,_V*_\ JKW[KW7O[Z[-
M_P">MVS_ .?[%?\ U5[]U[KW]]=F_P#/6[9_\_V*_P#JKW[KW7O[Z[-_YZW;
M/_G^Q7_U5[]U[KW]]=F_\];MG_S_ &*_^JO?NO=>_OKLW_GK=L_^?[%?_57O
MW7NO?WUV;_SUNV?_ #_8K_ZJ]^Z]UE@W=M2IFAIJ;<^WJBHJ)8X(((,UC99I
MYI7$<4,,4=2S,S,P554$DFP]^Z]TH??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=$R^6'\O+X5_.>KV/7?+?X[[#[UJ^M:?<%)L
M2;>J9>1MLT^ZI,/-N*+&C&97' "K;;]$92X8G[9+6M[]U[HH?_0/W_)G_P"]
M?/17_G-NK_[)O?NO=>_Z!^_Y,_\ WKYZ*_\ .;=7_P!DWOW7NO?] _?\F?\
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MU[KW_0/W_)G_ .]?/17_ )S;J_\ LF]^Z]U[_H'[_DS_ />OGHK_ ,YMU?\
MV3>_=>Z]_P! _?\ )G_[U\]%?^<VZO\ [)O?NO=>_P"@?O\ DS_]Z^>BO_.;
M=7_V3>_=>Z]_T#]_R9_^]?/17_G-NK_[)O?NO=>_Z!^_Y,__ 'KYZ*_\YMU?
M_9-[]U[KW_0/W_)G_P"]?/17_G-NK_[)O?NO=>_Z!^_Y,_\ WKYZ*_\ .;=7
M_P!DWOW7NO?] _?\F?\ [U\]%?\ G-NK_P"R;W[KW7O^@?O^3/\ ]Z^>BO\
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M?/17_G-NK_[)O?NO=>_Z!^_Y,_\ WKYZ*_\ .;=7_P!DWOW7NO?] _?\F?\
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MU[KW_0/W_)G_ .]?/17_ )S;J_\ LF]^Z]U[_H'[_DS_ />OGHK_ ,YMU?\
MV3>_=>Z]_P! _?\ )G_[U\]%?^<VZO\ [)O?NO=>_P"@?O\ DS_]Z^>BO_.;
M=7_V3>_=>Z]_T#]_R9_^]?/17_G-NK_[)O?NO=>_Z!^_Y,__ 'KYZ*_\YMU?
M_9-[]U[KW_0/W_)G_P"]?/17_G-NK_[)O?NO=>_Z!^_Y,_\ WKYZ*_\ .;=7
M_P!DWOW7NO?] _?\F?\ [U\]%?\ G-NK_P"R;W[KW7O^@?O^3/\ ]Z^>BO\
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MX]U[HDV1_G3?S9<Q_(QPW\VREWU\6ME;AVQWP-B5W7&/Z3SV[:3MC:L_:/\
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MS78O%]==;8T9S9.$VU1X^LKY9WJAE,]258*SS885;&2'W7NA&_EH?RU/F?\
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M?=>ZC_.3^4]\T(OYG/4G\W3^6MOCX^;6^01V1B>MODWTMWY7[MQ/6O;FVJ#
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MWM@]W;KI3%% :;<NY.P/Y>.9SM.8(7D1-%56RKH1F46L"1[]U[JV[Y*X38.
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M>;FFRF2H=X])[^JZDFIZMPH6'[V*%$IBD<:ZV/OW7NH'<G\F/XP=W?/'9?\
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MV93Y*GVW2Y.J3;F1W]L3[:.O_NM15>2H9))TEKJ2"NII:*=':7W7NA(_FO\
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M*_K_ *XKMD93:^<ZYVY3[3P63R_7'^E'<#3I4T%+&E<M-N&DD\\%/5T\L$L
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M1PNX-G]X[DZ;W!2=E[2IFI-Q8;<<L5'B<ICY5Q=3!#)%4U%(B4$?NO=!)_,
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MGP _]+(^.O\ ]L;W[KW7O^'8OY67_>RSX ?^ED?'7_[8WOW7NO?\.Q?RLO\
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M.O\ ]L;W[KW7O^'8OY67_>RSX ?^ED?'7_[8WOW7NO?\.Q?RLO\ O99\ /\
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MQU_^V-[]U[KW_#L7\K+_ +V6? #_ -+(^.O_ -L;W[KW7O\ AV+^5E_WLL^
M'_I9'QU_^V-[]U[KW_#L7\K+_O99\ /_ $LCXZ__ &QO?NO=>_X=B_E9?][+
M/@!_Z61\=?\ [8WOW7NO?\.Q?RLO^]EGP _]+(^.O_VQO?NO=>_X=B_E9?\
M>RSX ?\ I9'QU_\ MC>_=>Z]_P .Q?RLO^]EGP _]+(^.O\ ]L;W[KW7O^'8
MOY67_>RSX ?^ED?'7_[8WOW7NO?\.Q?RLO\ O99\ /\ TLCXZ_\ VQO?NO=>
M_P"'8OY67_>RSX ?^ED?'7_[8WOW7NO?\.Q?RLO^]EGP _\ 2R/CK_\ ;&]^
MZ]U[_AV+^5E_WLL^ '_I9'QU_P#MC>_=>Z]_P[%_*R_[V6? #_TLCXZ__;&]
M^Z]U[_AV+^5E_P![+/@!_P"ED?'7_P"V-[]U[KW_  [%_*R_[V6? #_TLCXZ
M_P#VQO?NO=>_X=B_E9?][+/@!_Z61\=?_MC>_=>Z]_P[%_*R_P"]EGP _P#2
MR/CK_P#;&]^Z]U[_ (=B_E9?][+/@!_Z61\=?_MC>_=>Z]_P[%_*R_[V6? #
M_P!+(^.O_P!L;W[KW7O^'8OY67_>RSX ?^ED?'7_ .V-[]U[I#]C?S%/Y-?<
M&TLGL'M?YW_RS^R]CYD0_P 5VCOOY2?%W=FV\@U/(LU++58;.;[KJ=WBD420
MR&/5&ZAT*L 1[KW0?[>^8?\ (PVOF\/N3$?-+^6>,[MS(ME]L93)?+?XZYZJ
MVIE6@>D&1VD^>[+R7\*F6&5X(Y,>*9DBD>-"J.RGW7NAX_X=B_E9?][+/@!_
MZ61\=?\ [8WOW7NO?\.Q?RLO^]EGP _]+(^.O_VQO?NO=>_X=B_E9?\ >RSX
M ?\ I9'QU_\ MC>_=>Z]_P .Q?RLO^]EGP _]+(^.O\ ]L;W[KW7O^'8OY67
M_>RSX ?^ED?'7_[8WOW7NO?\.Q?RLO\ O99\ /\ TLCXZ_\ VQO?NO=>_P"'
M8OY67_>RSX ?^ED?'7_[8WOW7NO?\.Q?RLO^]EGP _\ 2R/CK_\ ;&]^Z]U[
M_AV+^5E_WLL^ '_I9'QU_P#MC>_=>Z]_P[%_*R_[V6? #_TLCXZ__;&]^Z]U
M[_AV+^5E_P![+/@!_P"ED?'7_P"V-[]U[KW_  [%_*R_[V6? #_TLCXZ_P#V
MQO?NO=>_X=B_E9?][+/@!_Z61\=?_MC>_=>Z]_P[%_*R_P"]EGP _P#2R/CK
M_P#;&]^Z]U[_ (=B_E9?][+/@!_Z61\=?_MC>_=>Z]_P[%_*R_[V6? #_P!+
M(^.O_P!L;W[KW7O^'8OY67_>RSX ?^ED?'7_ .V-[]U[KW_#L7\K+_O99\ /
M_2R/CK_]L;W[KW7O^'8OY67_ 'LL^ '_ *61\=?_ +8WOW7NO?\ #L7\K+_O
M99\ /_2R/CK_ /;&]^Z]U[_AV+^5E_WLL^ '_I9'QU_^V-[]U[KW_#L7\K+_
M +V6? #_ -+(^.O_ -L;W[KW7O\ AV+^5E_WLL^ '_I9'QU_^V-[]U[KW_#L
M7\K+_O99\ /_ $LCXZ__ &QO?NO=>_X=B_E9?][+/@!_Z61\=?\ [8WOW7NO
M?\.Q?RLO^]EGP _]+(^.O_VQO?NO=>_X=B_E9?\ >RSX ?\ I9'QU_\ MC>_
M=>Z]_P .Q?RLO^]EGP _]+(^.O\ ]L;W[KW7O^'8OY67_>RSX ?^ED?'7_[8
MWOW7NO?\.Q?RLO\ O99\ /\ TLCXZ_\ VQO?NO=>_P"'8OY67_>RSX ?^ED?
M'7_[8WOW7NO?\.Q?RLO^]EGP _\ 2R/CK_\ ;&]^Z]U[_AV+^5E_WLL^ '_I
M9'QU_P#MC>_=>Z]_P[%_*R_[V6? #_TLCXZ__;&]^Z]U[_AV+^5E_P![+/@!
M_P"ED?'7_P"V-[]U[KW_  [%_*R_[V6? #_TLCXZ_P#VQO?NO=>_X=B_E9?]
M[+/@!_Z61\=?_MC>_=>Z]_P[%_*R_P"]EGP _P#2R/CK_P#;&]^Z]U[_ (=B
M_E9?][+/@!_Z61\=?_MC>_=>Z4&T_P"9K_+;W[NK;6Q=B_S!OA!O3>V]-P8;
M:>SMG;3^5_0VX]U;LW5N/(TV'V]MK;6WL/OZLJZ_(5]760TM%14L,LT\TJ11
M(SLJGW7NCO\ OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NB]]Y?$CXI?)Z;;53\E?C'\>_D-4;,BRT&SY^\NE^M^VIMJ0YY\?)G
M(=M2[^VWGVH5K6Q%(U6M*8A,:6(R:O&FGW7N@$_X:=_E9?\ >M/X ?\ I&_Q
MU_\ M<^_=>Z]_P -._RLO^]:?P _](W^.O\ ]KGW[KW7O^&G?Y67_>M/X ?^
MD;_'7_[7/OW7NO?\-._RLO\ O6G\ /\ TC?XZ_\ VN??NO=>_P"&G?Y67_>M
M/X ?^D;_ !U_^US[]U[KW_#3O\K+_O6G\ /_ $C?XZ__ &N??NO=>_X:=_E9
M?]ZT_@!_Z1O\=?\ [7/OW7NO?\-._P K+_O6G\ /_2-_CK_]KGW[KW7O^&G?
MY67_ 'K3^ '_ *1O\=?_ +7/OW7NO?\ #3O\K+_O6G\ /_2-_CK_ /:Y]^Z]
MU[_AIW^5E_WK3^ '_I&_QU_^US[]U[KW_#3O\K+_ +UI_ #_ -(W^.O_ -KG
MW[KW7O\ AIW^5E_WK3^ '_I&_P =?_M<^_=>Z]_PT[_*R_[UI_ #_P!(W^.O
M_P!KGW[KW7O^&G?Y67_>M/X ?^D;_'7_ .US[]U[KW_#3O\ *R_[UI_ #_TC
M?XZ__:Y]^Z]U[_AIW^5E_P!ZT_@!_P"D;_'7_P"US[]U[KW_  T[_*R_[UI_
M #_TC?XZ_P#VN??NO=>_X:=_E9?]ZT_@!_Z1O\=?_M<^_=>Z]_PT[_*R_P"]
M:?P _P#2-_CK_P#:Y]^Z]U[_ (:=_E9?]ZT_@!_Z1O\ '7_[7/OW7NO?\-._
MRLO^]:?P _\ 2-_CK_\ :Y]^Z]U[_AIW^5E_WK3^ '_I&_QU_P#M<^_=>Z]_
MPT[_ "LO^]:?P _](W^.O_VN??NO=>_X:=_E9?\ >M/X ?\ I&_QU_\ M<^_
M=>Z]_P -._RLO^]:?P _](W^.O\ ]KGW[KW7O^&G?Y67_>M/X ?^D;_'7_[7
M/OW7NO?\-._RLO\ O6G\ /\ TC?XZ_\ VN??NO=>_P"&G?Y67_>M/X ?^D;_
M !U_^US[]U[KW_#3O\K+_O6G\ /_ $C?XZ__ &N??NO=>_X:=_E9?]ZT_@!_
MZ1O\=?\ [7/OW7NO?\-._P K+_O6G\ /_2-_CK_]KGW[KW7O^&G?Y67_ 'K3
M^ '_ *1O\=?_ +7/OW7NO?\ #3O\K+_O6G\ /_2-_CK_ /:Y]^Z]U[_AIW^5
ME_WK3^ '_I&_QU_^US[]U[KW_#3O\K+_ +UI_ #_ -(W^.O_ -KGW[KW7O\
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M]U[KW_#3O\K+_O6G\ /_ $C?XZ__ &N??NO=>_X:=_E9?]ZT_@!_Z1O\=?\
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ME_WK3^ '_I&_QU_^US[]U[KW_#3O\K+_ +UI_ #_ -(W^.O_ -KGW[KW7O\
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M]U[KW_#3O\K+_O6G\ /_ $C?XZ__ &N??NO=>_X:=_E9?]ZT_@!_Z1O\=?\
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M\<2.Z^Z]UKE?SJ/Y8_QY^,O6&^/YN'P%W#_LE'S;ZAJ]M[KVYF.D*F+!]?\
MR<S>\M\8:C'6&Y.K\0RX[+93=U5GA#3KC:77EZN6**NAKE<-'[KW5X&Z?F%N
MN'?G1'Q2V'M?;^=^:7:/4.W^Y^S-HYN;(1;'^.75:/C,)O+M3M$XAY*B2)LW
M43X3:VW:>JI:G-UT$T:U='14E?D:7W7NG?Y>?+&J^%/2>P,[O2MP/8_<G>7?
MW4'Q<Z/P=)C?[B[=WAWI\@]Z0;2V%B&QE3N'<%5#BL9')5YG*+'75U8<=B*I
MHVDFT^_=>Z8!\DNWMH?)^E^%>]<WU3E.W.QNCLA\@.B^QX=F[MVUL[=6$V!O
M#;NSN[-C[DV/%O7<U325^'DW;BLCAZF'.2+5T63:*6+S8NHJ:[W7NC!_:_+;
M_G>_'3_T$^R__LS]^Z]UU\E?CGM7Y;_%SMSXQ]T14E9M_N[JC.]=;SJ<)#-#
M#C\AG\*U*-Q[:BKIJF2*7'5_CR.,,SRM'+30ERQ4W]U[JA'^1EO/Y"?(?:75
MG0'RJVUDL?O;^31FNS_C9V'E<ICJY\/V%\@<6,GU7TWN;;67SCK4UHVWU=-7
MK4U\E/&*YMX460B9 0GOW7NA1_X57R1I_(_^52NZ(TVZ_CE'$K,JM+(/D7U?
M*4C!(U'3$S6%S92?H#[]U[JV;8GPO^):;CZG[R7HOKC/]I;!V]35'679&Y,4
MN]=Q]>KG</2QY*IZUS&Z)\TV#^[ALDLF'-(9([*24X]^Z]T17Y";<V;\W/YC
M>^/Y?/RVVM1Y[XK[:^%&%[MV%T]GY7H=N_(WL#?78V=V'OOL*KJ(/LZNNFZO
MIL1BX,72T-4JXROW?%F*B/[Z/!55'[KW3!_*!ZQ[A^)?:_SI_E]UG86[>Z/B
M5\3]U=(S?$;L/?.5ASNZNO=K]N[&S6[=Q_%C+9S_ #M6FQJ>DPL^.\I+04.?
MIH@L%.:6GB]U[JWZKZ8ZJKNX<-\@:S8FW:CNG;W7V;ZHPG9,E$#NG&]<[CS^
M)W1F]GTU?JXHJC(8.DJWC(/[D(((NP/NO="=[]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUX_P#A5+_VXX^7G_:^^-W_ ,$Y
MU![]U[HLGSHI^PODG\SOB-_+>_FAYC!;'^ ??N.Z_P"P>B-U]#[:R>V=H_*'
MY*=;1564K?B_\@M][RW;NVMP$?CEI*["8_%PXXY>;PQQUSU4B047NO=65_SD
MOEANOXC= ?&/8/5F1KNOLU\O_FU\8OA#2=B;=\6.K.H-D=LYZNFWWNW;E9KC
M2BR,&W=H9"AQ%0B.:6HJHZI$O3@CW7NBZ?S6L7F?Y<F-^)OS=^).3W1LRNVC
M\JNE.C?D'U2NZMX[FV1\C>B>]]STNQ]QX[>.V-P;GK:>JW=0UTE!6X+=KQ39
M2&5IEFGG@EDB/NO= U_+HZ3ZYA_G]_SY&@Q>:@_N'5_RX-T;<2#>V^8(ESN[
M/CQE]T;AK\Y%%N1%RYJ<A(U48\N*Y$=V\:J&(/NO=%7_ )FN^]U]'_RL/FE\
M@NI?D-VEWW\KNDODV-XC^8CL.;);!V/U1GW^9?7.W<7\<-IU\^]:\9Z@PV$S
MJ;$K\%M?&9C;<==!6Q9O[*JCJHS[KW5M/\[/K3N+/_!E/E1T!G>RZ/NOXB9C
MK;Y.5^S>N^U.R>LZ#O+J;K#+TFZ^Z>E]Y4O7N009''Y7;[Y2:.GGHJMO/31Q
MQZ5D>_NO=&-V]O+KKYN]G_$G>/4V>SE7TKL[HW#?+"LSFTM[;NVM3;@@[KVS
MD=G?'C8&Y:';F1H*7,X]Z0[MW!D\3DGG%%D-NX666F+31LONO=%(_EPX/<.Z
M_D]_.ZZ<W#VKW;N#;FUOE?U?L_9>6W!W)V)F-Z[)VWE_COLC=LN#V=OK(Y^K
MRF*I8Z_/U<E/%05$ A$S"(+>_OW7NB5_\)Y_C,_RU_EW? OYH_('Y#_*SL#N
M/K_>GRGJ<6M=\@=_C:&Y\!G>W>X-BY?:O:&V*C)UD&Y8IFFER)R.1U9(2"GI
M16_P^D@I%]U[H;OY2NX=Y=C_ !Y_G<[5[%[%[1WYC>I?YL7\PWJ[K&JW=V=O
MW.Y_8'7W7&U>N_[B[1V;N>NW#+D<908EM4E!34-5 D,CN\:JSL3[KW0$]4]T
M_+Z@_E"?R?ODK1=,=V_/KJ[!;0R.Z_G-U5LW=];N;OGLO9>7V!O?';<WTN-W
M%N"FJ]\?P7+RK6U>VYYZQZZ<T<C1!:<U5+[KW5OG\J_O/XD?(KK7O'MKX>]M
M[SWSL3>_>T^;W+U;V-6[WI][?&C>V,ZMZRZ^S_3-?LGL/(5N1V[2QU&P9<M3
MXN )CUER=0V/+TY!]^Z]U:+[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZH!_D%_P#=:C_Q
MO]_,;_\ F.>_=>ZN8[2EK-ZTN1Z?VQ6-3Y7<^+:EWEFZ9@?[D[)RHEI,C6,P
M(MD<A")J3$PW#:V>K(,5*X81;&%VUEW"856-JPH?]&F6A _TB&C2'THG%A0,
M[^6W1&VV!J/*FF:0?Z! ]58_Z=Q58AQK5^"$%<+L?9<FTJ38%1MO!939V+QN
M-P<6V<KCJ++X>.@Q,%*,;1U./R$53&_B2&)T\BDW"M];'V6'<[D7!NQ(ZS,S
M.9%8H^IR=1!4@BM3P^SHT_=-JUL+-HHV@55C$3JKII0#2"K @T %*_(]%$W'
MT[A.C^\>G-\]-TC;5HNQMY2]>=@;$Q#O%MS-XRHVUN#/PYR#$^J.G;'+A)9V
M$(100A54U3>60+/F&7F;;+NUW$^*;>$7$$[YD1A)'&5U<3KU@9J>-:T6D;7O
M+$/*>[V5WM:^"MU.;:YMTQ%(AAEE#A>"F/PR<4'"E*MJ/3[C#J6^BU_)CK3=
MV^]C5V2VAV-N':.9V? -VX?#4\.#FVOF<SMAGS6/&>AJ<1+52'RTL?B+53P1
M.B2FFD9?8RY,WJWVNY5+BWCE24^$[DN)423L.@APHP37MU$$C4 >@-SWL-UO
M%HSVMS)!)"/&C0",Q/)%WKK#(6.0*=VD$!BA(Z7?3NZ\YV3TSL+=V:9\/G]V
M;,QF0KZK&P4R-3Y"LHE$F3QU-7TU="HD;_*((Y8ID =0P=?J5\PV,6S;C/;Q
M]\<4S*H8G*JWPDJ5..!((/V=&_+&XR[[M=O<R]DDT".Q4##,OQ*&##/Q $$<
M*UZ+WUWB^P>H_D]ENOZ[>>5["V/VQM+-=CID-R4^/.YL)N+ UF*PU1][7XRB
MH8Y(/ ]/31A(H8@K0QQQ1>$^46;O/:;_ +(EVL*V\]K*EN5C+>$\<@=Q0,S$
M&H8G)-=1).K +V2WO>6]_>S>=[FWO(9+H-*%\6.6-HXS5D505TE5& *:0 NG
MN)U_,Y_[+4_DB?\ B^78W_P(?>_N->I6ZNB]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$@[!^$F.W+
M\C=S?+#KSO7NOH_N_=/6?7W4.9RFP:_9>9V1G^O^MMP[UW1M[!;MZS[(V;O?
M#5[)6]@Y5TR*4U)D:=*IXZ2MIUDE$GNO=3NGOA;MO8'?>YOE7V7V9V#\A?D=
MGMBQ=4X/L/LB#9>'QG574W\5I]PY#K;J'8O7NU=HXO$4&2R=+'DLO75463RU
M=-%"E5DI*6FI*:G]U[J@[X3?++Y4[ _EN]S?SML]LCK[M2/O3L?M;Y+=S;+W
MEE]QCO'_ &4'KCM/=>P-C];]3;FHIJ;;^W8=D;.VW)E\%MR:DRM+D9YJR>JK
MZ.ORM3/%[KW1VOY:?87^G#^:?_.<[<K\ED\DE%0_RX^O^K*3)"ABAVQT;7_&
M7,=S;6I,5114QJ(AELGVQELU622U=3'-)5)X1&D7J]U[H1?Y%6X]R9CXH=[;
M=RKS3;3ZR_F%_/CK;J2HDKEKH&ZLP/R/WG6X&DQCH[+%1455EZ_'T<$86.*&
MD1(E6((![KW5T?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JN?X*_
MRV^G?@7V'\S=^=6S33'Y<_(+(=U/BIH98Z7KS"9+%T^0FZXV^)JRL"XZ+<N=
MW/FH$A%/&BYI8%B5:="?=>Z2G\V[^7UOW^9Y\1=Y?#_!=[[4Z%V;V)EMBY3=
MNZ,GTUE>V-R'^X6]<1OK'TN"2F[?ZSIJ99ZO TB3--%5$1I(%YD!C]U[JP?K
M'";XVWL3;.![&W/MK>6[\1B:'&Y?<NT=H9'8F"R\U%20TIK:3:^4WAON:E\A
MB,C1G)U 4MI4V%S[KW14-]?$+<E'\P*/YJ]"=BX+8/8^Z.I\5T5WWLO?6S*_
M?&PNY>MMHYK.;IZVKZ-\/NW9U?MW<^W,CN2O6DS,,N3I:K'Y"IH:S&2RBAKL
M?[KW0@]$?&2CZL[3[Y^0>[LUA]Y=\_(ZJV#3=@[KP6UO[H8#';)ZFPN1P/5_
M7FU\+4YK<U8M'BXLWD:NHJJ[)5<U779.JJ+4U.::AI/=>Z-5[]U[KWOW7NJB
M]]]-9'XY_P V3;'S>AD$?2ORO^-V/^(W>5<\;M3[%[LV'ONBW7\;-YY6>"("
MGQNX*/-9W:4]95,T4>2.%IPT;5OJ]U[I]R?\OGMZM_FQ8C^9Q2_(7KNEH,7\
M43\.'Z-GZ#W'5U53U6_;N2[BDS:]G1]]T:QYXY#(>!:D[>DI1"FDT9<ZQ[KW
M2C[6^ &X(_G/@_YAOQ>[3PG4/>6:ZK_T$_(79^^=FYG?O4OR%ZLQ]=39?9U1
MG,+@-[;%JL5NK;]70PKC-QQ35]Z%7Q\M(8I/(ONO=#?\=OB51=/]H?(GY#;[
MW53=E?(7Y1Y;9+]E;SH-M)M#;6 V/UAM@;3ZSZGZYVX^6W'5T6#Q4%175\SU
MV5R-56Y/+5];++'%+34=)[KW54&U/Y")HOY9_??\JG>7RQR^:^,^[LWO*K^/
M,6V>IZ/;&Z.GL;FN^L;\BMJ'L;,UV_-R/O:NQ&<Q4=,)D_NW!/1S5*O3B:6G
MFH_=>Z&_??\ *]^4?=G;'P"^1W=WSSPV7^0OP?W=VAD:?=6POBQL[:VT=Q;3
M[:ZZJ.N]XTNV=K;AWYO2IQFX*ZGAH)ZS+9+)Y[&-/112P8&F5&AD]U[HUO\
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M_P#_ *!7Q)_^T+[]U[KW_#8'S)_[W<_/_P#] KXD_P#VA??NO=>_X; ^9/\
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M^]W/S_\ _0*^)/\ ]H7W[KW7O^&P/F3_ -[N?G__ .@5\2?_ +0OOW7NO?\
M#8'S)_[W<_/_ /\ 0*^)/_VA??NO=>_X; ^9/_>[GY__ /H%?$G_ .T+[]U[
MKW_#8'S)_P"]W/S_ /\ T"OB3_\ :%]^Z]U[_AL#YD_][N?G_P#^@5\2?_M"
M^_=>Z]_PV!\R?^]W/S__ /0*^)/_ -H7W[KW7O\ AL#YD_\ >[GY_P#_ *!7
MQ)_^T+[]U[KW_#8'S)_[W<_/_P#] KXD_P#VA??NO=>_X; ^9/\ WNY^?_\
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M)_\ M"^_=>Z]_P -@?,G_O=S\_\ _P! KXD__:%]^Z]U[_AL#YD_][N?G_\
M^@5\2?\ [0OOW7NO?\-@?,G_ +W<_/\ _P#0*^)/_P!H7W[KW7O^&P/F3_WN
MY^?_ /Z!7Q)_^T+[]U[KW_#8'S)_[W<_/_\ ] KXD_\ VA??NO=>_P"&P/F3
M_P![N?G_ /\ H%?$G_[0OOW7NO?\-@?,G_O=S\__ /T"OB3_ /:%]^Z]U[_A
ML#YD_P#>[GY__P#H%?$G_P"T+[]U[KW_  V!\R?^]W/S_P#_ $"OB3_]H7W[
MKW7O^&P/F3_WNY^?_P#Z!7Q)_P#M"^_=>Z]_PV!\R?\ O=S\_P#_ - KXD__
M &A??NO=>_X; ^9/_>[GY_\ _H%?$G_[0OOW7NO?\-@?,G_O=S\__P#T"OB3
M_P#:%]^Z]U[_ (; ^9/_ 'NY^?\ _P"@5\2?_M"^_=>Z]_PV!\R?^]W/S_\
M_0*^)/\ ]H7W[KW7O^&P/F3_ -[N?G__ .@5\2?_ +0OOW7NO?\ #8'S)_[W
M<_/_ /\ 0*^)/_VA??NO=>_X; ^9/_>[GY__ /H%?$G_ .T+[]U[KW_#8'S)
M_P"]W/S_ /\ T"OB3_\ :%]^Z]U[_AL#YD_][N?G_P#^@5\2?_M"^_=>Z]_P
MV!\R?^]W/S__ /0*^)/_ -H7W[KW7O\ AL#YD_\ >[GY_P#_ *!7Q)_^T+[]
MU[KW_#8'S)_[W<_/_P#] KXD_P#VA??NO=>_X; ^9/\ WNY^?_\ Z!7Q)_\
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M=>Z]_P -@?,G_O=S\_\ _P! KXD__:%]^Z]U[_AL#YD_][N?G_\ ^@5\2?\
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MZ#'-PW%[*1-M2)Y61E_4D*$ BG8-#*6()IJ95!H37AT72GQL'R3^$=9M3K;
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M>O\ ]\ZO_M7+X>?_ &$^_=>Z]_PX?_/7_P"^=7_VKE\//_L)]^Z]U[_AP_\
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M_P#OG5_]JY?#S_["??NO=>_X</\ YZ__ 'SJ_P#M7+X>?_83[]U[KW_#A_\
M/7_[YU?_ &KE\//_ +"??NO=>_X</_GK_P#?.K_[5R^'G_V$^_=>Z]_PX?\
MSU_^^=7_ -JY?#S_ .PGW[KW7O\ AP_^>O\ ]\ZO_M7+X>?_ &$^_=>Z]_PX
M?_/7_P"^=7_VKE\//_L)]^Z]U[_AP_\ GK_]\ZO_ +5R^'G_ -A/OW7NO?\
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M]U[KW_#A_P#/7_[YU?\ VKE\//\ ["??NO=>_P"'#_YZ_P#WSJ_^U<OAY_\
M83[]U[KW_#A_\]?_ +YU?_:N7P\_^PGW[KW7O^'#_P">O_WSJ_\ M7+X>?\
MV$^_=>Z]_P .'_SU_P#OG5_]JY?#S_["??NO=>_X</\ YZ__ 'SJ_P#M7+X>
M?_83[]U[KW_#A_\ /7_[YU?_ &KE\//_ +"??NO=>_X</_GK_P#?.K_[5R^'
MG_V$^_=>Z]_PX?\ SU_^^=7_ -JY?#S_ .PGW[KW7O\ AP_^>O\ ]\ZO_M7+
MX>?_ &$^_=>Z]_PX?_/7_P"^=7_VKE\//_L)]^Z]U[_AP_\ GK_]\ZO_ +5R
M^'G_ -A/OW7NO?\ #A_\]?\ [YU?_:N7P\_^PGW[KW7O^'#_ .>O_P!\ZO\
M[5R^'G_V$^_=>Z]_PX?_ #U_^^=7_P!JY?#S_P"PGW[KW7O^'#_YZ_\ WSJ_
M^U<OAY_]A/OW7NO?\.'_ ,]?_OG5_P#:N7P\_P#L)]^Z]U[_ (</_GK_ /?.
MK_[5R^'G_P!A/OW7NO?\.'_SU_\ OG5_]JY?#S_["??NO=>_X</_ )Z__?.K
M_P"U<OAY_P#83[]U[KW_  X?_/7_ .^=7_VKE\//_L)]^Z]U[_AP_P#GK_\
M?.K_ .U<OAY_]A/OW7NO?\.'_P ]?_OG5_\ :N7P\_\ L)]^Z]U[_AP_^>O_
M -\ZO_M7+X>?_83[]U[KW_#A_P#/7_[YU?\ VKE\//\ ["??NO=>_P"'#_YZ
M_P#WSJ_^U<OAY_\ 83[]U[KW_#A_\]?_ +YU?_:N7P\_^PGW[KW7O^'#_P">
MO_WSJ_\ M7+X>?\ V$^_=>Z]_P .'_SU_P#OG5_]JY?#S_["??NO=>_X</\
MYZ__ 'SJ_P#M7+X>?_83[]U[KW_#A_\ /7_[YU?_ &KE\//_ +"??NO=>_X<
M/_GK_P#?.K_[5R^'G_V$^_=>Z]_PX?\ SU_^^=7_ -JY?#S_ .PGW[KW7O\
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M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TP[J_P"/8W'_ -J',?\
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M;M%AZB2O1Z3W7NC3_!OY@?*/N?YX_P T_P"$_=6=ZIK:;X08GX3P]<=@]?;
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M@!0 2  *$G7T">7-TN8-^N;7<K=([B>)989HG+Q/;PG0(P652"I9F)(!)+5
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M9Z:R6(R;&2O.V<WN+&=N]7[C%0;BHI<SMGLC%9&DJ59PZ3$,5D1T3W7ND3\
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M_!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\
MP=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^
M_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O
M_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_
M /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\
MH<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?N
MO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=
M>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"
M_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__
M  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?
MS_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_
M +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.
M-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-_
M_H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .AS
MW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO
M=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_
M (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"_
M_!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\
MP=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^
M_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O
M_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_
M /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\
MH<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?N
MO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=
M>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"
M_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__
M  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?
MS_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_
M +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.
M-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-_
M_H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .AS
MW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO
M=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_
M (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"_
M_!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\
MP=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^
M_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O
M_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_
M /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\
MH<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?N
MO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=
M>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"
M_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__
M  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?
MS_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_
M +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.
M-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-_
M_H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .AS
MW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO
M=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_
M (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"_
M_!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\
MP=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^
M_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O
M_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_
M /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\
MH<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?N
MO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=
M>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"
M_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__
M  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?
MS_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_
M +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.
M-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-_
M_H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .AS
MW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO
M="!U/_))_P!%':?6G:7_  [G_.^[*_T:]@;-W_\ Z.NV/GQ_?'JS?W]SMQXW
M<7]RNR]H_P"BC'?Q7;^5_AWV.9QOW$'W-'/-#Y$UZA[KW5WWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZHB^=_P I?E?U'_-)_EE?
M#GJ'NV#:?5OSJI?E++V!49KK+K[=^X=C5'0_6]/OS ?W R%7A\<%BK9*P4U7
M'E5R;A$U1R*Q/OW7NN]N?/\ ^2?QQ_F\=9?RPOE)7;([CZ]^5W36Y^W/BS\@
MMJ[0'7F^L7N#8V+W7E=W]4=K;/Q&:SV-J_%2=?Y.MIL]1T^$C/W%+#X)7>;[
M;W7NKW/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5!_-#_ )IN#_E7;8ZK
M[1[=Z0W7V)TMV3V5CNM<CO;K;< R&X>O*F;"Y+<F5W1N_8]5MA&.*I*#"5T_
MFH,A62N:?QM#&TD>KW7NK3,)FL3N3#8C<6!R%+EL'G\709K#92BD$U'DL3E*
M2*NQV0I)EX>*:&=)(V'U5@??NO=599;^:EM6O_F=-_*ZZPZBS&^>T,9U%4]M
M;L[3S&[Z3:/56VX<7%35>;V@*RFV[NJOKLI209K$F6*CI)$27)K#.\)AF9?=
M>Z;?EE_,/^6/5&=WF?B/_+&[@^;'6G4%;747<':V'[LZHZ:Q*5^W9%3?&V>D
M-F[G&Y=R[\S&#O+#604&'H:-ZVBJL;!725T+Q#W7NC=?!;YJ=,?S"OBWU;\M
M.@ZG.-UWVCCLC)!BMTXY<1NO:NX=O9BOVWNS9^Y\=%45D25N,R.*J:622FGJ
M::=8UJ*2>>EFAF?W7NC<>_=>Z][]U[H ]D=Y4G:7:._ME=<XN+-[.Z=SM1LG
MM#LBHK6@Q"=HQ8VDR55UCL>CBIICE*S#PY*FDW+7M+3TM#-418V%JW(+DX<1
M[KW4#I_?7R+W1VM\D=N=O]&8#K#JG86]=J8CXX]CXOLS%;SR?>VSLELZARVZ
M]U9O:-!103[<;&Y6H?&QTU;(99V25DC\,4535^Z]T8OW[KW18?EO\H]H_$CJ
MK&]B[HQTV>R>[^T>I>C^M]J05R8IMW=K]X=@8'K7K[ U.8>DR(H:,U^X$J<G
M7BFJVIJ*FJ:A*>HDC6"3W7NJR?E]_,R^</PERV[8^U_@ALC<W6+[\^-&U>M_
MD7L3Y 53=:9:+O[M3&]39S";GVIG>MZ#.4^X]MUV9I:J/&4XDI<E12M4_?X]
MHQ!)[KW5ZGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NBZ=/[Z^1>Z.UODCMSM_HS =8=4["WKM3$?''L?%]F8K>>3[VV=DMG4.
M6W7NK-[1H**"?;C8W*U#XV.FK9#+.R2LD?ABBJ:OW7NC%^_=>Z][]U[KWOW7
MND5V%EMZX':N2S>P-J46^MPXE!7Q[-JLY%MNJW-14X:2NQ&!SE9!44D&3DC!
M_AXK_#22SA(*FIHH97K:?W7NDYT?W=UO\BNLMN=N=49Y=P;-W(V6I(I9::HQ
MV6PN?VWF<AMC=^S]TX2M2&IQN:PF6P];B<SBZN..>CK:.>GF19(V ]U[H6/?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW53>Y_YE6_,3_,+R7\MS;?Q;;>'=%'\;H_E72;H
MI>[,)A>O:[JF7?,/7FE\AFMC4U=%EDR<VAZ$T#Q^,&1:AQ:_NO="5\//YE'5
M7RO[N^17Q3R>QM^=#_+7XIUV+3NCH3LK^[U?E*+;NXTIZK:N_ME;OV=F,]B<
MY@\C2Y&AJHJFGGBFB3(TOW--#]Q"7]U[JQKW[KW7O?NO=>]^Z]TV9F7,P8NM
MFV]08S*9J.$MCL?F<M58'%U51<:8JW,4.$W'+3I:Y,D=#4GBV@WN/=>ZJS_E
MU_S8NM/Y@?:GRPZ&INKMZ](=U_$/?LNS=][%WQ7465&Y<5#N/=&S7W[L?-XZ
MCHX:[$'+;-KZ,2A5<6AD=$6HC!]U[HW?S4^5^QOA#\8.W_E!V#BLSN/ ]4[5
MJ<W3[/VTL4FZ=\9Z62*BV_LW;4$NH-69"KJ8H$8JRQ(SSR6BB=A[KW1>.G/Y
MA]5VY\'^K_FM0?'G>U7'W_M[;66^/GQ_V-NC!;R[H[+R^\$RM1M[:U4N3I-F
M;?Q-0]+BY,I65=1G)J*AQT%565U33)22K[]U[HM_0_\ -W[/G^9G7'P8^?/P
M,[%^!'</R&Q&\-P?%G.5G<77OR*ZN[GI-C8>+<.YMK5?8'6./H*+"[EHJ-W:
MIQ9;(TRO&D?W^NMQJUONO=7=^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>ZK]_F7_.Z'^6S\4]^_,'='559VMUCU=4[,I]\8?;>\:7;N^(!O
MW?VV.N,#4;>Q>7V_54-:BY'=M(:OS9*A>.+6Z+*5TGW7NC>=2[OW-O\ Z[VG
MO;=6U<9LK([LP6'W'#MO&[HDW?\ PS'YS%464HZ7(YAMN[:C-7&*LQ5,=/%/
M"KI^U43*0WOW7NA&]^Z]T3CN;Y35&U/D1U=\0>K,)MO<WR![7ZH[1[OHHM[9
MW*;=V1L_K#JO,[*VID]P9^KP6"W%6U537YGL''4..Q]/!")$BKJB2IB^T2*I
M]U[HEGP(_F._*WY&?,'O[X;_ "S^$V ^(>_^@^I-N=FBKPG?M#WE0]H8G='9
M&ZNOL/N[;;X[8NRCBL/6-LNMJJ"'(K+6S0R0SND$;IY?=>ZN:]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-><J,M283,5>!QM/F<Y2X
MO(5&%Q%77C%4N5RT-)-)CL;4Y0T]9]M'/,J1/4>&7QAB^AK:3[KW0.?&/>/>
MW8/0G6.\_DUT[A_C_P![[AV]]_V3TY@=^8OL[%[!SC5];%%AZ??.$BCHZ]C2
MQ4\\QIFFCBDF>!)ZA8A/)[KW0[^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NJC_Y4G\P/Y)_S*^@.JOESF_B_T=T;\<NX,3V/+MB?%?*S?O:G=E#G
M>N^S=T=6ST&>ZVJ_B-UG@HZ2JKMEY&=*RGWG4R) :=C3-)++'![KW1VMX]\;
MRQ&YLQ@]A]%[S[0Q>"J1B\AN?!9?#8W%KG(H8ILCB:=<CZY6I?N$CFD7TB77
M'^J-O8RV[E>VN(4ENKV&V9QJ6-T=FT$D!CIX:J$@<:4/ CH#;IS;=6T[Q6=A
M/=(ATM+&\:)X@ +*-9!.FH!(Q6HX@]#W-E*^EP"Y:7 9"KR8H*:IFVYBI\=4
MY ULT<1EQE)59"KQ-*[(\A3RRS01D*6+*/866!7E\,.H740)&#!:#\1"AFX>
M0!/EGH7O.\</B&-BVD$QH5+:B!V@L47CBI('G4=!KTEVZG=>P'WUCMN5.W@^
M9W!AZ7#Y>N22J\F$K)*)7R$U-2,(&D9/W$19_'S9I+<G',VP'EJZ^E:19"$1
MRR@A>]0V*G(SQQ7T'1)RGS(O-=F+Q8VB!DD30Y!8>&Q7-!0$TX9IZGHC'7_S
M<^4&-^='57PF^3'QFZ$Z[R/<70?;_>VU>P>BOE=V%WI145%U#N?K[;.2V]N'
M;V__ (@?')X9:Q]_Q203TU75JJT[!ENP]A[H2]6F>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[K6;_FH8[.Y;^>[_P )_,?MK<;;2SE11?S$_P"'[A7$T.=_ATD70>"G
MD+XG(E89UECC>%U9D(60LC*X5A[KW5D.W?Y?_4W5GRYWS_-"^2O=V]>Y^[ME
M]+938>TMT]AT^T-I=1_&7IC#4>8S>]?]%VRMK82C-%+6PUF0GS&8R^1R]4T5
M14QQ200S31O[KW4G97\TCKC+?)+87QK[6^.WRO\ C'E.[JC+4/QP[+^0G66W
M]H]7=^9G!X;^/Y#:>U,Q@]\;HKL1G6HHYJREP6Z\=@*Z:&%@L J :<>Z]T=+
MY$]]]>_%[I'LOO[M2LR%+L7JW:F3W5FXL+CI\SN'+"AA/V.WML82E_=KLID:
MAXJ''4<=FFJ*B.,$:KCW7NN7QR[LV]\EOCUT/\CMHXK-8/:?R Z9ZO[LVQA-
MQI0Q[AP^WNU=D8/?>%Q6>CQE9D:9:VGIL]%#5"GJ)XA*C".1ULQ]U[H9O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U4-_-#Z=V+\ANV_P"6?T3V=B8LYU[V_P#)KY/]<[QQ<J1M
M]UM_=W\J_P#F 83(^$R(X29(ZPR026NDB*Z\J#[]U[HAG\ICYI;L^+'P?^5G
MPL^15--O/Y0?R@-U-\<<3LS%38O&;E[_ .OL_)%COA)4;+QF1SCQP-O1<GBM
ML8..HJT2.]%]Q+&96(]U[H"^F.F\ST5_PI5^*.R-X9FBW3V=6_R5]V[Z[HWG
MCZ2JH*+>_=O8ORX[TWMVSNN@H*[)9F:FHJO.YRM.,H9*RI%'1+34:2-%3I[]
MU[K9^[F[0P'0W6>X=ZM@JK-U\4LM+LW8&V*>E7<G9?9.Z*V;^[>Q=JT3-31R
MY3.Y6M$8EE>.)&FEK*N6*GBJ)T]U[JI#;V,R_P#)*_DY9S,Y:3;6Z>[-NU=9
MNW<C4U-+'U]5?*3Y@][T5%'CL5CCDL:4VMA]U]P4M#2Q2U](S8K&(:BMBD:6
MJ'NO=-7:_P#PYWL?NKX=;]^+W77S![&P/^F';6R?FULCY(]C?"2CZQW;T+N.
M!Z7>';NUL7M?M^NJ\%NC;]0D==C<?M."BI:B)Y()Z2H"HK>Z]U;#\N>ZF^-G
MQ2^3?R)2AGR;]"_'SN;N=,;30Q5%1D'ZOZYW'O=**&">:GC9I3@P@$DD:>KU
MNJW8>Z]T0_\ D2;9_@?\I/X89F;(U>5W3VSUEDN^]^[GR3_=Y;<O97?V\-S=
MP;[W)EJAPIEGGRF\ZAN;*J*D:!8T51[KW2$^!O9OR4[5[\_G!=,=A?)'>VZ)
M.@_DEU]UQTIO:MVGU?393KC:F=Z+VGV%)18?;.,V50X*>2.KW).OGK\;5R2A
M8S4-*44#W7NJ>?CKWO\ S#_D3_PGI3^9OF_YA?>.UOD+T=L'Y5]XXK&[,V=T
M7C]D=IUW37;_ &=+%A^]<?G>K=Q5>5HCCMIG%T&.V]6;4H(*8Q":DJYX_.WN
MO=&8_G:9[='<'QZ_D?=P-OK>>T3WO_-"_EA09W9^W)MLIMS"UV^MO=D=B/N[
M!?Q3;&4K8<U157@BI9WK):814ZJ]+(2[/[KW1M?YZ>V:O:'\N39N!KMW[KWU
M4TGS:^##R;FWK/A:C<5<*GY;]:5*1ULNWL'MRD*PK*(8A%1Q>A%U%GU.WNO=
M+7YE?(7OSJ#^<?\ R=>BMA]M;BQ71OR]IOGC#WIU3-B]I9+;VYI^A/CIB=X=
M=U=#D\EMVJRV.:GR68-7,N/R%,LSPKY0Z%E/NO=)G='S4[%^.'\Q#^93BNQN
MR-V;Q^,?Q8_EH;&^9>,ZUR=+MR0;?W'!F^X,COO^ YK%;7ARLB5E!U_3P4]-
M65&06%B?"@U:??NO= CVYOC^:MOOXF]&_)GX=[%^4V\_E_D#T_V_D-CY_?/P
MLV[\/.X=C[ZEP><W_P!6C:N9[QK:K%[=I\-G*C^[.8@$&X?\CI7K:^:>6=C[
MKW3[O7MOYF;U_GMR_"'&_*[L?J;HS??\J.N^2S[2P&S.E,IN3J3L#._(].MJ
MZHZ^SN1V/G:"IS%!1X9(*/)[FI=VTD7GJV2BD,L+P^Z]T+7\O??7RHS>?_FT
M_!W=7R.WCW!O?XD=K8C8/QS^1/;]%L^;LBBQ'>GQWPG96QCV'6;(V?MS'9.?
M;^5S1D-6F'C:2,^,PE$CB7W7N@W^9G8WR:KOD?T3_+0^"WRL[^K_ )3[KIMO
M]M_)WY!YZFZ1W5MGXH?%W"Y2!,MO#>.VI^J*;%U.ZMYSH,1M3!K1@$2R5LRP
M0+!,_NO='![<F[6P_P F=R[/[@^2.XML]"U/0O7^'^,'6O0>6W)D?EEO_M^F
MRV6Q_<7<&^]G]?['R.3R>/Q0J-O003QC^[]/]]/-EJ2-6$L?NO=)S^1#\L>\
M/FS_ "M/C1\A?D?G\/NWN?<?^E7:N]=VX3'X;&4>Z:CK'N3?_6V,W#-2;;TX
MW[JKHMJTTM9-CDBI9IVDF@BBBD6-?=>Z:?YV6]_E#\?_ (HI\O?C)VKV=M*'
MXR]A];=D_(CK?8&.ZURTG:_Q9Q.[J2/O3$8Y.QMM9=:#*46%R$^4@R5%5T,B
M0T$JDNQCT^Z]T:'.[XK^\NY/BS@NB^X-X8WKO_1A5?)?LG<6RZ[:V3PN^^I-
MS[>?:_1>U=R2Y_#YJIB3=F6S=5N*@R.+-)-+#L2OIGJ5BG:.7W7NBA? KLKY
M+=L]_P#\W_I3?_R0WMNJ?H;Y*=>=:]([UK=I]74N4ZYVMG^C-I=@-0X?;6.V
M708*>2.LW+.OGR&-JWE"QFH:4HMO=>Z(S_)B7Y]?S$_@5\,_FKW'_,?[JVWF
MJ?=OR/\ ](&PME;"ZEI\'W1MO'=H]G;3PL>]JZHVFDM%D\?68RG%%-BTBH(L
M9004D>.CJY*C(/[KW33\;_G)\O\ MC_A+WF_GYNSO_=9^76V.DOEEV-1]Q8K
M;_76-KJS</5?>/<FU]FKE-IQ;); 34T&.VS14<D'\*42+ '8F8M(?=>Z/!\W
M?G)O'XO?'?\ E^=V]L4_>,_Q>W_2X:?YN]S]$;6S.?WKUMA<IT)4;@VKN_='
M]R,16Y3#[:J=QR"?.Y?"I1U$/VT-/!+_ )4*6I]U[H\GP+WWM7M?KWLGMKJW
MY:TOS!Z([*[6;<G1.]8=P[<W15=?[$I^L.LMNY?J;)YG X;"SO48[<F"SM>\
M>:CDRD0RHBKY'F0L?=>ZKM_EE]GYG;O\UW^>C\.D:0=>]=]V?&KY+[%H#5U,
MM/A=P_*'H7"[F[:I<?1R^2.F@K,IB*7*-'"T:M55M7,8]<LC'W7NK]_?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW6L1O+-[NV__P *IJO(;+V.>P,L/Y*E/#-@4W)BMK3B
MA?Y9(TE;3Y#,QM3NZ21Q)X7>*ZR%@]TTM[KW1N_AG_+X[[QO\S[Y>_S6/E8W
M76S-^]S=9[>^.'0_1W5NZLQOFDV#T9MV79-=6[A[.WIDMM[2AK-RY>KZ_H)S
M1XVEGI*%7G1*NI$D8@]U[JSKK?Y9_%KN+L7>G4'4OR/Z+[.[6ZYU_P!_>MM@
M]K[&W=OK9ZQ21P3R;BVK@<Y7UM(D4LRPS/-"JQRGQ.5D!4>Z]T-V<SF&VSA<
MQN3<>6QN!V]M[%Y#.9[.YBMIL;B,+AL3235^4RV5R-9)##3TU-!3O-//*ZHB
M(S,0H)]^Z]T&>-^0?0^7V[M#=V.[GZLJ-L]@;0V[V!L?.?W]VO%C=V;'W?C8
M<QM;=VWZF?*1K58[(TM0E11U<.N*6-@R,1[]U[I08+MGJO=.3I\)MCLSK_<>
M9JUF:EQ&"WGMS+Y.I6FADJ:AJ>@Q^2J)7$<<32.50Z54L; $^_=>ZTTLS#5_
M 3._#C^<YM>BA@Z\VM\ZOYGGP?\ GR]/3PQ-)\9^\/YKORL;87967KC6TEH-
MI;G2*61#'4//+5X^,&.*%B?=>ZML_FWY+_9DNC_YA6"QD\.4Z5^%?\M?Y<=C
M9W(4IIZW"[N^4?=?Q.[3HNM<119.AS]F.R]@Y7(YVOI*K'30S2=B;>K:6H2>
M@=??NO=&B_D>4E+4_P H;^7#-44U//-0?&#K.KH99H8Y9**J?;U10O4TCNK&
M.0P5LT)="I*2NE]+,#[KW4SN#IM/F#_,.^*^]:1$_P!$?\M[)=K=@[DW5# C
M#>'R;[3V+2]?[0ZIP65^XNU+M; Y?(Y_=8BB*_?UV!I%G\D&3I4]U[I%;M^2
MV_N__F/\M?C5LG ?)3)=??$; ],[+W.GQBW-TEL;=57V[W7L!^VI\_NS=W:W
M96P<FE)C,%E\'#@:/"1O2253Y5LG)5E*6FI/=>Z%/^5EE?Y@;=*]E;._F&[+
MSV)WUUWWKV!M3I/LC=^<Z3R6_>[?CA#-1UG5N_\ LO%="[CW!@L=N00U,U#E
MH8%HQ(U,DHA+.\C^Z]U9K[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM??_
M (5*_P#;BWYL?]17QH_^"VZ)]^Z]TF_YKO?_ ,H/CCT[_)^S/QR[WR_5<'>G
MST^"GQA['VS%M+:&>V]N_8_96"W'F,W#GZW(8I<VD,C;3IJ6HIL1F,09J>2:
M,RJSK(GNO="OCMR?)CXK_P X#XV=";F^6O<GR1Z5^</0'R?WSG=D]RXCI^EQ
M_4W9?055U[F\56=0#J[K+KF3&866@WA)C_X96OE96 6:IJZJH7SCW7NBS;VZ
M[W-G?^%/V#V@G>'<.%I9_P"3/NCL;&Y7"UG7T.:V\-Q_-S*8RLV/AZFMZ\KX
MC@HTQ5,]/!5P5=4CPAC5M=PWNO=&BZGHC4_S^_F[CC65T)J/Y9/Q,HCD*:<0
MY*(R]O\ =4'WD%2L=DG75K1PO# &WX]^Z]TC/Y9/R,^2'R$Z%_F]4G;_ 'KO
M3=6X_B[_ #+OG+\=ND]^0XO8>"W5L_JWH[;6PZCKS!J<+L^BH:UJ6>MJ)I:C
M)45;+.:AUG>1-*K[KW26Z<_F*=Z4W\HO^6!VMNW<^=WY\IOGOO;HSH2#?.-P
M?7<6Z:C=_94N]MU;UW7MS 9^39FTES46V^O<PN ARCT>+&3>B^YAJ(0U'4>Z
M]T-&'C_F3[3^?'1C=5[ ^4.0^#_:FP>R=J_*7_9F^R/B5N:HZ+[ QF">OZE[
MCZ;&U^U=W;CJ9*ZO+4.<P*I5XT1>.6"CA8LR>Z]T27X-9;YV?.[K'^;'MO>G
M\Q7Y!=>YCXL_S,/EWT7T_O;JK:'06VMZU.W^E,'M>DV!MK=]?E^I=QXU=N12
M%*JJQNWL5M^NJ)YJEJC*R0RB!/=>ZLA_E_\ :GR$_F"?RT?Y?W?.>[@S/6'8
M'8.W-M[R[]WAL#&[3QVX=[4&W=O=@[3S%#@*/-[2W3BJ%LSN"BQ.1K52AB6*
MG6ICI6A?Q >Z]T 'Q=[A^1GS/_F';WROQ[^0W<4'\MOX85^X.K>R=Z;BAZJS
MV+^:7REA,:YW9/7.;3KZ*OI=G[#O'%E\QCJBD.2R$C4L$DU(#,ONO=%%_F._
M+CY?_#WX"?*KY)UGRBCR_P ]^AN^\?N:EV=THV1WS\5.L^F,M\FNO=K;)Z2[
MGQ%9L^CV[C*_);!W;23S4N>K*?<];D,EJQ=9(IC\7NO=;4.'K7R6(Q>1D18Y
M*_'4-;)&ERB/54T4[(A8DV!DL+^_=>ZI3ZV[B[[Z-_G1[Z^)7?'>'9&_>@OD
MQ\9*7O+X,XS=-/UI0[?V[O3JO*RX/Y(=12Y;;NV\!G,SDH*3+X[<>..3DK5@
MQ_EU2M*FH^Z]T9K8E7W#OOX]?*#O/!=^=E;?H^R\MVANWXTUM3C>L=S0=8]1
M;+Q*X#8>X-ETV3V=DJ7)T>[9=HU6]**HSXRTRT.YZ>F'A6"../W7NJ0_DK\V
M_FOMO_A+AUU\_P#8_P E]Z;2^3T/4/1V[=X]E46W.NLIE]ZY'M;Y#;"ZUW"]
M<FX=HY6#'A*3>-0U,<-3T#PLL2Q-'%&$]^Z]T*G\W.?Y_? K^7Q\R/Y@&Q?Y
MCO<63W^VVOBQ4[$ZN/6_38ZPZ=W3NKN[K?8'9+;%@S.S<Y/58FOQV]&@H*3,
M+65E.8&J*FOKJF420^Z]U8A_,)[M[HZ9^3G\J+&]:=H[EVMM;Y%?,BGZ8[FV
M7!2;7R&V][;%/379&]UHYUR^W<A644XR&W*5_N<;643LBF-]2&WOW7N@)^6?
M\Q#K[X[_ #\W;T#\X.UN[?B!T5O/K3J:?X=?([!P9#:OQYSW8V6I=^OVO1[]
M[4BVYE\1%N.AGHJ(4^*W;)48>*BHXZB>FA:J62K]U[JX[X[8W=^&Z Z0Q'8/
M9%+W'OO%]1]<X_>7;E$V+>C[2W11[0Q%/G>Q*5\'3TE$8\U4QR9)31Q1P$5-
MXE":1[]U[H8_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U0!_P )<P3_ ")O@V Q4D?)H!ETZE)^
M87R# 8:@PN/\01[\.O'H^.^^I.T?C-BLUV[TYVKO7>&W]OU63W;OSJ[L;(TV
M7Q.;Q-57568W3D,/445!01450&JYZR5X::.1O5(97*^*67-KW^QYTD3;]QM8
M8I) L4%S;J4='"A(PP+,6& H!8@<*#B(4WCEO<.0HY-SVN[GGCC+SW%I=,'2
M1"S22%"JJ$;N9R0H)R2332Q^L'EJ;/X7#YVC$BT>:Q>/RU(LJZ9139*DAK(!
M(OX;3,+C^ON*KF!K61XFXHS*:>JD@_X.IDM;A;N))5^%U5Q7C1@"/\/15_A+
M_P R7J__ !)797_O4UOL<>Y/_)2'_//;?]6EZC[VK_Y)9_YZKO\ ZOOT1GNG
M_M_3\%/_ !GG\V?_ '['QP]@#J2.KHO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U6;\
MB/Y9&SOD?\POC/\ -?<OR2^26T>T/B+/OV3H_;NR).A*;8& A[0QB8+?M'EL
M7N3HC<V0R,61H(TH9#59-W2) 8G275*WNO=61SXVDKL:^*RT46:HYZ04==%E
M::CJ8LE&8Q'-]]2+31P/Y+$NBQ*ER0% L![KW1 N^^GL%\P?DA\7:62-*SKG
MX-][S_)/=&Y*8T$T&1[_ ,%UMO3KKK+JK'S20U+N<9!VI7[FW \1B^UFH,13
M7>6IG%)[KW5?G\P/YK=(Y[$?-#8O96#^3M/6]/\ 2'R"ZMZ8VAB?@S\TMZ[(
MSW;6Y.H=W;6S_<]9VOL[X\[EVF]/'#GI-N[<KHL\E+24E3F:VLF9*^G-![KW
M1S_Y+?9^T^T/Y5?P"J-IC=2Q[&^(/QDZPW -U]?=@=>R_P![-D="=<8W/' P
M=@[8VN^7Q1E(-!N'$+78K(1_O4%;4P^OW[KW5H'OW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZKU^
M5G37R7[-^2GP7[*ZKVMTID>O/BUWCV#V_O.3?7;6]=H[QW)3[V^+?>GQVI\+
MMG!X/I3>]$LE+-W9+DY)*K)QK(F/2,:&F8Q>Z]T$'9'\K7:?8/\ -3Z3_F1C
M<M3@(=G](Y;97;W5F+SFXZ?"=M=G;0S6)J_CSO+<V(I'I,=E8=K19O.U,3Y&
M+7#78W U-/%Y*9GA]U[H%-_?"#YKY?\ G;];_P R[;NW?C/5=*;)^&.2^(-?
MLK,=Y=F8KL^NBJ>P^Q.R(-_4-'2?'',8H'[G==+1MC9,DMHDEE^X+JD3^Z]T
MD^]NN/\ A0;F_E)NCM_HW#?R@&ZVVY5YC ?'_;/R WY\S-YYS8.T*NG3&UFZ
MZBEZ\V%UQC4W5GHO-_%:YH\@:.CG7$8^9(/XC4Y?W7NC$YCX4?*3YT_R]OD7
M\6?YJ>\N@)NS_D3#D\*H^(V&WJ>F^HL/M^JP6:ZHS.SH.VTCS>1R]!G<!%N*
MNFR<Q5YO%21%8(%9O=>Z#[X@=3?SMJ*'8_2'S7[>^'5?TQU?D,/19[Y =+)V
MG6_);Y&;.VC(7P.&R^(SM#MO;^UZK,_P^BCW9E88LC-+2RUM+00T]341Y6G]
MU[JW_M#K_!=L]:=A]6;HB6?;/9>QMV]?[B@>))TFP6\L!D-N9>)H)?2X:GR4
M@*-P;V/'OW7NJT_Y+6$WGU+\$-A?$CM2GI\?W5\)<_O?XQ=A8M91&*['[#W7
MF9>I-^T5/^XZ8S=FS,C@-PXU_P!T>+(&+6\D,MO=>Z3/P[^+?S3^/_R5_F<=
MT[UVI\:\GMCYD]I;*[=ZAP.V^\^R:G-;?RVS^K\=UA/MSL*HR/QOQD,$59%@
M**L6LQQR)A9I8O!( LC>Z]T3[XQ_RM_FST3_ "%^R/Y4^77XS9CNO<_5WR,Z
MIP?8..[B[,'5[T/R#W3V?N&7<>4GJ?CY396GDQ,>]X(1118ZJ%2T;OYX0 K>
MZ]TM_F;_ "^/G=\C_BO_ "K.G-G8/XKX+?\ \$?DO\.?DIV36[B[W[3&TMTY
M#XL;*W/M&MV=L>MQ_P 9JZKDCR[YM*J&OKZ*C,"J8VIY#ZC[KW1JOYKWQ9^6
M'S:^(6V.F>C<'T-M[M%.Z^E>V\U4=H]M[ZQ.R,".D>UML=E8_&8O+;6Z,W?6
MY1LG_=P4TC2XW%BF\NO]_3I/NO=)SY__  V^47='R"_EO?.?X[8_IBM^0OP.
MW3WS+DND>T>Q]V;:ZMW_ +-^375^.ZSW[0T7:^ ZKW-D:;(8E,1!48VH?;0C
ME$LWEBU)$C>Z]T@\;_+Q^3W8_P ]OE!WY\B<E\>LU\=_EQ\#-G_$3M[KG;51
MO6NSD"IENQ)]RX+9@R6 QJU&-AQN\VH6S65JJ>>NJ*F>I7$T,*P4<7NO=!/\
M./B%_.M^*NT<'\%QWW\0=U?"_K5*38G4ORKR>+[(E^8.TOCY02T]%B-BX_K:
MBHL5M3^\V*Q(?%8+,UU;74=#X*:IGILHD7V+>Z]T83_9(/D]1_SJ\/\ S#*"
M@Z0E^/F%^ E+\(*7 57;G8#]OR/%WE+VX>QJG"3]*56,=4@J&H3CVW TCR)Y
M3568CW[KW7+X[_%[YW]$_([^:Y\A*3:OQ6KLC\S,[UKV'\>,//WCVI-3;=WI
MU7TA2=283"=P:/CE3&#'5D^&H\A45>'?)2HCS0K Q"2GW7N@1^"'Q,_F9?"?
M8_;M36=$?"CO/Y1?([=>XNW/D7\LM\_/7O6BW+VAVYE,3/#MNDCV%%_+DRJX
MG9^V_P#)\/M_;5'GC!18^%Y(0DT\D9]U[H0^L_A7_,%Z(_F(?('Y/[)W]\?.
MV.N_F!TG\8-@]@[A[LW1V?5=A?&W<OQPZ^S.V*FGZ?V9@MI)2;DV[G\MN3(9
M^KP\N?V7Y:RM>HFG2=&>J]U[H7/Y,7P=[Y_EU?#G$_$SN/<?46X,%UKO[MNH
MZLJ.K9MZY.IJMF;X[;WWV#C\EO#+[RI<08ZQH-TT].N,I*.5:;[>1Y,A7/.!
M3>Z]U:7NW:NW]];5W-LC=N*I,[M7>.W\SM7<V$KXQ-0YG;^X<=4XC-8JMA/#
M15%-620R*?JKD>_=>ZK?_E.?!+?'\OSXOQ])=E]DR=P;QP.[-W;5VCO2MJ(J
MFKH?CIL3=NY<'\8]@2U<&!P 7^&;5DIJRMIEI62GR>7R,4,L\*QRO[KW0;?#
MCXP_-7X[_)K^9EWAO+9_QKS&VOF)VUL+N#J+;VV^]NR)<S@,IL[K7%=8U6WN
MPJO)?&['0T\57!@*.N6KQQR)B8RP^"0:)6]U[J9_)"^$_P B/Y>/\O[K;X:?
M(]>G,MN#JG,]D5&+WCTUV!O/>6$W9C>Q>R]Y]BR-7T&\NJNL:C&S49W4*/QQ
MMD%E$7E\D1/C'NO=5Y]7_P JK^89U-_*A^2?\H; 97XO5/4<>Q_D1LCX[]\5
M._.P*KLGL;!=T[[WSO[ 8+LW8#]64&*VJ])5;U:/,9FBRFYF:"*2"BQHEDBK
MH/=>ZMEV_P!;_._K#8OPXP^%3X^]G'JOJ?,]4_)C853OC?77^U-]8]]O]88/
M;.Y>NJZHZ\WFM3EL?+M'(5"KEZ'&4\E-D*FC!@-0)XO=>Z8/Y?'P$IOAUVO\
MZ^Y*'#[,ZMP7S([IV9V=@OCMUA4^?K+IK'[(ZXQNS\EDZ&9,%M:F.<W9E#DM
MP[@%#00TL#3TU'!)4K2_<R^Z]T"?\K/I5]P_)W^9]_,FE:O& ^>'?77^U>E!
M5AHZ3._'_P"(6QI>D]G=HXBGJ<?3S"CW=DX\SDL55"HJ::NPU/B,A1Z8*H-+
M[KW5U_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[JC>#X3?--?YV[?S*)-O_&A.D)_A6GPX
MGV>G=W9DO:$=..T8NT7[#BH&^.D.+8BHB^S&,.36\7[GW ?]L>Z]U=!O;:>/
MW[LW=>Q\O5YBAQ.\=N9K:V5K-O96JP6=I\9G\=48K(28;.4#QU%%5"&J?P5=
M.\<T+VDB=)%5A[KW51GRM^''6VY?F5_+#G^-W7VP^I>T_CIW3GNW^Q-Y=;[9
MP>S*_ ?#W"=2;^V/N;K#,5&W,)$),=NS=&>VMB\?B:IHTFBH,E/3#_(*EXO=
M>Z$7^8YYN_OC9\R^L:2[],]3?&ON[.=P9&*4"F[!['Q_4^Y<]L_I: K#)YL;
MBRM-G]W@20K(_P#"L2WW=+59NEA]U[I;?RLMH[4SG\KO^6E69O;&WLQ6+_+[
M^&D"U>4PN-R%2L"?'?KMTA$]733,$!D8A;V!8_U]^Z]T>6KVGBMO4=5EMB;"
MV.^ZZ6GD_A$-1'2[1IZB62T4L%1N+$[:S]13(T;N"T='/?\ 25L2P]U[JL?H
M[X&=A;O_ )???_P6^:&V.I!A>\MW_,[.93(]1=B[OWWCHZ#Y6_)+NCY XB6F
M_O7U;U?44M?MJ7M.FCIYU\X>IQ:3J4#:5]U[I ;<_EN]T=.?R8=]?RZ>N=S;
M+[5^0';?Q8[;Z8[,[D[<[(W_ (W"9SM'NCJW-;!SN_:S<LFR.QLW78[#KE*;
M&X6CFI(7BQ.'H*-/#'"L:>Z]TE>G_C?_ #9/C5_*EZ(^&_0./^$V#^474NR-
MH=/5':NZ>].Z<EUK2[$P4N5I\QO7:M-0?&*ER7]X*F@IJ.GHJ6KIEIJ*IKI:
MLS5BT4=-6^Z]TS_&KK#_ (4$[5W%U'UAVY5_R>NKOB]@]Q8E>RLC\:8OF7N#
MOMMDPY*3-;JAV57=UU.8Q51G<[*\R5V;S;U%09LA49&22:L]3^Z]TY_*/X,?
M/?J#YZ[I_F'?RN]W?'BKW+\BMB;!ZU^8_P ;_DY-NW;G7G:1ZHQU5ANKNV=M
M[UV!A,WD:7/XG'U Q1BD2.+[4,P\S.T/OW7NK5OC1L_Y ;=V179OY1;ZV5O3
MN[>N9ESFYZ+JG%Y["=.]?XZ&"+'[>Z^ZPQVZ:_)926BHJ:G$]=E<G,:G(9&K
MK*OQ4=+)2XZC]U[HQ?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ._G:_#
M/Y%?S#?Y?O</PT^.Z].8G</<E;U?)6[T[BW]O+:.&VS2]>=N[&[0G-/CMG=5
M]CSULE4-EK2("U*$-0SDG0%?W7N@%^=_P7^<7S Z:_EE[1PVV/B]L_>/PS^9
MGQ7^5W:L&2[][0KMN;@I_COMW-8K*[-Z_P Q2_&-:F=LI+N.9J:LR-!C_"M.
MODA8R$)[KW0_]Z_%WY9=E?S,?@?\PMM[;Z!INI/C%U9\B=@]@X;.=Q[^I.PL
MK7?(C;6QJ*LK]H8N@Z&R>.GAPM7LQ$05F2H6K(I6DM3.%B]^Z]T@=R?#;YB2
M_P ZS$?S'\#@/CO5]'XCX(UOPI;:63[H["QO:60#=Y9_N>E[$&+I_C[E<5"&
M?(4]$^,_B\A4*\@J6L$;W7NA#Z^^+'RKVU_-U[T^:N4P_1"_'/MGXN=;_':B
MH*'M??5;W#0Y+JS?^X]WXC>E9M*?HZ@PZPUT&ZZNGFQ\>XY&A>.)Q43!F">Z
M]T7_ ..OP-^;WQ3[*_F.]:=8U?QXSWQB^<OR9[]^86%[9W/O'>R=W];;V^0N
MW,'0[TZP@ZBI>O/X'D8H:K""+$9NIW5!'2Q,E354.1=7HG]U[H--N_R<N_\
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M7CX99X(&EE7W7NCP]F;+SM)T+NSK?I;;.SSEDZVKM@]?[8W'N#);+V7CZ9\
MVV\/15N<PVUM[5-)24=.RZ1!C*MBL00*+ZA[KW6O7V;_ "H_GMV+_P )]\%_
M*,E_V5*B[OHML=9]?5G9G^FGM5^KH]M=5=_[.[@P^=I@/C>N5DK*VAVE'CIJ
M%J"-(IG:85,J64^Z]U9?_,6^$'9'\Q?^5UW)\,MT9+9?4/;G:>P]C14=?A-R
MYK?77^!W_P!8;^V;V5MFEFW/6['VC7U6)K:[8E-25U0,%!/%3U<K10-+&FKW
M7NBP]\_$_P#F>?*W</\ +A[5W[2_#[J3?WQ$^4^+[IWOL?;/8/9W8>S\MMS%
M];;SV7FLK#O'(=6;0K:C(Y1MP1Q8_ T^*HJ>@CDJ):C,5TC0)3>Z]T<SMKJ3
MY)=B;@^2G67:/2GQN^4WQ0[IPV!&SMD]D]BY_ 9+;.=AZNVMM/=FW=R;1R_4
MF^\>FW,AEL7/E*2KQV1J,A0335%0M-4RU">'W7NA'_ER?$K(_!/X/?&SXD9C
ML"K[1S'1_75+M7+[YJH9Z:+,Y6HR>2SV2AP])52SRP8NBGS$E!AX)6+Q4-+3
MQMZE/OW7NCK^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7T_P"$P@R+?R%_A2N(>CBRS47RD&+D
MR,<TN/CR)^7GR&%$]=%3R12-")=)E6-E8K<*0;'VY"4#KXE2M1J"T#::YI6H
MK3A7SZ:FUE&\.@?2=)8$KJIBM"#2O&AK3JW>GV[WMV)M&KV'V]0=;;?Q&9H)
ML-O'.[&S^X<KD=R8:J!@R>-PV%RF QD>,^\@9X):N2OK7C61C% KE'C%SW>U
M[1<"ZV]KB1T8/$D\<:K&XRK,RR,7TG(4(H-!5B*@@N.RW?>K9K/<UM8TD0QS
M26\LKM*C8951XD\/4M06+N0":*#0@P-3'4X[%&' 8^AGGHZ>&#&XVIK),50>
M.'QQ1P-64]!DVB1(QZ=-/)^D"W-P$T*RO65F ))9@-39S6A9:FOS'0R<-#'2
M)5)  522BXQ2H5J"GR/0"?&7K??G5&Q:W:&^(MJ/4-N;<>X:>OVOG,KE(9AN
M')29)Z66GRFV\&T?A,K(&#RZ@ ;#FPJYTWBUWVZ%Q:F6GAQQE9452/#4+6JR
M/6M*^5.@?R'L=YR[9FVNQ#7Q99 T,CN#XKEZ$/%'2E:>=>JZ^Z?^W]/P4_\
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M[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\
MA@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\
M'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!
MU'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_
M -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_]
M.-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\
M^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"A
MSW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]
MU[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[
M_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_
M /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\
M!U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/
M^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\
MO_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW
M_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^
MASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?
MNO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U
M[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\
MA@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\
M'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!
MU'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_
M -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_]
M.-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\
M^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"A
MSW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]
MU[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[
M_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_
M /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\
M!U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/
M^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\
MO_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW
M_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^
MASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?
MNO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U
M[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\
MA@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\
M'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!
MU'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_
M -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_]
M.-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\
M^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"A
MSW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]
MU[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[
M_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_
M /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\
M!U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/
M^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\
MO_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW
M_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^
MASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?
MNO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U
M[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\
MA@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\
M'4?S_O\ TXW_ /H<]^Z]U[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!
MU'\_[_TXW_\ H<]^Z]U[_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_
M -.-_P#Z'/?NO=>_X8+_ /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_]
M.-__ *'/?NO=>_X8+_\ !U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\
M^ASW[KW7O^&"_P#P=1_/^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"A
MSW[KW7O^&"__  =1_/\ O_3C?_Z'/?NO=>_X8+_\'4?S_O\ TXW_ /H<]^Z]
MU[_A@O\ \'4?S_O_ $XW_P#H<]^Z]U[_ (8+_P#!U'\_[_TXW_\ H<]^Z]U[
M_A@O_P '4?S_ +_TXW_^ASW[KW7O^&"__!U'\_[_ -.-_P#Z'/?NO=>_X8+_
M /!U'\_[_P!.-_\ Z'/?NO=>_P"&"_\ P=1_/^_].-__ *'/?NO=>_X8+_\
M!U'\_P"_].-__H<]^Z]U[_A@O_P=1_/^_P#3C?\ ^ASW[KW7O^&"_P#P=1_/
M^_\ 3C?_ .ASW[KW7O\ A@O_ ,'4?S_O_3C?_P"ASW[KW7O^&"__  =1_/\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUF_[D[8_Z"A/]&'\)I_\ 1?\
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MZ+<F<C2>@HL?#7U6+K*7$1U];339*6@K(\=%5-1U8A]U[JH;^9UWY\:?GO\
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M%BH<SBL?2X3"TM/49.I+4='4Q?=QK4+X_=>Z37>W7'_"@W-_*3=';_1N&_E
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M_8HP&\L!O6KVO7XW)0=@459%E!EX*98X:AGD$4:RO[KW4[O7^9+_ ++[V_\
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M_([9G>6=78N/ZUJ\Q40[<J<ITW/6R;B%939J!<[+%1U-?24=-DI*">3'-4T
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MEI)0X>";<6\ZW&T0KY:3$M%3AIA(T<!5?2I'OW7NF'=/9G4'R!_GZ?!O<?\
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MC@V3M[KK>,&Y-T5A3(L(:'&RY&&'(U4A6.FDD6.9D8V]^Z]T>7Y;]T].4_\
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MBQ=!2X^.IK)R#-5U"4D40>5[>J1@6/Y/OW7NI0HZ0!@*6F 8:6 @B 9=0:S
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M]U[KW_0/M_+5_P">8^3?_I=?S1_^WM[]U[KW_0/M_+5_YYCY-_\ I=?S1_\
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MNO?] ^W\M7_GF/DW_P"EU_-'_P"WM[]U[KW_ $#[?RU?^>8^3?\ Z77\T?\
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M]U[KW_0/M_+5_P">8^3?_I=?S1_^WM[]U[KW_0/M_+5_YYCY-_\ I=?S1_\
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MNO?] ^W\M7_GF/DW_P"EU_-'_P"WM[]U[KW_ $#[?RU?^>8^3?\ Z77\T?\
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M]U[KW_0/M_+5_P">8^3?_I=?S1_^WM[]U[KW_0/M_+5_YYCY-_\ I=?S1_\
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MNO?] ^W\M7_GF/DW_P"EU_-'_P"WM[]U[KW_ $#[?RU?^>8^3?\ Z77\T?\
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M]U[KW_0/M_+5_P">8^3?_I=?S1_^WM[]U[KW_0/M_+5_YYCY-_\ I=?S1_\
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MNO?] ^W\M7_GF/DW_P"EU_-'_P"WM[]U[KW_ $#[?RU?^>8^3?\ Z77\T?\
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M\K.QI]YQT.Q]OXJAK44H)8,3E]P4X?4(ZR9+.?=>Z$+.YW"[7P>9W-N3+8[
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M[UE%5I'[KW5G7\^SK? =W?';X1=>]>T^,RO>&Y_YA_Q#R'Q8FV\M-5Y/'YK
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M1D"'Q.XY95- 2:Y8 DZ10 [=RW#L_,ADVY1%$]HWU<<=!$LAD7PCI&%9AJ(
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MMV'73939?7>R]K9.HC>*7(X';>)QE<T$A!>G%72TL<BQ$@7C5@O'T]FM_O\
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M_@@'_P!J*>_=>Z]_VU-?^" ?_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\
M@@'_ -J*>_=>Z]_VU-?^" ?_ &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@
M@'_VHI[]U[KW_;4U_P"" ?\ VHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@
M'_VHI[]U[KW_ &U-?^" ?_:BGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'
M_P!J*>_=>Z]_VU-?^" ?_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_
M -J*>_=>Z]_VU-?^" ?_ &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_V
MHI[]U[KW_;4U_P"" ?\ VHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VH
MI[]U[KW_ &U-?^" ?_:BGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J
M*>_=>Z]_VU-?^" ?_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*
M>_=>Z]_VU-?^" ?_ &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]
MU[KW_;4U_P"" ?\ VHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U
M[KW_ &U-?^" ?_:BGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=
M>Z]_VU-?^" ?_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>
MZ]_VU-?^" ?_ &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW
M_;4U_P"" ?\ VHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_
M &U-?^" ?_:BGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_
MVU-?^" ?_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_V
MU-?^" ?_ &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U
M_P"" ?\ VHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-
M?^" ?_:BGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?
M^" ?_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_VU-?^
M" ?_ &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U_P""
M ?\ VHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-?^"
M?_:BGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?^" ?
M_:BGOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_VU-?^" ?_
M &HI[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U_P"" ?\
MVHI[]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-?^" ?_:B
MGOW7NO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?^" ?_:BG
MOW7NO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_VU-?^" ?_ &HI
M[]U[KW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U_P"" ?\ VHI[
M]U[KW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-?^" ?_:BGOW7
MNO?]M37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?^" ?_:BGOW7N
MO?\ ;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_VU-?^" ?_ &HI[]U[
MKW_;4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U_P"" ?\ VHI[]U[K
MW_;4U_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-?^" ?_:BGOW7NO?]
MM37_ ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?^" ?_:BGOW7NO?\
M;4U_X(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_VU-?^" ?_ &HI[]U[KW_;
M4U_X(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U_P"" ?\ VHI[]U[KW_;4
MU_X(!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-?^" ?_:BGOW7NO?]M37_
M ((!_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?^" ?_:BGOW7NO?\ ;4U_
MX(!_]J*>_=>Z]_VU-?\ @@'_ -J*>_=>Z]_VU-?^" ?_ &HI[]U[KW_;4U_X
M(!_]J*>_=>Z]_P!M37_@@'_VHI[]U[KW_;4U_P"" ?\ VHI[]U[KW_;4U_X(
M!_\ :BGOW7NO?]M37_@@'_VHI[]U[KW_ &U-?^" ?_:BGOW7NO?]M37_ ((!
M_P#:BGOW7NO?]M37_@@'_P!J*>_=>Z]_VU-?^" ?_:BGOW7NA ZG_P"@D?\
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M+>Z]U;7T[W+\INY^\Z6#<WP^[;^(_0VT]G9K<&>S_=N]?B_N+?';_9>4EQ.
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MNFG.Y*JQ&(KLE0X++;FJJ.'RPX+!28:++Y)M:J8*&3<.7P-$'LQ;]^L@4A2
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M5M-@X-K[GZKSN8ZQW?A]Q2Y2:F6BJ:+*[9J:.J@J3$\4R-&ZJXTCW7NJ^/\
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MNS?^>MVS_P"?[%?_ %5[]U[KW]]=F_\ /6[9_P#/]BO_ *J]^Z]U[^^NS?\
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M?WUV;_SUNV?_ #_8K_ZJ]^Z]U[^^NS?^>MVS_P"?[%?_ %5[]U[KW]]=F_\
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ML_\ G^Q7_P!5>_=>Z]_?79O_ #UNV?\ S_8K_P"JO?NO=>_OKLW_ )ZW;/\
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M_O7ST5_YS;J_^R;W[KW7O^@?O^3/_P!Z^>BO_.;=7_V3>_=>Z]_T#]_R9_\
MO7ST5_YS;J_^R;W[KW7O^@?O^3/_ -Z^>BO_ #FW5_\ 9-[]U[KW_0/W_)G_
M .]?/17_ )S;J_\ LF]^Z]U[_H'[_DS_ />OGHK_ ,YMU?\ V3>_=>Z]_P!
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M*_\ .;=7_P!DWOW7NO?] _?\F?\ [U\]%?\ G-NK_P"R;W[KW7O^@?O^3/\
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MZ]U[_H'[_DS_ />OGHK_ ,YMU?\ V3>_=>Z]_P! _?\ )G_[U\]%?^<VZO\
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M_O7ST5_YS;J_^R;W[KW7O^@?O^3/_P!Z^>BO_.;=7_V3>_=>Z]_T#]_R9_\
MO7ST5_YS;J_^R;W[KW7O^@?O^3/_ -Z^>BO_ #FW5_\ 9-[]U[KW_0/W_)G_
M .]?/17_ )S;J_\ LF]^Z]U[_H'[_DS_ />OGHK_ ,YMU?\ V3>_=>Z]_P!
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M*_\ .;=7_P!DWOW7NO?] _?\F?\ [U\]%?\ G-NK_P"R;W[KW7O^@?O^3/\
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MZ]U[_H'[_DS_ />OGHK_ ,YMU?\ V3>_=>Z]_P! _?\ )G_[U\]%?^<VZO\
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M! ((-00<@@CIBBWAM.HR>1PD&Z-O3YG$1239;$PYK'2Y+%PPJ))9<E1)4M)
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M2J7#^_[7?1A;ZZ82I.3IG1UD0L.*U4]I%#1:"@! %!@3<N;QM\K/M]HIA>W
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M;:^2_9V6W%M2CHUKB\N2H:7,TM15T,8::&.97D11<CW7NG#^;9A.T?B+W_\
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MSQY'$Y1ER&.>?'5()F^QK(H_=>ZM=^,'P8[5^/'9C=@;Q_F*_-OY18=MN97
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MS-1+@*##X# BE%/]S+EIGQT5)3^/Q+Y&G8VT#46MS[]U[K5U_EL[X^-W:/\
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M=>Z"?^2O\COC3U;_ ,)I.L=K]V[_ -ETT]-U+\N=J;@ZGR61H*KL#>=5VO\
M(/Y"IL;8.V>N'G3*9O([NBW11T6W\;04T\F3FKXX*422,5'NO=7#?R=NH>T/
MAC_*;^'G57RVW-3[?[$ZPZB\N_JC>M?C,%'UYC]S;OW!NG:776?R%1D9:6&3
M:V(W)C-L2.:C07QG%KA1[KW18O\ A.7V9UUO_P"!&[*?9&^]J;IJHOE]\U,]
M/3;>S^*RE?283=?R3[!W!MG,5%#35$\D5/7T.5IJRCFEC"2Q3(Z%E8>_=>Z-
MGT?_ "[.Y>H.UMF=D[B_FD_S!.\\+M3(U%=D.I^W-Q=!UG7.\XI\=6T"X_=-
M-M'HC:61>&-ZM:F,4N1ICY8(RQ9 R-[KW1/OY?>U=M_R_P#Y_?S7NF.XZJBZ
MWP7RP^1;_/WH3LW>N3IL#LGM7;/;F,R,W<6T-O;JS=324DF:V9N'&U<F5PRR
M&HI\?EJ*MT?:S!D]U[H6/Y.7QXK>J\__ #*N\</BJS;?3?S%_F$=O=\]$X2K
M;(HF<V+64.&PV5[:QU!DE#T^/W?G*/*9/"JMHY,4M!/ J4TL"+[KW5UWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HF7SV^9/67P;^-?
M8'=786^-@[0RU+B)\+UA0]@;IQ>U<5NOL[/2TV!V3A)J[)2KHHOXGEZ-\M6*
MDB45$)ZN?3#"[#W7NBS[?_EK=,;E^&M5T!O#Y,]\=A]0=@=2[JP/:F>QO;V#
MH=E=EMV50YC*=P[_ )_[N[?H<?$NX<KN++9RMEI#!$)JZ61- M;W7NJ]_P#A
M.'\X-@5_Q=[._E^]H=]=?[K[G_EL]O=O_'FEW--NG;=!3=H?'KK3<NXEZ[[7
MVA%_%)$FP%!C<35XI9X):J.FH<-333U#K,LK>Z]TE_Y5'\PCXJ?%7^6K\_/D
M3V/VQM&JV;T5\_OG=N;<F.VYN/ 9;<6:;>/>&2SG6^&VQC8<E>JJ-SC<F/AP
M;AEAJ6JE99/$KNONO=1OY<WR>^(5/NGM[^97\QOE[\,-X_S)/D]BL/M3;?QU
MV%\H>F.Q=X?%?HN7=-/B^F?AGUQB<5NFKR/\7JLEG,?)O*>GH(34YVL998KP
M-)-[KW0@?R].W.J9_P"?I_PH KHNS.OY*+,[?_EQ/AZM=X[=--EDZ[^+&4Q^
M_P"3&3_Q'34+@YZ66'+M$7%&\;+4&,@^_=>Z(YU/M;<_RZ_DR?SD>I?B%N?:
M78G>./\ YGWRY[AVAL+;N4QFYY][8O8'RZV%WSB=ISX#&Y2%ZJAW?A]I/04*
M,RT]<E>L0:2*1U/NO='J^*_S:_DK?.?_ $)X3I3X?=-;Q^7IW=M?(R?&_/?$
M'%T_8_QF[+VW6"7=V\.P]T9'K&7$;8I]FO05U2=P')P-424:4>,:?*5=+1R>
MZ]T(G4?>?3<'_"BOYG;9F[2V!'FZG^7+\=<5'0ON_;Z2_P :V%V]V36[RP3:
ML@+5V-@W10U%;1_YV&*822(J@GW[KW0(_P C3N+J2DHOY\.2K.T.O:/'/_.1
M^?'8BY"LWGMVDHFV!N"KV9C\%O8551D8X_X363NL%-D=7@DD9420LP!]U[HB
MOP+[3ZRQ/_"-[M'!Y/L/9%!FZ3XL_P P+9-7A:K=.$AR]+O'>G;'R4K=H[5J
M<8]<)X\CDX*V*HH*-XQ+/%(LL:-&=7OW7NC&?,;L':NQ.B_Y%_\ ,;RVS,1\
MJ/@;\;NF\OUK\PMN;3VSB>Z<5M#97?G0?4&W,'WC+MV&HR%*Z[+S6P ,G(:>
M>H@CJY*=!$\[^_=>ZL_^'WR#_E*]Q=B9OO\ ^$G5/QV.$V)UA7P=N?-+;G0^
M&Z8VUL+;68R%)_!NHI.X=U;!V5-7UF1G@GK<AAJ"LJ(<=%CP^4%+-6XV.J]U
M[HK_ /PE%WEM'.?R5OC7M7"[IV[E]S[(W-W[2;SVYC,UCJ[.[3JLW\ANU<[A
MJ?<F)IJF6HH7JZ*NAJZ9:F.(RPRK(FI&!]^Z]U?+W]N;;^R^B.Z]X[MVU#O3
M:NT^I.Q]S;FV=4/#'!NS;^!V=F<IF=M325$-1&J5]-2R4K%XW4"4ZE87!]U[
MK6/Z%V%-\%/D-\!*G^4U\OMS_)KX$_+WO*'K;??P)WQOBF[QH?CIUM7["W#N
MC=O>W3N\,KDJ[<VS\5LL;<>'/X?+3.JY'+PT-8\E760Q1^Z]UL._/#J[LCN_
MX2?+WIKIS)#$=L]K?&?O'KOK3(G*U."6EWUO+K7<FW]K,^;HE::B4UM?"K5<
M09X0WD4$J![]U[K60V_\_OC+F/\ A.!W/\0-P[_QFPOF%\?OY:O9WQG[7^*.
MYXZS']_[3WWU1T[6]8YC*9'JTTG\7_@TCTU/DILXE(U!2TU6)*JIB$<I7W7N
MAB_F;?(/I^+^0Y\(-U9/>V-VYCZK>'\L?)4M)N]*K9N=JJ;KWL+I'/;[:EV_
MNJ##UDO\'I<=429)HX66G\$@D92C6]U[HZG\POI[X0_,[Y*].;4S_P G=V?$
M/YA[%Z/I^U/AY\Q.D>[:+8FX<OMK>6]]PT&\]C8M9,A#@]TXV*7KVAK*W#5C
MSR5-'D:O[)Z:):^5_=>ZK1[CWE\_.\OY473/R&[SV#C_ )9;D_EW_P TNHWY
MV$NQ^N\:<5_,,^%WQVW!V-U%NGNW:W6M+/'BZE,[1[RK<YCVAADH:A<(F5IX
M71X6/NO=67?#SY0?R<_F7VIT]O#X#?'GI#N/N7:]%E=XR=@[8^+-!LC<'Q=V
MY/@9(LY6[E[0W%UQA8<!FLE+64V"HL'C\J:ZNDK7G2.3%T=?64_NO=4)_-SY
MDT?\P3^1+\[]S]I[JR^W_G-M_=N6EWU\%=LTN\J;:WPQV3L;YB;9K?X9OSK?
M;.!@I:BHK-H['ES)W_OREE:3-92HCQ%3BV,='#[KW5UGRWV)\$OG]VE\;:6L
M^2?9'PW^6NT_CEA^TOAK\O\ K+LG*],;SS.VMT;OSV&WOLS%X/=\6WZ'=&'6
MHZWHZ^3&U\,AR6.R5148N6*C>JJ9O=>Z(CW'O+Y^=Y?RHNF?D-WGL''_ "RW
M)_+O_FEU&_.PEV/UWC3BOYAGPN^.VX.QNHMT]V[6ZUI9X\74IG:/>5;G,>T,
M,E#4+A$RM/"Z/"Q]U[JS/X:_)S^3?\S^V^F-V? OX_\ 1W;7<&VZ?([NJ.R=
MM_%:DV7G?BMMFIPCPY_)[H[,SG6N)CP69KY*VGPE'@L;DVR%?)6//'%)C*.N
MJZ?W7NKXO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6O
MI_PF$R%+B/Y"_P *<K7/)'18RB^4F0K'B@GJI4I:+Y>?(:IJ'CIJ6.:61@D1
M(CC1F8\*"2![<AB:=UC7BQ"BI %2:#)H!]IQTU-,MNC2/\*J6- 2:**G !)X
M< *GRZM-[![3ZH^0G3N[-E=<[@PV_P#<6_MLUN)V_MBC\CYC&YBM018K-;CQ
M4L2SXNFQU5XJR:KK8X440>@NYC1QYM6QW_*.XQ7-Y&\$<$JL\A^!D7+*C T=
MG6JA5))KF@J1'6\<P;=SMM<UI8RQW$EQ"R1Q+ET=A17D4C5&J-1BS@ 4Q4T!
M%W/]C]?]&8'K[!=A;KCPT.1@HMIXO.92FK?X?55^'Q,*RS97*14\T%()%AU>
M2JDB4ECS96*D%IL]WS/+/+:1:RI,K(I&H*['X5J"U*\%!/\ +H2WV^67*<-O
M%>S",-IA21PVDLB?B:A5:@5JQ _GTA*.AP79W?.R.U]D5-+D]N['V+O' Y?>
M>+838C=-=N.LPZX+;^*RD=XJ^''K39"JJ)J=Y(HI*B*/69&=8S.2679=KFL+
MD%9)IX76%L-$L:OJ=EXH7JB@&A(!-*4)*8X8=^W>WW&T*O%!;SQO.AJDK2M'
MH16&'":9&8@D*6 K4D -?BG_ #'_ (?_ #5J?D=0?'7M&3>V5^*&_,EUYWEA
M)]J;MV_G-I9FAFW%3TU='AL]A<?4UE!7R;0RT>.K*6*5*A\;41I^Y$R^P?#$
MT[K&O%B%%2 *DT&30#[3CH;33+;HTC_"JEC0$FBBIP 2>' "I\NE1V#VGU1\
MA.G=V;*ZYW!AM_[BW]MFMQ.W]L4?D?,8W,5J"+%9K<>*EB6?%TV.JO%635=;
M'"BB#T%W,:./-JV._P"4=QBN;R-X(X)59Y#\#(N65&!H[.M5"J237-!4B.MX
MY@V[G;:YK2QECN)+B%DCB7+H["BO(I&J-4:C%G  IBIH"F=Z;3/57R!Z$[4S
M4TE1LRBZUDZ2W+NFI]-'MO(T\5?5[;SN=J&;33T]?/724KU,I$<;LHD9=:W6
M[;?_ +]VF^L8P!,;@7D<0XR*:*ZJ/,H &"C) -!CI#NNV_U?WK;]QE),(M38
M2RGX8F%6C=SY!V)4L< D5(J.E+3X*GWG\P:#L?:<\59M_9/4%1M;=FX<;.M1
MB<AN'*YROJ,5M9:J!GBFJ::GJ&K:D(6,2FG60@M&H1/=';N7FLYP0\UV)8HV
M%&6-4 :2AR%8C2M>/=3S/2Y+(;GS,M];FL<%D89I%-4:1Y"5CJ,%E!+M3X04
MKQ Z(YW3_P!OZ?@I_P",\_FS_P"_8^.'N/\ J2NKHO?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=([L+&[YS.Q=W8GK+=F!V'V'DMO96AV7O7=&SJGL+;NU-R55'+#B=P9C8U'
MNS8DF6@I)G69Z!<SC?,$T&>,$GW[KW57'2WPI_F1=<2[3V_N[^9AU/N;KJ+=
M^/W1VS#L?X!Q=>=P=O(U=2UF\!D>X,]\L>STQV1SR4OVM7EX,!/-2P,(\:M$
M(*0T_NO=6 =Z]!;2[IZC[BZV2BV[M?-]K];]@;$BWXNTL9F,KMO);XVOEMO1
M;L2G$V)FJ9Z*3)BK6,5M*\C1!1-&3K7W7NFSXA_'R@^)_P 6/CE\9Z#-TFZQ
MT'T7U%TW5[TI-MP[0&^J_J_KS;>PZK>U3MN'*9W[*;*';PK)*9J^O:(R^,U,
M^CR-[KW1B_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6$TU.TGE:"%I;JWE,2&34MM)UE;
MW%A;G\>_=>ZR.B2*4D1)$:UT=0ZFQ!%U8$?47]^Z]U'^QHO^5.E_\YXO^C/?
MNO==FCI&-VI:9C95N8(B=*J%47*_0  #_ >_=>ZYBFIUD\JP0K+=F\HB02:F
MOJ.L+>YN;\_GW[KW56?6_5_\Q[N3Y![G7YMM\1]O_%3I[Y Y;M+XY83X^CL[
M(]E=NX7;M?F/]!4'?"[]JY\?CI=M--0[EK6PW-9G:"C\,=+143_Q#W7NK4'1
M)%*2(DB-:Z.H=38@BZL"/J+^_=>ZXQQ10J5BCCB4G45C144L0 20H'/ ]^Z]
MU IL+AJ.OK,K28G&4N4R 5:_)4U!2P5]<JZ=*UE9%$LDH&@6#LWT']/?NO=3
M9*:GF8-+!#*P&D-)$CL%!) !93QR??NO=8,CC<=EZ*HQN6H*+*8ZK01U5!D:
M6"MHJF,,KA*BEJ8Y8W%U!LRD7 /OW7NNZ7'8^A):BH*.C9J>EI&:EI8*<M2T
M"/'0TQ,*)>.%9&6)/H@8A0 ??NO=3/?NO=-E3A<-65]'E:O$XRJRF/#+09*I
MH*6>OH5;5J6CK)8FDB!UFX1E^I_K[]U[J?+%%/%)!/''-#-&\4T,J+)%+%(I
M22.2-P0RL"00000;'W[KW43&8K%X2BAQN&QN/Q&.I]7V]!C*.GH**#6Q=_#2
MTD<4:W9B3I47)O[]U[J3]O3FH%7X(?NA"U.*GQ)]P*=G65H!-IU:"R!BM[7
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M[KW7O?NO=8I8()M/FABETWT^6-)--[7TZ@;7L+_ZWOW7NLBJJJ%4!54!550
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MTP##2P$$0#+J#68!>1=0?]<>_=>Z]]G2:2OVM-I)#%?!%I+*&"DC3]1J-O\
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MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X
M]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\
MZ+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?Y
ML?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]
MZ6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z
M]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO
M?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?O
MW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\ W1?OW7NO?\.Z]X_]Z6?YL?\ Z+/X]_\
MW1?OW7NEMUI_-&[C[![&V!L+*?RCOYF_6V-WOO;:NT,CV+O[KSHNBV+L&AW+
MG:##5>]=Z5F([YS%7#B<5'6M79&6EI*J9:>"1HX97"HWNO=6\^_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB ?S.=]=Y]+?"#Y/_(SX]]J
MP]<]C?'7H7M;N[$4.>V-M;?VR=W?Z+-F9C?5;MS<F'R]+25Z??4^"EHZ>JH,
MI2?;R3+/)%4JAA?W7N@:_E-_S(W^>'4VYMD]S[73IGYW?&7)TG67S+^/&2IQ
MA\ILWL6B@^W.^-JX>;)Y>27:FXGII:O"UD=561+^Y3BIJ%BCJ:CW7NC#=$9;
MN/)_)GY3[.WMW/GMX;!ZDS?5=-UYMJ?:'6N&G&/W]UA3;HSD>\<Y@=FXVIKI
M:?(U4AQST38L1P1QQU*U;^25_=>Z-9N'L7K[:.4Q.#W7OK9NV,WGSIP6'W#N
M?"87*9IM9CTXG'Y*NIIJDZ@5M"C\BWU]^Z]U6-_.@[6^:7QK^#/<_P J_A'O
M?"4'8GQ^VNO8.Y^OMZ['VQO'9NY^M,!7)6=D9I364E%DJ;(8G$-491&BR7@>
M''O$:8RR"4>Z]T=[XD=LX3O_ .+?0O=VV-^93L3!=Q=3[-[)Q.^,KC,#ALOE
M*;>^#I=PQ_>87!X/!4='-2'(FD:D^R1X33>*H\DZRN_NO= S\&<]WUV+B.U^
MU>U>XZKL3K7/=P=F;9^.&(DV#L7:%4_3.Q=TS[*P?8&Z\KMC$TCY6NS]9MK(
MY3%UE*N+HWP]?0R&A\[F1?=>Z*O_ #X_EK\@_@3_ "[>VOF!\;M\4. [#ZKS
MG5&.H]N;IVCMC=^QMP46_>T]J["RK9BBR&-BR*3Q0;G,U/)29.G0/3J'B<,W
MOW7N@!_F2?.GYB?RE>OOCO\ +C?'8.S_ )2_%;=/:^QNJODKLS/]9X+KGM'K
MS$=A4=5D:'M/J_=>QLK24U:,>,-44TV!K,)7R5$E3!IJ((S+-![KW6PI!-'4
M0PU$+:X9XHYHGLRZXY4#HVEPI%PP-B ??NO=9??NO=>]^Z]UCE1I(I(TED@=
MXW19XA$98692JRQB>.9"RDW ='6XY!''OW7NM:[Y+?S4_D!_+B_FDTO3GR>S
MJ=G_ ,MC=74O166W7\@'ZWV]MW=/Q+[.^1W8/=FQ^II>VMS[0JL51UVUZVH^
M/&X8ZO)G!40IEJJ;7()J8)D_=>ZN$^;^]>R]I?'#*]I]%=J#9.XL-E>N)L7E
MJ;;VS=\;6W'@=Z=B[)VUDGKJ//8G(M*O\,SE3-C)Z"MHU$[Q2S?<P*86]U[H
MU$=31;&VJ:O>&]7JJ#!TLDV8WMO:IVQ@V: SLWWF:JL/BMK8N!4$JQ!HJ6F2
MRKJ!<EF]U[IN&7Q/9NS*RKZW[(I8Z7+0208C?^P*W:.[$H*J-HW^XQTN2H=T
M8N<K8+)'-3S#2YMI;2Z^Z]U2_P#RE_F)\I.Z/DS_ #(/B?\ -7LS!9KOOX4]
MUXC:F VAL[8&V]C;6W%T#V-AH=R=0=P2FFH:VNJ<GE*6@EEJ8(<FM-2PU].L
MM+Y9H9??NO='E[PSG?F=^87QYZ?Z7[GK=B[,KMC=A]I_(W$C8&PMUG']>;5J
M<-MC8=-M;/9_#5$^)SFY=P;H:."6L7+4LF/VWE3#2PU$/E?W7NCR9>AJ<EC:
MNAH\QD=OU53%XX<SB(L1-DL>^I6\U)%GL7FZ-FLI6T]+.MB?3>Q'NO=:Z?\
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6IY_(_\
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M6DN/R*QS:"3 $<,CJZ,R.I5B#[KW5R'3_P  ?CATW\B-_P#RXQ^%W?O[Y/\
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M]RTU/#&,EFMC_#;L3;6:^QJ#)4.*6:NQ;-3P^:0:?&+L0#[]U[H5?YF;*O\
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M>75G2G>'27R2^,&[>NY_BMM;%;@WY4UE%@.M]KT&5V!\;,975E%G9-Q0X>?
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M*IXZ:E]U[HG>]OG/U-VK7?\ "=OM3K/.;P^*/P8[YB^0^TML;EGI.LU'2/R
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MLR:[$018RI%;F)%:EABI@%@BCC7W7NC%?'7X[=5_%3J/:'172>,W-@>K>O\
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M;[]WUVSVYOW=ZG>XV_%NG-[WW+N_?&9KMT9&J@VO0T8K-RU&6:&EIUIJ?Q0
M1CW7NGC:W\N7XL;2VO@^O*+;G8&8ZFVYOS;_ &?ANFMY]S]N;]ZFH]^[6W)2
M[TV]G1L;>F\\[1O#1YRBASM/B75L9'DHHZ]*):J**5/=>Z9/FO\ RN_A+_,&
MR/7VXOD[U#)N;?'5=1/)U_V5L[>F^.K.R]MTE69#68:EWWUMN':^2DQ\K2LY
MH:B>:%)&,L21RDO[]U[I92_R^/B7'T+UW\:<%UC5['ZBZGWM3]F=?8?K??\
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MY<W\?=Z=JXS-9C._'"?=<)6)I*+'T]/D?X7$D0IJ66CJ6IZ:6ND\WNO=-O\
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M=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\
MA_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/
M_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!
M*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^
M_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O
M_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_
M^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\
MIC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/_!*_\_[_ --R?_IC]^Z]
MU[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!*_\ /^_]-R?_ *8_?NO=
M>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^_P#3<G_Z8_?NO=>_X?T_
M\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O_3<G_P"F/W[KW7O^']/_
M  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/
M^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_
M +_TW)_^F/W[KW7O^']/_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)
M_P#IC]^Z]U[_ (?T_P#!*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?
M_IC]^Z]U[_A_3_P2O_/^_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?
MNO=>_P"']/\ P2O_ #_O_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO
M=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\
MA_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/
M_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!
M*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^
M_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O
M_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_
M^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\
MIC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/_!*_\_[_ --R?_IC]^Z]
MU[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!*_\ /^_]-R?_ *8_?NO=
M>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^_P#3<G_Z8_?NO=>_X?T_
M\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O_3<G_P"F/W[KW7O^']/_
M  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/
M^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_
M +_TW)_^F/W[KW7O^']/_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)
M_P#IC]^Z]U[_ (?T_P#!*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?
M_IC]^Z]U[_A_3_P2O_/^_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?
MNO=>_P"']/\ P2O_ #_O_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO
M=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\
MA_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/
M_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!
M*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^
M_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O
M_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_
M^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\
MIC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/_!*_\_[_ --R?_IC]^Z]
MU[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!*_\ /^_]-R?_ *8_?NO=
M>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^_P#3<G_Z8_?NO=>_X?T_
M\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O_3<G_P"F/W[KW7O^']/_
M  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/
M^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_
M +_TW)_^F/W[KW7O^']/_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)
M_P#IC]^Z]U[_ (?T_P#!*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?
M_IC]^Z]U[_A_3_P2O_/^_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?
MNO=>_P"']/\ P2O_ #_O_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO
M=>_X?T_\$K_S_O\ TW)_^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\
MA_3_ ,$K_P _[_TW)_\ IC]^Z]U[_A_3_P $K_S_ +_TW)_^F/W[KW7O^']/
M_!*_\_[_ --R?_IC]^Z]U[_A_3_P2O\ S_O_ $W)_P#IC]^Z]U[_ (?T_P#!
M*_\ /^_]-R?_ *8_?NO=>_X?T_\ !*_\_P"_]-R?_IC]^Z]U[_A_3_P2O_/^
M_P#3<G_Z8_?NO=>_X?T_\$K_ ,_[_P!-R?\ Z8_?NO=>_P"']/\ P2O_ #_O
M_3<G_P"F/W[KW7O^']/_  2O_/\ O_3<G_Z8_?NO=>_X?T_\$K_S_O\ TW)_
M^F/W[KW7O^']/_!*_P#/^_\ 3<G_ .F/W[KW7O\ A_3_ ,$K_P _[_TW)_\
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M%A<=M'>6Y*_;^2-?]G45^WZYJ>%:N%Y_=>Z2O>/<'^R._.7XH8^.LBQOQO\
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M-%B\714F-QF-I*:@QV.H*:&CH:"AHX4IZ2BHJ2G2..*&*.-8XXXU5550J@
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M"\YBC"3#L/XLR3R1-):S>+RLY'.G63QJ]^Z]T8_YQ=Q[ ^/?\['H'+_,/?\
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M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUA?\
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MNE3\@MT[KZ>_X4=?"?>W;%;44GQ\[\_E^]S?&7H#,UT$PVMA/E%#VC!VYOO
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M*Z"#=>%_@V<^14-=_&<"\BU5*T$V?H%=*B*,@U<0(]8O[KW1@N_>O.Y^Q/\
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M8X&&K1U>EGRQHXYE96C9E8$^Z]TT[A^?7Q.VKW'5?'G.]HU5%WM1[8_OO-U
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M"2,S1_!KXN2R0AU,J13=/;52&1XP;A7,#A218E& ^A]^Z]U6;_PH]H%RL/\
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MCIG&#FIY(LNT1<4;QLM08R#[]U[JNBCV/NSYJ?R*/YV?1OQ W3AM_P#;]?\
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MNO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\
M]HGW[KW7O[_?\*%O^\;OY3G_ *4I\H__ +1/OW7NO?W^_P"%"W_>-W\IS_TI
M3Y1__:)]^Z]U[^_W_"A;_O&[^4Y_Z4I\H_\ [1/OW7NO?W^_X4+?]XW?RG/_
M $I3Y1__ &B??NO=>_O]_P *%O\ O&[^4Y_Z4I\H_P#[1/OW7NO?W^_X4+?]
MXW?RG/\ TI3Y1_\ VB??NO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^
M%"W_ 'C=_*<_]*4^4?\ ]HGW[KW7O[_?\*%O^\;OY3G_ *4I\H__ +1/OW7N
MO?W^_P"%"W_>-W\IS_TI3Y1__:)]^Z]U[^_W_"A;_O&[^4Y_Z4I\H_\ [1/O
MW7NO?W^_X4+?]XW?RG/_ $I3Y1__ &B??NO=>_O]_P *%O\ O&[^4Y_Z4I\H
M_P#[1/OW7NO?W^_X4+?]XW?RG/\ TI3Y1_\ VB??NO=>_O\ ?\*%O^\;OY3G
M_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\ ]HGW[KW7O[_?\*%O^\;O
MY3G_ *4I\H__ +1/OW7NO?W^_P"%"W_>-W\IS_TI3Y1__:)]^Z]U[^_W_"A;
M_O&[^4Y_Z4I\H_\ [1/OW7NO?W^_X4+?]XW?RG/_ $I3Y1__ &B??NO=>_O]
M_P *%O\ O&[^4Y_Z4I\H_P#[1/OW7NO?W^_X4+?]XW?RG/\ TI3Y1_\ VB??
MNO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\
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MNO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\
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MNO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\
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MNO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\
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MNO=>_O\ ?\*%O^\;OY3G_I2GRC_^T3[]U[KW]_O^%"W_ 'C=_*<_]*4^4?\
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MEH5HE\.FC%))$T8B'V\=H].GT+QZ1;W7NDYNJFW5C=IU&,ZMQNU:7<+0KCL
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MZ!3,455U+_+@^)^W^S,UM-'I:MJCY8_*BM6@VENC+1!&,,NW^N8,C#C4D/D
MWA43+H5E,GNO=%4_X4CY?'[=P7\GW<>5@R-1CL#_ #J?AEE\A#AL#F=TYJ;'
MXZC['KJV#$;:VWCLOD<C4O'3$04&/I*JHJ)-,4$,DK(A]U[H6?YI7\P;H'L7
M^6G_ # -B[>V?\S*'.;K^&GR4PN*J][_ ,M_^8CUCM&GK:WJ#=T4$FX>P>RO
MBWM/ 8BE!/[E=ELE14T8YDE0<^_=>Z#2B55_X2?.%4*#_)(R#64 #4_Q(J69
MK#\DDDG^I]^Z]U/^%/\ ,1V5\5?Y'/Q;[+J>E?E1OG)=)_R^NI<T,;M/XL=[
MYS;^?RFUNGL,*1Z7>E+LN##'#RU%.CU&;_B4=%!1EZV6HCIHWE7W7NK+?GI\
M#>NOF?\ R_.__A=2XG$[;QG:.P-S2=?S3PSU^.V3VK)E*GL#8>ZX8):VG?PT
M&YEIZQZ:*>G3P!Z>,Q0D*ONO=%(_E*?S$:;M?^5)C^Z?D!/D\?W#\*]M;WZ%
M^7^WYXZ:OWGC.W_C+BEPVYXZS%8E LN5SU%18_)PTM*A$E3E?MX0S+I]^Z]U
M8O\ #7JS<_6/0.VU[+QM#C^Y>T,CN3O#OJEH:Z7,45-W-W+F*O?>_=NT&7J:
M#%R5F.P-1F5VWAI9:6F;^&8>CC\,001K[KW5>G\JKN,;9^2?\SO^6X\T\F#^
M"GR$V=N?I6EG.0F7;GQ]^6>R1W7LSK>AJJVJK1]CM?)U>9QF(I8VBCH\4V/H
M8(D@I8U'NO=7:>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>ZI>_FG?&6'^:!2;C_EQ1[JRNV]F8KI?</?/
M<.6PN0%)%'O_ #E'NK9GPYVCN4Q4-3+)CVW5ALQOFKI89Z5W?85##/YJ*MFA
ME]U[I1_R-_E[N;Y<_P OCK.3M:2N@^27QNRF<^)?RCPF:J:"HW)B.\>AGIMI
MY^IW$<?))%]WE**.@R\[Q^@RUTBH2$)]^Z]TK:[YT=L=H_[/+#\3=L=*=D[[
M^$F[M[]:Y'H'>>\-R8;M/LG>NT-A83=T-8:S!X[(C;M!E*K*S8W ^;$9B/)-
M1F3[RCUNE/[KW13/YD7R.^66R?YJ_P#)C^.O5U5UO2=5]\;U^6._,EMG.Y+<
M^*R&\-V=(?&[)_;4._-P8W!Y4TN)I4[3FJJ"AHJ&L:6NHH9ZF10D21>Z]U?M
MBSDVQF.;-)0Q9DT-(<M'BY:B?&1Y,T\9KTQT]7#3RO )=8A>6.-REBRJ;@>Z
M]UJ^_!7N'KGI_P#GM?\ "A/)]B[A;;U#73?R]Y*.<8;/Y@5!QGQ]W)+5P1QX
M'%91S-:J3Q0:?)*21$KE6 ]U[I?_ /"?_H3M[8_:_P#-=^2%3U?V'T!\2?EU
M\Q<AV1\3>D^T]H9_KO> Q./RN_QOCN.3K?=M-193 4.Z1F\,F.H*VGI&\.*4
M101TD5*TGNO=;&6ZU5MK;E5@&5L!F596 *LIQU2""#]0??NO=:HO_";;YN])
M='_R</BIU]O3:ORLRFX:#*?("OJZWJ?X%?.?OK9LD>4^1_;-72K2=D=%?'/L
M;;M5,L;JM1!3Y666!QXITCD4H/=>Z%S^4AV!MWM;^>-_/Q[$VM1;QH,%N7$_
MR[*O%TO876_8?46]*:GCZ%SE'+%G>N>V-K;*W%B93)1$BGRF+HY&31*$,;QN
MWNO=)_X5=Q8#J7^?S_/W?.[5[9W,N>I_Y>ZTW^BWI[LOMIJ)L9\>*@R_QN+K
MC;&Y7H!+]^OVS5:PB;QRB,L8WM[KW5X'Q1^0^Q_ECOCY$[[PO5/9'7F;^//<
M&3^+M+DNVNO=Y=3[VW)A!U?TAW+ELDVR-ZTV)KQC)<AO[QXJLJZ*'SPTOW5)
M>FJO-4>Z]U3]\@:>+^6S_/KZ%^4\318/XU?S<-D4'Q#[RE6*BH\+@?E_U\:6
MKZ!WKF:V6=I&J-P8Z.+;E%%%'#&K?Q"IJ'D9D\?NO=6Y]GJW=_S.Z6ZB6CCK
MMA?&# 3?*?LZI>:I6%^UMT1;CZO^,VT9:48^2FK(DIY-\[JJT:KBEHJW ;?J
M!!**E)8?=>Z/7[]U[K5O^"O</7/3_P#/:_X4)Y/L7<+;>H:Z;^7O)1SC#9_,
M"H.,^/NY):N"./ XK*.9K52>*#3Y)22(E<JP'NO=+_\ X3_]"=O;'[7_ )KO
MR0J>K^P^@/B3\NOF+D.R/B;TGVGM#/\ 7>\!B<?E=_C?'<<G6^[::BRF H=T
MC-X9,=05M/2-X<4HB@CI(J5I/=>ZV2*VCI,C1U>/KZ:"LH:^FGHZVCJ8TFIJ
MJDJHG@J::HAD#*Z2([*ZL"""0??NO=:V?\E62;X*?+GY_P#\F+==6U+M[JCL
M'(_,CX21U?VM-'E/B7WUE*:HRFT]OPI45,LT6T,_6+0UE142-+/65]7(J1PH
ML:>Z]U;5\95;N'O;Y*?*JMHX_P"!R9^+XL=$5IFJ9?N^J>@\SF8NQ]W04M5C
MZ(4LN=['S6Z*)GIY*N*NQ>U<%6"<AUAA]U[JEKX*]P]<]/\ \]K_ (4)Y/L7
M<+;>H:Z;^7O)1SC#9_,"H.,^/NY):N"./ XK*.9K52>*#3Y)22(E<JP'NO=!
MM_*Y^"/=7<G5_P#/ID@VYVC\1/BQ_,N[8[=H/A]L?L':>YNN-][6IMVX3M;;
M.[>_CUON.''9C!8_<+[LPC46-JH*-WIL1XXH(Z1*5I/=>Z0?6?S&W5\^MH=)
M_P D+Y:T.S?BU\I]A=G=1UF^>V*//QY3J'Y*]6_!_N38^\XLQ\(MUXXTE-F-
MS;ER7546+JL<:JG?"1T>;J&CGJ\948:'W7NKA?YK'Q2WYW]NGXP=I;"ZHZPJ
M:OXR5O;G:F5^362WEW+1=^="8:AVMB:K+[8Z!ZKZAS>RHMZ5V^*/%U6%JL1N
MK+U6!!CA.3P><IW:@E]U[H%/Y*OQ?["ZSQN%^0N^^G-G1Q]\?#?XI3[=^0&Y
M-P[^Q/R9_AF,Z[V[3_[+EVATAGI*_;6UJ+:J8^$4R[)7 8NHD G.'@J99UA]
MU[J_OW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U'JZ2EKZ6IH:ZFIZVBK:>:D
MK*.KACJ:6KI:F-H:BFJ:>9722.1'*.C@A@2""#[]U[HMNQ?A7\.^L.PLKVWU
MM\5?CIL#M7.U'W><[*V9TMUSMG?V:JC.M5]SE]WX;;E%D*F3RHLH>>H<ZU#W
MU 'W[KW2@[,^*_QD[IWOM#LWN#X[]']I]D=?4LM#L/L'L/JK8V\M[[*HIYY:
MJ:CVGNO<.#R%?CHFEGDD:.DJ(5+2,UKL2?=>ZR=H?%_XY]U[IVWOGMOI#J_L
M3>^S\7DL#M;>>Z]EX++[LP&W\S-%4YG;N+W)4T;UL6.K)*>.2JH%G%/,Z*TD
M;,H(]U[I9Y/J+JG-=85_267ZTV#DNFLIM.HV%D>IZW9^WZCK:MV/5T#8JIV=
M4[(DQ[8Q\6]*YIVH#3& QG1HT\>_=>Z"+='PC^&^]NG=I_'G>'Q4^.^Y^A]A
M5%'5[)Z;SW3G7^4ZQVE54!D:EJ=N;(K,!-CJ.1?/)J>GIXRPE<.6#O?W7NA%
MV[T#T7M#L&I[9VGTSU7MGM&LV7@NMZKL7;^P-JX?>\_7VUS(=N;'?=&/Q5/6
M_P )H?(12X_S>",!0B (H'NO=+"KV)LNOWM@NRJW:FWJOL+:^V=T;+VYO:HQ
M%#-NG!;1WMD]J9K=^V<5G7@:I@H<G5[%PM374L<BQS28NE>16:&,K[KW0?\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z!/N+H_
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MY==;]X_*_KGXJ2=*=ZT4K=/[]^45+OCMGHOMKIS;&,S?3'9_2>U-LXW:F?[
MP.TQDLFT_9T]36T="M1X*>GC^\T0UL4=3[KW56'\XZ@;X(_.?^7Y_.<P,?\
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M:>VMM[>VMVMUCW+$YI]G=:]CU=763KLV3&S4DD-"::9SY&+1M$/=>Z$WY\_
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M_P!C/OW7NO?]! G\F?\ [V#=%?\ G3NK_P"QGW[KW7O^@@3^3/\ ][!NBO\
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M?NO=>_Z"!/Y,_P#WL&Z*_P#.G=7_ -C/OW7NO?\ 00)_)G_[V#=%?^=.ZO\
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M_P#O8-T5_P"=.ZO_ +&??NO=>_Z"!/Y,_P#WL&Z*_P#.G=7_ -C/OW7NO?\
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ML_\ GAQ7_P!2^_=>Z]_<K9O_ #R6V?\ SPXK_P"I??NO=>_N5LW_ )Y+;/\
MYX<5_P#4OOW7NO?W*V;_ ,\EMG_SPXK_ .I??NO=>_N5LW_GDML_^>'%?_4O
MOW7NO?W*V;_SR6V?_/#BO_J7W[KW7O[E;-_YY+;/_GAQ7_U+[]U[KW]RMF_\
M\EMG_P \.*_^I??NO=>_N5LW_GDML_\ GAQ7_P!2^_=>Z]_<K9O_ #R6V?\
MSPXK_P"I??NO=>_N5LW_ )Y+;/\ YX<5_P#4OOW7NO?W*V;_ ,\EMG_SPXK_
M .I??NO=>_N5LW_GDML_^>'%?_4OOW7NO?W*V;_SR6V?_/#BO_J7W[KW7O[E
M;-_YY+;/_GAQ7_U+[]U[KW]RMF_\\EMG_P \.*_^I??NO=>_N5LW_GDML_\
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M>3>^\\'U_@*J;"=A]J=:/41OE=S4%/)]DU2Z"J$A7QI*T?NO=#YU#W#6=O\
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M2R5%+MS 38&GS.9F076AQL^Z,WMO'K*_]DUE?2Q_ZJ1??NO=$G_EY_.3'?S
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MGSDQW<'<W6'5?0/07RP%?O/*K6]H=S=T_"7Y6?&KK+KCK'8L.1W'7T.3W?\
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MPW[,Z+Z@ZTZKZ^WGV9NW*Y*OZLRVS=D;=Q>V-AX'<%<^ME@A>I:G6)"=4TB
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M&;_NG!028,SU<K54%3D*F6!*J>?'U3#W7NKV_?NO=5Q_RZ-N[IS^%^2WRH[
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M(/*49ED1U'NO='3Z[_F$8W>_SX[:^!N;^-?R6ZTR77VU)-T;'^0._NNJO$=
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MIDD.7WCD::>@J)ZB.1<M5&:1X_=>Z/[OC+[XS_\ /A^)O:E1T%\E</UYM?\
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MF@@KYL/BX:ZOJSD(*;%&OA%57TGNO=7_ $2ND4:22&:1(T5YF54,KJH#2%$
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M9G0E'D]C;:FS>1H:FKIWGW+F)MR;^:.G<I N\4HRTKTIGD]U[HD])0;ZP_\
MPI=WAWK6=*_(MNC:G^4T/CA#W31?''O/(]32=R4GR@P/9\VSX>PZ#K^HQ,K'
M#XN6H2JAJI*=WTPI*TK!/?NO="%_**J]SX_Y4?S?#NKI_P"1/7&.[>^=^6[>
MZKW%VU\;>^.I-I=A==2]:;.V5'N/:F[.R.O-KXZK4U^S:Q13I4^<Q&&<1&&H
MA=_=>Z#G;U1G?@Q_/!^>?;F^NC/D[OOK3^8SU!\-:[JSL;IGHKL+NC9>.[,Z
M#VCE^F-R]=;MRO7.V\Q'MQY8&Q>16OW#-0T44<TL]160TP+0^Z]TH?Y9'^S
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MZ&CIH5+RU%55U+QQQQJ!=G=@ .2??NO=-^ W/MO=5(^0VON'![DH(IVII:W
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M]NV0J9H%2&\Q8$KZC[KW2X&[-K-E<?@EW+@&S>7HOXEBL,,SCCE<GCO%)/\
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M?##XY=\_SS?Y^'4'<'7E#V#TKA\=_+7W'5],[GJ:O+=;;LW-F/C4VX(<]OK
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MK.;BFHVW'N++[MSU559O<N1RU=4S5>2SU75S25%1(2\Y LH51[KW0"_S8O\
MMUE_,L_\4 ^9'_P.O8WOW7NJK?@Q\1.^/F5_(U^'7QTJ_E1B>G/C_P!T?!_8
MVP^Q*;KKHBGK.],ALC=6W,#19C:6([5WCVEN';]'1UV);+8C).=B3U4L611Z
M>JHY*=C4>Z]U=OU1\/\ X_=+_%# _"?86QDQ?QSP'565Z:CV3_%LO'49'9.X
ML7DL7NJ/)[BHJVBKVKLM_&JVIR&2BJ(:B2IK):A9$E;4/=>Z,U[]U[KWOW7N
MJ O^%"W7^P]Q_'+XK9_<.R=HY[.Q_P QOX([5CS69VWALIETVQG.],5'F]N)
MDJZBGF%!6+(RU5&'\4H8B1&!/OW7NNOY[NPMG[.^&/Q;V5L/;F$Z^VTO\S/X
M'146(V'B,7M.@Q4N4[YQTM96XF@PU'2T\$[2U#S^1(KF0ZVN2;^Z]T&_SO\
MB_\ 'OXH?S$_Y.'R*^/_ %5M[JWN'LWYF;OZ![:WWLUJO"[F[HZ_[0Z+["K<
M[%W;N"&=ZW>-<E;MVBK8LGN.?)5?DB;5.=5U]U[H=]E]N]@?)'^;O_,/Z RV
MS^N=V[0^%W2_PHQ/5&T>Z8JS^[R9+OS:/:W8_;?:6P\52;=SR5<]<M7M_;60
MR,ZAZ9<']I3E$J:P3>Z]T/7\NCX)=A?!OLKY@TH[.V _QY[^[.Q7='2WQ?V%
MA,YC]O?&7/9BFR4':E%LVNR^5\9PVXJ]J?(K0T>+QE/2U,4OBC+32,WNO=6J
M^_=>ZU%_^$VW6/R7[,_D==.[6Z>^26T>A<#N?>_R5PV1W%%T/+V)VOMJER._
M=_XI\IUONS*]N8'!4&3AKJFER%-4YG:>XX46"6!J5S-'/3^Z]UL)?R^_@3T-
M_+8^,.ROBQ\><?E8]G;7GK\YG=R[DJH:_=_8.^LZ*=MR[[W=6TM/1PO6UII(
M8UCIX((*>GIX*:"-(8(U'NO=$/\ YL7=?WGRF_E0?R^,Q/E*+K+YW_(?M+)]
MW?PZMGQU-O3JSXN=?XGL.;IG/55#*M0V*W9G]T[?I<S1HGBK\;2UF.JW6DJY
MDD]U[H%_YL/0W5&VOGG_ "->W]K;-P^T][Q?/:@ZNKJS:U%2[?H<]LZ3J+?^
M>Q&/W)C<5!2Q5S8>?"R#!RU"NU!'D\C'3:$KJ@/[KW0H]8]I'Y-_SWOF3TCV
MECZ[([&^ WQ=^.B=%["W,*6?9%;OSY!TS=A=H]]X;;55"Z5^6AHZO"[1I,S*
M)6QD='D*:D-.<E6FI]U[H)<7LFK^-W\^_-?&GK_&TL/P^_F&?!;<G=W:/2&/
MKL[#LW:G?_3._)MK;B[(VUM"EJ*3%X&#<>(RF,H\T,4D8RU;533Y"$S)%-+[
MKW0%?RB?@K\3?DS_ "EMZ[0^0?1^QNYMOX/O_P"?^WMDT'9.'IMX#K2E@[[[
M3Q<64ZQESJ5SX'+Z(PSY_&M!DY"J+)5O%#!'%[KW16?C9T+T7\P/^$J.5^3'
MR0ZHVAW5WKUQ_+U^<$'6?:?:^*Q_8.^NJY_C4>]=D=:R]4;DW%15-1ME((NG
M\-//'A31&ID@UUCU4I:5O=>ZM'1]C_)[^03\-JSYA?(K>/6VWNUOCU\',OVK
MO?#47]Y-Y=VYFM7K#)3=,2;2I:2MGW+4=BUD*[=K,%34=9+DQE)(#35"RR1/
M[KW0,][;BW7LS_A0!_)ERNV.H,9\=,9\A^E?GOU9V)C**LVF=\]I]9=8=&?Z
M5-A[6[5PVT<56XZBAV_N"GAR.%@I<[EI(GGJ4+4J/+#/[KW2AV7LG:V$_P"%
M4O;M#B</!CZ7>'\C^JSNY$I9:F-LKE\U\UMDT63KY9A/K222&EBC!B9 BQJ$
M"V'OW7NDC_+"^#OQ4[8[O_G4]8]N],;2[=ZLV[_,UWJ,!U7VI3S=A=:XBKS_
M %!UOFJS+TNR-V397'-7T\F5>+%5\T$L^+A18<9)1QEU?W7NC7?\)Z ^ ^!&
M[NH*2MS%9M'XZ?,[YF] =;1YS-Y3<%=B^M>N^]]TP;,P*Y#,5-9/X:"DKUHZ
M>-I7"1PJ!8<#W7NK5_D_\<^L_EKT!VS\<^W]OX[<>PNW-B[EV3F:6OI4J),=
M_'\/68RES^(ENDE-D,?)5+5T-93R13031))%(CJ&'NO=:M.Q.J</\X?Y"N5_
ME<;RZ\V3EOF)\?.RMZ?RZ\)M]S48!-G]\_%S+UVZMK=P0Y5<<:RCI)]E["I=
MSU,J 0Y8SMC'F:/(7]^Z]U9'\2.ZNLOYH_P\_ES;6W+UEM.2#)T%+VK\E.J\
MQL62/#==[P^%^X\5M+<.Q9\#EL70)AJA^V*/!U./H:N,/5XO%9!(H:B!*B>'
MW7N@@^=NSML8'_A1+_(2W#AL-1X[,;FVC_,II\Y6TRNCU]/MWXD5-'A(&BUF
M-$IHZJ58TB1!^XQ())/OW7NE3\9^C.DG_GX_S*J=^G>K'I]L?%OX)[MVW W7
MVTFAV]NO(U_:M?D-SX.(X@K29">>CBFFK:<1S/)$CLY95(]U[K#L/HSJGO[^
M>Q_- V9W3LK#=G=?_P"R?_ V;*];;SIDSO7&['D/;<<,6^]CUPFQN>IH+,\%
M!EZ>LI%E9:CP&HA@EB]U[I8_R6MC[1Z$^0?\XKXI=3X=]I=%](_.?;N=ZHZ]
MI<C75&V>O:3N3HG86^MU[8V7B*F66+&8I<H9ZBEH*01PQ"<HB *+^Z]U>SNH
M4YVON05>?.U*4X#,"IW0*JGH#MNG..J/-GQ75;)%":-;U'EE(1/'J8@ ^_=>
MZTM_YFV'V7\?_P#A/WM[>WQ&QU?V#B?C%V?T;V]TM_,(W_0[=VIVAV%VUE?D
MS@I\O\B>L\:NW\WD\W-N2JWKEDKMQ9E\1#EZ+)3UD,V8I*I):KW7NK0_YM'3
M.Q-S_P R[^1YNJMI<WC]Q[E^2_R"V'G<WM[=>YMMY*OVG4_&O<>0FQ2U6$RU
M"U.P.)"05E*8*JG6IJ333PO42NWNO=-Z_'?HOX:_S]?B'2?&'JO:'1F#^4_P
M9^5&'[KVCU;BZ?8VRM]9;J'>77&[MF[WW)L_;R46.K<['+GJV*?,3T[5DZSE
MIIY&%S[KW6QG[]U[K6J_E]X+._S:/Y:6\^U>\^I>A=_97Y>[X^6N&W]4=ST>
M5JNS=CXK%_(3M[8W5^PJVCH]IU8Q+[)V_B,+2X:CHJN$P&D2LU+6U-1/)[KW
M2,_F3?$C?'3_ /PFR[XZ'^4?<L'RD[7^-71E51XOO"B3<NU\GE9-H=F86KV+
M)EX)]U9NIEKL?B(:'"9&2LJZ@UL5/**A66JG1_=>Z:OYL/Q4^/O3'PY^'GS>
MV%UIA\+\LNH_E+_+\W/BOD5235D'=^X:?=/9FP=C;GVCNSM))_XQD,!5XS=%
M52I@*FIEQM+&4CI*2"*-(U]U[HX_6?:N*^6G\\KYB])=BT<F8V?_ "T_C]\=
M:7J38>;TU>T)^V_E%MJ;LOL/NW^ ,:FEJLQ0X"KP>V,37UB+/CX:C*)1JJY&
MIDD]U[H-_BGTYU[TU_PH>^?U'UM@*?:N'W[\ _CAV3EMNXO32[;QVZL_VUO3
M&[AJ=MX*G2*FQT60FP?\5KH*6.-)\C75M=(#45<SM[KW2]Z@_G?[N[9[:ZNZ
MLJ?Y.'\YOK"F[+[%V3U_4=E=H_##)[6ZRZ\@WEN7&;<EWSV+N>3<U0N.P6)7
M)&OR]>T;BGI*>64J=%C[KW0<X%5;_A5=OE6 96_D44JLK %64_-_: ((/U!]
M^Z]TE_Y4NRMK[:_G-?\ "C/9F!Q$.+VRNX_Y;$*XNEFJD14S7Q[[BKLJ5J#.
MTP>>;(32O)Y-6J0L"#[]U[I(?RPO@[\5.V.[_P"=3UCV[TQM+MWJS;O\S7>H
MP'5?:E/-V%UKB*O/]0=;YJLR]+LC=DV5QS5]/)E7BQ5?-!+/BX46'&24<9=7
M]U[I4_RH ^ _DM_,OJ"DK<Q6;1^.G9/\S;H#K:/.9O*;@KL7UKUWN_LZ#9F!
M7(9BIK)_#04E>M'3QM*X2.%0+#@>Z]T5K^5#W#U-\M^G/Y?O\LGY>]7979VP
M]D?!?XU_)7HO8?9&$VOGNN?GC4[6Q:5&8W-C]PT]5F85H^OLI3T52=FS?99&
MLG5LC5QOC*1Z9_=>ZLT[P[3W+N#^<5\?_@1@-E[!DZ<V=_+O[2^66.V-OR@_
MA'4V\.VJGY#=?=4;1FH\?A\#E%K<MM#"8/.U5)0/!X*9-P_>Z?N8:22+W7ND
MU6_'#L/^6MVY_,1_F6[?W1U9M3H+/?#3L;N#L+X5=68'-4V!W-WW\>MF9/?*
M]Y;>K\CDMN4%+E,IA\#-A\Q#3XF#[KS0SU%4SQH4]U[J/\*^A>K/DQ_)3PF_
M^Z<33]F=D?,CXV;A^1_>W:V7'G[$S'=/9FULEO*;=6"WA44XK<35;3JYJ:@V
M;_#WA7!4V$Q\&-\45)"??NO=#?\ R ?^W-7\OC_Q N/_ />DW%[]U[II_G??
M(_=W0'QW^,^U=KYC<&UL7\L?Y@GQ&^(O9V]=L5\N'S&T>F.UMY9+,=M55-N"
MFEI9L;_$\'LJLV^<C33TM13_ ,9\E//!.(Y4]U[HS';O\O3H/>7=?P_^0^V:
M[(?'W>/PUW+GY=HS=/P;6V-A]]=?[WPU%M[/]+=BQQX7_+-N5LV/Q\ZT*/$5
MFIP8BLDA8>Z]U5MO;K+K3^5]_/#ZM^1&!V;LS9OQY_F\[;?XV]CYR#$8W#47
M6OS?V&E5NGJ?*TV4GRU+%21=FXYJK#-C<?0 U>:I&K9W::H<M[KW5DOQ\ZVI
M.V=R?,+Y=X2BVUM3?7R K<STKT;V93;2AQ6Z\'T=T=C\_L'9>?K<U]]5SUL.
M5WG7;MWC05D0QXJ,5E<3&\+-2I42>Z]U2Y\;?DAL?H6L^#7\NG^;G\3<W\9/
MDUTKV%TEB?B[\VZ?!4?:7Q[^27<NR,A28JDW;M?Y#_P)*O$[OW\E/D(-STF9
MCAJ9OX]4S5M13RUL2^_=>Z-/\9^C.DG_ )^/\RJG?IWJQZ?;'Q;^">[=MP-U
M]M)H=O;KR-?VK7Y#<^#B.(*TF0GGHXIIJVG$<SR1([.652/=>Z5/PRWOO#YW
M=P_S6J[L?K#I;LJ@Z>^?7;WPOVQM'O\ H:NNKMI]%=3=8=2X.DPFW]O1[3SU
M/%@MTYBNW!N8U1839!\G^^7AI:1(?=>Z ;N?X&;P^&_\AS^9C\<.X>V-M][[
M2Z\ZF^7'9GQPQ-!CMQ4+?'_K++]:YS<&P.F8ZS.[BS%37TNV:J6L.(J)A3(*
M>>*)*:.."%4]U[H.?F9UYM+??_"27K*KW/C9*ZKV7_*J^&>[=L54.1R>.GQ6
M>Q'4W1M=2UD3XZLI=8;[7PSQR:TE@EF@D5H9I4?W7NGO^;#\5/C[TQ\.?AY\
MWMA=:8?"_++J/Y2_R_-SXKY%4DU9!W?N&GW3V9L'8VY]H[L[22?^,9# 5>,W
M154J8"IJ9<;2QE(Z2D@BC2-?=>Z.=LOMWL#Y(_S=_P"8?T!EMG]<[MVA\+NE
M_A1B>J-H]TQ5G]WDR7?FT>UNQ^V^TMAXJDV[GDJYZY:O;^VLAD9U#TRX/[2G
M*)4U@F]U[J!TQTEV?_)WV5\_^[,;MO>_R5Z%[$[.V#W1TC_+V^%?5.X=^=E]
M,9[?VZ\=L?MBBZ8VMD,_0BOPV1K=Q0[GR%#14&*I\?#BZ^HCC8F4O[KW1AO@
MS_- W#\UNVMP]69;^7%_,F^(%-@.NLMV G97S%^-==TYUEG)\5N7:.W%V-@M
MSU.;R2SYVI7=35]+0",%Z3&5LNH> @^Z]T4'^4K1=??S5?Y:7:O=_P GMJ4V
M]-\_-K?WRTV;W%_>S'8K);IV+L1.TNP^M>NNI-NR9&DK1AJ3:FU:/%1XRCIX
M:=8JSRY)XY*ZJJ:JH]U[I!?+N&J^,N?_ )%_\J#_ $I]K]K])=U=][NV1WAV
MEOO<F/JMP]K[$^+&Q*?=FU^C.VMS8ZDHDGI=Q9W<N%@K\0BQ'*8_;L^+J_/2
MU%9#4>Z]TI_YUNU<A\3=R?R^/GU\7<3B.O\ MWK+YK]&?'GLO%[32MVSC^[?
MC5W]4Y'8.Y.I-W[:VN*"CW!]O7G%3[?CRZE<6[5-502PU%DF]U[I&='?$?X]
M[Z_GG_S7M@;ZZXQ>^.M-R?&3X+[UW5U9O.JR6ZNLMX;BR=+V1CZJ?>.Q<]69
M#&Y:D/\ "5J?X7D:>IH6K)9*YZ9JTK.ONO="=_)\ZEZRZU[I_G._"_:^RL+'
M\:NJ_G'@<KU_T]E*<9WKS:&*[FZ/V#V!NC9VV]GYH5]#189,JLM338VGB2GB
M\NF.) JCW[KW18?Y5W3'0=1_)7^5F;W7O+;'Q-CSW87\QS8N\?EGM3%[;VAV
M!U'UY+WUV;B:K-8W?,<&/JX8L;24D0I:=:I /!%'" ZQV]U[I(?/P4G2N7_X
M3S;K^/G2Z]';6VC_ #(/AM\7^N^U,W@MM=?]P[NZ#[7VU6;#W[LNLZMQ.V7D
MPVW=UX3$P5%?0Y>LQE?%/#3>3$4M3&)*?W7NC+_S_P#:FW?]+_\ (WWO_"J?
M^]8_G;_!;:XS5Y?NEP$NY=S927&JODT!&J*:.1B$U$QJ"UE 'NO=2/D'\=.I
M-W_\*(?CK39[;U95XSM7^67\B7[-PB;CW'387?E/@>[]C)2XW<N-ILK%'-1S
MIF6@R-(H2*NIH(:*M2HHHQ3GW7NE/\&>F^J/B;_.Z_F%_';X[;!V]U!T?V-\
M./BA\AJ[J+8%%%M;JS =F#=_9'6^8S>T.N<0E-B,4V2H,?3&M7'4E*DDD.MD
M+,3[]U[H-?Y7W6.PXOYQ'_"CWK./;=&FQ:O</\M2FJMN"6L^RJ:?+= ]O97*
M0U$GW/E=:BHJY9)PTAU^1@UU8CW[KW1=?Y6/\O;XB_(O^3-V[M7O3IS;W;M'
MM[LS^8;L[8%;V4U;O?*]5TF'[G[8QF.SW5F2W%55\VW\ZII4GGW'BWILK4R*
MOW%9+''$D?NO="9!N_YK]Q?\)2-A[F^*^7WOG/E3D?A)L#'4.5V_D]Q97MC.
M[1V=N#%;<[-;9.3Q\LN4J-RU>S]OY1<<*9I:R6HD6.DU5;0'W[KW7#Y\[$Z-
M^9VT/Y*U'\ ,'UOOK=FW_E[\=JO<5#U?08<U_6GP)J.N]\YOY"[9[9I]M4<$
M^W=KU$NTL/C\EBLNF.2;,4M/1I$,FD:)[KW6T3MO;N$VAMW ;2VUCH,/MS:^
M%Q>W=OXFEU_;8O"82A@QN*QU-Y7D;QP04T<2:F8V47)//OW7NM:'^;?T_L_>
M?\[/^051U39_!U/:61_F.;<WSF]J[ARN!W#E]LX#XZ]:K'@:/,TM09L;'/2Y
M2NHI:K%-0U:1UTTM-4T]6(:F+W7ND=WQ\,^J_P"63_.#_E1]N? K96'Z V+\
MPMY=O?%GY0]%]:P28'KCLG;^'ZVK][;)WA4[2AD-##5X245F0FJ((X96>BIB
MI(>J6;W7NA4_E]X+._S:/Y:6\^U>\^I>A=_97Y>[X^6N&W]4=ST>5JNS=CXK
M%_(3M[8W5^PJVCH]IU8Q+[)V_B,+2X:CHJN$P&D2LU+6U-1/)[KW1+/YH'Q0
M[+^/WP?_ )%G3_?'?<O?G?G4W\X7X6]%2?); 4V1PVYZS94U;WO6;8C?';IS
M.]X3E\314F)I9JZN6LDJ)L5'-4*^MXV]U[H8/YM_P.Z5_E_;O^"G\Q#X);(I
MNB?D-LWYX]#=6]M5^S<AF_XE\F.L/D)O([>[#VQVU793(Y&3<.4S%:T#UF8S
M$E15SBKJYI:AJLP31^Z]T:KO;I'I?<G_  H:^*M%N+J+J_/46ZOY<GR<W5N>
MDS6P=J92EW'N>D[HZSI*7<>>IZ[$SI65\44[Q1UE0))51V4. 2/?NO=)+YV[
M.VQ@?^%$O\A+<.&PU'CLQN;:/\RFGSE;3*Z/7T^W?B14T>$@:+68T2FCJI5C
M2)$'[C$@DD^_=>Z&S^6]V1M[YS_,_P#FN=V]GXB+=&4^,?RXW5_+[Z<VINZ"
M#,X3K+JGH_#XZDWQD-J8&K6MHJ6IWONFKRN2S61C_P JK:6@QE)4Z(,?30K[
MKW13?@=+MWX*;Q_X4M[KZ>V?7U.!^.G:U5W'L7KO%))DF23;?P_?MJ@Z_P!H
MXMK+#00U)_A>"Q, 2"DI$IJ&G5((8U'NO="'U[\,=W_S,/Y.GQ]H-QP]!4?;
MOR*^,_1G>:?+2I3<F6[PVG\FMQ;)VKOJM[YCS.%P6!JH]R4&X)9V:"AR]''3
MK&<?3R14<4<:^Z]U?KT-@NP-K=)=2[7[7[ Q7;'9VV>NMG;=["[0PF,?#8SL
M3>>#P-#B]R;VI<0]?E#2C*5=)+6M3_<3"-IF0,0![]U[JDK^;#U1U;N;^8Q_
M)$K=R=:[ W!6;R^6/=6#W?5YS9VW<M4[JPN(^,F]*O%8C<D]?CJAJZEI984E
MIZ>J,L<;J&15(!]^Z]U,_FI; VM4?-?^1'UQCJ!]J;./RN[UV]3XC8U54['&
M+P$7Q:WI"<1@*O:LF)FQL1A0TZMCI*62*-CX'B<*Z^Z]TCQ\>.B/AM_/U^(U
M/\8.JMI=&8?Y5_![Y58ON_:75F-I]C;%WUENHMX=:;LV7O7/[)V[%0XVJSL4
MN<KHI\O+3FJG6H+32NX);W7NB_?+'JOI7'?RJ_YPM#TW02_,*#+9OYG]]]H_
M++M)=N8?&X+N_;%-79['[>ZSWM#A]PY;=65ZMJ=E8K"8.MH88\?0S8"+&QYB
MDFH):6C]U[IC^><5#WK_ "8/Y+_=O<.%VWV+VUV%V5_)MR6\]_[HVSM[([ES
MT_9;=8YS?\%57OC 5I<O592HFKJ*(1T\IF8-%I-O?NO=;56T=F;/V!@J7:^P
M]I[:V3MJADJ9:+;NT<%B]MX*DEK*B2KK)*7$8:EHJ>-I99GED*1@L[%FN23[
M]U[JG7^9SWEE*#YK_P H+X5Y9J^GZ5^8_???N3[Q2%UI\-O;!?'7I4[RV)U!
MNN<M$9<9G]T;KP]56XWR*F0APLE%4I44<U32S^Z]T<.H^"/3N$^<.POG/L_<
MFX>J]^8GI3-?'C=776R)-N[9ZQ[HVU696HW%LV7L' 4^)BEK\EMV>HKI</-'
M,KQI,4_S4>@^Z]U1Q\L>J^E<=_*K_G"T/3=!+\PH,MF_F?WWVC\LNTEVYA\;
M@N[]L4U=GL?M[K/>T.'W#EMU97JVIV5BL)@ZVAACQ]#-@(L;'F*2:@EI:/W7
MNDE\_P#&GOW^3=_)"^0/:.2S.X.ZLYVW_)TW9E.QXLK5XO.UFY.T,9L";?&7
MJ(,9)24;O75&Y*BM>-Z5HA4I!,L8>F@,?NO=&9^=_P 7OC[\3_YB7\F[Y$?'
M[JO;O5O;O9?S.WKT'VWOK9WWF'W7W3L/M7HW?U=G8N[=S1U,E=O&LCK=MTE9
M#D-R3Y.J$D9_? 8^_=>ZV1_?NO=)K=])O"NV_D:78F>VYMG=,U/,F*S6Z]J9
M+>N"H:IH)5@GKMMXG>&PYZE$D*.T:92E+*I4.I8,ONO=%U^%71?;WQJ^.O6O
M1W<?=FU_D!N#K7;-%M6E[,V[T_5]+5.XJ+'5->*6OSVU'[2[1I5JVII::*4T
M$U%3^2&22*FABE2G@]U[H+=X_P NSI3/_P P?IK^9#M^F&T>^>O.N.PNH-^3
M8RBIACNW=@[QP0HMOG= 41N,KM^JIU_AV01B7HZJHI*E9A'0M1^Z]T&]5_+Q
MW9U9\Z.S?G7\1.Y=O=3;@^2FV-F;8^6_2?8?6)["ZK[IK>MJ/,T?7O9N#R.W
M=W]?YK;FZ\;%F9:22K6LRM!5TTTPFQPJ7%4/=>Z,G\;_ (G[?Z,WOWQW?G\M
M1[\^1WRCW'L_<O>W:5-@/[LT68AZZVC1[&ZWV)LW;<N6W#+BMM;>QM+)'C,=
M-DLA*:BMK:VHJ9ZJLFD/NO=+3Y7?''8'R]^-G=WQC[0HQ6;&[NZXW-U_FV54
M-5C&S>/EBQ6XL8TB2!*W%UJTV2H)2K>.HI(GL=-O?NO=)KXK?&/ _$/XA=0_
M%GKO<,U+2=/=2X[8M)OVNH:&IR.4W9#BY9MR]GYJ@G6.GGK\KFJVLSV060!)
M:BKEU\,??NO=%L_E;[*^7W7/5G;.R?EK\KT^;53@>XJ^'JSY&R=:XCJVIWAM
M*JVCM2MW'B*7"8+-9ZEK,=A]PU&5QE%DUG!E>GJ(E04\%.S>Z]T<KY*=9;V[
MIZ&[;ZAZ_P!_8'J_<G9_7>]>OJ;?NX=A579=%M>+>>U\OMN3-P;.IM[]?"KJ
M*4Y-:F&.7)1Q,T6B165C;W7NJW*S^5]V[+_*,3^591?*7KRCB'0%!\;'[VD^
M,VX:N9^O(::GPM?6CK0_)F!1EY\;') E7_'C3QSR"H^T=%^W;W7NES\@/Y7V
M.^3_ ,-_CE\=NU.Y9<+WC\3<OTIV#T#\JNI.N*#:><ZY[IZ'H</3;.['PW6^
M^-U=ITCPU#8D_P 2PU7DZJ&:*8HLL4D<4Z>Z]T)^1^'?9/?6<^.69^;79'5W
M;]'\8]_;8[NV=M+JOJ3<'5^T]V_(?9^%W!@]J]L[UH-U]I=I2/#A1N*?(X+
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MW%M?([#WYM7<NQZK=6RGE6MQ.6F6EJH<E \$J@CEM<?NO=(GY,?R_P#N?O\
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MXB?'W=^0PU+N.EZTR78^?Q6$W5VNVWJJKIEK)L-39B"''1,E1&N1R5%)/!-
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M6M@LKMJLR:XS+1[U8I722NKS?<1+(LD31Q^Z]T7G^=ST9\=/C7_PF>[TZ/\
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MY*2!\C14.4JNSI\G14E:T9DCBJ7Q5*\\:,JR-31%P3&EO=>Z1/Q^WKN' _\
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MRVU@,73>"*;(Y;+]!]@XW$8V%YGA13)/5I&FMU4%^2!<^_=>ZHJ[SS.(I_\
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MIL[%;IVKN#&34N8V[NS9^Z\7%78^LA<>:*:GJ::L&M&!X8HXN"/?NO=:ZO\
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M\&W*;*9O-&.6DCC@PHGJ9A30RQR>Z]THOC3C,=-_PH(_F=Y>;'T4N6Q_PO\
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M;J\]%TL^P-\[6WEM'-P34V5PV5P78$\%;!#+%4^$O+%Y88ZF*3W7NF;^6O\
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M@I^B^JY*>&24#4R1M52LBDD*9&(L6-_=>ZI[JY>TE_X38_SD\5TZ*:',;?\
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M9;!Y&F;_ &NFJHF_Q]^Z]T4'X<?R[/B/\ L-N_;GQ,Z^W;U?MW?N[Z_L#=^
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M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
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2[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ttable_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ttable_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M=S%;38W$87#8FDFK\IELKD:R2&DH,;CJ&G>:>>5UCBB1F8A03[]U[JA[?/\
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MOZ..HIX<_FMZ?<Q"@4S0T^AS--+#3QRRI[KW5-M)_.'[H^3'\OKY ?*[?O\
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MM;MW*9*B1-R;1ROV-9D*2/-[/W)!5XNMCCGF6.JI)%#L!J/NO=:"OR?1)/\
MA;+MI7174?(?XAN ZA@'C^%/2LD;@$$:HY%#*?J" 1S[]U[J9_PMIKJ[%_+O
MX+Y/&5E5CLECNA-Z5V/R%#434E=0UU)V<E125E'5T[QSTM52SQJ\<B,KHZ@@
M@@'W[KW5O7_"U;_MUET'_P"+_P#5G_P.ORJ]^Z]U;S_(!_[<U?R^/_$"X_\
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M /+V?_G1_?NO='R_X4=(D?\ PF_Z-CC18XXU^$"(B*%1$79=(JHBJ JJJBP
MX ]^Z]U[^6U\),)_,Q_X2B?'WXF[U[*JNO,CV)1]O1;$[$KY_P"(1;<WYL3Y
MR=P5_5M%D:.NG4Y;;=3E,'18:;'Q.L[8Z<Q49CG6G9/=>ZUR_CO\\OYG7_"=
M?N$?!CY_=49WM+X5[LR.9H]R](;QFBW;MC<'6N1J&PNXM^?$CLZHJX<=2T\B
M2QUYP4E1%BY9YFBKZ+$9.KDKJ?W7NOJ0;5W-A=Z[8VYO';5:F2V[NW X?<V
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M^RKOFY_XKUL/_P!^1[]U[I-_S5?Y=/\ ,;_DR_-OMC^:O_+=[ WON/X\[^[
M["[1WIO/8LM%N@]2UV[=X93*]A=4]_[!_P MQF^.I*+<M?5K19*KHJRCH4IT
M&0>CRE'!5U'NO=7L_&W^:+MO^:I_PG]_FN=S5O6>"ZF[]VI\2_F)M;Y+X#:B
MR+L_=?8_^R>YM,;VEL^.JKLAE*/;N]-JXVDA6CKI9*R@K,;44S35<<45=5>Z
M]T4?_A$(B#XQ_.:0(HD;OCK-&<*-;)'U]DF1&:VHJC2,0/H"Q_J??NO=5J?R
M>)MZ[9_X5P_+/ =:XNG;8]9\EOYGVVNS0LB%,+U9C=[=M93 STAFR%/++;M'
M!;5I1I6K?QSDF,*&FB]U[I7?\*K?^W]O\O/_ ,5Z^)G_ ,&9\B/?NO=;'G_"
MD6H_D^8KH#IG=/\ -4P^\-X9S:FYM[5WQEZ\ZASN3PO=F^\S4XS;_P#I%VYM
MV;'UN/I*#8-=#0X0[@R&3J*3'4DT>/ G%;)1PS^Z]UKC_P#"HBN^8&ZO@]\
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MV.QVTL!UUU3V5D-QUB[1P,^/I$GGQD./F$$[_>H)*<^Z]T5#_A/3_+,^:/\
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MVU,=N;@HIBD&2Q--2I%4T3Q2M/[KW5SG0'4U;T[UW#M[<&Y5WOOS<&?W)O\
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MOE%O/J?>&PI-Q;%P'?&\]D=-[Z^-7<%3M1MN=F29ZGQ.(Q66VA!4US9O/TH
MH)?NJ*3W[KW4C_A(W\//DQ\4/@%VGE/D5M#=76$'?7>3]F]:=9;UQM=@=S8S
M;-)LC;>TJK>F8VUE*>DR>WZC>]1A(U@AJ8TFFH,;35&GQS1D^Z]UM9>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NJV/YL_P#+HVI_-*^$W8OQ/W%NH[!S>8R>WM[=:]@C%PYN
M/979&SJN2JP.6K,5(T4M=B*^BJZO&9"."6"I;'U\XBD232??NO= ?\6OY6LF
MTOFC\ZOY@'R8J]B;C[M^;_6'6?169V'L*KRNY-D[!ZDV/U'UMUMO+%T>]MR;
M4V1N'<5=V]E^M:'+9&(XB@IL>E/3TJ?=&$U4GNO=%HV9_(RJJ'XW_!WX#[VW
MIL[.?$+X(?-_='S$V=N2FKMPS]M]L8N/=_?>^^M.G=Y[0J=MTFUMKTV S??<
MM/F\[3Y_*G,T>#418ZB;(O\ 8>Z]UL7>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K3*_X6N=F]=T_P#+[^./3<^]]K1]
ML9CYC['[-QG6[9O'_P!]:SKO;?2?R)VMG-[P[;$YRIVMC-R[JQU!)7&(4XJZ
MM(@Q>X'NO=6T?\)Q.XNK.T/Y/OPQP?7V_MK[LS_6'5O]R^Q]NXC+4T^XMB;G
MQV\]YXZ3$;NV^SIF-OSUDN*GEHFJH(H\A2*M32M-3/'*WNO=7F^_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MBT_WVW3_ ,[>;_J32?\ U/[>T+TSK;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;K
MW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WV
MW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\
M.WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^
MI-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG
M_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_
M:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%
MZ]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW
M]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]
MMT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.
MWF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_
M *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_
M -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/
M[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z
M]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMN
MO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]M
MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_S
MMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_
MZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_
M]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3
M^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]
MK;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;
MKW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT
M_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\
M[>;_ *DTG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_Z
MDTG_ -3^_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DT
MG_U/[]H7KVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^
M_:%Z]K;KW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7
MKVMNO?WVW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;K
MW]]MT_\ .WF_ZDTG_P!3^_:%Z]K;KW]]MT_\[>;_ *DTG_U/[]H7KVMNO?WV
MW3_SMYO^I-)_]3^_:%Z]K;KW]]MT_P#.WF_ZDTG_ -3^_:%Z]K;KW]]MT_\
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M74;3]Y=\8:MVIV=L63(2[0WX^2VYV7A\EN+=6WFRE0*:MRLM=,B2E=16P'B
M>M5IU)I?A7\=J/Y+T_S"BVOO%_D;2]9P]-1=C57='=U<S=5P;C7=Z;#J-J5O
M8M1L>LVXVZ5&0>"7&.LE7>1KL23Z@K7KU<4ZC[&^$7QQZU[9[W[SV3M?>^#[
M8^35)M.B[QWHG>'>U=D=]P;#PE3MO91J*?)]E5N-P=1M3 UDM)CYL9!134D#
ME8V4>_4''K=3PZC=.?!#XH]#?&_)_$+K?J>&F^-&8Q6Z<%D.G=X[Q[![3VC+
MA=[9',9?=>)B@[3W9O.MI,=G<MN"LJ:B&&:.-JB=I+!@I'J"E.O5-:](O%_R
MR_@MB]C=<=<2?'O;FXMI]2[VV;V'L*FWYN'??8^8Q&[.NL/NO!; K:S=>_\
M=6Y=V;BQ^R,;OG++B<?DZZLQV/EKI)H((YM,B^TCKVH]"+3_  J^.%)\DO\
M9NJ/9FXZ/Y!+U4>CH=]4?;/<-)24?4/]X!NJ/KS';'I]_1]>XW:]/N0"MAIJ
M?$Q+!4@/'I('OU!6O7JGAUFZ%^&'QQ^,P[BCZ;V-E\!2?(#L3>7;/<6,W#V5
MVIV1AM]]D=ABD7?&[\KA>S=[;PQ,&7W3'00QUK4T,"S11B,KH]/OP '7JD]!
MK\</Y8_P'^(G9VZ^Y?C=\7NM.I^S-Y055)EMU;?I<M455!CJY**.OQ&T*/,Y
M7*8OK_!Y 8^$U%#@8,;1SLI9XV9F)\ !D=>))X]'M][ZUU[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO= I0=XX?(?(+<7QU38W;%-GMM]68+M>?L:MZ^S%-TKD\9GMR9';,6U,+
MV:X_@F1[ H*C'&IJ<2 LJ44@E1GT3K%[SIU[Y]"ABMQX+.5VY<9B,K1Y#(;.
MS<&W-TTE+*))\%G:K;F W=3XK(H.:>LFVSNK'5RH>33UD3?1O?NO=/?OW7NO
M>_=>Z][]U[KWOW7ND]N[=."V+M3<^]MT5\.*VSL[;V:W3N+*5#*E/C<%M[&U
M.6R]?.[E52&CQ]))(Q) "J??NO=2MOY9\]@<)G),5E<#)FL1C<L^#SL5)!F\
M,^1HH:QL5F8:"LR-##E<<TWAJ%AJ)XEF1@DCK9C[KW3O[]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z!3HWO'#]\
M8/>F=PNQNV-A0['[3W]U16T';O7V8ZZRV;R?7V7_ (16[KVK09D>3/\ 7^X)
M")<3EH3XJR+4"L<L<L2>Z]T-?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NBI]+?,
M?J'OGOSY-_&[8]/OFF[)^)*]/'MZ#=FT*[:N-II.\\#NC=6PH<"^7D@RN4:J
MVSM<U\[O2011P5U,%=Y&F2'0-33K9%,]&L][ZUU[W[KW7O?NO=,F5W'@L'7;
M:QF7RM'C\AO'-S[<VM254HCGSN=I=N9_=U1BL<AYJ*R';.U<C7,@Y%/1RM]%
M]^Z]T]^_=>Z][]U[J'D*U,;CZ[(R05E5'04=36O38^DGK\A4)2PO.T%#0TR2
M5-;63*FF**-6>1R%4$D>_=>Z"SH/N3$_(/I_8G<N#V;V9U[BM_8F3+T6S.X]
MD9+KGLO 1Q9"LQS4FZ]F99I*W"UKRT321 O)'/3/'-$[Q2(Y\,]>X="_[]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[H#]L?&WI'9F=AW#MC8&.Q-31[EWKO3$XJ'(9R79^WMY=CSY:K[ W
M=M78=3E)]D;3W3O2KW#DY<ID,;CZ6LK9<MD'ED9J^L,^J =;J>G/KWH;J7JJ
MOCR6P=FT> JJ3;5-LK#E:_,Y*GVOLBCKFR5)L?9=%E\ED*+9&R:2M*/%A\1'
M18V/PPJL(6"$)Z@'6NA=][Z]U[W[KW3)G]QX+:M#!D]Q96CPV/JLWMK;E/5U
M\HA@FSN\=QXK:.UL4CGAJS.[FSE'0TR?62HJ$4<GW[KW07]C=XX?K7LGH[K+
M(;&[8W-D>]]Q;JVWAMS;&Z^S&ZMB;#GVEM:IW759+MK=E /X?L##Y:GIOM<=
M-4ZC65K:%71'-)%[KW0U^_=>Z*C\T?F7TY\#.A-V_(_O>/?)ZXV9_"TR\NQ-
MEY7>&26ISF<Q6V<)2R?:BGPV)?+;@SE'1P2Y&MH:9YYU'D #%=$T%>M@5-!T
M:[WOK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]T5/&_,?J'*?,BO^"U/3[Y@[RQO0&2^2U2,E
MM"NQ.SI.K<=V+@^JUR5!N+)R4C9:KR6\LS)!3+24\\#ICZF1ID40>?5<TZW3
M%>C6>]]:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NF3;6X\%O';F W=M;*T>=VSNK"8K<>W<WCI148_,X+.4,&3Q&5
MH)U],U'D,?51S1..&1P??NO=!?WEWCA^A\'LO.YK8W;&_8=\=I[!ZHHJ#J+K
M[,=BY;"9/L'+_P (HMU[JH,,/)@.O]OR RY;+3'Q4<6D!9)9(HG]U[H:_?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54V[?DKNWOOL/Y
M1]==4=P=W]%)\8NT,3TSB=R]1_&2N[SIM[]K4/5^Q>UMUKO[-5_27>&VHNNZ
M2/LW$X63#XM-O;HCEH:^I&02.JH&BJ3Z=;P./1"M_P#\R+^8/2_#W^5)W/F^
MK:7XV]Z_*#^8-\<_AY\B^D^W^G]V[&S-6N\-W;[H=Q9? KOQJ[/=?;2[%Q>P
M(7IG?"Y#(4%!F'DIJF26&*0ZJ:#JU!4]&%[1^0?S=^"_S;^)>%^0G>/7GR(^
M)7SI[6'QZB@@ZDP?3FY/CAWYG<":SK3%[)R.%RN:JM[["[ RV-FI4IMP5M?E
MX)I)2M6P2")_5(.?/K0 (^SH7H/DK\B)_P"<[N3X.9;?.VH>A:W^6=G/E-M>
MFVKL+'8G>6![ R?R9P/3>+K<IN;<F0WI'GZS;F"H*Z6 +2T>+GEK_P#**"4P
MQGWNIU4ZU0::]54_R_.[LU\(^@/YV_S,[G^2W?/;FT?C)_,K^;&PZOKOL2NZ
M/DQO<&[-E8[HKKWK#=.Y]XT_36'[#H.S]V5(PNV::CPV=Q.S*6 T\5%MZ#0J
MG0- 2>K$5H.K._E/OWYK_%'XL9SYU4'=Q[BS'5>P]K]L=Y_%?,[%ZMVWTAD]
M@XZ.@RG;U%TENO ;%IN\]F;FV]MJIK*S$U>Y-V;NHZ@X]8IZ4><R1[)(&KK0
M )H>D%\D?FW\C*[YD_RC.N/BUV-U?!T9_,5V!\F]]_>[CV"^X*B/ ]=_&?!]
MJ;%W.V=BW TN:QT<F^H,U%C\>N%?(2XR"BEKXZ:IGE'B344\^O "AKY=2_B_
M\N?DATE\[/DQ_+^^<7:VVN[9=H_'K_9W?C]\@,+USANKLSF_C_)O+)[4WELW
ML;:.V$@VE3[BZZW"GV6.JJ!6_B6.H):JI<5#M%'X$@T/7B*BHZ";M?YS_+;)
M?$;J_P"?7QDH_DEVOO3=>*Z;[/I_@CM_X:[VW)USOGI7MK>&T*VJPN!["Q'1
M>0[$G[<VAU)N?[R3<5!ON?:=764=34PXJ2E>GA753Q'7A2M#U;3WS7R=A8WI
M?J*FQ65CB[QWK@,AO.AJJ=*.NP/4_7])%V?OR/<M!6::B#';DJ<-C-EUT2(U
M1'-NE /%9IX;'..M#&>C4>]]:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[HA?\Q+Y2UWQ!Z1VKVM40[NQ/759W)L#9/=O;&R
M]L8W>66Z!ZCW*,R-P=R3[=RU+E**KQN%S%%CL9-/)CLM'COXN*R2AJ8J>2,Z
M)H.M@5Z=?BUN'>G8F6[-[.V7\N=N_*KXS;_V+UA6?'S=R8OJ'+2;1W]2U_:L
M?;-%D\YTM@>OZ+=N"FI*G:,E/3U4=+6TC0U-.91(9)6\/MKUX]$F^"O=GS!^
M;O7WSKVGN[Y!'J_>?Q__ )JOR!^+6([5Z7ZSZOQ>8P?2'0^&ZY\.,VIM3MW:
M7=6T),SN[-U]3YZK.4N<J:6+)RF.4_;TZKH5-?MZV:"G2$Z^W/\ +OM'^8W#
MT!T)\^/DWV3\=OBFU!F_F[V'V=UA\$:_:>X]_9,09'9_Q4ZXR_6GPYZTR])N
M^HQ\1K-YU\-<]3AL34QP0&EKYX*A/5.J@/7L::TZ4'9WS)[\[J^.O?7R4^)^
M^.]<-O3JC<GR7Q7Q\Z+V7\0MR]P=8_(&J^.F[=\=8T^W>RMW4O2V^\YN"K[8
MWYUUD),5)LS=^TFQE/7T-+6:ZFGK3+HDG(Z\* T/5MGQT[,W/W-T)T[VQO;K
MC=/3V\^P^M]H;NW;U5O?$93 [LZ[W/F\)1UN>V=G<1FZ3'Y>AK\!E99:9DJ8
M(9B(P612;"XR.JG!Z&?W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6MMT5LKOOL'^<!_/SVMT-W=A?CUEL
MA3_RR%RO:$W66([9W9AY&^(.[Z?!1[.VKNS)46QHJI<A4-55-7EJ?*PB*D6F
M6B8U1J:6F=1IU?&D5Z&CXU_,[^8'V/TG_,+^-LVVND>S/YE_P5[#PO5N#RPJ
M4V%U+VM@.TZ&CSW3W>&Y]O3Y" ;1@J-FMDLG6XB"I2*K?$>"!XI)FCB\"<CS
M'6B!@^O0C9OYG[TZD_F-_ KXH[;[OC^3O5WS'VY\L\#OC/Y['];0U_5O8/QI
MZWPO9&.R.S]U=0[!V9MG,?QO37XK-8*M-=58^62&?S4V@056ZYIUZF*]*#KC
MM_Y-?/[XN]@?*SXF=]0]3FLW1\A<3\0MD8G;G4^Y.M.UH>E]W[[ZDV?D/D/N
MC?&P>Q=TUFUNU.Q=B3Y)I-EUVUJG$X&LIXTFK)XI*BH]DBHZU@8/1!_EUM?Y
M3;Z_F8_R%*'M/O\ [4^/G:7;NQ/FM7=E;%Z*RG3>Z>L^G>WNK?B5!4;AW)U#
MC^U.F.QL#N'(;M7?F7Q-55[OI=UM18>H,6(;'3M-5SZ-:CK8I0]6D=J_([);
MI^0_8_Q#VGV?W=U=5]-=(=3]@]@=O=,]$P=U=D5&ZNZ<WV)C-B8BBADZ8[IZ
MRVG#C\+U+DLCEERVTS_%&RU&N->F6DK%;9.:=:X"IZ*[L_YH?.!OY='\PWMK
MLC8>4ZM[]^$U3\MQUUV-VS\>M_=?[6^2G6O1NSMS;XZL[BVYUUNZ?8M914O8
M&'Q]/!630+)CDJH9GCI8UE6GI_ G2:];(%13SZ&GX.5W\P#O7IWXU_*+?OR>
MZG?9W>/P/Z9W1-T\_P >:6K_ (+WMO7:&QMW_P"F*MWQ@]\;,RF;IMQ8O(5S
M5VW*:#%8S'5%2D-+Y$A\[^&KCUXTX4Z +X(?+WYT?,/^5#\/_DKAZOKJK[K[
MN[OW#C/D!V37P[5V5M_I_P".FWOE#VSM+L7L'9.VLM'-MO+;MV1U1LNFQV#H
MZV.N2;(2Q5E<E:L=2LW@25Z\0 :=#'T/\TMXY/\ FD;Q^"U/V53?(#IK*?!#
M"?,;8W<.1H=GT.Y,/N&E[WEZ:W'LB@R_6^SMF;#W_L?,462H\A1Y*EI6EHJF
MFGIVJ:LNRTG@<TZ\1BO5OWNW5>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[JGGYM_)OY8=6?S%_Y9WQCZ4WAUGB^OOF
M)!\RH=VT&[=A5.4K,;6]"]!TF\,!E:W.1YUJ[*8W'Y[="9;^&XY,'/D),3#0
MR9"""IGG6I)J .K "A)Z2O5/R+^7_P :?YEFR_@M\MNW]G_(WJ_Y9]6=F]K?
M%GN2GZYVWT_V!MO>O4\O\>[#Z1W'MC:!&U]T8?#[*JC78[(QJ,DM)3Q_<O42
M//*F@2&TGKU 5KT#'S>^:OS,^$OP,W#\Q>W^P=I;9^4?7_8.#W=N/X3;?;J[
M=G4]?TKNKY,X_JO;VUZS=6/V/E^V:#(-U%N;&U]3N>/<$5$F[ \:0/3LF-;Q
M) KY]> !-!T8_P";7R6^5_6/\QC^6=\7^FM\]<X'KGYCQ_,BGWA!N'KI\UE\
M/-T-T'1;OPN6ES,VX'DRT%!G=SC*QX^BBPKULV+@HIJQ:>>HD.R34 => %"3
MT0S^:CU9\M=H]5_RA-N=U?-_L+=W9^<_F\?$_J+?.].F^O.J>H-D[OI]V]D[
M^WSU]V;7]8YG9_9.,JNQNJ8MF88XNBR-5D]F/7T[U-;@Z^=89H]&N,^?6Q3.
M/+H^W>'R!^2WQ^_F-_RF?B53=NTG8/3?RBQ7S I.ULOO'KO9M)V]O#)_'+XZ
MIO7"9;<.[-G4.U]ATC9S=NXJ:NFAVWM3;4434 A >"62,[)-0.M  @GH6.O>
MXNP_G#O_ .76W.G>]MP= ]<?%3Y 5'Q?H=W=5[=ZBWGOG>O<VP-F[)WMVY4;
MGJ.X=B]J[/HMBX');^I-MKB:'$T69%9C,A,^4B:6&"DWQZUPZK _G%U_RQK_
M /A.C\F3\W,!UA@/DE1/TCB]^KTYE*W*=?9J/&_,[IFCV]N?"_Q!158Z3<6W
M8J:JJ:1B1!4R.%6)2((JM71GK:TU8ZMX^2?R:?:_R ZD^)^V\]OS9VY>SNIN
MW.[-U;^ZUZJRO<.]=G=>]:9[KK8='!M;:^.V;V/CL;N3<V]^U*)X<IF=O9?"
M4U%B:RGE@-55T;I8GRZU\^@N^!???R?W?W=\NOCSWYM+N+=.P.C,YUCD?CO\
MM.S>@-R=%-\@MA;^V/1Y;<&)S=#5=>]9;'S/8G6.[XJF@RE3M_"XF@G61"M#
M (]<V@3Y];-* CJT7W;JO7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW59_<G?VYNQ^]NZOC9L#MON;HBFZ4V-UE7;@[0Z$Z D[YWZ_:
M'9\69W1B]M55-N'HSOCK3;VUMO;$Q>/JZRGKL6N6R_\ 'U^TJ*%:,S5%2<TZ
MWBE>JW/DC_,<^?O6G\EOO_Y<Y3:7^@3Y6?'#LF#I_<E1V7\<]_[.Q/:5+4]X
M]:]7;?[MZNV/VX<!48K:N\]G]APYFF>IH<WCUR4<]$#>EFC&B3IKU8 :J=&V
M^8_?GRU^'/?7P+[)W'W5MW>?3?RE^9_7/PG["^.&%ZIVS0;=VQ5=_P!%N^;K
MKL3:'9-;.>SJS</7V2VE%3Y26LR"XO,4]3//%AZ-S#3P;-01UH $'H#>S,-V
M#N+_ (4:2X/K;>5#UWG<I_(Z2EJM\U&!H]T9+;&)/SQJGJ<CMK;V623;^3W(
MU2D,-/\ Q)9*"G$KU$L-5X123Z-=6/3KP^#\^A/^)GRX^;_>/PA^;&)Z^H-A
M]Z?.3X=?+GY%_!_;&[=\4.$ZQV%V_NSI[>.U\;A^W=VX7;M7B<%AHX=C[TAR
M63Q^/7%P5M=C9J>DBIUGBML$T^?7B #\NE/NWY>]B=*?S-/@K\2L3WA+\BNN
M/E[MWY7;;[%BW1B>L*/*]-]B_&SK'$]J8G);7S_5/7FRZ2JGW+35E3C<Q@LK
M+7U%$II:E)*4@QUGJYI7KU.VO3%TCWU\U^__ .8#_-.^(4G>6P=A;%^*D?PS
MAZ^WOM?IO$UF[MO4_??2V^^RL\V!P^ZLUN/"U^?JLP]!'+79Z;,T%-28<0T^
M+\M?+54WLDD=>H  >@EZ&_FC=OX?XE]CXCMO-;/[&^5_6G\U'-_R@-D;_P Q
MM[';(VEW+W1/VAM;9FS.W,YLC:^3Q=/'2T6R-V/N'.8?#G%"K_@E9%2+0PNL
MT6@33/'AUX@5Q]O5B-5LKYX]<_)?I"OVAV]0_(3XR;X??U'\F\+W#BNJMD[J
MZ:J*7;F*GZUSOQWDZIZSV/D\W@\IN:*MAR^-W56;DK8H7A\-8 SRPVS7K6.B
M5]G?,GOSNKXZ]]?)3XG[X[UPV].J-R?)?%?'SHO9?Q"W+W!UC\@:KXZ;MWQU
MC3[=[*W=2]+;[SFX*OMC?G760DQ4FS-W[2;&4]?0TM9KJ:>M,M22<CK8H#0]
M=?,SYU_+G8?1G\J+M_KC;F-Z+W/\S_FC\*_C_P!S])]Q=<9>#>^S4[T@W!GM
M^;-RE?GYH\AM%Z&?:SX:H+8$Y6"">6HADBJ!$(]DF@IUX 5->E%M+O7YE[?_
M )G7;/\ +PW#WQM;?N,WU\,]K_-?KOM;+]0[7P&3Z/Q8[GJNC=^=;[:VGMF:
MAH][T5;E(*?(8&7<5;7U>,-1,]=5Y1(8Z.;7=6G7L4KTC.H_YA_:7QS?^<%U
MI\K]\5'R(R'\K'#=3]F8?M>FV7LOK7=7;>P.].B*SMO9&S=PX39L.$V-!OS&
MYS"SXB6LH,7BZ&;[J!Q%</;8)%:^77B :4\^E;VY\DOF-TMV3\4-[[ _V93Y
M2;;[=[RZZZA^4O1D7PF[ VEL7I?9.],!N%<WWGU!NZGZ)VIOO:^V.O\ =U+1
MG)Q[RW5NV*;'2HJM3.9*E=5-?7KPH?ETHMV_([Y?9'^<5D_@IM+LOK3;W3V1
M_ER57RGQM=5=6MDL_M?<E9\HL-U(U69*C<TT^[,]C=K8JJIZ%7JL9AXZG+/6
MU5#6BCAH9MYU4'7J#37HE_9_R ^4.Z?CW_/V^'O97R9[!R':/\N_I]>U=A?)
MGK/:O6/4V_MZ]>]R?%G>WR#V5UUNBFP>TJ[;F+GV_5[8J,%D\IM[&X',38IX
MI*2OIZ\O6#530@^76Z"H(\^K/?Y0FR]R;1_EN?":IW!VYV%VE#NOXD_&#<^!
MH-]XWJC'TG6>$R/0^P)*/KO9#]9=8]=5]?L[ +Z*2?<D^X-P.O\ P*R=2WJ]
MV7AU5N/2(_FA?)[Y!?%[<'\N^;I[=.S\/M/Y&?S)OBC\4.UL5E]BKG]S5VQ>
MVL]N/(;I?;^Y:_/-B,$*W";1?'L!AYJR,5C3P5<$D:6TQ(IUX &O2)W;\COE
M]D?YQ63^"FTNR^M-O=/9'^7)5?*?&UU5U:V2S^U]R5GRBPW4C59DJ-S33[LS
MV-VMBJJGH5>JQF'CJ<L];54-:*.&AF]G50=;H-->EE_+V^1G>NY?D[_,8^$G
MR"['3N_=GPE[#Z&R.UNZY-C;1Z\R^\.M/E'U75=K[1VYN;;VQ:;$[4?<77;X
MZKQDE71XVA2KI13O()9_+(?*34@]>8"@(ZMD]VZKU[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U1=N;JS^8S\(/E]\A^T_AU\>NMOFA\</FKV;M/M'>G5^X>
M]-N_'+>_Q^[?396!V%O/?R[MW1M[<V,W9UYN;';5H:JMI:*@R&:26)$IJ4Z9
M'FKW XX=6[2,]!'_ #B8NY,5U9_*'R78/]UMR=RUW\\#X/;BJ=M[>KZK'[#Q
MF<K!W+5[=Z\P>?KL:,G/@,!3+2XR7-5-''/D9HYLBU)3^<4<.FKC[>MK3/V=
M6*=P]"[S^8'>GQ&W9V%UIF^J>J_B/V]7?(L8_?&<Z]S.[.P.X,5LK.;-ZQQ^
M$QO7>ZM_XK';0VI)O+(9BMKZW)4=:^0H:."&CDB>6HBW2I^SJH-!]O0'_P"@
M[Y#?\/G?[-U_H,W5_LMO_#:?^RD?Z4?[Y=->#_2A_LTG^F'[O^YW^D[_ $B?
MW5_NIQ]U_"/-]SZ/#^??LZJ]>KVT^?1;M@_RQ.WMV=7?S>?A'W=M# T?1OSJ
M^8_R*^5W7OR!I=Q[>S<= G=])L/<W7^,HNLHJN7<R;TZ>[.V'05M7)D?X?05
M<=+JI)F=U\>J'(/5JC!'1EMR==_-/Y$?"+=?P-[KZ979O9&]NF<?T%V?\J<;
MOCJ_*] [DVMFL>FRNP>QNN=NX[>-;WE_?FOV6E37T6"S.S</C(LQ51P-D_MH
MWG&\D4/6J@&HZ+'\YMO)TQ_-1_X3P;,ZKV74[BQ76FVOYC.R]J;)H,GAL7D)
M=G[8^)?6FW%H<779VLPV!_BF+VI2.]+'55-'35$\*1/- KF1/'!%.O#X3T>C
M:_PWK.W/F=WO\UN[=HR[*J-\_$?#?!CJ_KRORV&S&[L)T\^\MX=B=G[LWA5[
M2SVX=B4^;W_NW=%/3X^CI:C*2X_%XA)'JTDR-30TWJ5-3UJN*=%(^&^T/YO/
MQ/VKLWX 5?0W1?9/2G56UO[B=1_S#*OO'&8"FVUU?BJF7%;(QV[OB]'MO+;\
MWSV;LK;'@BCI(*W"8&MCI(HYLH)#)*_AJ&.MG2<]6X;4V)N.;O?>'8>Z*6M_
MA&T>O-K=1=55F6JL+75V4H<B]/O;M?>T$N+J9JJBBWEG(]OXFIIZN&BG:JV>
M9UA---3S2;\^M>70_P#O?6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z WOZL[=Q^TL%6=.;$P_9N8BWOMV/=^Q,YN3$;5H-
MQ]95GWM!OVDBRN<HJ_'/F8,'5//C*258J>OR<5/35-124DL]7![KW1&?B!\+
MJ;X^?*_Y0?(OJSIVH^-'2W=_5_6>-G^,F.K.OXO[P][;3W+V-F-Z]R0[<Z]W
MCN3JW9<FX]L9W"XBE@I,FC5<]/55%8M./%>H%#7JQ-13JOCIWK?^:%\5OC7_
M #1J#HWX;[SG^1'RT_F=_)WOWH'(57:WQ0EQFR^G/D -G18_MK-)D_D-CL7/
MNC9F*VK5O3X"6H26?+U%"LMJ/[N:'6:'K=02*]'0^&N.[5^)?2W3_P :NI/Y
M=7S$Q:'?FR6[7[R[L[-^ 53)N/([TW[@ZCOSOWM/([ ^:_96_MS[JK\16Y7+
MR14&'R5?4S1Q4L*FR$;&!2G6CDUKT#G1W6?\T+^7WV/OWXX]#?&GISY:?$'L
MWN[MSMSJ+MO<?R'Q/0F8^,&-[<W;D^P]P;'[0VG5;,WKN7L?!XS=NX*Z3&-M
MO'3U509G%1-2H\8AT-0QY=>[2.KR=DXO<F%VCMW&;QW%%NW=U)B:--T;EIL:
MN%H<UN%XA+F:_&85:BL_@N'GR,DAHZ,SU#4M+XXFFE9#(U^J]*GW[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW5.>R>COD9\4_YC_S^^5&%Z+W#\C^I_GK#\.X,!%T[OCJ';^]^G,K\<NI,
M[U=N"7LO;_>O8?3^)R6V,W/E%KH*O;N4S.1CB7QG'.Y)%<@D^O5L$ >G0!?(
M_P#E_?+<=+=\]K]1TVU=\_(GY,_-[HKY/_)OX[XW=U'MC:G<WQHZ9HL'M2F^
M$^*[-W&=MXU:?/;)VU0KG,KE128O.32Y.CDBAQ]8JC6D@8\^MZAY]+_OKH/Y
MG]P?.?\ E-_+':_QMV-LC8/Q1K/ES@-]=<9+N7:7]Y]@8OY#_'G%;!V]N'<O
M\ QDVU*C![>W+A#22X_:M3N*K"&"5+Q3SF@V:U!IUH4H1T%GQFZ=_FB_RT-P
M[U^)GQX^*'1GRR^&NY.X>U.P_COV;DODGAOC:WQIV7V/G:W?3=9]H[-JNO.Q
M=U;JQN"W/FJR"AFVSC<BTZDS2&DCE2FI==RX&>M]K9..C&?+/XL?*#-?*[^5
M#\M-D83#]\Y[X;[@^5.,[QVO1;BP?6TV9C^5G3M!L*JWILR?>F7EHZ#9_7VX
M\<S)B&J*_*#$R0QQ&JFA<R;(.#UH$9'2<^3'3?S]^._S R'SV^%/4'7/RFD[
MEZ-ZSZ9^3WQ.R_:>&Z6R^<SW5^<S]=LCLWJOMG>]"-M4LF H=Y9"BJ*;+1J9
M* ,R0RSO&D/B&!J.O#210]#Y\C-F?+SNO^79\R-G[QZMPM=\A?D9\=N[>L=@
M_'_JS?\ M7-[<ZUJ^P>G=Q;&VOMVO[<[(EZCPN\JT[ERTE=F,TU+BX42JCI:
M:DDCH_N:G9K3K6 >A8^"&V^U.E_Y?WQ5ZU[*Z@W9MWMCH[XR])=3[KZT3<?5
MF9S.0W5UCUAM/9N8_@.XL)V%D.OZG'5^3Q$KTLU1F*:\0O(J$J&\.'7CQZH<
M^*7PE_F1=!?!?^4_UCG?C74;O@^&_>WR W/\K?ASE.V^B:2G[OQ?:/8/:FXN
ME.PL!O>E[/S'6>>I_C]D-\1;E."S553?=YF.EF@1JC'PGW6C #JU5)/5D6%^
M/7S!G_G);/\ G!F>G]A8CI?<G\N?(?%+-R4/;6/RF4ZTW!C/E%C.XJ=-QXUL
M%C<EN'-[AVC/,M(F%I:O$4U=%)!4Y!(XH:FNWG57K51IIU=#[MU7KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZH,_F2
MY3<.%_G%?R%LIM;;,F\LS1R_S/I(MM4^4QN&K<K0GXP["3,Q8ROS-11X=<Q#
MAGJ):.*KJ*2EJ*J..*6HIXW:>.K?$.K#X3T>J'X\[I[L^</4WS%[,V56];83
MXU=.=H=:]+[(W'EMH9O>^4WIW=D]O1=C[^W =C9K=NU\#A\7L_9U)C,-!!F:
MVKK!DZZ2IBH_%"DWJ5->M5Q3JE;N/X(?S,NVOY2GS9^"6[NEMD[U^2N]NW\I
MV'4?)G)]Q[(H4^8T5+\D]J]Y;;SN#Q<E97YC9FXZ#9. IMHT.-WC5X3'8?'X
M:BI*>H-&L;PUHU*=6J*@]6!?*/I[Y7]G?S(/Y1GR6Q'QJSV6Z_\ BK#\U*CO
MC*;9[,Z7DH]IGY(=*8#KS8>/PU/O+L39&Z-WUF$KZ _QEZ3%B"-D<TK5"%&:
MV:@]:%*$="__ #7_ (P]S_(_8'Q!W)T1MR@WSO7XD_S!_B]\R*KKFKW!A-J5
MO8VU>F,ANFFW)M' ;EW-78S;>&S]30;M^ZIY:^>.G<4K1E@[J??F!/#KRD#C
MT$WR@Z:^5/:'\R;^4;\DL3\<\[D^N?BM!\V*KO;-[?[%Z:-'M(_([I'!=?\
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M'^9A\/\ M#J78/65)\#Y/B12[:R6SM[YS?V1WRGR4V#V/V<<WGLSD]M[-H:
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M#5"RX[;T-3!7/,KRHDU/)[KW0W93YM4>YN^ODU\:/CWL2C[G[>^(G6O6&_\
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MW%UC1Y;;VS*7(5> K:-,AD&RV2>MBB%)4>Z]T&'1?RL^;/7W:OSAZ*W-U_\
M)7Y?;/ZA^,]=\EOA_P#(7M'XL;B^/.Y.Y]UT>*R4&=^*&_,]0],?'_H;-]JT
MF\_X>N!FPV)P$M?@ZYGG@DEH:RL]^Z]T^_![Y75OSCJOC9W)\;OGM4]I8' Y
M?-)\Y/BUOK8O0NVMZ[!7)]/=D4E)M]]IX/KW;7<_4V<V/\@GP, AR&4S$==B
MZ:2,U=1IFJ:GW7NKJ_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW6MS_ ,**ZG=5'5_R7:O8N&V_N/>U+_.V^%E3
ML[;V[-RY'9>U<[NJ"3>LNWL-N7>.'VGOW+[3V_E,NL,%;DZ7!9JIH*9WGBH*
MQT6GD]U[H1?YK^_/YCM=_+)^?M'V#\5/A+MC8M5\0^_X-W[CV;_, [VWWNS!
M[<EZTW$F8RNV]EYO^6AUUA]U9NAH2\E-CZK/X:"KE58WK*=6,J^Z]T?W^5)/
M!2_RJ_Y;-34S14]-3_R^_AW/45$\B10001?'+KJ26::60K'%%%&I9F8@*!<^
M_=>ZUB/YBWRG^&W=WQ0W]_,3ZE^<_P 0Y_GGTK\PMC_-'XO]9R_*;I>C[)7I
MCXYYB+K/9WQ^79^W]P4G8%33=K=-4V9WE6;5K*6JRLFY]UU.-E9(F^WA]U[K
M<4^.?>NQ?D_T)TW\BNLZY<AL+NSK;9_9FU9[N9HL3O#!T>:AH*U)8::>GR>+
M:K:EJX98HI8*F&2.1$=64>Z]U31_W=-?^8 ?_HBGOW7NK_O?NO=59[_Q6Y<[
M\L_D/A^VOD-OG<VTLOUSTQBOB]\:?BIN_N7:/;'4#MA]]U/:':O=\W4^;VSC
M4E[0WD*2GVYD=W5T6VZ6AVZ:>%TGJ:Y)O=>ZH7[/_F$_-/LW_A)7A?YAH^0V
M].OOE;C]OXW;V9[,ZRIMN;4R>[4Q_P \Z/XLRYK+3C"5M?A]QY3KJD:HJ:O"
M3XDG+U$M1&L:^**+W7NK/NZ=S=N_&3^<1_+@ZA7O_O+LSK_^95U9\ZM@][;#
MW9V)EZ3KO:NX_C9U/MGN38O8/2&S<4T,'3>93^.U^$D_@%10U=1024\U965E
M;2K4O[KW1??^$]'QQV#L_,?S=\_M;</=>*R77_\ .7_F#=#[2IZWY$]\[NVE
M1[+P4?3T>'SF>ZSWWV+NGJSL+MBDU+Y-[[FPF9WA7*BQUF2J(AX_?NO=#)_+
M#^4/R1K/CG_.SW]OS>78?RH["^)'\S3^8IUETEAMXY' 1[@SFS?CIUEUI)U?
MU5AH\;1;4V=MZGR^1HW014E-CL>,ADIZ@K&99&]^Z]T77O3Y4_*>F_D:_$;^
M89TS\@NVU^7':TGQ"R&ZJKKROV1N2G['S'R4[9V7L;LOJ#9?4?<. [ Z#PF9
MQU=O6:@V_/\ W>^\Q%3B(5>=HFKEJ/=>ZLQ[K[2W7E?E#UA_+Y3.?(;N&DVW
M\.<EWQWOF^JNPNMND?D)V53YG>]#TIUON+,]A[)WS\6QUY193-[?W3E<M-U]
M_ 9VS,5!'2QT&/2:EG]U[HG5=E?YCOQ__E__ ,X2B[2S'R ZOV[\8^J^]>YO
MY>?R&[([&Z%[2[UW5UC@^A-][]Q6P>R=PX+>W=VX,[E^G=^[9CHWSNY#3[AS
MN+JZ.1Z^KJ4KI%]U[HJ7RK[0^3/0O\B'XB_S9Z+Y>?);<'R*Z6Z _ER=VUFU
M?](TF$Z@[8Q?;A^/'7O9.PNW]AT^/K<=V@-[8CLC(Y&OSNY?XWF$W!,U;1R4
M<:TM)2^Z]UMO^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NJW-]==[?\ FQ\J>B=UM34^5Z,^!7:&ZNRL?N1HI)L?V-\L4VAN#K##8C:5
M<DHHLGMGH3";MSKYRLC$L?\ ?"6DH(I!48C*1)[KW1RNZ.WL'TOLJ;<^2Q^1
MW+G<A60[=V#U_MX03;O[,WYDH:A\!L;:%%/)%'4Y?*FEDDEFD9*3'4$%17UD
MD-%2U$\?NO=%]^!'Q*H_B-TYNS$9./#3=O=^=W]P_*_Y'YO $38C-]_?(/>%
M9OC?D>&KGQN(J\GMK:"U-)MW#5-330U4^&PU*\R+*74>Z]T0+^:EV-\LOC!W
M/\2OF*=M_'?O3X4=/=]=:;/[ ZESNP]X8GO/JO=WR*W-!\=</\D-A=A_WRW#
MM7,;IV.G: PU!1G 4-Z'<.3@9GDK*>LQONO=7L>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z!'OS'=YY[9N.VQ\?]T[>Z\WEN?<^,Q.6[2W+M.DW_2=9[,BI,EE]
MQ;FQNQ*W<VU*;=.YLC'BXL+BDEJ)Z7'Y'+0Y&KHZ^CHJBBG]U[JMW:F>_G0_
M&W=D/7^]=@="?S+.L,T\E%M/Y ;<WAM?X9=R;*JA353TM5\@^M<AC=S=:;CV
M^S4<4=1E=@Q+7_<U>J+;X@4K%[KW0S?S**'=N-_D_?S :#?N;H=R[XI/Y;_R
MRAWCGL70)BL3EMSK\9^P/X[78?&)''_#\/-D_*:2%]4L=/H61W<,[>Z]T G0
M>'W_ +A_X3L]+8#J>N@QG:><_DM=<X?K3)5,/W-/C]_Y/X-X:BV;75%/_#<S
M]Q!2;BGII'3[.KUJI'AEOH;W7NBB=0Y#"T__  DPRU32ST:4+?R8^[\>TE(J
MF$YJI^->_P#%5D#BG4C[R3<,KQ3DB_W!8N;ZC[]U[JS[^3MA]R;?_E3_ ,NS
M#[MI:N@SU#\./C]'54%?234-=04S];;?EQ5#64=33TM1355'B9((I$= RLIN
M6/J/NO=61>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JF;^;U\9<EWE6_!;
M=O4G9L'3/RGVC\LL+UQU%OFD7$_WGR_5O=VS=T8#Y9[%P,>3QN4&3DI_CG@,
MYO-:3Q20FJV7!-*OCA9E]U[I:?S(/A;W9V=L;XE=E_!BOZ^V?\CO@%V[BNT^
MA]F]@BKH^LM];.'7F?ZHWOTAG\I1)49';6)WCU_GFHH:^*[4S0J"R:O-%[KW
M0P?#;LC^8)WBE%OSYE?%_8OP=Q^#Q65QU-T=MWO_ &W\EM[;XW1555-2T^\=
MT[WV5M7;^Q]D;3Q&,I*IZ'"4%9GZNNFR44]564C4/VM1[KW1$)_@SVW\C.S_
M .7U\E>TOC/@_C#\\?CQV%UAO#Y*_*[KO=O5-3B^S]@[8VKE(.U>G,?5;.R]
M?O;L_;G<V2KTQS4NY,%BX]OTM56U%%7>2&!:_P!U[J_3W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2=\Z_B+3]N?S(O@)V)
MU_OS'[+WANW9G<W6'RNV;!'BI,IWA\&^NJS9_:U?A<K1U..K*ROV]MKY 5FU
M=N3S!HOLJ/L6K$4L4T\9;W7NA/\ YGGQ6^3':><^)/RS^$DO7=7\M/@]VEN[
M=VS=C=J9+)[=V5W/U+V[M ;"[QZ7R>[<5)Y-K5&[<+2XZNH:RHBJ*./(XBG,
MJ(0DT7NO="]\>-Z?/[N'KG>'8_R4Z!V5\/=['KW<F Z[^.FSN\MN_(G/ON_(
M4-+74F^-_=HXW9NS-AXS)4.1H8Z#%8C&'(T4$4]545F0G\L$5)[KW1.LU\(M
M[][_ "T^#GS#K?BYA/B#\J>C-^-N+Y6]Y;-W?UIF\#WAUK6=1[_VQNOI';^4
MV'G*??/:V$W/V5G<-6TN3WGMO;\^.Q./F98EJ6CIQ[KW5Y/OW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JG#^:W\
M)_E%\T-X_P OC(]$0]!T6!^'?SXZ(^:&[JGMOM+L/9^7W9CNEJVKJ6V'MO%;
M.Z+[*HX:W<"Y:<"NJJV*.F,$?[,GE;Q>Z]T:?^89TAW=\I/@I\D_C=U-CNJZ
M+LOY!=%]A=0QUG8G8&[MO;%VI5]A;9J]L5.9?.;:ZIWMG\U3X:#)RU"1#$4K
M5+PI&3")&>/W7NBT8#XP?-S9?\K?X\?!G;>%^.$_8^S/C[TA\5NXMU1?([N[
M9&WZCJC8NQ=G]9=G;AZKWOM3XXOO[$;_ -[;)Q&2BP\K46-;;]=60U:U4[0!
M&]U[JTV+;T*; &U/[J;7BI4VDVW8]D15LIV8M&F).,AVP*_^[\4J[<-,%I3(
M,7=:;D4QMXS[KW52W\FOX:_,O^7[T_V!\6>]#\=\O\>=L]N=C;M^*,W5?<?;
MO8&^>M>I=^;IS.YZ#IO>E-V1T?L*'-1;-K:XO2YB/+33U'WLT<D"K!$\ONO=
M*)_AO\G_ /AZN+^8JE-T*>A/^&^C\')MN/VAV$.WA4?[,E)WP.QXMN#HX[,:
M'[710?PP[A#>0E_N; 7]U[JWGW[KW5/7QF^&_P W?C%\F/G/EML]K]!;P^/?
MS#^2>5^4^+[#["H-_P"X/DIUKN3=FV]H[0SG47]TL=0;>V!N7KC9&UMCT&.V
M;63;C23$TZC[C'U85XY_=>ZK;RW\D[YN4/\ (!W-_)PP/9?Q<W/O:;=$]%L_
MLO,YSM;8^SZ#9%!\U:CY3T>X]P24/6G8.>R.[]T8F1,?48BGH*>APL\86/(9
M)2U0WNO=63_*7X=?*OO+^8G_ "J_F5MC'_'S&;,^"M'\NV[2VIGNV^QZ?<^Z
M*_Y2],8'JE(-@/C^@LGBJVCV;/B&K#+D9\<]:CB/QPF[>_=>Z47P0^$'?7PI
M[@^>;T>]>JMW="_*KYI]W_.?:4,@W32]KT^_._L%MJ#='6.Z[X3^Z>WMF;9W
M%MJ*>@RM"^6KZJFLDM-&VHO[KW0!_$3IWMC^51T)_-E[S^76]>B=B]?=O_,G
MYC?S%<3V#UEN3L?MI^M-N=Q8K:E1C-K[GV1GNH^L*S<^<VM-M)2(,953MEZB
M>.EA5&</[]U[HH'QU^-7\[;XW[)V3G<YU;_(Y[3ZOZNBRW<&'R64W9\K.H>Q
M\GOW-T.0RNZ^^,FN-VMV/\8>L^[.PJ7/9:LW#D]KXNFQ"Y#,5GVE8,>Q$ONO
M='L^5/Q2^4?R>W%\/OYEGP0[ V=\8?FAL7H:OVY6=8?)_9^6W#U3V3T[WAB-
ML]@Y7H7O=-F1)O[:^2V/OO'4E1%7X<R34E9'4@0LYC>/W7NA<[<^,/S9[J_E
M_P#RXZ;[6[&Z!W_\M/EA\=.TNB:N?;$?9/3/Q:ZNI-^=<;[V'@UV7B:^E[T[
M(K(,'4;VFR&3KZ_SY#.3MH_R.FIZ2EA]U[HH'RP_EF?,#Y ?R%]B?RJMN57Q
MLPO>&%Z#^(_1F?WYFNUNT/\ 13%%\8L]TCFJK=&'R%#\?ZO=^1DW>.J)XXZ*
M;$4@HS5(QGELP'NO=7\;=FW%48/&3[LQN%P^Y)*5&S.,V[FZ[<F#HZVY$D.,
MSN2V_M6OR=*  5DEQU(YO8H+7/NO=/7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NBU?+?JSOCNOHG>'6/QS^0>,^+W8V[HH<4O<M;U96=N9';6WJCR1
MYZ+:^W*/LWJ>3%[HR-*PAI<M_$W?&AGEAA-1X9H?=>Z(!U]\&/YG>V8>N]C[
MA_FK]8IT9M'([,Q^XNN>H/Y<FR>I-RY[K';60QK9CK?;'8==\C^Q1U\FZ=N4
M,F*?+TV(J\A005+STK1U2QS)[KW2K[Y^&?\ ,:[#^3N>[ZZ=_F3=3].;.AVU
M1;0ZLZBW-\!:'N6#JW$L'GW7E:+=^7^4FTWS.]-^UK1KE,H,;1WH**DHZ>&"
M)*@U7NO=#9TO\;?F?M;J[OC#=Y_S ZWMGO'M+Q4'6'=.P/C+UIT_@_CU@<?M
MBFQN(IMF=-9[</<FT=VYY-USY'-5^1S]17_Q)JJ"CD@6DH:9![KW2@P_Q<[3
M[ V;L#9?S'[TVK\D,5L#?.V>Q)*3:_16/Z7Q'8^ZNN=WTN]NI\KVEA).P.SJ
M'+3;#W/A<3FEAPG]WZ"LW!BH*EZ9*0?P[W[KW1W??NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW19/F;T'N/Y4_%3Y"?&;;>_\ #=82_(/IOL[I3+[Y
MS.Q:SL9-O;<[4V+N#8F<R6.VO1;ZZ[-7F:*BS[34S2Y%85DCL\;AO3[KW6/X
M8= ;E^*_Q0^/OQCW5V#A.U9?C_T[UOTGB=\X;8-9UO%N+:_5^R<%L7 5V3VI
M6[[[&^VS-5C,$DE6\>2,,DCG1$@'/NO=%BR'\LK9<O1>\OAKA>P:W;WP>W]O
MK/;MW'T-0;?KCNBGVMO/?<G9F_\ H[:W:QWE&=M=&;TW=65JU&)CP<N2I,/D
MZK&T62IJ4TZT_NO=68T%#18NAH\9C:2GH,=CJ2GH:"AI(4IZ2BHJ2%*>EI*6
M")5C@IZ>"-41% 55  %A[]U[J7[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNB+?'K^7]U5\>.Z.X>]J#L_Y*=N[Q[9W_O/?^*Q??W>N[^U-B]'S=@5$=5NO
M;G0.QLM)3[<ZYP65FCT23B"KS#4>FB-<:&.*FC]U[H]/OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZCU=.E92
MU-)(]1%'54\U.\M)43T=5&D\;1,]-5TTD532U"*UTDC971K,I! /OW7NB2_"
MOX#]6_"#;F7P^T.R_D9WAN+,3Y"%^R_E/W9NCO3L7$[6JLW6YZBZ^VOF-P?:
MXS:&PL/75K-'C\714@K)E6IKWK*S54M[KW1XO?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]TDM^;"V1VELO=/7'96TMN;]Z_WQ@LEMC>.R]WX>@W!MC=&W<Q2R465PF=P
MF4@J<?E,9D*25HY89HW1U-B/?NO=$LZJ_E;_  4Z6RR9'K[H^2BQU+68#(87
M86X^TNYNP.G=HUNU:J.OVU5;!Z.[![$W1TYU[-@<C!%4TAP>"Q_@J88IDM)%
M&R^Z]U8![]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[HD_;/S!WGL#N?+]*==_!_P"7WR4R6WMC
M[4WQN#??33?%3;O66)3>.2W/C\9M9]T_(WY3=!2Y+>5+'M:2JJZ*AI:H4U)5
M4LC2?O!1[KW1+NH?YT-'WYLOO[L'I[^6W_,3W]M?XP=O]G="]W3X1/@,<MM+
MMOIRAP^2[&V;C]KU?SVI=T[XJL!1Y^D=:G;]%E**N,NFDFJ&5PONO=6!=M_+
M/9O6.6V!L7 ['[&[J[M[4V7N'L7KWH+J:'8?^DO<6QMH2;9I]V[MJ<CV;O[K
M3JS:.V]N5V\L723U^>W+BJ.6OKX*2GEFJ9HXF]U[ILZA^9?7W;W;^_\ X]T^
MQ>X.O^]NJ^M]I=I]A=8=F;*IMO9' ;8WYE,[A-FRX[=V/SF;ZRWVFX,OM7+4
ML5;MK.YK$QU&,J(YJR)U4/[KW11=L?S;*?L3Y#_*OXP=1_ #YU]L]I_##+=?
MXKOJEVM5?!7!8C GM;;V9W7UO78*N[+^<6PJC=M'N_;VWZNJ@7'03U$"QA*F
M*"62.-_=>Z.%\0/FQ\??G'L/=>^^@]RY;(?Z.NP]S=1]J;)W?MK,;(['ZH[3
MV;.E-N;8'86R]P4U+E<#N#$R2+JXEII@289I K:?=>Z'3??8V"Z_FV-1Y:#(
MU^3[&W]A>N=IXG$I0R9#(YW*T.6SE;.D>0K\=$V.VSM';F4S>1*.\\>+QE2\
M44TBK$_NO=%[W]\T-BX#L;=O2W5'7W:WRC[KV!B*'-;_ .L>@,=L6IJ=@T^7
M0RX+';[[&[;[ ZDZ/V5NC<-.CST&$RNZJ3,U5+&U2E*:<>7W[KW4K9OS%V5G
M^U.N^AMZ]<=S=*=Z=E;1W!OC#=8=I;1PYEI]N;3HJ2IW-4_Z3>N=T]B=%;EK
ML!5Y&FI*RBV_NO,UM-+4PR21+2R)4'W7NF_<'S,P8[(WIUIU'TGWC\DLAU+N
MFAV7WIN+I:FZB&U>D]T9':N&WQ3;>W;6]K]O=69/=FY4VEN+'U]1B-FT>Z,Q
M105]+]S2PM4P+)[KW0?Y#^9+TI)\.>[/G#LG8O=_9/3_ ,?1W:_9>$PFR,-L
MCM'$)\<I,Y2]U*=A=V[MZHKZ:MV'DMKY2DJ:.KDI:Z6HQTH@AE5H6E]U[H!]
MN?SC.N)_CQL[YB=G_$+YJ]$?#[>^Q]H=CXOY+;^VW\;]\;(QFR-^/A3M;<VZ
M]D_'/Y-]Z]Y[0P5=29V&IJ*W);1IJ/&TZNU;+3$*K>Z]U;%M;=&V]\;9V]O3
M9N>Q.Z=H[MPF*W+M?<N KZ;*X/<.WLY0P9/#9O#Y.BDFI,AB\ICZF.>">)VC
MEB=64D$'W[KW3][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z+=1_*/KS<_9N]NH^K,=NCNC>?5>8QNW^X%ZVI]O
M3[<ZESN6Q<>:HMN;VWINW<FTMH)O%<14T]54[?Q]=D-P4-)64M154,,%53RR
M>Z]T4GYG_P T_:7PY[6Q/3>.^%_\Q/YB[QJ=F4&^-SO\&_BY6=^;?ZVQF:R>
M4QFW<=V'N%MW;1QF#W)N(X2KJ:;'1/4U2T4:3SK#'44K3^Z]TL?@5_,:P'SW
MR'=.)Q/Q,^;?Q6RW1=?L?%[KPOS1Z8VYTAN'*9+?N)RF?QE'MS;%'V-O/<LY
MH<%005E5+6T=#!]ODJ1H'G\CB/W7NK%O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO= -\E/DGU1\2^G-\]\=TY'<>+ZZZZVYF-V;JKMJ;&WG
MV'E\?M_ T;U^8RS[>V+@MP9I,5BJ-#+5ULD,=#0P@RU,T,09Q[KW2AZ$[EVC
M\C.B^E_D)L"',T^Q.]^INN>Y=DP;BHZ?';@@VCV?L_#[WVW#G<?25N2I:#,Q
MX;.0K50Q5%1'%.&59' #'W7NB\5W\P+H.CQ>[M]QMNK(]#=?]GU'3F^_DQC*
M/;E7T=M+L+&[DHME[@QV4S8W0F[9=N[0WO7KALWN.EPM1MG#9&*ICK,A"**L
M:G]U[H[RLK*&4AE8!E92"K*1<$$<$$>_=>Z[]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW1!_C'_,!V=\G?D?\ *_XMX_HOY =0]F_#G)[ Q_:A[BI.EJ+!
MY6G[3H-PYGKW.[#EZY[L[)S6X-N;JV_MR6NIZV:AHX5BD6*0I5I/3P^Z]TN]
MO_,C9>7Q_9^3RW77:VT*3K_O:;XY;7_C-%U_FZKO+M"G:FI:C&],X_K[L3>U
M?E:"AS4L]!6U&;BP(QDV-R$U:*:CQ];50>Z]TR=*_.[JOMGN#M#XZ;JVCV1\
M>/D3U#L;%=K[PZ5[T@Z^I-T-T_GLOF,)A.V=M[EZL[#[5ZNW;L:MR.#FBGFQ
MNX*FJQ<K1Q9&GHYI$C/NO=0MK_.S:^\Y?CUGML]%?(/,=+?*)L$_4'R,H</U
M55=2Y7';RP46ZNO<[G\?3]NR]P;-V_V)MAVK<5697:=) 0J4U2U-6U-'35/N
MO='E]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0:=N
M=@9OK#8>X-[8#J7LONROP&,KLH.ONH_]'TF_,Y'04LM6]'M^D[*W_P!:[<R&
M3J5BT04[9..2:5E1 21[]U[HMW\O_P#F#_&G^9;\>,#\DOC#NBMRVT\C6U>#
MW+M'<T.*Q?9'6.[L>5:OV5V3MG%9G/TVW]QP4TL53&(JNJI*RBJ(:JEGGIIH
MY6]U[I;;E^4=/MGY0]<_%:;I+N;);G[0ZQ[3[=VWV%C'Z</6,6R^F=V=2[,W
M]592JR/<..WY35V+S?>&V1'3)@)9*B+(:HPWAG$?NO=$YQ?\V6CWC\K/DO\
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M5=5R&(R5=2\ONO=;$'\P_P#[?K_\)U?_ #+E_P# >;)]^Z]TQ?S MK;9QO\
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M6GKHV/NO=5O?+G^7_2X'I#+_ ,HWX.][_(G+8#Y'Y?;N*S_2&X>P-I;CZ:^
M7Q3RNXYL[V_O9]T8W9.([XH]M[UPRUV&V7LS=&\=P8_-9JL6&CH5PU#E!![K
MW6R;LK:.#Z_V;M+8>V*7[';6R=LX':.WJ*ZM]G@]MXJEPV)I;HD:G[>@HHTN
M%4<?0>_=>Z4WOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NBX]K_$CXY=];JKMU][=
M/]>=US5/7%3U50X;M?9.TM_8#;NS\SE:W+;RHMLT&Y<'D)<++V'.V.3/&*4)
MD8L#BPZ T:,?=>Z*CT+_ "FOC?\ &K?5)F.H]^?)K!]-X;<F,WQM+X@Y'OW>
M&XOBAL??F&R=3FL5NO:76N=-?F<:,5F'I:RBPKYF;;&.KL9155'C(*JG6;W[
MKW1JYOE%\3MSU7=FQ*_O;HW*5?2[U>VOD!M'-[\V<9.O(ZW#I6UF-[+PF6R"
M?P;&UV%K+O\ ?1K331%T);2ZCW7NBY_RJOCU7_&+XC4_6 QM1MO8\W?'RFW]
MTCL>LI,GCJSKWX\=F_([L[?O0NRJW$9BFHLCM^NQ'5.?Q35&,EAB?%3S/1E0
M8#?W7NK'??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5)'S-R7P;_F
MFY[ISX=;1W]US\BM[]1_,S9V]NWL-UAO39FY]P?'+$_'NHW-ENT:KMO%Q9*;
M,[:VKV93XNJZKFB%.\N3K-X-'$C04M?44?NO='5^?'P0ZX^??4NVNOMX[NWU
MU7O?K'L;;?<W1?=_5F4CPW9/3';^SXZZ+;N^-J5L\<U+/)!3Y*>"II)U,%5!
M*0=+K'(GNO=)_P"&?Q'^0W2,5/NGY?\ SDW]\\.X\7ALIM;:V]<_U%U?\?MC
M[)VQEJ^AJ\A!MOJKJJGDHZ_=&7AP]#%6Y[/93.99DIY(Z26CIZNKIYO=>Z1N
MT_Y>VX:[8/Q&ZF^0_?--\A]@_#/?G5/:O6]=F^H\?MKM'=?9'1^$J<=U7N7L
M;?:[VW#AZ]MIY:J&34X;!8.MJZFCI5JJN:(5B5ONO=6:>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K#4U-/1T\]963PTM)2PRU-55
M5,J04]-3P(TL\\\\K+%###$I9W8A54$DV]^Z]U2KN.I^$G\TOY@_!3M[HG>W
M7_R/QWPKSW;'>>>[CZBW?M#>6S=EY2KPN#VCL#I'?]=BLA692BW1O3L"KQ^_
M,3C6A5J<=<"LJ&@6HQ_WONO=&\^?_P "=H?//KOK[!U79W9'0G;W1_9V$[H^
M/GR"ZBR,-#O[J/LS!TE=BQE:.DKEDQ&Y=O9W!92JQ^5Q-<C4M=2S6)21(Y$]
MU[J+\=/A]W1U]UQO"B^4/S)WW\R^^-X[#SW7)[HW;U9UCT_M[9VU,]00Q5N%
MV#TWU)08;;F'I,CEZ:"OR5375V4S.3DI::*:O\%+3QQ>Z]U!B^#^[-\9?XHU
M'R2[TI.]\?\ #3L/%]N=3Y8=44/7W9.ZNSL#UIO3JO![N[AW?AMZY3:^Y9J;
M!;\KJZHH]O[<VK0U>9CIZB2'Q0+3'W7NK#/?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0';V^,?QL[*["VMVWV-
M\>NCM_\ :VQ_N/[E=F[VZFV%NKL+9_W=/'257]UMZ9W 5^Y-O_<TD212?:5,
M.N-0IN ![]U[KS?&/XV/VO5=\-\>NCF[QK<-/MVM[F;J;81[7J]OU50:NJP5
M5V(< =WU&&J:IC+)2O6&!Y#J*D\^_=>ZE=5?'#X\]$UNZ\ETAT-TQTWD=]YF
MNW%OBOZJZNV/UY6[RW!DY8ZC)9W==5M'!XB?<69R$\*//55C33RN@+,2![]U
M[IOP7Q:^,>U\#N_:NVOCGT1MW;'86[*;?N_MN8+J'K_$X'?&^:+<D&\J/>>[
M\/0;>I\?N7=E)O"EBRL61K8YZR/)1K5+()U#CW7NNMZ_%CXQ=E;ZVGVAV+\<
MNA]_=E["1X]C=B;UZAZ^W5OK9<<E/#221[3W;G=O5^?VZCTE-'$11U$(,<:J
M>% 'NO=3^V/C=\=N^JK:]=WGT)TMW/6['R]'G]E5G;'5NQNQ:K:&>QTDLV/S
M>UZC>&"S$VW\O0S3N\-32&&:)G8JP)/OW7NF^F^+'QAHNS/]-5'\<>AJ3N3^
M[QVE_I:INH.OH.S/[J-()3MG^_D6WEW3_=XR@,:+[O[;4+Z+^_=>Z<NJOCA\
M>>B:W=>2Z0Z&Z8Z;R.^\S7;BWQ7]5=7;'Z\K=Y;@R<L=1DL[NNJVC@\1/N+,
MY">%'GJJQIIY70%F) ]^Z]U.V#T'T5U5N7>6\^K^ENI>M]X=BUB9'L'=FP>N
M=G[/W+OK(1Q4\,==O+.[>PV.RFYZR.&DB19:V6=PL2 &RBWNO=";D,?09:AJ
ML9E:&CR>-KH)*6NQ^0IH:RAK*:92DM/54E2DD%1!*ALR.I5AP1[]U[H#>J?B
MA\6NA\UG]R='?&OH'IK<6Z\C/F-T9_JGISKOKO-;DRU2*M:G*9_*[0VYAZ[,
M9&H6OG#SU$DDKB:2['6U_=>Z<LU\:?CEN3MO'=_;BZ Z3SW>^'P]+MW$]UYK
MJK8N4[;Q>WZ&>:JHL%CNQZ[ S[QHL/1U-3))%2Q5JP1R2,RJ"Q)]U[H6ZK#X
MBMK\9E:S%XZKRF$:L;#9*JH::>OQ#9"G^TKVQE9+$]10-74O[4QB9/+'Z6N.
M/?NO=./OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[H"=D_%OXR]:=A[C[=ZY^.G1.P.V-XK"F[NS]D]1=?[5[#W2
ME/2M0TZ;CWK@MO4&Y,VL%$YA05-3*%B)064V]^Z]TX[Y^.?Q[[0WCM;L3LOH
MCIKL3L#8\DDNRM];YZPV1NW>.SY9J:HHY9-K;GS^#R&;V_)+25DL3&DGA+1R
MNI]+,#[KW0N5-%1UM'48ZLI*:KQ]732T550U,$4]'4T<\303TE132H\,U--"
MY1XV4JRD@BWOW7NF+:NRMG;$QKX;9&TML[-Q$E5-728K:N!Q6WL;)6U%C45C
MT.(I:.E:JG*C7(5UM;DGW[KW2F]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]T#-9\<?CUD>TJ;O+(=#],UW=='0MC*3N&LZOV14]I4N->:DJ
M7Q]-V!-@WW9!0O48^"0Q+5B,O!&UKHI'NO=#-[]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[H.MD=0=2]99;?6?ZWZNZZZ^SO:&YI]Z]EYK9&
MR=M;4RW8F\JF"*FJ=V[ZR.!QE!6;MW-44T"1O7Y!ZBJ=$53(0 /?NO="+[]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NNF564JP#*P*LK %64BQ!!X((]^Z]T'O6/474_2>VFV9TUUAUYU)L]\
MMEL\^U.L=E;;V%MI\[GZZ;)YW--@MJXS%8MLMFLE425%74F+S5,[M)(S.Q)]
MU[H0_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5<'SX_F4['_ )>4
MW2U1VG\=ODWV3M+O3M7:_26U^PNE\/TGF=F8'L[>]7!1;.VWOJJ[![TZUS.U
MH]R3/.*>OEH7Q@-)*LM1&YA67W7NK!TR=:V!.8;;N8CR Q;U_P#=5Y]OG/&K
M2F:=<(*B/.OMC^*2R@0J_P#$OLO(034".[CW7NJ\:7^91@'^&_=OS>R_Q0^6
MVU>J^B*#N'/;FVSN;#_'S'=E;AV;T15[KI.R-][*P47R)JL#F=HXX;*R$]#4
M396DES5&D=3CXJJ":&1_=>Z"7;G\XSKB?X\;.^8G9_Q"^:O1'P^WOL?:'8^+
M^2V_MM_&_?&R,9LC?CX4[6W-NO9/QS^3?>O>>T,%74F=AJ:BMR6T::CQM.KM
M6RTQ"JWNO='XWU\H^H=E[<Z?S]!G1V)4_(G(TN'^/6V^MZG"[@S7=V3K=CYO
MLRGBZ^J:O,8G;-9CAUYMRNS4V3K,C18FFQE*]1/51QV8^Z]U+ZZ^0^U=^=B[
MDZ:RVW-X]8=Q[5VCA>P\CUCV'!MC^/577>XLUF=N87?."S&Q=T[YV/N+ U.>
MV_54DXHLM/5XZH6-*Z"F:HIQ+[KW3!V/\N^E.L]^]*]<Y//5&XMP=Y]T[@Z!
MV\^R$H-T8S:G9.U^K]^=OYO$]D5M#DO]^6M!LSKC)RR"H5IXWC&N)8Q))'[K
MW1@=N;FVWO'"T.Y-H[@PFZ=NY-9FQN>VYE:#.87(+35,U'4-0Y3&5%50U:P5
ME/)$YCD;3)&RFS*0/=>Z>_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T1/^9A\-
M<-\_/@Y\A?BSD9ACLYV%LF6LZWW$LU333[1[?V;6TF\^IMV05-'D,35Q)@^P
M,#CY:A$J8%J*/S02-XI9%/NO=$>^$O\ , [&^4'\J#KG?K-4;>^:=9D1\']]
MX+(4*U67V5\R<#N,=-;GW+N'"4>7UKC]NO$_8.0IUK(Y(\!%*=22*5'NO=&8
M_F+]?;8ZF_DW?//J_95",;M'KS^6G\J-E[;H=1=Z?"[;^,._<1CUFE;UU%2U
M-2*TLK$O+(6=B68GW[KW51&S.X-Q]D?\)UNEOB!T7\:_DKWS\A>_?Y6>S.B]
MD;7POQ][-P/6%-D^Q>C,;UJ-[9SY%=A;9VI\<,-AMJ_QT9J$ONO[ZJBIE:E@
MD8,8_=>Z$3M_X(]X_%[^6=_*UV_UIW/L_ _S&/Y?,^RX/CABL]%E-Z]>=^]Y
M[OZJW5L7L?XQ+1T@V]N;);'WQM/<.6QD&6B?%IA<'CFR.0FH,;3UM33>Z]T-
M/\KKY0;1^:/S$^0';GR(VGN3X[_S(>G.HL1\<]V_";?F-@HLC\?.DZ/? W7N
M3=?7N[I\;CZSN[:G>78D.+RM9N>C/\)CH*'!4M/"$"Y#*^Z]TC?E%\%.[:_Y
M,P;@I.ONL:;!_,3Y/;QVEF\I\9NE=Q8_;6T.MZ#XQ=[S[>[B_F!5<^;,'>^0
MW5N'&X[:>27_ 'ZV/_@VZ<KAXLA4565IO)[KW5TWQ(ZLW1TA\;^H^I-Y[<Z*
MVGN3K[:XVU7X'XT;,R?7?1M''09&O3'R=?;&S%57Y':V.K\88:FHHY*BI\-=
M-.%FF6TK^Z]T8OW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2K\<OY8.>
MZ'_FI_+;Y58O<,5+\5^XX-H?(+K[IFE_NX,%A?F[OW![OZR[\[=I\33X"#.X
MG<,G75"S-6&M\&4EW_DC(L\M,AI/=>Z.7_,IV-V;VS\ OF9TMTWUOG>T^S^\
M/BW\@.F=B[6P6=Z_VT9MU]H]3[MV1MZHRF:[)WGL?;N.PU/ELY"U5*:MI(X0
MS+&Y 4^Z]TE_Y5VP.W.FOY?GQ#Z([QZEW/U#V?T9\=.HNJ=YX'<.X^K]U4\^
MY-C;1H]K9B?!YGJWL#L##UV+DJ<-YX9))H':"IBN@D$L<7NO=._ROZ1[2W)W
MC\/?D[U504N^J[XK[J[?EW7TO69&@PU9V%LKNCK2;8>8R_7N9SN5P^T\3W!L
MBII:>3#OF:FEQE9BZ[+8^6KHC6K60^Z]T@S\8,[W!_,+Z+^=F9ZXKNBVZ%^/
M/>'2E90;AR&Q\CV7W/6=Q;CZYR6"I-S2=:[MWMMBBZZZCH=E9.IQR5&5J:VM
MRVXY&^VI(Z)9*OW7NK+/?NO=>]^Z]U[W[KW7O?NO=,,^ZMKTV?HMIU.Y,!3[
MIR5-/68[;4^8QT6?KZ2FC>6IJJ+#25"Y&JIJ>*-F=TC945220![4+:W36[7:
MQN8E(!<*= )X M2@)^WILS1"00E@'.0M14CY#CT_>T_3G7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%A^3WR*3H7$=<X
M? X2/=O:_=_9>W>HNHMHS33T]#7;GS\CS9'<6XJFECDJ:+9VQ\!35&4RDJ ,
M88%A1DDF1@*N5>6FYAFNIIY/!M+"![FXDP2(TH%1 >+R.51!ZFIP#T2;WO*[
M2D$:)XD]W*L,*>KM4EF/DJ*K.Q]%H,D#HBOPQILQW9_,*^<?R/W//M7.1],4
M&T/ACL?<NU<97XK&U]7M:HDWCVRB8W(9G.S4-90;F:@A?55U3 .T:2Z%)DD'
MGAHM@]M.7^5[821F_:7=)8Y"&($E(;8Z@JU!16/ >M,X"'+(;=N=MWWV70XM
M!%81NE<E*RS@@DTH[J.)X4\LW$>X4ZDKKWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@G[3[QZMZ6_N=#V-NE
M<1E>Q=R2;/Z\VOC,-N#=V]]_[H@PN5W-6X/8^P]FXG<&\]W9#%[9P5=DZU,?
M05/V6,HJBKG\=/#)(ONO=)C8GREZ [&V_P!C;EVSV7AHJ#I[/G:W;E%NNDS/
M7^Y>K=R'&8S-08/L79N_L9MG=^R<I7X;-4=720Y.AIGK*6KAE@$D<J,WNO=%
MQP_\U[^7IN'$=([CP7R<V=F-J_(K>M7UWU)O/&8/?5;L?/;OI][;LZWI,5FM
M[4^U)-J;"CW'OO8^4Q6#JMPUF*H]P5E+HQLM7Y83)[KW0)?-7^:ULSXC_-[X
M0_#S)=9]^Y^J^1F9[AW'OG>&Q_C7WQVQB8.N^L.B-_[K7"]88WJSKG>FZNX=
M_GL6;;$F7H]HT&:.UL":BKS;4$,L#2>Z]T._9G:70X^=/Q VOEOF=O;KWN/<
MNT.Z<7L+X58;/T=#M_ON+)]>Q[^R>Z^V>N:K:==NW%Y'JO:&T:O)8JIKZK"K
M35#F$%I)WIJGW7NC)]B_)#IGJO)Y_![QW@\>=VGLH=D;MP&VMM;NW[G]I=?/
M6U6.BWMNO![#P.Y<KMG:U15X^K$5=70T]-,M#5NCLE)4M%[KW2.ZF^;WPR[Z
MVWOG>'2'RS^-O;^U^KL%0;G[/SG6G=W6V]\?UGM_*4F6K\?E^Q9]N;DR(V+0
MU='@*^1'ROV@*T-1_P <)='NO=>ZU^9?QV[7[6RW1NV-Z9W$]P8K"5VZ8>N.
MS.L.V.EMV[IV=C*G'461WWUSB.X]C[$J>TNOZ"MR]+!-G]MC*X>.>=(VJ0Y"
M^_=>Z"[=O\SOX'[,JN]L=DOD7M;,9?XTTVSZKNO ["P6]^T-R;-7?F'W=N+;
M$$>V^M=K[LSNZ,A6;<V'ELC-2X>GR%30X^C-351PP212/[KW6#L7I/8/S?S_
M ,*OEKU#W]/1[5ZIJMR=E]?[JZ]I<)NO;W:.PNX-G8[%U?\ #,AD99*##UM3
MCJ.G:DR?VU9-112U,:P)42)/3C;EGG(\N[)N^QO:)=1[M'"A+LRF-H9/$1NW
M++DU2J@G222 58-;URZ-WW7;MU6=H7V]Y& 4 AUEC,;*:X!X4:A(&H  M4+S
MX:?$ZF^(?7NZ=B4^_P#(]@MNGLG?/8M5E:W"08"U7O+<%;E[5=,N3SE7E,W3
MT$]/15.1GJV-7'10LD-.-2&G._-[\Y[E#N#VXMO!@A@"AB^(8U3!TJ%4D%@H
M':6(JW'ISEO8%Y=LI+-93-XDTTI8KIS+(SYRU2 P4L3F@-!PZ-[[!G0AZ][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[JJWY&]I]1;Q_F/_%?XR;3Z[V+NOYN]9= ]W_*OKKM+LNJSW]U_C;TO
MO"NQ7Q[W=NS%;5P.8PU;V=OCM+,Y X6EPD=5C!'B*'*54F4HA%'#7>Z]T2C^
M6+!4T'\[C_A0W09S=%#NW+/5_P J2FK\U!C\9AJ7)90_$WLFHR%!1XC'RST]
M*F*:.:F$#2U%4D=,?N99IQ+*WNO=44XB./;_ /PAJ@W)@8TPFXJ7.T>Z*;/8
MA5QN:I]S8_\ F\4F,Q^XH,I1B&NBSM#C:""GAJUD%1%!#'&KA$4#W7NM@#^8
M@RK_ #UO^$ZI8A1?^;@MR0!J;X?;(51<_EF( _J3[]U[K%_,'EIZG^>E_P )
MT*NEDAJ(:J'^;;+#50.DL513O\.MDRP2131EDEA=)-2$$J0UQ]??NO=+SI[K
MS?7Q^_FW?S4NT,[29_OO8/RRZ)^&>[=HX?:*0;OR_4.5Z6V7V?UU)T+O' /7
M/)M6D[7K,S6;AP57)34^#D@:K^_F@F"S5ONO=5];SZ&[P_E5_P#"?GX;=.]X
M]B9:&KZ*^4GQ&W7\L-W[(J4SO^C;I//_ #FV]V[O_;F'J:O&;JQ6?V_UWC<S
M1X6J^ZHZ_#9"FIYU>EDH)12GW7NK;=Z_$SX_]I?*#X!?-'>'S#[M[*['Z>RG
M:V+^*]/MW/\ QTI]D]M4/=W7T2=@8W,Q=7]#[>S'86SZ+8^SI,N&I\K!38Z*
MEFJ"]G97]U[HJ'\OG#XBL_GO?\***JKQ>.JJE*#^4_BTJ*FAIIYTQF:^(.Z9
M\QCEFEB:1:#+38VG>IA!\<[4\9<,46WNO=/W_"8')9'*_P B_P""U5E*^MR5
M3%1?(?&Q5%?53UD\>.PWRR[XP^'H(YJB221*+%8FA@I::('QP4\*1H%1%4>Z
M]U?C[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z*9W]\&?BQ\G^PNI^VNZ^JX]S=G]'S99^L=_X
M7>/8'7N[=NT>>C$6;P%1G>M]U[1R&X]HY8 -487*R5N)FD'D:F+^KW[KW39M
M3^7]\.M@]I]D=V=>=&;;ZX[3[:V/L?KO?>\NM\INKK[(Y+:_6^)R6W]E)BX=
MFY_"8_:>?PFW,M/C!F<1#09FHQ92CGJI*:**)/=>Z!W_ (:'_E]_[)E_PWK_
M *%-R_[)O_%OXU_H/_V8'Y)_P3[[^_W^E+3_ '@_TO\ ]]?X=_I$_P!S/V?\
M3^S^_P#W/%?W[KW1A>V_A?\ &OOC&=/XSN#KNHW^_0FYCO#J3/Y_?78TV]]G
M[@EQM1AJ^LI^PH=W0;ZRM/F\/5/29*EK\C54F3I2(:N*:-54>Z]TS=E_!+XO
M]N]X]#_(_?6Q=RU?<7QAIMUT70.YMO\ </=6QL;U;1[[VY1[0WG2;8V3L7L3
M;>PX:;=&U\?!05T<N,E2IIHE1P1[]U[J@KY9?#3X7?)KYF=_[R_FE?RC_D[V
M;O&;LC!["^.W?GQEV?W]V%UKV7T90;?P^-V)D=\9;X>;WPN\,3OZDJ(JHYRN
M[!Q5/1X>F-+CZ/(M1TB#W[KW5MOP?^$G7'4&P^\=@X?K?M':GQ-[CH=MXO;'
MQ5^379&Z._:O!FAI=V8GL/=%4_9O8';N2VSMCMS#Y/"P+M.;+U$=#'@Q5S04
ME;D*NEA]U[H2/B!_*U_E_P#P(W/OS>OQ'^,6P^FMX=E55=/NW<^+J]U;DSLU
M)DJNGKJK;V#RF]]P[FK-G;+^\I(I8\#AGH,+ \:F.E0@>_=>Z7/7_P #/C%U
M;W%\A._]A[3WY@.X?E51[.H>_=])WW\@LAD^P8.O<#5;7V(:BFRW:-?B\!4[
M/V]6RT>-GQ5/034=.Y2)U'OW7NE5\2_A[\>O@UT[A>@/B_LO+]<]/;:JLQ6;
M<V+7=C]H=BXS;\VX,]EMT9L8.I[2WGO7*8FGRNX<]65D\-/41Q25%0SE;VM[
MKW1F??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=$W^4'S[^+7PTSO4^W/D7O3>FR,KWGV#@^I^
MI$P_17?O95#OKLS<TD<.W=AX;,=5]8;VP_\ >K.2RZ:6BEGBGG*OH4^-]/NO
M="9WS\FNG?C+TSN3Y!=U9?=NT^I=F[?JMU[OW/0]4]L[TJMK;;H84J,AFMQ;
M5V)LC<V\,+C\;3OY*F2IQ\8IHU=I-*HY7W7N@JJ?Y@OQ7H_B='\XJG>'8$?Q
M<EV%!VFG9_\ LO?R+<_Z-*G&TV:I]_MLE.J&[$39TV$K(ZY<BV(%(:$FIU^!
M6D'NO=!?M;^:W\2-\[2VYO[96!^;N\-B[PV[B-X;2WKM;^5Q_,[W!M+=.TMP
M8RGS6!W1MS<>)^(%7A\WMW-X>KBJZ.MIII::III4EC=D8,?=>ZF=]_S7?@G\
M8.A^K/D[WGVQO+8O0O<^.P.2V#V7)\=?DQN'!5*[FH:C(X/&[GBVGT]GLGUY
MN.OI:26V)W%3XK)QR1/&].LBL@]U[H_&&W'C\]MZDW-0T^>@QM=0MD(:;,[6
MW/MS<*0*'8QU>TMPXC%[JQ]=:,VI:BBBJ2; 1W(O[KW0#?'3Y=]$?*]>RI.C
M<[O;<<'4/96\.GNP:S<W3'=?5E!A>S>OLO+@-\;-I,AVSUYL>BW%E]IYN!Z2
MO&,DK(Z6I1HW8,I ]U[HRWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZZ9E
M52S$*J@LS,0%50+DDG@ #W[KW1>^H_EC\;._.QNXNIND^Z=@=J[_ /C\=G1=
MSX+8><@W,G7E9OZ;>$&UL3N#,XH5.!ASU=+L++"7'QU4E;1?:7JHH1+#Y/=>
MZ5O8O>'675>4VYM[=^?K?[U[O@RE9M;8^U-K[N[#[ W#C<"^.BW!FL/U_P!>
MX+=&],AM_;LF7I%R.0BH6HJ U< J)8_+'J]U[ISV'VSUYV5M_*;GV=N:EK\7
MM_(5V'W1'D:7([;S6S<WBZ6GKLI@=\;9W-1X?<FR-P8RAJXIJF@RU)1UE/#*
MCR1JKJ3[KW5*%=_PJ!_D6XZNK,?4?.BEDGH:JHHYY*'XZ?+;*4+S4LSP2/1Y
M/&="U>-R-*SH3'/3RRP3)9XW92"?=>ZO/V7N_ ]@[.VGOW:M165>V-[[9P6[
M]N5>1P^9V[D*K [EQ=+F</45VW]QX_$[AP59-CZV-I:.OI::MI7)CGBCE5D'
MNO=*7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!CW!W5U#\?MA9OM+O+LS
M8W4G7.VX/N,YO7L/<V(VGMS'(>(TFRF9JJ2F:IJ']$4*LTTSD(BLQ /NO=.O
M6'9.R.YNM>O.X.L\_!NOK?M;8VT^R>OMT4M-7T5-N39&^L!C]T;4S]/1Y6DH
M,I209C Y2GJ$BJ8(:B-9 LD:."H]U[H,\C\J^@,5N^MV57]B4D&3Q>^,1UAE
M\Q_ ]TR[!PG9V?.+3"=:YWM&#!R=:8/L3*U&<H8*?!U>6ARDM374T*P&6>)'
M]U[HPOOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H@_P 8_P"8#L[Y
M._(_Y7_%O']%_(#J'LWX<Y/8&/[4/<5)TM18/*T_:=!N',]>YW8<O7/=G9.:
MW!MS=6W]N2UU/6S4-'"L4BQ2%*M)Z>'W7NEWM_YD;+R^/[/R>6ZZ[6VA2=?]
M[3?'+:_\9HNO\W5=Y=H4[4U+48WIG']?=B;VK\K04.:EGH*VHS<6!&,FQN0F
MK134>/K:J#W7NF3I7YW=5]L]P=H?'3=6T>R/CQ\B>H=C8KM?>'2O>D'7U)NA
MNG\]E\QA,)VSMO<O5G8?:O5V[=C5N1P<T4\V-W!4U6+E:.+(T]'-(D9]U[J%
MM?YV;7WG+\>L]MGHKY!YCI;Y1-@GZ@^1E#A^JJKJ7*X[>6"BW5U[G<_CZ?MV
M7N#9NW^Q-L.U;BJS*[3I("%2FJ6IJVIHZ:I]U[H\OOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#3MSMO9O1^P]P=E;_7>7]TMK8RN
MS.=J-C=9=E]LYNBQ>,I9:ZOK5VAU/M'>V\*R"DI('D<P4$ME4^_=>Z2WQL^3
M'1/S Z8V7\A?C9V1A.U^G>P:2JK-J[SP4.4HH:S["NJ,9DJ#(8?/4&)W%M[-
MXG)4DM/68_(T=)7T<\;1S0HX(]^Z]TVYSY2]-[<[XVE\:<M7[_A[CWUM'=V_
M=J;>I>DN[<G@LQLW86:VEMS>FXXNP\7UW6=;T^+VSF]_82FK))LO'X9,M2:N
M*B(M[KW17JS^;7\)H.ZNU?CGC,Y\D-Z]W]&OM\=O=;]7? KY[=M[AZ\CW;BJ
M?.;5J]T1]8?&?=U+CL=N7#U<=3CZEI?MZR%M4+N ;>Z]T/'4?SC^*?>'8)Z?
MV#W%A4[J3:L.^)^B]_8;=?4'?%'M*7QJ^?R'2';F V/VMCL=0S2B&K>?#Q_9
M5%X:@1R@H/=>Z-?[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>ZUN?^%%>Y<=LNK_ )+N\<Q3;@K,1M/^=M\+-RY2
MDVGM/=6_=U56.P4F]<I74VVMB[%PVX][;TW!/34K+18G#X^ORN1J2E/24\]1
M)'$WNO="+_-?_F =$[[_ )9/S]V7A-A_-JAS&ZOB'W_M_%UF\OY:'\QWKK:=
M+7Y7K3<5%2S[DW]V#\5-L;%V;A(II@:G)YC(T.-HH@TM1/%$K./=>Z36[_\
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MQD.R=H9X197:VZMVTF-.:.+J(*:JQ=%D:>CJHEJX*@M[KW5-^POY>'>_6?\
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MV=X[;K=P[8I:L''Y[#PX;<5*494KQ%4UD=3[KW2!V]_*)^-FR>@?FI\=>O\
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MOW7NO>_=>Z][]U[KWOW7NBV]R_)#!=8=A]2='[?Q,>^N^>]/[WUG7/72YJ/
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U6E\V\)UKO/O\
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$]U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>timage_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_003.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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MYF5:B$1N7B5K*@$C L=/ /!/N']K^\M[6;NS0VMY^HM0 1Q(&*4ZE'</N_\
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MEE*KR;<V]Y*<C[#RALW+L0251=7)U^'D&H^%#Z)ZTR?RZX'?>^]IOO(?>O\
MO@P;(5_=W).W1I:_6QJKPPQM(!<7$:5J9]/]F6!1 "2#4JTK:^;RN^=C^;>=
M!-/#F2(J*E=M4M/3B)(H2'=M6H:>/J;@?D^X^YE,5KS.UYM4B1R*=3Z1122<
MJ.N]/W;O9;:?9#V@VSVQVRYNMVL[>V">-(:Z5"4+N?LR3_+IQK][[8VQ@%VC
M5RY"&:1#3TU)ZB=$J&(+<<<A@+^RJ#8-SW/=OWW$(R!DG[#7J83NW+]E%)M;
MUHJD'[*9Z8^M]L)M7S9?;M;7C"Y%YI:K'9$#P"IE<NT^K\"_U]KN9MP3=?\
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M88'B?@)'#XJ>?4;KK%Y[=.-FI-PR4L=113FBIYJ<DL*=':-7?5:UP/H>!_O
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M;,8V4_AD0E"*_:#^SH'>]W,>P<Y<QP\V\KW0N[#<(A+#(,51L\/(T/Y='?\
M>5W4+]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=)G>&5J<'M/<^;HD1JS$;>S>4I4DYC>JQ^,JZJ!
M)!^5+1<CVDOIF@LIIEXQQNP]:JI84_ETCOYFMK*:XCRR([ '@2%)SUK89G^<
M-W70](;S5<7B%[*QO8-1@L7FTIU:C@P4==.'22+2 TBA%53:_P"+V]X\6WN)
MS%>6B[?XJK+,R2+,%J4C:,R::%N-5*\3BA_H]<]]Y^^-O^V^WFZ[HEG'^]+&
M_ELTK_9:4F,>HT'\-#]N*T[NEKM[^<MO/9E9MR'L[;='EZ7(X*GJJF+%TJ"<
MU<L4=U+T\0:Y+#FW^P]G&U>Z6[2*KS0B?2G<00@J:T>A*^AKGHW?[X\?*L]G
M!SE!I^JA5],:F0AJ+5"54G\5!C/IT9#:/\Z?I_.Y-]OY?8NX,+F9*626B66=
M8Z6HE$/DA0F>$DZK@V#@D7_H;&T/NQ$7\6YMBMMI[900P$F:*P#$@5 %2 ,\
M:TK(6R??%]N=WW,[!)%-!?$:ECD5D#C2&&DNH!-#6@-<'&#3/F?YP>R=F4LN
M0WALC(+15\LB822@9B78*QC61=$K,+KZN+V!]N6WNA'XS0R1-*74L@6@H!YF
MM.W('KZ9Z6\P?>KY3Y2L1N7,4#PPR/HC90S%C0D !0Q\C7'D>C:?$+YR[9^5
ME5F,5C]M9#;V4Q-/][9V\U'4T;OI212VEE//L7<K\X67,ZMX(TLOD?EQ!KY]
M27[8>\&U^YGBI90/"T0#9^%E/PL#QIT?7V,NICZ][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NHM1-%3125$\JQ0P1R3322.(XXXXU,KN[L; *MR2386]LS
M316\+W$Y"QH"S,>"JH[B?D*9Z\J-(XC0%F)H .))X#J@'^85_,.QNX),S\>.
MJ%K/N*BJ;'Y_=<94T;(KM!+#3D@CQBX+'_#_  XP0][_ 'Z7?;2YV7E"6EG
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MNH?;KF&,;59-)6NM?6AZE"^L;#F?8EM;F*G$MI &?4_ZORZ7='UMLS;?4$6
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M6%;!Y'TD!5/Y)X _XI['NQ62\N[HMU!<J;AJ5)].B*>W@W?;Y[#<6JRQN/\
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M7]H>9>0/<-8T:\NOJH!4/&&^-2/@ /K7Y \#Y]'W('N![;6.ZM/)MQC((<5
MSI(.2"?3JF?:U%VK\+\)B&[:V]E<9DLAAV@G;*P54\A^Y#0R@>506OJN;\$^
M\)?<?D'?Y.>HC#!]#<P.L\(;2%8)ZT-#3SID==+MLYQ]N?=ODZ&RLYQ;"WB
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MD*LH+&>IEC #N-1^BK8?T'O-3V%VR\V_VTV^XW2GU=TGBRGU+>7Y9_;UQO\
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MD,G0Q1I$*F@B/@J18W4$RVLXN 2/]?W)C^]?*&T2OOUERK"@>I$LTR*5/$,
MI:M,'AT7;5[ >X'.+M;[]S688%QHI@CS Q3/[/\ !U7]\]NXN^ODO5XG=6U^
MO7V;M;:42T\6/H\5>%:.ZM+&9 MA<* #86X_V(;D]S-G]R-Z_?G,4,:>&AAB
M,.MXT!-1KET@5P,5_,XID'R#[5;![3[3/L%MNPO&NHY"QJI;45() 'E4]$ :
MDR?\'BRFP^O*W%[_ )CX&R\=&VJKK(N&(?4>2_/T'UY]NQ1K=7IM-UNA<6 4
MGPU#'MXDD >0X^6.G+->4N7KN:YNYZ2%&H/4TX?GT,&RMS]U=;;2JMV_('"3
MY.K42G;]4PA=Z2GCC=XHQ&K W(4<<_IYO[$6Z\F[F;:"YY71X+% &7Q#BH(.
MI022 /0_LZ@_<N<N2;C>I;28@F0E1IIP;MH?V]([9OS0WUFNT<#NJ&E?(;1P
M]?2/6[?F\<$;(E9"@:9+#4I1""NJQ'''L^:\WS9K",W5T'FC(913M;3W4Q6A
M-*5\N-.AS:>Q&U<Z;4USM"T\='4>M74@?X>MNGI[^9'\8L_LC9]-/N:/!9]L
M)00S[=BHYVCI)8H(HYUCD4 :5()^M_\ 7^ON?.3_ +QG)-QM4%ENHEM+A.R0
M/'2,$&C-J/$?BQ6N2,=8/<_?=O\ <'EC?I[>6-9(RQ*-J.IAY  #CY<>G7MK
MY7U6^,1_=;X^T<VY,GF U'-FHKJN/1E]3QCZA@3^?P/\?:OG/W3W'=[06W(,
M7U"S KXGHS"@:GD!QZ0<G^UT&WWGU_.,O@?3L'\/U5#6A)\VI2G^'H9OC]TE
M+MW"T&Z.R:6GS'8=6WW<E9-:5Z!6?S10QN#;4"H(N3]#_A[-_;'VRM+!1S3O
M\6K<IFUU)^&F:D>M:_[.>B'W"]PIK^=MCY?D,=B@*M3\=:@BOI]G^;HQTFU,
M!-FX=Q/C*?\ C$$8CBKE73,L2LKK&;<&Q7_C?N99=LL9+E;IE[T(84]1YTZB
MN+<KV*V:T5_TW%"/EZ=*3V9=(NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[H(.\N[^N_CQUKN+M?M'-+@]H;:I_+650B>HFGF=9&IZ.CAC!+
MS2F,A%XN>/9ILNR;CS#N,>U;5'XDTAP*_M)^75E4'+L$49)/ #UZU3,EOKY6
M_P \'Y!)LO!4]=UQ\0MH9RFGRD4,31XQ</2U4G^Y#+5G/WF5JHG;QQ!C''K0
M!>%+Y4Q6'*GL?R_]?.1<[S,M%KQ#'R4>2@\3Q]>D EGW)V@3].Q'$_BF/R]!
M3_5QZVF?CM\=.K?B_P!:8;J[J;;U)@L!BJ>!*J5$O6YK(I'IJ<IDJAFD9Y9'
M8DW8@%B!R23BWS%S#NO,^YR;KNLA>1C7CA5K@#&!^72ZHT"-0%5115'!1Z=#
MS[)NM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UI^_P#"A_:^P<-V
M#M?<^5P*U-5F:2A6KK#:P!B19Y?H#8!!<$\6/O%SW:M[M.;[>?;WT51@WH30
M&GVUZS'^[5S7M.UHUEN0JS,%7Y:C0']G6MIN7K:&AV_)N?:AIJG$5M.DDLPM
MJA0QEI$!'Y O[C.SWL2WGT%^"LJDX]?*O6:N]<L6EKMIWVQ^"=37[".BO4V\
MMP3X+*[<QD_VU'4/X:E3_NY/,4>+G_5*UO8R>RM_J4NI%U,O#Y8ZC!^8MUD!
MVJP%5TD%?7Y?GT8"H[.QV!V%M7&8?;^K.8TQFIK3^EI.&9S96_('T!]ARVV-
MKG>Y)K^<K;2L 5'X5KG^73_NGS?O6P>S$G^MU8D[TJR%*<3,$/A ?:],]&6H
ML7MWY"YCKVLRV<6GK]O21R3Z@D+4U-#3>6>)H!X[_N: K'4;-R3RP$O--AM?
M)')^X2[7;J$=0T3+DNY-%&K/$5]!_@Z^<_[H/O#]Y_??OM[3RYSQ<7FYQ7%Y
M+'>0246.WM7<B8A!0 +J ).IJ'B02>FG9&?H>@\_V(E)0WCRE<R+E1Z5E4"6
M .U@>!KO;CW$&^[1_7FPL/':FC2Q3YXQU]6>VWEI[>W-]=16.F2Z,"J?(,<+
M^P]/7:E/4;=J=K]HQYX;DQN3IHZZ>D>^BFT@5#4EQ^++IX_I_K>V.69TO([G
MEPP?3/"=((\QPU=%EWN.][;>1\R3"L<CJS?( U/\NA2P/8^V.Y]FS0;DI*7%
MU=+$*2B60@BS1F.&10;'\CT_U'^M["EWR[NO*&\K/M#-+%(:R#\P3T.>7MPV
M'FGENZN+S$A9J5]<T/\ J_+HIIZH[1ZOWY3;LVE"]91Y2K$4>2@NPBHY9@"I
MY']D?[Q[D\<P<O<Q;6VW;@P!0=R-ZTZAZ#EGF?:N8_J]G'^+R,H<C^ M5J_E
M7JTK"=24E?M&DQ.XRN6JLY2T];73U9X5YXPSH3QP+V_K;WBKNG/US;[]+=;4
M/!CMF:-5'F%Q7K)&*.TN=L6WW)/$"K1QY'4*D?9Y'HMO</4_Q^VCEL3C<Q0X
MS'9:JEA%'4("LHJ2Z^%B03SKM8L/J/<G\C<U\_;_ &4M]%62%>((\O.G0/WO
MEKVY!MWW&Q5)6=?#(\FU *Q^8-#T;C:&1P=)LG$[?DB@FFBBACQ\P-S]OI"0
M'Z#CB]_<+\Q6NXS\RS[I&Q523K'](<>I VW9KNTC26V:D"*<#(TBM*_EUWDZ
MC'P5$M%5S""66!$:HN/5&]KPDD#Z@V/O5C%>O$MU;KK",3I^8\^/1B\,5[;M
M Q'Z@92.!H05K7\^'35C\-@MF8*IK*A%I\0:IJN4%=*,6;R-*0./Z^UEWN6Z
M<R;I';P]T^G2M.(\J=4M[>"SC-C:T4*IU$Y !P:\<?X>@*J-T4>2W?4U.'VP
MM=@8KE<FQ!2GD O]R2Q "QVU7O\ CW+VV\L[E-M,6V/<D7CTJ@\QYJ?MK3K'
MGW>^\-[=^Q7+-QSO[DRF/;[5F(?S58P69@,Y !-.G-<?T3MW?D.^L]'1T>Y*
MV!5IJ^54T12D4/VQBE 0^1GD,JDEK)<&UTO(F^;=S7%[<-L5O"K)'133XVD.
MO5FI[12GD.'SZ^<?[M/OYS/[^_WB*\R<M<P7CV-[<37/TS$"UBVN-X?![/#!
M$TH8.*DM1G#4&@=9^S-^560C_@]-N'^&Q9DQ0X>IIP#YVE"I$ WX!++ZA]+\
M>X=Y/Y8M[,F^GM/$>&NM6_#3)H.OJ>WJ[CLH+2WL[H+-<(,CB684!/YT/^3K
MEU=MVJC#X?=V[/*2ZRI42U%F2!N+KJ N1?Z6/T]ZYTW,,@O-DLM1&*!?,>6/
M7K6RK>[(DEW>W/C/)6BU K4?/H.^PLWL>DW"V*R=9%NFGP\O[:FQ$=W'+V(O
MPOL4\LV.^R[4+N*/Z-YAG]G13OFX<L7#"XW4Z&7NU<:4\_RX]'E^.>$ZY[!W
MWU?NVJV#2XV@VWD:2>JD":9*J'[BG5@MK?K"<"YM?\>P):[CS!R=S%'%N6X-
M=027<#.*?#&) 77'RJ.L=/=GGCDV*U.RVM\&GNU:&-?5Y1H0?.K,/V];MFTI
MZ&HVQM^7'((J XB@%)$HTK%!'!'%'&/^"Z;?[#WULY;O+2_V*TO+ 4BDB0K]
ME/\ /7KD5OEO/:[Q=6]UF197K]NHGI2>SSHKZ][]U[K'++%!%)//)'###&\L
MTTKK'%%%&I>2221R JJ 222  +GW[KW7QU=U+5?SK/Y_.4HHZV+,;/\ EE\U
MA@J;)XJ6NH'7XT;'RT>%I,G13RM53+54G6^P$F5QXPT\%U6!&"Q^Z]UO42_\
M)!_Y.;Q2)'M;Y#0R-&ZI*.\\FYB=E(60(^$()4F]B"#;GW[KW6AK_+RWUN_^
M4M_/#ZAQV_*R6EF^/ORXW!\<.WJRIFJ-IXZNV+N+<>:Z*W[N>J@K_,OV,>-S
M\NX*.*I8Q/\ ;T[B9!HJ$]U[K[*'OW7NO>_=>Z][]U[KWOW7NO>_=>Z@Y U*
MT58:,:ZH4U0]*M@0:A8285-_ZN/:+<#=+MT[669A&^CYR:3H_G3IZU$1NHUN
M32,NNH^BU&K^5>BP9C;V"WG'0XS=\3R;AK\CX:ZF4JMZ=Y_$HB.J]])_K8'W
M UQM^V;O*D>_DF]=J,?]-^SSZF.SW#<MG@EEVLJEJD9*$<0RBH8<>%!T@.T?
MAMM3.86NGP66J\.:"CGJ:>$E71!!3R2./*!^=/!T\?ZWN"?>W[EVU<]@[YM^
MYO ]J&D"% 0VE267-1FE!4<3T,.0_O#;WL]Y%:;C;K<"1E4FN>Y@!CY5^?0
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M)LO;?QZZC/;&?AVOC<TD623*5]1GL3DDFCR-%3T:FH<QM[KW5F6Q-Y57P_\
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M/864["VOF=Z;93)#<^%IMQ+D<8M4D-'4TE3-2HDONO="_N'XJR=M_';^:_\
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MWS;38?4;8"1(!^5?^+Z.9LG=F\AD*N&OQP@HZ63Q4IHK22U"OQIE//\ @O\
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M-#\NA$[#Z\W-CMMR#'339RLQI>N:K \K-%'>0T^OBQ(33S_L/9/RSS;M-_N
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M7_-T3F[NV%#*Y_VS?Y^H68V;M7<./J,7G=NX3*T%5#)#-2UN.I*B*2*9&BD
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M'T&"&(J89,4\&1)^^3W7NJ]N^:3Y5S?\*==QUOP^R_1-'VEAOY*&/R>0V_\
M(G&[YDZYWYM/_9O*;'U&T)MS]=3S97;M4V3K\7D8LW!C,\$CQTM*V/E%5Y8/
M=>Z57<G\BSY(=U_';Y7;FWMWQT-N+YT_+?Y<_'WY<]JXBNV!N>G^%_8&(^+>
M+FQ'3OP\[,P<IS&Z,OU[#'4R35^1TPUTU0L,QI"(YHZKW7NL.>_DY?-_L7Y
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M]MRM%::8/#,;GC1" K'\EKT;WO[^;=W!%1087:2QI34>3\M7EH8D>62& '5
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MT.1V%@OX7@J"'/U2Q,]-(K"22-5%EC$C..;@6/-C[1(]ES9N?UNY2&U2M"O
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MVA21JH2 *MJIC<<_E5_S2,3\[MNS;9W/14F'[5V]0F7)T=(;)714T:-/4E-
M7D<DK;^A%R;.^]/LW_K>.FZ[:Q:SF;"DU*5X#Y?G^71/[(^[^Z>X(GVS?;7P
MKBWX2+E'  /GQK7!\_,5ZN6]X_\ 61'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T&'9_;FP^G<&FX=_YJ/"XN28PQ3.A
ME:255#:$0$$GD?7^OU_/L$<[^X?*_MYMO[TYGF,4=&("J69@HJ:*/V 8J<="
MKE'DGF'GC</W7R[")9>T4) %6- *FN:]%YWK\X>D\-U)N7LS;.[:#,'%8V:>
M@QKMX*FJK"&\,>B8 6U#D'ZD6]Q7N?WB^2+WDZYW_E:Y\6X16$<;II;Q%!(4
MHWF2-(!/G7J2]L^[][@?UMM>7=XLFC25T#LI!&AF )!'VUX=:]/>O\^GN+!$
M8;%]<;=J\'FX:S'SO,M.?+3RRO2 .WJ8*5;U%1^.!?W)GW,]\YE]Z/<!]BYP
M>-0BB6/PAI,9!!%:!:D8^1\^@3]^SDN#[L7M_!O6TZI;F\5HPKDZ2SJ0 >-!
MG/RX#J@+-9BJ[@[7W%O6N98*3<.2>JEQE/'_ )+#]W.E15)1$'^P9F1=>OZ
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M/[<C(L5@;W!) /U-OJ/S[@[W$]N_<?E'>;?>][VV6PBN(]2NX #T%30@\:9
M-#UD7[6>_GM9[H7]SL/)]XLGT\C)*F34$TI7'I0_X>LV?ZXIL%EZ#/8>:&DK
MJRD2.HH8QZ3&?K( 1]1I_P"*W]@S9^<9MSLI=NW%3)&C$B0_X#U+L&T;9XSW
M%I%X?=IQP)KY?9]G^;I9)M"II*!,K'-?6G^4* +2'GR \?[$>PTV_0W5X;%U
MIGM/IZ="/]ZI ALD6K1BOVD9_;Y#JMWYP;?S&Z\OBSD6J*JG@IZ3[.@BN%5L
M;J>"4/Y%TZ&).G\EN;VYZS?W;T?)NX[A<;=O3E&LE,\%"%K(YHS%B#6E,?\
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MMDXU,HSII4ZJ^E!3[!T!O;;G";DK<C[0<^3:MZLB0YXU;M!!&/,@DTXM4@5
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MN^6?+W+2[SRYJ:6-:NGD0!4G->/D1T"?:OW^W'?>9VV'F<!4E($+#-22!I)
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M-J4V!)]-@?>%\6T;ON&]VR;@Y<,PK7SSUTIW*1Q$1K\18U)*#S'FOGQ&/SZ
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M3M74$%:%BI/GT%_??^]7]C_:;WPM/8KGBQO1=[);6]K>;F$_Q=97I&I8TKI
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MRJX*-J4JW*D,+7!M[B]6# %<@]2[US]WZ]U[W[KW7O?NO=>]^Z]UHY_SA/\
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MRO''^'I"_<?P7+R93-+/4Y3,R1O34BC6M+*]UC6Y(L S"Y_P]B!X(]RL%LK
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M6VWVXVVWN;N"R8"WFI7MIA:_+U.<CKM#['<U<[<R<M69YK31ITLX."*$%OV
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M;O+D\O;MN,(O(2$77( QJ11*$BK?9UT/^[CSCS3[B;(]GN=K%+/"C#4[!"0
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MT"(S(6<'T@,%-Q]/?9?^[2V>YMK7==WOK@Q1K"B*M.()XYX@ZB/RZXM??_\
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M[BL^U79!'<[T!((#*"2IIQID=%^Y;;]Y7DS<P-MD^OL@066@H5![E_VPJ/\
M57KGNW^7;TQV#LS"1=:=\14F?W)9J>CER:B\A-H$0PKJX8CDC_;6]F=K[=\K
M/)#N/*^^Q78E(58YHE(JQ  J-)R33CT4_P"O=SM!+-:<U;(T?@#47!. H))I
MGAQZ SHWO_Y*_!7O_;OQ3^0,U=F^F=SY9:2AW//5&>E^QJ9H8E>*55:UXIN3
M8\?7_ ;V$^^\LRP[7NERT-@9%2:WRT?AE@"\1.0*$]IX5Q@9!7,-OR9SM9R[
M_P NV?\ NUT,XDX,'52PU?F/S\\\-C.#IG9[01;KZMW<-M4N9IF:>HIZU)Z.
MO^]A,JN9!*=+$2 LMB;$\?CWD#=<C;9<[.L_*^ZFPBEC.:BH!4C' U&>/#UI
MUC%%SE?P[E);<T[<+V5&X4(((85/F"/,$8./MZH>[X_EP=CU^\=Y=F8K>PW7
MEJ;+55?2X:CE\M1.JR-51 QECJ+FT:BW)-O>&O,GM)S9M.TWDMM<P;G&7D9F
M ;QI*ZCABY%:"@P!PX#KHM[9?>MY*V.TM^7+O:VMHS$JO)Q$:D .Q&. -?RZ
M(W64WR)[5[)PFQ]Q["S]#2;36&A7,9&F\5)1PT4B)H4&YY7G^H]QK8^T=WMN
MU-+%XS3RC2$=64(IJ::FH#0G%*UZER/W?]KN4XG&Q-J;< TCGYL":D U\^KI
M^G/Y:W4_=&U,;N+L&@J\=7XVMIHG6G"R&MDIHX[N#(_'J4?CWDY]W_V/Y7W'
M9'O-ZCF8J3&R^-(H8G)X&@K7R]10=8-^]7WA><MCY@:PY9O (Y*/P!HO!1D'
MJR6MV'UO\:>@MT8';-(F*PE/MW(T!GG8-+4SUE!44L<M0Y^IL[?3_8<GC(5>
M3>2O:'DS=/ZO1"T2[62K$ZF,KJP4UXU%:GUIGK&A^8N:_=?G6UN=VD-Q.A4@
M>6A"&( _I4I7Y_EU7=_*OZ@VCM[<O:&_L;MUGRN7K9"VY'TK'XZV65WCA4&[
M%N5-S]&_Q/N&_NW[5=P;_?3WK?4@K^D_DB*25I6N22<\:TSU+/WA-].Z[/ME
MM-^C);*(]'\5  :_(?ZN/5C"T^XJCY/25L6'J/[N4FT1%-FD'^3"M\0C>G<L
M"/[14_G5[GN#9O']RY.8!D1Q&+[.TBOY]0S^_88O;S^KLJT=Y/$4_P"VKT:'
MW*'4<]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%L^6G3F\.^NA=_=6[#WG
M_H_W1NC&_:8W<Y-2L=',+M&TTE$IE0!M+ZHAJ!7TV/(/^4]XM-BWZ#=;R'ZB
M.)JLF*_E7!_/IV%D5J2$@$<1QZULXOY"GS1CCTI\JMIQ6G.E%RV^M-F9F:4E
M:'Z@L3:U^3[R-?WYY0;)VES^4?R^?6H[.U7XKIZ\?@\^/IU*/\AKYIPVED^6
MVTXD3]V249C?P\*I8LY)H0!I O<'\>ZCWVY/.!M#UK3A%_D;JYM[8@K]1(V.
M 7)^0J:5/#/5*/?/QF[0J/DM%\<=J]B4OR)WG%F:? _QW:M?7YFB7)O.M//3
M-6UWJ1*9B3-*6*( 22+&TX<M<T;7!RTW,E[;G;X2NK2X"DBF#0>OD.)Z"G,F
MUW&XW,-AM[$KDM7BHQQ\AUO'?RY/C;V%\5?C#LKJCLK=)W%N'&PFKEI8YWJ:
M;;WWODGDPE+.]M2QM+:XN/2/I]!@[[B\R[=S7S//NNVQ>'&QIZ%J4HQ'V="1
M4$4,<&K48Q0M_%]G1]?8'Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5?\ \W:L
MVG0_"_L&IW1) KQ1M)BHZ@!_/50T\S-'&FDW8@"P]S'[&+N4G/,*;</BTAOS
M=<?X>H1]_?W>/;VZ-X_AL%?0Q_"0C=WY&AZ^>?U\E&]=E\[E:>KPU?1U;-CZ
MEZ=WI7\TRO3Q(MT"D&R7]5N&L?>3OWEN59?<7DR[Y=GMEN=4,IA7X66=%?PF
M#4/XJ'YC&/+,W^Z&C]B.7+CZG?[F.[NYXU29F<5AF:-&'KIT-2HH"0*US7JR
M+IS)P[PQ#9REWI%+.L4=/58NP#4]5#8:"I0FY-B&_IS[^:'W$LKCES<&VB]V
MUAH=N_TS0CCY&M1^77=&VM9;3?+D)=B9'+>!P(-O6E3^7Y@_9TO-^9;:FP,=
M09['[?\ XUN"25$RL$87R5 ^BDN5OS8Z?82Y8M]\YGN)MON[GP+11^D?3I%S
M \VS)^\)116.*4SBM3Y=%FRN^OXWN>DW-%AS'14[P&?$-I)B\<NN56X_U_<N
M66Q?0;4VUF;4Y!I)ZXQU&O[R;=+I[I6S&-5/6@KT(&[>S]Q[EIL*V$QSI3X^
M6G/B0 SZ4D4Z(4']NPLO^U6N?:7D+E3EWE_?&DWV0,LI.IC\()X%OZ(\_E7K
M%7^\:@]X^9ON_;CM_L8)/W@R'5X?]L69"*0TSXG\'EJT\>E%B>J>L-YM7;@W
MW724^Y:)J.'%8F22:GK:F1A.U8[-)9G,HG!!'"A[7-N)&YW]V/<3V\^BE]N+
MAH0^LM/$5*"/MT56A6BTQCUX5SR9_N+.6.;.7_>;G";FFPD\=H8XIX;Z%Q)'
M=1M(99&:;+NY?633!\S7'/L.7&==;92@ZV1L?)-4T\59J9G+12.$E9WD+L?3
M>Y-S[A+:-RW_ -P^8Y^8/<&=KVX<%O$?+%O7R_("@'7T[<^[GOT^U)JTZQVQ
MA5"A13MHJT&#_GZ:]X[,PV2V]MK=NW*D0[HBIHWR-3]-<KA6D!(_.K_>C_L'
MMDWK<;?=KO9]T2MIJ_2'R^SJ.UVN.\BCEE'^,BFK[>DO)G=Z;#Q*1T,!SV9K
MV:1:==1=XW_W4I!7]5[#\\^S9]LV+F*Y)N3X,,>*_/UZ6)O&X[-$UO$-3Z3I
MSY^7KY]+';6XL/N>A_AVXU3;VXY_\[1U%@Y>0$:4+$GG5P+W_/LBW7;=RV><
M76T?XS:KYCT'1[MNZV^Z0&/>R%E8$ D\&. ?RZ&;:F?VCM"B&+R^9I)&EFM!
M53NJ^(,P54Y ^A]QWO\ M7,&_P!S]=8VSK094>=//HX:2VM+81QW8;34T8\<
M<,?9TC.YJRKSFQ:J39.X8:@0U#U#4\)!2I2$!_#>Q'J(_P!Y]GOM_:KMO,/A
M[]:E'9  QXBOGT3\VPWEYM*M9KDYJ#Q '^3_ "]-W7^^X8MDTCYK(I!G(BE,
M<:64,958!#8FYNUOQ[7<S\KS7',+&PBK;N-1D_P_RZ<Y=WZ$V*V=\!XJ"@]2
M?(=+Q<W7URM65>02@A,#+'(WZ0A%]3&YX_K[#3[7:6KBUMX3*VH5'SZ$R-&\
M$DWPA%+$?8,]94S4]+B)JJBOGB/(C>+]"_K/+6'X]T;:5N-R%O<_XJ,'/$\.
MM3;K9?2"6'XP*JO\3>0K\^D!CL?N0S5>Z*'.24IJJI*%L0L7F,4,H$;3& QR
M&106%TL+F^H@$D2]RQ9\O[C?)M.YQ K;*)58D#Q&4UTZCP%./G3AUR>_O3?>
MWWB]E/:2&V]J(#=OS!XMG/<+&TS6(N(WB\>..-6+NI<% 1IUT+$"O2)QW<'\
M+W!+L@RPK-/')1Q2R431LS_=M5U4\@=BRNS.&(8"Q!](N3['GN/L]AN>U)):
M_J%6$L@5]2KI32B C!H/2N//RZY__P!R_P"PGNOLWNC<^\ON)9W-E:BWGM[+
MQ(6BDN#=2&6>XN%>KJ96*DJP4BC$J*U+SELBN4JA@\ZM72Z$66ES$]EIY6?Z
M)%R!P218_P!/Z^XFL++Z" W^V:7!^*(<13S/7T<WU[%NU[)875(V7@?('R(^
MP]"#EL[L+;6U?M*[-4LV3D$81"X$TAL BQQZA<DFU_ZW]A"UV[FC=M_^IAMV
MC@!X^0]:G_5Y=*QNEAM$/@33!Z*=*DG5(^=*@4\SC\^@ZR6X-F[7V%D\IG\1
MY:_(4,C8P@B.TM1J%-*9!?39F#%C;Z7%[>Y*Y2Y,YT]Q/<.RY5Y1<R.\J(R>
M66526/DHKD^0Z#O/MWN/+?MM?<W;;::)+>*684XJZ(SHQ^PBO1IOY%&W<SV1
M\ETJLZXW'M['31SR4\L8J4QT4$LLT*ER"0NB/42Q/%SQ;W]">^<FV/M#]WO:
MN6F8&_6W".X\WT=WRH":8X]?)!8<W<T^Y'WH-^W'? 12X+,II\(F.D@C^)%+
M9KGK>ABCCAC2*)5CBC0(B*/2@6P"Z1_3CWAH2SDLQJ3_ #KUF<JHB!$% , #
M@*=9_=>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M!YV)6PT6,H)*JG-31?Q.G^] (&FG5AY+W_VAV/\ L/<>^X5PUO86\DBUA\0>
M)_I*BO\ *O0LY0@DN;V9+=],OAL$^;$8_G3J6=Y[<I:"#^'5,54658J2AI"/
M(TA'HA((!6YX_/)]F+<T;'9;6DFWL)!3]-!@G%:4SG_+TG'+F\W%VWUJ&*F7
M=N 'F:^=.F3/=AUFW\979.NVKD(HZ6FFJ4O*K>98X6D.DB+C^GLLWGGFYV?;
M3N,^WR&BZ@*\<5 &/RZ,MJY0M]VOH[&VOHR78*<'%2!7C\^J\,]_-#VS@L_D
M\#4;"R.K&U$E/)(YG /C.@L!H '^V^GO%#??OI':-PDL5V%G*$C,R@D^0H2#
MGK)_:_N?WFX[:FX#= JL*_!@#UKT%N\/YA_0F_45-Y],0YXQJ0&JZ6GJ)V7]
M)C63QA^1Z;7!%^/82W[[T_(?.FWG;^:>4FG#@JX9XZ ,*'-1Y>IIT+]G^ZOS
MORLZWVS<PK;U-58 X(."./ Y\NB2]][VZV[EQ=3B>E?C-6X[/5X\<%=2PR+I
M=QIAD6.(&]B0>>2/<%75UL?.]^EGR'RQ]"FK#0LSN/0 1@KDD8+ >1J,=9#>
MW,?,7(%V+KGSG#ZB"&C%"!5@""RBN<@$#'GT5+!_!7YPUT,6<QF#SNTJ7%2/
M74=9)43T:4\0*R@,LQ]006N.;>Q[LG)._37;06VP76I0#),Z"-4IQD+ Z@!2
MI(%12O1YSQ[U>R6XEHK*^\6Y:H\,FNLM4"//\1Q^?1<.S\U\HM]Y&38F[DJM
M_P"Y]LSG'T%8DGW$E$U([)!JDF]2E'%RXO:WLODW39)-PC7<=QEHCF$0R2:P
M7U:"B?Q5(H!Q\NA+M5AR1L7+G[]?9U47:&K <%<5UFI\JD]#YU;OWM)\+#L[
M>O>%7L*OQM.4APCUD@-.ZBR0*PL/U<7N!QS[!>Y[QN_[P^CVB69=O2I#NT@C
M!6H*T7(/'!I\NE][9>WDMG%>;+L:W$D@ =@.X5X$>5!_DZ/G\1NL.WX-V_Z2
M\]W=2U6V\-4'S0UN19_XC3NWD56BE(%G"V]7%_<I>WVQ<U;W+%S;L]X(4@=1
M(!-)(9%!HR:6.D _+/6,GO%S3R,(SL5EL^BY=60M2F@D4#5]037JW.@VW!VJ
M[4VW:7%RXFM>E;.;FHOL9&D>"5/)'K0ER^G4PTV_V_O)^/8=TYWBCVB2HC.D
M.W]$X<T]*$]8AG<MJY-F?<[@!K@5,:#/<,K6GSH:]',P&$H]OXB@PU"NBEH*
M>.&,D+=RJJK2?GEN2?\ 7^OO)+8-FM>7MH@VJT^"%0*^I\R?M_P=07NVY7.\
M;C+N-T>^5B3\J^0^SHM?<>6VU6[YQFVLU*NX%DQ%I-F>.!S5S3R-I+?5SY Z
MQZ#_ *KCW!ONEO.R-S)!M-_<B\[<V(/"HI7'F?/S'#A3J6?;W;MW38KC=+%A
M;@,/UC3LI2K'T X^F*CH(ZO>M=\:XX:C!=5RXK96=KZ:D=5A=#23RS$^0-$2
M182LQU?7V#;;F?F?VW?Q[793%MUTP&LU[0<:S_I0:GY#H;-L6T>Y,1AW+>UE
MO;5#H5<ZC2H05QW$4'S/1XMH1Q?P.BKHN?XQ#'F'X4%/OXHZA%YY-E<#WDKR
ME;)'LT=TF3=?JG_;YI_J]>L>^8)6;<Y+=N%N?"'V(2M?SITJO8HZ)>O>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JE'^;MVA\O6P6S_C;\8>M
MMR5X[KI&H=S]HX"+)M)MZF>N>CGP25E$!'2+-&?)45,K76($( 3<3'[2;;RD
M+F;F/F>X119&J0-3OQAJ')IP '$].M#*UI6UJ96J WE'3-?F?Y#I;_RQOY86
MT_A1M0[RWL:#=_?>Z::)\_N$J*BFVW#,!*^&PDDPOJ#./-/9&<C_ %( "7W.
M]SKOG>[^CLJP[?">Q*TU4X,P_P  _P /26UMH]OB,49UN_\ :/YN3Q%?3\NK
M=_<3=.]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%>^4_Q?V?\ *O8V.V%O
M2HDI\11Y=,HZ11B85)72)8)$+KZ'12I']&]C'DWG&\Y,OI+ZR%78 #/ @D@_
MM/0)YVY*L>=["/;MQH8E)U*0:.K:=2FGJ!3\^M7?^:UM[XF]$UT7QUVGUW3P
M9BEP]/!D<N:0ZZJ=H8YU+>/D:0X+$<\<?X8I>[GWAO>KGWW<@Y=V;<9+?;K"
M6..X$9[Y7D<#PEP3Z\!6I4#SZR0Y8]@-J]J?NJ<V>[G(5FL.]?2SMM[$55+M
M+>1K5S2AH)%0_P"#K7^3<FSNML]!AML_[@*"H2&L%2L<LB2_<D/J.E#IL6.K
M5;Z?7FWL<Q?=)]VO<J"3?DMBL#J2?J6.HOFM QK1O4^=<=0K]RG^]2YKV#VQ
M;9/>XON6[6MT1;3)&Q_2-.Y@BD J>/E0 ^= .^;[5)J-GM@\K05<]2M153-4
MB18)1!X1XYV5-8#AOJH8V^@Y!)?RQ_=]<Y>!=R<Y72;; U5C\*,S25H:,%+Q
MC!I4%AZ?9UQ^ZU]]KVA^\K?74EY?SI]%*$>&%.]C6I6C:>(&*D5!J">L+Y?+
M[VWM3XRFQ&.QU?E(E,O\)DF>&>%%5C4NTD<9( #7NJGC\_4Q#[R^P;^PFSVU
M]<[DVXV4Q<)))&(G5UH2A0.X_$""&(ICUZS1WS:/;V7;DYDY-NY3XL@B9)5T
MG63332K4XCSS4>? R4.U,J)\8HI?L)<"L*R4RFPJ^!=. ;AM)'^Q]X<3[Y8+
M%*?$\07=:/\ P>5?RZ=VJ&*Z0%@3X%"0/,KD#\Z4Z9>R\:VZZG&;GH<+'C,Q
M@WA\E>>'G$3!3J-B#;2#^+_X\>S#E2Y_=$,FU7EUX\,U=*^@.:=1_<<C;)MF
M]2\Q\O6FF[DJTS>B\6/Y#/3]/4;?W7LBKQ>/GBJMQNGC<AC_ )/4+$2CL/5:
MS 'Z7^OLJC3=MEYE6[NQHLCP^8)X="IX+3F#;GBM2-:(2_&HI4_LX?/TZ3.$
MR-/]W0[>I<4:JOQT0&0I+6$HCT!FN;7UW']/K[/=PM9#!+N4L^B.7X&]/3]G
M7HKGZ>"*V*ZA$00/6AK_ #Z<LIM'%]AY2@W'3[CEV-6;8GCH9<6RJPG]<9U2
MD,/2;'Z#VAL]UO.6+%MLEM_WBET"_B#R^70?W>7=GYICGL7,*I'4I04<4X8H
M*'APZ<LGU'LG"Y:CW--GTW1DI4A\C1LI6(@JP<*MK6(_-R+_ .M[+[/G??\
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MM]Q=KON5W\/<))"UYH8Y1065CZ-J ^PGYGK.O[KEMOO-&SWVQ;\2=F,31KJ
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M,U >5R%T:M>JPL1?V23>X_WB^=+,G;S=20LM +:%%.13#2O\Z?#T(_\ 6O\
MNI\CD/N.X)*\9JT;/7Q"N=/^VI3\^E)US_+5[E[?KI-W?)#L7)4;5%09?X&B
MK4S31O*#-K(=$36I(L /K]?K[&_(_P!V7G#G)3OO/$S;>[$&DGZERXXFK?"@
M-."CY@UX /GK[T?(W*:+LWM?9!T2M&&$4CAGS((^=/3H\=#_ "XNB\7MB79^
M,3(T>W<@R29O'NL<D.6E4.)6J"TJZ1(KLKC2WU]Y7[#[)\O<O[3^Z8)7D5UT
MNSY8@K1NXDG[*]8@<P>\',_,>[-O-WI6;5J4@_"P-5-/D:>F>DW/\8OCA\9L
MS@\KL/JNDGS*@?NF!:B:(%PTLJZM" @>I;+Q?V .:.2.6^0MP@OMDL#<SU5B
MY)_3H0==./;\5/ET--FYRYLY]VEMOWR]I&M504^(D4 XT%>'1F]L;?P%?V)0
M;NCI4_B$V/;0/%9J2/Q"18U>]Q;3R?8QY:VS;;GFF#=[/$Y6L@I@</\ )T$]
M]O;^UY6FVF0]BM357+9H?V]&5]SOU$'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M@JH9*BEJ:>*HEI)9Z>:&.K@$;3TLDL;(E1")DD0NA8,H96%QR"./?NO=::7Q
M'P-/_)AP^T/C=_-0_EW;([,ZRJOE$F=VE_.%VGMOKONG$[^[5[&[JRV]>LNU
M/E+#NJBGW=LS+XW)O@Z.BW!7UN1:&>GI5C<FG2LJ/=>Z,_\ +?\ X408GJKM
M#YJ;>ZAW[\',%BO@=NK<VQ\]U9\B^UMVX+O[Y<[_ .N=K5>5[0V%T)B=KI!2
M;<..R>G XO+Y2FW1_$\K05>/&.I5T5J>Z]U$^1G>6*^3O\W+_A,U\C>I85H\
M5WO\;OYB/;G7M)NZ&H08Z/L+X/T6Z=O4&Z(*!ED'V[92*&N6G:_[;^-CZ3[]
MU[H ?Y#O?^^?BUAOYK'>7S<[V^'O5GQMJ/YL7S$V?VIOFMPG8&S=ZY/YE5U?
MTS65U;@]^[MW[F,73]>U-#-DUP^#R='5YA*Z?7)E)5=XI/=>ZO ^5O\ ,2VO
MB_C/U'WW\0OE!\(!MSN_>>>VAUMVCWEDNS>QMC;]K]NON;$9/!]0]>="RP[@
MWEFH,MMBIHJG&8ZLI#"M-4.9&DC2"7W7NB.=+?SR^T^SOY6GS:^:6-^+%=V9
M\@/@_P!U=A?'W=G4_6>/[#VYMCL3<>RLILJ#_2EA-M=E;>Q>],#M^+';W3,9
MC"9W$IF\=%C:N"I@25"R>Z]U-W)_-M^0_6/\N3+?,,;L^"GS,KZ_O/KOJBG[
MD^'+]NK\:^@-F;TF2/=O<WRBVKN#=N^]WX[&[.5EDS&,QD[ULJ5=%(R4,,\T
MU)[KW0K=I_S='^+?\M7:GS)[?[2^%/R.WGVAW+MCHCI[>OQC["W%M'XJ;UWO
MOG+U&-QE3N/>>[<IV=D-O4>WZ? YW*;O5ILK-14^#J45&G4QCW7NBK;&_GZY
MG.#^8'U5BMY_#+Y%]N_&;^7#WI_, Z/[G^+69W]N;X\[KDZLQF\/NNE^UMK9
MK<TV6H\OA*VFP35KT6XX?XMCZUZR&/#/)%3)[KW2?/\ .'_F@;'ZJ_E?_)#L
M7XY_"?<O4O\ ,U_T+]#=?=>[.W[W+M+LK:_RE^0&SHLGU!OC=N],S1[UQ./V
M#ELA%+)D\)28G.Y;#4,B$9/*U:-!)[KW2W[7^=_?'>GQ/_X42_![Y6;(ZHP7
MR#^"WPI[DJLGO;H=]V1=2=B=;?(OX>]I]D]:56+P^^\KF\M19;'8V**FS*SU
M4D4TTHE@2 :Z>+W7NB_?&;Y_?.G^7_\ RJ/Y:/RD[5Z?^,-1_+QP72WQ/ZF[
M/H<7O#L2L^4FTMA[VPVQ^N]F_(,YN:#&[3^Q>JKXJNLVK'05E5%3UM./XD)%
MJ5A]U[IWP_R]V#\"?YJ7_"H'Y>=F4=5E-I=(]1_ROMQ2X*AJH*&NW/G\G\9\
M7M?96T*&MJE>.&?,9K/8_&0S2*RH]6K$$"Q]U[HR'P]_GJQ]Q_-3XT?$[?W8
M7PB[E/S!V3V7N#9F2^%?9&\M]9'XX=@]9;%Q&^ZWI_O.;='W$.:3*44>7;$[
MLQT&W(Y:B@>D.'"Q-6O[KW6R5[]U[K6F_FG_  #^0W=_<V4[%V70U&Y]BU>,
MA:JQRL)(Z** Q&8(J:B" CD @<G\W/O#CW*]L>9;3FG<N<]GMA<">LE5-)1I
M5B$ .#6N!4?;GK.KV ]_N7.3=DMN6=S<PFJQZB.WN(4L3_/K7&[VS6]?CU4I
ML29U&*JI&H<IBI%TBD(+1U:2<'TKJ:_^\^XP]J>49?=;FBWLMI@9=V>Y6",G
M!636%!;TTFE?Y=3O]Y;G+D/9_9"XWOGF 7VV7D4H_P!,C1,&%/2A_P IZ)AE
M=Z4V-EGQ]&CFBG!R%/21:WUR5:,ME46(.H_3FUP??T#[Y]W]-W]JK/DG<T\>
M:*RA@>E1HE@C7PS7Y%0:_:.N=7W+_P"\SL.49]TV;>Y%VK989#'! S4,L(;]
M&@/XC\-!PJ/,]&YZTRFV]A=?8S+45&,UNC(1^?)8L@M+%*P+B*.]KA;@+;ZG
MCW\^ON;RMOHY]W#E7<V-K#83/&&X$E&*@G[:5Z[&>UOO-RCS]R_=\W<I$O;W
MK9&>_5Q&,9!Z6FRNR\Q%+E:.3;W]W%W2TL( I 'G:96B52]O3^KZC^OT]A;?
MMD^HM($-X]Q'948*SU44H:TZ)>5/:GV>Y>YRGYXL.5?H-TOV&N\ ^-B<&M/*
MM?/I3;%V9+2YBHBK))<XE7([+22"Z1(I>4APM^.2"/9!S/OZG;A-;TMRE.[U
M\L=3+M.S)=_5V>ZFMK.CI_M64@_M!ITG]\5F'V[GZS;$&2R%#!-1UM1408VG
MGJZFF6LB/GIE6(,P#>,<GTBR@6##WDS[6\L\[^\W(5S>;!M?ULUHBQF1Y88H
MV903'W2N@+T_"./$D=<$=F_NFO>#VY^_WL_NM[<W\%IR9=;D]]++<2B,QF>1
M6NH5+$ JU-8JW;IHH*\ 8R/?TFPL9$),2VY;R/#C*NH*AW@F5FM;402%4FY-
M@0?J1[%_MI]R[W#]V^9KK:A$VT"S4FY,@P)%_ H!R2<5&/RX=#?OI??#V_[I
M]V>1+N/ZS< T*J5.=2T8O5J :>)R/09('0U;)[>RT=/A*_.8*.3:^Z:=WJJ7
MA1&[^F-3_@=0'T_QO[Q6YT]N8-NW?<-E@N-&X;5-)#K'K$[(Q ^T'K)GV*YI
MYA]XN2-MYKVY/$BO84G/S#+KI^=?\'20W!LF*LW7!NJBV]'C=EFI@>M,90)X
MI)Q]U(Z:B=(2Y/'T]J=MWLQ;4=IFNO&O@ITUXU Q_/H1;KR_>V^Z/X]II5#5
MCZ 9)I_/\NG7MR'K2+*;7AZBSR8O)1R12Y 4K#1YU53,9+$V^AO[0<E/S;):
M7;<ZVXD0DB/_ $OET3QP0^.HV8TD#]WV:O/_ %?GT/. AI<B,5_$]P+%E8J.
M(3PD K4*%03/S] Q/X_!]Q_NTES9F?Z&UU0,QH?X3FG4EVBHMO%'=K1]2BGJ
M:CI=UZ;0IXY:>&*FJZQ8@[TY"@2%4N&+_3\?U/L(6O\ 6*5TE=GCC8T#>E33
MA^?1V;YC%(\SJL=NID/"H"*6)_(#C^WHE]+V]#NBNWEMVDW5_ ((J2MI$QL:
MD&0*)XV36BN;O:W)%K\>\JMH]HN9#)M.YVNQ2[D9'CE5]!*LNI375P ^WRZQ
M@B^]G[.<J3;AOG,.]".3:W:01>;-#5]-*?BTT_/HH%5O.OQLRRZ=<2U$=,<?
M&Q,E3!]QH%>Z-8E"'5R"1>_YN+_0AS2W)'M?[>C?>?7%O6V73;4))D:.@MP0
M*5#=AZXH>Y?]X/[L_>2]WKOE+V4M)(QN,K:;F2BZ('8!I@F#I5'!7@2*$#%#
M9YLC&/N'J[;M10YFO2HFJ*;(C$K31&"$^59D1I@$.A2 3?4?K9N/?SK<Z^[E
MG:<[;D(-M6.-S*L<ADRL;5"=M/B"D#%!T-N4_P"Y0WC?MWV[G'F'G@K87%VN
M\36?@*6>Y,_U3P^*N/#:35Q!<5^+J;O+9-158.>JK)&;+5#&HIW)"R1F)+13
M,/K<$7X]P_L',L2;H(K=*0$T;T->(_GUW[;9T3EVVY:CN]4>UVL4""E-3(@C
M!/VT _P]$TR6UZO'2S9JDG_B&0HZMWFQ<T?EDE>-6MX4U(7UGCQET!-K$'ZY
MU>R/W@=P]L[XV-W";G:[E K)XF@QU8$R1D@@,!7!%#4UH<@RV/>+#<[&38>=
MT:18=)CT'2S+&0?#U:6IJT@!B&I4X(Z"ZMK-U8^KH\S5XML <A5S-)050$35
MD415E$L/[VCR"'TD%K!?]A[ZS^UG._M#]YGDW=O;C:+V7ZGP*MJCI) SJ5$L
M1KI;0Q]0"1\L?+-_>L<J[OR][Y;5S;S=L8NMGBE_0UL/#FCUB1K9^VO>BD:J
M&@!(%>.S?_)5V'U%\CLCD<OO;!15^?ZTCI)<1#+.MA6QSQ5,<R^+1J52P:WI
M/'X'O!_W!^XMM7LSS4.;+G=I-SBNW)1' 73Y$LH %?*N30FA%>I3]E_OS[E[
ME>W ]K>6=H&R6>W)X94'4I[01I/F*'S ^8ZVNX(8J>&*GAC$45.B00H+ 1Q(
M L:*&/Z?0%'^M[,(HH[>)8(@%10  /(# '2B21YI&FE)9F)))XDDU)_;U)]N
M]5Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KQYX/T/NA 84;((R.O=)/)[+VOF)155^#QT]6AUPU9I(
M14T\H;4DT$FE2'! (8B]Q[(;SEC8KW4T]NFMJ]P%"#3CC (\NC:TW[=[,!()
MVTC\)-13TSY'S'4/';1^UKA5U>6KLC' \9H:2ITK!2-$X,130238@Z?H/9=M
MO*(LKL7-Q<M.J$%$(H%H:Y]?LZ6WG,9N;3Z:"W2 N")'7XGK@U^WI53X^AJA
M^_1TT^H ,9H$;4/P&U(2?9]=;/M5Z"+NVC>OJJUSQST1PW=W!3P966GH2.LL
M$$,$8AAB2*-% $:(J!0.0 J*!Q?CVKMK.VL81#9QK$@X!0%'\NFI)9)G+S,7
M8\234]2?:GJO7O?NO=0IZ*DJ'$D]-!.RBRM+$DC+8W%FTG_>_:66SM)R&GC5
MF'G3_/T]'<W4 TQ2,JGB 2/\'62&CI(#KAIH(G*Z2T<2(Q XL6"J3[NEO!$Y
M:)0IZT\\THI*[,/F2?\ #U)]O]-=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6"JB
MFFI:F&GJ7HZB6":*"KCCBF>EFDC98JE(ITD1BC$,%=64VL01[]U[JA#<O\G'
MY1?(6LH.N/GI_-@[@^8GPXQ&]]A[XC^+F2^+GQKZADWS/UUFZ/<V V]W9V[L
M3!ODMT8MLAC*:>KHQ0XI9Q"!(6?3(GNO=&"W%_+9[MZ]^07=G>/P9^;N5^)N
M(^46_</V=\C.IMR?'W8WR(V3N7L:FQ=+M_<?9'6C[IW3L^JVOG\Q0XVDCK9I
M9,YCWEIEGDQLILH]U[H3NZ/Y?F1[H^=O\N3YP9CNS[++_ ?;'R3P>4V-_HW@
MJ?\ 37D?D7T]'U779O\ O-2[TQ46V_X;*K9/[:/$YE:C7]LK4P F]^Z]TY_R
MZ?@-_L@>%^7F'_TK_P"EC_9J_G7W]\U?N/[B_P!Q/[A_Z<J39%+_ *-/#_?+
M>7\4_A?]S=7\9U8[[G[FWV-/X[O[KW2;^=?\NS*_++N_X=?*3JKY 9/XX_)#
MX4;C[0KNKM[3];8+N;9F1VOW=M?&;)[3V[N/K7<F>VU!)4U.+QHCQ>4BK8WH
MII/.T-5HC1/=>Z!_XR_RLNX?B!TO\S-B]%_.S=F+[@^6/RPS?RXA^1&[NA>M
M]W[HVUOC=>-V"=]8[>^Q9\MC]O;BAW%D]GUE5F'Q-%L]5ILW44N+BQ<D--5Q
M>Z]TG>G_ .4[WI\?L!\A=^]-?/:MV7\Q/E;W'L?MWOSO-/BYUED>EMX1=?\
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MZW=T_C]HR;2R?5%%\>>J8>N*3,XCLB+>&:.4K:RJI8,U1R?P7%"@FIXXR*P
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MV'VSW,;5M-I]/:H0%3^(5H /\'1Y,]4[9J<3M7+T])!,,A")"VE;PGPJ0P)
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M@VFK!*^E32O^7\CT:G=NPTGZKHYL#B,O48[Q+)#4P4;U(+^+6UI&TB_UXO\
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MV9AMP8[MW;G>FW:S$;J[-Q<&Q^R]K[NP6_<?E.M\90;XIZ7;-!/F=L8[)97
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M"4W CBYN/\#];V_UP_[A\^G=X(8]G<-0=Q3)J/GY=:Y>CL[)97LIC-(QI3'
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MIW?L7<=:]+7UM/V_V7E*#:VV99(Z>K>CFQ>!Q,ZT]12>892JCJ#!2^Z]T?\
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U@JJF&BI:FLJ"ZT])!-4SM'%+.ZPP1M+*4@@25W(5#9$5F/T )X]^Z]UI4
MOV_\->P?YD?Q:WY_(IJN]-F?*_L'YB;"'\R_HO$=+_)OI_X_I\8\_C-V[A[E
MWW\C]A=E]?[9VKB-Q1FA08>LQQCJ*BKJIGB$M6T32>Z]UN,5';_4M)V'_HBJ
M^T>NJ7M?^ZF2WW_HQJ-[;:A[#_N/A:C%TF8WE_<N3)KDOX522YRBBJ<C]M]O
M$]9 KR*98PWNO=<^LNW.J>Z]LG>O379W7O;>S5R^8V^V[>LMZ;;W[MD9[;U;
M)C,_A#GMJY+*TOWE#4PO3UE-Y?)#(I2158$>_=>ZT@/B5VG_ "R=B;F_X4 ;
M:^=/5U!OC??8_P#-6^>^Q^M*3<70.^.TJWLFFS^XLJ^.ZCZ+W)B=E[EI8]WR
M9'$O75.+Q531Y)$.-R$W^3T]//3^Z]TN-M]C][?&WI/^31\0_P"8%#U[\:L7
MN+X7=E4N3^;O<_PVQ'RE[<V[V7N[?XJNL/A#U11[OQ?86.VIN^+:&V-M5V8_
MO-MS-1Y>LPM!1PT,U;3R4H]U[HAU7E]Q;1_X3)_S@-DXS<6\Z2@^/O\ ..W)
MU_U2F<VGC>HMW[$VWM_OOXD[LQM%_H\VK@=F4VU*V/,;AR.1FPV/QN+BQU;5
M3T]/34R0I#'[KW5ZG\]7X:?'KXV?#S^7UF>GOCILG:/0/Q5_FI?%CO7OZHVI
ML.@RL.R^@*>#?U)W7O[><4=%7U^1H*RJJ<//N:1EK'JW"5=:L@B>9/=>Z4FP
M=R]9;Z_X4B=&;R^.M9M&;JC>?_">REW1U!E-I8F/$[)K-J[D^9>[,OM3,8/$
MTM#CUCH*B*MBJ8E2GC#))<+S[]U[H*OY&W87Q!Z+VAB/C/\ .78V'V9_.,S?
MR>[ER?=61[IZ,W!6=O\ >':&6[OW35;#[=ZQ[&R.Q*M,GMQ</7X:''9C$UE-
MCZ7[=ZI/!!,E1-[KW5<^'Z\^079'\L7^;GC>B:.NS6"V]_PIA^0.]ODIM7&=
M<Y+M^MW9\7]IY7I;*]GXM^J,/N;:57N>AIYXL7E<SMRFK8GRN,QU9C]4:U+3
M1>Z]U<1_*1V%U?V/\].X?F)U!_,3Z'^14U;\8MO?'OMWH?XS? W>/P_Z[BR.
MT=]TNY-A[VWXV?[E[%IGW?MVGR5;@I<<U-!74U!D8(IDIHU J/=>Z0/\Z23?
MWQ=^:^R^Z>G<EF]M;L_F;_"WLC^57@\QBZ>?)8RD^5&\.T^OQ\6-RU^.IHI)
M(*^EH^S=W3T^1LT2P89X7 E:".H]U[HN/Q4^-=5MW^91TA_)WJ-K559\=?Y8
M_P L?D!_,VV'59?;N0R&"EZGW]UKU[D_B;@:7(Y!Y<>*O$]F?([L"6DJ(WDJ
M8EV:L?@,XFR1]U[HFW:726Y^]_Y2_P#PJ.VML#KF;LOL7!_SQ?D?OC:6)Q>%
MI<SNC'4VRODE\?\ <^_,SM:.6-YTJ8-LXK,M,M$?N)J?S4\:RF7Q/[KW1_/Y
MH^YOB%\JOC+_ "#<I\>J+K;?'Q?[?_G._#+:U=CMH;5@V]L;==+6UF^MC]F8
M/(8"+%856=ZFFK\;E%: ,TD<J,Q()]^Z]T;/HG9.RNB?^%.7>O5G2VS=H]4]
M<=H?R<=F=O[^V1U]MG";3VSN;LW9?RLP'7>V-Z5^(PE#1PBMI,)E:C'+)$L8
M:.0^0.X##W7NBX_.WX+_ !8_F#_\*5^MNC?E]U;_ *7>K<3_ "7Z/L7'[7_O
MMV+L'[?>6!^979V$Q.8_C?6&[MEY%_%2[GKHOMWJV@;SZGB9TC9/=>Z1O0'P
M*^)W\NW_ (449?I3X==4_P"A_K+='\D'?_:6=VU_?GLGL#[[?>;^5&0VGD\[
M_&>TMX[VR$7EQ^R<73_:PU<=.OVNM(EDDE>3W7NB#?$O!?&^7^19_)3['[<^
M5.W?C!V]TAOKYU]B?'BH[HZ)WW\BOBCV1N*M^37<>R=T;$[TZXP-(,1)D*RE
MW/##M*IK*VERT,LN0EP454T>0B'NO='@^0?:_;OSA_E]?RD.D\-\<L)\,/YM
M/?O<&)[>^,V$Z]P-=LO%?#3;G3&^,GE.VOE-)M(QU&1P6S<_M2A<+M7+15BU
M,FY8:&<UTE(*AO=>Z+GF>OINZ/Y-_P -.OMD]>=L87??\L[^:9TSN?\ F\]0
M[ K]ZYWY+9O=/6N\-W4/R5[PQ];MALGN+<&7S=3NZ+?..KHG>44\AFI9-6(A
M1?=>Z/I\)J+X[;H_F^=.]C?R?,GO^L^'V3Z#[TR'\QW.15?R&K.@]U=CU=+M
MK#]$0)-VYD(J*7M*+*XX/F',=1D8L91U,=4D<LDSCW7NMK[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MUI?;M^*7\R;*=4_S OCUU]L;M#=G;WROP_\ ,UR/RA_TA=,;+V7L#)T6[]T=
MLR?#[.= ?+RIV_AZO>64WCMZCVMLYMH5NZ<KC\!@V2&JI-MG'0QY3W7NKX?Y
M?&R<]+\B_G)W]@>GM_\ Q]Z"[D@^*.V.L>K>R.LWZCW#DM\=+]1YG;7:W:7]
MR<B*3)0PU=/G-L[-BJLE14C5*["$](:G'O25,ONO=";_ "__ (#?[(OFOG)F
M/]*_^E'_ &<[YU][?-7[?^XO]R?]&_\ IKJ\35?Z-/-_?+=W\8_AG\+T_P 9
MTXK[C7?[&#38^Z]U8G[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>ZC2U$$.GS2QP:FTQ^1TC#M_1-3<GW<*YJ0*_YNFFDC
M7#L%J:"M!GY5Z#S)=N=;8G=M'L7);OQ%+NNN$!H\-+,PJ9GFDCB@B5T1UU,9
M187]F<>Q[M)8G<4A/A ')(X#B0">'Y=!BZYVY4L]\3ERYOHTO9*:8B>XDD #
M XU(\^A,]E/0LZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z@5];1XRAJ\E73QTM%14M165
MM3(UHZ>GIHGGFFE8?15523[<BCEFE6&-=3,P51ZDX'2>YG@M+>2ZN&"1QJ69
MCP"J"23\@*D]!KLGNOK'L/+9#![/W;C<QD\8SK64E.SQ2'QDK(T F2/6%OZM
M//\ A:_LXW+EO>=GMTNK^ HCC!.:?;T$N7?<'D_FN]FV[8;Z.>: G4J\:CTK
MQ^?^#CTK-T;WVELJEAJ]UYZAP<%1)X8)*R1E,CV'^;1$=C]?K;V66]C=7C$6
ML9<XKP%?EGB?LZ/-VW[9]BB67=[A+=6P"Q_P4!Z3;]S=71QTTAWO@E6M=(Z0
MFH8>5Y"$0+:,GD_ZWLQ;E[>U!=[=J+Q-13_#T4?U[Y/ 0C<(?U" N3DDT X>
MO0BTM535T$571S1ST\Z"6GJ(FU))&W.I&(_WCV421M&Q24$$<1T*H9HKB)9H
M&#*V00:@U\QU,]TZ>ZUROYMWR [.ZG[\V+A]E9?)+0U^U8FEQU(X1:5Y9HD-
M4]M!L1(67U?4&_O(?VPL[:YY88/;>*[3Z21_H@KE16O'@>N3GW[/<GG3DGW)
ML(.7-U%G$+%Y#&PJ-=5"G%#ZD9I7B#U6KL3M;L>B[GV?VGO/*Y*>EIZV"OJ*
MNOJ'--+%'^Y'%<?MA>  .&^@/N4=WV9+O;YH-MM5@/AF/2/B#X'#CPK\NL#>
M1_<_G"P]S=IY]YUOIY(O%$K2R-I@,.EB%%.P9T_TN%?GL[]2?.GIO?(P>$KL
MJ<1F*NFI:;5,FJAEJV1(]&I>4U?\A#_8?3&WF'V]W;; ]RK*P-6TUHU.)IY'
M^77<;D'[R7M]S<MOM_C^',ZJN<H6H!2O$?S'^0Y6+W+@LVO^XC+4.0].K333
MH[E;?7QWO;_6]@&6SN+<:IHRH]1D?M'4_P!INFW7_P#N',DGG0$5I]G'I^]I
M^C#KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NJ#?GS_,%G7=.Y/CWU^9H,C1SS8O)5E*\7EJ:H Q0P/*QN
MH=IE "W -B; W]Y!^W/(]HD,.]WK?JDJPKP # DJ.%!3UJ> ZY:?>R^]K-MN
MZ7OM3RBCM<*3#(Z4H)76D<;,34,^H4 !TX+4!!ZJ(S>^]V[ R%!GL#V'F-K;
MBCI4H\G1XVK99@K%I)IZ@:Q$=6KD.J_X&W'N8/H=OW&%[.]A7PRY<.?Q"O '
M)\O(]<[=[YPYOY,W*WW?E[?)[3<?"6&:WB)++6I:1EJ(R3489:^AZD]@]V=R
M[KJMJ9/=79NZ-T;<I8J.6*&2=8((I(VB::$JG-[)<K(2"'(_LD^VK/EK:[1"
M=O1(VU%36K5!/:V> \JKZ?MMSG[S>Z.\MM]WS'O5UN%B/!E4KHAHR@>+"= J
M:X;2YH=1 X$@.>Q^Q-[8#=6+R-'N'*G#R"GJH88Z^3PQI)#'HDGAOI;F)K\'
MBW^'N\-I:V5LK3J'$K&-A3+&O 'B/B'#HIYIYNYI;F-Y;+<IHPB13VJB1M 4
M@#O0$(Q)4\0<4Z-OT%\O>^,#FJ#.T^Y<Y4X+$55.OVSU-1_#95O&YHVAD+J0
MPC ?GZ2"X]D_,'*VRW43JD);6C8-*KBNKRX'/#RZG3V9^\=[O66[)=WEV\EI
M;2*K4U",DT_2H:BN*'-1K7'GULZ9/L#-9+X^/V/A42DS>0V%#GJ86_X#U571
M1R/(B\@%3(64?CWBY%MEI;\T';;LUA24@_Z4"H^W_+UVUNN9MPO?;'^M6W#1
M<2V:S+\F90:T^W]G6G9O[L#?/=&<W!EMV//F]STV3KI$J)#>:BH(*N5*BFC1
M"NO2Q4C]1-S_ (>\PMDLH+?;H7M9 D ;1GS/X6)/#%?]5>OG#]P.<>;?<W?[
MV;F*-KO<(F>0%?BAA4D2PJJTU48KQ#$]U/(=(RH[;KXVH]G9+&PST$>.^S#D
M3(?(%\&N63S'U^DD^D<D?3V_*;<78@B<C]0$D:2/B!H,</S_ "Z0)SAO-QRY
M]#>10S6\,1@\,F19#V:=;-J-6_(?MZ'3#Y/&4&W<=439HXVIE0/2UD;!=(<'
MQ4Y+%N5'X_P]L;E;Q3R/;1*2I[7 R0#ACC^74E\N[O8;9R[:WMW>_32L-44E
M0!YE8R#YCS'R/2\VE\L>V>B,SA]T87)9;*4;DT%/E*^5XHJP/Z3!>.'2?3SI
M( /XX'LIWGEK8MU@"3_".TI353RKW'H7\L_>)]SO:_<(=SL3+?0,&TSRGP_%
M -2*JE*Z<T(%?+ /1]=O_P XG=>V,91TV[=CQ9V2:DBJH,D'6'1'*S@&I(GA
M9E72=1 OI_K[CB^]G;*8FXMI3$NO2<FGEG@PQUE/M/\ >07.T6\%KOVT/<R3
M1+(CIIX,2 &JZ-Y>0)IPZ5A_G/TCT>18['Q:SO32)B3#)7D_<F.7Q-()&T&S
M:2%8@?[W[2_ZS=F&1A<FE1Q9:'U'^3'0@;^\HV;P;C5MA#A3X8"2ZM0!H>X
M<:<2!GH;OBG_ #/J+MK,U&&[8PF+V;'([ICLI0/52Q&?R 4ZUD1X =&!)5;*
MW%S[)N;/::\VA!+8 D. 5#4&L>>DFM#7U.>I0^[Y]]_:_=.ZEL>;;:/;71F4
M,C,XK7MUX'%:$T% 32II7JV_$Y/'9J@I<KB:N&NQ]= L]+50/KBFB?Z.AN>/
M<.W$$]K,UO<+H=#0CS'6>]E=VFX6R7MDXDBD%58&H(/F.G/VSTKZ][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NBG_-;N;+]#?&_L?L;;L0GW'A\
M)4_P9-6C16>&5TG-@?T:.?K^KZ>S_EG;1N>]0VT@JA=-7G@LJG_#7J*/>KG2
MXY!]M=TYFLZ&>WMYFB!-!K6-W%30T^&E:8KP/6E8W:<FZ]RTG:^YIE.>3)_Q
MS+M)J4-*M0*CQII5[(/MPJWN0/J2?>7UE+8?NJ&WIH$) ]32I_:?]6.OG(WK
M<^9+OG6??+UOJ[JXNH[BH 4.Z,K*HXT  "CC0#->E[G]W[6W[N:AW2L#34CF
MFDJ(3(&=@GIF574J5#( MP%/].>?9K:B"XLP86#2(Q*FE #Q%0?GT6\W;XF[
M<V?O.]MI(87\(3Q%NYPAHP5E/ J !2GRH<]/62KJ?"F@R&=I?'L5W6I2.GEC
M%XE36K&?6C"7U^K61]2+GGV\EVFB1D<+<H.]F!I4?+A3&/V]6FM)8;NS_>%H
MTNRSO6**%E)8:211@582=U3J(KD5.>DKO?N/:):B;/P"CVQ3JS4,XD*R-!I&
ML2SJ)5((MP%%@>&/LL&Y;9MJ//.PH5+2FE5T#+4!SP''^71MN5[N'.]Y'96U
MDS06II'$KA9P3_$<KGT J/XJ]++KGN?%R[;%10TF.I=K'(4JJHD:2L>EJ*A*
M2.L9%@%]6D!CZFX-P#Z%Q5V7[UG+.\>\W^MA;&306*1S%0L9=2"54UQ3) I3
MT)&>LY]T^Z7[W>TOW7++[QW.&QQ;=RO?W,<2_J%[BDK"-))4$=>_ )JS'\2@
M]BV&=R_S)L]N#J/:76^Q*B3&4M)M>+$Y:6)B#6 4KTZZP5!%HY0EKD<<?@GG
MC]\?G3FV/W2GY-V"_,-A#(D\KQ@!G:M1'JIPP:DY /[/H^_NUO;3E_WM^[O:
M>X&_6)(N+9K>,,?P-'H5M/E4'A7_  =42'?_ &QT_6YK?III]S[?K<S6U4D:
M2+&U*]9,\]0CD:P8VN0ZZ>!?ZV%LD_9#[YECM^Q)R9SHSW+004C&"7*K10>%
M": :AZY\Z\O?O7?W0'NSL_NC-S;[/Q+##=W+R L2 @F<LX?CJC[B2OX?P^5#
M))N!.W-MX[/5.(@H)ZMJ5I<Q2V@BCD)'BIIE'D;R$E0D@O\ IL  0OO)SV=^
M\[R?[N<Q3\HS![/<H%8PP24)DC!_ PQ3U'$5KFE>N:?WOON4^^7W7EV[?O<#
M;K<V^X4_W80$I"Y8:?#FB)+:C5:'N';04J%Z$/8:X66HBFS.2$U1"Z46/Q]3
M*QTN0%@FA+%OTMI"@6 M_K6R=O'N;1/I+6*B2Y=AZ>=?GFI_XOK#?D2#8[R[
M6^YANM4L3".WA<G#$#0R$D\#0*!0"G#A1\[CP>X'V;M[;;R4E/A\?GDW!$$5
M14HY<)$B^I!I(<AK D7_ *7]ARTVV&ZO&(4F1B!6M014$G^51Z]2ES]N6]\N
M\F0\ORQ0O8%S)0@++&S!D0K3%/U"& SGTJ>DYN*N@R.U=OX^IC--4TL*4]W0
MVDBI%--)J*@D"Q#'B_\ @?J!)'&6N)8HSJ"]QH>)-&H/V=1%ONZQW7*^V0S(
M8IXP%6JG*Q5C)-!4#(;A7RH>@FJ^K9<#)#N>FRJU%+4,":*GD>81AR6UN&AC
MTCBPY/)]ESVD44[2Z6!S4$ 8\Z9_/J^X_O"/E^.6X\":*2@#Q,S,M0::ZH !
MBG'C0=&8Z<JL+4UF$V_'D:Q,UGLHE!24VD^.*5FC$9'U6Q9S8D\F_OV]UEL)
M+F"BK%&6U#C4 FO4@>R]WM'U]IL+W$AO+^X$:QT.A:TI0Y !K49R:];=WQRZ
M[RO5O4.UMH9K+/F*^DIONI*F2P,"UB12+21\?[K'%_I=O>&W->Y+NN]2W*"M
M.TD_BTUS_FKY?LZ^AOVIY4N>3.1K+8KV<SO&M2Q\M0%!^7^?H>/8?ZD;KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>ZBU,T-+3U%54.L5/312U,\K_IBAA0R2ROP?TJN
MK^ONXK6@XG ^T^0Z:E=(HVED-%4$L3P  J2?L ZIT^5W\S[8&WZO(=8]+YZ/
M-;JA>HQ^>R\%._AH&D\D#4='*\1'F^K!C8WL!R1>7^1?;\[@O[SW8?IKW*H/
MIDL16M!^S_)@)]X3[YG+')UX_(W)DYFW,UCE?PWT*3@(DA73K/$"M:D"@J-2
M*Z"_FAXG;0I=J=W3O4PRTS24&9HH3/D%DFD(CIJN(,VHLQ/-^?9YS/[7K> 7
M?+ZT-1JJ:(?,D=!#VM^_#L>U-'L'N=,$9T+1R*"SY:BHZBN2:_;T:SLSYI?#
M'?O7U;M?LG=R+@-T024%9C)Z=C5(LD4B&=2LE@RK+>]FM?Z'V";'D7F^QN_J
M-O5:QT[JFGJ/(^8'^7TZR!YM^\E]WK=N76VWFW=8XH+P%"C$!L@@D=P\B?7C
MUJR]K;*^/NX.Q=W;:Z7W%49;95,TTF/;(0R0%)Y)Y/'1QF1D++IL;D/:S 7M
M89 [!'=W.U&WWRGU!-&T'R/XR!\ZCR\OM/%?W2V_E3:_<.1O:V_>3:YHO&@>
M92!KK_8(SA6H%()-&ID DC2N:7J&#;FW**.DJ*>,2W9K%HHH8FC_ ,YK*R,S
M%N0UOI^/8G@3:HH_HE0UJ IXL7]!_FZ V^<D[W#;)O5W<I)+(=3U[41 ./ D
MY\Z 4\NIFT=O0]C$;1SF4=<=CX"]) R(Z2 NJO I*$6;C@W]O7ICM8288@36
MC-]F0:#IKD+;[GG.^CVB_OY($M4UP* M06-&"L5-#D4K6G[>@A^2O6NT8]H1
M[/-1XLS/D&7&4T"^@T\$<\Z*RMKL7\ 1%!0&_P"3P,>_O&<X[7RQ[93277QM
M#((V\Q(RZ%P/(%JG\OSRC^['[47>_?>8Y6Y)V%6O;V_W2%98,LLEFKEY6<L3
M0D)I6I%:DT/!03^.^/RFV,%,-\.V+H*59Z&**921/2AF\4PL5OQ]+6_(O;WP
MX]P=PDN-PAEY:.NY8A]:D54X\\TX]?>7RA[:;;S/[)M[>^Y^W1WMC91(&M90
M=$<*1EG# 4-*#/K\^C#G#;9H-E;IWCM.:JW'0H[&LFAE>26CR$M-)(J14_ZG
MLXB7@DWD72OU/N<>1/NS>Y'NU[<?ZX,SA;R&8I';'+7"+BNL_B.=(X4''..,
MWNE_>G<H?=+^\3-[,\F[3:MR3M\]K:W]W#J::T\=5,A15'<L8=00*M5@0* ]
M%\Z\J:W.=2[GGWG45,-<^6GBHJ+)TTL,ST4]253PF6-+D?X'\V_/LCYU]BO<
M_EO>+;F*WV2:.RA73+*E& =1P8*33]G65OM5_>\_<TYLWU/;Z?>O"N+EPT0G
MCDC1YI6!C75*B@]P'"OGZ]..[*^DZPZBFRVV<E4Y.;[.!I<5"$D:!PS31,0R
MD"S>I386-C_K%_('^N)R][BV_-JV$EJL#]LQC;2R\&5C3%1YU_V0]]ZWW.^Z
M#][GV0W;V+N][M&O8UEF@5&!D6?2QA9*U[A)0K4$5 ZY]3-_I/VOM_=E!6UD
M.9%2LF1@X4.:6?54PO&\A.EE0VYO8GZ\V[J<B7\O,'+MEO%P3XK1J3YZ:@')
M_E7Y]?%O[C;%<<D<Z[GR1'&EU# TL<3 !2ZK55D6IXXU%?(?8>C'=H87MNHS
M.!FQZR9+%P04L5:T44DZ0PI34_WF@(A(_M'\%A;FPX/[B2[2-)+(JL0D)?51
M21J.<\<>F*]-[YL^Z7$S?UDCGO)%MXU@:%7DC1A$OB*0B]O=4DL,K3) H%$V
MW:+<. HJ7;T\U5GJ6)9,E0RDQLGEXG> S+&OH;2.#_KW)%SF59G37>4$+4T'
MC6G &E3D5_/Y=!F#8MMW?:K>'EHO/N, UW$#=F&^,IK"@Z6TC!P.))(JD=O-
M3XO(Y>AR.01*E*6LIYJ25O6%>-T>)C3VTV*C22K7/%KV]M6\?@3%$[M3 G([
M1C-#Q%.B:R"VLTQOAX $<L1!#T=J$,FM2:$$8XU(  KT.?3]-BLB-L_P6ECE
MW+3[J1Z"4.3)%5%8PDX*\&Y5 @M;4/ZB_LMWR:"+;Y6!_2(J>&17A_A_XKJ9
M/:"PL;Z?;A9PUW2&\JA).I6*BC>E" M!2E1YL*];BFR<E6[=ZKV]E=]UD-!5
M8O:U+5YVKF.F.EAIZ02F6H*7Y$877^;\?6_O"V_C^LW>9+12=<C:1ZU)'7T8
M;#=3;9RA:W?,#B-X;=6E8\% 4$UI\O\ -T&NR/EST+V%N*JVMMK>U+/EJ5IH
MV6IA:F@E-,2)/'.[:>+_ %8*/9K=\G<P65J+R>#LXX/#]M.@=R[[X>V/-.[R
M;)LVYI)<1D@@X!*\0#\J]&)I,ECZY%>BK:2K5UUH:>HCJ"0!>]XW?^OL./#*
M@_50CU\O\W4I17-O.*P2*]<BA!_P$].'MKI3U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T1;Y_]O;]
MZ8Z*S.Y-B8U:MZF.JH\S560G'8N6%(YZL^4JH54FD=S>]EL+G@CCD+;-LW7>
M4BW(_CC"@G!)8U%/,^0\A6N,4QO^]%[@\V^V_M=><P\HVYGE1)-9! *(%%7J
MQ HH)8@9(4A03@ZA<$.'K=Q93=^'E0UU7D*[/51>)6$]9YY,I5QDQ32+^I6/
M]F]O>6UI816EHL\,8"(54T;@HHOF/3KYYMYW[<=[Y@GW*XF<SO))=@31@:I-
M33L.UC_2-32M*=-FV-X#*[EK*C"*F1S6.J9)FI9HG=?NAY)%=8Q>^EAJ6U[$
M#CW:*Y2]:122$H!QTT Q2OV"AZ10VV][3N5KO A$LTKM+&"GB!G(+%@@()8'
MN45^(#CT4'/]U;^G[.S6WLY1&**LF:&*21M0*2$1F8O_ &K:N"+  6%@+>P8
M^ZWEIN4MF#I5@551@ &O^K_9ZFN/D78=RY6CYK%TUQ<L?$E8GN9N-/D*"@'
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M $GZ_3W1+!;*=KI024[E( .0?/RX]+H[FZYBM;;EF/0DE.,S% .W%#0DU4X
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MU[IMUIRO:?1_I%'U@1J#@A"17$84\*C/;7I,=P+346#I,36U8:JI,>)):RF
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MT]I.^D.\3-&"!C.DC J?Y]%LW)B-W=@YW)9 X^F23'$^9JR7Q(S",,NBP<V
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MCZFWMR"&2XD6& 5=B HP"2<"E?\ 5GI'>WMKMUJ]Y?2+%%&K,S-\*JH))/V
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MRXY:^8R)3Q2?;X^GJ)9)/MR^BR&)"1I)O8!O]:8QL\]W+#/(OA!F4Z215B"
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MQ,%N-;&OZ<I):OF.ZH(%20H )(IU7?A]TY' V;(U!GI/[6- LS_7]))OS?\
MWGV#+:Y:/N+8' ?,>?4O;CL-ENN+./3)Y2>GV]6(=?[QZEK=@QY.#++MO/XZ
MG>>)F\2ZV1$>Q<>I75HR03<<@DGZ*,X]ZVJ.S#WFG2%(J: KZFG _9G\N)QU
MWGEJ^AGGAO&N?W@DNJ$J&>&9:C0H* &-EH0#BA.K41A45MC>^T=Q;JGHJG=\
M&6R/D9Z./[A"FA905/C0GZG^H(N?Z^V-IW_EW>;LQ&[K)'E5K@E<J .B[?>6
MN8MKV5;L6#01-3Q&*DFI&22:_GY]"-ENT]DYNLDQ9-)!4;2IX:6M GDF,DD8
M=TE]3-_JO18#ZCD\$'C;E922O9N?$TMJTX\_+'&O_%#HNW'8N8+FRL+J&T\!
M9(1$K*7)DTDY;4:#C2@X#!)Q0/\ !=J['KMP97;F[LY%DL9E8:JGQ^&IXPU0
M(IH9:95<1@<!ID+>0Z>#<B_L(\S>X7)FR[?<6G-]ZL4!1@8VX,M,QTXU9:@
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M_><A)OTY3EFT-Q>3#A&M2:BGE]O'@.L6.??O1\D?=VV#]Y>ZNY?0V,"EU->
M0$C3YDFF *DFE 3T:O?&;['Q?9VV,"-O5L^)R<D R$KT\D/^0R)'Y89Q41 6
M:.0H!:Y#W!X!$O\ L#]V[=K/G&RFY\V:6."-Q)I8KI9PX*4*,:BH)(X5%#Z=
M<IO[RG^]&]H??S[MTOMU[&[_ #P74GB17J/!+"YADB*L")HT(UHVD&FK2VI3
M@$6%T&PMKYVEV_D?[L-@7--"*Z.E>IIAD134[-'*BB4J5:X*FZD \$\^^G>Z
M^V7).[LK;OLZW*P(4MT>-&[S@(<5S@?Y.OG*Y;W7>$V^TN-AN[G9OJ0INQ;7
M-Q;I<)&K$/H6320:ZA4@T/'U*K\ONK:ZJVA)D-@RU..RV'H7>IQLT :?Q00R
M3++#4-%K9V2%].HWN#]2;""?<G[O^S<LVDO-'M1#^[KQ5:27PS0$)5G0"I I
MC@*</3.2OM-]Y1-LY\V;EGW]>XYBY2UQP2V-XS2-;E\17<<C@R,2 U0S5(#'
M))I1]E\3492H:KS*5!SPJIJ29JC]896\8N00+@GBWO!W=]\WK<KLG=[B29HR
M0=395E)K2@%.'7U$^U7L7[#6G*NW[W[:[1]%9;I"KR  4,;CO_XS6G2WVOMS
M/YB:IH<2KT.-ID5<A,"?\H] 5H0MSR57ZGGWDA[(6/.>[6!N)KEOH6)6,,:U
M-:4'^#KC%]^N\]FN5?<@[7RA:!;V)B9F&!7@M1PKBOJ!3UZ.QT;4[GV=B:Z"
M*HD-'ID8APK:=(.IK<\BU_\ 8G^OO+7:?K=ELVCD<J"#W>F./Y<>N3WNC#L?
M,>X12R(!+CA_@Z5VZ]IQ1''[DI]VU$+[BJ8XLA 2I4++*L<P )8@@.1?^OO2
M[8W_ "44OBVKN"^I' ?GPZ#^P;_(XFV:;;U862DQMGR%1Z>G1ONKNL]U[,V3
M5;PQNX_N,92IY$+S^&4:@&(CLIU!B0+-IO\ T/'L;0VTEE:!G!=W6M*5'PUK
MQ_F.@?N:[WO=O)SGMJ1V*6K%&992LK48+IT@$<?)CD^1QT^[5KLXN)RF;W#@
MQD$S25%/2Y"4RZJ28DK#5K,VN[+J)()Y( U @W-+-KM)(Y1-X9:A9%IW)Y@C
M'Y?(G&>@C/X%I!<W,MD;V*>-HA<2ZZQW!%/%62AJ03D'BP U"A!$O9^XLM]M
M54T<[5CQ1:X1*[:HK7O"9&O8&W']/]Z77B689+@T&<T'I\NC3DOF'?1!<;?&
MQETI5-;$TX]NHUP?+C3H<OC5V9#2=NX"MR<M/0XG#9F"LR^15M7C2FJHG5VN
MH'Z7+#_#V%^8+&-^6Y9(F/B/K10?XBII_DZF_P!@N?KA/="T?<U2&SB82RS
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M392K[%Z/['F5Y(;0XJ7*;#S] GB3R"]C-<K?@*HO^1C]S%O"WON+9BC4M[J
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MO!:8AJ>0*@\*_L'R_/J>??'W!V/D/VZY(GOMOAW._2U5H(I#4#0HUR:]+:0
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MGRG4&U7NVFW-W-^;:[O:T?=78IH/;Y=U:G@<TZ-_;;G7FWD7F;P.19Q:S3S
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MZC-[7P.:"9[&S/\ Q6G4,\)<DJRC1J-V)L!;V9;'/:W^Y2[7!=ZI(%+,O $
M5(K^5.BSF'>]QLDM-ZW*U+6UP (3^(^F//HCW<62P,F]\E020:JC%J<?62,0
MHGF@>1)A8_Z^D _T_P!OA3]X/=I-ZYDCV?E<,T]FS&33QK0$4^SB>NO7W"=G
MY5Y9Y5O.=/> !-AW6$K;:C\5/$#?M)H/,YQPJA>NLIFL%4O7/CON4-231TT@
MT_Y-Y;Q1L"+@$6X/TOS;W.?($V]V>P60W;,OA /^S/Y]8X^\5OR=OO,=^G*C
MF#;VFD,)I0A"3I(!^60/+T'5EW7U&^]-@SMCVJ<-E9V\QAA8",R1J3%&PY%B
MP-R?<U;9$]^&"@ZJ5%/(^IZP$YON%Y:YL7ZP+<P(*5/&AXD?9T+^QL=CX-R8
MC&[DIJS(9VG2(4[HZ$NADT1(C,RJ 6(#7-K$_0^W_P!P;4[K+=VNN\1@T<K5
M(C=6!60@?PG(^8Z#)NC<3I<V8)V^:4+)%'I5Y"V-'<0*.30U(P3T"_RIW74S
MY^BQ5:\U#BEA\<J2<H(80*<Q ^KD)& ;?D'VCYHF462;9+WTXL.'=DG^?4H^
MVEL=TNKW>DC_ %PXC2,FK1K$ B*?LTYIBO0<=2_Q+>RP['HZ@0;0C<25$Q)!
M=7D"S"ZJQ'I8@V']/9/L\K[BBV%B2(U-#ZG.>C+GN.QY=F_K)<@?O!Z*M:Z4
M]":5- <G!/&@/5IFV]P;=V7L^39F%BGR,4N-J!-4-3'[>>J-)*B12P,0[)Z%
M1[CZ&Y/U]R*=JN[1$FN>Q!04U9H:5R,>I^WJ/[/GW8MNV>YV&P5[R:[2:224
MQ$1O,R-16C8ABF%7A33FO$]%3W)EMN4^5\F4P$:2)4&>.:"!7+JKZ@+LQ8KQ
M;U.WT]HKBZLT=6;B#D\*T.:TH,_*G0-VNQW>ZM6.VW.A'![-3:4K^%=18XKB
MIKZD]+JO;9F2KL1N:+'4^/=EI:2&5':29F(""TKZ;N]B3J  -_H+^S-(K>>W
MCF\0,^NJXI4\0#I_9T@O;V[DFDVJSA:WMU5?%B5R_P   =P6\V K@ 5\O,C1
ME,GL[L#$Y_:>4RE+%D*.ACJ\,M:!#'4RI2R)%2SO:0A2TAC#,.0UUO\ @)<W
M[--S1L4VTQKHN6MYHE*Y9'=&$<@&,ABK8\QFG4N['S+RY<SF7<I%T6<\%S;&
M<>'!.8*,UM))1C0BL;5%2K$J":4+OUYD>K]B5<F-R.3#97/5<Z/"!JECC>0P
MM'H37=AJ*V%_4.3;W\[WO!R7S\G--WL80.=NE="U?C<,:-ZYI7[.ONB^Y3]X
M+V\YV^Z9M/NULL*[19""WBFC8U_QA5TF/%1AZJ36@IU [MV;M/KO;^6W'4;9
MJ&FK(7JZ*L^S$;335*:XF>2,C3];D@@@V/U]B+VMA]S;/G7:[:\22%XWA?20
M2"@=<UI0BGJ?MZCW[ZW,/W9/=#[OO-$MZUJ]_);3 %>U_&,#A=)KAJD4ID&A
MZ:=M[SVGE,!M6LIT(R:I2Q9.$+I>,"C!+#3'?Z:B;DW!%OI[^AB*]AEV^Q$Z
M_JFV@!'G7_*/]GKX7=[Y;W6PO[NWDUZ2\I5BPT,NI= 7S#5U5K4<*>=16SDV
M#[-6FQ6U*RLCK72"!*&A*/*) [DQ1 2'T$O;3HC M>_U]F,AL]QVY[:X.H0@
MN6'H%S6H'IQKGIF=9QOMM+MMA)KFTQ+ Z@J78FGA,&I2IP-( &?7JTGX1?RO
M-Z]F5M!N/N6?+8;85'3?=T41$/WN2DU)X(6L;:18ZE#'BUVM<&(>;_<6'9HU
MM-J_4E3X"1A:<"!^S)I\O7K//[OGW)-V]P=S3F?W-@.W;9IUBWC-7E;R$C<
M.-56M<5:E5-ZW0GPHZW^/NY:W=&V<GFLG65</@B@R)B^WH@H(_85";?06MIY
M]Q!S!SUN/,-HMI=(JZ>+#B1\\#KIA[6_=VY+]IMUFW;E]Y9&F  5S54IBBBI
MI^5!7HYOL$]9 ]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]TPY[ 4&Y*%Z#(QL\#'4K1L4D1[$!T)^A]7^/LJW?:+/>;86EX,
M*:CY'HQVK=;O:+H7EF0&^>01Z'J#%2X/9V))XAI:>/3JF*/-(S !(P=*W8Z;
M  >R=K3E_E2R:;P\-VY&IG)X**X^7YYZ4O<;GS%?BIK(V:# 'SZ(+\J*[K#?
M%!74F8H'9<53F:6=J,K8&%FUQ$<"WU'Z;7]XH>^5WRON=H]Y<V!C2)'9G6@(
M55)9@!2A !(^?63/LO!S1L]TL,+AC(RA5.1J) 6OKD_LZJ6RFV?A77)IW=4;
MRAK*>>5X_P"$D"*2="[(MBCE03:_Y/O$WE3G?VJ6:07D%\!3L8*6!]"*$&E?
ME3TZRMWGE+W=WF)6LOI5C%"VH@4'GQKY5/0S=+?&;XK=B5%1%M^;LBHI:PC[
M>*OD?[="S'39S'8<?4V"_P" ]E',_N?[=[C>#;=ML;JY<$ ,01I/#NIF@\^H
MYYGN/=#V]@%Q/<6X6@U:6!-./:1_+'SITI/D_P#%K&=6]8SIU!U__>"M:&<R
MU512?>Y*)FII;3:D(YO:W'%O\#[37O-$-O&O*LFTM'!.-;ST8E5*TU5RU0/V
M>>.BKD#G_<.8N81NVYW@CNH2OAJ6XD,""M?F!6F?/JB/J3K#MS<'8F9S%'1Y
M"DW-B,E)%%AJJF2GAA:.;5'&@) L64+<D^Q/O^Z[.=KM-CVN#ZM9@IK&=35!
M %:^=?+S..L\K3F?:+KE4MS#>E&9"M:4TU4BN*8'&O'JQKLCK3YT]@=;5>%S
MVS]I;=P5/2*E)G<O1X_'RO31TS(TBUJ %BJDL".>/<H;;MW/^[;%;6-]:RI8
M)2B%5C+#R%07J#P/ _9UB5-N/LWL?-,^X;;=?57C&NKB%(\_V]$U^,>TODCU
MOO2IZRP.:I=PT&9FJX,IF<%6>9,=)*^F2!90!:VOAC< "_T'M;)L)W&^:W6-
MK25AHI6H#'M#5'Y5_EQR1[]O]K$Z7UJ!*C$, :Y\Z?GY=,_=76>].@^_\/\
MP[(Y7<^\MR59RL60H$^YDHIU:&<TTD@^@5N"?8>YDY<O]CVXV^XS(B1!9(Y%
M)#,X:H.:]P-#\_3UF+V8Y_Y$WO8[C:.9+0J)',<AI@(W8Q_($]7#](?.KY58
MC;E)M[=FTJVHJX_%18BKR.+]<Z-&JPB0R*;^IQ?Z>Q7RA[O^Z.P;=':7<[7-
MO15@>1-!J<!&%!45^SC2E1U _N7[1>TFZ<P3W'+0TJQ9B%8\<T/'JR+JWKCM
MON*F&Y^\:YZ+&UJ1U&-Q-)XHY3 UFM(L7"@@V M?Z^Y[Y:Y,YK]Q2N]<[MHA
M<50>9&,*/R^SK'#F#FCE[D<G:N5%#3QFC'R!\R2/.OEQX]&+V;T!L#8F[GW=
M@*.:GK&H/M#!.R3QK)K!:J61E4@VY M]>;_CW.5GR/LUAND.[0#O@0(H^0P#
MY=13>\X[O?[2^T7!!21_$8_.M:=#K[&?04Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[IJR>*QV;H*O%Y:BIZ^@KX)J:LHZJ)98:B"HC:*
M2*13?@JQ_P 1_7VXDCQN)$P5(((/ @U!Z37-M!>0/;7*AXY%*LI%:JP(*GY4
M)K]O6B[_ #3?@WOCJCY&[\WQBMOU6)ZLR^0?*8:HI*1'QZI4$/-&2A4J"23J
M /ZB>+>Y_P"5=QAO;&":9QK4:1ZDBI&>%1@$<>N.?O\ \C[M[;\[;G<0;<QV
MV\E\6.4&BQZ@J\!FA/=7(J34CJJ;(8^2KHY*5D:HI'#12!"5+:;HP4CZ$^SR
M[@BO]4=UB(U#_P"E.&_EU FW[@UA>I?0.8IT8.C T*D$$,".!!R.@9WMM%<7
M0P1XB*>0Y-I89(&_<E4.H5E4\EKZR #<W]XF^^'M+RWRUL8YJL)2LC/7^BP-
M3PKC\N'74W[AWWIO=$\^Q>V>X7;75C>TC!?+1ZR%+:CDBA/$DU\Z="/U!G>[
M=HX'+[1V3M/<+4F:1S4YJ" )%3PU$(AG+,%%@JJ'^OU2]O<-\M_>'ON0>6)M
M@L9+9?$J%=B2ZD@@$#S(KCK*OW>_NO.4?=WW@@]QN9-VN8(;YXC<11L%2:(R
M(9$8@5TLJ]PK3S&>F>+";UZDR<V:;-5-'FJF.I%6"UI_\O.I@_DU"][>HJ0/
M]:]P;RE[P\R;9N-QNVP7/ZEU7Q'85U$UU$4I3B>!ZRC]W?[L_P!A/='DC9>6
M;V5[>UVF(00NC$%!116F00-(/<&X'YU#2FQN0R^;ERE'03YJHR<LL-3-)JG\
M$E2&_P I\EG-X]))U-P 3<GW-WL'S'N=USE="YA^IENP6:6GP.3F3R%*M7[:
M=<]OO_\ M;[9^T_*'+>S<E;N%M=F06@A+'O"K@#C4T3%3P+9)Z,SL#IG=V[8
M8J/%XE35*Z:@JF61P!K*JB EC8%M*WX!O[SKLMGO94\9W I0DDT _,TZXS;[
MSQMUKN*V\)DN9):Z(HD9W8@$G2J@DT /EY=67]4;.R^T<+!E<YC(DQF"#PY9
M41TF\N@ABD<@2[#4 2PMP1]?H.+1I;>U.W>**NM>W((\ZG/^KY=0?9V5V^\S
M<ZWEK(;"UD97$H*R D4[$)&16F<<1\7"14U^WZ[<@S;4DD4(GBF$:K$TDLBR
MK(_E0FP5B#J O?\ UR?9HMM!+"FAAXB85LX]*'_5_+H%W.\;;<\Q-N4D+I;,
MZR&,!3J8$%BXK2C9U $U^T]$9^;V<DW378['X[$_;4LJ%Y)T UI%H\3ESJ(+
M&Q(MQ_MO<:\[0'<((]KDD+F,Y/Y\%^6>LCO9S<+"^WV^YFC46ZN45(O,E0 &
M:AIJ-,T\J#YDKVT-S3;-IL?1[6DD^]EJ:=*KR"T:R.Z*"QXL.>>?9)L?B;05
M@A/<Q 7[2<=2'S%LD?,DTUSOP'A*K%:<: '^?1S*#NSL#:&7P$(BIJF3+M%3
MM+"0CH*GQQM=;68'7>S _0'Z@'V-$WG=_%2RN%5U>1>/E4TJ.H$V_E#:%6ZW
M;9;J2SEME?(R&6AJI!J",<#Y@'B!T:"7%19!H$RDU#'6Y&G^ZEDJ9B(HA50^
M9?N6,;:2P-[#5?6.![%K6MO>6[O>)E.T"F21C&:GT_+J&3;W27\40G1&G_4+
MNY"J'&M?$(7!([L5^(<.B)]V[TS&T\J=O;8K:*>+%O+D E*5+//#_E$,/AE6
M]C8$J5#$$#TF_O$[WI]\S[>;A:[+L*:KBH+ G 2HK73Z\!F@H>/73_[B/W*-
MY^]A<W^YO#.+&W'@-/"M=<C#\&M00 I#&J@D,!QK1VV#AI.V]OU>[,MD<S@=
MUX^"6-)Y*C[.GD$4/DBC)!C.EBH6PMP+V)]\]/<#[QWN:O/";E;7!"7%%\.+
MNTJ30@@@U_U#'7>CVX_NF/NQ\G^PM]%SZ UY&TK&2Z.B8LH) 5D*%:THH6GJ
M:DDE$]%8#?V=[-WG5U\=)DGV\73&U) FCO2 F+6]S:Q5;W^E[^R#G]-U1[*7
M=(9EN-SEBD[U(+^(5SD"O'H5^R/NY[&<D_=UYFY&Y5O[:"#8Q=1Q1HP/=%$^
ME,'!) _/K<[^.7Q,ZM^8?PWV%1]M8*BAR=)+50T]?B0JU---2I 8)C)KC=CJ
M<,M[ 6(!M[Z [57E&6TNI;)5G-M">XY TBAKD8SZ]<T]NY4V+[POME-#OES(
MUM/=7&DQMZ.=)'H17!%#YCHB>Z?Y(W:.S^Y:2?K#)X/-=7Y:KA3(5&5K&ILE
MC*62L7[@QHL9U:8QZ;E38&[$V]S%MGN3LQM7FNZQS*AHH%06"XP3Z^E1\AUA
M7SY]P?G>XWVTVWEV[2[VHW"&1YI-$J0%^\#0G=1305TD<=1ZLRZ!_E'="=*[
MSQW8TE=EL[N6D>"KEHI@%Q"5Z,DDCP)J9[-8@^D&S$?DCV"][]R]QW%)8;:,
M1I(NDG&IA2AJ. ^SK*?VV^Y/[=<B[S9<QW<\]_=6-#&LC5CC;S*>9-.VIR%)
M .36UZEI:>BIH:6FB6&GIXTBAAC%HXT0$*J _P"''N-7=Y'+R'N;B3_EZS-B
MBB@B6*$:54  #@ /3J5[KT[U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TG\_A:?-4\44H7R4L\=53,?TI/"=<
M0/ X)TWY]DF];1'O$"1L:-$P=?\ 3 US^SHPVR_;;YRXRKC2P^7RZ0^8ZJVY
MO"CKJ?>.-IJXU\+4DSTQ9',!0QD-,4O?UM]>!_C[#=UR)MN]VLUMOJAQ.C1L
MJGBK*58$GU!Z$%ISCN&S74-QLC:#"ZNI8 D,K KP]"/7HLF6^'?QZV!0SY)M
MEC+032U+M%50"LFCDD1F_::P.KGT\?7W#LGL-[9<BRR;O!9"4S!ETL*K4@T5
MLGM-:>6*]2E9>[_N'S;)] ][X;J 58FE"/,5]./'H/Y>WLEB\5F\'T/U53XH
M[0&B::JQ;*DZPQNP])*?K,?)]5K^PEN>]WW+D;MR[L-J8XU9R%^-@@)(!/F0
M,?,CH0;/RYM7,5Z?Z[;XQDD(4#@%+&@-*CS_ -5>BKY#^99W%@*U,)N/J&!J
MVDFFI\M+]K+'32)$Y5F2+205*W!L>?\ 6]P;??>RYBM[IK278[7L/]C+(X>H
M/PE1$0:GB?V5X]9![/\ ="Y*W6P_>%MOC L 4H:9/ @U)]/]CHG&3S/<7=^[
M]Q[YZJZ[FP]6*EZRL7&4NA Y(F(T$)>]@+#Z_3V 7]SO<KF[<7NM@VSP$&66
MUC+!/MD?0/R J./IU(LOM3[2<B;;'9<Y;KK+J:U(R*>@KQ''H9-N] _.'YB;
M.DVKO[-56PMFT!?&???<#&U4BHGVS"%""6D5&)%EL">1[G/:/;+WQYYW*RNN
M8F>*P 4E9M*@H2NH!%;NJ*\6(_HD=1'S+[D?=]Y#UCDE?J+NGQJ"=+A>QN&*
M'Y?Y.K"OA1_+0ZK^(.ULW0'+Y??>Z-T35%1F,UFJ@NU.]2I\\="QT,&NP*RV
M%M(L.;G+[EOVUVG9[+Z>[_5=EH2.U144P!Z?L'IUB#S9[H;OS!N9N[:L:!J@
M')-,T/R/^#S'0S2?"_J?%;FJ=_XC"?Q+<T;O54T.<*UT(F1O,H@U)PY,8 9A
M[(MS]G=A2[.\V2:Y8SK"M^(H:@5%/LZ<VOW-W-8OW=>'1%*-#,OD&PQ(-?(G
MSZDX^K3>V[:;;>;ZZH\978.II_#DXX 4:.CFC(D,@4&RE0UA>WL-,IYFW&'9
MA8JA@91\EH1W?ET?3H>7=MFW2ROWDCN4>H)!U @BG#SKPZ-]#$D,20H $CC2
M/2.0$5 B!?\ "R_GWD1;PBWMXX>'AJJ_[R /\G4'2.99&=C4L23^?6?V_P!:
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
MU^OYW."^1>]-I;9VIUKM6HS&S:J1VR-5BZ9:RI,@AD8I.7=2!J_5I!(4C^M_
M<G\@G;E20.09J52M<-@+P_EU@?\ ?(CY_O;6SV_9+-I]OD)68QZ=12A+ ZB*
M5- :5-/3CUJ3X;JKL<=@TG7M-A\K-NFJR$>-APQH2*C[N2HC0TGB8J0Q9OS8
M6Y)MS[EL%[>-'G7M3N9OPA!DG_8X]<XYG3<7&V16S&\:40+#PE,S'2JT- ,^
M9P!DFF>KY_C)_(W[=W/O'8F\.](,#B-E4D]'F:O&K6B7,3P3&*=J9J8Q:0=#
M,3Q("1_3GW&G./,/*^_\N76Q3%I/&$B%-) *L"K4.>(/G3K,+V(^[-[R[#SM
MM?.6[F';+6UF@NE"R^)*QC(=5="JZ> K0M\\<;M/E!TQT)\6_B)VEFMJ=;;=
MBDPVW9A25]900UF4%65NLRU15"D@1'*>,6U&]O>.%M[8<N75O+MFUV2B25'4
M-7(U#37C^$M7AUT^]T/?'>>2.7+CGC>[IFBLO"+*!74$846@]0*4^?7S[.T-
MX9'LO/UU9A<9E:.6HR-2,@&C9*2*-#,4>-F"@Z0+BQO_ (>X]Y(^[QS>-W6T
MW" ?2))7Q*@EU+5*CCDCUZ./=K^\Q]LKKV4@V'DE9(M]EMVC+E&71(\3(CU8
M 45F!H#7'Y]#?U/D,-L/9-;0M1T$[U1:2NJ*DZZK[F16#R1@W]7(TJ/]2MK#
MWT-Y0VO;.4N7TVJ*T,9C  )_"PR#7Y'/7SI^ZMUS)[C\\-S%NUW--<2L6+$U
MUY'Q'T_D!@8'1F-@]SUW4^T:S<6-Q+FGJI6B-2M*I*K+R&0NK6(OZK@@@6(]
MC:*2&WM_J+FK*:\,5J.H_L%WRVYKDM=DNHH[F6(*3(HD*A:_#4T'\P>A_P!I
M[HK-VU5&T]<Z4NZEC^ZUA=(EKHA$DA15(#*76Y4#](OQ[/;:>#=+19K9 #""
M5^17/KGJ-;>YW0\P2[3N=TVF^E\&=J#2Q<&(/0+0$8I0# %<#I7;>Q.WL!G:
MW&[UU:B%;%R*7^T>7R,L,]08S_FVL/U BU]7M6CW"1UMFJ[$U&-0P.T5\Q\L
M^G2O9MIY=VC?IMOYW1AI5? ;/A,2Q =])^!J#XL4KJQT"'R*ZW;=V5FI<=+1
MTB?9F2DD]1!IWHHHHV0*K6&J!K@V^MQ[#]SMS7]H&8T<:@3D9J3_ )>A5+O]
MMR7SE<NL>NWE$#QA.&@(JU\J5TD_9U6W28'&8,9S#5%6C5U)6R*M33\,)@25
M<#_5!B#_ *_L!FS-O=.E:@@@TZGN?=K[<_I=RBC(BD0'2W"GF/LITK^NJ"KE
MR5)DZC,35*4-5&?'/:XCCE5W!M_@/\?:VRA".CZ22I''RH>@[SC=VZ64EC#;
M*AE0Y7U(H.CU9G;E/G\!2[IK*BO3"&U!]Q2L$2&=HEDUGTDZE5]0(!_23^/8
MZN8HKB-"7((4,?+2 :5X^5/SZQMVT;QM,;RVT"%?',6IL@R!!)X9SYKGHK78
MW0 Q\5)GMGY6JKI$JA/)354?W#2+))Y=,[QNET-RK'2W%B02?>,7N#]V#E;F
M2\N.8+;<62>YJS*.&LC!R/7T/[.NC/W;_P"\N][/:#:H.2++Z6*PM::*Q:7*
MJ:D!@P -, D&GG6G1G-K4N#W!M' 87=6VY<%%BX!/DZJGBC89":&$>-%O+ 1
M$--V<E.!;38F\<>Q?W0K7DKGBXYNYGG_ '@FH-"'JL<85@Q8C.:#YT'GPZ&G
MWV_[T7W*^]/RGL_($EQ-M]G9HPN1 4D:9].E(QW)V$GNK0F@&FA/1A.J.M]E
MTL57EL;38R?'U$<T$D2IHG74BL[2*TDY+68!0&TV:]S<6SBGVWEN[I:1VL,8
MB(>-UJ6#+E2#C@17\L=<].3=ON]TU[UN5T;V/2\#12*%**P'B:DJW<00!0TH
M:DFHZV+/Y7$DV/P6ZMN4V2#X6@BAJ*;&@#]B1Y50:?P -1M_K>X%]U;>)5AG
MC[CJ(!/E4'_#3KL#]RK79;#=;+#)_B\"@K'_  YI3\JGJW3W"_6=?7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UQ95=2K!6#*001J4JWU!'Y!][^1X=:!
M\QQZ;FQM T4L'V%'XZA7694@A42(XTR*UHUOJ#<D_4'\^T4MC:3QF.:)65@0
M05%""*$&OD1Q'2A;NZ5Q(LK:E((.HU!!J"/L.?MZ3U5U_LJL4I4;5P<RMJ+>
M3'TY;U <:UC!_P"3O9+-R?RK*A23;K<A@0?TT!H>.0*]&T?-',<3!XKV92I!
M'>V".&*TZ<,%M3;>UX7@V_@L7B(I6+R+CZ2*#RN0?UE02?\ 8GVNVS8=FV=-
M&V6R0 >@%1]AR1TBW#=]SW5_$W*=IC_2)I^SATHP HL!8>SDFO1< !@==^]=
M;Z][]U[KCI75JTKJ_+:1J/%OK[II74305ZW4TI7'7+W?K77O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=8)H8IT,<T
M$<T9^L<T<;QGC\JX;^ONP)' T/Y]-NB2#2ZU'H0"/V'HKM#\-_CWC.VY>[:?
M8&,3?TLJ5 R9IX-$-5#**B*>!1#J!5H4(&JUU'L_EYFW2?;AMCL#&/ED@X_R
M_P";J)[?V1]MK/G1N?HMNC7<7()DH,,I# @4XU4'CY#TIT:GV'NI<Z)S\]MI
MUV]OB9W+MO&TS55?DML55/24ZAG=IW)1-(0,Q)\FD  _J_/L7<C.J<S6P(K5
MOVY!I_+J"/O+;3>[W[(\P;=MRZYY+601KG+T.G@">.,#KYY6]-E[@ZNW?483
M.8K)44E<X*ID:6KH_3--*HTQRA?K?BXYOS[R"E26P)21*!ZT(-0>(Q0D'KC/
M87IWO;*7*-;W%L!KBD4I*I"@C4CJ&'[.DQDL8*FDFBJ%*HZR$17Y=2I.D?Z]
M[>V" RE6-*]*;*],,ZO#DBF?3Y]#+L/NO&5&,AV/N7#Q_P +B2.GB,A#&9%:
MS*J-?GG@<$\<_3V:V7,,31_NZ1OTQQ^8_%3J.>:_;6_@O'YEV2Y/CL2Q _"2
M.-?\/E\NCH46X>M\IM>BR%!#48BIQ<204DDDO^35(#(KQNKHFEPI)4* I L+
MD  80W%A#&KU#1D$@TH4Q^$5-<TX_P"?J)-VL[;Z:2P:"6+<%I6CB9+@,XJT
MAT@JPJQP /+. $YN?LK;-5M>''[>B:?<8G*O5I=F-KQ1*NN-3I4-?BPN!]>-
M-=PW) WBAB2RTC'H<&I_/[>EEGL<7T-M:7=GX+HQ>>=F!UH%(2->)H:U(J *
M 9Q0 MR;@SF6SV/V_)-.PJH!'+!2  HT^F-_( /SY/8:EN[V5A$Y)UD T^>*
M="O9=HVO;]IFW9% \-JAGX'34BE?LZX4/P_GQSMNO)SSC#9"3RV9D#F25_5Z
M2\;,"3P0"/R"1[97EJTM)V9I.YQW#CCYFE.!Z%6Y>ZO,9Y;CO8[$QP"BI,Q4
M!LZ054MJH?(Z:'CPZ'G;74O65-MS*T;JZY5()OM8U6_E84P*$L%LI)U6N0?I
M]?I[$5ML.B$BV4,K#)KE2<8%?\AZC+^N,VXP2[ANM[)#=(28(PM8G  (#,5/
M$@BFH>5,\4GLGY X;K>BS?76[\,U1A:FIFBHON+Q"*0,\:3K*HNI&KFQ_LJ1
M8@W+(;Y1<FTCD*21*U6XU6AJ*'%/\E:@]#ZPVS<[O9[A[2WBW*UOE222%F*&
M.95 $B.JL:D 8P:JI#"AJ]5/:6R\-MV66F2GJY*N56I)%9T: RZ@D 0:$&II
M/6S:OK]+V(.?WU#;L5,NH:&[<4J>&2#U&%KREN]\\FV7%K2;6I,[,Q940955
M! -?.M<>0-".76G:^&WW_&,#7TT0>GCG= MR\6M!&9$X5GX7_-E@IX/ !O[:
M-V_?4LEN^ @.H?Q(/B'VY.:<,?8IYAY4EY2M$>[7Q8)JE'H \4Q HP(H6& -
M)8"M#49JLMH[HKL)N)<-@8*^@,TO@$]7!-]BXGE$88-(7'!DN#^/Q^06WN[5
M9#:-&Q@C.K(-0!D@9\QY=%VT3;Y831[GMEW&L]P5BIJ!R_:I=:?A)J#Q&?(D
M&[S^77D.R,3W51TN QN3J\774]+29^OF2-<8U%+4K]ZZ &_I16E#$"U_K[C[
MW,CVBYV-IYPJ]IT 5J"%JM?SQ3SZZ9_<YN>>-NY^-C9Q320.J">9PHB8%^_0
M :\!JJ105&3FFQS[Q;ZZ\]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=1Y8DJ$DBEC21)$:.2.10Z.C@JR.K @J0?4O\ K\>[ E2&4T(Z
MHRJZE' 8,",BHH<$$'R]1U5?_,,_EL;2^7VVJ+*[4I\5M7LO;T-8N,R,=/!3
MTN02:&15IJK3&H UA+A='T!!!^HXY8YRN-F+6]R2\3TJ?,"O^'C0FO'K%3[P
M_P!W"U]V+"+<>6W6QW2TU%* ".8$?V<F.!(6NG2>T>F=/+Y=_"#OWX<YV+;W
M9N/AR%-EFGFQ.>Q4PGH9D()AC,E@+C^TO/ )_J!*UCN5EO,/U5JQ<4-:@ BN
M/+R_P=<[/<'VSWWVNWB';N;(XX?%5=#1L61R!5AD"C4!(X@@8/$ I>.PU97Q
M(]?']NU,1(A_#LAUK]?];V:1P'PZ1BGF/MZC2]W*VM'*VC:P^#\@<=#+2_WF
MW5MV2CG=/L,5!,\ HS=@L*%Q?@'^QSS[.+,7VZ0F'RCXT]!U&UQ^Y-AWA;B(
M'Q;A@&U_TC3_ "]'Y^#'P0[F^4V#W;OOK]<5#'L_R8K_ '*U IVJ\@U.9HXH
MB1]#< %=9O<!21;V47G-6U\MO&M^Q$A8%2."YXG..'G0#UZF/E/[NO/_ +Y;
M5>R<G"%;:T.3,SH))-(8(M%.#6A8:B"#VFG1$=Y8#L+XS_([<V,[0IOX=G*&
MN>BBA=]=,L@F 2IB?BX!.K5I_'MW;]W,MZ-S!UAZT!Q45X'HDYRY#OMOV3^I
M+1_3[AM;JTNDZJ,HU J2!48Q4#YCHTN(WIG-V8NG&0R0FHG.NDA2>1E36-(8
MAWY-CI_UO<C;7=7%RQ*1JK/Y@?YNL6.8WOX&3;;J>:9;8U"R,64'A6GK3S-2
M*D>9ZC8:AS.V.P:/,K7BIP\OVCU%.S%PMWBD:)@/J"I*.HM]2IO^4D=K/:WS
M*X[)SH;[&-"?\H_(]/VF]6$%I;2>&/J;26.4,I.EE[6*&E#D'2P^T=&(I/B/
MFODQN&N7K'85554WVBDY:>*2"@6L*6E>ED,;%HU:12/20-)"V4 >R+?N8N6-
MEBT[[(%F-=%,MZ#5D"H_;2GV]3UR'[1^YON1N<VY>S]BXVJ,QAVF9HX#*PU.
M(:HS>&>&!I!J%P  ..Q/Y&_R(RD6*BW7_!L90396FEJUCK!)54V.-4GDF1*B
M.GTR*MV0%6^@(O[ ESSUR>JM+ [/(%;2" !J )7@QQ_J'KUDWL_W,_?C<MPA
MN=U%K90NR+)HE9Y!$:!V&J- &I6@((X$^G5Q/6?\EGXH;#FPV9EI<[7;BI_M
M)<G(,G,U)554(5ZI?'(SK9V6Q.C\7 MQ[CN7W,WF.9WLUC1&%,J*G\Z _;GA
MUF-MOW'O:00V3[W]3=SVI5R6GD*,Z_Q1ZM&#P[: T(&.EQ\L?Y=F$[<Q/7>.
MZNI,5M1-KY$'),@AIZB;'>E6=:@JGKTLY.D?J"^GVHY1]PGV.YN;V[75)*,8
MP<U ."<<,GATW]X'[I.U>Z6R[/LO+17;X["=7;116* %6H< 5!.0,&A Z/AT
MEU#MOI+K[![)V]2H@H:&G7(UUS)/D<@T:"KJ)99/41J'I']/\?8(W[>9]]W&
M2]EP"Q*J. 'EP\S_ *L=9->W?(>S^W7*MKRSM"46"-0S'+.U!J))R<_M^WH8
M_9+T/.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[JLC^:QTT_;_P 6=QX[$;7_ (_NJ@JZ>7#U,%(*BMH5\4S2," &TDJ@
M%S8'GBY]C[V\N$BWT),^A&&?]Z&1\P*\,]8L_>ZY6EYB]I+I]NV_ZZ\MW5X5
M7#AE!(H:C-0*5-*\: ]:GFU_@UW8*^E;+[-S)QLIDIY9/X;)''$7!7URJKE=
M/U)TL>/I^?>1-NNVLJK/<O)&6[EKEEKE:&@R.N.E[R3[KW\?@V6P7-NS,/U9
M2/#6GF^AG-/L'5L?P_\ Y*6\XZG&[E[7SE%C=E9Z09.JV[$\_P#&WHI9%E6G
M\L9B*,\3DCTQ@-IY(!O'V[^XNT;+;W.V[(&9PU%JH*CC7!QQ'$UQY5X9<^WO
MW&>;^>[K:^8/=>6&VL5CU/;0/()'%0%K(/#9>VIH .XCOH"&V'>@/CGU;\:=
MHR;,ZKPAPV(J:G[^M\LQFJ*VM8L'J)I;*23KOS?D\G\^X1WK>[[?KGZB](J,
M"@I2OE3\NNFWMQ[9\J>U7+Z\M\H0F*V7/<Q=B:DDEF))J23DU)XGHG_S4_E@
M]"_+YZ_=V:QE1B>SH<?4IC<_13"..HJ5BM!%51RW4:F-RS!A<WM;V;;!S=>[
M/IM2JO!4!@17M\Z>=:<*?SK7J-_=_P"[ORK[G)/NBM):;FT;B.6-RH+E3H+C
M@1JH2&JORZU=NT?Y?WR4ZZW-E-H[?V9N#*#!96:.*LHHXC#54T$O[,IC$^I;
MA=+*!>X(74 "9W;F+;YMICO[9P- UJ#6H(R!PH?49X4X=<A-X]B/=+9^;[KE
M_==DDNE5S&EPF@QNIQXA&K4O'((P0::A0DX_PC^&N\^UNT]O[8[BV#N7;N"H
MZ>.;,/D*2H@\Y@FIV=X9%?2P*(]PVI3>S<<>S;F7F^UVOE@7MF5:=T-#]H(X
M$5%3P/$=&/L-]U/>N:?=X[/[@[;-#MD($A#85B75@NJ-J, M=2U*FH!\^MJK
MJWJ#8?3NW8-L[$PT&+HHHXHY95'^5U1C4*'J9PI)M;]/ ]XK;KN]YN]P;F\.
M<D <!7T\S^?7<7DWDCESD3:$V;ENW6&) %QQ-/4_Y.A2]EO0OZ][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z+1\M/EOTG\)^G*WO#OG-9S&;1BW+
MM39&$Q>TMJ;AWYOC>N_=]YJFV]LS8NQ=D[4H,GD,IE<G652Q4U+30M8!Y9&C
MACDD7W7ND#\4OF;5_*7.]@;?K_B+\T/C!5[!H=N9457RLZAV[UOB-ZXO=51F
MZ;%56P\OMGL+?U/72H=OU+5]!+)2UM"I@:MIJ<55+YO=>Z.K[]U[JNS^7_\
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M?NO=,FP?Y<GP>ZPZE[MZ$V/\;.N</TC\BMP-N;M_J.6DR68ZWW-E?[G[4V%
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M3IS%&3456F=&#1PQ/(L2,K?K9P.#<6!XM[7;G[Q<Q>XI%C- T("T+,"* X-
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ME4DR:C7*TH /,UX^09*D5*&,2F/Q@J=/'%E^@/MZ]:6?5.S$>9(].B>U2&U
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M/6JD?+K+'/*MCK/!N"NH'^G]D>Z,B:L"AZ=2>53QZ>J/-U$ 'J-[@@#TD'_
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MOMTT)TU64 Z&7X@U.TK\Z\/GT='X[]&9O=%;3Q"IR1CEDAND$K! #*J$'U
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M$97M[K 56,Z;W]E'K,<[:9*5,DY%?(L952!8K9A>^I?ZD7D].>MU&SB.P%/
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M_<2M):V-UI13P#]NLC_3$LU#4U/5VWO"?KK'U[W[KW7RW/\ A9M_V]CZZ_\
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MR&H5_EU\\W^8/\C]Q_(GO3,[*Q=9/%M+ 5\M/4/"#XZA!5Z:IG)L0K!2I^G
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MU=-4T-+.C2EV\\3QA&T7:[VL+'^@(Y]S3]V/[MON_P"WN^1\Y\V[.UG;EE9
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M%-D:K<#)1@,.'?1&SH"/ZE;<?CW 'W>-FWOEGW8W';*XVZ)XIRIJC,CX/V$
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M[&Y6BJ<=D:*I0/!4T==$\%33RHPY5T<@@_U]VC=XG62,E2#@_,<.J,J2 I(
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MJK'XVD8EC8 6)]XR<V<C6>Y1S6U^A#Z66GGE3UE+;\T[?86HW.:=(X -1=B
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MLP0_+J3N7.9^8MZY<M+O>W*W$L2-*H% '(J0,GS^9ZDM(S&[%V9_]]^?;*H
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M630&<EXU8$Q.&<H01VEM :APU>[K82VEMC&[.VYAMKXB+QXW#44-%3_U81*
MTK_7U.=3-_P;Z^\6=SW"XW7<)=PN3WR,6/R]%'R QUTMV+9[+E_9[?9MO73#
M;HJ+\Z#)/S)STI_:#HWZIF^??3.Y]KYFH[5V5MVIR^#K(8SF*"@3RR4\\2B2
MHECIX@S$VC9T3Z'Z?GWE7[(;]LV^F/EW>YQ%.O:DC&F":+4GRX GRZYO_>_Y
M%YHY:,ON'R?8/>P:0T\,8JW;ERB#BU 2J^9P,GJI&G[4W=DIY*/%;,K:^LCD
M-/+244&0J:NGFYB\$D4%&Q#<?2U_\+^\OI/;?EBUC\6ZO0B$5U,R!6&#6I;A
MURWM??GW!W:Y>RVGE]YY4)1DB6>22-Q4:65(20PIP(KY=)[<VX_E3'0SU.W>
MB-W97TR- L.W\I#]-<D085E[GTBQTC_8#V0[K>>T'*J%KJ\60J*C3(KBM,BJ
MU_RGJ1N4]I^\O[@S".UVB:T1C0EK&:-@">)-S(@Q_$0!YX%.@;ZF^/'\P[Y3
M]M8+;V0Z_P!P]6;.ILQ!/G,IN"FF@@EH8G5:EX#(&BC)@UA6 6VJY4B_N/\
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8[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>timage_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_004.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M;=I%_P#8D?['V$Q]X3>8\-!9 @T/9<5KP-=,E#]HQZ8IT-E_NX^2V%?K=\.
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M\(<@L%_""0!4T\Z4X^1Z,=O>Z)(NE4'U3 )\Z<: G('I3H9(]7C35^K0M_\
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M>NNW)O*&V\B[?'8;3!'###&D42QHJ4CC142I10"0H X>7#KADLQ386G:HJY
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MUW2^[/\ <YV#[M\3S)_CEZ]-=S*H=RWXB&(+'4<\<^?3O)+"D?D?1$(5*.G
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MO?;,.V\CF9*:E@F@-;'19:G>NK):2DI_#55WE/NO='WV'\0!\*?Y"F ^/_\
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M8$)IK\52!Q%*4]>@][R>^&Q>QFRS[ONLZ%XPQCAC8>-)QH"!FH_$3Q/5Z?\
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M[8K9-=U'B=BY;JG>G8E/+#0Y/<6T<M+FLG6;B_A-/-+2C=60K\U-53TM#/\
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M?$4=%_?.GR#T60G$%3D*2>KB=VGTOI]^Z]T'7QH^%/\ PI9^$W5&ROAUT/\
M)'^6/V'\>.K(!M'J_N+N;:^^AO#';=%1)-!#+BJ"@DQ[2XZ*5X:6EEJ*Y$B2
M& UQC4/'[KW1C/YV_P#*2^7G\TGX _$GXS;<[LZ2J^_.HNS>KM_=Y=M]ETN4
MZZP^X*O;VRLUM_<67Q&*V]A,\:.IR>:RGWM/CC%!2Q0,\(JX_$@?W7NE;_PH
M8_E.]_?S<?CGT+TW\?M]=/["SO6G?,?9.Y\IW'F,UB*1\7)@LKBI%H/X)@L[
M-49!)JZ)UAEBIX70/>I1@ WNO=$F_F2_R>_YO'R+_FU[>_F*_&+O7X/R[.Z1
MVUL["?%?8/R>RN\:_P#NE-1X..',UCX#&;*S>$J*^?<=5F<A35;5LLB^2B=H
MTFH*4P^Z]T.WS(_E0_S)?YFW\J+=7Q9^=_R)^,<GS.V]\A:7O#IK>W1>*S^$
MV%+1[5P\F,Q6 W09\/C\G+]T<MN-IJNGP+K2O)CIDI:V2B?S^Z]T5CY/?RCO
MYY?\PK:7Q#IOEKWY_+QV;3_$OY#=6;VV_P!1=(XK>F#Q&3PFU(-&3W'E,Y78
M;+5LN[(DIZ:DQV*I*"AP[4]36SSU,$JT\(]U[K<.]^Z]UII_SI?^$V_RF^?'
MSEWI\FOB)WGT/TSL'Y(=3];=;_*O;_8V4W)ALCDY=@9;$52U=-28;;^9H<S
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MP_=#W'O?<K<FN;O)UNP%2RH&8G2M:@*H- HP !0=?3+[$^S&S^R&PP;3M"!
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MIZ:CIHXJ:*.-55$4  +;Z6'X!]AEI#(2[5J>))J3Y\>/4=Q@1J%& *8%:?\
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MM)P&MI^QU< KG'PG!I]GY]!??[&>*>#<K,L+FT?QHRA*M44-0PR#^?6E!NS
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M_P#+Z_Y^_G?_ $5NYO\ ZU>_?ZS/,/\ RC+_ ,YX/^MG7O\ 7EY=_P"4EO\
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MO_K5[]_K,\P_\HR_\YX/^MG7O]>7EW_E);_G!<?]:NO?\/+_ ,OK_G[^=_\
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MZS/,/_*,O_.>#_K9U[_7EY=_Y26_YP7'_6KKW_#R_P#+Z_Y^_G?_ $5NYO\
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M )26_P"<%Q_UJZ]_P\O_ "^O^?OYW_T5NYO_ *U>_?ZS/,/_ "C+_P YX/\
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M_P#+Z_Y^_G?_ $5NYO\ ZU>_?ZS/,/\ RC+_ ,YX/^MG7O\ 7EY=_P"4EO\
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M?_16[F_^M7OW^LSS#_RC+_SG@_ZV=>_UY>7?^4EO^<%Q_P!:NO?\/+_R^O\
MG[^=_P#16[F_^M7OW^LSS#_RC+_SG@_ZV=>_UY>7?^4EO^<%Q_UJZ]_P\O\
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M_K5[]_K,\P_\HR_\YX/^MG7O]>7EW_E);_G!<?\ 6KKW_#R_\OK_ )^_G?\
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M9U[_ %Y>7?\ E);_ )P7'_6KKW_#R_\ +Z_Y^_G?_16[F_\ K5[]_K,\P_\
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M_P /+_R^O^?OYW_T5NYO_K5[]_K,\P_\HR_\YX/^MG7O]>7EW_E);_G!<?\
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M?_16[F_^M7OW^LSS#_RC+_SG@_ZV=>_UY>7?^4EO^<%Q_P!:NO?\/+_R^O\
MG[^=_P#16[F_^M7OW^LSS#_RC+_SG@_ZV=>_UY>7?^4EO^<%Q_UJZ]_P\O\
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M_K5[]_K,\P_\HR_\YX/^MG7O]>7EW_E);_G!<?\ 6KKW_#R_\OK_ )^_G?\
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MU[QW_B;]IZ]_ L)_SIL5_P">^'_HSW[PU]!^P=>\=_XF_:>O?P+"?\Z;%?\
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MT/6^W*>1ZK(QU.=R$TKSU-=E:AYC))*2SNR@A6+,227UL2>6)Y]SM%M\4(
MX"@\@ /0#'6/]QNTUPQ8M2IJ3Q))S4DU-3Y]*:/;NWX5T18/$1K];+C81_A<
M^CD\?7VI$2C@!^P=(S<2-Q9OVGK)_ L)_P Z;%?^>^'_ *,][\-?0?L'6O'?
M^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA
M_P"C/?O#7T'[!U[QW_B;]IZ]_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OV
MGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C
M/?O#7T'[!U[QW_B;]IZ]_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\
M"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#
M7T'[!U[QW_B;]IZ]_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_
M #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[
M!U[QW_B;]IZ]_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL
M5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[Q
MW_B;]IZ]_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[
MX?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;
M]IZ]_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\
MHSW[PU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]
M_ L)_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[
MPU]!^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]_ L)
M_P Z;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!
M^P=>\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]_ L)_P Z
M;%?^>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>
M\=_XF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]_ L)_P Z;%?^
M>^'_ *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_X
MF_:>O?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]_ L)_P Z;%?^>^'_
M *,]^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>
MO?P+"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]_ L)_P Z;%?^>^'_ *,]
M^\-?0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+
M"?\ .FQ7_GOA_P"C/?O#7T'[!U[QW_B;]IZ]_ L)_P Z;%?^>^'_ *,]^\-?
M0?L'7O'?^)OVGKW\"PG_ #IL5_Y[X?\ HSW[PU]!^P=>\=_XF_:>O?P+"?\
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M>U:6#>O8%/75&"VUN[#;=RD];MW(9+^'3HCPS9*D5F0&I)2K%+[KW2S^4/\
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M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NF_;N\^P.@^P]O\
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MX]?S*OA!WO\ !7YJX/ 8YYXJ#L.78VX:7ICL"IBI,?/)>KJYIML5E3/64]+
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M[KW6KM_/"_[*T^.?_B(LE_[M<I[RX^[A_N)<_P#/0/\ JT.L1_O*_P!M;?\
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M[MOT\2R>153^T=4U?SA_GMV)\<)=F]1]</+BLQOQ"LVY#"YAC6IX"ZTMZE!
M^O/U_/,G[?:ER*YQ_+J)/</FM^6[)I815AG'']HZJ4ZPZ>W=VQ%#NGLO?6<R
MN2R@2I::BS,A1VK )&8 R-:[L2%^H^G'L5?2*BCM' 8IUA%N'N5NW-,K(LSQ
MC406\1CQ/ #6.C2X_P").R5I+2U63>58P&)R3DZAP2.; GZVO;_#W72H_ OI
MP!_;CI(FT7<H+-=S$G)[SQ/'C7S^?0<[T^*.'QT$^0P.>SU%61K(82,B18MR
M+'6&_ISJO_K^]JB'&A1CR I_@^WJK7NY<O\ ZJ3/*!^%R0?R.JG2 ^.OS6^0
M/Q1[YVCU?F=WU&Y>OMT9NBQ46(GDEK95U.(UO(&=@NFUS^?Z>RK<;0*"5%*Y
MQ0>?RX=9">S_ +H77,+K!/J 0*M"21@"E*DCY8QZ=;?<^^X:3:>(W1/%X&RM
M-15(@+D "KC5AZ3_ $5EY/L#;[NZ[)'XC\.LM+.V^L-%_+[#D=:UG\^O><>>
MJ^E\#0U<<]!E--95TR/=;3 , Z Z21<_5?\ 7Y]C*YOU;D6^OU8I(T99-)*D
MJRU&10T(Z$GL#'/<^[6T6B('0.BL2 =-&R*TX_9U1=24D%#1I24_$,"II"\:
M0.!;^EQ[Y6//).'D<G42:DG.>/\ Q7GY]?4(( KJH  7@*"@X\!PJ?/[>C?_
M ,M?-=947S)QM;V374&.P%-1P&#(Y18WA$T1'I)DNMPW^/!L?Q[Z2_=DV\6O
M)-Q=*JB4L0)*4D"^2Z@ U/E6G7SZ?WF/.\MM[CVFSRLYM6MU8H6)C5J5)"DZ
M0W'(%>MW+:&]MF[PHX'VGN+#[@HH((E6;'UPF("QBS76WZE)^JCV:CN&KU%3
MY<>L3;:XCE4",A@  #QJ/(_LZ7\=M"Z?TZ1IN;\6_/\ C[V.E%*=<_>^O=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2:SN=Q>W:"LS>9R%)
MC,7CZ6IJ:_)UU4*:*-*6['TLX4LH!!-O^*>]&M?V]>\OV<!UK[?+#Y^]J_*3
M>T_Q5^#E#D,G4UU?+C=W]I4%/+)1QT<DAAJ8XYQ9!(J@_1O?J?['6Z_[/5@W
MP/\ Y?\ LKXC8!LQ-4UVX^U-R4B5>Z]PUTQ)EJ)U#U U$,3^\[$#59?H/?CU
MKY]621>J.(Z67TJVECJ(N/H3_L?>APZ]UD]VZ]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M56'\V78&+W7\1NP<Q+0QSY3;L0JZ64PQR2HMV!$36:2/@"]F'+?XCV.O;D)?
M736<X'AR1R]K"JD@-0D'%?.M*^?0-YRW*XY>2#<;0E9X[F$"5"4D"EJ$!UHP
M'J*TZTP=GU$53@\9IO>.,*T$G.EHP+@_7E?I:WX]\Q?=JP&W\P;A!& %2=J!
M<#XJ5Q3B<D^IZ^G_ .[]O4V_\C;/>2LS22VL!9V)9B3&#0DU)ICCY4'7=76S
M;8R2[NQ6LY2F4:95)1BLB@/Z@=6F.0D@7X87]Y _<OOF_K9%93$B*74K)7L=
M09 -2\&X#CZ=87_WKEM-%[8R7EK'JFCF0<.Y%[:-P!! \ZUSQZ^C]Q_J!_P%
MM]/<^^#_ $F]./\ JSUQ_P!9_E7_ %?ZOSZUO?Y\W_,T/AO_ -0_:7_N5MSW
ME/\ =N_XF_Z>V_P3=8N?>4^&S_TEU_A@ZJ']Y9]8>]>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0
MF_%O_LNCX>_^)=V__P"Y4'N-?=C_ )(=Y_SSR?Y.I6]F_P#DNVO_ #73_CK]
M;O?OGCUT2Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NM7;^>%_V5I\<_\ Q$62_P#=KE/>7'W<
M/]Q+G_GH'_5H=8C_ 'E?[:V_YH-_U='58'O*#K$_KWOW7NO>_=>Z>]N[FW'M
M#+TN?VGN#-[7SU"6:BS>W<K/A*N$N+$Q5--)%-&2"0=+BXX]I;RQ@W&,PW$:
M2QMQ21%=#]JL"#^SI78W\^V2":VDDBD'!XG:-Q7T92"/V]#MG/F%\I=QX=L#
MF.^^T*G%21/!/3Q;KJ:%I4D)+)/-3O%/.C7((DD8%?21IX]A2U]N-ALI/%CL
M+8-6H)B5@#Z@-4#\@/7H7W?N;S!>Q>#)?W)7@0)"A(^;)I8_F3Z<.BW>QKT!
M>AVVE\G_ )$;$VN^R]G]T]C[>VM]L])3X;&[IJH(J:-[72B/D+T XX^V>*Q)
M(L2;A3<.1=FW6?ZFYL[>26M2[1*2Q]6Q1_\ ; ]"_;N?]ZVFW^EMKVXCBII"
M+(U$'HA-2G^T*T\ND51]M]JX[ ;@VIC^S>P:#:^[:K(UVZMMT>\\E2T&3GS"
MJE7-D*-*E:>MEJD1%F>:-VD"@.6 'LSDY>L)I8YWMK=I8@JQ2&&,R1*F5",5
MJH6O:%(IY=%4?,FXPQ20)=7*Q3%FEC$\HCE9\,74-1BWXBP-?.O6+;7:?9VS
M,'F-L;/[&WYM3;>XA4#<&WMM;OR&"H:X5</V\HK*2EJ(J>J\M/\ M/Y(VU1^
M@W7CW>]V&QW*5)[FW@EDCIX<DD,;NE#J&EF4E:'(H10YX]4L>8+_ &N)X+:Y
MN(8Y*^)'%-)&CU&DZE1@&J,&H-1CAT(&VOE-\C=G;178FU^Z^Q\%M.&F%%1X
M;';HJ8$I80"!#12!_-11#4?13R1KS]/9/>\A[+N5Q]7/96[RDZB[1J=3>K"E
M&/S8$]'5C[A;WMEM]';WMPD(&E460]B\*(?B0>@4@#H")YYZJ>:IJ9I:BIJ)
M9)ZBHGD,SR/,2SN[L2S.S$DDDDDW//L5H@C 50     *  8  '00=VE8LQ))
M)))-22<DDGB3T-6RODM\@>N< FU=B]R=B[6VW$93383#[JJZ6F@\]R_VT0DT
MTVIF+'Q!+L=7ZN?89W/DG:-YF^HNK.WED-*N\2EFI_$:=WYUQCAT*]JY\WG9
M(?I[2]N(HAP19&TK7^$&NG_:TSGCTB]C[<R/:79.U]KU>;C@R>_=X8O%5VX\
M_D%"I)N&K1)ZZKJ:B1=6@RO+(SR:G(/)8\F6ZWJ;#8RSJE5@A9ECC7B(T)"J
MJC'   "@^SHKVBQ?F*_BMV>C7$RJTLC<#(XU.S,<G)8U-2?4GJ]K^:KW-M?:
M'Q_Z]^/.R-S8[.3;EJ\/'G$I\VN=J8L-UY'3M3?>2),[B:KKQ0NDDQ)E^VF(
MNP++BM["\MS[CN\^[W,;((E?02FA3-<%@=(( HJ:P0O#4OV'+/[P7,L.V;/!
ML]M(KF9D#C7K806X4C4:DU9]%"WQ:6\\BK/^7UE,9A?F)TCDLSD:#$XZGS>?
M%1D,G61T$"&HPN3BC#RRLD:EY'1%NPNS!1<D#W._N[ ]SRY>I&K,Q2.BJ"Q-
M)HR<"IP!7[.H!]FITM^9K%Y&55#RU9B% K;R@9-!DD ?/HZ7\SKO;>?7ORPV
MIN+I;M');?KDZ-VOB,S6[)W(#&\E)G]S2_:5R4\CP3-$LROXIT;2'#:1J!,:
M>R'*MKO.P2P[G:K(OUTKH)H\@&"V&I"0"*TI52*TI7'4G>^G-EWL7,,4VV73
M1-]#$KF&3!(N+HZ7 )4TU5HP-*U\^JH.PNT>QNV,TNX>RM[;FWQF8XC3T];N
M3+S9,PQ$ZO%3I(QCIH=7/CB1$U$G3<D^Y]V?8;+E^+P;*".!":D1H%U'U8C+
M'YDD]8][US#?<QR^-?3RSN, R.6TCT4<%'R4 5STV[/WUO7KW,Q[AV'NW<FS
M,["C1)F-K9NIP-3H<@M&9J62)VC>PU(258<,"/;^Y;5:[Q'X-W%',ASHE176
MOK1@17T/$=,;9N]WLLOC6<TL#\-<3M&U/0E2*CU!P?/H9]Q?,+Y2;JQ9PN<[
MZ[.J<8\0@FI:;=-1B_*@OZ)WI&@>=6N=0D9@W&J]A8,V?MSL-A)XL5C;!JU!
M,:O0_(/J _*G0IO?<WF#<(_"EO[G3P(60I4?,QZ2?G4FOGT#6T-^;VZ_SD>Y
M=C;NW)M#<$5].9VWFJC#5)#,&9'EIY(W>-R!J1B5;Z,"/8EW':;7=XO NH8Y
MH_X)$5UX4J P-"/(C(\N@OMF\W>S2^/:32PR?QQNR,<UH2I%0?,&H/GT)6_O
MD]\A>T,0^W]_=Q[_ -RX&546HP=;N&>.CF\8 7[BEA:."H(M<&1'-[M]2223
M:>1MGV*3QK2S@CD'!Q&"Z_8S5*_D1T>[QS_O6_Q^#=WD\D9P4+E4;_3*ND-^
M8/0$^Q7T$.E1M#?&]>OLM_']A;OW1LC.FEFH3FMH;@J]M5?@J2IDA^YHIH9O
M%(40LFO2Q47!L/:'<=KMMWC\*[ABG2H;1-&DB:A6ATN&%14T-*]+]MW6ZV:3
MQK.:6"2A77#(\3Z30D:D*FAH*BM,#H1MF?)3O_KW*9_-;/[A["PV4W77S97=
M%6FYJFL.1JYP5>LKEJ7F2JK&!MYY%:;^C^R7<N2=HWB..*YL[=UB4+$/#5?#
M09TKI"E5_HBB_+H]VOGO>=EDDEMKRX1I6+RDR,_B.134P?4&:GXCW?/H-]W;
MTW=O_/5FZ-\;GSV[]QUY7[S-[CRL^8JG$?"(9IW=Q'&.$0$*BV50  /9UMVV
M6^T1""UBCAC7@D:JBCYT4#)\SQ/GT1;GNMSO,QN+N62:1N+R.SM3TJQ.!Y 8
M'D.A%Z[^1_?/4V*FP77';6^MHX.<RL<+BL],E&C3ZR\D-,[/!!*[2.S/&B.S
M68L652";>>2]IY@D$M[:02N*=[(-9I2@+"A(%!0$D4QPKT>;)SSO'+D9ALKN
M>*,U[%<E!6M2JM4*34DE0"3DY Z:5[U[N0[I\?<7:4(WP\TF]%AW_EH5RYJ8
M33R')JE6%KM=.3$?,'O'^W^CCVH/*FUGPJV=J?!H(:V\1\*AU#15.W.>VF<\
M>DW];]V_5I>W8\8DS4N)@)21I.NC]W;C-<8X=<NMN]>Y.GWG/6/9F\MDPU3^
M6KH<%G)J6DF?T^N:C+-2RR * &>%F X!L2/>MZY4VWF.GUUM#,1@,Z N!Z!L
M,!G@#3K>Q<W[IRS7Z"ZFA!R51SH)QDH:J3CB17J#V)W'VMVY54U9V;V'O#?,
MU%J% FY<]49.*GU"S?;P2.8*?5_:\<:ZOJ;GV[LW+>W\O*5L;>& -\7AHJEO
MM(%3^9/36]\T;CS(P:_N9I]/PB1RRK_I5KI'SH!7I@V?OK>O7N9CW#L/=NY-
MF9V%&B3,;6S=3@:G0Y!:,S4LD3M&]AJ0DJPX8$>UFY;5:[Q'X-W%',ASHE17
M6OK1@17T/$=(MLW>[V67QK.:6!^&N)VC:GH2I%1Z@X/GT,^XOF%\I-U8LX7.
M=]=G5.,>(034M-NFHQ?E07]$[TC0/.K7.H2,P;C5>PL&;/VYV&PD\6*QM@U:
M@F-7H?D'U ?E3H4WON;S!N$?A2W]SIX$+(4J/F8])/SJ37SZ+M!5U5-50UU-
M4U%/6T]1'5P5D$S12I+$P=94D4AUD5P&# @@BX-_8R:-74HP!4BA4@$$$4H1
MPI3RZ!*2M&P=20P(8,"0P8&H((S6N:\:]#IN;Y3?([>6U4V3NCNSLC-;7$ I
MI\36[IJG6HB"Z/%62!Q-71V NM1)*I/J(U<^PK8\A;+MMQ]5!96Z2UJ&$2]I
MK6J@BB'YJ!Z<.A;?>X6^;G;BUGOKEXJ4*F1NX4I1R*,X^3D@\3GH.\]V;V3N
MG;F#V?N?L'?&X]I;82DBVUM;/;LK\OCL<M!#]M M#0U%1)34BPTY,48BB0)'
MZ%LO'LYM-CLK"9[F"W@CEEJ9)8XHTDDU-J.IE4,U6R:DU.3GHCN]]OK^!+:>
MXGDABT^'%)-(\<>E=(T(S%5HO:* 4&!CI#^S3HJZ5FS-^;VZZS46X]@[NW)L
MO/0IXDR^U\U48.H*$AFB:2FDC9XG*C5&Q*-:S*1Q[+]SVFUWF(PW<,<R'.B5
M%=:^H# T/H1D>71EM>\7>R2^-9S2P2?QQ.R$BM:'2148R#4'S'0I[Y^57R.[
M*PTNW-[]T]A9[ 5-/]I6X2;<,U)25,?(*5=/3F&*K4WY\RO?B][#V0[5R#LN
MR2B:UL[=) :J_AAF4^JEM17_ &M.A#NWN'OF^1&"ZO;AXR*,FO2K#T8)I##_
M $U>@8V_N+<&T\S0;BVMG<QMK<&*F-1B\[M_)SX:LII"K(9*>JIGCGA?2S#4
MC@V)%[$^Q+=V<.X1M#.B21L*,DBJZ,.-"K @\/,=!6SO9MNE6>WD>*1#59(V
M9'4TI4,I!&#3!X=.>\=][X[$RL>=[ WENO?.<BHH<;%F=X[BK-S5:T].TCQP
M+45LT\RPH\LK*@?2&=B "QNSMVU6NSQ^%:0Q0(6+%(8TB4L0 31 HJ0 *TK@
M>G3^Y;O=[S();R:6=PH4/-(\KA020-3EC0$D@5I4GUZ>*WMWMC);-AZZR/9_
M8=?U]3P4=-3[%K=ZY*JPT<>.D6:GC3&/4M1*D$J(\:B !'4,H! /M-%R]M\-
MR;Q+:W6X)),ZPQB8E@027"ZJD$@YR,'I5+S)N,]L+)[JY:W 51 T\IA 4@J/
M#+::*0"!3! (Z#SV<=$O2UV)V1O_ *OS7]XNNMY[EV1G# U+)D]L9B?#RR1.
M06AE,+IYH6(!*.&0D D7 ]EF[;+:;[%X-Y#',E:Z9$5P#ZBH-#\Q0]&NS[[>
M\OR^-8S2P/2A:-RI(]#0T(^1J.I_8G;?9W;F0H<IV=OS=6^J_&4ST>,GW-F9
MLK]M%*0SI3K(Q2%9&"E]"KK(!:Y ]L[-R]8\O(T=C!% K&K"- NHC@21DT\J
M\/+I[>^9+_F5UDO[B6=D!"F1BP4'C0<!6F:#-!7IPVKWIW=L3"Q[;V1W'VIL
MW;L,M1/#@=J]A9?;U$CU;:I76EI*R&!7E8DN1'=CR;GVU?\ *NU[K*9KJSM9
MI" #)+;Q2.0, :G0G'EG'3MAS9NNU1""UO+N&,$D1Q7$T: DU-%1P,G)QGI'
M[:WEN_9F=BW1L_=6Y-I[F@^Y$&XMM9RJP5<GWBLDVBKI98JA?*K,'M)Z@2&N
M"?9C>[;;;E%X%S%'+$:5CD170Z>':P(QY8QT6V.Z7.V3?46TTL4N?U(I'CD[
MN/<I#9\\YZ<MZ]E=C=DU-#6=B[_WMOZLQD$M+C:O>NZJ_=4E/'.P=XX)*Z>=
MHD=@"RJ0"1<B_MG;-DLME#+9V\, 8@L(8DB#$8!(15J1\^GMTWR]WPJU[<3W
M!0$*9Y9)2H.2 9&:E:9ITQ;?W'N#:>7H]P;6SN9VUGL=(9<?F]OY2?#5<#$%
M2T-33/'-$Q!(NK@V-O:J\LH=PC,-Q&DL;89)%5T;[58$'\QTELKZ?;9!-;R/
M%(OPO&[(Z_8RD$?D>AYS_P P_E)N?"MM[-]]=FU6(DADIJBFBW144#31RBS1
MU$U.T4]0C#@K+(X()!%B;A.T]N-AL9?&BL;8/6H)C# $>8#5 /V =#"\]SN8
M+^+P9;^Y*4H0)"A(]"R:6(^TGHMOL:] 7KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z,-\!/^WD/Q<_ZB-Y?^\]G_<1>]G_*OW?^DB_[2(NI
MH]B_^2]:_P"GE_[1Y>MT+W@)UT Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[H >]_E%T3\9JOI&B[PWY#L6?Y&=Z[(^-/3@GP
M.4S2YC>W9$=;)@\'Y,;15B4#Y 8^J5*FL:GHUD58Y*A'DC5O=>Z'[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW07Q]V].2]Q5'
MQZC[3Z^?OBEV#'VK4=-+N^@.YTVS+7#&KGVP?G_B0P_\0*TQJ_M_ )F2,N&=
M0?=>Z%#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2<S><QNVL379K-5
MT5!C<?'4U5=53N%5$CNQNQ_ %_>AZ_/JDKB(5/I4CK74^87\UO<NZMTY/IGX
MTQ35-71UDV*K=V4ZLX5HY&A,BR1D,%8K>^JUOZ#V;VNW^+0^HKGRJ/\ 5]O4
M(^Y7O!;\I1E(LR$Z:#+5K2@IGCZ=$\V[\>.Q.TI_[Q]X[TR.Y,G42M5$+DYV
MYJ#Y&5GD=F;U%A:UOZ'V<P6ZKC2#CT%!UC!N/-N]\WDF25HHR20/$8L03C@P
M Z%F?XN=68O'NL^,53!=WFEJ#SIX_+?0_P!/I[5"@QI7&. _S=!RZV-U0F6Y
MN#YDF4T_(5ZKB^4NR.O*.I3;/7U+4UF_L@8(L3'B:N63Q2"72O\ FN49>!P>
M+>V;UD1!VJ#ZT /3O)$VX7.XK!:22R( ,ZVTGY"E*XIGA\^MJ#^5SU]VIUW\
M6-F8CM:2N7-V,T5+7U,TK^*IBC,0/E)X5>+'D?4>P3><3Z$_EQKUT3Y=MI;:
MVB$Q);PX]0))H= !&>&<=3:C<E5U]\A:J1/(F-R\\D=8\<A5=3R-<M8\GGZG
MW@ENG-3<E<\A-;*DUQ)559E5E:1C0@$ _9D=9$6FS#?-F:15%8T K05[13C2
MO2L^8OPEZN^9.RJ6#/)34^Z<?3+-M7<"0QNT#%0R.-09@0+'AA]#_6WO/"SW
M 2@2(30@,,^1%?\ +UCQO_+<&\1&VG"U(I4K4G]HZI%K_P"6U\G^AJC)';FY
MZC<^'IEEJ$E@>63T4JM)KT:B$9D4D\7_ !_C[$5OO0% U3]N?EUC-S/]W&.=
MF:TD,9U$@IVFE2?+_+U6QNS^9C7];[KKMCYS&/\ Q3%5)HJL-+)?R4[F)@03
M<6=3Q?VO^LC;-!_+H!2^TF[V<HB6X8CAD5)H:>5.CJ]1;#^2?S*VA2;NV$7Q
M6V\RS0+5*TB! 1>X;5]0".;B_M-<;K''@4'ET=67L!>;@VJYE9QZ$]O[.K%O
MB1_*'H-A;RQ_:7>.=&\L[0S193%X_1]SXIBP?UF4/8*QXO;CGV37-_XGFU#Z
MUI_J\NL@>3/:NTY2",@C+A%J JC-,^7KU8U\A]S#$U^U-I8V50DOF:2DADTV
M2(:51U4VLM@+>\3??_G;]W7%E8PN0\L@4A216IX&A%>LH.0MI%PES,R@A(B0
M" 0#3R\AP\J=:E?\SOL++[C^0&'VO4RB6GV\52"$R%Q&I8@$ FP-@/H+$_X^
MYN]T=R;EWD.VMJE&EAAX5!H8DQBF!Z<.LA/[N[D:#FOG.[W:XHTEO+*8@X#$
M$2-3236A^8Z)U572&ITW4^"I  -O\V& -O\ !OI[Y\V2&9XH3DO**^=:L!0U
MX\>N[MW<&"WFD)HR(TE?,5!;!XC Z,!\+?C[CNV:/-YK._<+)!6RP4DJU!1S
M=FLX:]U+  FUN3<'WUSY$VE>4^4X;?2%$^AJ*-(.I0?*E>/7R ?WAGNE>>YO
MN5+':RNAM3.A?4U2L<K( #JK^']G1_L(?DQ\5LT<WU=O7)5NSJ:<O5[7J*FH
MJ99HJ1N$!UD&ZKR+<_X^T<NUK32%& !P _U?Y/3K&+EOW9W3E"0?7%GA!TA@
M[-11PJ"<"@^8^?5ROPQ_F2[,^0DT.Q]XPC96_P"DBB@-#E)A1K.Q"KZ Q!+W
M!M]3S[(+JR:W.KYXK]O66/)7N'9<X0AHV&IE!\O,5_;U:Q!_FUO>^E?[>O\
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M=)9945258L 1I=P1V^9!X8Z&W//MCN7M\L3WIA99BP5H79@&4 D-K2,@T.*
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MC;DOV0AYRV!-QBGD2ZE9PJMI\!0DYC.KL+GM4G#<?+HRNW/Y3_Q?W1C<WM3
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MI7%PZKQ&IHG102 332?E6G4RO[#<N["D<>[[F\<\@[?U;:W1V% =*RI(Q )
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MY-#'L=HI\KM!^RWF'6N9[S(ZPIZ][]U[KWOW7NA-^+?_ &71\/?_ !+NW_\
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MS-)H#BC%8@ 0<U I3SQT%MR]DKN#?5V.UN(Y6-L+III$,*K'K,9JH:4D@@4
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M!;L>V0CMSI-?4<#^SH/OC_W6N%:DVSNJMD%-7&):"LJ)F<@&VD,S$G4 1?\
MQ]Q5]W;WU,;+LV[NQ;MCC:1V=@%&@ :B33 X&G[!T*_<3DA:->6JJNJK,J*%
M%6))X >O1S=[XBFW9L7<F($D-1#F,#DZ>!U(<,T\$@!N+@ZC<CCZ^\];602
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M@!E(H@/4?I+6G0__ +II19S\P@\9)"X/GW2$] @Y/VL[2<+'%Y&N+\$7'/\
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MP>AO^$_N.[F[LSORU^=^7K]Y]D9K,S55%M*HG$U)!#).\T?$NL:06 !TF_\
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MO8K]F_\ E6K'_22?]7Y>@E[U_P#*T7W^FA_[1X>K:_YN/_9'_4W_ (E_8?\
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M17P776OA@S!*:OPA:!?+32F*=*+^7)2;3I_Y?6Z)LN,F,-7S]Q5>^#MR(QY
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M8VGVML*':)8D@XYL7!)*5N3Z?XL^3' '(/%[DS!["K"O+<)B^(RSF;_FIXA
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M&RK&-)Y5J/,:D!(.#P(()'6=>[[M<;'[>Q7-JYCE6PL55U^)1*T$34/D=+D
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MW]YQ_=W]_(^:(1MFXMIFC"11LS59P@"UJQKFG&O'J&.?N16V]FNX1@LS,H%
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M)#Q( *1FM"<G\^I3]U_=S;N>]J@L;2*Y22.>.5C,L2I1(98R 4E<DUD%*J,
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MKNE+CGBBIV@BC\C(S,>;5[$7VS;K8WZ7,4JQ/%-=-(T@D>596=O#'AL"-.D
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M]\?.^?C?UOL+JO?4NY=VX;L+:>X\OB7VKF,)]M2XO YFBG9Y\A04M-(Z5-;
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M\$CCTD>_'K0-/(=5-_SH,=OO*_'IWVACZK-T4-;!4Y/'4-.TI*J =14 W/\
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MCACDD7W7NA^]^Z]U[W[KW7O?NO=!?U?W;TYW;!O2IZ=[3Z^[3I^N-_;BZJ[
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M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HPWP$_[>0_%S_J(WE_[SV?]Q%[V?\
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M3WJG7N@<[AZ6V'WEL;-[![#PE+F<+F:9X9#+3123*+"WC>1"P*$V!_5[\/\
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M%UJ84IP)^WJEFBQ>0R4Q>LUR:B3:1M8%S]!?Z ?2WN(MFY0M.7*&U*Z@ "5
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M@ZVPM!+65E3&LDD.CR61H]&JQ^G+ _0>JWY]YG?<_P"69;.Z?F0XACCGC4<
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M[^H.T_\ *):_]DT/_0'7O]<?=_\ E*NO^RJ;_H+KW^D'Y*?]Y6_('_T:&?\
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M]E4W_077O](/R4_[RM^0/_HT,_\ _7;W[^H.T_\ *):_]DT/_0'7O]<?=_\
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MG_\ Z[>_?U!VG_E$M?\ LFA_Z Z]_KC[O_RE77_95-_T%U[_ $@_)3_O*WY
M_P#HT,__ /7;W[^H.T_\HEK_ -DT/_0'7O\ 7'W?_E*NO^RJ;_H+KW^D'Y*?
M]Y6_('_T:&?_ /KM[]_4':?^42U_[)H?^@.O?ZX^[_\ *5=?]E4W_077O](/
MR4_[RM^0/_HT,_\ _7;W[^H.T_\ *):_]DT/_0'7O]<?=_\ E*NO^RJ;_H+K
MW^D'Y*?]Y6_('_T:&?\ _KM[]_4':?\ E$M?^R:'_H#KW^N/N_\ RE77_95-
M_P!!=>_T@_)3_O*WY _^C0S_ /\ 7;W[^H.T_P#*):_]DT/_ $!U[_7'W?\
MY2KK_LJF_P"@NO?Z0?DI_P!Y6_('_P!&AG__ *[>_?U!VG_E$M?^R:'_ * Z
M]_KC[O\ \I5U_P!E4W_072-I,1GI=SYC>.ZMY;@WON/.P1193-[GK)LK6SM
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MSFQ\7-*JY!H',\L<<,31Q^MB?3I(L?I[B.]VR]Y+F,ULSRP:C6K$A!4X K0
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MEZ_:>CA=<U,6[]AT^19TG$,5/3N@&LJ50 C_  /U]S?[L<L'E_>JT"K/'XP
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MZC!T>R\2)JNACK%'CJ\U%/XO,A94F,2W%AJ 74.!:4?O%W[M:[;)$S()#,]
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MC2-588ZYDD _:$6H+D>H'$@&6?;+V^N.<+OPQ5(UHTTGE'&3P]-;4(4'T)X
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M3WB![D_>.OK&[^AVA*LCM$=-?B0Z*46E>'4$\S^YEQ)-HM&TJC%&8ZB-0)%
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MD5I6IH>G??KVWW'FFZM[_;8C.5A\"5%90RA7:1& 8K4'Q&!H32@Q3/5//?\
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MW_Z>Y_X[#T$ONO?VNX_Z6U_PW'1#=R?]O&L__P"+L93_ -[J3W*UG_RIL?\
MTI5_[01U$MU_RNS_ /2\;_M//5AG\[?_ +EE_P#*S_\ RI^X@^['_P M+_J#
M_P"UKJ8?O1_\LS_J-_[5.J&_>5G6)?6R%\@M6YOY0FS:S$HU0F)ZA^//W2(C
M2-;;]5@:&J*A%;B*2.1V)L%C1F8C3;WACRB19>X<RR8UW>X4\A^HL[KQIQ!
M'J2!UFWS@#>>W,)C!.FRVZH%2:1M;JW#TH2?0 D\.J\?Y2O_ &5YCO\ Q'N]
M_P#H2G]R_P#>"_Y5X_\ /1#_ ,_=0W]W7_E8O^H6;_#'T(/\T;MKM39WRIR&
M&VAV9V#M7#KL39U2N)VWO/(X.F$DZ3ZY!!2U,40=[#4VBYL+GV4>Q7+]AN6P
MB6XMK>5_J)AKDAC=J#30592:#HY]^^8]QVO?O"M;JXA3Z:$Z(IY8UJ2]31&
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MDJ=>NV9@PHW<&95=/4ZO.N:8OY6^'J,G\T^L:V$VCV]B>P\Q5C26O'/M_)4
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MN8@&4E2<D@T)]344SUL?_P L[Y![)W1TI4XG(S8/;M;L^.1:Z>NJX<>)8Z%
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M&8EO9;!R/M=OMK;0D%+1ZZHO$E-:N'/>7+_$ ?BQY8Z-)^?-VN-S7>'GK>(
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M^_K]M/\ REVO_93#_P!!]>_UN-W_ .46Z_[)9O\ H'KW^C[Y*?\ >*7R!_\
M17Y__P"M/OW]?MI_Y2[7_LIA_P"@^O?ZW&[_ /*+=?\ 9+-_T#U[_1]\E/\
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M#L^J5E9RSG-2B(/*@HHZ9YSYQNN>;TWUXL2R:%CTQ*RH%2M,.[FN36K=#/\
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M_P! ]>_T??)3_O%+Y _^BOS_ /\ 6GW[^OVT_P#*7:_]E,/_ $'U[_6XW?\
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M9SD_94^O1C9;(MNVI@OSJ!_FZV1^B_C!T[\=]M4NV.L-HX[#T=/%3K_$)*.
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MG?ECUGO5]\9"JBW3N*;O#85!M/%5N/I*/&R8MGER,=;79 R5]*D"LL=+%,"
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M;+Q$6"P'>V^H\73T[4E-!EJR'<C11-:R139*&KFB5  (]$@\:^F/2./8"O\
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M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K2]^??\
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M9MWO\D\-BOBOMZMZ$R^-QFZ%QM"9,51IX)5>*-?*K)Z1Y%86/^V']!@U[?\
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M-_>2?+?*$?-7+L*;S&C2=B^)*JNZ]H% S@D4^1ZE/8N7%YAV^(;@ 7$4>H2
M,0V@5^('@:]!%OG>6Y]\9^#<FYZK[O+4\PFIID8Z3I-U8 GTK;E0+:0;?CV.
M-DY-LN4(3:6I72PII4 *P'J *'HZVGEV'8D:VC5 KUX*H# ^9 %#7C4]"9@^
M]/DKV'783I_;FZ*XPU,E!08V&*5XC'%4Z48A@X)95^K<WMS<GV']YY6V+9T:
M]GB.I22U%6@:N:8P*\.D=]RM9;5&UVR1C2231$%#6OD.KB^K/BKMKXY;/@W?
MNA,SV%VQE(D:EG^[6J6DFF4'U"1FU+'(Q _I;C\>\;.:_<6'<W-K;56+4RA0
M:!@"0"P%*U'&OKZ]0WS7OQD"@*51C154BA'\3 8R/^+\NB)?);XG=I=_9;(;
M_P!R=B05.7Q-')4XG 4\[RB"*&\BPE 2B.BG2P '(/%O9QRG[U[?[;F&$V[!
MVD%70 $BM,$4-,?LZ0VO.L=BC6CP2 %1XCJP!;@-5*@FOK0]$ ZUWE-L[-Y7
M:F?</68FI;'U"N2 #"QCUJI/!NI(_P ./>1WO)[>6WOAL7[ZL@%N88EE^$>(
M49 VEFI4C/ ^?\NA_P!PS[R-][0;VFS[C*!M=^RI!%)(WAQEB-+!:Z1)2E6
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M\70&6:.A@/\ FT9Y7O43SR/@-SSSI<<[7AN):K&M5@BKB-*_S=J NWF: =H
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MV(5)9 "0Z=NM&.0214$&OSKT+?6FX()<= PK4DQT\<(B,DFH:V4<6)//]?\
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M3CHT!U"O7.PMI_%K6]UIUOKK2O/I7U?JX^O^O_7WZG7NO(BHH50%50%55%@
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MRN,V]A49YXG5A-@<=,C"939*NI44Y+PQ5<;3H_N5^X>6K3;;%J7+QR>+(IS
MC32F@(X2,#@_A7."5(@]/;;]^<RW6Z7RUMT>+P8S0B=UAB%6!XQJ0<?B84^$
M$&]0 * J@     6  _ ]P7U.'7?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7ND=NS=%!M+;N?W
M-DJCQ4&&Q];6SN6L%%$KD_3^MO=3_FIU0MI1G/X:UZU%?E;_ #-?D/V)W?DL
MOT7D<G1=:[#R@22*D@=5KOM9V1AK1A=65>+_ .QY]G4&W]H9>) ...0/,9Z@
M/F_WFMMEO%MVIDD<:\#UL.? ;Y54GR@Z:Q&;S"+1[PQM+]KGZ(@*Z- $36X_
M#,0>?\/99=0*C<!YU^T=3#RQOJ\PVJS1\-*''S7HY&<V?M_.1NN8Q$-:LSLQ
M9XEEY?GZFY4?\@^PWNO+UIOBZ+F*-AZ,BG'Y@]"VVOY;8@QNRGU#,#^U2.BG
M=I_#G:&^C42X.:IVW4NLC PMXEN]S_8TV'-O>._//W6]GYF#-;B*,LS,2L:*
M:L:\5 ]>AYL7N?>[4VEM3@ #N9C4# .2:U^?51?R_P#B=NSIC:%1N27+39/$
MJTD'D,K$$<V<@GTEAS[QKW+[K]QR7<">+O16)':#4 ^M*_D>I6V_W0CWU?IY
M $9O,4!J>/"G56NR #50U)),:51G<'FX,9?G^O\ 7W/O+MHT4$:4I2- 5& "
M%7%!Z<.B"^)5FH21J-"3Y5(_V>M>/^8%72]D?*_&[-2:7PY&N%,3Y"UBX3\7
MMP23_K^\\/9NQ6.PPH%44F@ /PCTIU ^^0'==V6T'XW-1Y$D^?D?/CUL9?"S
MXB;'Z>ZUPF3H,4J[BR%+2FJKHE4D^2)#R0I(&HWL38>QON%^5/@H*  :C3+'
MS\NLVN2>5;;DFS18E3Q'BC9B%4,&*J2 1D9Z9OG;@MY8+JK-9/:FX)Z*"&GD
M-5XI'IRU@00-!!(_WBWTX]N;>^M7 J& K4$UITYS[>O)M$LL;,C(,D,03C.0
M1_L]:V%!)4U2_<U\[3ULTVN1E:[-_2YY/ X _IP./93*Q+&I)-3YD]8&.Y9V
MF<EM3%JMDY):M34YKT+^W=G;LSM/)58?;];/2TH\4LJ13'A!:W L1;^AM[#]
M_P RV>V2B*6ZB#'R8BJGTR?+ATGEWJQM<O+0_B%>!].A<ZM[(WOTOF9:W!O4
M8JI"RT]1CYO(0?/>Y$=_H3_A_K^PMSAR1MON0J--X;A  '**U?F"1P/'[.D>
MX\HV//$/CE@*"JO@'(XU]3_/H./DVF[-V8+,]T9S;\DV7I:1FQ^=CIY(75RM
MUTD+<V!L #;\"P]QY=MM?+!CV3;I?U%TAQ&=/P@"ATT'EPZ"L!L]G*;59N!(
MM-10T9P*#-,FM#QZJI^-GRZW=T3VSF=W9FCJLGA\_7''9IZI6@015$EG#-(A
MXC:]B;BW'X]F6Z<OQ[B$4'25],'@ ?3H3;AL<=_H[J$4.,<0/GU?=UE2CY)S
MON'J+'QY2@R2B1XJ*=66)Y!J?E  &!/)XO;GV)+[F[;N1[6.&\DH1&B@DU.%
MIBO1E=[Y9\I0K'=R&I "9)/#%.)_+I5;XZMWMUQ41T>\,+48O[HWI6F!"NJ_
MI:_T86^AO^?9CRSS79<SQF2SDU4XT/'[>EVP[W9[Y&SV[%J<0>)\\U_XOI9=
M?=Q9W86)R6V D.3Q&5IY89*:<6*^;@A;W^O]0.?81YL]M8>:;Y-Q55$D8 9P
MHUBGEJI6G0>WOV[CWV\3<8Z*5H7*@*<>1('D2: G[.D%34-7F<])_"5D27,U
M:HE"KFT8JFN; ']5F-S]2?\ 7]C&XGCV/;_&N%6D*A0Y )H@ K4Y\NAON%Y'
MM]HLEPHTPHJJQ K1 %!J1Z#H<]^?&;=FQ]JINE837H\4$E;&EW:-)%#6:YN"
M.1S]#Q[C'E3WLL.9KWZ%"-6LH#YD@D?Y.@#M?N5;[]=+9J"FIBJM0@, >(./
M2HI^733TK\=MQ=WR3KB62BIAYE2IE](,D=QIU?DFW^]_T/L\YV]S8.1[E;60
M!V<]M14TK\^C7F;G2WY7N5L2#(["O"I &"?^+Z1&Y>F]S;9[<INGLQ3M'D9Z
MZDIY95%B8Y7T:U(_#?4?@@\>Q)9<WQ7^UON"@ (H)^6*_+I>N_1RV#75,:=7
M#/"N<5KG[:]&_P#DE\#L!U3U#3=A83)35>3Q\%.N8B?@:IT#,0W.I5?4+'Z?
M4?X1?RA[OMS!N'TCJ-+2,J'SI7'\O]7J"-JYQFN;J-9U3PV-%/$Z1PU CC3C
MTT?$^+;7675&6[,KWTRRDTU14E!J5%"Z@'^H!8_@_B_U]P][Z;E?<P[RNU1*
M6(=HX^-31B!Z^0\NHJ]T-SGWC>U@CU-I/AQ1@G34DJ/D  I\N!H/3I+[\^8?
M5V$>KS6!VE#N3/31,8\K)%&S1,?IR5UG3;@CZ^U'+/W=-]W >#=7'@Q\-.L@
M4&,BH'[1TSMOM9NDKLER7B0D@]S4I7T..'R/5:/<_P @.PNY*N1\[E)(\&C3
M-2XF,O#'&)6) T A=8%@6M<VYY]Y6>WGM+8<B14*0R3  >)H0L6  )#$$Y.>
M/GU,O*W(5IRQ"2-,DI'QE5+UX\:5X^G2T^(766X^U<GF]OTM7,M/BH#645,T
MS,FL#TG3J*ZKVYM?W/?+5XHM9[:]'Z4A*LK#4K*30 @X(IY'J6.5N2KOF;3>
MV;-%<6;!U:,E'JO ZEH<TX]&.G;)[+W#+LO>4%1!60O)#2U1!A5O Y6Q;^T+
MC^O^]^\ /O(_=^EY3F.[;1&K6LK/*5B0!$#DN %4  *#2@ H,#AUV&^YY]Y^
M+G*'^K._2O'N5O2)&N9&=IA&/#J&<D]VFH]>G^HI8JRFEIZR.-J6H#(R)9@"
M?Z?4$V_-O>(EK=R;=,+J%BKH0:J2ND^8P10#RSUG_>VR;C&UO.JLCC205!5T
M/R8&H(\C4=(;&5FZ.J\[#7X&1ZC;M4Q^[@$A](<\KI!MQ_K>\X?;+WCVSGS;
MOW1S#H\4(L<4\P#RJ%4*-+O5AP\B.N.GWN?N3;EM&X2\W<D1*P4/)=64:*BZ
MF)=G5$HM:L:$"OY]6F_ C;>V/DQVW2;2J,I38B&&..JJ5GJ!2MJ:Q:.]P=(;
MBPX]QM[C?=S??[V(PR/):&FF5B6K&<J:FM:K0_\ %]84<H^[CV4$EO<Q&&\3
ML>.49\5>UJAOZ0->MJ[K+XQ=3]9XZEBI<10Y'(0+&QK:PC5Z!INCDAM)M<?3
M_6]C3D_V/V+E!-2QB1U &ME%:@4QVDY(]>BS>N=]PWRHE9@"22%8A14^0#
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M)XF[3J)/:>%23V@DGJ1?<*PNKGDN9-VTO=1P1O(Z4H9HY$.H450-5,T %&(
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M?]7^#I5[?_XMS.M,55"*8X$CRZVJ-A3R5&R=JU$Q/DJ-M4E1)?TMJ*1VN?\
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MCYB*8!&_XV(_RJ>M?FAK(<A1TM=3-K@K*>*HB:]_3,H87_Q%['^AX]YOJP<
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MX_GT'?NSL!LUUGA>,3\AX$/^;JK'^66RI\W^DBS*H+=C*"QT\OM+/ #G\DD
M?U)M[G?WN%>5[W_J'_[2X.H!]C#3FFQ_ZB?^T2XZ$3^;5_V5YD?_ !'NR/\
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MO:?"FH?]%EK]NH]:^W\R3);TH^QR.MY]Q458Q'WU1MLS"RZB"9%IR.;?6_\
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MP,QJKJ.FKX,-2UTY:)'F)*1H')5=)/  ^H%OH/<>^Y')L/(UC'#MZCP2B!R
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MLW=&5R]#32[:$B4.*KJ@+*3J)'BN;B]O[/U^OL.\P[;N%AJ$L1" D*U,E0:
MGUJ,GI%[!\L6NP%F>2L[]T@)!*N<D#[#@4].MLJ*[1HS+H8QK=;<C_"_L'#K
M*5A0]9?>^J]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW3%ELSC</3/59;
M(TF.HZ=2T]1/4_;JH'U)-U"A?^#>W8;>2Y(6%2QX4I7IB:YCMEU2MI'K6@ZK
MO^4?\S/X[?&3#"MR.X:?>&0D5EBH-M5PR$D<K\*)0KD^DG\_3^OL5[;R;++1
MMPDCM$:A#2F@I^?E3S\^@Y-S++?2BUV>WDOICC1"-1U</(5KZTZUT/DO_-7^
M2/?^2S. V-52;7ZDS K$"QC[.K*SR,4.I6#E-)!L?I_O'L%<[>^'*OM@'M+9
M3=WJDH)XJ%-2]M:^A(J*9(ZRP]F/N#<\>]*0[EO4O[OVUY:RVKDI<,A.HJ!@
MF@-*>7V\:T:3;L$-5493-U=5F\M52F:IJLBQJV+R'4P4OKTKJ)L ;#Z?X>\'
M_<3WEW[W*G*32E8 2%0LP736@U G-!\NNUGLI]W+E/V'MEM=EM4,A55,TL<;
M2@JM/B*5%:>OKT\3UE/20K-452P*H+P)J"Z01?\ !')'^Q]Q?;P/-.+>UCDD
MD)H=-2"P.2H ^&O#J=;^\BVF,W%U,D,*C]1Y& 44^;&@'3SU)UWVC\D>P*3K
MKJK;N8JQ55/VU3N5:61J6(JV@EG%AIN/S]?J./>6GM)]V>??6&Y;PQM[=0&>
M&4=SC!X'R^6<=<X?O;??WV;VLA_<W+<GU^XW(_2FMGK%$S?Q,OF*\>MH3X$_
MRC]I]!P1[U[HIZ3>?9GW,=;3S+3H\$:K8JFAU-WC(87N#]+6!O[RWN^8;79[
M=+':(HXHXHUB1HT$;,D2Z%)* 58A036IKUQ9W>ZWWW%OI=TYFN9I9))I)?"\
M9Y$U2.9"*,Q&FK4 'E3TZO I*.CAI::*&DB@IXH41*=:<1A5/T&G\$'V")7,
MQ+ODG-2:FI_R]&\42QJ%4 "@ 4   >0_+IU][Z>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[HJGR]^(/5?S)ZNJ^N^Q:3['*47W%=L;?>/I4FR."R
M$J!144Q8IYJ:72BU5*TBQU,8 )CE2&:(5<H<WW?)MT+FV-0:"6(DZ)4]#Z$?
MA;BI]14$+\V\I6G.-J;:Y&<F.0 :XG_B7_*.##!\B-1KY"_&OY!_";<IVQW3
MMBKS>PIZMZ7:/;FW()<ABJZ*Y\:FH*C[>JT#U4E3XZE+,4$\.B1LY.2?<BPY
MOB!@>D@'?"Y E3\OQ+Z,M1ZT.!@KSW[7W_*,I,J5C)[)D!,3^F?P-_1;SK2H
MST&.+SN'S48DQ>1I:P:0S1QR .M_]7&;2)_L5'N1TE63X2#U%TL#P_$"/\'3
MM[OTUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=8:BIIZ2)IZJ
MH@IH4_5-42K"H_UV8@#_ &_O18+QQUM5+&@%?LZ3^"KMU=E;IQW7?2VT,]V7
MOW.3?;8S$[=QDN1Y) :5@@OX(;AI9G*4\2 R2S(BL?9'O',-KLL+3SR)&BC+
MN0JCY9XD^0%23@5..A)LG*]WODRP01N[MP1!J8Y J:8517+&@'$T'6RG_+D_
ME;4GQPR%'WQW]4T&\?D/5P2R8;&4TRY#&[52OB\;K!(!HK<R8FDBDJ4_R>!&
M:&D#@&IFPP]SO=F3FW59V>I+6O>QP\Y!J*C\*"@(7B:5;R49M>V/M-%R>%N[
MO2]U3M RD (H0O\ $YJ0S\*'2OFS7-^X3ZFGKWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NB5_-OX/\ 6'S8ZW&U]VZ=M[[V^M35===FT%"M76XBIG +Q2)KB-;B
MZHJ@J:1ID#V62-XJB.*9!KR1SQ=<D7/C0]\34$T)-%D4?.ATN/PM0TX$%200
M7SMR1:\[VO@S]DBU,,P%6C8_LU(:=R5 .""& 8:E7>'2/?GP[W4-D?(/9U;%
MB)*AZ3;'9F$23*X;*QQABC4M=XT69S&I9H95AK8E%YJ<7!]YR<G^X-AS="'M
MI*D#OC:@FC_TRU./Z0JI\B>L%>=?;>_Y2F*SQT4GLD6IAD\^UJ"AQ\+4(]*=
M(['9C%Y>+RXROI:U+:F$$P=E_P"#I^M#_@R@^QXDBR?"0>HYDA:(T8$?;TY>
M[]-]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW4>JJZ6BB:>LJ8
M*6% 2TM1*L*BW^+$#WIF"Y./MZLJ%S0 D_+ILVA3=@]T;NH^M>@=CY[LK?.3
M)$%/AJ RQ0Q@A7J9I)#'!3TT18:ZBIEAIH[AGDT^PYOO-%GR_ 9[F5(T'%W-
M!7T4"I9O10"3Y ]"KE[D^\YAG$%O$\CG.A!FGJQ-%4>I8@?/K9Z_ET?RR<#\
M3%_TN=IY"EWW\C=P8R2FJLE$_P!UC=NP9%1YZ/%%T5YZV5?VZFN8"\8-/2I%
M"TS56%'N5[I3<Z,;: &.T5JT/]I,PX,^< <50<#EB2!ISA]M/:V#DE!/-22Z
M9=)(^")3Q5*@5)_$YR>  !-;:?<1=2WU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW6GW_*TK?YW/\K;X<]7?"5/Y)-5\A*#J[='9M7D.X\/_,6ZHZX@
MR";WW7E\QY<;@ZQ,E4F"*EK8O$:FNII9FN)8:7W[KW5KWPP^+7?O57\R[^=?
M\G^S=@C:'4WRXC^!K]&9J3<^*S<F7_T']:Y;#[G8TM!65-70QX_+9"*F4UD%
M.U0RO) CPA9&]U[JD3^1SWW_ #-M@_R1?CSU=\;?@=C?D1B>Q,'\CL;\=>]-
MO]][9Z[Q>V*G.]D[SH*]NQ\5N&NH<R/X-G6R>1@FP<%<M=CC34@2GK8Y&?W7
MNCT]@_RA>Y>F/A1_(@^'_0F"H^SY/@G_ #,?B9\E?D=NNEW#1[?HZ7%[4R&[
M-S=@;CIDS=?!65=*VX,_4_9T5,D]68YH8XZ9(HV$7NO=&7[TZD^9_P 0_P"9
M[V+\\_C%\9JSYE=+?+7X^=8]-]]=2;'[$VUUIO#;VZNDZJN&V=R4,^[LQAL)
MDL!58JNEHJN$5(JH9F%3=8(F$GNO=/7\O+X]_.G _P QC^8%\O\ YA]8=>=:
M8GY/]0?$[&]:X+K7?E-OZAQ"=72[SHI-LU=>32Y#)9O%8R?$5.3KSAZ3'2UF
M0DI\6]534OG;W7NKQBJM]1?TE?\ 8-]1_L;>]4KU[KOWOKW2(WW+G8=H;BDV
MT63<*XZM.'LS2WE128_H>-7''NI-/Y]>I7J@7/\ 9O\ -%Q6X,HM$*^KQPJJ
MK[< 5+@1B1]']HC]-O>^!ZT:4Z9X_D7_ #-\6 :K;N3JPMU8BFJ&)M^?U'WL
M]W6A0'_BNGNE^8/\P>BTBOZVS\[+IULM+.02+"]@3]?Z>ZD4ZV#7IW'SO^<6
M/6]3TQN.IT 7TX^9[V/UY4^]_/K?7)?YC7S"I.:OH3=DP_M:,5/^/]9/>^M<
M.FO<'\Q3Y&;BVQN':FX_C)NRMHMP8O(8Z2^&DE 6M4C459&%[<_X>]97A7KQ
M4,"I (-:@@$'[0>/Y]:\N\^HOFK#NC<B]=].;QQ^R]PY&HK)<>V-FI["IF=V
MLJ@*6(/)MS[,TW'2 *^5/Y=03S+['6F^WINUTK5RY 51\1)IPX9P.KJ/A3\O
M.V_BOU!B=CY'XJ;ZR><A9&R.5BQLJ^1P@#,S".^DN-0YX^H]H99#*2220?G_
M *O7J6^7]E3EN!;55&%4"@ KI4 &HX\.AM['_FZS93 ;@V-OWXO[VEQN8P65
MQV0IWBD32TD##4RLK#0C'T\#BW-A[!^]\\[1RS((KF8!SQ!/PGS'V UZ&5CL
M=S?D,B]JX-//RKU\^CM;Y[_(3XK_ "U[+WM\;M[[GV+15>YZJLBV]65<U9X3
M7SO+X%B$H%U+:3QZB.>>0>V=Y!NT'C0N=+C6C D=K=PH?+!Z07%HUK*^K^(X
M],_ZO\G1X]E_SO?E9V]AX:/NG:&Y.R999(66LI<=,NO6!RP8N+DF]OISQ[QJ
MYX]H8+W</K1N31ZG:1T,M!5V+$4!%<GSZECECG2.SM?IOIF+:0NM5R:"E:\<
M]6>?&3Y 5_;@@^_V'D-K)5QRA8:VF,&DR"]F! &I2>3[5)MMMMX AE,A6@U5
MKJIBH/SIT9F8W8I0BHRIX@\37YU.:]5 _/[%OUO\O,+ON:%#CJ;(4DU01& I
M4R<WM]05X/X(MQ[S#]G=P%UM_AMFBK@Y&J@SGSZA_=Y?W+O<-QP"-]G#[.MD
MWXD_(_KSLWJW;8Q&9H)LI!042U&-@=0T96%+J4' TFX^@L1['=_:N6\094@5
M/&A/6;^Q[C!S;:I/;.&(B3Q!7*OI%1^VOY]!U\]=[9>?I_-XC"X.IR*U-+*7
MJ*-"U@POZRHN?H+W/U]O[= %5WKFE*?L_P!7#ICG6.6RV68*NMF6@4YICRK7
M\NM:S RRI')35L9I:E)&DDA/I(8&[*?\0>/99=>?V]8'Z2A.H:6KW  "AKD?
MED="7MVM2DS. R#PQRI1Y3'Y"0.@?B%@S?7ZWM[)K^$SVDD*5!>O#&3UJ4'Z
M9X@2&>IJ#0YSQZV8-E_(#XY]P]&;6V]V'EL;CL?B*"F>KPYJ%@\K4(12!&!I
M8$@\%>.!:UO>%&[<M;QRWN;O:QNP:65O%3B-3D\10_SZ@6ZVN[M;B@676DCL
MC)^+4U<U(R?,^?KGH;>N.[.N<ND6SNC-F04&WL-H:JSBTT<4!$7I%KHJM(P'
M)O\ DV''L)<[7-S"=%X[232'6%UEG[JMFIK7UZ+=ZOY8)5#U\8]S>(Q=@*Y)
MU&BT)X#'10?G_P#)/ 9?;>,ZKPCTN9W)4UI:O_AX#M$[74HY7^TK$@VX!%A^
M?<E^QW)US 6W.Z#10IFIQ4&C9X?\7T/>4[66]E6]E!6-%^*E-5:$G[/3_,>J
ML*C:.XMIT-/4Y[&U5'%5E3"TR,JL)+$/] #J^M_]Y]Y&6_,%AS),3:L'*$@Y
MKE33J7;#F&RW:31&P=E)7.2",>=?3RZX1NI4)P5)U!3]";WOSQ>_/TY/L_"Z
M"=( +8:F*CYTXCHW*!"U !JJ&Q2HS@^OV'H4-K=S=A[-HYJ+ YR5*!C*K1U$
MT@9?*?4$]7'(/(^O/L#;S[;;/S8_B7$; KVL0N,8IP^'T'#H*;E[>;+NS^+)
M&QD*TKI&!_",849H.%*8Z=DP^]NSJ>OW35-4Y=X0]14QB5Y_2?5<AB3<7X_I
M_7V7_6;)[92164/AQ:U4#2JHQ% !72!FG$^O6K;<]LY *V@5%U@4[5#<*9(
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MEJC_ .SKW[_@D7_Y06_[+#_VS=>_X&R+_E-7_LB'_;3U[_A@C<W_ 'G#G?\
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M;_LL/_;-U[_@;(O^4U?^R(?]M/7O^&"-S?\ ><.=_P#1+5'_ -G7OW_!(O\
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M3*SSO4F'86XUKL=KEY<_8Y>'(-"ER=,=-54\:?14" +[EK9O?#>]L 64Q7
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MEJC_ .SKW[_@D7_Y06_[+#_VS=>_X&R+_E-7_LB'_;3U[_A@C<W_ 'G#G?\
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M;_LL/_;-U[_@;(O^4U?^R(?]M/7O^&"-S?\ ><.=_P#1+5'_ -G7OW_!(O\
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MA?H+6U6_Y"-S[T!3KW7'PQ:M?CCU%=+'0.1_3W[2.O=8_M*7_E6I_P#J2O\
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M$JI,X+D@&UF)N>.>?K[)]X<V\,[1(&/A%N /=3CPXU\^JL[0).\<8=A$64D
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M^?KTXM5101EWFBB6/@+PH 46Y_3["UL$':J22.W @U_,4K^7IT/?!\%0SZ5
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MO_\ J;W[_@<(O^4N;_G"O_0?7O\ @E6_Y1(O^<S?]:^O?\/J]_\ _>*>S_\
MT-:__P"IO?O^!PB_Y2YO^<*_]!]>_P""5;_E$B_YS-_UKZ]_P^KW_P#]XI[/
M_P#0UK__ *F]^_X'"+_E+F_YPK_T'U[_ ()5O^42+_G,W_6OKW_#ZO?_ /WB
MGL__ -#6O_\ J;W[_@<(O^4N;_G"O_0?7O\ @E6_Y1(O^<S?]:^O?\/J]_\
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MO^42+_G,W_6OKW_#ZO?_ /WBGL__ -#6O_\ J;W[_@<(O^4N;_G"O_0?7O\
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M^_X'"+_E+F_YPK_T'U[_ ()5O^42+_G,W_6OKW_#ZO?_ /WBGL__ -#6O_\
MJ;W[_@<(O^4N;_G"O_0?7O\ @E6_Y1(O^<S?]:^O?\/J]_\ _>*>S_\ T-:_
M_P"IO?O^!PB_Y2YO^<*_]!]>_P""5;_E$B_YS-_UKZ]_P^KW_P#]XI[/_P#0
MUK__ *F]^_X'"+_E+F_YPK_T'U[_ ()5O^42+_G,W_6OKW_#ZO?_ /WBGL__
M -#6O_\ J;W[_@<(O^4N;_G"O_0?7O\ @E6_Y1(O^<S?]:^O?\/J]_\ _>*>
MS_\ T-:__P"IO?O^!PB_Y2YO^<*_]!]>_P""5;_E$B_YS-_UKZ]_P^KW_P#]
MXI[/_P#0UK__ *F]^_X'"+_E+F_YPK_T'U[_ ()5O^42+_G,W_6OKW_#ZO?_
M /WBGL__ -#6O_\ J;W[_@<(O^4N;_G"O_0?7O\ @E6_Y1(O^<S?]:^G?#?S
MY.T:"KC?>7Q%HZS$M+"L[[9[#JJ.>*.Y$C@38>MCE8 @JI,0)!4NNK4B>Y^[
M@-),5XX-#\< ()\OAD!'S.?LZ4VOWDU9@)+1--173<$$#SH&BH3Z"H^T=6&_
M'/\ F\?$+O\ R-%M?(;BRW3&^:Z>&BI=N=K4\.'IJF>9E01T>8@FJ,8Q:1U2
M-*F>EGD8V2 V]Q9S+[0;SRZID"+<1BI+P$L5 J>Y"%<8%20&4>9ZE;EKW=V;
MF-A&)#!(QH$G 4,20!I<%D-2: %@Q\EZM$5E=5=&5T=0R.IU AN001P01[BT
MBG4G]<O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1.ODO\]/B_P#$
M]'I.V>QJ,;N,"STW76U(O[SY^194,D3/00,!013*I\<U=-2P.>%E)X]C'EGD
M+=.;36SA/AUH9G[(AFA[C\1%<A0S#TZ"',O/>U\IBEY, ]*B).^4UJ1VK\(-
M,,VE:XKU4CO'^?=7UU9+%T]\5,YEL/96I,_OS>G\,DDN_(>@Q^.JX(_0.",P
M_J;Z63US/MOW<YI5#7-W0^:PPEEX>3NZ5_WC_#B%MT^\=;P/IMK0E?XIIE1J
M_P"D1)/+^G^6,HC_ (?5[_\ ^\4]G_\ H:U__P!3>S7_ ('"+_E+F_YPK_T'
MT4_\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%_P I<W_.
M%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\
M*7-_SA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P
M.$7_ "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]
M3>_?\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&
MM?\ _4WOW_ X1?\ *7-_SA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4
M]G_^AK7_ /U-[]_P.$7_ "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>_
M_P#O%/9__H:U_P#]3>_?\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[
M_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\ *7-_SA7_ *#Z]_P2K?\ *)%_SF;_
M *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P.$7_ "ES?\X5_P"@^O?\$JW_ "B1
M?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%_P I<W_.%?\ H/KW_!*M
M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\ *7-_SA7_ *#Z
M]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P.$7_ "ES?\X5
M_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%_P I
M<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X
M1?\ *7-_SA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-
M[]_P.$7_ "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U
M_P#]3>_?\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V
M?_Z&M?\ _4WOW_ X1?\ *7-_SA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__
M .\4]G_^AK7_ /U-[]_P.$7_ "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^
M'U>__P#O%/9__H:U_P#]3>_?\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.9O\
MK7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\ *7-_SA7_ *#Z]_P2K?\ *)%_
MSF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P.$7_ "ES?\X5_P"@^O?\$JW_
M "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%_P I<W_.%?\ H/KW
M_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\ *7-_SA7_
M *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P.$7_ "ES
M?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%
M_P I<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WO
MW_ X1?\ *7-_SA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_
M /U-[]_P.$7_ "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9_
M_H:U_P#]3>_?\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\
M[Q3V?_Z&M?\ _4WOW_ X1?\ *7-_SA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?
M5[__ .\4]G_^AK7_ /U-[]_P.$7_ "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M
M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.
M9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\ *7-_SA7_ *#Z]_P2K?\
M*)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P.$7_ "ES?\X5_P"@^O?\
M$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?\#A%_P I<W_.%?\
MH/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\ *7-_
MSA7_ *#Z]_P2K?\ *)%_SF;_ *U]>_X?5[__ .\4]G_^AK7_ /U-[]_P.$7_
M "ES?\X5_P"@^O?\$JW_ "B1?\YF_P"M?7O^'U>__P#O%/9__H:U_P#]3>_?
M\#A%_P I<W_.%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\
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M%?\ H/KW_!*M_P HD7_.9O\ K7U[_A]7O_\ [Q3V?_Z&M?\ _4WOW_ X1?\
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M*O%R..>?:6^Y/M]^4>,$DKY.H8#]H/07O/<NTY7N/!=]+$D&AH:@T/[.K/\
MXX]O=*=\;+QV\.L&Q4E+4QI+-0PF/S022 ,P;TZK)>PO]!_7VDM>5++9JK';
MP+IP*1(.&/(#H2P\RG?%#)(Q# ,#4U-17/VUX^O1F#!#'&"8DX"F61W\*_M?
M0M_JM)_VG\>S(!:4 %/0<.K@4SY^OG]O00=G]Z]3]08JIS'86\L'@**GA$\_
MDJX)F;2>2$9@["WT)][1 .('IPZH\H&#Y>75.G?W\^SXJ=;O7T&P\@F\JV@B
MJ(F*%8AJN5X _2&(!L./]?V[]"SBGX3Y'@0?ETD.Z(AI056@KPI3'[.J+MV?
M*W;WRU[&KNQ\%AXL)%7SRAJ:FA6F1G1F-W" !F4&UR+^\=>?-J-I<D\!J- !
M2@J>%/+J9.4KWZZ 5R0HH3GR'43N[9U%VETQNG;E= *B5<36/21F,26<(;!0
M00"IX'NW)NZG:=PA:I%=/ G.!\^G=_VT7UN^H D5R0"1UKX?%/Y+[W^$';FX
M]K"E>>EJ\N8*F@J)&/HFF*AM)-KD6_'O/K9Y5WFU\1\J54\?.E:_;T#_ &W]
MP9^2;MK1X_TV8C2*@$ T!H*#@!UMG=.[\S7>.PL)NY*6;&#.4H6*-=2 "2,'
M4 MA>WYM[+KR!+)P5-00'%<G.:<.LYMMO8KRU28+3Q(TEH0,:U#8_;U6?\VO
M@M-+CLQVOAJN:HRL2S5DU.M[7B)9F^OUM?G^GY]KDNEW'L&&'EZCJ'O<SVZA
MWR%]PMSWI5W %,UJ>'S/5+6*K9EG>CE+)44\K+*@;208R0RV_ !!X_I[*KE=
M&*9&/V=8C:621@Q.&8&M?(D="#15(9DD4E6]+J0>05^EC_A_K_[S]"MB34>H
MH?F/3Y_SZ5I(T==)(U"AI45'H:<?LZ.3U-\O>S^L<.-OTE94Y+'^,1T\=3$M
M4$4BW&LMR?R?S^?K[ACG3V)VOG:X$[".,D=Q5$''-#V_RZC[>O;BWWJ<2HP@
MK\?A@)J)XUI2O^'J!OSOSLCMO(14%?E79*J2"FI,13!J9;R6%C&A"%S^>.3_
M +?VNY9]J=G]O ;H+"!'C6(T!(7@:@5\O\O1SM7)ECRFIO&"'0*:RJEF Q4F
ME<_;QZ%.;XI]PXS8:[TBPP6@J(:>MEIX9]4@C=@S2! ;H64FYMS]/S[3_P"O
M-M%[N4ED'%-! ]*C'V5Z20^ZEC=,T9&"[*C$8P2,$BF/*GIU;KT)LSIG#_'N
MDS&\MI8RIBJZ-H<[65*+++#-7!5)D+#7'H=K*+V7@+[@#F'>+RYW(_2RS.-9
M$8$CX74:4HW"E/\ BNHTWG=)KB]?2\U"Y$6B1P "30D @$4]>GW;'0>%Z_GK
M8]L5)K>N-[T5;F:"II)C4K2R,C-%8@D!#K%_I>UR/S[#?-6Y>-<I+?HKM%16
M9U#M5#0@E@36H]:UZ#NZSO)=I)<J'"54DC6:J:9J#]IK]O11MI=D4. W=E^D
M^X9X9:"/,_<[>R];PH6Y,2^1Q<#@'@CG^GL3;[R4-[LX]]V9F/Z,8D2/%'T#
M5@4S4D='.\<L-N-NNX;2&H55I1$-)&H G  ]<@\:"N>D'\PLUM4X#$T. S%'
ME*XS758:@53JA("KKN6-AP>3Q[7?=VVG=+#=+DWD3)$RES4$ L:FI'J:UKQZ
M/?9_;KBPNI)")%1LG6-.2344]!P]!P&!T02JAS46/3(C&ULE$&\4LT=),T:F
MUCKTC23_ (_['WE6V[;>)%@,@#-3%>!/4[7N[6T$PB9A5C]O$\,]'#Z+^,^W
M>T-HG=FX,M/144\@*Q0N8Q&R>M'<$@*A^IN/]<_GWCM[K^\=_P I;@+.PC#@
M5C)(^,*=(J/.M/.M>H2YV]QKW;+Y[:WTJJ576U>Y:Z5&,YI^7SZ--2;NW9UA
ME-G=9Y2<9G9&0+4^-W)$C2"+78*NL$@7^IL2"?Z@W,&<PV-OSG:3;JX2"[B+
M%H$4*"]:M@ >9/\ EZB?>)EWN!YPX22M98E44+$YIP(-:\*<,C'2B[5Z7@W=
MLJJP=)G_ ."X*NK5RN=F:M:$S>#UNK,&&I"=7I-_K^?99R-[BW5@F@01R2@!
M59U#.A  HI(J *4 %.%.D.T[M/R]4J%G)H(VDHTB8H M02 /*E.JIOEUWG@:
M#:M#TAUK.AVQA(Q%FJBG<1(\D($;$A+!KLI-R#_7\^\J_:+D2;<;EM_OQ6=R
M95UBK4D)>G=4@"M .I:]N^4[C<9'W?<:@EC*BMFH<ZQQ^W_5GH%/B+\8ZOY#
M[EITEEE7!XJ>.1JG_.:S&1IO?@D^\J;<T!GE&#W:?(:JF@'H.'R'67_M9R&.
M;7DNIFTQAB0*F@!R !6@XXX?RZV,.O>L*SJ79U-MW%U=-+3XJ)Y4C-C(X@72
M%_J?T_3Z^TUU=B]=<%0 %'R'68&SVEIM%LMLM6 4*-6:$"E:'@?Y]49?S(?Y
MB&Z\.VYND,3CI,8\L1Q];.L30-IJ28[ K8D ?3_#Z6Y]G\5O#MRZUJ6(XGRK
MZ?MZQY]W?=3^KZOMD,8UN635PK0D'A]E?/IS_E4]+#96R\OV-N&G,E;N=9*F
MDJJB'4Y,J^0:68:A]1;GZ^\4O>_F,W<ZP*S4!*D FAI4</RZA[DC;S(&N)0"
MS'74BI4GNP3D4KU8AN6HK<C%4&"GDJ)VI:F>%;FKEE9P2 /JW/\ 3WCY+&9I
ME13Z"@X8ZD^&MO$SDGS(-2#GTZKUI_Y@WRS^-V]:W;NWL[N+:V IZUIJ?%G&
MS('".0HU.RH#8*"?S[R@Y)VXV=F%?)9%*U\@5%*5ZQ[YOY@G%S3)[CYGU/S\
M^K4OC]_PHF[+VR,;B.T=G_QNE-3#!D<C42&6552RLY)+>.Y%]*FP/T%O9X=O
M<>9]/7Y=%L',(8 /Q\\G!_XOK8X^*O\ ,_\ C1\H<9CH=M;UI,;NBJ^U%1@*
MZIAHF61U#.B$D:E5KCZ &_U'ME[5EJ/0YX_9T:07BW/#HX?<G;VUNH.O]P=C
M;@R%-%CL/BYJ^B#U$9\[*I*&(J69E=2+7]Z@1F8K7'IU6^N8K&(SSG2J5-3^
M5.M.+YI_(;LCYQ;BS6Z\;MC^&;,P$NC#3QPE#-#2.VH@V&H%%!/]1[&.R[I>
M[7VQ-(J^BLP%/7!^?6'WN+[G6.Y7ZQJJ.%8J"P#5 J/3Y ]*GXP?R],%\S>M
M\MN/:N1DV?N39<7@-+3 VK)HP%&OQ$$*S"]B.+_3VJN[O9>9T>'>+;6]2!))
M&KL*5J5+ACY5P>'62_ME[I<V<H65O>\O[E)'&NC5!$\B*% %$(1E!"C%#@TZ
M _L[X!_+OI>3(/4[#KLQ@Z*2<BOIJ9ZJ\2,0K$@'ADTGG^O^/N"]_P#NL[-N
MT<]Y8WA5Y'=TA! H&)95ICA6F.NE'MY_>?[QMDUMM>^6 :,1Q)+=L&!U*JJS
M5K3)!-#T4.;/56(FEH-R8S)XO)TD\E/-!-BIJ=$^W)5M1"A39@;FYYO[QCWK
M[OW,6T)),MLS1HQTM2NI0>/#S_U5ZZ*<D_?(]O\ G=XK5=Q2.X=5[)'-&8J*
MT[N%:^73Q29/'5Z^6GJ*;3I71*TPY6UQP22!]#8VM]/</W5E<6K$3!PZDJRF
M,T4K@J*BE :C&*=9,V^X6UQ&CP7$,BLJLM)%-58 C ../"G4SR(R+&L].T:W
MD5(B+7?Z\?3G\_U]HW+H=2\3FM*'US3SZ712&('0H:O&G _8?,=,<^V,!6SM
M4RT#FI<L35(^ECKYX-KCGFU_8AVKF7==BH]I.5.#0.01BOD0>@]S!RKMW-$+
M0;A LD;U+QN@:,L>-5:H/'TSU"EV9BR!H2ICLQ9"*LH0?]4.1S_C^3_A[&L/
MOQS3%11?RC2*4JQ IBGQ<.H+N?N>>VM\Q=]FM@SL68I#$O<34FGA@#).!]G7
M>/CW_@Z]*W";]RE&E-(#2TQJ9R(POZ5)60<J  6MR1[D'9OO0[QMZJ)R\I
M)9V(8@4K0F@KZ= 7?ON#\A;M \=M9B%V)*LFA&4$D@ J*XK3CT.6+^1/R?Q<
M428SN#-TPA1(T_RB<6"K:U_+<\#\_7Z^Y$L_OC104\7;E=J"I*QG4W G/K\^
ML5]\_NH[.^=VMMTDA5F8JNN0,JL20I*\2*Y-:U%>GF+Y5?+JED9Z+O',T\S.
M6=M<ZW;Z\GR\F_YO[.+;[ZEC$:OLD;U\SX>?RIC[!T"[K^Z$><=O,$J^>/$J
M/M)-2?F<GCTY1_,GYI)"\/\ IRRDC$V\K-.S#FWU\MQ_K$_[#W9_OHV+DD;'
M'YT_L\?RZ?C_ +HN>) O]9)\ #XI?(>7=U#7Y<?-"12E1WQF'B8M=$DG8\_Z
MK]TB_P#KF_\ 7V\/OIV"C.QQ_LC_ ,W2>'^Z#D#%FYBF())[C*>)KYGJ"_RB
M^63:PG=&?&LGR%*J>,,1_4"6W]>+&WM$WWT+,G&UQKG"^'&:5\L#R'1A#_=&
MK$>[?W;/ AC_ (2>@VW%V!WKNBH-5ENS\U+-,H-2\=3*2VOE@?W.5N2 .?87
MW3[X=[,&2WM5CU$Z**%*J> !4>0ZF;EK^[)Y5VAX&OI7N="()"RATE< :FTM
M4=Q!-#Z]!V=L5%;(\V9RV2RDKN[U >H>/4[DEF(/%RU_^(/N)K[[Q7-,LC&*
M^EB!9B &:H!)Q4&N*TR:]9'6?W*O;2UC5'VF&32 M6CCTF@ P-% /.@P!BG4
M]MH8)XD26@EEB5;(DLY<>CZ?7_#_ !L?K["&[^Z/,/,8I=WLCUXEY7-2<G!8
M_LIU)/)_L/R?R0VK:=NMH"H%"MO$M ,#(1?3U-?/IYI*:EH8%IH$\%-#=(PR
M<*J^D ?ZP_WW]0#.!.Q:1ZL<DUP3FO\ .M/EU,D8:$!$4     4%!PQU)$T2
M1F0STYL2"SR#4;?DG_'W:.,N1X<,CE0*$5(QC'R^SATED"PU)"I4DG6^D$DU
M)_;TFIMX8:*HFIHS5UE3"I0PT,<U79DX(4+=>"/H /\ ;>Y#Y;]K.8.?) ;"
MU8 4J74T/S-0>/Y]0[[C^_G*?L\%;>[V.&HXHXD^T 5P/\'2LZYV'WKW'E?X
M/UIL#(Y1:@F&*7(XZ>EMJ_20Q2UR".;\^\B>4?NFW%R=.[RFW!^, T4-YTX#
M!X?LZPM]U_[S;E?EJU>7EB%MP>K%30T?T.D'@>-#Z]6F_&?^2MW5VA(^2[KS
M=1LBBCK&GFH897.M'8DK:XU*/H+@_P!3[R$V3VSY/]O82IC6\E0: [QQN05Q
M4%U-!CR_+KFS[C??+Y]][G66PFEVB(U9HX_$@'<:T/ALFHBM"36M/GU?3T#_
M "ROC5TAB,= -FXC<^<I&IIAG<CCC*[20*/7I:ZDLW(M_K #V>3<[SPQ>#9Z
MH80 JI&Q0:0,"BT'"@-1]@Z@B]Y:/,%U^\-UE-W=D#7-,=;L>+4+EFTU)H*T
MH:=6+XS&XVAH:6BH:*GIJ*GIXX:>G@@$*!8P ++]!Q_7G\-["#2-*?$:NIN[
M/\1ST(8XDB4(@ 4    !0H% !3R P!TZ"&, #2I 72+J/I_3WLYZN!II\NLO
MO76^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[JE+^9S_,TK?CW5/\>/CS-0Y;Y 9FBB;<FXO%%DX-ITV3BUP_LOK@ES
MD\+I/''.K0TL!CJ)XY!+$AG#VI]JCS61?7H86H:B(*J;AE.<\1&"*,10DU (
MH2(0]UO=5>4E-E9,INBM7<T86ZL,&F09"#55-0!1F!! .MI'MFKS&:R&\>P<
MUD]^[XSE8^3S>XMRU\V:FGJ9K%Y9):EI):B4D#]R5F8V%@OT]YJ;=M$&VQK%
M$BJJBBHJA44>@4  ?LZP@W7?;C=96ED=V9S5G9BSL?4L23TKP      + #CZ
M>S3HEZ[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MTG,[M3![BB9,C11F<KICKH5$4Z?TM(!<@?T8,O\ A[9E@6;XA^?GTH@NGMSV
MG'IY=6$_ S^9+V%\0]QX'J/OG-Y??/QJR<T>*PN?J5DRF0VFTA'CEIC^Y43X
MJ(']^@NYCC!FH &CDI:C'OW1]GXM\5KRP58[K+$"BI<>H;R63T; 8X?CJ7)+
MVJ]Y9-I9;/<&9[;"AFJSV_H0>+1^J\5'P\-)VU<9DL=F<=C\QB*ZCRF)RU%2
M9+%Y/'U*5E/44]=&LL$\$T9:.6&:)U='5BK*0P)!'O#22-H6*."K*2""*$$&
MA!!X$'B.LRT=95#*000""#4$'(((\CU-]TZOU[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U0U_,X_F>Y_J_<%?\8/B]74TO:[P&G['[(@TU:;;6<<X_'<M'_&0A#5$\B.
ME"C+%&CUKEJ/('VG]IAS$%W#<%/@5_1AR/&I^-_^%^@&7.:A11X ]VO=K^K.
MJPL&'CT_5EP?!J,*H\Y#Q-<*/(D]NO5CMH0_Q"KW%N>NK-W;MRM9/D\ON#/5
M,F3FFJJQC)-.[SM(\LTDC%FED9I68EBP)(]YD6>VQ62*B*H"@!0  J@8 4"@
M 'EUA5N&[S;B[.[,2Q)8EBS,3Q+,<DGSZ67M?T5]>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TEMP;.P6XXW^]I$BJR/1D*91%,
M#^+L!^X!_1@1_2QY]L2VZS<1GU\^E5O>/;G!QZ'AU:3_ "]OYF^]?CSN7 ="
M?*/<U;NGI7+RT^(V-V=EYFJZK;3%A'##6U$A::HP:ZE5UE=Y*!=+1,U(GB7&
MKW5]G4OU:^VQ LXJSQ(*+..)*@863Y##_P"F-3E'[4>\S6S+8[G(6A-%29S5
MX"< ,3\4?](Y3UTX7:CAFAJ88JBGEBJ*>HBCF@GAD$J.DH#*Z,I*LK*000;$
M<CWB(05-#@CB.LN@:Y'67WKK?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6HGU;A?G;F/^%"'\\H?
M"+L'XL;"KJ?:G\ND]C/\G>L-T]EPU44O5.*_A8PZ;8W/MEZ26%UK_N6J))UD
M5X1&J%'+>Z]T;C^?'OSY6])?R%.^=^]A]E;,QORGV7F_CQD\QV+\=L3EM@8-
M:Q>X=IBF?$4&7R67R5/3/BWIX*J"JR%2E0QJ$<-3R^+W[KW0 _/?X0;(_EG9
M[X2_.SH3MSY(Y?Y79[YY_$OI#Y)]N]D]][IWT_:NV^W\K78;/X_=.WZS+-M6
MEIV_B=;54%+BL)046,FD*T--"BQA/=>Z.9L?>6X/AW_/&^0?66_]]Y]_C]_,
M4^+N+^373]+NS<QJL5MW>_Q.CCP^_L+A*6=KT4.3VY7TNX*P1DJTB2N5"H-'
MNO=5*;O^67R*VS_+![2^>&$W7WK@>POYS/\ ,XV#U9U!D.MJ&;([FV1U#NK/
M5>U]K1[1H,C.U%A\[DME;8R4N/J)9*>*7*YRDGU0SRPE?=>Z$C!]:;^ZF^0_
MPSW]_+5_ED_S3OBGO.C^3?5N%^7NX?D5F\/GMG[^ZOW5X\-O.KWL6[KW;49'
M=F.HUH<AC\O)BY*B*2D9'D9/%&ONO=&(^.W;L_Q]_F=?\*M.^J;;^2W94](]
M0_ #MVGVMAZ7[ZKR;];=%[RS*8^E@#Q&:IK&HA#$GD36[JNI;W'NO=-/P[_E
M0]+_ #M^ G4/SC^2';/R5W7\^ODU\>9^WH/ESA?DUOC9&6V/D>VX8,]14FRL
M/B\]2;4V_BMNO#BZ>*E3!M')%1Z*CR(Y4>Z]T2+?OS2^4'S0_E!_\)[NXJWN
MSL;ISO/Y(_S4.@_C#V7W1UU645+F:J%\CV=UGDMQ11ST#XB?(5\&.3*B*?%R
MTM/E-+I$S4T4GOW7NCJ_+#XT=9?R?_EQ_*Y^0?Q$W1WAMV7Y7?/#KSX2_*_9
M.\>^MU]R0=F4?R,H*JCH]T;FCWAFLQ+4[CVW7XNCEIZ^F>G=8C'2D&GBIH$]
MU[HON>[9VI\Y/F[_ #$,A\J?@O\ S'OGEUM\9OE#D_BC\?\ JSXYI08/8FQ(
M^E:/%3Y#<,U'7=E]>3UF]]Q[@FER--E'AKWI<?#CI,?/2I*NOW7NKD?Y)L?R
MWPGQR[CV#\I=C=_[+VYUY\G^T,#\2E^4L]%6]@3=1UT&,R.U:7=571;AW.F0
MRN$FK,EC35ME9#-#2P\MH+'W7NKD/?NO=>]^Z]U[W[KW7O?NO=>]^Z]TB-]"
MI.T]SBD9_NGQ&3AIU$A4W:G/"V_U1^O/OR^O3<N.!ICK2QH^IZ+>OR@[4I=Y
MT J<C5559$T521.S1F62Q.L-_4GGV++$*J!J#X5\J>7'K KWL$K;PL2,P+R2
M$$'/$MT,W2W9F^?Y>7;--F:2HK:WIW+R22Y^DF=V6GCJ&NQ5 ="LJFU[<B_X
MN/=+^R\4:A3.:="?VB]QYMMNEVZ_9R0%",S,05H *5-<<#_FZQ?-W_A0ADLA
M55>P/C3C$GHYXIJ5\VKLTJ".Z*UVTJC6%_3:WLDAL\T.?^+^?66$_,4=*KY\
M#ZCU_/CUKK=R?*;Y"=V9&HJ]\]F[ER\%;+.SX 22U(_RAF9HE"RMK5;E1?ZC
MVJ-I\O\ !T'KK>IIZ^&*>E.)_9T^?&_X"]\_+#=E#A^O=@UB45=5XY*W,Y"G
MG5M#E3*3YELJJ+G2#I %AP/;33^'4>F/V8Z6;;:O/0L34@$U)XG/S\Z];1^1
M_DW4'Q?^+5/FMN5=1E>S,3$,GN!-/E10(PU0L1'(TR:P"!_2Q]QES]M W2!I
M5 JM22*5\\X%?Y]2YR?<-8N%U$#&*FG^'JO+9^7619:?(HR20&6AJZ*H-P-?
MH+.K?5@?J?Z^X!M248$DZEP#FN!Z\?+J4YT,R5'!LT\L_+AY]46?S.OCE6=<
M=B4?=NUZ)JK%Y&2DJ<H8(-*@K/K)X '&HB_]./>8?L_SE]3;_1NQ8Z57N)/
M 'C]G4-\W[:VVWL=QP7!(X ^?#J\S^7U\HNL=[]&[3PM'FZ&BS. QT<-7135
M@I'$L2(C!>056XMQ]/H>#[E_<K%YG5T&H!54CTTCT],?Y^LQ^1.8;+F7;(A"
MX#I#$CJ.(944'A3S'[>C;]O5#[[V;E]N8",3U&3I*^BA:/\ <C!<%>".#_KC
MZCVGLD^GEUN=/^SC'0R.W^):- 6PZ<2<FHXGS\_.O6LKWI\4>UND\IEMS9C'
M238>MK)*AIXT("BHD9C:WT%C?VIN[0&KHP8$GA_JQUASSO[97FS/)=IF/Q'.
M.!%217\OSZ _&Y)9'TK=1P-!/TM^/]<>R0P$FO4;"K@$X)%2/0\3^SI84=4J
MGBXM^0;_ /&_:-HP":CS].MT\J"GS_R]"KU;EZ2@[(V;691E?'TN3@-0M1^Z
MEG8:-0-P=(M:X_WCV&.=+.2;;+J*) [& E00#0E:X].BOF@?4[5+;CB00/EZ
M4]/RZN>[)^0>9ZQS773U%#15G5^Z8J9*QA$LR&*KC"C4Q!5;Z@2+6O[PI]L_
M;RWYE%W#,PCOHD+ _P"B>9(U?%2OSZQEY8V ;O'/$TA5X9&54U8)4E2:>I(J
M?G7->CH[2V?C<[U-O+ XH??;>W_0OD<(8F^[\3O%YA<#4%&JQ;_'GZ^TFP[@
M_+M^D=S7])O#))))\/M)).233CY]+]HEN+&?3<ZF",$J:L0%J/.N/\W1"_C[
M\SH^F,]N_ICMZ:HK\%@IWI,96N[$H%#)X1Y"1XVTBZ_3^GN<></;).=X$N[
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MB>=;SZAP$(8G4*5R:X/^;K9HZF^1/QIQO7.V-H[%W?BV7'4=.I#5R+([F$*
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MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JBSL/\
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M_P!Y/M":'_57^?1H@T"@P/08'[.I*HB"RJJ_@Z1I]ZZOUC2"%&U+%&K?ZI4
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M*M)XY/&6;E1:X(^O'O,ZRW2WWV#Q@/$P#3YD5X^719RY[Q;CR7*MI<(75:*
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M,U'4.WN[_O61I 2=1)&<@$FE/R/#HV'8_0'7G94,@S>!@$RZS$884"MKN3<
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M]U[W[KW6M?\ SYO^9H?#?_J'[2_]RMN>\I?NW?\ $W_3VW^";K%G[RGPV?\
MI+K_  P=5#^\L^L/>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H3?BW_ -ET?#W_ ,2[M_\ ]RH/
M<:^['_)#O/\ GGD_R=2M[-_\EVU_YKI_QU^MWOWSQZZ)=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW6KM_/"_[*T^.?_B(LE_[M<I[RX^[A_N)<_\ /0/^K0ZQ'^\K_;6W_-!O
M^KHZK ]Y0=8G]>]^Z]U[W[KW1W/Y??2G7W?OR)Q^P.S<75YG:S[2W1F)L?1Y
M2HP[/-C8X_"3/2R13A4:0M99%N0+W6X,8>[O,]YRELYN[%@DOC1(&*J]%:M<
M,"/+TZE;V;Y6LN;]Y%I?H9(O EDTAV2K+I RA4XU>O7OY@G2G7W07R)R&P.L
ML75X;:R;2VOF(<?692HS#)-DHY/,1/522SE7:,-9I&L2;66P'O:+F>\YMV<7
M=\P>7QI4+!52JK2F% 'GZ=>]Y.5K+E#>3:6"&.+P(I-)=GHS:@<N6.=/KTV?
M!G=OQPV7W359CY08G%9;K]MEY>CQ29W:TV\Z.'+RU>/:GGJ<?!3U;RQK1I7H
M#]M(%=U)7\A_W2V_>=SVP1[&[I<>,A?PY1"YA"2 @.S( =10_$,#CTF]I]QV
M3:]S:3?E1[?P'5/$A:=!,7C()15<GM#BNDTKTB?EON+I'=7?&\<W\>,13X;J
MZJCPBX>EH</+MZF>>&B@2MFI:&98Y*6"2I$A"&&+G4PC4,/9G[>V>Z6&U11;
MPY>Z!?66<2,%+L5#."0Q IFI\A7'19[CWVU;CN\LNRH$M2(](5#$A8( Q5"
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M]94R60!8VNQO_0<^P_S;"VXV,T*Y8K0?;3H<^V5T-HW:&<\ PKZ4KT/7<O\
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MSS/9NZAF-7>-8ED4$Y)89%34TT\>HA][^2K7:M^MX[-4@2]5"RJ*(DIE,;,
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M@;6:,A49D<,NM3HDC:1%(((8%:L* :JAJ=%3_E)=#]?9>N[EWUO3;F$W5O\
MZ[W'B]J8''9B"'(IC&$=3)-5P13!T2HJIXO%'4-$&C6"01,-<H]C[[P/-=Y
MMG:VTCQ6]Q$TKLA*F7*@*2*5"@U*UH2PJ,#J/?N\<HV<C7MW=1I+<V\P@0,
MPBH&)90>!8X#4J I .6Z9/D=\\NR*O:W9W2WR7^(M)M!]S;2W;M_9595F828
MVOFII8<?D*::MI)*3)QT5689144,\2G0'B+"P*GDSVILH[BVW/9-V,WA2Q23
M**4DC# NA".&0LM1ID!XT/2;G;W:O6M[K;-\VCP/%AFCA8DG1(4(1P733(%8
MAM<;#A45ZI,]Y.]8K=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=&&^ G_ &\A^+G_ %$;
MR_\ >>S_ +B+WL_Y5^[_ -)%_P!I$74T>Q?_ "7K7_3R_P#:/+UNA>\!.N@'
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]TB]Y;HVSL?!9#<NZJZEQN&Q\3U%1559"Z0O).H_IL?;?AAN(%?6
ME>J23>$*L33T/14-L?/KXL;US,V PG9^&GR$$Z0^.24)ZPP5@IU@&S?0^J_Z
MA[?$3$8''Y=%\6]6<A*F4!@37)%"#0C\N'1O\7G</E<=%EL764U;BY:5ZG^(
M4=0DD82-=0-[WMIYO_R5[;T4/#[?\O1DKAQ4'!X$#!!R#7YC/6LO_.+_ )O"
M=14F4Z!Z+R$=5O:M@GI\SG*.L]5,E0Q62))(F#(5((-FO_7^OM9;6NOCGHKW
M6]$"T4T/G0T/6G>N.WQW/V%%3K)F-U=A;RJ6A9X!)6LAKJ@DEV)9K@N>2WLR
M8K:"I Z"D3/N+4)9@2: DGC]O6^!_)V_EMXCXD]44'8>]<49>S=Y8Y*FL%73
MK(].M2%D5@39T8EK<-Z?I_@":68N2:FA-: \*FO^JG0MV^Q^F ^0%*CT _9U
M=GE<%B\_C:S%Y+'PY#%Y")Z2KH9@I4WX<A74H21_4^T$JAP5:A!X@Y!^T'HX
M#%<@T/DPP1]GIUK0?S+/CGUWUEO6++]:QP4=5D//4U^(BB4@/4,Q>R(H4E23
MS;G^OO%+W;YKVKE7<$AU*C,3J"4&:Y^&GGU-G)&W7>\VS2$%PF.ZIP!_2KU6
M%BLU)CWBIZA##PBN95TBZ\$V^BB_X_'M!:[M:[R%EMI"P %5KC]G#\NC&6Q-
MI4D 'S%*4/IT($67Q^=H9L+DZ?'Y/$SKXZB!J9&:QX(Y%C;_ 'U_8CL;XP'5
M&2AK^$E?7TIT@FMA<UU@,#Y$ C.:9J.BB=R_R]^CNZ:;(2X/&T^ULM4Q2()T
MCBB)>0EB5T*"+MR/Z$_CW*O+WNS>[/17ULJ@*"S,:@  <3T$M^Y-AW-0$HI
M P *?908IU4]VM\<?DG\(JNDAZZWSD:O%YZJD@QM&:A@LC2L0A50X4EE(-[7
M/^O[GWE/W;BW6(^, I]?/_/T']LDW'D(%()9AJ-0%D=1\N!IPZ":A[6^9/7N
M^<+OW>E-G:M\55),]/XYY%8*URI%R"O^'TMQ]/8\L><;.[[=0/Y_ZN/3</N3
MO]A>"=S,54YU.Y!'SR>K.J;^=E-B=HC%9G9-;!N>/'/$6:@E4>1D"\^FPLP^
M@/'^MQ[4+;[?.P9'8<#IU8_STZG"+W[M_IJO /%**22!\5 3Y5X\>@P^./\
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MS#5]7" &GI7J7D2[$EA3217L@ 2^^^V_0\QQW5RCM;SI"25--2Q$)(BGR8
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MS&*FVME9<K%XZ*;PR+(9J6D=)%8J;>,J0PLU[@$/)?/MCSY%)+9"4")@CB5
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M]P[E^6_RYR./JL@8]E];Y=J):.&I>*%X::5U5'3A7#Z5U BQ;DW]B;:K8+W
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MNCX\<EFCS:@ELD1D[C5@==2Y-*"@4 L33 R)TO/NVV8,$D5Y(D6DO<O+X9(
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M]^Z]T8;X"?\ ;R'XN?\ 41O+_P!Y[/\ N(O>S_E7[O\ TD7_ &D1=31[%_\
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M?LW_ ,JU8_Z23_J_+T$O>O\ Y6B^_P!-#_VCP]6U_P W'_LC_J;_ ,2_L/\
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M_9ZUT?/XO$^7IY]$?W83/]%?:J>#X\6CC7Q/#/B?+X?"IY\:^76;^5Y_#_\
M9B?G%_"=/\*_OK2?PS1JM]O_ !S<GAMK]=O'IMJY_KS[I[XZ_P!S;)XGQ> =
M7^F\"VKP^?3WL7H_?6_>'\/U(T_Z7Q[NG'Y=<O@%#1M\]/GK.ZP'(1[W[%AI
M78CR"&?>=>TX0?707CIM=A:X2_X]Z]VF8<J[$!728+<GTJ+..GYT+4_/K7M
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MP :?0Z0/+H4;''MT7(\ OM?TGT<9G\$,'HSAGIHJ?B)U4XC43Y]%;Z!^1_\
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MHM/S0_[([^6'_BM/>W_O+97V)N2O^2S8?\]MK_U?3H,\Z_\ )&O_ /GBNO\
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MO=:U_P#/F_YFA\-_^H?M+_W*VY[RE^[=_P 3?]/;?X)NL6?O*?#9_P"DNO\
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M2MGE=I\@C*7IX@41B;,0ON,/:[VHW#DC=9[ZZEMWCD@DB41-(7J\T4@)#Q(
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M44DK2>-%,B1:XG'GMS[+)RE=?O&^F%S<C44T@^'&S5!>K=SN030D"E2:$T(
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=&&^ G_;R'XN?]1&\O\
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MU]D4G%OMZD>,]J_9_FZUQ?\ A1-UC!MG?'7?9M+ R/N.>MH:FI,84LZ$D#6
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M;,GDCGS:4B563J$726ED1 WJTER$8&VJW!'L+3R:F;YDG^?70?8=L.TP1P\
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MCQ_P-S_\IS?]D9_[:>LB?^"3B_Y0E_[+1_VS=>_X?WW-_P!X/9W_ -'34?\
MV"^_?\#<_P#RG-_V1G_MIZ]_P2<7_*$O_9:/^V;KW_#^^YO^\'L[_P"CIJ/_
M +!??O\ @;G_ .4YO^R,_P#;3U[_ ().+_E"7_LM'_;-U[_A_?<W_>#V=_\
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MBJG&5!C7)2?9>-9*3+T:)*SR,\A/BEIF 4QO&N]H=^EY$WM]CO8(U>:7P'E
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MDC-''XBUU1J[4+ ^1_"#Y%@0:TZE?V7Y>M.9-^B@O55XU227PFIIE9!A2#Q
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MKWOW7NM:_P#GS?\ ,T/AO_U#]I?^Y6W/>4OW;O\ B;_I[;_!-UBS]Y3X;/\
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M3ZBPL!'6Y^R'+NY2F7Z=HB35EAD=$)K_  U(4?) H].I*VOWWYDVR+P?'28
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M>:I:MFI&#PODZV8J]6L$@#QQ)##"'"R-&\D<;K)_(7M%MW(DAN49Y[@@J)9
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M;'_7'^F_QGZ?Z?QO]!\77XOA?\-BI3POG6OE3HN]KO='_6U^I_Q;ZGZGP?\
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M94)92H]U[HB7P8_GO_#SYB?(KO?X\Q=U=)X_<F&^0DG5GQ5I-M[IJLG6]CX
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MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NA-^+?_ &71\/?_ !+NW_\
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M0FT#4%8@E=7UTD@&U[7 /OW7N@4^2GR#ZY^*/0?;?R1[<J\G0]:]+;&SN_\
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M.]=G;=["V?NC8>[L;#F-K;RP&6VQN'%U ND]'FX'IJB(_P!"T4C $<J;,+$
M^U-G>2;?,D\+%7C=71AQ#*00?VCI/=VD=_$\$JADD5D=3P96!!'Y@]:1'R(Z
M WA\(N\]P]);Z^[J=EY"IFSO5.^:A (,GB:V1A!*SJ%2.HC(\-9%I7P52.P4
MT\T4S]"/;OG>#F^Q2=2 ^%FC_P!]2TR,_A;BI\P<Y# <\O<KD*?E&^>$@E#5
MH9#_ *+%Y'%.]?A<8R*@:2I*4]R/U%G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW23W#E\E]SC=J[5Q]=G]\;HK
M*7#[<P.'I'R-7+49)Q#"(J>)7DEEDD94BC52TDA 4$ V+]RW"/;XFDD95"J6
M9F("JH%2Q)P !Z]&NT;7)NDJQQJS%F"A5!+.Q- H R2>MNS^6S\-X_AS\?:#
M [@BI9NW.P9Z;>/;&2@83:*R6,BDQ"2AG$D&&@D:+4KE)*EZJ>,A)@!SY]RN
M<SSGN+2H3X$58X ?X:Y<_-R*^H&E3PZZ)^V_)B\E[<L+T\>3]2=A_$1A!QP@
M[1Y$ZF &KJPCW'O4@=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0>]L]8;2[IZTWOU1OJA.0VG
MOW;N1VWFJ="$D6.O0A9X'(/CJ::41S026O'-&CCE1[,-JW.;9KF*[@-)(G5U
M/E4'@?4'@1Y@D=(-TVV+>+:2UG&J.5&1QP-&%,'R(X@^1SUI#=L=/[Y^(O<F
MY?CWVJA63&5;5NQMT",Q4F6Q60DD^RK:=B2!%5!6NI8F&H6:F<ZX_?0_D;G"
MWYLLDN830-AE)S'( -2'[*X/F"#Y]<ZO<#DJXY3O7@E%:=RL.$D1)TN/V48>
M1!'E7J%['/4=]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=)C(MN7<N=PG6?7.'R&Z>QM[5]-@L!@<+":JI:7(G0
MFE5_3(UR06951097940DE&\[M#M$#S3.J*BEG=C0(H\S_D'$GAT>[!LDV]7"
M0PHSL[!4114NQ\OL\R3@#B:5/6X[\"/B5BOAQ\>-M]9!Z2NWME)GW=V?G:0^
M5*O.96*)9XX)"J,U%00Q0TM/=5U)%YBBR327YY<_<VOSEN+W61&/TX$/%8E)
MI7CW,26;YFG #KHSR'RFG)NW):"AD/ZDSC\4K 5IPP  J_( G)/1TO8+Z&77
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]T3GYI_,_9'POV%LO/YO9N^>V>R>W^R,!TQT
M)T7U?14]=N+>6[-T1SS4N*H#65%)04--!2TM555^1K:J"BQ]'#+45$JA55_=
M>Z+ITG_,?WK7_*#8/PV^9?Q2W#\,^]^[MH]@[Z^.J5'<.W^\=L[XHNL")\[C
ML7G\-'02P;GP^)FI:^MQDV*"QP/*]/5U4,2S2^Z]T$/:?\W_ '53?*#Y9_"/
MXJ?!/O/Y>?*OXLU'7$N3V=MG>.W^J=KU.,['VIC=S4V8S&^MRRT^"VW3^7*0
MX^"D<UN6KIXJJ>DQTM+2SRI[KW3+MO\ GF]1Y/J/IKM7=70'<?7C[I^?5!_+
MC^1.R]SRXZ3)=1=@925X*>;=+4<M325.WII#2:<A35 C*UE+Z?)+XQ[KW1^?
MD=\T-J_'SOGX;_&]=H9GL#M'YE=E[LV=M/!X#)4]$^'PG7&'ES6YMVY)90\C
MXG"TWVD3A$#25%73Q!U+W]^Z]T4#/_S2^W=\;H[HG^%WP#[6^8'2?QOW_N[K
M#M[NK$]L[9ZDAR&=Z\BG_O%BNN,-G-=;OVKP==''15$@EQ=#)4^>"BKJN>G,
M+^Z]U7K_ #ZOE)U!\U?^$T_>ORBZ&STFXNJNX<;\:MQ;9K:F)*:JA:F[=VA1
M5^.KX4DE6GR6)R5+6459")7\-53RQZFTW/NO=7,?-3Y]87XF[FZ:Z;V3TQV5
M\HOE/\C*C=J=(_'+J6JQ.&K\C2;!IXJK.9O,9O/5N/P>VMO8N*>!9J^MJ@IF
MECBACE;7X_=>Z"?XJ_S+MU]I?(JD^&7R[^(79OP8^6>:Z@3N[9.Q-U[\P'=F
MUMTX7'R14^;3:^^ML2'&9+)[<JIHDR%%-24E0D3I41I)"69?=>Z+[@_YSO8W
M>6X_D'U_\)OY<_R"^5G87Q:^1/<'0O=Z)V!MGI3;&);I_.5&*EEI]V;HEIZ/
M-Y_-TE)45N/P>*I:V:*.2B7+U6*2LCF7W7NC&;._F]?%?=7\O.7^8S54O96W
M>N<;65.R]P=29+9TLF_*/?5'FDVR_7HV]$[2U&ZY=R20T%/3I)HF,L51Y$IV
M,B^Z]TB=O_S1>T]@=O=!==?.3X-;\^%^T?ECV+C>H_CMVIE^[=I=PXZIW9N*
M@^^PVTMXT^#>&7:6YLVT-?!0TT4F5I)YX!$M?Y7:.+W7NKA??NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW73*K*58!E8%65A<$'Z@C\@^
M_=>ZC?8T7_*G2_\ G.G_ !3W[KW4KW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]T6[Y1_%7J/Y==9UG6G;&'>HIT>6NVSN?&%*
M;*86N9"BUN.J&1PCVL)8G1X)T&B:-P%TB3E;FJ\Y1NA=6C4/!T:I21?X6%14
M>A%"#D$=!WF?E:TYNM3:WBU'%'&'C>F&4T-#\C4$8((ZU5/D5_+Y^6GQ K<A
M.=JUW>?3=&TLF.[ V)CIZZ6EI4/I.4H(Q45F+9%(UZUFI%-ECJSR!F7R7[Q[
M;S&JQNX@FX&&9@N?Z#FBN/08;^B.L,.=_93<M@=I(D,\/$2PJ6-/Z<8JRGU(
MJOS\NB9X_LW:-<H\E=+CY2+F&NIV2W_(:"2/_D__ (GW+R7L;>=/M'4+R;;-
M'Y5^8/\ Q1Z>EWGM1QJ&X,6 ?]55*AX_P:Q_WCVX+F,_B'[>F39RC\#?L/7+
M^^&U?^>@Q/\ YVI_Q7WOZB/^(?MZU])+_ W[#U[^^&U?^>@Q/_G:G_%??OJ(
M_P"(?MZ]])+_  -^P]>_OAM7_GH,3_YVI_Q7W[ZB/^(?MZ]])+_ W[#U[^^&
MU?\ GH,3_P"=J?\ %??OJ(_XA^WKWTDO\#?L/7O[X;5_YZ#$_P#G:G_%??OJ
M(_XA^WKWTDO\#?L/7O[X;5_YZ#$_^=J?\5]^^HC_ (A^WKWTDO\  W[#U[^^
M&U?^>@Q/_G:G_%??OJ(_XA^WKWTDO\#?L/7O[X;5_P">@Q/_ )VI_P 5]^^H
MC_B'[>O?22_P-^P]>_OAM7_GH,3_ .=J?\5]^^HC_B'[>O?22_P-^P]>_OAM
M7_GH,3_YVI_Q7W[ZB/\ B'[>O?22_P #?L/7O[X;5_YZ#$_^=J?\5]^^HC_B
M'[>O?22_P-^P]>_OAM7_ )Z#$_\ G:G_ !7W[ZB/^(?MZ]])+_ W[#U[^^&U
M?^>@Q/\ YVI_Q7W[ZB/^(?MZ]])+_ W[#U[^^&U?^>@Q/_G:G_%??OJ(_P"(
M?MZ]])+_  -^P]>_OAM7_GH,3_YVI_Q7W[ZB/^(?MZ]])+_ W[#U[^^&U?\
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MP-^P]>_OAM7_ )Z#$_\ G:G_ !7W[ZB/^(?MZ]])+_ W[#U[^^&U?^>@Q/\
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MT@C,L(J1-"I9*9/>HJT?#)/;Z,3T52A[*VA6J"<BU%(1<Q5U.\)'^NRAX_\
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M?MZ]])+_  -^P]>_OAM7_GH,3_YVI_Q7W[ZB/^(?MZ]])+_ W[#U[^^&U?\
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MP-^P]>_OAM7_ )Z#$_\ G:G_ !7W[ZB/^(?MZ]])+_ W[#U[^^&U?^>@Q/\
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MP]>_OAM7_GH,3_YVI_Q7W[ZB/^(?MZ]])+_ W[#U[^^&U?\ GH,3_P"=J?\
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M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:Z?\^KIK,9???\
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M^?7,_P#US]^_UT-__P"4V7]B?] =>_UM-A_Y0H?V'_/U[_AKGX"_]XU;-_\
M/KF?_KG[]_KH;_\ \ILO[$_Z Z]_K:;#_P H4/[#_GZ]_P -<_ 7_O&K9O\
MY]<S_P#7/W[_ %T-_P#^4V7]B?\ 0'7O];38?^4*']A_S]>_X:Y^ O\ WC5L
MW_SZYG_ZY^_?ZZ&__P#*;+^Q/^@.O?ZVFP_\H4/[#_GZ]_PUS\!?^\:MF_\
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M9O\ Y]<S_P#7/W[_ %T-_P#^4V7]B?\ 0'7O];38?^4*']A_S]>_X:Y^ O\
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MP%_[QJV;_P"?7,__ %S]^_UT-_\ ^4V7]B?] =>_UM-A_P"4*']A_P _7O\
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M]_K:;#_RA0_L/^?KW_#7/P%_[QJV;_Y]<S_]<_?O]=#?_P#E-E_8G_0'7O\
M6TV'_E"A_8?\_0D;7^"'PSV;7Q93 ?&3IB#(T[PRTU97[%H<X\3T]RDD)KHJ
MGPR*3?6FEKV)-P+%UUSWO-XI22]N2IJ"!*Z@@^1TD5'R/1A;<D;/9L'CLK8,
M,@^"A((\Q4&A^8Z-524=)CZ6"BH*6GHJ*EB2"EI*2!::*-(Q94CC0*B*HX
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MLW_*%9?]DD'_ $#U[_7.WG_E,O?^RR?_ *"Z]_IG^8G_ 'FK\EO_ $;NZ?\
MZ_\ OW^MQLW_ "A67_9)!_T#U[_7.WG_ )3+W_LLG_Z"Z]_IG^8G_>:OR6_]
M&[NG_P"O_OW^MQLW_*%9?]DD'_0/7O\ 7.WG_E,O?^RR?_H+KW^F?YB?]YJ_
M);_T;NZ?_K_[]_K<;-_RA67_ &20?] ]>_USMY_Y3+W_ ++)_P#H+KW^F?YB
M?]YJ_);_ -&[NG_Z_P#OW^MQLW_*%9?]DD'_ $#U[_7.WG_E,O?^RR?_ *"Z
M]_IG^8G_ 'FK\EO_ $;NZ?\ Z_\ OW^MQLW_ "A67_9)!_T#U[_7.WG_ )3+
MW_LLG_Z"Z]_IG^8G_>:OR6_]&[NG_P"O_OW^MQLW_*%9?]DD'_0/7O\ 7.WG
M_E,O?^RR?_H+KW^F?YB?]YJ_);_T;NZ?_K_[]_K<;-_RA67_ &20?] ]>_US
MMY_Y3+W_ ++)_P#H+KW^F?YB?]YJ_);_ -&[NG_Z_P#OW^MQLW_*%9?]DD'_
M $#U[_7.WG_E,O?^RR?_ *"Z]_IG^8G_ 'FK\EO_ $;NZ?\ Z_\ OW^MQLW_
M "A67_9)!_T#U[_7.WG_ )3+W_LLG_Z"Z]_IG^8G_>:OR6_]&[NG_P"O_OW^
MMQLW_*%9?]DD'_0/7O\ 7.WG_E,O?^RR?_H+KW^F?YB?]YJ_);_T;NZ?_K_[
M]_K<;-_RA67_ &20?] ]>_USMY_Y3+W_ ++)_P#H+KW^F?YB?]YJ_);_ -&[
MNG_Z_P#OW^MQLW_*%9?]DD'_ $#U[_7.WG_E,O?^RR?_ *"Z]_IG^8G_ 'FK
M\EO_ $;NZ?\ Z_\ OW^MQLW_ "A67_9)!_T#U[_7.WG_ )3+W_LLG_Z"Z]_I
MG^8G_>:OR6_]&[NG_P"O_OW^MQLW_*%9?]DD'_0/7O\ 7.WG_E,O?^RR?_H+
MKW^F?YB?]YJ_);_T;NZ?_K_[]_K<;-_RA67_ &20?] ]>_USMY_Y3+W_ ++)
M_P#H+KW^F?YB?]YJ_);_ -&[NG_Z_P#OW^MQLW_*%9?]DD'_ $#U[_7.WG_E
M,O?^RR?_ *"Z]_IG^8G_ 'FK\EO_ $;NZ?\ Z_\ OW^MQLW_ "A67_9)!_T#
MU[_7.WG_ )3+W_LLG_Z"Z]_IG^8G_>:OR6_]&[NG_P"O_OW^MQLW_*%9?]DD
M'_0/7O\ 7.WG_E,O?^RR?_H+KW^F?YB?]YJ_);_T;NZ?_K_[]_K<;-_RA67_
M &20?] ]>_USMY_Y3+W_ ++)_P#H+KW^F?YB?]YJ_);_ -&[NG_Z_P#OW^MQ
MLW_*%9?]DD'_ $#U[_7.WG_E,O?^RR?_ *"Z]_IG^8G_ 'FK\EO_ $;NZ?\
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M@>:%YC.SJH1E73X84DDFO\0H*>O37MM[9S>X[SK%.D @6,L75GU&0N   1_
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M?SI_^9D=(?\ AD;F_P#<^'W%/W:/]P[[_FM%_P <;J6OO/\ ^Y5A_P TIO\
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M/](+=&)2,RF11,>]-95CV\*_L7/\E#_CXOD-_P!J7K?_ *WYKV6?>9_L=O\
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M<3C)9:6 L28H#++,X12%5Y'90"QNK^\1;1V.]P30JJ.]LCN0 -3K+( Q]30
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MW_\ QR;ICG(5]N(?^>3;O^KD'0/?R4/^/B^0W_:EZW_ZWYKV(_O,_P!CM_\
MI[G_ ([#T&?NO?VNX_Z6U_PW'2Q_EQ[?Q59\U_F=N2IAII<O@MP[TQN*>4%I
M(X\_NFM:J>(:2BD_90HS:@X#:5!5Y+%OO+=R1\L[- I(1XX6:G F.U0+7_>R
M:<//B!T;>S%G')S/OD[ %XYID4^8$EU*6I_SC6OG^T]1.[>D/AYG_D1O?LW>
MOS<K=J=HT?8,V4JL5)'2>3#5NV:E4I:&,RPLX7%BFAACN?TQ*1]?>^6>:.8[
M39X;&UV42VK6^D. ])DE4EF-&IWZB3]O7N9^5>6KO>IK^ZWHPW2W <H6B!A>
M)AI4!E)[-( ^SH,/YKW??0W=.$Z:I^K]^8/?.X]MY7=TV0EP,<E0E-19B&B4
MK+4LB('EGI8RL8+-9&9@@TZS[V"Y4W7EJ6\:^@D@CD2(*)* LZ%^"U)P&-3\
MZ9\@Y]X/FS:.98+-;&XCGECDE),?<%C=5!JW 595H..*X\SJ?S0>P=Y]?_#_
M &6VR]Q9+;4V[M];*V?GZO$5!HYYL=58/,5TM*)TM+$DM104VLQNK.BM$Q,<
MCJT:^QNSVV[\Q3?4QK((H)IHPXJHD$\*!J'!H)&I6M#0\0#U)WOSO5ULO+L1
MM9&B,UQ##(R'2QC,,TA4$9%3&M:$$BHX$CI/_P H',Y;<_QHW[M[/Y*MRN(P
MW9>6P>(I*RI:<4M'D<3C)9:6 L28H#++,X12%5Y'90"QNK^\1;1V.]P30JJ.
M]LCN0 -3K+( Q]30 5\P!Z=(_NY7<M_L4T4SLZQW3QH&).A##$VD>@JQ('D2
M>J*_C+U1V#WCV[MKJWK_ "N6PD^XZI)MQ9G&U,]/'0XO&G765]3X60,M/$S"
M)78"2=XH0P:4>\IN>-^L^5]NDO[Q$D$8I&C!27E;"HNH'B1DC@H+<!UBCR#L
M%[S1N4=A9221^(:RNC,H2),L[:2. -%!P6(6HKU<1_,C[^P7Q_Z?VS\.NHJV
M6FR.7VO2T.]*G[QJVII-OE2GVM34.6DDK\_)Y7J69_(U/Y6D%JM&]XY^R_*4
MO-NXR<Q;@H*I*6A&D*KW''4H% $A% H IJH!\!'62GO=SC%RAML?+FWL0\D0
M68ZBS);4I1F-27FSJ)))743\8/14_CU\$^P>WN@L;V'W/W[/T[\?,>,IN3;F
M"R]7+E:98)9&6?)FFJ:^CQF*AJ:A04D(DEG-V\:B1'<>\X>ZEGR]N[6FV6 N
M]P;3%)(H"L6 PE5C=Y" :$8"\*FA C_DWVGO>8MG2[W3<&L]O75+'$S%D"$F
MLA#R)'&"<@T8GC05J;8_Y??6O1G5^U.Q,+T3WA+W/@J[<.'RF:<K"B8ZKDII
M(E"B%$755PPIJN+VA7\>X!]V][W7?;BWEW6R^CD6-U0=U9$U _B)^$D_M/60
MGM'L6T[!;7$6T7IO(VE5W-4(C<IIIV #N"C]@ZU9-Z110;QW9!!''###N7.Q
M0PQ((U18ZJ4*JJ+!54   "P' ]YV[6Q>UA)-28HR2>).@=8"[RH2\G   $TH
M &  ';JW7^2]F*"G[?[>P<TZIDLKUUC<C0P,P'DCPV2B2HTW-R4-9"; '@DF
MUO>/?WE+9WV^TE [4N'5CZ%XR1^W0>LBONQW*)?WL)/<\$;J/4))1OV>(O[>
MBM_S--M9C;WS,[6J,I2/3TVYX]H[EP50;::FCJ,114IE3F]DJZ2K@:X'KA>U
MUL2._9&]CO.6[58S4Q&6.0?PN)7:A^U75OL(\^@#[ZV,MGS-=-(*"40RQG^)
M/!1*C[&1ESYJ?*G1"?<L=1#T9C;7R^[^VCTEE?CU@=ZBCZNS%%GL548@X:BF
MGCH]T2229&C@K'@:IBIJQYZDR*)+_O2A2H<^P1>^W>T[ANB;Q+#6Y1HW#:W"
MEX@ C%0:%E"K3'X16M.AW8^Y.[[=M3[-%,!:NLB%="%@DI)=0Q%0K%FKY]QH
M1T6?V-^@)U>5_)0_X^+Y#?\ :EZW_P"M^:]XN?>9_L=O_P!/<_\ '8>LK?NO
M?VNX_P"EM?\ #<=%TR'<G9V4_FCXVLK]YYRHDPWRP_T4XJ(UC1PT^WSNL8-\
M7# A6%*:7'#1* G[KDS2%IB7(QBY:L8.165(4&O:OJF-!J:X^E\<.2<DA\C.
M!VB@QT#)N:=PGY]5GG<Z-U^D05.E;<W7@% HQ0IQQD]QJV>C3_SE^RM\8BOZ
MEZWQ.X\EB]F9["YS<F>PN/F-(E;58^IBAIC5.EI)HJ=2Q2)F\8<^0J76-D ?
MW;MEM;E;N\DC5YHWCCC=A4HK*Q;2#@$T%3QIBM":R!]Y??+NT-G9Q2LD,BRR
M2(ITZV1D"ZB,D"IHM:5R02 0,^Z<[D]Z_P G]\QNBI?-Y.7J;!PSUF28ULDA
MVYN"FIZ261Y2[//&E) WD)+>10]PW/L,V%JFV>X?AP#0HNWH%[0!)"S, !2@
M.HBG"AIT*MPN7W3VZ,EP?$8V259^XDQR*%)+5JPT UXU%>/47XN?]NC^Q?\
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ML';6^JA\IM[![C[*V'C8\HQF1<+48/&U;T^J<NA@CGR5<JBWC1+1A;(?<?\
MO;;)M'-,$UJ-,CQVT[:<'QA-(@/;0U(C4GS)SY]2+[%W4F\\JS079UQQRW%N
MFO(\ PQO3NJ" 9' \@!2F.BY_P E#_CXOD-_VI>M_P#K?FO8S^\S_8[?_I[G
M_CL/0(^Z]_:[C_I;7_#<=%9WIW)VAE/YE0R5;O?<$M1M;Y3S=?;?1:]X8:7"
MX_=(Q0QL,"%84I9J"%8YT"6J"6>;7([,1UMO+=C!R5H6".DNUBXD.D$M,UKX
MNLDYU!R2IKV\%H!3H";CS1N%QSP&>>3]+=?IHP&(58!="'0%&-+(H#"G<<M4
MYZ/-_-TP.U,SV/\ #6BWCE9=O;8W!N;?.!WAN*&14>BQ,E?M-*JJ0R))&K4E
M/554H+1LMQZE8"WN+ON]W=Q;66\/;+XDL<4$D,9!H\HCNRJX(/<548(^74I?
M>)M+>[O=ECN7\.*26>.:0$ I$9+0,U2"!I5F-2"/4=!\?AC_ "M "3\PLW8
MDV[AV>QX_H!MVY]F_P#KD\]_]&A/^R.[_P"VCHH_UK^0O^CPW_9;9?\ ;/U2
M=N*DQ=!N#.T.#KVRF$H\QDZ3#Y-UT-4TM/.Z4\Y&E;&:$(Y&D6O]!]/>35E)
M)-#&\JZ'9%+K_"Y4%AY\#4=8N[A%%!/(D+:XUD=8W_B0,0K<!Q%#TS^U/23K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z$WXM_\ 9='P]_\
M$N[?_P#<J#W&ONQ_R0[S_GGD_P G4K>S?_)=M?\ FNG_ !U^MWOWSQZZ)=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW6M?_/F_P"9H?#?_J'[2_\ <K;GO*7[MW_$
MW_3VW^";K%G[RGPV?^DNO\,'50_O+/K#WKWOW7NO>_=>Z,5\2=^[5ZO^2'4.
M_P#>^2;#[3VQNN+(9W*+0U&2,$!AFC,G@I8IJF4*TBW6.%WM>RGZ>P;[A;3<
M;[LMW:6JZY98M*+J5=3:E-*L54</,@?/H;^V^\6_+^^6EY=MHABD+.^EFT@H
MRUH@9CDC@">C;?S/?D7T[\B-\]6Y7I[=K;OQNVMJ9K'YFL.W\GM\13UU8DD<
M83*45%+(3&A8LD;(+@:KW C[V.Y-W+DZVNDW&+P6DEC9!XD4E55"":Q.X&3Y
MFORZD/WWYUVSG.XM'VV;QEBCE5SX<L="S*0/U40G \@1T-O\Q+Y??'SOGXW]
M;["ZKWU+N7=N&["VGN/+XE]JYC"?;4N+P.9HIV>?(4%+32.E36P)IBFD)N66
MZ#5[#/L[[>;ORIO-Q=W\ CB>WEC1_%A?4S3PN,1R,P[4)J0/3CT*/>GW'V;F
M[9;>TV^<RRI<Q2.GA3)I18)T)K)&BFC.!0$^O#KW\LSY??'SX\]1=@[7[>WU
M+M3.97L*7<>*H4VKF,]]Q2R8RAIPR2XV@K(8W\U-(NF62,_I/Z22/>]OMYN_
M.&XV\^W0"5$MQ&S>+#'I;Q9&X22(3A@:@'KWL;[C[-R=ML]ON,YBD>Y,BKX4
MTFI#%$M:Q1N!E"*$CHIW\M_NWK+H/Y!9#>_;&Y3M7:]1USN/ 1908;(9W_*Z
M^KQLT41@QM+65(UI3RG5X= M9F!(N/\ WFY8ON;-H6UV^/Q91<1R%=<:=BI(
M":R,B\6&*UZCWV2YIL.4-X>ZW&7PHC;21AM$DG>TD3 4B1VX*<TICCT$GS1[
M&V=VU\G>U^P^O\N<]L_<N4PM1A,N<?58KSI18J@I9&^WK8:>JCM-!*MI(4)M
M<"Q!(A]M=FN>7]CM;.[3PYHU<.FI6TEI9&&49E.&' GH.^Z&]VO,>_7=[9OX
MD,K1E'TNFH+#&APZJPRI&0.K#/YB7R^^/G?/QOZWV%U7OJ7<N[<-V%M/<>7Q
M+[5S&$^VI<7@<S13L\^0H*6FD=*FM@33%-(3<LMT&KW#_L[[>;ORIO-Q=W\
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M=#GWWYUVSG.XM'VV;QEBCE5SX<L>DLR$?VJ)6H!X5Z&3_9M_C[_PVA_LO_\
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MCF$"-&8Z@LH+,5))-$U-0XH.IGW[F#D&6Z&_3.D]QVLJ1B9F=U4:2T1TJ&
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MO?NO=";\6_\ LNCX>_\ B7=O_P#N5![C7W8_Y(=Y_P \\G^3J5O9O_DNVO\
MS73_ (Z_6[W[YX]=$NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K6O_GS?\S0^&__
M %#]I?\ N5MSWE+]V[_B;_I[;_!-UBS]Y3X;/_277^&#JH?WEGUA[U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6Y_R
MG^C>I.Z=P]U+VIL3![XCVWAMD-@X<Y')/'3MEY\D*ADC61$+R"FA&IE+*%(4
M@,VK'KW^YHW#EN&R^@GD@\1Y]9C(!;0L=*FE<:CC]O =9'?=ZY6V[F66^^OM
MXY_#6WT"0:@NLS:J#A4Z!GCC'$]5K=SX3%[9[A[7VW@Z1,?A-O\ 96^L)AZ"
M-WE6"EQ64JH*>%6D9Y&$<,:*"SLQM<DFY]S5RU=27NW6LTIU/);0.[&G<SQ*
MQ.*#)-<=0?S5:QV.Z7D$*Z4CNKA$45HJ)*ZJ,U.  .@U]G?1#U[W[KW7O?NO
M=>]^Z]U[W[KW0_?%S;W4>ZN^NO,!WMEJ;!]4Y"NRZ[KR59EVP,*"#&ULM&DU
M8C(U-%/D(Z2)Y!(FE7/K7]0"7/=YN%AM-Q-M2%[I0GA*J"0FLB!B%(.HA"Q
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MSS#M$=L=ACD?4TOCF* 7#+3P] TE'H&J]33RXCJ:/9[9>7-X>Z',$D2:%B\
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M8Z+,QTDU54Y:&K, ?4@=S31C6HO91I(_,C>_?--[LUO82;?<2P"8S,QC8H7
M6(K6E#C4<?/J-_N_<J66[W&XQ;C;PSF'P5 E19 C%IU:E01G0,CTZ--LZ/\
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ML/O'>^]=P29G,T=;LZEWWC=K46XW::BIY:&LD-'C:*"G>-DC@IJBN:-TF9/
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MNO>_=>Z][]U[H3?BW_V71\/?_$N[?_\ <J#W&ONQ_P D.\_YYY/\G4K>S?\
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M1T^9"12M4SH[P0>=*1S'&'0,@9W0-J5@(Y]UN5(>4+J*UCO7NW*,T@D(+0Y
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M5<J^XNT\YS206$K.\:ZV#1NE4U:=0U**BI'SR,=&W-OMKN_),,=QN$2HDK:
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MEOU:C_-Q_P"R/^IO_$O[#_\ >7W+[@?[O?\ RL5W_P \D_\ VDVW60'WC?\
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M:DW#D8,?C:VK3&YN61ZVLK(LA3X'<2--ELI5U\&5Q[PC(9""OI3#[KW1&/\
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M1#_^$VW=_</R(_D]?&#M/OCLW?'</9F7RW=^)S/8/8^Y*K=^:KH-K;YW%C:
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MB,1CJ';\T;15)K,<V-5)'F>'_)R) 1XQ<6-[^Z]U0_\ \)S_ /M\#_PI1_\
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MIX9'Y+R,QU>XRWO[O&T;E.9K>6:V#-5HUTO&*_P:A5?S+ >0ZE38_O'[OML
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M';EQU7]YEJBHR'2^"-=M.2;[A#-6MDMNRX'6\;S))4"HB5_)')''[KW1'/\
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M_A+AUQN/9O\ )*^,6/WS@3CTWUD^[-[8S%Y2%9/N<+O#=N9:@J)86!4P9&D
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MGC%Y)0TDGNO=; '\D7_MT3_+H_\ %2^G_P#W5P^_=>ZHD_X1/?\ ;N;Y.?\
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MG\=F,;]L]2V"I\J:.E3/Y::"E3(I3I4U$DQC9G?5[KW6P=[]U[K4"_X6K?\
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M^9/\KZ7OFH[33^89W-)W =@5'6:[-.T)*O<>\-QST'\67/Y09]&GW:\,<O\
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M0KA?*U6)Z=9#-H%+&(]3^Z]U[^7?_*5I/@)\P_YD_P KZ7OFH[33^89W-)W
M=@5'6:[-.T)*O<>\-QST'\67/Y09]&GW:\,<O\,QQ1*4,T<C3'Q^Z]U[J_\
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M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K6O_GS?\S0^&__ %#]I?\
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MG_I+K_#!U4/[RSZP]Z][]U[KWOW7NCL?RY_^RT>B_P#M=;E_]T65]QE[R?\
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0F_%O_ ++H^'O_ (EW;_\
M[E0>XU]V/^2'>?\ //)_DZE;V;_Y+MK_ ,UT_P".OUN]^^>/71+KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>ZUO?Y]V.JJ?>7PUW&T9;&"N[2P\\X4VBF,^V)4#M;
M2/)&TA07N1$_]/>3_P!V^=5>]0G.JV:GJ/U@?V8K]HZQ@^\E;L\5G(!VZ;I2
M?($B$@?F :?8>J>?>7/6&W7O?NO=>]^Z]T=7^77)''\T.BFD=(U.=W#&&=@@
MU2X/**JW/Y9B !^20!R?<9^\8)Y:OJ?P1_RGB/4I>RI YGL:_P <O\[>8=&4
M_G)NC_)_9"HZ,T71&UTE56#%6.?W.UF ^ATLIL?P0?H1[!?W< 1L<_SOI:?\
MX+8=#3[RQKOT'_/!%_VD771U>[IX&_DYX+3-$?)U+T!!':0'4\.?VYK0<\NG
MC?4/J-+7^A]QGRNI_P!<9\'_ '+OS^1@N,_S'[>I2YL8'VVCS_Q#VX?F)[;_
M #==?"_L?8WRC^%TOQ?;?K=?]I[<VY5;0A^SR7V61$>-J?OL1F<=$DU//5TT
M&B".ICBE#!HI$D,<<T3M7W*V6ZY%YE_?G@?46LD@F[EU1DLNB2)R0P5C4E21
M2A!%2I <]L=\M>?.6?W()S;W441@[6TR@*=4<J ,I911=0!&002 02#N/_EB
M?*"DKJRIWK\O*;;NT:.02R9S'[EW#DYQ3II+RS4]7-C*:!AZN#D'7@$OR0!'
M-[W;$Z 6VT>)*1\#1VZKJS0 HLC'_> ?ET'(/8[?T=C<[RT<0/QK)<LVG%20
M[QJIX_C(\Z^71;_Y=/>^R?CO\GM][9WQNBD.S=_#*[+C[!KJM(J1:S"Y!I,?
MD*N<R21QTE<JSHTIE9$>>.1Y!$'D S]XN5;KG#8[>XM8CXT&B8VZ@EM#Q@.B
MB@)9,&E*D*0!6@Z!'LSS9:\F;]<VUU*##<%X1<LP"ZXY&*.QJ0%<5[JD L"3
M2IZ/-\@_Y>_>_9_:NX.R>E?D>F)V1OW*ON=L)E]W9RC2A;+KYJC^'/C?O*:K
MI9:@M)"O^3JD<F@%A&&>+>4/=S:=CL([+<]NUS0+X>M(H"7TF@U^)H96 P3W
M$D5\\2OSC[1;OONX/>[9N;1P3MXAC::<"/4*G1X996!;('8 #2N,U@?+GIC<
MOQ6[%ZKBS7=I[FWM2TPW56)5R2SC$38:OC>FI2M3D*ZH\=08]=Y(X-5FM&0+
M^YQ]O>9(.?+.[\*R%G"3X0T@#Q0\9#-VQH*K6F"U*C/4$^X_+=Q[?7MF9;YK
MZ=?UB'+'PC'(I44:21J-2N=-:''5V7?W3VPOYE?0?76Y^MNPL=A*W%9#^\&&
MR4E+_&DII,G3K#D\/DJ=)(9Z:IB=8KFVI7A%HWCE#C&;E+F.[]EMVN(;VW9P
MR^&Z5T%@K521"0P8'-/(AN((IUD]S?RU9^]NT6\UE<*FEO%C?3K"EETO&ZU4
M@C%?,%>!!Z5OQ,ZHZF^.W6_9_1&R.P:;?^^]K44>\.V\C 1&D-=NZDJZ6EB\
M*2SPT82'#2+]N9WG1566>WGCN@Y_Y@W#G&]MMUNH#!!*QAM%/FD+HS&I"ELS
M#NH%))"_">C+V\Y=V_DNSN-HM;@3SQ 37;>CS*RK@%@F(2 M2P !;X@367_*
M-^1^QNN<WOWIS?F:QVV5WY68G<6S\WF*V/'TDE?CXWIJC'RS2E8XZBJA:!Z?
M4RJ[121 F5XD>;?O"<F76\1P;E:HTG@*T<R(I9@C'4K@#)"FH;TJ#P!(@K[N
MG.MKM$D^UW3K%X[++"[L%5G T,A)H Q&DKZT(XT!&#?/\L3Y*5N_,O5; ^3\
MM)UWD<I7UV+CSNZMQ0Y&BIJJ7R04OV].9Z6K\$;%/+]Y#KT*WC7650-[5[W;
M)%:(MWM8:X555BD5N8W8"A:K ,M2*TTM2I%33(HW;V0WR>\=[3=G6V=V90\M
MSXD:DU"@*Q5J TKJ7@,9P0/>E$?AM\T^MZ_,]I3=TOU]E=BY_=VZ"6J)1%5,
M5R6/17K<C():6C>41AY@]V1C&EP/<M;9)_KD<LW*16HLO'6>.&(4 )6A1\)&
M*,P%:"F#D]1#NL9]L^:;5YKMKTP&!YI6J6"L2KI0O*:JA) )KD8'5Q_RY^'.
MUOGE1=7=J];]KX3$)C\+-0Q9^/''<E#D,3DI%JHV0PU%.\-31RM.=#'U&5HY
M/"T?..?M[[C3^U+W5A>6KOJ<$QEO#>.505-:JP(84S\@14'K)'W%]M;?W92U
MOK2[1-*$"0+XL<D3D,*4=:%36F?,@T(ZD9/;G4?7O\OKY"=4=/[OBWKA.I]@
M]F;-W)N!*H58FSE7BUR^0_<0M3DE\K%=(7:.%B:?49(I+4@O=PWCF[;]PW&+
MP7NKBVFCCI2D E\),'/^A'+4+#NX$=.7%CMVS<H;AMVVR^,EI;7<,CUU5G,)
MF?(Q6LH)"X4G3Q!'6K/[SMZP"Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNA9^)%#4Y?YZ_$3'T,9EJ:;LJ@R\J#\08HM5SMQ<^B"EF;Z6X^MKD1C[N2K%
ML5X6_P!\,/S9E4?S/4M>R\32;]:T_P!_ _DJ.Q_EUNW^^>O70[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>ZT]?CW\H?YP_\\7LGY4=C?"OYJ]3?RY_A[\<N_=U=#]<4N+Z,Q/?.
MZ]VU6W:6FG_B>>ES\&FDBEI9Z.JC%'-2PQ??O2-3U\F/6ME]U[K8:_E_;;_F
M#[+ZNWCLO^8MV/TGW/V;M;L&7%]<=R=+;7DV.NY]J)B,4T&4W%A1'3T6,W&^
M7;+I4PT-)!1+&L/@C*^M_=>ZI$WI\_/YE?\ -7^:/R)^(W\I3L/KOXF?&CX>
M[DJ.N/D+\YNQ^MH^R\KD]V4=36TT^&V9ALI35.(J84J\=4P'7 DAI5?)?Q"F
M6?&P5?NO=(W=_P U?YK?\E7Y(?&3:O\ ,O\ D!UG\^O@I\K>S8>G8/DI@NJ\
M3T9NS8.X\VT0HQDZ'&BBQ4V&6$S5T@FDKIY*2'(-%5TS4-/1UGNO=7Q?S$-W
M_P PK;?46T<+_+7ZKZ;W_P!\;^[(QFT<QO#OW<SX7:VR-OOC\E6UVY\C1TT\
M&2S#+44=)04]-1B>5*BMCJ9*6I@AEA;W7NJ(ODOT=_PIC^)G2_9GS#Q'\TSI
M#Y)9;IO:6<[7WK\6U^(^W]O8?)8?:E'+7YC&86LH<*F8K9:.D@<TD:-CZVM$
M=C5I4R%9O=>ZN#_E_?S.MJ_,;^5OM;^8[N7:DVQZ7&]4]I[Q[;V=13"J6AR/
M1396GW(F/D,DC/0U,N&J*F@,K>;[6> 3A9A(H]U[JC_X7;Z_GX?SF.EQ\\^H
MOYB/2?\ +VZ7WEO'L##=&?'K97QMP/>;?9;%S=5C?N-R9G<=%)6R5AJ:6:ED
M>\M/4)2K518RA2K>#W[KW6S)\1ZWY6;<^-6WZGY_9CI=_D%M>7?H[(W;TJE7
MB]IU>,P.6R/\(S%/'DF^XHVJMNQ4%16HXC2*I:<)'%&%1?=>ZUJNI/G1_."_
MGG]E]S[E_ED]O]:?R^?Y>_4&^Y^O-K_(S?G5-%VEO/?>3PT+RSBDQ&<HZV"D
MI)H*O'5<T:TV.DH8Y*6 U]74-74D7NO=-^X_YA7\VS^25\GNB=B_S9NVNJ?F
MK\#?DMO\=>[>^7.T-AXWJC/[-R%7%0C7FJ3&T6'QD%#CVDJZRHI:J.OGJ<='
M55=%E@]$^+]^Z]U=!_/;^5_=OPI_E0?*SY0?&K=U%LKN;KRBZ9BV+O&IV[C=
MX1T1W_V%M+;=;4IC\M2UV+JI/X7F:P1?<4DT2R%)#&^D#W[KW5.'QJ[_ /\
MA07_ #AOCGTYV[\;.TNGOY<G1U'U#L2@K>[^Q>ML?OS>O;.^]MXB"DW9G,9@
M9L5E,-MOKW([G&0%"T-/3UBQ4T<T35D%3)1TGNO=&+_DG?S0/FYV+\O?E=_*
M=_F@TFQ\G\R/BE@8=Z83M;8&-I\73;LV_3RXJ*IJJR'&TM'B-<]+N#;F2QT\
M&/QLM309 I5XREJZ.</[KW6SU[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[JIK^<UT97=O?#7.;HP5//4;BZ,W%C^UJ>.FMK?'4$4]'F
M0=0/[5-05;UKV*FU&+$\JTM>R^_#9=[2-S1+E3 2?)R0R?F64*/]-^8B?WFV
M$[WLDCH"6MF%P!C**&5ZU\@C%OM4?9UK!;=S$6>PN/RD14FI@3SHO]B5/3*G
M^&EP;?U%C]#[SZAD\50W^JO7/6XA,#E3Y''V>73U[<Z9Z][]U[KWOW7NO>_=
M>Z][]U[KG'))%(DL3O'+&ZR1R1L4960W#*18@@BX(^GO3*&%#D'!!\^MJQ0@
M@D$&H(P01T_Y7=V[,[2PT6<W/N+,T=-H%/297-5.1BC\=].B.:5T73<VL!:Y
MM]?:.WVVWM&+Q11HQXE$52:^I '2^ZW:ZO5"332R*."O([@4] Q(Z3OM;T7]
M*/&;PW;A*.7'8;=.X\1CY[^>AQF;J:"%[G5ZHHI41N>>5^O/M%/MEM=,'EBC
M=AP9HU9A^9!/1A;;O=V:>'#-*BGBJ2.JGSX*0.D\S,[,[LS.S%F9CJ)+<DDG
MDDGVL I@=("2QJ>GC#[DW%MXU1P&>S6#-=$(*TX?*3XSS( PT2^&1/(EG86:
MXY/]3[37-C#>T\:-)-)JNM%;2?4:@:</+I7:;A<6&KP)9(]0HWANR:AG!TD5
MXGCZ],OM5TCZ][]U[I20[RW?3XLX.GW7N2#"LI1L/#G*J*E(*E;&G6416TDB
MVCZ$CZ>T+;9;/)XIBB+_ ,9C0OZ\:5_GT8IO%W''X*SS".E- D<)3A\(:G\N
MDW[7=%W3U1;DW%C<;7X;'9[-4&(R@89/%464GI::I#@*PG@CD6*:ZJH.M3<
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MC9F!>7)84Y2:?,8Q,C0))/5BG\69V_FJ6KH!EJT0R4RNE7)#4PD>Z]UJS?\
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M?Z4-F_\ .PG_ //?/_T9[]]='Z_R/7OW9-_#_,?Y^O?Z4-F_\["?_P ]\_\
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MW\/\Q_GZ]_I0V;_SL)__ #WS_P#1GOWUT?K_ "/7OW9-_#_,?Y^O?Z4-F_\
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MOZP7_P#RDW'_ #FD_P"@NO?N6S_WQ#_SB3_H'KW^RZ?'S_GQ/3?_ *+#"?\
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M#"?_ %#[]_6"_P#^4FX_YS2?]!=>_<MG_OB'_G$G_0/7O]ET^/G_ #XGIO\
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M?^<2?] ]>_V73X^?\^)Z;_\ 1883_P"H??OZP7__ "DW'_.:3_H+KW[EL_\
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MZLV?^^H_^<:?] ]>_KEN'^_I/^<LO_0?7OX#N7_GYW9'_H45'_1WOW]6;/\
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M7OX#N7_GYW9'_H45'_1WOW]6;/\ WU'_ ,XT_P"@>O?URW#_ '])_P Y9?\
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MKW7O?NO=%P;Y=?')?E%%\+3VAB3\GY>LI.Y$ZD7&9%ZT;9BJ!2'+-5BC.,2
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MVUV/CLS24N-PJ==8_+5\\-=1RH:JH:I3$NB&)P%,BEA93?W7NK+??NO=5/\
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MD^2>SMT;S^)7RM^.N&RNU\-N.;9=-)/D=N9W"5XF%!EX8:.KF::)X8(VEI(
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M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H3?BW_ -ET?#W_ ,2[M_\
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MWY@\DF.PNZZRG2OQ.5IZJ@K$@K*:GGC$M.X2:*.5;.BL/=>ZOG_X:=_E9?\
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M.K[L>33'[KW0N?S/O@U3?S)O@OWK\*ZOLR?IZ+NF#KQ4[(I]HKOQL9+UYNS
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ML]9+3T3EXP6BD>1Y/?NO=%&[Z_X3G=<=_?-SY>_/')?*CM#K/O+O'+=+[O\
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MW+E=OXZGI,AN"KH*$"BH:G,U<,U7+3TX$$+S-'%^VJ^_=>Z7OOW7NJJOA?\
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ML$./E?058MZM('?._N?N>U;DVT[18-=31JC.Y$CJ/$4..V/20 #EF<"N*8Z
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MJ2R1!8YB5 6:&96"L0  &JC Z:#"D4)ZI#V-\5Y][?,BK^*C[BDV\E-V#O\
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MEI^SRZ9^[2QDV2Y1B2!>. #P ,$%?V]$*_D_?]E69?\ \1!N_P#]V&&]RO\
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MPK\^IV]HCR_]/<#E_P 7P_$3Q?%\3X])I3Q,\.-/EUJW[Y_X_;>'_AT[@_\
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M*R:0?56ZIZ[J[4R^9^4W:':_6F<R.*R5?VUNS,;)S^U:Z6GJ?%)73Q4,]--
M^LO4TWC)T,5?R,H!1K>\BN6=ACMMAMK"^165;2)9XY5!6N@,X8,*=K5XY%*\
M1UC?S3S#+=<PW6X6$C*YNY6@DA8ZB-91"I4YU+3A@U(X'H*^QMZ]B;]W35Y[
MM+<.Y]R[N\%+155=NZKGJJQ(J9;PPVJ#KBB16NJ!54:BP%V))_LNV66TVXBL
M(XHX:E@(@H0DG)[>)QD\<4\N@]ONZ7V[W!EW&262:@4F8MK  P*-P&:@4 S7
MSZ36"PN0W)G,-MW$PBHRN>RN.PN,IRXC#U&4F2"%"QX75)(HN>!?VMN[I+&)
MYI#1(T9V/HJ L?Y#I!96C[A-'!$*O(ZQH.%6=@H_F>KL=W_![X4_$[:.T<I\
ML>S=^[CWENI'@I\-M-FI::63'1I]U]E2TU))7?:T?GA5IZBN17/CTQH7,7O&
M3;_=#F?G^XECV"V@CABR7EH6 8G3J9W":FH3I521G)I7K*;</:OE;V]MXI.8
M;F>667 5"P4E0-6A8T+Z5U %F:GPX%:=&_[G?K)_Y7>[FZ:;-/U@.O*=-G'<
M+2-6?:QY^%2)O-^Y=9A*%#<A H^GN.N6A?#GF']Y:/J?J3XWATT:_!/#3CA2
MM//J2N9C8GD:;]VZ_I?I/T=>K5H\04KJSZ\?+I%_$G)Y'"?RHMZYG#UU7B\O
MB.KODMD\7DZ"H:DGIZF@_CTL$\$J%7BFAE171U8,K $$$>S7W!@2ZY^ABD4,
MCW6VJRL 596\ $$'!!!H1YCHF]O+B2T]OI98F*.EIN;HRDAE93<D$$9!!%0?
M(]$'_D^5=4ORHW!$M3.(JWJ#=9K(Q*UI?'DL,ZF07LY5^03<@_Z_N6/O$QJ=
MAC-!5;N*F.%8YACTZB+[MTK?O^45-&LY2V>)$L!SZ]#;FH8H/YU\*0QK&C9[
M S%4&D:JCK:FD=O]=G9F/]22?88MF+>V1)_@D'Y#<6 _ET*9U"^Z(I_&A_;M
MBGH)/YRO_93VQ/\ Q VV/_>AW1[$/W;_ /DAS_\ /=+_ -H]KT&OO+_\EV#_
M )X(O^TBZZ/1_-DRN3QOPXZZIL?D*VBI\WV?L'%9F"DJ7ITJJ5=OYVK%/4*I
M FA%524TVA@5\D4;VU(I$6>P%O'/S'<,ZJQ2VG="0"5;QX$J*\#I=A4>1(\^
MI:^\/<R6_+D"HS*)+J!' ) =/ G?2:<1J16H<5 /ETR?RL,SE:?X0]R54-?5
M1U& [#[-.$E$I)I?!MC!5:>&]] 6JEEE '&MV;ZD^U/OS;1MS/: J*26]MKQ
M\5;F=,^O: /L Z3?=^N9!RQ=G4?T[FY"9^$?30/CT[F)^TGJO;^5?F\Q4_-'
M"U=5DZZKK-Q[6[#.>K*NI>JFK#/2M62-42R%I)7DJH8Y69F+,ZZB2;^Y>]^+
M6./EIE55 CEM_#   2C:  !0 !20 , =0[]W^ZEEYF#LS,TD-QXC,26<D!R6
M)J22P!).2<]#G\L_C]G?DS_,LRG5V#R\&WEJ]G[.S6;W!/":G[*@Q&*IGGGC
MA5D,TY9HXXDUJ#(ZZG1 S *^W_-T7)')2WTJ&2DTR)&#37(\C4!-#08))H<
MT!/0M]P^3I>>N=S8Q.(Q]/#)))2I2-$%2!45-2 !49.<=*K<71'\L_XV=DX?
MK7>^].W-T]JXBOV[55#459+4"CK:QXJBC28XZBI*2%Y!+!((M<KI'H,C M=T
M%IS5SMSI9/>VT-K%:NL@%54:T *M3Q'=B!0BN 36G#!E<<I<C<D7\=C<S74M
MXCQ-\3DH[$,E?"1$!-0:&I H3QJ1!_G5_P#'D]"_^'3O?_W$H/93]VC_ '*O
MO^:4/_'WZ,_O/?[A6/\ S7E_ZMKTMN\/^W.>%_\ $0?'O_W?[:]EO*__ $\9
M_P#GKW#_ *L7/1ES;_T[9/\ GBVW_J]:]%P^)?SJ^/F6Z#QGQ7^6&WD3:^/H
MUV[09^?$RY7%5E *D5%&M>M'>NH*VAF9/'4PQ$*(HYS+#,A9AC[@>UF[VV[-
MOVP2?J,QD9 X65)-.EM&OM=7%:J37N*Z64] WV\]V-FNMH38>8$ C51$KLA>
M&2,,"FO15D=#2C 4&D/J5ND1\Z?@-U?U7U7C_D9\?-S5%=UQ75&"ER&!K,L-
MPTPHMV&-,?D,/D>9IZ5Y)8%:.:29V6595GLI0FOM9[LWV_7[;-N\8%P!(%D"
M>&VN*I=)$X!@ <J% (H5S7HI]V/:&PV';QO6S2$VY,9:,OXB>',0$>)\D@EA
MABU0VH-BAJ"]Y$=8V];)W\R/[_&_R_NNZ#989=JG*=/8[,!(](_@M-BYWHP1
M&61%_B,.)_)6]@"25]X5^R^B;FV=[G^UTW;)_P UC( W'/P&3Y]9Q>]^N'E&
M)+7^RUVBR8_T (2O#']H(_E_+HFW\F.7.#OSM""G:K_NU)U!4RY946\!KH<U
MB1CC(;<2BGDRGC%^5,OUMQ)/WDUB.TVI-/%^K 3^+PS#+KI\JB.OSIU&'W96
MF&[706OA&TJ_\/B":/PZ_/29*?*O3WC#CV_G-2'&&(TW^D3+"4PDD?<+L^85
M8-_[0JQ,&_&J]N/:68./;;OK7Z=>/\/U@T_\9I3Y=+H2A]SNRE/&;A_%] =7
M_&JU^?2:_G,Y7)R_(KKK!R9"M?#4/2V&RM'BGJ7:GBJLIG<_#4U$<)/C2:>*
MCI$D<+J=88U8D(MEWW;K>-=GN)0JZVO'0O0:BJP0%03QH"[$#R+'UZ+/O,7,
MC;S;0EF\-;)'5*G2'>>X5F X5(103Q(4>G1R^^Y),A_)[P-77.]951=1_'F2
M.HJ6,SADS6VX0VIKFXB8I>_Z21[C?E-1#[BNJ8'U>X"@P/[&Y/\ ASU)O.+&
M;VXC9R2?H]M-3DU\:U'^#KA\7/\ MT?V+_XB#Y0_]";@][YZ_P"G@V__ #U[
M9_AM^M<B_P#3NI_^>+=/^UGH"?Y-7<4<63[0Z S$T;4N8ID['VM3S7*M-2B'
M'YB&S,4=IJ<XV14" Z8)V8L/TBG[R'+A*6N[Q@U0_32D>AK)&<9P=8)KQ*C'
MF%/NT<RT:ZVB0X8"YB!]1ICE&33(\,@4\F.?(WGQ=Z%P_P (L)\P^T=STPI,
M-0;JW#7[8ED!N^T]FT+97'"$^MC)429&6G=5#%YJ9  2%41WSSS9+[G2[18P
M&KF*-9!_R]S.(GKPP!&&%> 8_;U)/(O*,7M=%O%].-,8FD>,Y_W$AC,J <<U
MD933)*CY#K6:WENK+;ZW=NG>N>E\^;W=N',[FR\VIF#5.=J)*F8@L6;3Y)6M
M<DVMS[S<VVPCVJWBM8A1(8TB0?T44*.'R'6"VZ[C)N]U-=R_'-(\K_Z:1BQX
M^53CI-^UO2#KWOW7NO>_=>Z][]U[H3?BW_V71\/?_$N[?_\ <J#W&ONQ_P D
M.\_YYY/\G4K>S?\ R7;7_FNG_'7ZW>_?/'KHEU[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=:U_P#/F_YFA\-_^H?M+_W*VY[RE^[=_P 3?]/;?X)NL6?O*?#9_P"D
MNO\ #!U4/[RSZP]Z][]U[KWOW7NAS^-'9^#Z8[XZQ[1W+197(X'9>Y(LME:+
M!Q0SUDD(BEB84Z5$U-"\@\EPKSQJ;6+#Z^PKSOL4O,VTW-A R+)-'I5G)" Z
M@<E58@8\@?LZ%O(F_P /*V[VVX3J[1PR%G6,*7(*LN S*">[S(^WHR_\PCY:
M=>?+'>'7>=Z[P>],+0;0VWEL3D%WI04..FDFR-4LRF%*'(9%#&J(+LTJMJ-M
M-A<@KVA]OKSD"WN(KQX7::1&7P6=@ JD9+QQFM3Y _;T.?>/W%LO<*>VDLHY
MT6&.16\=8U)+LI%!'))CM\R/LZ%OYR?/3J?Y-]#["ZOV/MCL/#;@VWO;;6Z<
MK5[KQV-I*,QX;#97'214\E'E*V>5VGR",I>GB!1&)LQ"^P_[7>U&X<D;K/?7
M4MN\<D$D2B)I"]7FBD!(>) !2,UH3D_GT(?=?W<V[GO:H+&TBN4DCGCE8S+$
MJ42&6,@%)7)-9!2JC /V=>^ 'STZG^*766]]E]@;8[#S>4W!O:3=.+J-G8[&
MUU/XY,?1TGBJ&K<I021.)*4FZ12C2U_J+'WNW[4;AS]?0W-I+;HL< B83-(K
M5$CO4:(I 11O,C(Z][0>[FW>W]A-:WD5R[R3F53"L3+0QQI0ZY8R#5/('!Z+
M9\#_ )&[)^+W=E;V1O[%;IS&"JMB9W:ZTNT**DKZL3Y.IH)XW,=;6X^'PA:1
MPQ\^H$K92+V&GNKR;=<\[8ME:-$CB=):S,ZII59%(JB2&O>*8I\^@1[2<[6O
M(6Z->WB2NC6[Q 0JC/J9XV!H[QBE$-<UX8Z#/Y7=M[=[U^079/;&TZ'-8W;N
M\<CB:O&46XJ>"EK43'XVBHV\\=-45<",TE,Y 2H<:2+F]P#OD'E^;E7:+;;[
MAD:2%7#-&6*$M([X+*AX,.*C/1'[A\QP<V[S<[C;*ZQS,A59 H<:8HXS4*SC
MBIX,<='?^<GSTZG^3?0^PNK]C[8[#PVX-M[VVUNG*U>Z\=C:2C,>&PV5QTD5
M/)1Y2MGE=I\@C*7IX@41B;,0ON,/:[VHW#DC=9[ZZEMWCD@DB41-(7J\T4@)
M#Q( *1FM"<G\^I3]U_=S;N>]J@L;2*Y22.>.5C,L2I1(98R 4E<DUD%*J, _
M9T)GQ&_F/=0[5Z+Q_P ??DEM'+9C"83&5FVJ'+4>"IMTX^OP]0S&.BRE#++'
M('ITD:)2D,R20HFH)(I,A'[A>S.XWVZMN^RRHKNXE9#(T4D<PXLC $4)%<E2
M&)I4<#_VZ][-MLMJ3:-[B=DC0Q!Q&LL4D/ +(E:U .G"L"H%:'B*.R_YK7QI
MZRW"^R=@]';EVAT;C,1D)<>VT,!B:'(U.8J:F']XXO\ B-'1P43TZSLTSUTM
M5+(8M<485A[(MR]A-[WN'ZJ[O8Y;UG4-XTDK1K"%./$\-V+ T&D*$ K0FO1[
MMWW@MBV.;Z6TL98K)$;288X5=IBXSX?B(H0BIU%BY)%5%#U6'U;\M\YTI\I-
MY=_[&QU17X'>&[][UN9VAEYUQS5^%W=D9:W[.HDA-2E/5PDT\J2)Y5CJ(EXE
MBUH\X[][>Q<S;%#M-TP62&& ),@U".:*,)J .DE3D$&A*GR-"()V'W'EY8Y@
MGWBU4M%/-.SPN0IDAFE,@4D:@K#!!%0&'F":V.[P^77\L+O;)Q]@]P=)[N&_
M?#1MD'GP$M//4R4L8A59JC"YF&#))%'94:K )C1 470B+#&W>WO/'*J&SVZ\
MB\"ITTD!503JP)HB4).3H\R<FI)FW<?<;D3FQQ>;E9R>.*5U1-K8@:1J,$NE
MP!PU^0&!0 5N?+_N3H7MK<>SX_CWU%'U1L[:.%R&,GCDQ&/PM3DIJZH\HJ*F
M*@>HU-&@TJ\M9-(0UO0% ,T>W7+>[<O0S'=[OZJ:9U8=\CK&%6E 9 O&N0%
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H3?BW_V71\/?_$N[?_\
M<J#W&ONQ_P D.\_YYY/\G4K>S?\ R7;7_FNG_'7ZW>_?/'KHEU[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=:V/\^A63LSX:S.K+$\?:D22L-*EDJMM74,>"PUI<7O
MZE_J/>4GW;B/\=_T]M_,3]8M?>4';9_Z2Z_ZP=5"^\M.L/.O>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[H3?BW_V73\/?_$N[?_\ <J'W&ONQ_P D.\_YYY/\G4K>S?\ R7;7_FNG
M_'7ZW>_?/'KHEU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5$_S+/YU?PP_ED8JJPO9>X,MVSW_-
M@JS<>!^,/2Z4^Z]X2X_'4T]=59?*T_F2#;F!HL=2UM;45^1EA7[2EJ9::.J:
M%H_?NO=&6_EO_-_:_P#,=^&'37S.V9L;/];;:[D_TA_PW96Y\E3YBNHO]'FZ
M\[M2;SU%(JT\GW-1@Y9TTJ-,<J*WJ4^_=>Z'7Y!_([HGXI=6[A[J^1G:FR^G
M>K]KQ(V6W?OC-18>G\L]Q!24RN?-6Y"J<:*>DIXY:FHD(CAB=R%]^Z]U3_\
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MRE?(U,M1D'6&!4@B#2RR22NJQ1JI>60A%4\V0WU\EDC.[!0 6)8@*H J22<
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M*4:)%(4D>Z]T?/\ G0?]OP_^$Z'_ (EWY%__ "E^_=>ZMA_G=?\ ;HG^8O\
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M?K?=?:?6WS._FM=LXRHI^SOYF'R?WSOG:S9*IGJ:FCV#UODLCC\#C2LD,%/
ME-E:C/4\?VR/'+0TF.8RMH2*#W7N@W_EZ[IVSB_^%1O\ZW:V3W!A<=N7=?3O
MQYFVO@*[)PTM9D5V]MC9,M>:&G=UEJOLXIHGF\2,8T8.]EY]^Z]T/'_"L[=F
MTMN_R5N\\-N/+8G'YK?G:/Q^VML&BR-3##-7Y6AW9C<W/34"2,'FJH\'A\Q4
MLL09Q305#D>-)"/=>ZI[_G1].]\;?SG_  E<VWD.WLKU3O?:=/UUT75?)ZHZ
MZQ79\>U.Q\W1]/T-%N>IVYFJZDQM540Y3&R9(I-6+H6BEEB=YJ9%;W7NKIJW
M^5K_ #N<C1U>/K/^%&&YYJ.NIIZ.JA/\L;KE-<=2A1UNN[ PU*Q%P01^"#[]
MU[H[O\KW^5OLO^7)\#V^"N<[$;Y&[4S&5[+K][[BS^R(]B4^6@[300Y+'G#Q
MY3+^"B>FUQ%6R<SLKM=^1;W7NJ7^ROY;'\QO^2+UKVQWO_*1^6U5VO\ $;JO
M';[[KW5_+I^4.V3OVGAQU$)\OGXMH9^C:')^:&B@:2FI*?\ A]942QR-/592
MLJ76;W7NM@O^6K\VMO\ \Q?X/_'[YD;=VS-LJ'N/:^4J,YLV:L;)#%9K9V5K
M]OY^@AJGAIWJZ2FS6*KUIJAJ>(STXBF,:%RH]U[H*?YU>/J\G_*0_F-TU%$9
MIH_A]WED'0?B+$X.KJIV_P!9((9&/^M[]U[H(?\ A/+G\/N3^2[_ "_LC@LA
M!DJ*GZ<R. GJ*<DJM9M3<.:Q>1IS< ^2DR%'50/Q;7&UB18GW7NJ[^MO^XOC
MY _^,KL+_P"[G9'OW7N@L_G6;&W3_*O_ )CGQ:_GP](X(GJW/Y/!?&+^8QM?
M T:!\EM[=$E/28_<,L,-"[S5,M#3PTSU$E6FG(X;;,"1N*BI/OW7NF/_ (3.
M;GV_O;^9/_PI.WGM++T.X-J[N^<6U]S[9SV,F%135V/S^_>^ZNBK*>0<205-
M-+')&P_4K _GW[KW6XU[]U[K4"_X3B?]O3?^%.'_ (O_ ([_ -^+W_[]U[J_
M_P"?WQB^7'R<V9L#!?$3Y];E^ NZ-L;GR.6W9O';O1^)[S_C]!64OABQDU%E
M<MATHOMJ@+.L\=0Y/JC:,A@R^Z]T!'P0^#7\Q/XV=R9G?ORP_FX;R^=76U?U
M[FMKXWIS._%3;W2<%)F,A7XNII=P?Q?&[BS-3*]%24==3"E^V19!6&1IAX1'
M)[KW59/\E_\ [?A_\*+_ /Q+OQT_^73W[KW0'=^XVH_D;_SY-C_*W!PT6VOY
M?/\ -YRE!U9\A*:EA2CQVU^T!*[P9F9(:%(Z."IR56N6\SU<C2ID]UNZ1QTM
M-[]U[I__ .$5/_;K+OS_ ,7_ .T__?==5>_=>ZO^_FQ?]NLOYEG_ (H!\R/_
M 'W6X_?NO=$ _P"$N/\ VXH^#/\ Y<S_ ._B[!]^Z]U?][]U[K4"^&__ '&2
M?S8O_% .N?\ W1?&GW[KW6W[[]U[K4D_ELX.?<__  J,_G==FXO-9<;?VETM
MT[UOD\+!4*V/J,AG*#8 2IJ425D:LH'VIDH:8E"R1U-6K>-F9&]U[K;;]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%T^3?Q9
MZ?\ EKUS4=<=O8 Y&BCEEKMN;@QT@HLIAZUT*+6XVJTMXY+$"2-U>"=0$GBD
M4  1<L<TWG*5R+FS?2>#J<I(M:Z6'F/0BA'$$'H/<R\KV?-EL;:\34O%6&'C
M:E-2GR/[0>!!&.M9+OG^51\R/CK7Y"IZNQ2?)'JV"6:3%S[8CT9^GIT74L=3
MA&D-6TPL544+U\;:0VB%G$8RWY2]]=MW5%CNV^EEP"LN8B?Z,@P!_I]-.&:5
MZQ&YP]A-QVYVDLU^IBJ2#'02@<>Z,\3Y=A:O&@K3JOS<FY=P[$J1C^QNM>P=
MAY0L\?\ #MR;=GPTNJ*VI0E>E'(2M^?V[CBXY]S%8\Q6NXKJ@D20>L3I(/VJ
MW4+7_*=YMAI/&\1X 2QO&?V,O2;_ -,.V?\ E1SO_G-3_P#U5[7?O%/1OV#_
M #]%_P"Z)?5?VG_H'KW^F';/_*CG?_.:G_\ JKW[]XIZ-^P?Y^O?NB7U7]I_
MZ!Z]_IAVS_RHYW_SFI__ *J]^_>*>C?L'^?KW[HE]5_:?^@>O?Z8=L_\J.=_
M\YJ?_P"JO?OWBGHW[!_GZ]^Z)?5?VG_H'KW^F';/_*CG?_.:G_\ JKW[]XIZ
M-^P?Y^O?NB7U7]I_Z!Z]_IAVS_RHYW_SFI__ *J]^_>*>C?L'^?KW[HE]5_:
M?^@>O?Z8=L_\J.=_\YJ?_P"JO?OWBGHW[!_GZ]^Z)?5?VG_H'KW^F';/_*CG
M?_.:G_\ JKW[]XIZ-^P?Y^O?NB7U7]I_Z!Z]_IAVS_RHYW_SFI__ *J]^_>*
M>C?L'^?KW[HE]5_:?^@>O?Z8=L_\J.=_\YJ?_P"JO?OWBGHW[!_GZ]^Z)?5?
MVG_H'KW^F';/_*CG?_.:G_\ JKW[]XIZ-^P?Y^O?NB7U7]I_Z!Z]_IAVS_RH
MYW_SFI__ *J]^_>*>C?L'^?KW[HE]5_:?^@>O?Z8=L_\J.=_\YJ?_P"JO?OW
MBGHW[!_GZ]^Z)?5?VG_H'KW^F';/_*CG?_.:G_\ JKW[]XIZ-^P?Y^O?NB7U
M7]I_Z!Z]_IAVS_RHYW_SFI__ *J]^_>*>C?L'^?KW[HE]5_:?^@>O?Z8=L_\
MJ.=_\YJ?_P"JO?OWBGHW[!_GZ]^Z)?5?VG_H'KW^F';/_*CG?_.:G_\ JKW[
M]XIZ-^P?Y^O?NB7U7]I_Z!Z]_IAVS_RHYW_SFI__ *J]^_>*>C?L'^?KW[HE
M]5_:?^@>O?Z8=L_\J.=_\YJ?_P"JO?OWBGHW[!_GZ]^Z)?5?VG_H'KW^F';/
M_*CG?_.:G_\ JKW[]XIZ-^P?Y^O?NB7U7]I_Z!Z]_IAVS_RHYW_SFI__ *J]
M^_>*>C?L'^?KW[HE]5_:?^@>O?Z8=L_\J.=_\YJ?_P"JO?OWBGHW[!_GZ]^Z
M)?5?VG_H'KW^F';/_*CG?_.:G_\ JKW[]XIZ-^P?Y^O?NB7U7]I_Z!Z]_IAV
MS_RHYW_SFI__ *J]^_>*>C?L'^?KW[HE]5_:?^@>O?Z8=L_\J.=_\YJ?_P"J
MO?OWBGHW[!_GZ]^Z)?5?VG_H'KW^F';/_*CG?_.:G_\ JKW[]XIZ-^P?Y^O?
MNB7U7]I_Z!Z]_IAVS_RHYW_SFI__ *J]^_>*>C?L'^?KW[HE]5_:?^@>O?Z8
M=L_\J.=_\YJ?_P"JO?OWBGHW[!_GZ]^Z)?5?VG_H'KW^F';/_*CG?_.:G_\
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M(W:F(X2)I#\NSM4_Z=EZD7EWV;WC?&%+>1%K0O.# @Q6O?WL/](IS^?6PO\
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M[5V^H:&ACD(HX[N2TI?W7NMF;XI=5=O](_'[KKJ_OOY#YSY7=N[5H\W%O3Y
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M$>XJ/;BF.CQF\=U4^;S.Y\UA(XHZ</0RY)S*%"M4A$ ;W7NK!_Y5G\K';O\
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M93QU4\;QR1205-/+-35$<D,KJ?=>ZJ0VI_*2_G0;&QV)ZUVQ_P *$^RH>EL
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MO)KD*N.N[&JJ>GE%?N/-S::6&"/55.-&E8U3W7NMJ_JK:^Z=C]7];[*WSO\
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M^??\TO>&+R5#N#^9/\R.S-\;'.<R#Y&JBV7UYF\W'C:4^MZ>G6BSN7W'C_'
M2@BQ].BL8HH$C]U[K:;]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1%.U?Y<
M_P 9N[/FET/\].R\5O7<W>OQIVOD=K]-TU3OS(1;:Q(RAR)ER*;<CD7'R99C
MDY]54R%Y/'2&7R&AH_![KW1Z_?NO=$NZK^ WQVZ:^87R,^<VQL1N>C[[^4^W
M=E[9[=R-=NFHR.,J:?8=+14= U'C9 8J&44^.I%D,;Z7*%M(+,3[KW1T??NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%1V=\)?C=U]\M.U/F[LK8M7MG
MY%=W[!P76_;6Z<1N[,4>.S]!MAJ+^'5&3VZE<-OU.7HHL?3009)L::^.F\E.
ME0(IIED]U[HUWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z";O?I+KOY)]-=E]!=N8JOSO5_;VSL
MUL'?^#QF?KMKS5N)W%$U/74BU^,J*2OIDJ8&>-VAJ(V,;,NK2Q!]U[K-TATM
MUI\<NG^M.A>F]LP;.ZKZAV7M_K_8.V8*NHR/V>,VS3I2TL4E55RSUE9.8XPT
MU143RU%1*SS3RR2N[M[KW0I^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NFO.9O#;9PV6W'N+*8_!X# XVNS.;S66JTH*6DI,;&TU14U,\K+'#!!$C
MN[LP55!8D >W(HFG8(@+,Q"JH%2Q)H  .))X#JK,$!)- ,DG@!UI<?S%_P#A
M1AVAN_<F>ZN^!E5!U]UQ0/)CJGO;*X1:W<.:9"GDFPM%D86IL%CF_>C62>CG
MKY5*3QOCY!X_>8?M[]WNWMXENM]!DE.1:JU(XQG^T9#5VX&BL%' ZZ]1=OG/
M#LQCLJ!1@R$58_Z4' 'S()/E3JA.O^>GSBR67GSM9\QOE&^6J*O[YZV+OS=-
M*RRJ0RM$(LJBPB.RB-8U58U"J@55 $[1\A['$@0;?9:0*4-K"<?,E"3\R:D^
M?0-;>KQC4SS5X_VCC_ >K5_AO_PHB^8W0^7Q>!^0E5#\H.K?N*2GK_[RK!A=
MUT-.&19)<?G::&-<A*B>1S'E(*EYWM&*RF4EQ%G-_P!WS:=Z0R;=6SFH2 I9
MX'.31D8DK4T%4( &=#'H1[7SQ<VI N/U4\S@.!C@10'[#Q/F.MT[XF?,?X__
M #7ZQH^T^@=[T>YL45I8=Q[=J62AS6"K*B/6<?FL=K>6BJE]05KO!.%,E--/
M%:0X<\T<IW_)UR;6_B*-DJW&.10::D;@P_F.! ..I4V_<H=TC$D+!AYCS4^A
M'D>C1>PWTNZHY_F2?S?<)\7\QF.C^AL=BM[=XT42T^Z-Q9=3587;$E2@80/#
M&Z-E,RL;!C!K2GIBR&H>9UEI!D?[1>PTO.L:[EN;-#9DUC1<37%#2H)!"1UQ
MJH6:AT@"C]8[^[?OK%R0[;?MRK->@#6S9AMZBHU $%WI0Z 0 ""Q_"=9G?GS
MQ^9W9.<DW!NKY.=SO7R!@*?;V^JW9-#'K-V\&,PDF/QM.6-KF*D2X"@W"J!F
M-MGMAR[M$?A0;=::?62%)G/VO,)'/YL?Y]8=[G[H<Q;O)XLVXW>JE*13- GY
M) 8T!^86IQZ#H9NAOYK7S>Z'RE#-3=R9[M#;=/*IK-G=R5<_8-+41  >):VK
ME.9HU11Z!2Y*%5X!5ENI#W,_L=RWS,C VJ6TA&);0"!E/KH4>&WSU(2?4'/0
MBY8]\>8^6G7_ !EKJ,',5T3,&'^G8^(/E1Z#T(QUM,_!7^9[T=\U*"+;B/%U
MCW924WDR?5NX,K'.U6(UN]3@*UD@7+4X 8O&(HZN !FE@\06>3"KW*]F]R]N
MW\4_XQ:$T6YC4@+Z"5:MX;>AJ5;R:M0,T?;?W?VWW$3PT/@7:BKVTC D^IC:
M@$B^M &7\2@$$V6^X@ZEGHGORX^8>QOBOM>&2MBBW-V+GH)&VGL:"L%.[JI*
MFNKY ':EQ\3@C5H+SN#%"#IEDBDSVW]LKOW"N"$)BMHR/&N"*@>>A!C4Y'E6
MBC+>0,3^ZONU8^V%J&D FNI0? M@U&;RUN:'3&#YTJQPH.2->7M'YQ_)_M;*
M5%?ENUMR[7H)9 ]/MOKW)5&RJ"!5Y6,)13)45"JWJ#553427MZ_2MLU.7_:3
ME_EV,)':13-3,MRJSR,?7O4JOIV*H^7'KG_S-[W\S<TREY+V6!*U$-HS6T:_
M+]-@[#S_ %'<U\\"B>V-\PODWU[DX\G@.Z^P*DI,DLF.W+N"?=]%+IM<24>4
M>KI_6HTLRQJ]K68$*0MW?VQV#>HS'-8VXP0&BC6%Q]C1!#CB 21\ND&R>[_,
MVP2B6#<;IL@E)Y6N(VIY%9S(!7@2*&GG@=7-_%'^9[L[M"IQVQN\H<3UUOBI
M9*7';J@E:FP.1DL J2O,[-B:J0WL)96IG(LLT;O' <7/<7V"NN7E:[VDO<VX
MRT1%;B(>H"@>(H]5 8>:D MUF)[6_>5LN:62QWD):73=J2@D6LQ]*L28F/D&
M)0G ?40O5L(((!!!! ((-[W]XZ]91]=^_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z+)\H/C+@/EEM'&=2=D[EW/C^E*W(-D^SMD[.S$^UZG=:4/C-#A,C
ME:5DK:;;WE,E160T<E/55<\-&@K(:6.JIZP1<N<Q2<KS&[MT0W %(9)%#B G
MBZHU5,E,*6#*H+'26TLJ*^L5W!/#D)T'XE4TUCT)&:>9H03@5I4$(8?Y67\N
M:#"Q8!/A=\>FH8:6.D2>;KJAJ:TI':Q?)2(V1DEXYE:J,C?VG-S[-C[E\P,V
MO]XWE:U_MY O^\@Z?RI3I,-AL@*>!%_O"U_;2O5:WR;_ .$V_P *>U\?D,CT
M#E=Z?&C>C+5ST,6-RE1V-MN2:I9'_P KQ69JI,DD8*NL8H\Y2QQ"1CX952.-
M9&Y;^\1O6TL%OA'>1X!U*(I0!4=KQJ%J?,NCDTXBI)(;_D:TN03%JB;/ ZEJ
M?4,?Y CK4[^<?\KSY9? ?+S3=N;+&=ZRJ<@:/;W=&Q6DSFW:SRL%ACJ9O&E1
MAZV6X IJ^"!Y'#BF:HC7RG*;DCW/VKGM0MK)HGI5K>6BRC&=/DZCU4F@RP7A
MU'.\<N7.S&L@U)7$BY7\_,'[?R)Z+-\<?DUWA\3>S<1VYT'O_-;!WCBF2.>3
M'S^6CR-+J#28[+T$FJDRF.F*@O3U$3H'"2IHFCCD03<Q\LV/-ELUI?Q+(AX5
M'>C?Q(W%6'J.(P:@D$OV_<9MLD$D+%3Y^C#T(X$?\6,];H'PP_G]]%_*G97^
MBGOK=&(^'_R$R]!#@J;L#),DNSJJ6NO'-D<3DZYI8,)D(81))#3YH_9QU!IU
M%77 R0C#OF[V+ON5)Q=V<9W"T5M1B6HG &0LBI0LI."T7<5#&B8/4GV/-T6[
M1&%G^GF8:0YH5!."REJ@,!D!Q2M/B%1U:3UU_+?^"FW< DM#T7L#LU\_(<_7
M;][*0=LY++3Y/]Z3(2Y7*O6F1JMG,K& QPNS%U3F_L";G[N<R7LF;V> ( BP
MVQ^FBC5<!0D6@ *!05J:8KTEV_VGY=LD(^A@F9F+O+<K]3+([&I9GFUL22:G
M-*^70/\ =W\G'X']J8^OK*'KNHZ8S8I7;^\_5^>EV_%"M."X>3%U;5>#$:^H
MR,N/CD9;@RBRE1!R[[_\S;$P#7 NDK_9W*"0FO\ 373+]G>0/3C4/\P^PW+6
M_ D6WTSD4$EJQBTTS71W1?:2E2// IKF?(_^4[W7U9M&'N/HG.8_Y4= Y&DJ
M<KCNP.M<<YKDHZ>62/[R7$)+5O5XUQ&SQ5^.J*VEE@'W1:*G>-VRPY+]^=LY
MAE^BW%3MUX"%,4[?IEO02$*%;R*2!&![1J->L5^>/N_[KRRANK _7VU-6J):
M3(,Y,8+%A2G=&6\R54=5<8G+97 Y/'YO!Y/(87,XFLI\ABLOB:V3'55-44C!
MXIZ>HA9)89HG 9'1PRL 001[F^XMX[M&BE571@59' 964X(((((/F#CJ"K:Y
MDLY%EA9D="&5T8JRL.!!4@@CR(/6Q_\ !K^>G78&GQ?6_P T(:[-XVG2.CQ?
M>6W<8:RNB1  HW%C*9==<% :]911&H-E$E)42-)4>\1O<G[M*W!:[Y=(4G+6
M<C44G_A3L:+_ *1SIXT<"B]9=>W'WE/""VG,() PMY&E30#_ $6-!4G^G&*F
MHJG%NKK>M>A_BIWJ^0[WFK]E?)G-[YD6>NWS5Y:'>.+A5%M%C<;CUEEH<;34
M$96&.&2)JM%4?<RO-K8P#NW.N_\ +*KM4?C;;'!A8$4PRDGB\CT#NSGN)J$-
M>U0M!U-VV>W?+O,TC[O<+!NDUQEKB4K<1!1\,<25:.-$':H UXJ[,U27W>_P
M"^)>^J-Z>JZ@P6W*C21!DMD33[0FB)&G4$HI(Z64@?B:FE6_.F_/MK:?>/F/
M:&U+>R2#S6?3,I_.0%A_M6!^?7MZ]B^5=\32^WPQ'R:VU6[ TI_H153]C!AY
MTZJ1[L_EDY3%Y;=\/QOW]1=M3[(7&2;KZ]R4\%'GL;_&EDEI834Q"/&5E4]/
M"\S0-]G4K$8F6G<3PE\C.4OO 0W21#>X#:>-J\.X0,UO)IH"=)K(JU--0\1:
MUJPTFF+7/'W7[BQ,C\OW'U@BIXEM*46Y35D .-,;FG<5(C:E*!JBM6N7P^7V
M_DZ["9[%Y'"9G&5$E'DL1EZ&7&U5/+$;/%/3S*DL4BGZJZ!A^1[R'MKJ*]C6
M6%UD1Q571@R,#YAE)!'S!ZQ7O+.;;I6@N(WBD0Z7CD5D=&'DRL 0?D1U8G\3
M/YC78?0<..V1O^&O[)ZJI5CIJ*BDJ5.7Q$2<!<;4S,%GID6P6DJ)!&H54@EI
MD#!H2]Q_8^RYP+7=D5M;LU+&A\&8_P!-5^%CYNHJ<EE8Y&0OM5]XB_Y&5++<
M0]Y9* JBH^H@4<!&S$!E' 1N0 *!60"AV!.F_D+T_P!]X<9?J_>V*W T4*39
M'"&3[')T6OBU9CYM%5" UU$GC,3D$QR.O/O#/F?DS<^3Y?"W"!XZFBO35$_^
ME=:J?LK4>8'6>?*7/FT\\P^-MES'-0 NE=,L=?XXVHZ_(D4/D2,]#1["_0OZ
M8JW<V Q^<PNV:S+4<.X=PQY"HPV%\GDJ9X<3'Y*FH$*AG6F@!C5YF"Q+))#$
M7\LT2.KBL9IHGG5&,<94.].U2YHHJ<:CDA1D@,:44D(Y;^&&9+=G42R!BD=>
M]E0 LU!G2M0"Q[065:U907WVDZ6=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M,FY=L[<WGM_,[3W?@,+NK:VXL=58C/[;W%C(,U05U)7*4FIJNDJ4D@J()4)5
MXY(V5@;$$>WK>XDM'66)F1U(974E65AD$$4((\B.JN@D!5@""*$'((/6G7_-
M'_X3U9C:\FX>^/@)AJ[<.VW>7*;J^-2SM6Y#'  M/4[1J*B4RY*DX+'%2NU9
M&=0H9*I7BHX,MO;+W^68)8[\P5OA2\_"WH)@!@^7B#!QK RYC/F'DHBLUD/F
M8O3UTU_XZ?R\AUJAY/&9'"Y'(8?,8^MQ.7Q-;5XS*XK)TDE!4TU302-%/3U$
M$JI+#/#*C))&ZAD8%6 ((]Y412K.H="&5@&5E(*LI%001@@C((P1U&[*4)5@
M00:$'!!'D>C*]&?-GY;_ !IITH.BOD3VQUOA(UJ@FUL%N^JDPH:ND\TLG\$J
M7GQ/G>4LWE^R\@+.0PUO<-;[R1M',IU7UI!*QI60H!*:"@'B+I>E,4U4X8P.
MC"SWBZV_$,KJ,]M:KDU^$U'YTZO-^ G5O\RK^<+GL?-\G_D-W=_LD&WLK#-V
M+5U&3EV9CMX"@GTS[:Q5/BHL;39>69HGBJZIUFAQJZG)-6889(.Y\W'EOVD0
MKM=I;_O)E_2QXK6U142,9"Y0BH*J*%\?AJ>ACLT-_P S$&YD?Z<'N_ )/(J-
M(6H\B?+[>MW3!8/#[8P>&VUMW&46%V_M[%8[!X+#XV!:6GI*/$PI3TM-!$H"
MQPP01HB*  JJ .![PUFF:X=I')9F)9F)J2Q-22?4DU/4IJH0 # & /0#JGG^
M8%_*"ZK^3U+G.S.EZ?#]4=^M%45TS4T H,!N2<EI&3,4T$9^TR$SDVR,$>MF
M8_=Q5/H>&??:SWYON2V2SW O<V50*$ZIK<</TRQRH_WVQI_"5S6!O='V+L>=
ME>[L@MM?4)U 4AG/&DJJ,,>'B*-7\0<  :@_;G37:'0^]LIUUV[LK.[%W?B)
M"M1BLW2&#R1W(2II)AJ@K*.6Q,=1!))#(.4<CWGKL',5ES1;+=V$R31-P9#6
MA_A8<58>:L 1Z=8'<P\MWW*MRUI?PO#(ODPPP_B5N#*?)E)'4+KKMCM#J'-'
M<?578F]NN,ZPA6;*;)W/6;9FE2!BRQSO1S0F>&Y-XY-2,"0RD$@N[OL5EO\
M'X5]!#<)FBS1I( 3BHU T/S%#\^FMGW^^Y>D\6QN)K=S2IAD:/5I-0&TD!A\
MFJ,G&>K)>A_DK_-1^9>[J+I'J[OKMC,2Y-8HL_G:"MCVW3X>@J6"2Y'*YS'T
MD-;14T:@V85!GE8&*G269Q&\/<S\G<D>WL!W*]LK9=-3'&VJ1I7&0B12.58F
MOF-(&6( KU,G*W.7._N).-NL[V<AJ"215CC6%&P6>2.-67@:4;42*+4];='Q
M.^-.U?BCTMM[JC;=;4Y[)1S5>XM^;VR(;[S<&X<[IDRF8JR[RR:ZF556-7FD
M:*GCAA:20QF1L$^=^;Y^=MP>^F 12!'#"OP00)A(UH **.-  6)-!6G6<G)O
M*L/)M@EE"2Y!+S3-4O/.YK)(Q)))8^I-!1:FG3+\F/A[U+\G,+(NZ,8F"WO2
MTQBP78>%IHX\A3E ?'%4_I&0H@QY@F;T@L87A=B_LUY#]R]RY"E!MW\2 FLE
MLY)C;U*_P/\ TE^6H,,=!KW&]IMJ]R8--VGAW"BD5U& )DI6@)_&F?@;&25*
MG/6M%\A/C%VO\:]SR8/L#!RG#U-3)%MW>F-C>HQ631;LI@J+#Q5&A27II0D\
M=B2AC*R-G?R5S_MW/< ELY!K !E@8@2Q'AD>:UX.M5/J#4#F_P"X/MENOMQ<
MF&^C)B9B(;E 3#,,D4/X6H,HU&%":%:,0(Q>5RF#R%+EL+DJ_#Y6AD\U%DL7
M628^HA>Q&J*:)DDC:Q(NK V)]C"XMH[Q#%*JNC"C(ZAE8?,,"#^?0&M+R;;Y
M%F@=XY%-5>-F1U-*5#*01@^1Z-ALSY<_,[,5.)V+LWM[L_<>6RLL6*P^)IY/
M[S9&HD<W5(IIH*BNDDL"2WE+!026"@VCC=?;7E:U5[RZL[6)$!=W-8HE'J0K
M*@'RI2OE7J5]D]V^<[UH["ROKN:1R$C0!9IF/R9T=R?,DM4"I)IU??\ ##XT
M[HZ>P>5[$[DSV2WGW[V)34Z;KSN;S,FXYL;00-Y8,-#6RRS&0++^[4O&_B>4
M1QIJCIXY'P[]T>>K?F:9++:XU@V^V)\&.-!$LLA%#*5 6E1A014+4FA8@9U>
MT/MW=<I0/?[O*]SN=T!X\LDC2M%$#J6%78M@$ZG*]I:@%513T>+W%'4S=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1-_D9_+W^%WRRJILIW]\
M=NO=][CGIZ>DFWHE%-M3<#Q4ES#"^X,+/CLT\,1+:(VKC&MV 6S,"+>7^>]X
MY5 6PNYHE!)\/4'BJ>)\.0,E33CIKT6WNSVNXYFC5C2FJE&I_IA0_P ^BQ]>
M_P CO^5[UOGJ?<F+^+N%W'DJ1T>F@["WIN/L.@&DAK28G,9>KQ-2&*BXGHI>
M+J+*S!A+N'O1S-N4?AO>NH/$Q1Q0M_O<4:N/R8=%\'*FWV[:A""?Z19Q^QF(
M_EU:EA\-A]NXK'8';^*QN"P>(HX,?B<-AZ&+&4E+3TJA(H*>G@5(8(8T 541
M%50   /<82RM,Q=R68DDLQ)))XDDY)Z$*J%%!@#R'3E[IUOKWOW7N@O[5Z3Z
MB[RP VOW!UOLWLC!1N\U+0[NP%/F/MY'&DS4DLJ&:CGT\>6"2.2UQJL3[.-E
MYAON7)?&L+B6W?@6B=DU#T:AHP^1J/ET4[QL-ES!%X-]!%.E:A98U< ^HU T
M/S%#T1#_ (9M_EU_QC^+?Z!9]/W'W/\ "O\ 2?NW[/5;Z>+^.:O'K]7C\FC^
MSI\?H]R;_P $!S9X?A_6^5-7T]KKI]O@\?GQ\ZUSU&G^L)RIXGB?0YKJT_47
M.BO'X?&I3Y</*E,='WZMZ>ZKZ2VS'LWJ+K[:776V4F^Y?$;2PD&'CFF*JAJ*
MEHD62JJ615#33.\K  ,YL/<8;SOU[S%-]1?3RSR4IKE=G('&@J<#T H!Z=2;
MM&R6>P0BWLH8H(P:Z(D5%J?,A0*D^9.3T)'LIZ-.O>_=>Z:,[M_!;HQ59@MR
MX7%;APF1B\-?A\WCXLK2S)]=,L$Z/%(M[&S*>>?:FTO)K"19H'>-U-5=&*,I
M^14@CI+>64.XQ-#<1I+&XHT<BJZ,/0JP((^T=$VS_P#+E^'FX<A+DINI8\74
M3LSS0X#=69PM.2UOT4L%>M-"!;@11(O]0?<G6?O=S/9((Q>%@.!DB@D;\V:,
ML?S)ZB*_^[YRCN,AE:P5">(BFN(D_)(Y50?[51T/'57QVZ2Z1CD'5O6^V]IU
M,T(IY\M3T[Y'(21C_=<N2K)*G(21WYTM4E;\VOS["',/.NZ\UD'<+F68 U"$
MA8P?41H%0'YA>AQRQR#LW)BD;9:0P$C2752TK >32.6D8?:QZ&CV%^A?U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>timage_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_005.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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MURQ><VW/TMB@>0(TAJP4*BD DDT\V ^TCHGWS?K7EV#ZB[?0A8(" 6)8U(
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M%1T,+7F^TO=M?<XM31QJS.M )%*"I4BM-7YT(((-#UK]])_.NAZ[^879O?\
MNQNS-P]>[TRW9=5A]GP99*RIIZ?=61:JQ<$E/4UZ4*KCZ8K%I29EBMIANH'O
M*;F/VR;=M@M]KMQ;1SPK;AY2I56:./2Y!5"QUMFI%3Q.>L?]CY^7;MXGOYC.
M\,IF*1ZJE0\FI!1G"C2N,'' 8ZV8ND^V,)WGU9LWMC;F.RN)PF],=-DL?CLV
ML*542P5$U,RS""6>'5K@8C3*PTD?0W P[YBV.3EN]EL9F5GA;2S)7230-C4
M?/S'62VS;JF]VL=W&&59%U -34!4C-"1Y>O1;?YA6;Z+V_\ '[^)_(+KW-]E
M;*CWOMV.@P>W<DV&JX<G-%6+3U<54E52/"(X#5QL5D8LDK(496-A?[5V^YW6
MZZ-JG2WF,,E7D74AC!4E2I5P:G21CB :XZ#?N!-86^WE]QB::(2)14.E@YJ
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M!I72* EFID@"@J-1%167^:.=;/E0*)RSR/E8HP"Y%:5-2 !7S)S0T!H>BS;
M_FQ=49C>^)V1VSUIV%T;49Z2G7&9O=L25-$B5S!*::M)CI:JEIIY Z^<4LL$
M9&J61(A))&,-T]CKZ"V:YL;BWO E=21$AZJ*L%RRL0,Z=08\ ": ANQ]U;26
M=;>[AFM2]-+2CMH30$\" 3YT*CS(%2+&>T.T-D=.;#W!V3V#FH<'M+;5&M7D
M*]U,[,9F6.""GB2[SU-3,\<<4:@EW91]+D1-LVS7/,%TEG:(7ED-%7APR22>
M  !))X =2'N>YP;/ ]S<,$C059C^P  <22: #)/57&U?YS70V:W?!AMP=?\
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M'D_\2GO3_K1CO9-[]?\ )>_ZAX?\+]&7M#_R1Q_S6E_Y]Z)1\,_^WK_R)_\
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M@YH/(58XX#@.EO\ S<O^RHOCE_X:N'_]Z*?V5^Q7_)%W#_3M_P!6!TO]V?\
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M,4B++(@ME@$.EF726BCE+"A&=3G/' 'ET)/:_:K9MDC9HT8S&7Q=2@ZJ2/&
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M\K#-9;,?"_KM,K435*X?,[WPN+EJ"SL*2ERM5)%'K8DLD+2R1IS9(T6-0%0
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MF%88'!CEGAADD$1=6$;-Y% E2-T&_O-O-SM>PVD=O(T8G,:2%31F00ZM-1D
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M':NS9=Q;CVI04N(HI5S=9CX)Z*BJIJR*CK*>"9(JBG2HJ*AM)4%A*ZL60Z0
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MXVEVMB]G9NEG&.\%17I45DE/1Q2RG[7[XL6TFIGE8VW#S]RUM6QWVT6#RH/
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M2S2U-%4U],7KJC+5PD5IF=_$K2K8K=7[L>X%KOEY9':I-45HOB(P1X@)2ZD
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MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!_P!L]@8OJ?JOLOM/.34U/A>M.O\
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M4N5R-3BL-3N90/=>ZM'^97QFZYW;\UMD?+KI7Y]]=_";YE=+]#Y'J+M.7<F
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M0NPHLUE]FT&5<JXS5(V\-Z4]354'I62>4XK$RRR1Q+DHF?CW7NKX]^?,??\
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MQRW=!O[;>-W&*2:7!8O=&(PN[.PZFBH\I4Q>%JD9R*I'ZZ:@J1K$?NO=6_\
M\KK^9'N;^8=_+BH?G5F^K<%U?G,E_IH\/7F*W)4;HI(O]%5;D**+5D)J6BFE
M^\-#Y'M3)XP^@:M.MO=>Z1?\C7^:GN7^;U\3.P_DINGIO!](9#9'R)W;T=#M
M3 ;PJ-[0U$.VMM;1SZY%JNHH,<\<LK[FDA,0@956!7#DR%5]U[HE/S$_GU]S
MYOY3[\^ G\G;X@O\^OD_UA3Y6C[8W_E<Z,'U[M#*8UIJ::AKZW[W$05[XZO1
M*>L>?<F'I!5!Z"GK)JM95A]U[HM\W\^K^:I_+_SG7E?_ #N/Y8>W>E.C.P]U
MT^TG^0?Q@W=3;PH,+/7,&B:MQ=%NW?U/4-%3K-*].=QTE9/'%*]%3U$D?@/N
MO=;$/RR^9VWNC_Y?O<WSPZ@7:W=NT]A_'O*_(+KW^';A\6(W-C8,:N5H'I\I
M2QU&FCR5*\;1U$<4EE=7T/;2?=>ZU\.O/^%"GSW^=W56QJ'^5)_+3I_DAWBG
M7M-G_D-O3>V_%VEUGL+<F=5YZ':-/E<S6[2BW5E::ADI*FO5-Q8QH]:PPQRL
M\CTGNO=+[X/?S[?E]C_G+U__ "W?YP7PNV_\1OD5W#X:;J;?G6>3EFVOEJ_+
MO5'%T7V]1F]ST\E/D3"M#!78_=>1B?)C[:6&G,EH?=>ZM*_FY?S9.M?Y5/3N
MPMQY/K[<O>G?O?6[:OKGXU_'C9-0(,ING-TR4_F=F2*KJX\715%=BX*B2DQU
M;5-59"@I8:5Y*I63W7NJE=V?S&?^%/W5.ULY\ANQOY0GQAR_1&%QV<W)E^GM
MA]LME.R,7B<+3)5M5U510[XS<62=H4J---C]H35^JRR4,3):7W7NKMOY6O\
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MIFR,#M3^2'\7,_B*"AI,CV9N[Y%[TW34TM$E+)55N.[#W-MR*:ID7U5,R8W
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MT-E82KRE9+D)HL7@<]N#["B\LSR/]O002BFIHP1'!2Q0T\2K'$BCW7NK/_\
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MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM'W_A;W_V3!\&O_$]=D_\
MO/0>_=>ZW7=YX:NW%L_=>W\97G%Y+.[:SN&Q^3#.GVT^3I98(I]49$@\,CJ]
MU(86]/-O?NO=?/K_ )&/SZZ1_P"$_D_RV^"?\T[K_LKXX=KY;NP[[P';--U?
ME=[X?/8[%8RCPR4M)4XJCJ,C78M)*1Z[&UE/13T<\5?-JDIY5T2^Z]T.'\\+
M^99V1_-Y_E[]W;._ER_'SMW</PHZCH\1W;\H_F'VKL^HZPP.6QO6N26:DVUL
M>DR2+79VKI\Q3"NRDHBB>A3&"*6)4J1+[]U[JR#$;_VWV1_PD,JLYM?,XO.4
M.(_E69?8%?4XFH^X2')=8X"7;N5HY3]4JJ'(XNI@G0_IEC<#TV)]U[HU?_"7
M'_MQ1\&?_+F?_?Q=@^_=>Z*;_/?^#7RIV3\MOB3_ #L/@-UQ/W1WO\.J)-K=
MR=$XFFJ\CE-S[/IY,G^[B*2E$\U54)CL_N+'UL5+1RUIIJNGJ8(J@T1A/NO=
M)*A_X55X'NR@S/2OQ-_EF_/CL'YTM2X_;U#TMNGKC$4>WL+N#</[%*=R9FBS
M\V:H,/33NDDM15[<QR- CM-+0QAIX_=>Z(O_ ,)(\?V]3?/W^=#_ *>)J/(=
MU8_>^V<?W9E,5)'44DN[WWIOW^/O!)"JPO#/EH,B\110C(+J MA[]U[H0>WL
M1WQ_PG1_FT?)WYV8SH??W>7\KWY]5U3N[N[/=5XE\[D=A9_+Y"LS53/7I([+
M2C&YRNS4U+]S-2XZKQF4--#4I74:PK[KW1E?E?\ \*I_C3V9TUGNIOY6.S._
M/E!\V.V\)7;.ZCVOANF<QB(MO9#/P_;C/9!*F U-?)AC/YX*:CI:F*>IB2.I
MJ*6E9Z@>Z]U=]_*0ZY^=/7GPHZ\;^8YW%N+MSY6;WJ\AOW>]-N&BP%*VTZ?/
MI *#:,4FW:"BHZM\7!#Y:N=WJG-?4U<454]%%2)'[KW6H!_)\_F7;&_DZ_/'
MYT_ 7YG=&][X7L?Y1_/+;\766Y]FX'&9#'PMOC<&1P=)D,M%F,I@JF/;L\5?
MC:ZFR./7)O4TTDVBC5X8Q4>Z]U]##W[KW6MM_P *R/\ MRAW[_XDOX]?^]CB
MO?NO=6E?RG?^W67\M/\ \4 ^&_\ [[K;GOW7NJ.?Y_/PB^5>R?EA\/?YUGP,
MZUK.Z.[/AQ#!M;N?I;"TE1D\EG=GXN?*54=3CZ* 33U:K1YO<>-R"T=)+D%I
MZZEJJ>*5:*3Q^Z]TI*/_ (5[?RM&ZODW!EL+\DL3W=3T$M+4_&D]0U-5GOXY
M"?"<+'E/+'@"YK+Q"62OB8 $M LMH3[KW0R?R+-Y?S:_E!O+Y'_-O^8+F=_=
M,]"=M9:NI_B?\+]S[?Q6,3#XS,UJ9$9N267$4NZE@QM$L.,QYK:FF-?Y*^NG
MH/'_  V2/W7NJT>U-F_)W_A/%_-,^4/S:ZP^,79?RK_EP?S <A4[Q[@Q?2&(
MJ=P;@V-N(5E=G)IJJ(BHCAAH\KE,_+1-52TF.J:+(FD^[I:FD19/=>Z0_P#,
M0_GW]B_S1O@!\GNJ_P"6C\+?E-ANL\CT1VUN#Y/_ "A^1FS,-L;;6WM@[*QM
M14[HQV&J\1GMQXS)Y[.444F-B@;(1U*B>8P4DA1ZFD]U[JQ7_A-'3SP_\)Z]
MI22Q/''5P_,&HIG86#HNX-QQ%E_J!)%(O^NI'X]^Z]T 7_"+W&4&:_E/_(W#
M96ECK<7EOGCV]C,E137*305_6W5D4T3V(.F2-V4V(X/OW7NB>_$7N#LW_A*]
M\D?DA\8_EETSVMO?^6-W[VH>T>AOE7UQMR7=T.!JZU(<;3Q9P)XX9*NHQ,&+
MH\E2F>*N2IQT=5CZ6MIJLZ?=>Z&7^9'_ #TJ'^:YT;N_^7%_)EZ;[O\ DOVK
M\F<.G7O:_:-1UM7;,P.T]J;E,D>62JER<<3TTN5HX:BEEK*Z.DH*:EDGDCJ)
MJH1Q+[KW5D/>GPCQO\NK_A,O\C?B%1Y:#<.5ZM^#G=<N]MQTJ/'#D-R;UBR.
M=W#4TXD=Y!1G,9*L2E#-=:5(5(738>Z]T)/_  EQ_P"W%'P9_P#+F?\ W\78
M/OW7NJL/^%,__;TW_A.[_P"+7G_WXO4/OW7NK*/Y]G8_\U#XR4_Q<^8?\OJ7
M??:G4/2W8M-)\NOBGL+:E-GJS<^"^]HJRER#R08S);@CQ8C@K\=DGQT3O1QU
ME/D)J>6DI:N2'W7N@%B_X5W?RB]P]1-N*;_3[D>PLOM=RWQV?I:HRF7K,C71
M^+^ +7K+)M>H:IE?Q"5LOX7C:[ ,?#[]U[I'_P#"7/X/=^]+P?/'YP]X]-5G
MQ@Q_SS[;Q.ZNI/C1E,-+@ZS;>W=MY7=>6ADEI9X:*HI*%I-T_8XV";&4DII:
M#[OPB"KIPONO=;9_OW7NM*C_ (4I[ZW7\,_YFO\ *)_F5;BZIWIV%\=OCWEL
MUA^Q\CLN%6EIJB/,PU$E&9YU6A@R%5C:^:;&Q5553Q5T]++3&HIAJG3W7NK-
M/EC\].F_YE/_  GF^<GRUZ'P?8>VNN][?&3Y)X&AP':F'QV"SM-4;'^_Q54M
M938G+9S'HLLM,983%DYM4$D9<1R%XD]U[I2_\)<?^W%'P9_\N9_]_%V#[]U[
MJK#_ (4S_P#;TW_A.[_XM>?_ 'XO4/OW7NG_ /X5:?';O*H[(_EK_/C:'3V>
M[]Z&^%_:U?F>^NOML4,V>JX**IW!M//+/4T"0SH,-E:;;U70UE8T?BII#2BI
M_;E5D]U[HZ-%_P *M/Y6N\-KX>#HV#Y-=]=Y;EQW^_/^,'6?QTW!DMW5^1%.
M9_X5$33C"230JDAE>ERM4B1Q221^954-[KW5,'\J7<7R<V1_PJ-[@WC_ # -
ME[;Z&^0?S6^*^_M[[7ZH7<D6=^PHMRKMS+;>VQ3UT(6"NR>$VSLRII:@C];X
MVJ8@2W0>Z]T:7_A2GOK=?PS_ )FO\HG^95N+JG>G87QV^/>6S6'['R.RX5:6
MFJ(\S#4249GG5:&#(56-KYIL;%555/%73TLM,:BF&J=/=>ZV?OY>WSTZ;_F4
M_%S9GRUZ'P?8>VNN][9G>6!H<!VIA\=@L[35&Q\I4XJJ6LIL3ELYCT666F,L
M)BR<VJ"2,N(Y"\2>Z]T;3>>&KMQ;/W7M_&5YQ>2SNVL[AL?DPSI]M/DZ66"*
M?5&1(/#(ZO=2&%O3S;W[KW7SZ_Y&/SZZ1_X3^3_+;X)_S3NO^ROCAVOEN[#O
MO =LTW5^5WOA\]CL5C*/#)2TE3BJ.HR-=BTDI'KL;64]%/1SQ5\VJ2GE71+[
MKW0X?SPOYEG9'\WG^7OW=L[^7+\?.W=P_"CJ.CQ'=ORC^8?:NSZCK# Y;&]:
MY)9J3;6QZ3)(M=G:NGS%,*[*2B*)Z%,8(I8E2I$OOW7NK(,1O_;?9'_"0RJS
MFU\SB\Y0XC^59E]@5]3B:C[A(<EUC@)=NY6CE/U2JH<CBZF"=#^F6-P/38GW
M7NC5_P#"7'_MQ1\&?_+F?_?Q=@^_=>Z)Q_/Y^$7RKV3\L/A[_.L^!G6M9W1W
M9\.(8-K=S]+86DJ,GDL[L_%SY2JCJ<?10":>K5:/-[CQN06CI)<@M/74M53Q
M2K12>/W7NE)1_P#"O;^5HW5\FX,MA?DEB>[J>@EI:GXTGJ&IJL]_'(3X3A8\
MIY8\ 7-9>(2R5\3  EH%EM"?=>Z&3^19O+^;7\H-Y?(_YM_S!<SO[IGH3MK+
M5U/\3_A?N?;^*QB8?&9FM3(C-R2RXBEW4L&-HEAQF/-;4TQK_)7UT]!X_P"&
MR1^Z]UL>^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZT?>X/^XVSXK?^
M(%W%_P"^,[(]^Z]UNT[CW%@=H;>SV[=U9C&[=VQM?#93<6X]P9FL3'T=#082
M!ZFLK*JHE*QP4U+3Q222R.P5$5F8@ GW[KW6K1O?_A3Y4=F9[=^/_ED_RL_F
MQ_,BVGL'<]9MG<W;FP=K9C9>U'?&T+5LYQ]=B=J;WKWG*M3""FK\7CJBI64/
M$AUTZU/NO=#9\#?^%'W47R@^3VU/A%\H_B;\A?Y?/RSWR%IMG];=YXNHJ*&O
MKW@J:F/&"OK<3MW+4595QTDPHS7;<I8*N4"FBF-5)##+[KW5A_\ ,R_F@]4?
MRP-J=";O[:V)O+>V*[^[OPO16$EVC78W'KB\AG::>JCR&4ER=32QQXN&.GE,
MTD;/)& "(G%RONO=5.XK_A4)UCV+\S-E_'KX^?"'Y&=_?'K>W>. ^.N$^8NR
MJE*; U^Y=Q96DQ$+8BBJ,6,;6X43U+RFKJ-TT4QIH_N%HVA<./=>Z/#_ #./
MYZ'QL_EO=A;'^/5/UYVI\K/ESV12QU^U?C1\?L9'GLU#3UD<CT<^8?\ >EH1
MD/$WVL%/0UM=,@:=:/[<>4^Z]T2/J;_A3;@L#DXMM?S'?Y=ORS_EC[AW+@MW
MY+J[-]^X/*TVTMPUVUZ22JBPJ;CW#M?9<]#D,CX_%#))A7H8Y2%J:R'4A?W7
MNKG_ .6Q\^^OOYF7Q/V=\N.K]D[QZ^V9O7<.]MO8S;._9**3*1OL;)SXNHDG
M_AU154BK-44TC1A*ASXRI;2Q*K[KW56ORR_X4<=1=:?(?=WQ!^#/Q0^0?\S+
MY+=?U]7A-^[8^/.,J(-NX7(XZI^TJZ"OW%3XK/5&N@J?VZVJI\'48^DD#Q35
MJS0SQ1>Z]UG^(_\ PHNZI[3^1>SOAY\XOB=\@?Y9OR9[$JHL5U[M?Y%T,O\
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M=>X2CQ66K]?9M524E$\<>6D@Q\CT<U=&9"TJ$(':.[65O=>Z,!U;\K>E,_\
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M&3->(JC)N7K_ &#CGFCCFC)@3--4>35 T*S*4]^Z]ULCTGS$Z\WS\+I?F_\
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M-GMJ9$J8Y%0G2MR ";#^GOW7NGN"""E@AIJ:&*GIJ>*."GIX(Q$B)$ J(B*
MJHJ@     6'OW7NLOOW7NO>_=>ZUR?YT7R<_F>_ SY$?$[Y@_&7!=E]^? 3
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MM[&8K'8_ X_'0XBAPM'1QTU+#2TT8BCIHZ=%$20)$ @0*%"C2!;W[KW6EO\
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MG_ AT)M?KO:>$Z;7:^Y)MX8Q=M8^BBCPRX[*3U==+6T"T @%/*:R;5$$TN5
M]^Z]T,?OW7NM/?\ D\_]Q'O\^;_R!?\ NYHO?NO=%S_X5']9;=[K_FF?R(^F
MMWXVGS.T^V^Z*/K+<^'JVT15>.W[V+U]BJVFE.EK1STU7*C'2;!CP?I[]U[K
M>"QN'Q.'Q-%@<3C*#&X/&T$&*Q^'H:2.EIH*:EC$4=/% BK''#'&H14"A0H
M M[]U[K2X_X2ZX^BVA_,:_X4!]=;7ITP6P]J_*/%X_;>T<:338^AAPV^NVJ&
MECIJ53XH1!1PQ0KI4$1HB7LJ@>Z]U8!\E>^OY%G\G7YZ]R?,?NGL_(T7SM^1
MFUYJ+?VW,359?N[/4^.R0HZJ)XL-30U<6T(*VFQ>-I:?RU-#%/30Q1HKQK)(
M/=>ZKQ_F*?\ "@[J_P"=?P ^874'QK_EO_/_ +5Z^["Z"[=Q%1\@-\]+4>UM
MAX2@QV,JICO.HRU+D,_&E#AA N1@^X6CF=XH8OV*B157W7NK1/\ A*I([_R/
M/B:KN[+%N7Y'QQ*S%@JGLG=;:5!^@U,QL/R2?J3[]U[HC7\GG_N(]_GS?^0+
M_P!W-%[]U[K<(]^Z]T 'RIZ?Z?[^^.?<G3GR!KI\;T?O_8>;PO;%9!NV7883
M :/-E!/F(9J>2@HWI(I%J91/&!3F4,RJ2??NO=:TW57\_+^11_++ZGVK\)/A
M?4=X?(3"=5Y',[>VELOXW=53]AU>9K\YD7KJVHI\]FJC;F.W%//4UM3(];#7
M3^:.%_$\UH%E]U[JDK^9_P#/K+_/[^:C_)#[2/P;^3?P\P>TOEKUWMG:F\/D
M[LD=>9G>D?\ I%Z]JW_A]$$9C0;<DD4B9*^IB,V2D2-D>*75[KW5HO\ PMK_
M .R%/B1_XMI+_P"\=N'W[KW6W3T#TMLCX[](=3]$]>;?Q.VMD]2[ VEL/;N$
MQ$.BGA@VM1P4J,I95>1W:'R/*X\DDC-)(3(S'W[KW7SPOA/_ #&-M=8_SOOY
MJ'S<^0'PY^6_S4[2P/;6]^G.EZKXQ]1IV\-@8G&;BS6#@6LCJ,C1PXFHFV[M
MS&X_'U"*TTL466"M&)J@2^Z]U=G\H?Y\O2WRM^.W=/QO[+_D]_S@,QLGNCK;
M=O7N:IJSXETQ\0W'1RT\-9"ZY\O!5T%0T533S1VDAGBCEC(=%(]U[H7_ /A)
M5DOD=A_Y:.Z.D_DCU[V3UQE.C/D-O;;G6&#[1V3F=CY#^ZN[<=B,_%XX,S3T
M\D])'N#(;A6*2%1$J_L:5,6I_=>ZVBO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6N]_PH
M'_G>;5_E1]#P;%ZNJ\/N;YK=VX>OBZAVG5P_Q*FVWC5;P5>\\]""%%-2N6BQ
ME+(P;(5P)"24E'7F/W7NODI;XWQO'LS>.Y^P^P]SYS>N^MZYS);FW;NW<V2E
MS&0R.0S$K3U59654[/+/43RNS.[,22??NO=)7W[KW3SM[;FX=W9S%[9VI@LS
MN?<F;K(L?A=O[>Q<^:KJRHG-D@I:2F26>HF<\*D<;,?P/?NO=7C?%S_A-;_.
M$^4\.-R^)^+.3Z3V?E:#^(4V\ODEG:?I^(*YC\2MA:OS;LU3(Y=&7;K1E%)9
MUN@;W7NKP>GO^$0/>^7H,55=^?/#J?K_ "+M')FL)U)U!E^V8T4 %HJ?(Y?+
M;-+.W*^1L;I3]>B4#0?=>ZL*VY_PB3^#=+%$-W?+SY79R<1S">3;E'M#:J,[
M.3&R)58+,E%6.RLID8LWK#(#H'NO=*2I_P"$3O\ +L>GF6C^3_S2@JFC<4\U
M3GMC5<:N1Z6>)=DPM(H/U42H3]-0^OOW7NBW]I_\(?.J:ZF,G27S^["VO5QS
M,XH^T^D,;OV.:,J@$?W.(SVVVIW#^1C)]I,"I6/Q*09#[KW54'R#_P"$:_\
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MXVCJ(XI+*ZOH>VD^Z]UKX=>?\*%/GO\ .[JK8U#_ "I/Y:=/\D.\4Z]IL_\
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M&V]W%+E\,:F6EHOXE1K#D*&HI:P4D!FIZB/S4]+4K/30^Z]U]$;W[KW5,_\
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M6)'^Q]LW&CPV\0572VH4!JM#49QP]<=>S^'CY?;Y=$O[U[1W#@LSM3JGK?\
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M8'=W47Q!^4.Q,AMC=$^/K*JGPN,R.<EVQ$)\955='-3T^W9\9!"RS:ECA5)
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M^8?_ ,*MHXI8\ME.C_Y0OQWIJ@A_MGQ3[\WW2+-&P!5YONOO=T1D?H?S[6U
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MS-;UZ8W-DZ/+9/'ON&.<0O2UV,EJ\5GL=4-CZM8*['5U1"YIY8)_MZRFJ*2
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M2%2%TV'NO="3_P )<?\ MQ1\&?\ RYG_ -_%V#[]U[JK#_A3/_V]-_X3N_\
MBUY_]^+U#[]U[JRC^?9V/_-0^,E/\7/F'_+ZEWWVIU#TMV+32?+KXI["VI39
MZLW/@OO:*LI<@\D&,R6X(\6(X*_'9)\=$[T<=93Y":GEI*6KDA]U[H!8O^%=
MW\HO</43;BF_T^Y'L++[7<M\=GZ6J,IEZS(UT?B_@"UZRR;7J&J97\0E;+^%
MXVNP#'P^_=>Z0W_"8#X)=Z=3XWY]_-+O[I2H^-6"_F =I4&?ZO\ B_FL)+A:
MK ;8PF3W9DT^XI)X:*>EQ\IW6:#'T\V,HY324'W7B6"LIPONO=$.^+O:79__
M  E;^4WR7Z ^3O2W:&^/Y6/R,[0/9/0WR;ZSVY+NR';E94+'24E+F"TA+5G\
M)^PQV1I*BLCK6J,;%78Z&KIJER?=>Z,Q\Y/^%)%5\P]@P?%'^1)L/O[OKY>]
MKU^&H8^UL1U54;:H=D8V&KCFJ:T1YZ!8Y*^K6 TPGR%-3XBC@FFJJBL:2%*:
M3W7NK1_G1UWW[U3_ ,)Y/E;L3Y3=PY'OKY$X;X,=JR=P]I9&@QN-_B&<RN/J
MJRL@IHL308RB_A^*:<4%'(*-9IJ6FBFJGFJI)II/=>Z:_P#A+C_VXH^#/_ES
M/_OXNP??NO=7(?)7H;97RC^/G=/QR[&I15['[NZRWEUEN11JUQT^[Z&:C-3"
MR,CI4TCRI/"ZNK)+&CJRLH(]U[KYR/\ )NZ1^1?S"_F.?#+^6]\HL))/U7_(
MRWC\F^Q]VT;U>5R%)59K$;W@GQU',\QHD\$>\$PW\/BEC(J<125,9IWI3+"G
MNO=?1Y^1'2.S_DOT)W1\>.P4G?9'>/5N^^J-U&D=HYDH=^XRIQE1+ Z/&Z5$
M,=2TD3*ZE9%5@P(O[]U[K2J_EO\ \P[?_P#PG*H]X_RS/YL/479^W.B]M]D[
MSW+\6?EQUUL:JW;MG,8W=57/65E,HIP9:FFJZH39&)8'J,E0R5=11Y"CA$43
M>_=>Z&;Y<?SS_DU_-+WSU1\0/^$_FW>[5S^0W[@<OWC\S<QUPFVL'MK$$- U
M$8\]2U$%-1(M4:ROJ:^"GJ76DBI,52UL]3KC]U[JU_\ G;_RIM__ ,Q/^5OB
M_CQA][5W9ORGZ"@V-V;UEV%NY,?M^IW?NK8F(FQ693*+00XS$4,V[Z&MRA"P
MTM/0TV0DI76&&FATK[KW5?'Q8_X51_&SIOHS!]0_S1.N/D+\9?FSTKMG';,[
M2V#6],9/(?WDKMM4PIDS.*313/CI<T(%FEILA'1T]/42NE/55-(J5)]U[JJ7
MK#OSY)?*K_A59_+O^2OR&Z/W)\<L/W3U7N_=7QJZ@WRGV^X\=UEBMJ]LX3!5
M>XZ8I&]%F,YE<3G\K)3$,(8ZV%(I)H1'*_NO=?14]^Z]U[W[KW7RXMW_ !;W
M]BOYU&;_ )%F1PF$K?B]V-_-JV!\Y:+$5VWGIH&VRNV<SGZO&Q4BL]%6T+=>
MYB?&NP18EJ,?("D:/+!#[KW6U)_PK%Z;W1N;^6AM[Y.=<UV5P_:'P:^1_3WR
M#VIF\+CTR4]-'4UXV[--XY$E58J&NR^*R+NT3H@H+RKX?(R^Z]TA_P#A*'UG
MO3>7Q>^5/\R+N2##U7<W\QKY6]C]DY'/8U*DB7";%R%?1K!&*MY9*:GAW?6[
MS2&G6HG5*9*8/.[@QP^Z]T6C_A1-_P!OK_\ A.5_XMIUO_[]GK3W[KW5C'_"
MJ+I7L[NW^3WV_C.JMH9G?&9V)V/U/V;GL%MV@ERM:,-MC(/'DJN"E@226=:"
M*K6HG"KZ*:.:4\1D'W7NF7^4+_.7^/'\S7X=]F=*]7=>]O=>=H?%+X>[ Q':
M]'V#089\/4U-;MK(8B1MM9/&YBLK,E1P5F&GU2UV'Q4K1S4[+3ZFE2'W7NBF
M?\(J?^W67?G_ (O_ -I_^^ZZJ]^Z]TE_^%L/_;N;XQ_^+K[;_P#>%WS[]U[K
M;]V1_P >7M#_ ,-? ?\ N)#[]U[I4>_=>ZTJ?^$N&,H,U\V/^%%.&RM+'6XO
M+?*;K_&9*BFN4F@K]V][Q31/8@Z9(W938C@^_=>Z CXB]P=F_P#"5[Y(_)#X
MQ_++IGM;>_\ +&[][4/:/0WRKZXVY+NZ' U=:D.-IXLX$\<,E748F#%T>2I3
M/%7)4XZ.JQ]+6TU6=/NO=#+_ #(_YZ5#_-<Z-W?_ "XOY,O3?=_R7[5^3.'3
MKWM?M&HZVKMF8':>U-RF2/+)52Y..)Z:7*T<-12RUE='24%-2R3R1U$U4(XE
M]U[K9K_E<_"/&_RZO@9\=?B%1Y:#<.5ZMVA5R[VW'2H\<.0W)O6OJ\[N&IIQ
M([R"C.8R58E*&:ZTJ0J0NFP]U[K0=_GT]1]S?'W^;+\LOASU)2XZGZU_G?1?
M#O.J)L--11T^=BW[B%22.6F8Q5U2-ZX/+5-4GB60Q9:)W'E5):CW7NMP+^=Y
M\(=L=@_R,/D3\:NN<-)08WXX?'C:&\>I,+M_%+(T%/\ $^"@RE)CJ.BB%@*G
M!X.JH$CB74BSVB5F55/NO=4I?\))<)VU\O.W_FO_ #3?D=7X_=_8E3M'HGX4
M['W?X98ZAH^K=LX)MQ%H6O2TLE5C,7L*:9J=@LU5+7.L%'"R1R^Z]UO%>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[K1!_F3_)3IGX??\*U?B?\ )3Y";RI=@]/=3_"[=N>WEN>I
MIIJXQ)6==]Q4%%34]-3I)45==D<C5T='24\4;25%5/#"@+./?NO='.WW_P *
MHNP-AK#VUF_Y*W\PS;_POEQ]#DS\G=][:K=E#P9&71!,E#-MFHVH]/-&T1BD
M_P!(0621_&O&EV]U[K9.^&GS$Z*^>?QVZ_\ D_\ '/<T^YNL.PZ2L:A?(438
MJOH*W$S/2Y#%92C8LU+D<=5QR13)K="0)(9)8)(Y7]U[HDG\LK^9W\=OGWW)
M\Z^H^D>B]S]/[F^&79FVNN>V,UG,5@\=3;AK\WE=Z8R&JQ\F(GEJ*B""HVGD
MY-59%%)IJHRJ:FE"^Z]TAOYG'\]#XV?RWNPMC_'JGZ\[4^5GRY[(I8Z_:OQH
M^/V,CSV:AIZR.1Z.?,/^]+0C(>)OM8*>AK:Z9 TZT?VX\I]U[HD?4W_"FW!8
M')Q;:_F._P NWY9_RQ]P[EP6[\EU=F^_<'E:;:6X:[:]))5185-Q[AVOLN>A
MR&1\?BADDPKT,<I"U-9#J0O[KW5JGQ ^??7W\S+^7;NCY<=7[)WCU]LS>NU>
M\=O8S;._9**3*1OL9<EBZB2?^'5%52*LU132-&$J'/C*EM+$JONO=:9G_"<O
M^<'TW_+S_EP[XZ/Q_3G>_P MOEIVY\X.W-X=??%OXS[*FWON23!4VP.M:3^\
M.36))&H,-+7T5320R14U753SQR^&D>&GJIH/=>ZO>^+G_"G?9&\OD=US\5/G
MW\$/DG_+3[<[<RN.PO7I[KAKLCB*BISU4*+%I6S9C;6S,U0Q9&K9((ZG^ 2T
M<<QTSU,2 R#W7NA*_P"%9'_;E#OW_P 27\>O_>QQ7OW7NA%VC_,#VM_+'_D&
M_P NSY9[_P"I^P>V^O=J_"[X$;7WCC>M*K&09#&P[VV'MS'T63E3*U=%3RT7
M\4EH:1PDYE$M7"RQM&)&3W7NKH_CWWAL;Y,=$]/?(;K.LEK^O^[>M=F=H;0J
M*B)H)OL-[4$&0IXZB)PKPU,"3B.:-E5HY4=& 92![KW1"_E?_-AZD^+OSI^(
M7\O6+K7?_;OR!^7I3(83';%R&&HZ7;.'>OEH_P"/;B;)5]+/'C1!C\_5G[6"
MHG:#$U8BAEF,,4GNO=6J^_=>ZKT_FA_-KI_^7I\0-Y?*3O3JW-=Q=<[,W-L7
M"Y39&WJ#%Y*LEFWGDX,723PPYB6&@;[>HJ49]<R,(]10E@%;W7N@E^1'\USI
M7XI_RN>J?YFV6ZGW_DNE=^=7?&_L# ]6[43$T6<Q^-^0E'B)L/1&*6KAQ*R8
MR/+4L=0D=6(E$;^!G"H&]U[JNSO+_A2IA8ZVLVW_ "_?Y>'RW_F5;HVEM_:F
M2[8S'0FW,I4;-VOD\_1T]=6[<K=TX+;6\99\S@XJA$K?'A/LTG(@6K:19Q![
MKW2H^//_  J,_E]=M_'[NGMCM+!]L?'?MCH?=VV.O-T_%S>6WUW!O/-[@WK)
M54N)Q&S*.B*/N&MJ<A09&EFIW@HJO'O23SY*FHZ/Q5,ONO=%BS7_  JRK>EN
MQ-N_[.=_*2^=/Q ^-V^=P8[!;&[][/V_D<?4U?WBJ\U1+MW+;6P%)(E'#YIY
M(L9N?*U34\3/#!+(1$?=>ZV0/D1\O>M>@OAOV7\W84JNT.I.O.EJOOBD.Q*N
MGFESF!@H$R<,N*FJ9(J61JRB=)(#)+&C:EU.@)8>Z]U1=NK_ (4Z]1[JZ\ZR
MG^%?PC^6/SM^0F_^KJ+M;<WQ\Z&VQ/NB78M'G9)QB:'?.:V_CMS'%Y3)4\#5
M*T]'A\B8*?UU#1EX!-[KW3Q\2/\ A4)\.>W(^^]K?,;K#M'^75W1\;.N9>S.
MR^L.^()<AY:6BEI*>IQV%J/X=B<O6[@6JR.+CI\55;<H*_(&MISCJ>J(J%I_
M=>Z+OVC_ ,*JMS]19&E[*WQ_)Q_F ;1^%59-0PT?RGW]MNNZ_%5_%IS%1246
M*R>VHMM3QUR&%J?7O^*25I/&(P0"WNO=;/WQL^1?4GRVZ)ZP^1_16YX]X=4=
MN[6HMV[.S@IWHI6AJBT<M/54T@$M)7T-3'/355.X#P5$4L3>I#[]U[HB?\N;
M^;3U#_,B[>^;73?6O679&P,_\&NR-O=9=@Y/?$N,EH\O6;AR>\,4D^&-!65,
MQIHYMFUSL:F&!RD\%DU>14]U[H>?YC?SLV#_ "V?B-V-\P>SMF[PW]LOK7([
M%QV6VOL-J),I.V_<[CL#3M3_ ,0J*2D(AJ<E%))KJ%_:5].IM*GW7ND]D_YA
MO7>-_EHQ_P SE]B;TEZMD^+^)^5 Z\66A7/C#97#PYI<?J-1_#OXFE+,$(^[
M\!E&GS:/7[]U[JH'=?\ PI_Z4W-L+JY?AK\+_E=\YOD;V1U7#VSF_CIT/MF3
M=-1LFCRSS+BJ+>^8P-#N-\9D\A&D4_@H<-DC34[B2I,;/3I4^Z]T(W\NC_A1
MEU5\Q?DK1?";Y+_%?NK^7Y\P,U'6';/4G=#5&3ILE44T516)C8J^NPFV,M29
M2?&0?<Q0UVW*2*;UPT\\\@C$WNO=7=?*3Y3=$?##H[?'R+^2/8.(ZVZGZ_QX
MK,WG\H6FDFFG.BEQV.HX@]5DLK7S%8J6DIXI)YY&"HEKD>Z]UK,)_P *A^[>
MPZZ#?OQC_D=_S!?D#\4)S52P_(S$8#.42U$&/GJ(JBJH\?AMB[GP4T$:11-=
M]Y0L&:2.58C%>3W7NKKOY9?\VKXF?S5.O=S[J^/>7W%M_??7%70XSMSH_LG&
MQ;>W5MJHR <0M64D4]1!58^HEAJ(X:RFJ)86DAEAD,51')"GNO=,'\T/^<'\
M6/Y56T]DU'<D6\>R.WNUL@N,ZC^/?4M#3YS=.>8S)3/5K3U%13PT>,BJ)$B-
M1+(6EF804D-5.&B'NO=5:]7?\*:\M@-VX#_AP?\ E5_-[^7?T=O7==%M?:'R
M5[1V=G\YM./^,W^PJ<_4939NT3C8J@&+4*!LOX@_D):!7F7W7NK:/Y8?\TKI
M_P#FF[+[SWYTQLS=>U=O=&=T93I3(9#<F4Q>8@S-7BJ2GK3E,/48JJJX*C#U
M,%3"U/,SH\JG5XU726]U[HJ?\PO^?[\<_A1WG'\0NI>F^[OG1\T&I(:JO^.W
MQIVY-N*JQ)K*9*RFI\U704U=+#6U%+)'-]I0XS(U<$+I+504Z2PF7W7NBQ]8
M?\*8,!LGMO8_3G\S[^7W\G?Y7F2[)S,6"V=V3V\E3N_8SS57A\3UFXZK;^U9
M8:1?N(!4U5/BZNDQY9FR$]+#%--'[KW5^GRP^2^U/B;\7.Z_E9N3#Y7>FR^D
MNL=P=JY?#;2J*9ZS(X_;U,:N1,?)/+'2/--""82\R1L2MY%4ZA[KW5!NZ_\
MA3_TIN;875R_#7X7_*[YS?(WLCJN'MG-_'3H?;,FZ:C9-'EGF7%46]\Q@:'<
M;XS)Y"-(I_!0X;)&FIW$E28V>G2I]U[H1OY='_"C+JKYB_)6B^$WR7^*_=7\
MOSY@9J.L.V>I.Z&J,G39*HIHJBL3&Q5]=A-L9:DRD^,@^YBAKMN4D4WKAIYY
MY!&)O=>Z-_\ SBOYG?QV_E:]-]4]N?(_HO<_>VV>P^S*CKG X7:>*P>7J:&O
M.*K,G]T\>>GIJ=8'IZ&6-FCE\FHH-!4DK[KW5H_9/9&PNGM@;R[4[2W;@MA]
M<]>[<RV[M[;RW-7IC*#&XW!PM45=753N0J10Q(Q/U)-E4,Q /NO=:O$__"G?
M=_=V=W'4_P N3^4;\V_GAU#L[(92FW%W7@<7D>O<3)!@XO-4R8J*CVINV2KK
M7CN:;'54E!D*GTJM,DC>,>Z]U:!_*[_G0_%[^:1+V/L;K_!]A]*_(WI9I5[A
M^-G=&#_@&X\,M+6R8V>HB9":>OIJ7(Q-2U04QU=#.T4>0HZ1JBG$ONO=6^^_
M=>Z+[\I/E-T1\,.CM\?(OY(]@XCK;J?K_'BLS>?RA::2::<Z*7'8ZCB#U62R
MM?,5BI:2GBDGGD8*B6N1[KW6LPG_  J'[M[#KH-^_&/^1W_,%^0/Q0G-5+#\
MC,1@,Y1+408^>HBJ*JCQ^&V+N?!301I%$UWWE"P9I(Y5B,5Y/=>ZNN_EE_S:
MOB9_-4Z]W/NKX]Y?<6W]]]<5=#C.W.C^R<;%M[=6VJC(!Q"U9213U$%5CZB6
M&HCAK*:HEA:2&6&0Q5$<D*>Z]UI:?SN_YAN\N[/YK'\IC?NX?Y>_S=ZJJ?BG
M\F\14XGK7M3IBJPN8[6_NWV/L^M-)UK0SQJVYFRK8B.EHU1/\HGKZ*/2/,![
M]U[K>K^!7S#W+\VNG]R=J[I^)7RC^&N0V_V3F.OH>L/EMUM4=6[DKX<5B\/D
MESU%CZ@!YL)5/EI*2&H'I>JHJR,<Q'W[KW1V_?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2:WAM#;F_MMY79^[\
M7!G-L9Z".CSN#JV?[>MIED222CK(U95J:&J5/%4TTFJ"JIWDIZB.2"62-O=>
MZ4BJ% 50%50%55%@ /H /P![]U[KOW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW24WA1UV0Q-31XS+Y# UU31Y&GI\UB(:6>LI6J(6C6HI%KX:K'-4T\C
MI(BU=%4T[%"LL$JDJ:B0JZKY&M?R'3-S&6C9QQ6E*4KDT\S3AZ@]$SPFQMP]
MC=F5V'[<W[O+/1[!JMO;IPV"VYKV3@JRER&X(\GMRMR#8VFI,I5Y?%2;>EH:
MZC;<E9AJ^(FMK<;$,G#BZ(7W$B6D :( :M603JJ*UXEA^(>2GR&!JZCVRV^;
M>KHBY9G\/2PKI5"-2$&B".M"O EUKW8/:#G#7X$I5!5*A"E01&?^69D-RSVT
M:;*S!@H LNG2H-@N#<ZV(RKL%SYC(]/7S_/J1YHO#3P@>ZG<?^%TH?,C]AJ?
M+JO3YT_(;_1MMB#JC;59X-X[SQLCY:I-&TZ0[=D:2CG ?TZ:G)2_L1"-FECC
M,LA =Z42SG[(\BGFF\-U=K6&!RRC4!JF4QD Z6!  >M>%:<0".L7/O)>[$7(
MNWG:87I=WEL5(TN2MC,EQ$9 1&Z$ZHR-.H2#)J@[@3K$]'[:HOAWW5W1N[;<
M._-T;MZ]SNPNN=HX7 -V (*++96AIH(UV_0&&IJ,A5[KQ=#,T$5;-+#'C*3[
M!Z.N-<K&W,^[?OKFG]V1E5BM'9-3.5"HL*O)5B%QIB*U)-:?%0X!/MK[?0[=
MR%-N<\;?47\(.D+KUK)=.MN576P7^T24 !66H[1(".JC?G/\C:OJ7X_4/QTZ
M^W?C]W=D]F;$QVU>W\_@JR>@K<9A\/)BI!!(:%JDI4[XJ*=Q5T-17RRC#"05
M-%609:CJ_<O[!R^.=KQ]PN00D3AT# G5)()%(!)7MCHK!E4C60JE/#=3&'*V
MT3;/LHCLYP/'B2%V54-(HF4:NULM*RD$,:Z VH-XBN#)?'#K.L^+/Q8ZYV5N
M"#(_WZSE9G.W.QL7E)I;8ZLWUBJ*8X:FH*JFHZW'/@=OX:@BR="8V%#6ID7
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M!][.:)[*[MG/"UM+?3\.'(5"?A-?A7C48XY)ZE#V;Y7VW=MMFEC),E_--XH
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M(NWD020"=>V$$:BT@"@%BQ"KI8,J-JP0&%'LARN=ZW([K,Q/;((Y"K**ODT
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MR*D1,5-31M2YJM57;P-GV'=;:[FN*WT@6-ZQRL9(YI*E2PU(H\:,%0*",ZJ
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M!?\ 3J!^@X_V/LHCH$"_PUK\JG'0WN(_!F>N =-//@HK\^G=F51=C8?ZU_\
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M.%LE6U<TC\Y;B_MCS^^Z7+/):3112)'&69U3Z0V[@I(\:*#,I9 '("@&I84
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MG81>2';=8=N8(^F4D:BBL<$X*M\![2."FE:$,<CJ6+JZO=[GDG@'@6RC3&9
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M\E/(M-&[86*OCV"DDE;KC926[2E@,TCA:WQ>/1[KW5F'\E3^<91?S1-D]N;
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M6VJC>6&?=N&J:'L#.4./GD:"GJZ-YE>CJS)"\=4H#:&]275O=>ZJ1V5\O/\
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M)/:9V)\ANE>J>\MF>85*;6[;Z_Q785!'*&1Q-%396EJHH9U>*)ED15=616#
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MOW7NO>_=>Z2N^]PS[2V/O+==-3Q5=3MG:FX=PT]+.Q1)7PM'-4I&Y7U!':,
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M&Y7U!':, D<@'CW[KW51W\C7^:GN7^;U\3.P_DINGIO!](9#9'R)W;T=#M3
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MI*J'RTZ>6GFBF35'(C'W7NJVOE[\;/D5N7_A6!_+P^1>W.@^ZMP?'S9/QF?
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MVYL/ 4>0QF3Q]9'#5T&0H*N&:"HIYX4F@F1XI45U91[KW6OW\O?C9\BMR_\
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M-7E<Q@<I3TM!)D: /'33S/6QL((*GW7NKF-A_P#"@?\ F,_#KY(](= ?SO\
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MJFKP5931UE-(.8ZFF\QDA<<I(JL.1[]U[K3Y_D"?+O\ F;_%G^7%U_MSX?\
M\E:?Y1]8;[W[VEORM^1F'^36WNLGW3DQFJK#5#U6*J<34UD,N%CP\.)4SSLS
MQT*RQA8I$'OW7NAP_FW;G_G4?S8?B)DOBWO+^0KN'J_(Q;]V9V-LCM*+Y3[4
MWY4X+);5FDCGFIL?+18H2-D,15Y.@<BOBTQU3/:33H;W7NKQ.^/A%W+\[/Y
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MEE]U[H9?YP'QM[X[NZ-Z5[V^&NUJ#?GS#^%OR(ZO^3/Q]VO-N>@VE%N.'&U
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MFN#FATD="+WVW>VL.7;BU#F*6YC$8,3+'-J,D-6C(!(IJJ]5.I:@D:Q0C/\
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M[_\ 'E[O_P##7S__ +B3>_=>ZU O^$3W_;N;Y.?^+K[D_P#>%V-[]U[I.?\
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M?&U3$"6Z#W7NC:?(W_N--^ O_BI>\O\ WV/=7OW7NMOWNC_F3O;'_B--]_\
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M[1004TL;U4F1VK59V"*!DF5ZIJ9UA::*%D]U[JH#_A,(G9O\Q+Y=_,_^<O\
M(FE@J-[?W+Z?^'G7O@R]7D:6FR6U=J[<?>=314]0NFBAJ*?'[<J8(Q/,\1R^
M0CDDE=GJJGW7NMV_W[KW4'*8R@S6,R.&RM+'6XO+4-7C,E137*305\;131/8
M@Z9(W938C@^_=>ZT0/B+W!V;_P )7ODC\D/C'\LNF>UM[_RQN_>U#VCT-\J^
MN-N2[NAP-76I#C:>+.!/'#)5U&)@Q='DJ4SQ5R5..CJL?2UM-5G3[KW0R_S(
M_P">E0_S7.C=W_RXOY,O3?=_R7[5^3.'3KWM?M&HZVKMF8':>U-RF2/+)52Y
M..)Z:7*T<-12RUE='24%-2R3R1U$U4(XE]U[JR'O3X1XW^75_P )E_D;\0J/
M+0;ARO5OP<[KEWMN.E1XX<AN3>L61SNX:FG$CO(*,YC)5B4H9KK2I"I"Z;#W
M7NA)_P"$N/\ VXH^#/\ Y<S_ ._B[!]^Z]U?][]U[H'/D1TCL_Y+]"=T?'CL
M%)WV1WCU;OOJC=1I':.9*'?N,J<942P.CQNE1#'4M)$RNI6158,"+^_=>ZTJ
MOY;_ /,.W_\ \)RJ/>/\LS^;#U%V?MSHO;?9.\]R_%GY<==;&JMV[9S&-W55
MSUE93**<&6IIJNJ$V1B6!ZC)4,E744>0HX1%$WOW7NAF^7'\\_Y-?S2]\]4?
M$#_A/YMWNU<_D-^X'+]X_,W,=<)MK![:Q!#0-1&//4M1!342+5&LKZFO@IZE
MUI(J3%4M;/4ZX_=>ZW'.M-M[BV;UUL/:6\-\9CLW=NV-F[:P&Z.Q]PT5%C:_
M/Y'$4<-/6YJLIL92T.-IZK*5,<M3+%244%-&\A2"&*)51?=>Z^:3_-6Z$^1W
MQ8_F7_,O^5%\=<5+C>F?YV?<GQ4[4V8**HR=1#0+G-VU59DC%2($@CIJ7>$N
M=2N1)S#%AJ.E:5HXPL=/[KW7TC^@.D]C?&SHWJ#X^]9XY<5U_P!*];[-ZPV?
M0AY)66@V5008^G:62:2:::>5(!)+++-)++*SR2R/(S.?=>ZTS>P:'O+_ (3?
M?S7/E/\ ,F/H7L7O/^5S\_LK5;T[7W/U5BVW!DM@YJJR-;G&DK8R4@ITPV6R
MV=6E2LJ*6DJ\7D D58:ZB,+^Z]T9;Y=?\*@>B._>G=R?'S^4KUUW_P#*[YG]
MV;<RFR.O<3@^FLOAZ;:[[E1:"7<&02K@%35/B_O!) D-,]']PJ-6U=/3!F?W
M7NCZ_P F7^6AN/\ E=_RE=W]/]EM2GO/M+"=I]Y=WTM#4K6P8W-;JV]#04^#
M@G26:*=<-B,5CJ>:2)O#)6"JEBNDBLWNO=$&_P"$5/\ VZR[\_\ %_\ M/\
M]]UU5[]U[H'?^%.F/[3_ )>_RV^$G\ZGXXXF#^]^W,)V/\4>V'^_K:"&HEW5
M@,Z=I3UJ4R-#)$*/([G#R2-&_FHL5&OD*QM3^Z]U;I_PFV^%+?#/^5?TG-N7
M'U5/V[\G_+\J>W:S*QU4=>]9VO34LN%I:Q:R:6:&>@VQ!A8IHM,06K^ZE:%9
MYIW?W7NB2_S^?A%\J]D_+#X>_P ZSX&=:UG='=GPXA@VMW/TMA:2HR>2SNS\
M7/E*J.IQ]% )IZM5H\WN/&Y!:.DER"T]=2U5/%*M%)X_=>Z4E'_PKV_E:-U?
M)N#+87Y)8GNZGH):6I^-)ZAJ:K/?QR$^$X6/*>6/ %S67B$LE?$P ):!9;0G
MW7NAD_D6;R_FU_*#>7R/^;?\P7,[^Z9Z$[:RU=3_ !/^%^Y]OXK&)A\9F:U,
MB,W)++B*7=2P8VB6'&8\UM33&O\ )7UT]!X_X;)'[KW6Q[[]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z#GM[J7K
MSOGJSL+I7MK;-%O/K+M39^X-A;\VKD'DBBK\7N>FDI*RG:2%XIX6>&5M$L4J
M2Q/IDB=)%5A[KW3_ +(VAA>O=E[1V#ML9(;=V/M? ;0P(S&9J]Q58HMM4D5%
M2_=9"OFJ*ZNJ?!!'Y:BHJ)9YGU232/(S,?=>Z4_OW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[H#\;\<.FL5\B=U?+"EV=&_?^\>I]K=&9
MCL*LS%?D)EVGL[)U^:HL)14D]5)C\;2'+9*JJZC[6DA>KF,3U3S&"'Q^Z]T.
M'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[IKR5/%-X6D6:R"0%Z< . Y0D!K7 ;2 1>Q^O
MZE1EJS4%*@5]>G(G$)\2@)7A45XX_P!GT]:]$!_F"=9=?[N^.]56[QVIM?=D
M6T-X[-W)AZ;<>(I<S!0UGW+XQ*J%*B-EBF^UR553H;6"SLHL&(,L>T>]R6W,
M=O"KE1*I4D<3W(<&M:Z@#49QQR0<=?O#\LK>\J74GAZGM_UE4#X?#CD)- .&
M@L*'M%:XH""8_%_KK!=@_%[Y']1]7Y#:>W>W-OY?;G:?5D59BJC"46ULMMK
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M_P"=N^LC3_:U:M5[MJY&H$^P<NVM),9'8C).C3PS7B",Y(X=2G/+X$*$#4I
MTM6F-/Y^0_U#IZHX8:>6ICA70!X;IJ+6N"?J2;WN?:]I->/3S^WIF.V$ U#
M;R^S\^I_NO5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
MF_?SM/D'_,QW;_->_E);@[P_E^;4ZF[0ZG^4&$F^'O7^-^2.U]X0=KU6*[)V
M=/BH:S(T60J*;9B9;(TF%IB<E+&*9:]I96T4\K+[KW6S3\B_YL'ST^%O\KKN
M3YT?,K^7WLOHOO#K?O3:'7^VOCJGR,Q'9=%F-L;QEV[14VXWW+M<9>FH9SD\
MIEX?LWB:8#'J[JD=5')[]U[H@.Z?^%!/\T#Y!Y7$=B?RO?Y662^47Q4V73[;
MQ/:?<&<P6XPFY<^]*B[@Q^PYJ>KQ@&/PF8::C-?_  [-:A3O--34T<D;>_=>
MZM8_FI_SI]E_RT\=TIU1C^F=Q_)#YR_(ZGH*?J;XL=8YAJEFJ:N2&C:IR>56
MBEJH<8^2DDI*$PX>6KR4T4@BIH8HJF>F]U[JM_<_\T?_ (4E?'?;-9\B?DM_
M)TZ.W)\;<?156XMS[*Z-[3-;O[;>(Q[J9JG*BEW=N]ZUA2EZ@_:[3"T\4;FO
M^STMI]U[K80^ GSPZ"_F/_&78_RD^.F:KJ[9>[/N<9F]NYZG2@S.W<YB @R>
MW\W2I)*D&1Q\DB7,<LM/40/#5TDT])4032>Z]U2Y\H_YYWR6[%^96_\ ^7Q_
M)N^(>W?F9WETX*['=[=T]C[J;;W7FS<G1524512UDD%;B1D$QE5]Q#6,VX:"
M5ZJGFHL=#73Q2^/W7NBX?)/_ (4*_P P7^6GUIO?"_S-?Y<FS]B]\5>W]LU_
MQIWOTYV/59GK#L;(PYO#TNYL0V0C.XZ_:==B]OY"NRE+%5UM3)4FBEII5@,E
M-+4^Z]U=;F/YBFXL;_)VA_FA1]8863<LGPNP?RP/4+[DG%#Y\KM^GSC83^+"
ME^X\*^8P"J^RU<"0P?[K]^Z]T(/\J#YQ9C^9#\ NA/FCG^O<9U5E^YO]*7W>
MPL/N"7=--0?Z.]Z;CVI'XZ^>EHI9_NHL$E0VJF30TS1C4$#M[KW12OYI?\W;
M=?\ +O\ EG_+<^-> Z2V]V?C_GEVY_HQS&Z\QO.IVS-MM!N79N ^\IJ2&@JT
MR3:-U23>-YZ<:J94UVE+)[KW1\OY@7SWZ"_EM?&7>GRC^1.4R<.S]L2T.'P>
MV-MT\5?FMPYK-,R8_!X6EFFIXIJZJ99'9I)XX*>GCGJJB6."&1Q[KW6O;LK^
M:G_PH_\ DYM/&_)+XL?R?NAL/\8\Q146Y-H;5[J[:6FWQNC#Y-BT%9AY*K>&
MT%I0:714!ZG:K1U$<B?8&L)&KW7NK2_Y3W\X[8/\R>3M?I_?'4>\/BE\U?CM
M6"B[X^+79#2OD*&(RK3C+XFIJ*3'SU^,%4RP5"2T-/544[1+40FGJJ&JJ_=>
MZ*S\_P#_ (4%;:_EZ?S%I?AKVATE7;MV)+\;L3W!M?<FP*RMW#N_<>Z=W5-=
MC-O[%P6W(J-J>HKLSEJ>GCCJ7KE2..21GBM&7/NO=$I[E_F_?\*1^I-M5ORG
MW-_)8ZFV7\/-M8"7=^\-JY;LT;WW]1XI$GE>IJ9<1N^'+8Q:2)J>2J:HZM8T
M\<4\DZ0H]Z?W7NMA'^7!_,.ZQ_F;?#C:?RTZ0PF2PXS9W%MO<?7.X:R"6MPF
MY]J!5K<)5U,16"5=4M+-3U%HQ-1U-/4-'"9#&GNO=:2?^S-_S8O^@D+_ $Q_
M\-F[0_V>+_94OX#_ +)U_LUVS_L/[N?P7Q?QW^_'\0_@'E^V_>^T^Z\U_P!O
M3J]^Z]T=;_A7ON3M/>/\J[^7KNOO'KBCZ?[DW'WOMS-]H=4X_=%)O:#;F=R6
MP\Y+D\+%F*"2:BRD>-JVE@%5!*T,X3R1DJP]^Z]U>?\ S-OYO.\/Y:GS"^"'
M4>^NCL)N/XP?,?>=)UYG_D"=UU6)JMH9:/+T..K15T+T38R>CIZ3,8NN#OE(
M)GIX\B4@D-&/+[KW5YWOW7NJ2/@3_-DWA\^/YA'SV^,77G2VWL=\:/@[G9.O
MJ_Y$/NG(U>0S^ZDR#XG^&4V);%0XZ&C^[Q&Z9/N1EI7:GI**2."1*YI:?W7N
MKM_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1+?EWT=N3M#
M%_W@ZZRVT,5V31=<]D=:4,6_MD4>_</DL3V7'22U>%KZ2LI*V*&ER64PV#\L
MLE'6TYCB:&?'5ODCC44<J[U:V=P+:_1GM6>.24(XC>BMX9TDLE3H=P%J*DUU
M"G0)YSV.]O(OJ]M8)=(CI$70R)6GB"JA6IWHA+$&@'PFO6N!0?'?^8O_ #,/
MD'MG9?RAGEVMLCXO;DH=I]F9W<^UL+L"51NZMP-;G<;@ZW"XG)4>6W7E=O+3
MY:$_PZ?"I3QT-6\E%39.CJ*W(Z^YRY<]LK5VY:!::[CK61_&*J4<@%?&&C2P
M7M8:ZE@=5*"!=OY.YH]R+E!S'18;5@I$<9AU:70$ZC =6I6855@N%IIXG:_C
MP>!V?M##X/;]'B-O8W X;#X';&,IHXL=1TE'@XX*6&F@BA"PQPP4T<<2+$H0
M*J@ +8>\3;?QKF\FNIV9S,YD9C4L2VHU8D9)KDDDD^?64;69M;-;.T !5$C6
M("M1%I% H%>T*> %!Q%.B+_.NAGQV]OBWO7/;NW5MSKOKOL[-[]K&V$TK9B?
M=>W*"*7;U'7,%1?[FY+ ?WWQF44UE,'KLEAHW84#Y)T/^5D?<XI8HU#.Z  <
M.W6=5*5)(.EL G2K 9H.C!+8[ANEF[ );P_4&>4L(TB>2$I$TCL&1$)++W49
MW9$2K-3JKWN/NOL[L_(Y&;<L^2W;B8,YF,GMGKREHZ.-Z6CR%--)44-)_#L.
M\V5^VPM'630-/C:PHM-43U4T,8E>E9V?;Y;0^%PS2I'"M2!72/4 4''^6>_.
MG(^S^U_*<DNTNOU8C1UE>6HNS!<1O,JQ,[CX'= J48!UJP($I/?\9Y_E'VEU
M?M3&[5[F^/\ L?8.P-IX;86!R&Q-NMVUE,F^!H4I8GKUJ:R&DPGAQ:T5;3T@
M:IJZI<A&*Z+&/2RT=<US)M5Q:L0M8V%34QL:UU9H0.VN-0!!((%13K#7:.=N
M5-]9IXE:X>X/U4JK<^"NWW\H5WM=)8R(T!?3)#<:IDTC6["K&OG^8]_+D[/[
M(Q.X.Q_X7U#"=E8_;N/Q&7V=V@^Q*_<M%))!]QD=R;?WM1''S;CI\I)5ROFZ
MOM>:;)XV!86AGR9IY0#+W9M2!R1K &LU"@FF2:BE:GB3PX]9.^Q?N580;I#;
M*FZO$PJ(TMX;F,7221]R/$%E,'A(#X2156I8=N>DQ\#=ZX'!?+OX^[*V%5YK
M(YK>6&WYA>^,96X.D,28^+:F6S^%I::>667)Q3X?,X:&"NJM=-!43S"&C>2C
M)FKJ[0ZZQ1AJ4$5J!C2,9 X9!/KPQGJ9/O0[=>;WR?>7^^)9>#!=P#;XH9)E
MO@%N1$C.OB^$P>">1B!4@U8T(*ILB]@=<;'[-QF+PF\<%75R4^1@S.)R-!42
MX^HQE;A)4J*:OI*N&19*6JCDC7QR+S^M+A7=6$VU[Y=;9>:H2@ !#*R*^H/&
MRD48$$48@CT/7+/?>5K'=PD<BEZ'5'*KD")A0UU+32QH5!I4Y&*FNJA\G_B+
MVIU!O')?*/KG<.$3XQIN??5-VD-L83"T\NW<=M?<*;7BCI]MUF6Q-!E:C)1T
MDTQI</34E,]4E72B.@"4LK3&?=SF+:+A(HW1E5>#1ZW&J,-EG)=OBJ&))IDG
MSZ3<L>R_M;[T[)(^\;/=S7[/-&]U#=W<4-V;>Y>$ B.[:)!&MNL3A80/X@[L
M0*^^Q^V*?96]MX=F[VVI+DNPJ>L?"=0T,F^$I<7041H@:O-Y 4<(AR=35P55
M3'1F:IHH*<#[B?'&LK(?L##W@]W)[B 6$(5(VR5,8UDM&ZY+2,1\1\O2AQF6
MONA_<ZDY"N[GF">\M-Q,$T-HIL+J6X"QN(;JE!:0+4-;')-=5!E2>MN7XP_'
M+>L?P$PW1/9V\GG[-[4ZF[*J]\[Z&,H\G#1YGO\ ?+9FO@C@I<I6464CP]5N
M&:G0TF66&L2F#Q-2Q2Z(H%VV<Q@2-0D-J(..ZH?R/"IXUI\NK>Z^^3;_ +Y>
MQPI)#$'ECT-'2D<;F$5#J6%4"U!HP/$@UZU=/GOWGW%O7X]_'WXA;QV2V E^
M(V3W1M+L/<C"GGBJJS9;U.W\!!C*V.2>*LHMM[2%-BJ[+/DFAK\NU2LK".EB
MFR&7WL3RL+=;G?'<:6C8HM2#4+%<5R*&OD*C"G)XC!7WNYG-PT&R(O<'0,:5
MQ6:#R-1\R1Q(P.!VT/Y;_06XOC!\+_CWT?O6ICGWG@]HU>;W93B*-%HLGOVM
MK=R9'$F6"JK8JO\ @]7EI*(525+K5_;_ '/I,I7WC+SQOL?,^]WM[&05$[Z3
M@ JQ9 :'.0H-,$>?IUD)R/L_]7-HLK.0&K0)J'&A"!N-!YL1\^CXK A;6S!S
M8 !9"X%F9N ;@&Y^HYX ^BBP5$2OG^=>AEXGA_#7I%[^V1M_>V!EPVXH,A-1
MI445;!487<N3VKD8):*0.DM)D\564.2HY""\<C05<9FIWEIY2\$LL;F-K=O:
M,&BIJ%::E1UR"#565@<'S!H<C/19?60O$(D4L,84NIP010H5(H1Y$=%5WC\)
MNIMP92LS%/E>QMM5F5I<##IQVZVR2ZZ&LEJWF=<W19@FKR0GFIJZ5GD=J94=
M/!4#[J,6[9[F[E9E4?PV"G \%0*8  T&/&, $?LZAW>_N[<N;V9+@?40S2CN
M87<A[@7<G3/XZAFUG4=!+ 4R57HI5'\(J6@[4SV*[ W+NW$=:Y!L0_6V_-K5
M-/C*M,GG,A+)0TE97,C383)8LT:"*5L>L%545&+>GK(,A*V*,G77OM?QV"PP
MP0R.^J.5'B>1?#,1#D*L@J"M02W:!4$.#41+LWW/-L_>KW9N[D);TN8BDT0<
M/',L@J3;'"D*1H[C0/5 I!'+<W>W;/4^\:CJ+;6+P7R)WYE<7NVMV%CMG5U#
MB-QXZCQ4DK4W]Z,+4U]%A8]O8B)L?2S9]<[CVJJZMHZ*+"1RU#5LT66FQ6N[
M?XS>/]/'4.X-5J&/".NMV>I.*, H)9L4.0<_-UY9?[J;$)<2*"J4&LKX:A*R
M:,*M-))["Q("I3(/;UNN[*?;>*Q^]L[3[IW/C<%@*/.;HI,(NW8LE6P4X2KK
MXZ*.2:*C6KG1Y13I/((0P0,RZ7<'SO 7*P'"G(U!B <BI'R]0*^G0WVXW073
M=?$H KH*5.:FA^?E4T_PB#[:Z,>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NM+?_A1-_V^O_X3E?\ BVG6_P#[]GK3W[KW1_\ _A61_P!N
M4._?_$E_'K_WL<5[]U[JQK^3+LC ]?\ \IG^7%@]N4%#CJ'(_##X\;WJH<?1
M)0(]?V5MC';BR<[HEPT]3D<I52S2'U2RN\K69R/?NO=:=7:???RMQ7_"K;YB
M]J]#_#>3^8+VS\>>JJ;;?5W3M1V9C.L/[K86#;&S,3/N#&Y#*TE;"CTLFX<C
M$\$,0F>7-U50'""6_NO=7GR_S5_Y[T\4D$__  G;S\T,T;Q30R_-C;$BNL@(
M964X(AE8$@@BQ'!]^Z]T6#_A.G\8/GQ\&X/YJ51\A?BUN7XE]0=GU])WY\<>
ML<KN#";PQ>%R%,-VMD,715>)K'EE^QQ<FUZ1FFI:=:B&AB>*.$K(A]U[K!_P
MBUP-#E/@-\M.YLM)-F>SNQ/G#NS [UWCEJA\ED\C!M?9FS,K2-75LSR5%4_\
M0W-FIR\CLS2U$TC,S.Q]^Z]T>3_A5SUSM#>G\DKY,[JW%@\9D\[U#O+X\[\V
M#DJV@BJI\;D\QV!MO:U34T<KJ7IIIL+N/*TSO&59H9Y(B2CL#[KW2%W3_P!P
MDU+_ .,=-G?^\!0^_=>Z'/\ X2X_]N*/@S_Y<S_[^+L'W[KW56'_  IG_P"W
MIO\ PG=_\6O/_OQ>H??NO=!5_P *[=U[[SWRL_DZ]%838O\ IIVWN+MK<^ZX
M_CU49FGP%%OC/5.Y-DX?'8*MJZM):.F_B5/4U>-CJ)XWBIDR52[JR,X/NO=6
M60?S5?Y[E+!#34W_  G:SU/34\4<%/3P?-?;$2(D0"HB(N""JBJ     !8>_
M=>ZKV^,73'\UWM7_ (4)])_S*^ROY9>[?@_U;O;K_+]1?)],=VMMGM2CRL$>
MU,SC*++Y.HI7QU<QDK*;9T96+'2/$<7!,TLD9DC'NO=2OF'L[#;[_P"%FG\O
MO!YZAHLC04GQUI=W1TV0IQ51BKZ^V=VSGZ"4(2!Y:>OQE-+$W]B5$>QTV/NO
M=;H_8%/3UFP][4E7!#54M5M'<E/4TU1$L\<D<]',KQR(P*NCJ2&4@@@D$6]^
MZ]UJ$?\ ")[_ +=S?)S_ ,77W)_[PNQO?NO=/O\ W>5?^6%__*W[]U[H/_\
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M:^T\%501XK:,=?BJ4OALGV#EJ7!4<=;7;TQ\N=@?(T5/!_$=OXI7676]VMP
M)Z(!D%&6.1B3QU,Q!(H0.TG.#4]8O;E>[COEK<[E8W=Z?I?#2SM-]E\5?UPR
MS.MN)1K$-3(XA;5&TD,LJE=8 -?,OM[>O4O<4F/[*V-1]";EWAC=PT>/^0G3
M^:S^T*O<5%EIZ=L?EZC(8FHH:BICHY,=MVAR^*J\-D\UC%CJGP<LZU6-FKLB
M_:[8-MWJU%Q;R?5.A4?0W0MI1H'AAE5)$(U-K<Q2*T<;%E20@>)USC]T]VWG
M9-[DM)(X+6)[:2[EO[ 7=O6Y68H7:2.2AMUC2,2!Q+(B ,K$Z.BIKG.ZNZ-I
MY#";&[+IOE9E]NT% **KQ6YLWNO>N-C_ (E)JIY,3G10;LRF$DJ\_0F?+''9
M:BIM%'##7TE-2UM-(NYSY!VN19C].NW2R-,(6OX(H=N:3PW91XL4,B(*H=,8
M9"5#D(S%#U/7W9?O,[I[275O)+</O5I6%[BTL)GO]S6.2:U\0K"]W;!D"H4#
M.7TO(JLWAUTO_P#*BZ7[(Z:^5G8/<_?.&HML4O6VU-P4>^LMO#M?:NVZK9."
MK<9DJ^2NWAL^KJWW/M^GRHQ]'4X^KK8*%5Q\-77R0_8U,,U-AO?\M[EL=^\<
MJVEP'D9(Y]M$LEF#74%U-&NIJ%<I51KC7B2%Z.^\OWFN7??+8(K?;C-8R@6T
MS[??QPVUU4(6#2)%=3JA =U97!=I$-"HCH]T_P F/ECU[N/XM]I[^Z![MVSN
M^79,6+AKMU=.[XILM%2M0U^-EREZ_$5LL<?V6+>6HJS%*IHX-;S!DNOL26VR
M317#/)#,JT#&66-A"PHR@J[* 1J!4FOQ#3Q!'4&?=WGV+>>:K&/>Y[**V!N/
M$CNY(([5_P#%+A@'6X)1M+!"HKABN02#UJ5;@^<O<&9VUE.H=F;TS^U</+4Y
M^EK,#2;]7;6"K8LU6S3UF1>&LKL7A8SFI:FIKZN-J0_<U,LE1,'ED9BOWW:;
MCF8DVMQ!#(:5C:5H[]Z:::%16)H$):O"(UX=9.?=\Y@Y9]J^4;*PYCV&PFOK
M8W)&[[3M=I)RI*9[VYD-+RY,,KZ8YDA)(!6^UQ973U9ULK:GQM[+VYM:/[+8
M^[LU@RN1QB19 4V1IJC+4(JJE(*K'3T]14P/'D+3)1U512&2,QRMY*4!,AN;
MN6MIYAN:M'$A---$@4D#M ^%@#FHJ1Y4J33KB9RQ[Z>X'W=[V9/K;DF8('L[
MFYW(VOBZ$D5Q!]1;$RA%(5@&;PVDK09Z/SM#^8/L_P",G4QZM[-JZW;\VVL)
MG]O=6=E[FPM?OW'4M904-5/C*?<E-CI3F'HZ*IBHH(TQ:SRQTTD<,T&/CIQ/
M[">Y>PQF2*^LY-=NGAO<01R*DPC![](:%(Z! <.54TJ"P(Z$/+7WMKGG:\OH
M=V@2#<&^I>.XCBD%H[G00CLUW/,97EE)9%JQ7)H^H= E\7^B(.T/GOCL_OW<
M6!WNIVU_LSU)F]N[@.XL1FJG$9"E;$U%%-2/CB!59'-4&=2NB@T9"GIYL?X#
MC?'#&GYTYF_=VW+;[<TL$+*(FB5C'V:71ED56()*H$:M:X!..F_:GE]]ZWV^
MO=WK/,LEQ)#J/C6Z5EMYHS'XJLRA3(V@ @A3CB25K_-&_F/?(/X_;SP75/Q?
MQ?7LE-0T&/RV^^Q*NG;.5L%909YZ:IV]CH&J*+%T<2IBZNBRE7/4U,X2N,=*
M*&MHI:^/&V:\1)&2,"KFK&@R02<^1/'UX^O77?[OOW9I?<:Q&\;@"8XG"00@
ML%D5HAD@0R$J-2E0'2FG(92!U8O_ "]-N?(; ]6Y;,]]]JTG9M/V!F:#?'6%
M;_'LOO')4F"S-!3RQ0Y7*Y&DQU')/,[H(Z>@Q%-3*J-50SU K?%2/J'"\3Z^
M? T^P?ECS_*%_>C?=HW_ '4OM%K!:1PHL3);Q00Q.P"C4$A>05)J=18L:@$
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M05]'%64]5*(?=>Z C_A0'_.QH/YE?P+[)ZK_ )>_3_;._OB%LS<W6.X_E_\
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MDN4>[NKG>K9M."7@C:JA@I)=ZL!HR*@TI0BG0_YF]K-XW:\3DW;=DY,WN6]
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MD&E2PC7BK548.:UU5>>W^ML=U!F=E]H;.W7V]LW9>-WQLW967P>R]X8[(8K
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M&WHN/M3'4./>&#,UN!_B-1E:3^&5]5E\M+5UE)!$ ]*,3Y'=(:=(O=>ZL_\
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MV-O_  ^H<50X^@P\*04M'24T.>2*"GIX41$1%"JH  ]^Z]U5+\,.]^PNR_\
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M T3JVS,ID(\#)C7;$X8U>0Q.-J*>:O0/45KU9/OW7NM@#W[KW6MM_P *R/\
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M]U[KWOW7NO>_=>Z][]U[J#D,9C<M *7*X^AR=,)%E%/D*2.LCU(" VB1674
M38VN+GW[KW4U555"J JJ JJHL !] !^ /?NO==^_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NFR9"LE8;7\WV]N?^.8
M'MQCVC\^M6R?J,?L_P !Z+)W0FXZ'=^Q]^;&PN9W;N38.8GQ==LO"Y'&XB7-
MX+?\$-+F*!*G-2P8ZFEQ\D6-SBN)HZN4X<8^*:"#(U/F<92BC\_\/1WR_<B]
MCO[5_@<6S$T-$=&.EC0"O:SI0L!W@G(7HIV?^1'0]/W)3=K;>WE29ROFV!VE
MM/.X6+<HP$]#D=E9K!T-3$VWLA'22IN2I>FJ:=UFFHJFJIL>E.B5<M-CX%-(
M0;R%8:5H3]O>30>1H#GT%2?,]'1]M^:-E2^N[*TE-BTFWF=U^G>)3IE"2:F8
MEE"O('96*C2JL=7AABK?*CYSXO=&VIMM[#V?NJ?8=;F<K_?;.TTN#R<U3E-K
MH*NKH:2&2MF?(U%.50&'$)72BNI*BAG2F>#Q5:J]VB38X?$GH:# 4C"Z33U_
MA/'Y<<@3A]VC:.5[Z\O-VBNDEFM7N P6*_1(98_ :1CJ6,N1XFFB@K0DIJ:F
M@,ZO-]E?"FI&_P#=?Q^R-?V+2B//+VCOW IOC#X)-P4?\/IJ;:M1C,KF<;M&
M*85.;H,AD*W*19?+3RM)/"N/EQ>(A">Y7;/&'9:T KQH,'%13S-./\^II39-
ML]_]P%HVZ!X$NG2TM(XQ [QQNW>3(ENTLG@R@C].D:ZE 906-=/Q.S^^/E=\
MKNZ.U<KG]X8[KGKG8?8G:78E1L'84N.CK]S]B?<XN@H,?C<?1_PZKSVXJK+3
M&+'I54&0S,XR+0S,\V01R7:KHM)Z<>&,Z:#RI4T^TYZE#WEYJ@]KX-LY5V>T
MC5E2VD+3RF?].#QM9)N$F*)&;9'#^(RPA%(4Z:DZW:E/\E^DLIA>I#OKL+I_
M<68WMB=\=?Y[:N\\?M^BW)D]CY'[15H71WQ5?0US5U(,AALSC2,A15%+_$L>
M'%!8^NM]M]FD"M'12" "6-,5.=+&M3QK4>7'J-]HW'DGWQ47VXV8$84+<-XM
M[K@4L1&#X?A/)5H: H=()<5IJK7[V!VG\IN[Z78'PLH=X;H)P=#G=E[>W)DM
MD#/R?:U;>?*4^=K=O;=_O%0%Z&]*:6AP^1_B)IZ7'?P[UN2<&[AW %Z$$\?B
MKCMID"G#ACH-<W>V-A]T_9W?8;8W&SWT<*Q$7<H7;H[:6#2*3SWLMW]1-<D(
M<?3J"$)C8T2'S(^-G96&W%5;XK<?6[M^+T.>%1L'Y ;)K(-W[4RN KJU::F3
M+YK'SK28ZM@K(Z:DJ$JX\9'45\E8N->2DCI)*T(;YLO@.6SBE1Z8J/Q4]/\
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MU0*$*N&/Z9UU(*ZF=AITHI)BZ=T1/*0'AA5:.(J[,+0W,9#$7<LI))YY^O\
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M_EY_!3XK9^?=GQQ^(7QVZ7W=4T_V<V[^ONI<+M[+F$ER81E(:05ZPMY&N@J
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MJ2I7#RTD$E=C<5*0VM&MTO;>1)6( ,<4@+IK4-P520!6AK6E12F:\Y(N??\
M6+W>?:]V@W!N7+J>>6:06_C&WE9W\"V;QYK:TAO8_I4\6+#"-G-9-,2H/W>'
MQ>^3_7QH-P=R]?;)W#TO@\!N6JSG9W06YJGL#<6U$Q1H(X/XKB<S#M&MW'@)
M(9*B1(:*&2LQ<D,U75Y!:&D2CR()W,$+0H:9.I5JP':<BHJ/MX<:TP9+]O\
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M17T[XS')MCA(&HCXOEZ5X'_#C%/7 Q5^\1SC)S???3;1M\ZI:([L'MG5^Y(
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M+XY_S$?D[W3O?K"#?G\J?Y:]&=(]S-0R;&[SW!OSKK>\=#39BBDKZ&NW?MC
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M4U4^)F:(K.]HW0O9M2CW7NJ>-F_\*FOC+W5U1UQDOC#\6ODI\D?E)V[NK>.
MV5\,NL:+';CW914.SC#')N'=M5BY<I2;9P53/,HBF>.IF\-ZMX%I$FFB]U[H
M2?C7_P *)]IY[Y-;$^''\POX5]]?RRN_>U*F#&]:#N3(+O':&:K\I4008W'T
MFZ/X5@)&GR1JJ:.*<8<X]*LO13UL50(EF]U[J_SMWMSK7H7K'?'<O<.\L)U]
MUAUOMW(;KWMO+<56*.CH*'&+JEFE?EF8G2D<:*TDLK)%$CR.JGW7NM77'?\
M"HO=W;V<K-V_#S^3K\__ )5?%C;V6S6/W7\C-G;5R%.J0X:H6G:HQ.(Q>VMQ
M8_(.Q82M356Y\;500ZI*B*+QS"+W7NJO<3\Z.A/YB?\ PJ:_E1_);X[Y7,U&
MT<U\7\MMK<>U]VXL8'/[9W!M_!=U#*[;W%CUEG2BS&-::'R+'4302Q2PU5+/
M44L\$\GNO=;MGS*^9OQZ^ _0>Z_DG\F][Q;&ZQVI+0X]JB*D?*U^1R.6++18
MG$4$7[V0R=84D\<*?1$EFE:."*65/=>ZUPZ[_A3-\L-[4&+[)^,_\@7^89W=
M\<LWC,3FL-W)D<=G]K-74.4%1/\ ?X^AP/7>],378\4$*3+50[F> LXCDDA5
MH99O=>ZM=_E3?SJ/C#_-AHNRL!U=MSL3J'N_I;[)NU^BNVL7%C\MCH:^IJ*-
M*RDJ*>22FR-''64TE/46$-523F..LI8//3F;W7NM4W^;7_,,WKF/Y]'\NSLN
M;X"_-[$5_P 0]^]B;(V[USD^G:NGS_:\6W-QY*G7,]8414/N3$9!8Q+2SQ"T
ML3JPM?W[KW6T=W]_-GZ[ZC_E@'^8O\EOA5\CNOMG0;SQNV\W\7N\.O:':&_*
M"6OW/+MFAK*W!Y]Z>E@CJ91%6TYDF4O0S1S1DE@A]U[H1/D1_-<Z5^*?\KGJ
MG^9MENI]_P"2Z5WYU=\;^P,#U;M1,319S'XWY"4>(FP]$8I:N'$K)C(\M2QU
M"1U8B41OX&<*@;W7NJZN[?\ A2UMHY:LV7_+[_E\_+;^9;OS:FV]GY;M*?X_
M[;R5;M+;.2W-34]94[=K=S8';V\*F?+X>*61*LQ8 T:U*"FCJWD6I^V]U[HS
MW\J;^?3T%_,U[!WI\=LQU)V7\3_E]UOAJG-;R^._;@^ZG,6&:G@RW\*R)I,;
M/5/B*NH2.HIZW#XVN",LXH_&)?%[KW1X?YC'\R?XP?RONA*KOSY-;DR%-CZR
MN?!;"Z_VI3097<>Z<L(_*,;@Z&>HI(97CC_<J)YZF&EI8K//,FJ,/[KW5%6V
M_P#A4)V#B*T]C_(?^3'_ #">A/AI428BHI/EC6;)S>Y<?3XW+R)&N7RM%5;/
MP>&IJ",.9":/=N1DDC4_;QS2E8C[KW5L'\OO^<=\;/YDOR"^4/1OQVQ>?S.)
M^,M'LK*U';XR>.R.WMST78#57\/J<$:6HDK5TI22?<Q5E-3RT\UX'0R))I]U
M[JW#W[KW6MS_ ,*<OE9N+IC^7=W1T5B_B_\ ([N#$?([IS?6*S7=O5.P)]S;
M/Z]7;&0P+)5;\RL:F+"4V2^\84CR']XP3@6T>_=>Z#;_ (34?.W=W:'Q$^*W
MP]K_ (1_,3K7;75?QLR&7H?EIV'U158'J[<YP>9BA2EVWN1U^WR-76C*/)3H
MI]<='6,#^R;^Z]U1-_)\_F?="?RT?EE_/9S/9^W^R^UNU.ZOFML3:/0?QVZ0
MVL=Z;RWGD<-O#NILBN)H/)#$*/$Q5]')6U$DP\:SPQ0QU%5/3TTONO=7(;;_
M .%5%#UGVKM;97\Q'^6!\R?Y>FPNPMRS8;8G:_:V&RM;32T:R*JY/)8S,[3V
MA6PP0I)$]6F,;,-3!KJ9E&H^Z]UM@TN?P=;@:;=-)F,;/MJKQ$.?IL^E;&:-
MZ&HA%0E8*C5XOMFIR)!)JT:/5>W/OW7NM8OLC_A31MS?W:^\>H?Y7W\OSY0?
MS0<CU]DWQ6[.Q>J*:LV/LM)*<2&5Z;/1;=W/4M3'PRK3U-5B:.FK7"_8S5$4
ML4K^Z]T:O^7A_/S^/7S<[RJ_B%VQTSW9\%OFA2XR3*4?QS^36 ?;%9EUI:?[
MNH@P5954^/GJZZGI U2:.KQ=!634J2U-+3SP4]2\/NO='B_F._S*?C)_*YZ
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MDI*#%35,59D\_1QK64M/!42::1Q//)"D<YA]U[JF2N_X4S?+#>U!B^R?C/\
MR!?YAG=WQRS>,Q.:PW<F1QV?VLU=0Y05$_W^/H<#UWO3$UV/%!"DRU4.YG@+
M.(Y)(5:&6;W7NK7?Y4W\ZCXP_P V&B[*P'5VW.Q.H>[^EOLF[7Z*[:Q<6/RV
M.AKZFHHTK*2HIY)*;(T<=9324]180U5).8XZRE@\].9O=>Z$K^9I_-J^)G\J
MOKW;&ZOD)E]Q;@WWV/5UV,ZCZ/ZVQL6X=U;EJ,>$$S4=)+/3P4N/IY9J>.:L
MJ:B*%9)HH8S+421PO[KW5-5?_P *=>XNIZ*@[8^6_P#)5^=_QJ^)68R]%CL?
M\B,S3UN7-/#7U-+2PU>9PN4VEMNDQ,51+6TXI0VXI37DLM :EU*^_=>ZV8NA
M_D=TK\E^B=B?)?I??V'WATGV/M&/>^U]\H9,3 V/TN9VK(ZU*>?'5%!)%/%6
M05444U)/#-#4)')$ZK[KW6N[V+_PIKV_V!VSN_J#^6#_ "]OE'_,[R.PLT,#
MNCL7JN"JV1LM)DEEC>:#/4^WMTSBA;Q,8*RLQE%2U?#4TTD+)*_NO=&Y_EN_
MSZ/C[\]^[=P_$7?W3G=/PM^:VU<95Y?)_&GY$;>FPN1J8<924]=5KC*N:EH9
M)*JFHJF*I:CKL=CZZ2DUUE/2S4L4\L7NO="UOS^9W\=MD?S?>E?Y8.7Z+W/7
M_(KN+K/*]C;6[SI,5@Y,50T&,VSNW.24M55RSIG8YWHMK9&F"PT\D9-1$"X1
MI='NO=/?SR_F^?'C^7C\C_BO\?>^\-G\70_*&CWSEZ?M]\MC<3MO:N/ZX^WD
MRU?N*6LJ(JI*>*GJ!)']M!.TA4H0A*EO=>ZJ%[*_X5);V\,O:'QB_DY?/?Y$
M_$+%UN3GS?ROR&ULWUM@9,+AID2?/8D4NS-T8VIH7IEJ:B(9#/8F0(L*U0I'
MDF6F]U[J]'^6I_,Q^-O\T[X]Q_(#XY5^=I:3%9M]I=A=?[RHH\;G-MYJ&"*I
M;'Y&*"6HII5DIYXI:>IIZB6GGC;TN)$EBC]U[HOG\S7^=K\5/Y9NX=D=1;IP
M79'R ^4W:%)25_77Q?Z&P(W1N6LILC-+34M;7:F6#'4E750RQ4ZGS5M4R2&C
MHJA(9GC]U[JM>A_X4Y;NZ6S>V*W^8]_*1^;?P)Z<WMD\71[<[QW#B<GV)AX(
M<V7-/)FH:K:>TZBAK$CC>2HQM*<ADH4'II)25!]U[K9ZVIVCUOOKK7!=R;.W
MSM7<O5&YMH4G8& [%PV;IZ[#5>$KZ45T65AR".:9Z!Z,B;S>30([L2 #[]U[
MK6=W!_PI>W%W/O+>V#_E=_RL_ES_ #']B]=[ARNWMR]W[5%=U3M&:7#4<=9,
M,9D$VINJ>6I=)H33T==28ZMJ8W26"G<21+)[KW1SOY;O\^7X[_/_ +OW-\2-
MU=.]Y_#SYE[0Q.0SN5^.7R'VK)@LA/2XBFI*NK-!5-%3R&JIJ6LCJ&HZZ@H*
MQZ0-5P4\U/'-)%[KW5Z'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z;:J:EA?6\A5]>APJ-)R%!YT@A;
M*1R;#D#ZD>ZF0DZ:?ZN/7BX@%3^+[?+'SZK;_F#;?[UW)M3:]-T]M#);EVK2
MINO<.^),%7QT];&N#@HS14D= :Z*OS*5FK(N::CH*JI:>GHFCB=HHXIG%N"I
MX5]16GD?2G61_P!W#F'E[EN_:?=V*44)$Q61T1F\:KD+!+0CM0$D *\E?BJN
MMMN3:_?GR%[8VS\=-H;7WG@=T=A[NAVE7Y'>.WJ[8M#1TV)AJLAECD)*Y:2,
M#%8?&92NFH$,E774L)@IH9)Y(F4IOKH7,GA@4I49)\P#Y]= >?/<S9N1-FCW
MRQ G6*.5HV0R*"TK1PU!> ZM1?!92,5&D&O2Q^0O56_OACV"W2_9_8O^DKK
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M8#2,HCI2E*Y&2W</Y'A_Q70<VSD7:^3;G<^>IKU)+=;B3ZB(6\@90TAM67Q
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M"@#2>$A?2TAD9%!:0]7$=D=3;2^<^#[MVWOG8N^MBIV%T7U.,=AM[&'8NYJ
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MJU_X5D?]N4._?_$E_'K_ -['%>_=>ZK%^"'PZ_G6_P SWX _%+<%+_,AR_\
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MRD:*L%.OV50DU#D:(0P9!:.E]U[JLO)?(S^8]_/(_F2?.OX<_%'YO97^6_\
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MJ6:$>Z]T,?PB^?7\P+X#_P S#:'\H7^:UV9M_P"2V+^0&U?[U?#GYDX?;_\
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M.N?V/6X#KNJH5GI*3$+YLCAJ09VIFP\M+/641EJ:1G\CO&*B.!'2CJ(7 Q%
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M&H*@"F@!/EU1_+MV_P!T=#[/WCCNW<KL[L'=%9N".OK6P5+NS")38"NR>/\
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M7)]OOK-5^X9(<CCI,#A\]MZKCS63%;Y1VYF(J>ME@HIOXUC9*BJ.Y+D+4&C
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MHWNO=+#^<CB:W>'R:_D;[$P&5J<9NB?^:9LKLF'^'F)JB3#=0;1W+F-P1:9
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ME75M=4BBS6B"N/\ -CY_ZLDY/7/+W3W*]7F;=%<4*W=Z"1I!%+J45.BF:\*
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MO/&]05&VMP;RJ-DQ4L60P&>S7WR55-09%I)$;#+%XC"H(E+ZP4"M[KW15/\
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MV;'\?$ZR3N8]P?QJ)\"=JRXT9=,ZE>I,3X^3&LM0DBDZXR"H)(!]U[K5@?\
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M$O-_N8-ZV3<++=RVW.MI<0T$4\R@-"8A1Y+2T3Q*NP5"V=*U<!ZKM+?'?/\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ\?YMVX]P[/\
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M>"?'4<SS&B3P1[P3#?P^*6,BIQ%)4QFG>E,L*>Z]U])'NC_F3O;'_B--]_\
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M_=>Z4GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM;C_ (5CJS?R4/D
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MUN'R,B9:'([?S-!.*F.J@CK7W+4SR3PFJ2EI4CIH_?NO=57_ /"E+^5'M#X
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M934&7A_<?&1^&KC)3RHJN_NO=51_%O\ EH?\*&_Y4^W<_P#&GX%?(;X'=_\
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MMI;NQF-CK(Z:FS1IZ7(34[2057V=5Y<-E*:>DCIK4L4])',WNO=%&[>^ /\
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MG,LQ>*14*VLQBDI#*?@<JV&%4+*QT,VHY?R!^8W0OQA3!4?:?8&"QVY=PY#
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M<\<,L5)!U;G8Z/8U#,1Z'R&\_%4TM?'R&"8:FR(>QCDGIB0X]U[KYZ7\P_\
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M8[.H>Z:?>=36U^5=J#8E:*.7#-01T]*H.\9%\BY"4D4JG0/*1'[KW0"?/_\
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MU-)05$U+E!3%:40.N.R4]764-+12S^_=>ZK,[0_FP?\ "BKX2[)R/R2^<?\
M*A^-VY/C!@8*3</8"_'#M9FW-L[$O7>&H;-R1[RWQ'6R4U+)%))5TF#&-A57
MFJZFFBUB#W7NMDCX6?+_ *D^=WQ8Z@^7'2]37KUOW!M:3<%!19\04]?BZG&5
M%109;$Y1:>>HIHZ_#Y.CK:2I\=1)%Y(6:*1XF1V]U[K7U[+_ )^?S ^5_P C
M.U_C#_(^^#6%^7<W2.:?;'97R?[HW4NT^OZ2OCJI:1Y**)<MM\5^+$D%08)V
MW)35>02":2@Q\].(JB;W7NG#JS^?!\ROBO\ (7JGXV_SP_@QAOA[2]W9T;0Z
MU^6'3NYSNWKBJRTLO@IXZ^V4W&F,H:AS"9)3N2>JQZ3PSY*@I:+SUE/[KW6U
M"K*RAE(96 964W!!^A!_(/OW7NN_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW3<\L1
MJ)8Y'B1$\>MIF"_47&@GCZ_7W<#%<_Y.O=Q(52,UPI[\>M/]5.@TFV]LVNK*
MW<.7VKBY,]+A#MJMS^3Q%*:P8R2<5 H9:N6,SK123ZG-.7,+L=9742?=9U(<
M4TGCP]*=4L=VN-M42$S**U!<LJU%5K6HR*_MIUID;GW/C.R/D'M7JK9W7$^]
M=\=M]B4U!6]=[.K7PQQ=)D-,.C'4<U!D1C<=B,3CJEZE)*:CHJ.AQ]7DV22E
M6>6(+36DCSLZT.JA X =M/3'^"F>NU(YQM?:[E.=8MPVX_0P-&\(NE>X!E=@
MC-&KQDM(9O%U89R6([J@V\?S!.H-D4G8?2NU=K]>8?KSIC:'7F<[%[-W-MW9
M\[8BDVUU:];F-Q,V%P^-JZ5IL3CH)!HCH9WFJ<I1TTJ+))2%#&X*Q@AAI)#D
M'@ *5I3UP1Y\1YY&*/W=O<ZVY5V'=[O<+R>2^OC/%M]L)(C<?47<,2QRAI)D
MG;5*R']/X1$[J7U.#K\?(G>55VU\C?C-C,KA=KXRLVWU3L'>F9V_D&3<F!.-
M["R&4[6V]AJDTU!#4Y=J/KS<FT\'5U=3B(GJ\M25-/*/X=HR4A5<7-%49J5%
M?]M4CS]"/^*IT+O;V&ROMJW![Q&6\W3<;K:1.507C?56\2.JO)60J9UD9%&N
MKT8HSZNK/OA)M?=78^[-MXCN;XG;QWUT[TT<KV31=IUNS,U6T63Q%>E#B,IM
M*ABD:IP.[%ASIQ>Y%QE/65==!3X?<%%34]?4Y6HQ4[]IM[7Y <8&1]F:_A-<
MY^T$=)?>S<8?;RUMK3:=VBM9?W99;5/;QWB0S+<P,;@7-RL31>'(R0"V>=PI
M)FC#Z%[^K;MA_*'X91?):@S_ %MO#JG:F.W/U37["W?FL_MZFZQJ%KMEY/$Q
M[6Q&*KZU<5"$K(<CFH9Z+Q5<M<F+QII&B3&,*L\-RN-++P-":@8('G3RKPKP
MZQIYE]H^:X=E2;=+>[TB4K:JWC2BC,QF8*0Y3N1*FB@F05KJ[2=]K=VR=S[N
M[1W8[XK*;)W=*NUNOY,MCXLT5V]MU8A$,::HS44$^3KOO<P)Z""#)/'64D&6
MFG&,PXIC.UM#==XI3(X>61_#^?KZ^762WMM[82\GFPNEUI<QJ\EVJ2.E&+2"
M.HBTLRT(1A*3$P#"(4:4,5'XT[/WSOK^8?\ '[#[7K-WY#K?KK![Y[5WWB\%
MO.KV_!)!M6C%)B:B2*DRF,EKXY-W5V%C^T:CGAJXS415<;1-(/:!FJRA@5P:
M^6<T\_G_ (>AG]XS?/H^5U9V6":\D-K('4*RQR>+5M+!F#:$H'HVA6!4 Z2!
M-H?C9O3YS_(%<=_&GZRP&XNNNX.S=V;VQ.TY\GC'J\MG\%!1TF/IY9J&HC@R
M\U1G:FCJ):Z2.MI\;7T].354]954:>5/%5@< @^7F13^=#_Q?0;W?WH_UD^7
M+:WVT0W1:WAMTF$NHB06=5E#PR*&95,3DJ%:DJ/4*\=;EO@7\+\-\&.G:WJ&
MBW]ENR,ENCL//[ZW!NG<V$@VV:FKSE/04HAHJ2(UJQI3XC$TE[Y"J>21*B0M
M3H5AI;6$)MUH/6O^#R_+K!/G_GZZ]RKDWNXFLNDKQ9OQ22<9)'/&5O\ "#6M
M3^110Q>)8Q#Z5*J>-7T^BV_'T_V'M8\@+4/'J/HU*"B_#Y_ZACJ3[UU;KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NF;<6-KLSM_.XC%YN
MMVUD\KALGC<=N/&PPU-1CYZZ!XH:V".H26GDFI)&65%EC>-F4!U920?=>Z^'
M[_,4R/RVA^8O?O7WS6[8[,[@[WZC[4W[USN?=/9F=R67DD; 9.HC6?$PY%V%
M!@<@@CJ\=!2QQ40HIJ=J2,4YB]^Z]T2+W[KW7O?NO=>]^Z]U[W[KW7O?NO=6
MJ_#;^=G_ #._@C3X3!=!?+#L*/KS I0TM!U'V//%VOM6*DQ\(@BH:/$9]*Z/
M#TBPJB!<9)0NH1-+J54CW7NME'XW_P#"W'NG"4^&Q'RS^%W7G8;+--%F][]$
M;^KNLIQ#^X8I8MOYNGW'3U-0!XED7^.TD;G7(@C%HA[KW5Q74?\ PLC_ )46
M_2]/V%M?Y3]&5<,5.\E5O'JW&[MH)'E25G2FGVOG\U7.(GC5"9L93W,L94$>
M4Q>Z]T;3%?\ "I_^1ID$=ZOYD9;!,J0LL65^-G:<S,902RC['9=8MX[ -=@#
M<:"PN1[KW6#,_P#"J7^1QBT=Z'Y>YW<;+3O,L6&^-W9T#,RWM$/XCL^@7R-8
M6)8)R+N.;>Z]T3'N/_A9K_+ V+4SXWJWK/Y5=Y52T?W%-F<1L3"["PSR&62,
M4[U&>S]+F8Y D:R%A@'CT21@.TGE2+W7NJ4/DK_PM>^6^\HZO%_%;XJ=,=&4
M3U53%%N7M+<62[QRQIP7$,L$%+'M7%452R^-G6:ER$:'4@+W$@]U[K6%^7/\
MS#Y[?.^L$_RQ^4W:W;^,4TCP[,R&9CVSMB*2ADEEBJ(-IX.'&;9@JU>9_P#*
M(\2LY4(AD*QQJONO=$9]^Z]U[W[KW6QQ_P )V/Y*N:_FD?(N/L_MK&Y#'?"W
MX^;IQ%=VOD?MS&N[<S0^"OI=AT4[#2$K(7IY<S+&?+38R58XS#4U])41^Z]U
M];#$8G%8#%8S!8/&T.'PF%Q]%B</B,72I0TU+2XV-8:>FIX(E6.&""%$2-$4
M*B*%4  #W[KW3A[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZTM_Y;W_<7Y_-V
M_P#%2]Q?^[3H?W[KW2.^8^S<5OO_ (68_P OK!YFAH<C14GQYH-W)39&$3QB
MIZ^VAVOGZ*4*58>:GK,9!+";>F5$:XM<>Z]ULG_SE(XY?Y3?\R!9$211\*_D
M;(%=0XU0[6R3HUC^5900?J" 1R/?NO=5P_\ "3C:N$V__)1Z S&*H*6DR&^>
MR/D)N?<M3!3)"]5646\LOA8IIW4!II$Q^)H80SDL(XD0'2B@>Z]U7W_,>BBC
M_P"%?W\HYXXXT>?XG[<EG9$"EV&2[V0,Y NS!$1;GG2H'T ]^Z]TD_\ A31L
M_&=A_P W'^0%L#-T=%D<-OGY";=V?E\?DHO/3STNYNS.NJ*HAJ$*L'AEBG=7
M72;J2+'Z>_=>ZW3-]0Q/L7>,#Q1O ^T]PPM"R!D*-1S*5*D6*D<6M:W'OW7N
MM.3_ (1*[5PE)\$_EKO>"@I4W)GOEJNU<GE%ID6>6AVEL[;E70T[S >1XH)\
MWD71"Q5&FD90"[$^Z]UB_P"%4440^>'_  GJG$<8FD^6'8\4DP0!F6'>71I1
M2UKE4,CD FP+,1]3[]U[K)_PMK_[(4^)'_BVDO\ [QVX??NO=;I'OW7NM++X
M3_\ <9)_,U_\50C_ /=%TA[]U[I+_,/9V&WW_P +-/Y?>#SU#19&@I/CK2[N
MCILA3BJC%7U]L[MG/T$H0D#RT]?C*:6)O[$J(]CIL?=>ZW1^P*>GK-A[VI*N
M"&JI:K:.Y*>IIJB)9XY(YZ.97CD1@5='4D,I!!!((M[]U[K37_X1Q9VLVO\
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M=1[BV]MR:M6.):K(8+;63P]#72",!JV"H//U/NO=&I^1O_<:;\!?_%2]Y?\
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MSV93S3A0&:.EZ\ZO:-"?J51II2!^"[?U]^Z]TG?^%L/_ &[F^,?_ (NOMO\
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M<;4R]?;GJ<I4I5U]8C4&/RY@-;6^>M>EFQ#F*MFGFH<CCXYF@]^Z]T!'=?\
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HO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>timage_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 timage_006.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
MA  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(!
M @(" @(" @,# P(# P,# P,# P,# 0$! 0(! @," @,# P,# P,# P,# P,#
M P,# P,# P0$! 0# P,$! 0$! ,$! 0$! 0$! 0$! 0$! 0$! 0$! 3_P  1
M" +/!4\# 1$  A$! Q$!_\0!H@    8" P$             !P@&!00) PH"
M 0 + 0  !@,! 0$            &!00#!P(( 0D "@L0  (! P0! P," P,#
M @8)=0$" P01!1(&(0<3(@ (,11!,B,5"5%"%F$D,Q=2<8$88I$E0Z&Q\"8T
M<@H9P=$U)^%3-H+QDJ)$5'-%1C='8RA55E<:LL+2XO)D@W23A&6CL\/3XRDX
M9O-U*CDZ2$E*6%E:9VAI:G9W>'EZA8:'B(F*E)66EYB9FJ2EIJ>HJ:JTM;:W
MN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ]/7V]_CY^A$  @$# @0$ P4$! 0&
M!@5M 0(#$00A$@4Q!@ B$T%1!S)A%'$(0H$CD152H6(6,PFQ),'10W+P%^&"
M-"624QAC1/&BLB8U&50V160G"G.#DT9TPM+B\E5E=58WA(6CL\/3X_,I&I2D
MM,34Y/25I;7%U>7U*$=79CAVAI:FML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(
MV.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H # ,!  (1 Q$ /P#?
MX]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW4:MK:/&T=7D<C5TU!CZ"FGK:ZNK9XJ6CHJ.EB>>J
MJZNJG>-(XHTC9Y)'9555)) 'OW7NJY)/YQW\IZ-WC;^9%\)2T;LC&/Y*]32H
M2I*DI+%NEU8<<,I(/U!(]^Z]UP_X>1_E.?\ >R'X4?\ I2/5/_V3^_=>Z%7J
M;^8__+Z[XS_]TNF/F_\ $[M#=O@EJEVGLCY ]6;AW3+1P24L$U=#MS';IFK9
M($DKH8VG2!HP\JH6U,![]U[HZ7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NN$CB-"[7(6U[6OR0/R1_7W[KW4;[V+_
M %,G^V7_ */]^Z]U[[V+_4R?[9?^C_?NO=<EK(F95"R79@HN%M<FPOZO?NO=
M2O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U#^]B_U,G^V7_H_W[KW7OO8O
M]3)_ME_Z/]^Z]U[[V+_4R?[9?^C_ '[KW4M6#*K"]F4,+_6Q%Q?W[KW7?OW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NL$M0D+!6#DE=7I (L21^6']/?NO=8OO8O]
M3)_ME_Z/]^Z]U[[V+_4R?[9?^C_?NO=>^]B_U,G^V7_H_P!^Z]U,]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]UCEE6%0S!B"VGTV)N03^2/Z>_=>ZC_>Q?ZF3_;+
M_P!'^_=>Z]][%_J9/]LO_1_OW7NO?>Q?ZF3_ &R_]'^_=>ZD12K,I90P ;3Z
MK W !_!/]??NO=9/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=899TATZ@QU7MI /
MTM>]R/Z^_=>ZP_>Q?ZF3_;+_ -'^_=>Z]][%_J9/]LO_ $?[]U[K+%4),Q50
MX(75Z@ + @?AC_7W[KW6?W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7"1Q&A=KD+
M:]K7Y('Y(_K[]U[J-][%_J9/]LO_ $?[]U[KWWL7^ID_VR_]'^_=>Z]][%_J
M9/\ ;+_T?[]U[J9[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NHK5D2LRE9+
MJQ4V"VN#8V]7OW7NN/WL7^ID_P!LO_1_OW7NO?>Q?ZF3_;+_ -'^_=>ZDQN)
M$#K<!KVO:_!(_!/]/?NO=<_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5_
M_.NK:O'_ ,H_^8U/13R4TTGQ![NHGDB.EFI,ELK)XZO@)Y],L%5)$X_*N1[]
MU[KXH_OW7NKEMK_\)[_YR6]-L[=WCMCX*]CY;;6[,%B-R[>RL.[NI8H<G@\[
MCZ?*8G(115/84$BK-3U4<BK(B, UF4&X]^Z]U7_\GOAM\J?A=O.GV!\JN@^S
MNBMT9!*F7"TW8&UZ_$XO<]/10XZ:OK-G;E"38S,P4W\6IDJ9\565D<,DHBE9
M9+H/=>ZOK_D,_P#"@WY$?!3O;KCH7Y']J;F[4^$G8VZL#LW<..[*W--G*OX]
M_P =J<=@:'L;86Z-SULDV-P>+_;GS."%2N/-**FIIZ>.MN\ONO=?5V5E90RD
M,K ,K*0592+@@CZ@^_=>Z[]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6.6
M585#,&(+:?38FY!/Y(_I[]U[IHK\K%#$I G!\H6Z!0?TN?\ CH/Z>ZAJXZ]T
M27Y&_P R7X1?$$K%\EODYU)U#DYH:J>CVUN_?VV:/>62@HA$U748C9"Y>7+U
MB1^:,.:6BEL94!Y=0=DTZV!7JE?MG_A7=_)_V/35TFT-W?(GNMX9(4@I>LND
M<KB)JU34TT+RTI[ESO4D2JJR-,?-)"VB)@ 9"B/JAK7JK#TZ*'6?\+._Y?4M
M;)]MT#\WX:)IT5)AMOI..I6F#*K2_:1]]E Y4%O&)K7-M=O5[MUM,<>AVZW_
M .%;_P#*HWJM+)NC=GR7ZB\[R+-3]B]15F4DHU6:>)9*K_1/NOM!&5A$LJ^%
MY3ID6X#AT7W5R0>KG/C%_-"^%?RN_8Z ^1.PNULM%-22U.W=M;WVM6[OQ]-6
M@?:5&4V>^X4RM+'(890AJ*.*YB<#E6 UQ'3;*:]'VI.Q,7,N@19;6\GC5FCI
M^"P4"Y^^)M<^Z@Z<'JX6N>G^CW%!4O&5^\L9DC(?1S<K>X$[<>KW<XZKTI17
MPM]%EX_P7_H_W4-JZ]U-]VZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW6-Y%0V(/TOQ;_BH_I[]U[H(=]]O[!ZOVY7;P['W
MC@]A[2Q<4D^5W3O+<.%VOMS%P11M+)-D<WG<GCZ:! J,Q:250 I)X'OW7NJ7
M^\?^%,O\G+I&N?$U_P L:7L3,PQU#_8])[3W5VQ0S&%HU"1;NVACZ[ EG+'Q
M@Y47 )O;GW0U/#K9%.JT-Z?\++OY;..R4E!M7I_YL;HIJ2HGA;-4VQ>H<'BL
MC$!$8:O&QY3O>&M9&.H::NBI'%OT\^[]44$<>L.SO^%C7\M_<.1BH-R; ^:6
MP(I6F)S&7V+UMF<'2QH%,0G.UN[<QD-;7("Q8Z11;EN??NG@PZLD^/'_  HG
M_E2?(+(P8G;/RRPVV,W4FFHHL-W'#7]/5$^2K9:>.EHJ.M[*?;M%5S.TFA11
MU51=O3>Y /NFW%>'5U&V^WMKY[%XW,8BJK,MB<GCZ>MQ^0H)\?7T-92SQQO#
M44M72Y.:.1&#75T9@?P?=/AR>MJM>E93[PHZTHT*Y!%EU:1((EMHU W"5+_Z
M@^[ UZ\13I44>3AE@C:TQ+:^6"D\.PY/D/\ 3WK5FG6NG2-Q(@=;@->U[7X)
M'X)_I[MU[KG[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KA(XC0NUR%M>UK\D#\D?U]^Z]TUUF3AB@D:TP*Z.5"@\NHX/D']?==
M6:=>ZK@^3O\ -[_ER_#BHS&&^1/RVZHV)NO!T!K\CL6FW-2[Q[)@IW64P..M
MMCR;CSY,AB98@,==V0A;V/O9Z]U3)VO_ ,+ OY3>SF>/9X^5/<3N9:6.HZ]Z
M?Q.&IXR(ZAHJV5^V>P^L95A+(HND4DH\@/BL&TZ44X]5(->BT)_PLS^ <]9#
M]QT9\XJ&BTD324>WNEZJ=6"R,ICI'[]H$>YTJ;S)87/-@#XBO3JD#CT9WK?_
M (5;_P JGL%\1!ENV>\NJ:[+O04ZT7975^Y(5QU57QP$09?,;'RF^,;3K%)/
MX)ZEJW[>-HWD,W@ F.F!/#JU1U=+\=OYA'Q=^3N(R.<Z$[HVGW'C,>U/'7S;
M!WMM#=LV)GDB$YI,O18?<];/13A)XG>"KC@D"R(2MF6]@:],NI\CT=B@[!QE
M1Y;198Z/'^M*?^UK^G^6M_J?>E!''K?2NH,O%-Y;BH;3X_UZ3:^OZ?NG^GOQ
M;3U[IXAJ4F.E0X.G5Z@!Q<#\,?Z^[#/7NI'OW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZA&OA')63_;+_ -'^]$TZ]T!?
M<?R3Z1^/.W*W>_>?:VQ>H]G49J//N3L?>FV-DX2,0ZG<#([FS.+A8@+8(KEB
M2  20/>QGKW5'O=/_"I3^3CU5ELGM^G^1NZ>TLOB:R."KAZBZOWUNW#N95C<
M/C-XU..PV"KHU2H#-)0Y.I069+^56C%0#7JK"O#JNG-?\+-OY>IED&#Z)^<T
ML$@UK-7;5Z1Q4T3F9R8EAI/D)E1I"!;-Y!R2-( N=D5ZNN./2OV)_P +!/Y:
MNZI32[FPGS%ZS=$A+UVZNO-GYC%R/(TFM*6787;V\*MA&$!8RT4-]8TAK-;5
M#3J^H=6E?&?^>[_+1^3>1P.&ZR^6&UJO<><J*NCQ^U-]Y1>LMW9"MACJI#1T
M6V>S*W:U;52:8"4%-#.&"ZD++S[\,8ZHXKPZMVPW:&'KJ:BF@3,-%4,#&Q6E
M975IF4,"F0<$'Z@@FX]Z(->JC'2XI-S4M<\;0K6JGF2(K((Q<W4GA9W%K./=
MSCK?2F2MBD*J%D!9@HN%^I('-G/]?>@:]>ZF>]]>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J/-4I"=+!R=.KT@'BY'Y8?T
M]^..O=)[*Y^EH1)/,\T,$%,]1-(6CCCCBB\CR2.[3(  $)))  ')]Z!KU[JJ
M/Y&?SV_Y5/Q1K,AB.X/F5UE_>3%U:T&2VAUUD*KN7>&*KS8_99C;74T&\ZNA
MD 8,XK8J<(""Y4%;^ZW3JIGL[_A8Y_*NVI61T6T-I_+[MG]F21<KM#JS9&"P
MB2"6-!!42=C=M;)KU9ENZF/'3+Q8E2>-*"./5&!/#H#Z7_A9K_+WFD(K^C/G
M/00A"5?'[6Z2KY))-2V1XIOD+BP%M<ZM;&_&GFXMTXI X]'/ZJ_X5(_RE^S<
MQ08.?Y ]@]>Y+)F2*D3M'KO>&V,2DT:O*5R&Z8QE,/1@I$Q66LR%/&20@?R,
MJ'1QULT/#J\#I'Y<](]\;8H-Y].=BX'M+:E;CX9X-S;!W7M7>6$E,GC'C.5V
MYN+*0^0$,&0O<%6!Y!'O1SPZ: (/1@Z??N-JU5(HLHKB-9"SI3BX 4'E:QC>
M[>_ ^73A6F>E#C\U'53P*OW-I59@)--K>)G&H"5OZ>[=5Z4ZL& 87L?Z_P"!
MM[]U[KOW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW6.6585#,&(+:?38FY!/Y(_I[]U[ILK,G#%!(UI@5T<J%!Y=1P?(/Z^ZZLT
MZ]T5;Y _-_XL?$_$0[@^2G?G6/2>+JI$@QTG9._MJ;2J<S4RPU,\=)@<=F\W
M1U%=,8Z.:00TD4SE8)&"D(Q&SCK8SU23W%_PK*_D[=='.4NW>V>X>Y:[$-50
M_9=4],[K,>3JZ 2>2EP^7['EZXQLXDD@\4-2M:*:0NLBSF$^7WJAK7JK#TZ)
M%E_^%GO\O62JD_A/0'S@:D6,+#+4[9Z1Q]0[6)+R4U-W[7JA!:PM*_ !X^@M
MUY<<>A4Z\_X5Y_RN-Y.!N:H^6'4X6J$#'?\ U7B\I&\06G8U:?Z+>Q^R6,1,
MS* RK)>)KQ@%"_NG=0/5P7Q;_G#?R^?EE/B\9T5\HM@[YW+E_%6X_951NC$[
M:[%FH7-$AJ6ZYW?E,'GHT1ZM$E$F/0QNX5PK$ ZX]-,IKU932]D8EM>J',-;
M3:\=,;?J_K7>Z5T\>KA=73Y!N6"HU:/OAHTWU:!^J]K6G;_4^W.J]*L5\+?1
M9>/\%_Z/]U#:NO=3?=NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]UAEG2'3J#'5>VD _2U[W(_K[]U[I);HWC@=KXNHSF?R
MM)@,+CH)JK)9?+5U'B\704T9C#U%?D*VJIXHHQJ%WD=0+_7W4-JZ]U35\@_^
M%%'\H+XZ5$F)W;\R]D[QSL%5/1R8GI*GS/>,JU-(*A*B&IRO5E'NC'4[*\!0
MBKK8#J(!_P /,*\.O=57]B_\+)/Y9&$R$^.V?UM\SM^K'-%*N=PO7?6. P53
M%*LIECA;=/=N%R/D0E05DQL:F]PYMSL=5 ->D;MS_A9-_+LRV2AHL]U3\W-J
M4U14I$,M-L[J;+XRAA;67J<A'B^^)*L(E@---253&_"\>]]/!AU8!T3_ ,*7
M?Y2O=.4I,53_ "CJ>OLK)$99J3NO;^=ZNH( ZR!%GW7NTT>#+ @ JF3<C@VM
MS[]U1\\.KP^O^^^ONP=MXC=FR-P0[PVOF(9*C%[@VUEL)N#!Y*#5)IGH<KB,
MQ6T\R'ZAHY&'(Y]T.#7RZTH\NA(I]X4=:4:%<@BRZM(D$2VT:@;A*E_]0?=@
M:];(ITI*#*Q31,2)R?*5NX4G]*'_ (Z'^OO1:F.M=.\4JS*64, &T^JP-P ?
MP3_7W;KW63W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5:_SNO\ MT3_ #%__%2^X/\ WEZOW[KW
M7Q4??NO=?=S^(_\ V2C\8_\ Q7KI?_WV^VO?NO=4^_\ "G[J7ISLK^3/\J-Q
M=KTN'@RG4$'7_8O4^ZJVCHI\MMCLX=D;2VMA*?;]74TU0\$F<BW)4;>JO#I+
MT^5E4E>&7W7NOD'>_=>Z^]MU'1Y?'=4]8X_< =<]0]>[+H\VLD,M/(,O3;;Q
ML&2$E//45;HWF1[H\LK*>"[$7/NO="%[]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MK!/4)3Z=8<Z]5M(!_3:][LO^J]U+:>O=5'_S.?YR'PQ_EA;'BRG?N]LED.R,
MTL\^Q.C-A#'9KM7>HBBKTBK8<*^4I(\;B?+2M%+F<K+24JL/'&\U04@?P:O6
MR*=:6.[?YF_\^_\ GJ[XW)LCX&;3WE\9OC(^5JL-79;KW<=7LO&XK%5QID)[
M.^3>73&UM36P+%,TF-V>F-<T]28I,?6%5F?P6G7B>C;_ !F_X2$[&J9(-]_/
M+Y6;[[*W[FLE3[EW;M+I!8<+A:O-U=0N3W#2YWM3L/%[BS&;6MJ995J*Z+$X
M"I<.TBNDKATMUKJ[3JG_ (3^?RB.HJ.6FP_PSV+N^IJ"K563[6SV^.U*R9EC
M\0:*'?6Y\W2TW')6CIJ=23JM>Q]^Z]UJ=_[*S\:_^@KC_98/] W4G^RY?WZ^
MR_T&?W!VU_HH^S_V1[^^?VO]Q/X=_#?'_%_]R>G[>WW/[W^<]7OW7NML3M;_
M (3^?RB.W:.*FS'PSV+M"IIRS4N3ZISV^.JZR%FC\1:6'8NY\)2U/'(6LIJA
M01JM>Y]^Z]U25\F_^$A&Q8&J-\_ _P"5>^^M]]X?(U&Y-J;1[P2#-X2ES5+.
MV2V_28/M/KS%[=R^$2CJ(HEIZZ7$Y^I1461G>5"[^Z]T02/Y\?SX/Y)>]L#L
MCYQX3LCOGX\P9&EQ>,W#O'=68WA@,OC:9ZJ*+_1M\D\.:^H@K90L31XO=0KI
MD@@5%Q])Y#*-$5ZL&IUM+?R]/YUOQC^<V II^K]Y]B4V^J#(T$FZ^K-W56.H
MM][92<8R)ZE\<=U3BNQOEJ/&F2H6G@+'0YCFU1*T01TX*'JZ[9?=&-S'\2L=
MS/\ ;?9_\"C3M;S?=?H_W*R_\<N?I^/?E;3UIEKPZ--C\]2UGFT)5?M^._D6
M/^WKM:TS?ZGW?6.J%=/2@]WZKU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW71-@3_0$_[;W[KW06=K=L[!Z;V=N?L?L[=^$V!L'9>WZ[<N[-X[JS..
MV]MO;V%QL4]16Y++9C*UE'!!%&D1)>1U'T%[GWH]>ZTA_P"81_PK3W1O;?K?
M'#^3]U#NGN/?^;JY]M8CNC<NR=R;FJ-PY04Z5.KI#HS$(^3RTRK]QXZS.01+
MJIBPQ533LLIJ%/F>MUIT2#8'_"?O^;O_ #,L]B^Y/YIORZW'UK0551%DJ#9V
M^<_4]S]E8JEDEBIZNEP77&W\_AMG[2CJJ2E5HUHZXR1/(#58P2B6,WZUU=KT
M5_PEN_E/]246+.^>ONSOD3N#'54->^;[;[4W+C*6HJX9Q41QOMGJ>;K;'24B
MLH7[2L@K%=!HG,P+ZO=>Z(U_PHS_ )>'P9^+?\K_ #6]OCU\4^D.I=[T?='4
M.$I][;0V'AJ'><>(KYLK39#'?WLD@GR#15"4J?<(U21*5U2:F))]U[H[W\LS
M^5)_+?[_ /Y9WPMWGVY\,.A-W;TWM\=.OLQN[>C[(H<)O+<68R.)BJ*[,9;=
M>W#A\A-5ROZGJ7J3*?\ 5>_=>Z0??O\ PD__ )8W9]#*W3TG=/QHSB"=J*39
MO860[$VRTDBL(ER^$[>_OG7SQ1D@JM+F:!S:S2&_OW7NJ5MY_P I;^>U_)SF
MK>R/@;\@-V]_],X*63*9?9_361W"*FMQZL<GEJG=OQ6W-6YJDK'E- (C+MR?
M.9 +4$Q20EI&7U*];!IT>[^7O_PJ(V5OG<6)ZB^=^)W1\=^U,;5U^"R&^:'-
M9&+J*OS=!"])6TFZZ+=V;H\AM.K^[,L9@KY,A21&$^>NIWTQ>Z%3Y=7# \>M
MNKJ?Y%X'=U%MNKH*S=-=19>"MJJ.J>HHZJEJZ;37305$<\.<J4DC=8PT;J6!
M!4@V]M@T->K%:]'*VONVCR=%0LB5]Y_N;&=8K_M2U .JU3)_QSX^OMS6.FRE
M.EU#,LZET# !BOJ !N #^"?Z^[ UZKUF][Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW41ZV)"P*R75BIL%^H-N+L/>B:=>ZH4_FT_\ "@KX7?RP
M,?FM@93)5?>?RC;'^;"?'OKK,X^&NP]3)2Q5F/JNV=Y*N4I]K44WEB],U-6Y
M&2.434V-J(0\B^!KU[K4E_TV?\*+/^% &6R%1UQDMP?%+X=[AJ*BFAJ<#F-R
M](=*3;=EKIS'#5[WC6KW9OR<TM1'3UJX[[S&R24VHT=!Y) ?4\^MUZL)^,G_
M  D!^*&RH,)F?E5W_P!L=X[BI6EJ,IM3KF#$]1=;UC2I)''C:R66GW=N"HBA
M$FH5%)E<.\CHK%$CU1/OK75RG6/\B;^4AU/C8L;MWX-]/9U(YEJ6K.SHMR=P
M9*><'46EKNT\_N^303]8$*0_@1@<>_=>ZU"OY%GQ4^-7>G\ZG^8'TKW)T1U5
MV;U)LSKOY6U.S^N=Z;)P.?VAM.JV[\L.HMI[?K-M8.OHIH*":@QF7JJ&CFI5
MB>""H>.)E5B/?NO=;3_<7_"<W^4)W%)/73_%:DZUS4U(U&F8Z=W]V#U]'2IY
M:J=)H-J8_<L^WS,KUC$328B1RJI&Q:*-$7W7NJ,/D%_PDG[1ZES47;'\M[YG
M;EQ&]]JQ+6[4VYVY4UFP]^4>3M5T^1J=O]]=2P8Q:>>:DJC!!"=MT*%M:S5J
M13$P^Z]T7+K3^==_-L_E4=DX7HG^:MU7VSOC;&1C#4&XMQY6FI>T),/CC##6
MY/8?9F S%7M?>D-*:V-:D/62RF25%FR<1(4Z(KU8&G6XU\+?YI7QO^:&P*WL
M;H3L7<N\\/3_ ,+BS6+FGI*3=.TLC5PU4W\'W5MN;<+U-!4@(;"5/'(!KADE
MC(<M$$<>G!0]6I;%['Q^7CI'5<RWFPL%7>I$!)$BTANUJZ7U?N\_7\\^[!P.
MJE.AKHZZ*L2-HUD&N%)1Y H.E@IYTNW/J]V#5Z;..IWNW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HM_R8^6/0'Q!ZKS7=?R.[-V[U+UE
MMY+9#=&Z*^"C@FK)!_D>&Q%$LKU.0R%204I,?0PU-3,P*Q1,0?= ]>M@5ZT4
MOEE_PIY^;GSI[4/Q6_DO]$;[Q=;F7JX:'M'*[9H]X=UY^@HZC[2KW)@]GS2Y
M3;VU,.@J(C+DL\^1:-)4DF;'2^A;$5Z\#3H/NE_^$P_SG^9.X\9WE_-9^9^[
M,=N/,?[D,ILJEW1DN_.YH:+)4SUL^!R/8^ZLS4[?P$]/5U O!B8MT482(I$4
M#*T>^M=7A=)?\)GOY1G3L6#J,MT-N3NW<6%I/ VXNY^SMZYP9:I>CDHZG(9?
M9^U<IL[;D[N)G<1MAO%&Y62*-)$1E]U[K7,_X5>?#[XM?$RF^ -+\9^@.J.C
M(M['Y5'>+=:;,PNU:G=1VXWQR?;_ />*LQM+#-6BA.XJ_P"S%0\GA%9*(](=
M@?=>ZVG,'_)8_E5=M=,["3>/P8Z&CJ-P]<[/GRN4V=MNIZUSL]56[6Q_W5;%
MG^N<AM2MAG=IFD::&=',A\A;7ZO?NO=5G?)+_A(S\#.QX,ID_CIV?W3\;=R2
MT#0XC#U>5HNX>L:2M1IY(:JJPF[4H=QR%S*L<MMUA0D:E(P^LR>Z]U4#O;XR
M_P#"A#^1?#%N'I;LS=OR)^*FTY#6/1;#KMT]K]58C!T.E4I]X=/91Z;/[5IP
MB++4U> :GI8P@5\G;4I]UL&G5W?\L7_A2Q\>/EK6;4ZK[G.[>@_D+FLW1T5'
MMS)[G7-=;[TK*BJIJ*FAV5OG*5^$9*F<A7&(R5/3S!I?#32UY5I"TP(Z<!!Z
MVEMC=S8G*TP8KN21SE13JU2*9V%XZ0@:OXI(=-Y/][X][7@>JO&2<=#E0;JI
MZ^%IHOOU596C(ET!KA$;C34/QZ_Z^]H:CJI%.EXCA[VOQ;ZV_-_\3_3W?K77
M/W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=0:RNBHTD:19#HA>
M4^,*3I4,>-3KSZ?=2U.O#/6JM_-F_P"%0WQ(^#V0W-U!\=XX?E;\E,/]S@LO
MA=L;FBH.H^M<[2U]9CLI1[\[#Q'\5^YR>/D@=:C"8B.>9)8S3U=302 E=_%U
MOAUKM8_XV?\ "B+^?3-!O'Y#]F[B^-'Q6W.#+0[>WC6;FZ?ZHK=MU_A6>/:O
M0F"GJ<_NA-- L]#7;L,T,JU!-/E1%*WOP%.O$UZMC^-7_"2'X"=:4%'6?(OL
M+N+Y,[I^UACR5)%EUZ;ZY:I #338[;VRYZK.QW:ZCS;HG73;T!N?>^M=64YS
M^2U_*JZEZ:W^FS?@MT(T^!ZYWA/BLGO';-1V7G::IHML5STE8VX.RLANVNEG
MC:G1UGEJ)) XUZM9)/NO=:W?_"5SX5?$?Y6] ?+;(_)/XX].]W9/;7;G7^,V
MYENR-B8'<^7P&-J]H5]=5T&&RV1HY:FEAEFB626*&5%<CU ^_=>ZO0[L_P"$
MRW\HSN"GS$F$Z-W9T=N#+0!!N3IGM+>N+?&SQTR4T-5C-I[UR6^MO0E1$K-&
MF'".P+NK.[LWNO=4:]S_ /"83YX?#?<N0[O_ )6?S&S^X-P8=Y:[&;.J-Q5_
M0?<DV/H8TK*7;U'O?!YI=N;@DGGA*209;^[5&ZN$D1UUZO=>Z3WQL_X48?-7
MX9]F_P"RW?S:.J.W:3-;?6+$U^_*3$9+9/;6*I!6C'4VX]P[&KJG$8C<6-E-
M#-)%E\$]"L\49FIQD"P+5(KPZN&\CUN0_%/Y[=-?)':FP.QNG]_Y?L396YL6
M\E'GL/DZ.NIA5TV(G:NQN5A_CK34M=321M%54=5'%/#*I25%8$>]5KCSZV%S
M7JRS:V_Z+,4- \7\7U5'W6EJGQ:OV9J@'65K9?\ CEQ]?Q[\ 1UIE\^A3Q]6
MM330R#R>OR<R6U>F1QR0S?ZGW?JG4_W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=89IE@4.X8@L%](!-R"?R1_3WHFG7NJ\_GW_,G^)W\O#JA^
MU/D_V4=DXJ?)OCMM;;QL"YK?N^\M&DBG$;(V?158JZZ0%T,\P6.GID82U4T$
M(:1=!J]6TTZT?>Z_Y\O\X/\ F[]G[BZ*_E-]+=B=+]5U/@Q5;NO:YBKNTZ.C
MFGE4Y[?_ ';DJBDVYLF*HA6)X:;'205<,B2B'*UA=%3VG->M5Z$WX^?\))M^
M]JY.L[4_F2_,W>&X^P]TNM9N7!]-U]1O/=U55QVI:6KW#WMW%C<S)6U"TE-!
M$\7]VYEC*Z(ZJ6.-6>W6NKQ^F_\ A.O_ "A^F4CEIOBEB^RLN*>&GGS7<F]-
M\]C/5^$EO-)M[+;@3!QR,3=WIL5!?Z?IX]^Z]UJN?SC?BG\:>F_Y\W\OSH?J
MKH?JGK[IC><7POAWAU?M39& PVR-V)NKY.[QVON<[EV]244=/7OD<=1145>]
M4DK5$,:I*746]^Z]UMU]G?R(/Y2';&-J,;N#X/\ 4>WA/,:A:[K%=R=1Y*FG
M,K3!J>LZSSVU2$!<@0,'BTV4QE0 /=>ZIH^4/_"0'XM[TAS&;^)WR![/Z/W!
M42)4X[9_9=+C>V^N*<1P1Q-BZ&MIX]J;@HXY60R-4U>1SCHSM:-DTHGNO=5=
M;C[$_P"%#O\ (KEQ]1W!E]W?(/XK8>JI<?+EZS>.Z>ZNEHZ*:6EEDI\7O_5B
MMU[/D6.*6GQZ9:'&T/EE9A05FD+[U2O6PU.MC#^73_/^^,OS>I9=N4.<[&ZZ
M[L2AI*K(]/;PSF/J,E4F)*Z2OJ=AYV3/4$6=I8A%KE:""GJ8TL]120H49FR"
M.G 0>MA[9?=&-S'\2L=S/]M]G_P*-.UO-]U^C_<K+_QRY^GX]Z5M/7F6O#HT
M-!N&DJYFC1*NZQE_W%CM8,B\6G;GU>[ZQU0K3I1HP=5<7LRAA?ZV8 B_U_K[
MN,]5ZY>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I+[DW'C-NT
M$V5R]?#BL70TM979')5M53T-!045'$LU565U94SP1Q11H"[R.P55!)( ]^Z]
MUIJ?S.?^%;/4'4>;K.B/Y;NSZ?Y4=TS5L>WH^V<H*[(=%XO.9*2:@I:#8V/V
MQDH\GO6O%0(5B^QEH,=(9XS3UM<=<(JH(X]:8?/JHO;G\I?^?%_.9K:'LS^8
MM\D-X="]299H\YM_9G<%3DJJMQT-6K9#&U6TOB9LS([8QF'DB^^:GF.X9MO9
M-5B595F"HWO8%.M]7*]!?\)1/Y8/6&,A7M^+N7Y+YYS#)75>]>Q<OUYM_P B
M4\<<T.)P?3\NR:N"!W5I E3EJ^5=6GS$#WOKW4_^;5_*S_EU?'G^5O\ ,C?/
M3?PVZ$V/OG9W4,^1VKOBBV+C<CO3;V13<F&5<AB-V9Q<GD()PM9(GFCJ0^AM
M&K2% ]U[HHW_  G-_EW?!GY2_P L'";X^0OQ3Z1[:WQ5=S]OX.HWMN_8N'KM
MY28BBGQ%/08X[JCA@KQ%3I4/]LHJ!XBVJ/2W/OW7NCM=[_\ "67^5)VU1Y!N
MO]E=J_'+/5E1+6Q9;JGM+<&;H(JJ5C(\4FW.W'[)I%I69B3348H= ]$+Q(%
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M1C8Y-A[<WMU=M6FKJ5:ME\]!0UK#A?NI;!O>..]?>5LK.8QV5I)<(#3Q'E$
M;YJ/"E-/35I/R'1+)O:J:*I(]2:?Y#T[;5K?YR'\E?;&#W?TGW__ +.O\1.N
MDC.\.B]\X[+U$6T=C424_P!]_=K;F8S&Y<EM['4U/1'POM;,RP4<LKU53C)J
M?[EF%/)'OKMG-DZVLZ-:3.0(P[AXY&/!0X5*,?(,J@\ 22 7[7=4N#I(TGRK
MD'\^MR/^7Q\].E?YCGQIVE\D>E*J6FH<G//M[?6Q\E505&Y.L.Q,734=1N#8
MFY33I$K30)D*>II:E41*JCJJ>J1528*LW]&O1W/?NO=4H?S2/Y&'Q&_F68+,
M;JJ\+0=)_)Y*&?\ N[\@MDX6G3(96N$4"TM'VQMNDGQD&YJ+_)(XA+521U]/
M&"M)60HTD<GNO=:EOQM^:7S^_D"_)7!_#CYT0[BROQUBGFEVS58W[?>N&P6V
M,A/58I.R.B-TY?#"IR&WM<C2UVW'6DEA924I:&N,]/55*@]65J=;\'Q0^7>Q
M>XME=:[QVCV=C=Y[7WGC<KF,'GL/B)),;F<;(V9EIJJEJ8,)"+6AL1Z2"I5@
M&!'O17TZODGY=6-[2WE09>F\D&2^X0Y#[8G[.:+U>.F8I9Z6(_24<_X_7W0$
MKU5E].A*CE252T;:E!TDV(Y !MZ@/Z^W0:]4ZR>]]>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NH%7D*:F6\DVC]SQG]N1O59B1PC?ZGW[KW6D3_ #T/^%&N^-J]
ME9K^71_*RK:_?OR-W!GI>MNPN\-A4:;BKMC;RR.53#MU+TE0T^/KQDMU:FDI
M<GEXPT>)F84](9,HD\F+T17KW2*_E+?\)I]I]<S8GY4_S-8(>[ODCN/*-OR+
MI;/YK^^.Q]C9_+S29:IR7;.8:KKXMX[E>HJVFKUDGJ\7'4:R&R3:*H;Z]UMT
M4-#18RBI,;C:.EQ^/H*>&DH:"AIX:2BHZ2GC6*GI:2EITC2.-%4*B(H"@
M>_=>Z"7Y"=^=7?%SI7LCY ]T[CBVIUCU5MBNW5NS,O&U34+1T@2*FQV+H8R'
MJJ^NJ)H:+'T<=WJ*FHBA0%G'OW7NM./"?*+^<Y_/3W!NG=?QK[*F_ER?R_Z;
M<6<VQMG>6%DR6.[2WU0T/^335%-N?;\M+F<UDH9Z;Q5YPN3VSAJ8SST7W-=6
M4<Q?&OWN^]#L'LJ_T4P>\W HKBS@95\-6H5,\C5$6I:LJA7D(TG0$97Z&O*_
M(MWS./%6D<-2/$<$U(XZ5'Q4.":@<<U!'2)VK_PG7^;?Q8W?F_D+\./YH67Q
MOR1J:7+O4YC*=<[HZP&^OXSDZ//9G"[YWE0=J=KMDJ3(5U!#5U=/EL+D:>>I
MIX9IXRZ+(F.NR_WB%C<7"IN&RS00$T:6"^2YD4>HC>UM0U/3Q!T,[GV<E1"8
M;I7:F%:(H"?],)'_ ,'5J/\ *H_G%][;E^0-9_+1_FD[/H^K?FM@*6*'KOL*
M"@QV$VOW_2T6,DK-4T&)9,4F8KJ:CDR%#6858L=D56:*"GHJF%::;/3DSG7;
M/<';HMUVB=;BVE!TNM05889'4T9'4X96 (^P@F)MRVR?:)F@N%*.O$'S'D0?
M,'R(ZV9?8JZ0= OW]\=>COE-UGG>G?D+UAM'MGK?<413([8W?BXLA3Q5*HZ4
MV6P]8/'4X_(4Y<O29&@FIJJ![/#*C@'W[KW6B'_,+_DX_+?^2UV)5_/C^69V
M'O\ W'T/MB>MR>^,!QN#>/5&U9'>JR&-[*P,5,*7=>R42XGKZBD:6@2..IK
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ML-"3+9J&$"YF'IX^OT]M$%>J, >''H<*"LCJZ:*99/)Y/)9M#)?1(ZG@JO\
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M+!2)%644T+4]7")#HEB="3;FM:X/3I%<CJ]KK7L^@SN&V[5#.?=?>UDD6O\
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M/;WPHZ1Q]7V%\@_D+N?:>T*/9&V'2IS5)C<EFJ.>AHYQI,4<^4J::"D2*>6
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M]W_=?:_P&W^X!X-'G_C-_IA(;W\/^-K>Z.:]7 IU:K@=P'(_=>.K\WA\%_\
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M_=Z 9ZHYZ,VANB$<@JI!'YX'NW377+W[KW6*=0T3*;V.GZ?X,#[]U[KY[?\
MPL\W)N??_?/\O7XQ;7J/)59G_29N&GPSR24])D]R[^S'56P]F5-=421>,&!\
M9D88F5B46KE+K9D)UULCK<TV!L[%==[$V5U_@8(J;![%VEMS9V&IH(E@@I\5
MMG#T>%QT$,* *B)#1(JJ. !8>]]:Z5OOW7NO>_=>Z][]U[KWOW7NNB0H+,0J
MJ"68D   7))/OW7NOGN?S1OD])_.@_F'1=!=?[AJZKX*?"FOR=/F<S@,E54^
M+[1[ JJML5N3=%/+#4K%4K6S8>7#;=K4C<Q8ZER%;23 9!@P6YMY@'+]MJ6G
MBO58P<Y\V/R6O[2!U./L)[3-[K[R(9M0LK8++>.IH2I)"1 \0TI4BHR%5V!J
M!T:/_A.K\K\_\+/ECVS_ "E.\<_42;&[%S64[0^)^X\Q62&F?/RT3UF3VO1R
MU;P111[AQ6,%8E+2QQPQ9C%5\2"6>N+$RV+=DWNU2X3B11A_"X^(>?GP^1!Z
M!WN?R#<>VN]7&TSU(C;5!(?]%MW),;\ *E</04$BNHK2O6\#[-^H_P"O>_=>
MZ][]U[KWOW7NO>_=>ZK;_G#=4TO='\KKYV;&J,(=Q3I\;NQ][X7$1T!R=55[
MGZLPTG:&T_X=0K',\E6F2V=2R4@B5I/,J>,:]/OW7NM+G^0;V;4Q]-C:]75X
M_3M#Y'4TM M9)H:GQ>;HMDY,1D&HB]'W<=9)?C]9_I[HS4Z?C:@IUO>_$W?T
M60Q%,OWN#;R=B0P?L5*L3JIMN"R_Y8_J]?'OP;5QZ;DZM*Q62,GG\;4\FGQ7
MT'5:_DM?3(?Z>]A=/32DGCTJ_=NK=>]^Z]T0'^9CVW6?'WX#_+?NK%*DN8ZT
M^//=&\,)#//]M'/G\'UANVOV_3-4 7C\M;!3QZP'(U^E6:RG1ZV!7K43_P"$
M<'56,Q?QE^8/>"T?^YC?7>VT.JIJ]A4-?&=4]?TN[J:C@+L8EM+W-*\OB"NU
MX_*6"0Z=]:ZW(O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U0U_/X_F;5OP%^*L?7O3
MU74UORX^4CY'K+I#$8)&KMR;4Q^0A7&[I[2HL73"2:2HH!D8*'"(B2-)E:^E
M98YHH*A126585+N0JJ"S,Q "@"I))P !DD\.M$TR>M1;<_PJ[U_E$;#^(/\
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MO&X_JC#_ &X/OW7NM+O_ (6C]H9+:WP7^/\ U7C,B]'#VC\C\%DL[3(@+9?
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M_=>ZJD_GD;7I-W_RD_G=B:VDQM;#2='9/="0Y6EBK*5*O9&<P>],?5Q0S13
M5-//@(YZ.4 -%41Q2JRL@8>Z]UI_?R4*F63XHUL<C%TIM[9J"!; >.)JZNJ2
M@('/KJ7;F_ZOZ6]M/QZ>3AUOL?&K_F-/_)<_^3WMWJW5E^WO^+3BO^U50_\
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M0R'=N,H9XZC;DLBL :?,4KR4+K(&197@G(+0(05>U?.S<C[JD[G]"6D5P/\
MA;$4;[4/=ZTJ/,]-V%U]+(#Y'#?9_L=6<?R"OYCLOSX^&>+V]V7EBWRB^,S8
MWJ;OC#Y0QTNYLF<=!446R^QLGBFBI98SF:7$RQ5KM#&/XECZ]  % ]]%$=95
M#*000""#4$'(((X@]#(&O5YWN_6^O>_=>Z][]U[KWOW7NO>_=>Z^6U\5C6;.
M_FL?S =EQ14]-C:'??R4I:G%TJ0+2Q5FU_D?0XG'BFE$)98X(\A4QHB%582
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M$\U51M'2Y19WAF^^HZB7QB&:%WB3J2^K./?NO=>]^Z]U[W[KW7O?NO=:0O\
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M4<GRZZ;VZ,GYJ'/K6WGR0TP^%)96]?Z_%8<L/;:@5QT[4^G5\_1_SI_GIXO
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M73]2]/X_(YL5DC2LHDCW75U\?H">-Y$0J9%9FTW#JR\>K_?A4O\ O[.M&O\
M\]EQ_P"0W=0]M)QZ>ZVF/C+_ ,>MLG_R9/\ W8Y_V]U5^'1SX?T?[$^_=,]
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M_P#F:=1J8$WH_#JZ=;NWP1_XMV)_\2_0?]:-H>_)PZ=ZV(NO?^+3/_VM9?\
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MWOW7NO>_=>Z][]U[JIW^>C_VZ/\ G9_XA6I_]Z7;OOW7NB,_\)4/^W3.W/\
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MC97C=5='1@R.C ,K*RD@@@W!'OW6NN7OW7NO>_=>Z][]U[KWOW7NJ%/YG/\
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MTYIV^]<1QSH6. #5:GY:@ ?RZD'?O8WFWEFV-W>;9<)"HU.Z&.;0OJPA>1E
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MW@X4AHHFB_B=C!&$5==?D&.FT*6OKYX]VKFG2:AK7H9((VBC",03<GB]N?\
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MC4DX'DJ^2CY#_9.>NUG(7(MA[=;9%MFWH D:C7(0!)/)3NDD( JS'\@**M%
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MM84,U*U#6Y^EQ^4CB<!7Q>WJ/RXQ*C5%)D-T43LA:")A%7O7[DQ^T_+5YO3
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MHJY \='A]O86FD>,U.3RE;54^-QE'&==15544* LX]^Z]U\R/;V^NS_YK_\
M,%[4^<O=%--!L_%;GIZ_:^V*BJJZS"[=H=OK!3=7=7X-:IZB,4^(HTAR&3,
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M^!W9RP1,)\-H,2U/K9CY3B"VL?0 O8 6 P>^_P"EQR7:Z:T_?%MKI_#])?\
M'Y:M/YTZE+VCI^\WK_RC/3[?$B_R5ZV</?'CK([KWOW7NM9/M":HI?\ A5_\
M"UVW-X:S(?&G<,.Y$I)$4U=.O4ORVEKX<E&YTO:AHX) K D"*)T]:H1V1^X4
M7/)$NJM/WI=:*_P^!:</EJU?G7K&SW9I^]!3_?$=?MU2?Y*=;FGO-?J,NO>_
M=>Z][]U[JC#^?3_-+Q/\M_XCYK&;&S]-!\I^^\3GME=%XVGFI)<IM))J>.@W
M-W%4T513UJ"' 19%9,>*B%XJC(O30LKQ+4:/=>ZT[?Y3WQ:R&V,+2]U[TIQ)
MOOMS+XBGQB9Q1-6XS9D^4I<A'4S3203S>7,S2QUM3K=M44-*2JN'NT[5Z>1:
M=;77QAZ?>J_OQJH]KOX_[M6\M.6MJ_O!^F^,;_4\^ZA=75NMDCJW9Z8_^.VI
ML4GF_AG^8A"W\?\ $/U_Y,G^KX^OO:MIZ;DZ,]3Q21:_(P;5IM8L;6U7^H']
M?;W3?4GW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TBLSA
MI*S[;510S^/S6\HIVT:_%^GR-^=/-OZ>]4'6ZTZUROYR7\L' _S ?CQ0=5S8
M##[:[ P7]Y-Q=3]@118:*?:&](X<**:*N>.02R8O)+!]EE8(PQ,+"6,>>&!E
M;2O3S"O6MQ_(Y_F];Y_ET=IY/^5[_,AKSU_U9MW-Y'&=5]F;XK*BF@Z2W%6U
M:54>T\]FJO\ R=]BYG[B3(8G,%TBQTLY=Y'QM6'QKO'ICAUOQ4U335M-3UE'
M405=)5P15-+54TL<]-4TT\:RP5%//$SJZ.KAD=20000;>_=>ZS^_=>ZK^_FE
M_$"3YV_ CY(_&;&1T;;QWOL9\IUI)7UKXVBA[3V1D:'>W72UV2CCF,%+/EL!
M2TE;+HDM35$UU8$@^Z]U1?\ R"?G7A>V_CKCOA'VO4G9?RP^'%'D.JMQ];;D
MB?#;CRG7NPLI)MG 93'8RM<222X%(8MNYRF35)2ST<4LR1)60 \9OOF>S%WR
M1S#-S!!&S;=N<IF,H%1#>2#5+'(0.TR,&EC)PP9E!)C;K)3VUYECW.S6S=@)
MH%TZ>!:,85AZT%%/I0$\1UL$^\,.I,ZU<_Y[/R+R'RKWQTM_)M^*]?C][][=
M^]I;,G[FI\5)_$J+K[;>#J5W3@\'NBHI'9:>:)J!=U9:(DS4>-PJ32HJ5<1;
MI!]Q3V8NFO6YQOXVC@CCDAV[6-)FDE!CEF4')C1"T8;X69V ),;=0M[J\RQ^
M$-MB8%BRM-3.D+E5/S)HU.( 'J.MOGH+IS:_QWZ-Z>Z%V2LHVCTSUGLCK#;C
M5#R2U4V'V/MO';<H:JKEEDE=YI4QPEF=F8L[L223?WU(Z@CH6_?NO=8*FIIJ
M*FJ*RLJ(*2DI():FJJJF6."FIJ:"-I9ZBHGE9%1$5"SNQ  !)-O?NO=?/_\
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MVI%)22192"FIH,I14,"04-%DTBAAB3)TPC2,4P554*++8<>V^/3Q.G ZN?\
MBE\9)J5,155NR-#TW9%!.)/[R*VB.$;=DUZ8L^P-BI-K$^[A<9ZH6]>KUNK>
MO8L'CBL6(^UT9W[L#[]I[,L&/ D]5;-_QQ^G^'T]^10>FW-.C$TD311LK+I)
M<M:X/!51?@G^GNX%.F^I7O?7NO>_=>Z][]U[KWOW7NH%7CZ:I6TD.O\ <\A_
M<D7U68$\.O\ JO?NO=%8[;ZGH-R44D1P'WM]QM6Z?XK-3WO%DE\M_P"(P?\
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M]EK7J((J7>VPZ^1*VD1IJ*>*GKD2:BJC [4E341C7[WU7H\'OW7NJ7OYJ_\
M)+^.G\SZGP>_:_/9GHKY/[%QR4&Q>_\ 8]#!65\U%0M5U>%V[V%MYZG&_P 7
MQU'5U7W=')!68ZOI9 135L<+S037CD:)@RD@@@@@T((R"".!'D>JN@D!5@""
M"""*@@X((/EUI2?*_K3^:+\'?FKTM_+>W-\P]K;NW)W9+T_B^NNP\;B:7*T,
M6$[>[ R'5NULAO'/[JZ[GW#3U5/6XB>7(K#49-Q&%DCJ*B1K"08?=GF*WB$*
MWLFD"E62)WIP^-XV<GYEJ_/H$R^VVQS2&5K1-1-:*TBI7_2*X0#Y::=;=/\
M*T_X3^=-? OL)?DWW?V3F_EC\P9H9FHNR]W4M1!M3KRLK8*JBK\CL;#9>OS5
M=4Y::DJ1139[+UM1-XH[4<% )9UE 5U=2WLC2S.TCL:L[L7=CZDL22?M/0RM
M[>.T01Q*J(HHJHH55'H   /RZV$_;'3W09]N]S=3] ["SG:'=?8NS^K>O=N4
MYJ<UN_>^=H,!A*);$I%]W7S1"2:0C3#3Q!Y9&(6-&8@>_=>ZT7_YI/\ PI([
M8^6^0S/Q&_E:8?>NV]F[IBJ,'N+Y 0TV1VYVSON@D=HJZEZUQTWV$^T\0\5O
M/FJ]X,DZ2D!,5XV:HT33K8%>B,?"GX!4?1E(=Y[PI:'=/;5521QR5<,T$F)V
M93U:2B;';?>9X3).Z^BIKBH) ,<06,N96V:O2B)!Y]7G]2]!9G,[CK:4[3^Y
M\>$J9]'\=I8;::[&QZ]7\9B_XZVM?\^Z@5ZWK/5^GQ6^.289,)55&SOMGDZW
MQL$DG]X3->1QMV1DTIG)1]8B;@6X]V9:#JFJO5P&QMJ##8[%+%0?;>+!4-(!
M]UYM*I!2#Q^JIEO;Q#GGZ?7W8*.FF->A5B4K'&I%BJ(I'UL0H!'N_5>N?OW7
MNO>_=>Z][]U[KH@,"IY# @C^H(L?I[]U[I/9K"TE=1UJ/3>4RT%3!;S2IJ#Q
M2C3<2I:^OZ^]'AUL=$H[8Z#P6\,@8,GLVES6.K-OG$5])79(R45915$^22JH
M*RBGR:QRQ2)5,LB.C*RN5-QQ[HC =.$D\.M +Y[?RB/EG_+9[UPWST_EAMN_
M;5'A:O,;FR?6NR:RGS&Z>NDIQ0OG:/;F$BKLH^Y-JU\=7(M;@IX*AZ>(&/QU
M5*;TCG566G5U_P#*E_X4N?&WYA4&U^GOEM6[<^,_R9DI\=BUS>6K(</T5VMF
MIY#11OL_<V5R50<)D*B0(QPV:E1"]0D5%6UCEHX_=4ZV>X9H:B&*HIY8YX)X
MTF@GA=989H95#QRQ2(65E96!5@2"#<>_=>Z"_NWI+JOY&]5[UZ4[KV5A>PNL
M>PL+48'=6U<]3^>BKZ*?2\4T,J-'+3U5/+&E11UE.\4]//%'-#(DJ*P]U[K3
M$^7G\IGY\_R;>I^^/DY_+B_F"9;!_%W8E-+V#N'HGM*@BR^=VWBGK:&CGCV[
MC<UM7L#:N=K_ +BM356S8O;,TE,%CGDJ'A#31CSY[,<K^YK+)OFW07,BC2)N
M^&?3_"98'BD*CR4L0#D 'H\VGF6_V,$6LSH#G3AEKZZ7#+7YTST&O\N/^7?\
ML/Y\_6.T?E1_,+^=>^MS?&[;W9.X=OX_H39&-QNV,CNG);/EQO\ $JG(P;<P
M^UMN899GJS M;38C*UI@U+%-2,P9+\A^SO+/MD6;8]O@M7<4:4:Y9BO\/BSO
M+)I_HZJ$YI7K6Z\QWV^4%U,\@'!<*M?72H45^=*];RW4_4_7'1?7&SNHNHMG
M8/8'6VP,'1[=VCM';M&E%B<-B:)-,<,,:W9Y'8M+//*SRS2N\LKO([,9+Z).
MA#]^Z]U0!_-'_P"%"GQ"_E\X_<'7NP,KB/DM\HZ8U&-@ZJV-GJ:HVKL++()8
MWG[@WSCS6P8XTSQD286C^ZR;OHCD@I(I#5Q^Z]UI1':GS _FU=V+\J_FUO?/
M5^TLM6LVV,#%;;^-7;-34&HQ^SNJMKF4Q87 1@PH:TK)45:+YGGJJJ22N%&:
MG3B)7CU?#T9T+'2TNT]M;9V714& Q6<Q&!Q>)QU=1X^BHZ.*3'1Q4<$2Y&#2
M+3<M]26)+$W/MOCT^W;@=7M?%+XR34J8BJK=D:'INR*"<2?WD5M$<(V[)KTQ
M9]@;%2;6)]W"XSU0MZ]7<]9]908C^-Z,)]O]Q_#;_P"Y)Y=?B^_M]:^6UO+_
M (?7WI!7JCFG1HZ.%X?)K73JT6]0-[:K_0G^OMP"G374WWOKW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-E5C*6HT:X->C5;
M]V1;:M-_I(O^I]^Z]T3GM'IK'Y_^!WVW]W]I_$_^7Q/!X_/_  __ *ND-[^'
M_&UO;2&G3I->'5%_SE_EL]:?(+:V;VMV+T;B=XXFKWUE*ND>NW*D61Q$]9!G
MHCEL!E#N:&HH:K3, )J9XGL=)NI*GQ('#JY[A0]:G/8O\H3YZ_!#LJO[M_EY
M]P;[VUDL5DZZ@IL31=@X+:'8/V<$M5,F$J,G09:DP^X*1Q2GR4F3@I8GL%:*
M9C?W8..FRGIT:+IC_A4;_,4^*F1I>O?Y@/Q5P_:Z8NJHL#4;L&)RO0'9=;)C
M*F:CW#F*BKI<)G]K9N1TC$M,N*Q&&IY&1B*@Q3(\5ZUZH13JW[J?_A6M_++W
MRKP=A[7^272=;"D3//N?KO ;OP-0TD52[ICZ_KK>6Z*YC&T"HYJ,92B\T974
M/*8O=:ZUOO\ AR/XC_\ 023_ ,.,?Z0,O_LJ']Z_XY_?K^XN\_XS]I_LG?\
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MDWQV7N'(U-?5OX:2.)Q32:PJ*J5=@![;+^G5Q'Z]77=8_&%=J8)=L[/ZZQ>
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MW"M:@_B]34698<:%EN<I./K!^D_T^G/OS-7ATW]O'HTV+Q4-#Y],'B\OBO\
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MC+UL&G1<NS^M<-G:#."JV[65OW7\,U^*3,#R^";'Z=/VU0GZ?"+Z;?3G\^Z
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MQ;I]XN,[6+'4[@V)G,U61('K45Z>NK:>HFC.DV#I(IL?KS[V">M4KT1S</\
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MF$R>8^/7H?3[KW5B5!6T^2H:/(TCF2DKZ2GK:61D:,O3U4*3PN4<*02L@-B
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M<:287'U3G@^ZD4%.M 4->@5W7U#B,M]_'*^X?\H^UU?;M3:OVOMF&C5C)/\
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MJDX(/U7\?\@^_=>ZR^!/ZM_MQ_Q3W[KW7O G]6_VX_XI[]U[KW@3^K?[<?\
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M:.W7VWC-L;:IAF\IFA0]!]*=>;FJJF&FH)(8J6AKY&F,S*E.\QB*>Z]U??\
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M:G_J'F_ZUM[T>'6QQZU\_F+<]D0\C_BY1?TOR1_9][I3KU-)ZMN^(=O]$N-
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M1V8^Z]T)_OW7NO>_=>Z][]U[KY[O_"Y+_C\OY;'_ (;/RL_]VOQ\]^Z]UO\
MFRO^/-VE_P"&S@?_ '54OOW7NE-[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z#SLL7VY4#_FW/_T(/=3QZL.'58_6H/\ IFO:P^^;_>)@OO3\.JKY?9U;
MK3_\!X/^6,7_ $(ONPX=;/'K-[WUKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NH]7_P !:G_J'F_ZUM[T>'6QQZU^/F +]DP74_\ %SBXY%OW />^
MM-PZMN^) "]3XT 6XB-_ZW5[<?[#W5>O=&A]VZ]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U7'_,9_E8_%#^:7L[K;8GRNQF^\GM_JK<V8W;M.+8N\ZC9E3'F,YBX</7
M25]334=89H_!" D9T@$D\^_=>ZTE*_\ DA_RQM[_ /"@%/Y7>WT[4Z=Z6Z<^
M.2=K[ZGW=VE/5[S^2'9>>P^Q=U83K[K#-YS%4J4U-28G?J5D[X^*KFE_@>6C
M!C:'5#[KW2N_GG?R-_Y9G\I[K?XS_+3KK$Y_>^T*+Y%[5V)W5\6.V^Y-S&O[
MYZMW'B\Y7[AEZUW'M&MV?G<=F\/'@S)%+#6QT:BH$]5Y!3BBKO=>Z^B7C,A!
MEL;C\K2B04V3H:3(4XE4)*(*R".IA$B!G ;3(+@$V/Y]^Z]U.]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SW?\ A<E_
MQ^7\MC_PV?E9_P"[7X^>_=>ZW_-E?\>;M+_PV<#_ .ZJE]^Z]TIO?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0=]E_P#'O3?\LY_]Z3WIOA/Y=73CU6;U
MI_S.-_\ J._ZZ/[J_#JB?Y/\G5N%/_P'@_Y8Q?\ 0B^[#AUL\>LWO?6NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZCU?_  %J?^H>;_K6WO1X=;''
MK7Z^7Q3_ $E0#_JY17^O^K)_XGWX?Y3UY_\ )U;;\2O^94XW_@L'_0C^ZCB>
MMG@.C0>[]5Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K6N_GO?RM/Y6/RAK>N_D
M]\T/E+0? _N';QP^PMF_(&'L?9FR*C>-+@Y<WN'![0J]O[UD2++5>/DK:FNI
M*C&-39"!(3><TT>A/=>ZKC^(7_"=;^5Y'N3X]?.#Y%_S0LK\[^O]P=B0X?H?
M+;XW_L+9?3G<FZL!O3==#M/K$YG.[TWSDMQRT.2P]1!/@,5FZ(UE?C*M9:7[
M:2IQ_OW7NMVQ555"J JJ JJH 55 L  /H![]U[KOW[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?/=_P"%R7_'Y?RV/_#9
M^5G_ +M?CY[]U[K?\V5_QYNTO_#9P/\ [JJ7W[KW2F]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=!UV7_ ,>]4?U\%3_O B/_ !'OW7NJTNME'^F!KB_^
MY W_ *?K?\?['W1N'5A_J_GU;93_ / >#_EC%_T(ONPX=:/'K-[WUKKWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NH]7_P%J?\ J'F_ZUM[T>'6QQZU
M^_EZ >S:<'_G9Q<W_P!K7F_'NW3?^SU;;\3/^958[_6A_P"A']U\^G/+HS_O
M?6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZTA/G'TQ\)_EK_PH.^474?\ -MWI
MB*+K38/PKZBJ_P"7YUOO#MO=/3G7N\QFL)2Y?L+(U6[,'O#:#G<,6Z3GHL?B
MJ?(T8R-/&QD@JGH$M[KW57?87R*Z%I?^$CWP>^-M#V9MC(_,#<O?VY,UT9U'
MM#+G.=UXW=V!^<W>69DW/B]L[8DK,IB9%PV8FBH\A41THE?)P4].[SU4*/[K
MW7TJ\'_$OX+A_P"-?\7C^%X_^+?\!_\ BY?:0_?_ / 3]K_.Z_\ -^C_ %/%
MO?NO=.GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JL#^
M<'_PX+_LC6_/^&POXQ_LWO\ >[KG^Y?\#_T6??\ ]W/[VX_^_6G_ $R_[@-/
M\+^XU?=>O_CC^[I]^Z]UI[?]MPO_ '\S_P!IN>_=>ZH5_G3_ /#V7\7^._\
MP\I_>7^+?PWM#_9??[Q?[+GJ_AWW.PO])GVG^R^^BWE_@6O^*^K]/V_'F]^Z
M]U]@S97_ !YNTO\ PV<#_P"ZJE]^Z]TIO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW0>]E"^W*KZ_YF8?[<Q?\4]UXTZWY=5I];*H[@(!/_ ][7^OIE:_
MO3\.MC_5_/JVBG_X#P?\L8O^A%]V'#K1X]9O>^M=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U'J_^ M3_ -0\W_6MO>CPZV./6OM\NR!V5#<?\O1?
M^AQ[V.'[/\ ZJ>/[?\/5N?Q-_P"95X[_ (+3_P#6MO>O/K8X?F>C/>]]>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z9MQ;BV_L_;^=W;NW.X;:^U=KX;)[BW-N;<63HL
M)M_;NW\)13Y/,YW.YG)STU-24=)34TE15551)''%'&TDC*JDCW7NM//YT?,'
M^2A_-/\ YA=1\%OF/4_$K-=#]._'R3M[JK^8W@?G#L39%!3[[S>3VG09?HW
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M9A?Z$_7W[KW4_P!^Z]U[W[KW7O?NO=>]^Z]T _RGZ2I?DO\ &+Y&_'"MRT^
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MXC<^!PVX\5)+%.^,SV+H<QCWF@;5#,]%D(*B,LAY5BMP?I[]U[I#?Z#>E/\
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M0=R;LVMM7;63ZSWITUF-T]9X[;^T:[%;LR76F_ZJLR= QR>4RN/BGE,*54=
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M=6/'J;[WUKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NH]7_P%J?\
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MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7055%E 479K  #4S%F-A^222?\
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MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]TVY;_ (MM=_RQ;_>E]TF^$_9TJL/[9/\
M3#JG[M<?\9(IC] *W^EP;RM?B_N+]R%;C\^L\.2F"[0?])_DZM6ZR%MDX,?6
MU,H/^P ]R)MO]BO6%G./_)1F_P!-TO?:_H,=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7%OTM
M_P %/^]>]'AU[JM3L+=64I>T?M8YW$2UF@J'-B-8!  ('N(=UOGCOJ XKU%6
MZ7KI>Z0<:ORX]'WV+525.%ADD)9BD#<DDW=26)^O]/<G;<VJ,$^G4D6$GB1
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M7O?NO=?/=_X7)?\ 'Y?RV/\ PV?E9_[M?CY[]U[K?\V5_P >;M+_ ,-G _\
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M>Z][]U[H..R_^+#4'\"";_HG_BGNOG^76_+HBNTC;>9/]*D_3^FK_#_6]V.
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M7O?NO=>]^Z]U[W[KW09=I'3M^0GZ<_\ %/=&-.MKQZ)3LM!_>"5E'UJ 1?\
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MM'^$=5E[B59-["P-_N";'ZW\GT//^/U]@28?K?GUE[M3$;;_ +4?X.K ^M7
MP5+'JO>,"UOR@O?_ &UO8RL#5>L8.;U_QEC\^A*]F'01Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KBS!%+,;  DGVW)((A4]; U8'3<<K3:_'JL;
MZ;E@!?F][$G\>R;^L%LK^&7&K[1TK^ADI6G3BK!U#*;@@$'V<QN)%J.'20C3
M@]<O;G6NO>_=>Z][]U[KWOW7NHM<2*.I()!$$EB."/2?H1[HW ]5?@?LZKJW
M]&?[\F0 6^YO?Z<%^?<3[JNJYK\^HOW$?XS7Y]'9ZUYP4%_^.,7^\HM_<C;1
MF$?ZO,]2'MO]D.A&]FO2_KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HEGR:7
M7!*+#2!?Z?4W=6]T/'_5\^M^7[.LOQ9A$=.Y^A*3-86_,8_I_K^_'K71SO=^
MO=>]^Z]U[W[KW7O?NO=>]^Z]T%O:W_%@8?C2YM^+\<^VW_U?SZLO^4=$PV9<
M9XV!-I5&JPTG]X'CZ6^GNS\.JCH_NV"30"_U"Q _\D7_ .)]Z3JS=*3W?JO7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-V4)%%5?T,+\7_J8U_P")
M]Z;X3^77A\7Y'JGGOH7WMJ^MJD '_IY;Z>]#K9_R_P"?H\GQR8_P&F&H76*!
M@+ \_0VO_K^]GKRY!Z-G[WUKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3N[_BT
M3_\ ++_>U%_]Z]HKOX1_J\NA+RY_:_L_R]$*V-_Q]Z\?2J4W'/'D%@/9#;BC
MXZE?=*_3G[.K3=K?\6*C_P"62_\ 6M/8K3@OV#J";OXV^T]*/W[IGKWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM*KYU_(NC_DE_P#"@/LG^8W\CND^
MS>ROB=\Z_C-L'I_#=O;(PF.W!D>H>Q=G4'6>W<_L_;QRF=PE)'&U#TY#FLEB
MII(:NKCR1J<>\HI:RG?W7NB@_P Y#^='\>/YX'4/5W\L+^75T?W%W5W1W?W=
MU5EZ+?V^.O\ ^[.W.M1A\YD:6IR>.IZ*NW'EHY88ZH?QW+3X^EQ]!AJNKG>I
ME998X?=>Z^@!A:&7%X?$XV>H-9/CL904,U6P8-52TE+%3R5#!WD-W,98W9CS
MR3[]U[IS]^Z]U[W[KW7O?NO=>]^Z]TR;EW'@MG;<S^[MT92DP>V=JX3*[CW%
MFJ^3Q4.'P6#H9\GE\I6RV.F&GIZ6261K&RH3[]U[K0B^6_\ PHHW]_,%S_8'
M7_P8_DB;=_F#]4[2RS[:P/87R"^-6]_E+C,Q58S)-7XK+9/IK9&R9SC*>8>&
MOH<?5YZ.K43)+*M/+>-?=>Z+5TK_ #6OEY\'LG4]U?('_A+G\<>EL)@4GJ<W
MVSTQ_+R[0^%^5VWLJ.HQU;FFJ-_[XZY[+B1(GH_N&>6JI*>Z0AU3Q!S[KW6]
MY_+^^>'1?\R+XO;#^5?Q]K,N=E[Q;(XG+;<W-204&[MA;UP$R4NY]C[LHJ6I
MK84K**21&$E/--#/!-#4P2/#-&Q]U[HZ/OW7NJR_YNOQW^9'RE^$6^^G/@;W
M76?'WY'YO=?7>2VSV=0]J]@]+U&)P>!W;CLKNRA&_>L*#)YBG%904\M,88(6
M2;R>.6T;,1[KW6HC_P ,4_\ "J__ +VY[F_].3?.+_["/?NO=4!?SN/@[_-+
M^%F8^.-)_,T^6>2^4V1[$QO:=3TY4Y'Y&]V_(0[)HMKU6P(M]013]RX7#OBO
MX@^>Q+,F/$@J/LP9M)ABO[KW7U^=E?\ 'F[2_P##9P/_ +JJ7W[KW2F]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=<&954L[!0!<DG2 /]<D6]Z(SBO7@">L$
M=732#T3Q,;V($BE]0_&FY_I[W\6?\E.ME"OD?Y]2O?NM=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]TQ[C;3AJXBW^9<&_\ BK#_ 'OVQ<X7_5Z=&.TC5.@^8_P]
M5J9D7WHQ_+3MP"?H'Y/^\^P,YK-^?66]BU-O _H_Y.C\=:$?PBF6_P!%)'()
MOI(/X_Q]BZR^$?9UC1S>*3M]O0G^S+H'=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U R;%**9E^NGZ7M>_P"#[*MV8I;NPXA?\G2BU%9!T"<F3J!F
M!&"VG6H(!M:[?JM8>\([OF2Z7>?#!-/$]?GU)D=E&;?5YTKT-V.8O14Y-[^,
M7O\ \1[S:V=S):Q$\2!7]G4:78TR,!Z]3?9OTFZ][]U[KWOW7NO>_=>Z;\F^
MF@G/TU)I^MOU<?\ $^VI#I!_/JC'M/V=5_[YC#;N+6-ON?SS_:%OK[B[<Q6X
M_/J-K\?K_G_EZ.3UKS@8_P 'Q0V_P]+>Y!V;^Q'0\VXUB'0C^S7HPZ][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z)G\D_4KK^"-/^W)-K?[S[TW'\NM?Y_P#)
MTY?&F!8Z9CIL?$]C?_!Q;C_"WOW7JUZ-U[WUOKWOW7NO>_=>Z][]U[KWOW7N
M@M[6_P"+"W_!9/\ B/;;_P";_+U9?\HZ)SM! F::P('G %P0.9!^;_X^[$U_
MU?;TTO'H^.UGO0@<DZ(FN3?^R01[JG3IZ4_MSJO7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=-N78+CJLGZ^(@?ZY*GCZ_T_WCW5^'6U%3U3[W>IDW
MF3<D>>ZGZ7)8B_\ M_>QUXYX='5^.KA</3*[#3H46M<?J0 G_6)X]T)P.M^?
M1O\ VYU7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3NSG$5(^IT?[;]I; >T-YP
M'0GY;_M!]O1$=E1L-V*?H3.+DD#E9+6 M[);<4;J4MT?_%_RZM&VM_Q8J3_E
MDO\ UK3V*$X+]@Z@R[^-OM/2C]^Z9Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z9<YG:# 44E=D)5A@B0R.S,
M% "\\L?];W:&,SFBY-:=/00-<&B] ]MOY$=<[MW"^V<+EXILDDWB*">,M>X!
M 0!C]3^1[,KC9KBW02." 1Y?[(Z-)]CF@36>'G_JKT/?LKZ)>O>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>ZU5?FK_,D[)^&O\ZG%],_S!.VNM8?Y0_R!Z4QV ZUVOE.K^JMZ[4V5W?/A
M]IP2OW_F$VWN3=F-$^1ARM3!59.6CPQQV3IY1$T6.R=93^Z]T>[I?^8Q_P )
M\_CI35&.^/'R/_EK=#45>SK64?3<_2W5E%5F>599?NX=E8S QN&<!W,@()&H
M_2_OW7NKO/?NO=>]^Z]U[W[KW7O?NO=>]^Z]T7/YA=*UGR3^)'RD^.N.R*XC
M(=^?'/N[I6@RSZ-&+K.T^L]S[&I<B_D#+:!\ZLIN"/3S[]U[K12_E3_S^^MO
MY(WQKA_EH_S"_A;\GNN^W_C_ +_[.-3D.M=L]=97)[HI]Y;[S^[&R>X\5OK?
MG6,<IBJ,G-08_+XW(9FBKL?24D]+4-%H'OW7NK!NQ/\ A:M_+C;9VX(=A_%S
MYD[QW+4XG(4V.VYV)M/HG:.SLM43TDT45#N#-8;O+L.HCI)6<1U!CQ-6?&S6
MC;])]U[HVO\ PDX^+W=WQT_EO[[W/WAU_)U37_)7Y-;Z[WV)UW58G*[>R.!Z
M\R6RNN]E8:IK-N9J-*G'QU=3LRMFQM+*96./^SG,C>?2GNO=;/WOW7NO>_=>
MZ][]U[KY[O\ PN2_X_+^6Q_X;/RL_P#=K\?/?NO=;_FRO^/-VE_X;.!_]U5+
M[]U[I3>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@5^06\I=@]4;MW3 ^B7&X
M^26-@>=0CE<$&X_XY\'V9;/:_6W"1'\1IT:[+;BZN%0\.J-_B3_,(W+V3V[7
M[2RT\QI37-%"'D!#Q_<E!Q:U^+?3W+?,W(L>W6HE3TSCSIU(NY;+&(J@9^76
MP_B:IJW&T-4229Z>.0DFY)8DDD_\@^X4?#$>AZBJ=/#<CT-.G/W7IKKWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[J#7UL=# T\GT7GZV_38GW95UX'3,TPA%3TB\?O[&U
MV1./2>)Y0X1E3EC?_4V/]/:AK5D75T3V^_0W$GA YK3H0O:7H^Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z3VZ#;"5WZ0?"]BWT'I;F_\ L?:>
MY/8?S_P=&>SBMPGVC_".JX<@GDW?(1^9B ?Z7?4"#_O'L#-B7K+.V.BP'^E_
MR='EZU?_ ""$7'"I_3G4+#_>^/8NL3VCK&_F]?U2?GT+7LSZ!/7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=0,G_P#EXOQ]#]/97O!I;2'^B?\'2FT
M_M!T!;%3FC< $2D<?B[^D?[Q[P:G8'>A_I_\O4I+_N-^70[8[_@#37-_VQS_
M +$^\X]FS;1T_A'^3J+;O^T;[>IOLVZ3=>]^Z]U[W[KW7O?NO=,V<?312#\,
MC@_[  BW^/\ 3VGN"=)_/IN4T4_9T1?>JAMQ>2P_SH(X^IUW_I_0>XVW ?JU
MZCN_S+7Y_P"7HW/6;:L&EOQ'$#_R?]/]M['6T_V(_P!7ET-MK-8AT)'LWZ,N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:?(RQGL6(&H7Y^GU_I[\W'\AUH
M\/S_ ,G3Y\>?V:<6L=2!3];>NX-KGZ^Z$TIUX=&O]WZWU[W[KW7O?NO=>]^Z
M]U[W[KW07=K6&WI"?\1_O#?3VV_^K^?5D&>B=[4L<LSZFT^;5<#^L@8< _ZQ
M]V/50.CT;2.J@0_@Q(P'^O?W510]6/ =*WVYU7KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NF?/,4QE00+^D_]",?^(]U;AUM>/517="WW>"+_ .>4
M<?\ !F/Y_P!?WOK71Q_CT2,5 ./\VO%A<W>.WNKCKRFI/Y_X.CC>[]>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7N@#[I)_ALP.FQ3_8\*@_WGVAON'^KTZ$_+?\
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MCWZE!UI?/[>C>>[=;Z][]U[KWOW7NO>_=>Z][]U[H+NUEU;=D'^O_O1]MO\
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M&%BJ)8I<SEW>-9)$\_NO=$=_G\_S?_Y0/\R[JWXV?'_H^*J7-_Z?MK[DW_\
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MLQRYY-C]9>>3[R1YRCU;<X_HCJ0[T5C;[#UO=[0J14;9PTO]:*G7C\GQ*?\
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M7JTA_P!G^74;JA/%/&" ;@GFU[#_ &/^/O9R3UI: #HVE,VJ")KDW0<DW/\
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MV3)/2N]R;T0]>]^Z]T@NP!_N)/\ K/\ ]"-[+=R^ _9TAW#^S/15LA'KC?\
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M^7HXOLUZ '2(WQ_Q9ZG_ )82_P#0P]T\Q]@_P=;7@?\ 5Y]5/[YC,N\90?\
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M%S*@N;HS W^MOZ?G\G_>/<E<A]K$?9T3[L>WI;^Y;Z#77O?NO=('L'_BT_\
M4S_H7_C?LNW,TCZ0[A_9GHM%1!>F,G)&N_-_ZG_;C\<^P?(NI<^O01(QT.?5
MY*T<5KWMH(_!# L?]M;V(MF/93H2;2:+3[>AB]G_ $<=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW4>J<QTU0X)!6&0@KP00AL0?>N!Z]U39\MA!G-Q1P5<?E6*;4
MNKU?VBX'-_\ D?N9.3JVT55\_P#9'1;>#6>C9_$K("FVY18U&T01B(?D"RD
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M;62["8Z#7HXT%:TZMUP%:*[&4DO'-/ &Y'J)4A@1<^Y,@?6@^S_)U@ON=O\
M33.*8U'_  ]/OMWI#U[W[KW7O?NO=!5V1)XZ23D\H%M<6/IU&W'''LNOCC\N
MAGRDFJ0?;T7;&P)(U2XL $9N!< ?[ #GCZGV2QK7J5;R7P@H^SH2>JF_W,2*
M+$B0_P!.%)-[?X\^UFW_ !=!/G9/T ?ET97V?]1'U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW29S;GR1J/H1<#^MU()L?]?V!>:Y2B$'HXVU:BO3
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M[KWOW7NOGN_\+DO^/R_EL?\ AL_*S_W:_'SW[KW6_P";*_X\W:7_ (;.!_\
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M\O\ )T(7N=^@CU[W[KW08]HNL>#U'^IN1]2!]%_WGV3[P=,?17NV(Z_/H/\
M&QZ]J/);_=18<7YXXOS[+8@# 3T6PK^A7J+L"8BLD6YXE/T)XY%K>V=J;4V/
MGUK:F[Z=&67]*_\ !1_O7L7CAT)^N7O?7NO>_=>Z][]U[KWOW7NO>_=>Z3FZ
MZA:? Y0L0"U'(J7_ *V-_;UM\:C^E_EZT16OV=5\=7XMYM];AG()#/4D']0-
M[V;Z'_;^Q_NLWAP(/L_9TCC%3TZ; I!2]TU)?B]20/H!8LQO8@C\>V]Q</9
M#^'_ "=61=+?G_E_V>K%2?26'JL"0!S>P^@]QXQP>E?0?$F7(-'?ZDZA_47/
M!M_6WN%)&$^ZE/GT+  L%>L-4/%51BYY< <'Z!D)'!O?GV@WT?1WR@>HZ=MS
MXD9Z6F.=12:V8_IU$<C2%O87]S-LLGC0@_9_@Z"]Z-#'HL_8BQY/<*0QCEG
MTM:Y);3>P_//L@W?]::GSZ ^Y@2RZ1TUT44N(S=%"ITAV1;"]O43;CC^GMJ!
M3%*!PZ:6L#J/GT8[)5K##Q11B[O3#4+@$J$L++>U^?;'/V[-9V+I'AR*#.>'
M4E;) )&5FX8Z1& GK:>N_P IN%=]2FY( )_ )/O'WV\W.\VZ]/CEM+'%:_Y>
MACNL,<T=$XCH9(7\D2/_ *I0?>74#F5%8>=#U'<BZ6(ZR^U/5.HU4P%+.Q^G
MA<_\FGWHCB/RZJQQ7HD?8&)AS>4K$(#:/)<$CZC^M[_T]LV]L"Q/41[_ !"]
MD(/27ZKFCPVY_LQZ;RZ=-PJ^K\<7/^V]I+MA&].DO*;"VN OSZL#I)?/3QR7
M:[*;FY_V_P!3_7VM@:J_GU-!S^SJ5[=Z]U[W[KW7O?NO=>]^Z]TRYY@N,G:_
M O\ [<!A_O?NK<.MKQZ+)3(*C)R@W8^0CCDD7L?;BIJX=:)ZQYA/MLI1(WZ@
MZWO];G2IY;W1L#KU.C1X+G%49'T:)3_M_?EZV>/3M[WUKJ+6<TE9?_E7F_ZT
MD^VY!C]G^'JC<#_J\NBLX*)YMW9&]R 9@+\_62P_/^/L%VZEKAJ\.@G:J7G-
M?]6>LF&@^TWTY)LIEX(^GUM]/>X/T[GY5Z] OA7.?7I5]T5:C!5,QL%-.WTL
M0WHO_C[&B]V?ET,5&H=5);8Q,F1[+>8!F453?XW <F]_]A[OPZK7HT^(G7'=
M@8Z$D(Q>%2&XL"JJ1:_]?>B*]:4^?5G&-D6;'T<B,2IIX_J;GA+>_+PZV<]3
M_>^O=>]^Z]U[W[KW3#N7_BQY7_J%D_WN/_BOO4@Q^1Z?L_[5?],.B?=9)))G
MLR6#$,\EOU6'J;D\_0>RJW[F/Y]2!O;:8D_+K(9_L=X/9K%I0O!M>Y_V'X/N
ME0K5_P!7'JJQF:W^T?Y.C@X"438R%QR#;G^I\:7/LVCX#H W(HYZ1W9<HCP\
MW/)@:X^G!+6YM_4>_>?30&#T0NEI3/GZAP"WK<@C@7')-A[L<9Z;'=CH1^NY
M63>4<8:Q$@N+V*WY_P /I?WXYZVHH>C[)^A?^"K_ +T/?APZWUR][Z]U[W[K
MW7O?NO=>]^Z]U[W[KW11/D I.;QP'^JI_P#8711Q[*;X58?ET/.4S2-_S_P=
M,.]XE_N]A6 /H2)OK];@ ?7\<>]3+51_J].E.VO^L_VG_+T8[J]P=NTR?GQ1
MD?X!01;VNMCBG04WM:3,?GT)?M3T2]<6_2W_  4_[U[T>'7NBB=GR,]=XT)8
M^0'3_P %X%O]O[++@U;_ %>O0\V1-*5Z:*G'+!MA)V7U$+R!I 8\?D#W01T7
MI0L^J;2.ATZ?D$F#9KW.KZWN/K;_ 'GVOMS44_U>?08WX4E)Z&#VHZ(NDYNJ
M3Q86I?\ H&_ZU2$?[U[JW5EST6W!'[S)S7^JR-8<D'GB]_K>Y]ZX<,]:I7KA
MFD*9^C4CZ31GG@#U M]?=<]7P.EIV7EFI-K14^K1JB.D *."I:PO_BP_VWNX
M.HUZJV!3H@4NUY:_,'*2)Z5<R%RH)L/5R;>]]4Z/7TGFDF@BQZL+QA4(_P
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MZ"78T+UV9DG:YLXNW_!F!^O/^Q]F&V RREOGT"=L4R2UZF=E4ZQ96BJFX\3
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M(#A$M?GFW_%?8NY7B#L3TFN#3/R_R]+[H7#7VI%5R*-4\-[F]V)%OJ1?^O\
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ML^G;\%@/-@E-N+6Y]D^X6DD[#2*_F!U(W)G,-ILT;B=RI-:45F_P ]"!A/\
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M2_'_  K2_DLD7/=G:ZGGC_9?^TC_ *W(P@]H^'GT(02>(/[1UD_Z"S_Y*O\
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M^[7(](_3QM__ 'GV)5_S='@ZS_\ 06=_)4_Y_IVE_P"D^=L?_8[[]7K?7O\
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M\W^A'LKR:-8/-.<)J^GXM[W3KQZ-\O\ PK/_ )*I OWCVFO'Z?\ 9?>UN/\
M#C;Y]^Z]UW_T%G_R5?\ G^7:?_I/O:__ -CWO?7NN_\ H+._DJ7O_IT[3_UO
M]E\[7M_K_P#'N^ZT/J?Y?YNO=>_Z"SOY*G_/].TO_2?.V/\ ['?>Z]>Z]_T%
MG?R5/^?Z=I?^D^=L?_8[[]7KW6&7_A69_)6,4@'>/:4C,K (?C[VL!ZOQ=MO
M6X][;(ZVF#GUZ+[NK_A4-_)QSV;@KH^X>RA3Q2*VINB.S0P -[:3@+GV730/
M(W#^?0QV_>+>TB*DFI'#2?3H2\E_PJD_DK5VVX\8>Z^SC5QTXC /0/:^DL%
ML7_N_;\?7VIDBU+2G1';7PBF+DFA^WUZ1?7_ /PJ;_D[[=RDDM?W)V9%2,S6
MD3HGL^8V)^OCCP1/^\>V+>%XSW#^?1IO.Y6]X@$9)/\ I2/\G0X_]!9W\E3_
M )_IVE_Z3YVQ_P#8[[7]!7I*;K_X5B_R:ZS'24^*[I[1J9Y%91KZ#[1@50PL
M;F7 K_3VS(&(QTOL&B1ZRF@^PG_!T%.S?^%07\FK%YG^,93N?LN"7R%],?0W
M:,Q%WU7(3;[#_8 ^TL=JRFIZ$.Y;W%-'X<1/["/\/0Z5_P#PK _DGY"GDIY^
M\^TF1U(M_LOO; Y_U_[NG^GM>PU"G03BD,35'1=H?^%0?\GO';Q&4HNX>RI<
M4)E<L.B^SD;2K7XB?!*?]X]EXMW5ZCA]O0T;>[:>U\-B0]*?"3_.G1D(O^%9
MW\E<H >\.TXK!?0?C[VMZ?3^D&/ $6'TM[,@>@.PSQKGY](3>7_"K;^37FX&
MIJ3N;L^6-K*7;H3M"(LM[W;7@5/'X'MLK7K8/76QO^%4W\E[;D$RU/=O9\4D
MJV]'0/:DMC=3]5V^?Z'WNG7O+K#VA_PJL_DQ[DVEE\=B.XNT*[+5%,Z48?H3
ML^E1I"A50TT^#32/]M[]2IZUT3?X^?\ "D/^4WM?=&2RW8O;78M'2/([41AZ
M6['R36UZEO%1X62P_P ./>R*];'5A"?\*Q?Y)T5,*5.\>TO"(S$$_P!E\[7_
M $$6(_X]T?U][ZUT4CN7_A2__)YW#E,?D]E]R]CU$L4HEJC-T3V=1,27N=/G
MP*7XY//NI!ICKQ/0I5W_  JX_E$0]75>W:'M+M*JW#+A:FA6 ](]B14[5$T>
M@/\ <28A5 MQS[46 5'4R'2 P)H"33]G2_;FCCE5Y6H%^1/V<!U3U\<?YYG\
MMG:GR6J>T^R.R][X[;,N6EKDE@ZHWWE*G0]1Y5_R2AQ,SCCBUO<N[_SG976W
MBV@=B^FGP,OEZD#H=7W,UL\!2-B6IBJGC^8ZN%[Q_P"%/_\ )7[-V%7[9I>[
MNS9:IZ::*ECGZ![5CB+F'1'=Y-NV^H')/N+MIOOW?,)#\J] [:-P%C+K8FA_
M/JG;XW?SY?Y>?3??QW=DNP-\2;%_B33"IINK]Z2S_;^;4K_8#&+)>P^FF_N4
M=_YOL-ULO"5V\33P*-Q^VG0QON8[2YA*!S4C^%O\W5^,?_"M'^2PZ@OW=VK"
M;7(;X_=IM8_TO'@7O_O'N&Z4_P!7_%=1N13AGK+_ -!9W\E3_G^G:7_I/G;'
M_P!COO?6NN/_ $%G?R51].\NTS^/^R?>U_Q_K[?]ZX=>Z+YV!_PJ0_D^;EW!
M!54/<?9CX])$9WDZ*[.C+!?K^T^#O?\ UA[)KNTDG>H&/M'^?J3^6.9;/:+4
MI(Y#^0",?YTZ&3;O_"K3^2CAL=!3#O'M!)5C42!?C]VR0& L0K#;]N;?7V9P
M0^$H'GT ]UW [A*7K45Q7H)NS_\ A43_ ";MTY&DKL5W5V7,:<QDF7H;M*$G
MQ@7XEP"_6U_9;N%B]RP91P^?0VY.YJM]EA:*=F&JO!21_+H3=H_\*POY-6.Q
M5-0Y+NGL^G>GC1!HZ$[3F4V2Q%XL"WY]KK9'C4!O\/01WR>"ZF:2%B037@1_
MA ZLW_E^_P XGX+_ ,SK<79&UOB+O[=F\LOU1A]NYS>D>Y.N]W[$BH:'=5=D
ML=A6I9MSXW'BI:67$U 98=>@)=[:ENLJ!_Q71'0GJT;WKK?7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T ORJ[N@^,_
MQ?\ DA\CZG#R[BIOC]T+W!W=4;?@=(Y\Y!U3U[N+?<N'A>2:G57J5P)@4M(@
M!?EE'(]U[K06^*'\J+^:!_PHAZ-E^>'RG_F@YGJCJOO;=>_Z#9?4.%V_O;L7
M:E%MO9^^,[M+*XZDZBQ_9W5^W\+CJ?)X6MI,?1F;(5$T%-'454S22ZV]U[HR
M&+_X2)_.+XL8++;L^#_\X'=6W>RL8E1N+ ;=Q/778_QNPFX=T4$,$N,I,INO
M87R"[$\(J&HHH7J9\15JJJH>-XP0/=>ZOG_X3I_S$>[OYB7P*R6Y?DQ&M5\A
M/CSW-NWXX]I;KCQV+Q2[]RFT<%M3<F+W968[#.*6+(/1[NAHLI]M%!#)5T4M
M1%%'',J+[KW5]GOW7NBU_+/X@_';YS=*9WX[?*;KS_2CTYN7*[>S6;V?_>S?
M.R?O<GM7+4^<P-3_ '@ZZW-M'*1^"JI(Y=$-=&CZ=,BNA*GW7NJE?^@7'^11
M_P!X,_\ LS/S#_\ N@O?NO=:<O\ PJM_EB?!S^6UN7X18_X6=(_Z&*3M[!?(
M&L[$A_TE=O=B_P!X:G9%?TY!M>3R=K[_ -]-2?:KNJO%J%J82>>\HD*1Z/=>
MZV^ML_\ "7_^1ED-M;>R%9\'Q-5UV#Q-953#Y+?+Z/R5-30033RF./Y QJMV
M<DA5 'X ''O5:=;I7I]/_"7+^12.?]D<L/Z'Y,_,+\W-O^R@EM;_ (CWX9QZ
M<:?ZCU2M,]<C_P )<?Y%)''P:_'!_P!F:^8?U_\ 2@3[U6F?Y=;ZZ_Z!<OY%
M-O\ LAH'_'_9FOF&+_\ LP/O=:<<?*G^SU[KQ_X2Y?R*0?\ LADD<?3Y-?,+
M_8FQ^07O7^7Y</V=>Z\/^$N7\BDB_P#LC?\ 7Z_)GYA?XV!(^01_P_K[V:CK
MPSUV/^$N7\BG_O!JYY^OR9^8?]?ZCY #WK/6^N(_X2Y_R*2 1\&@>?I_LS'S
M$M]+VO\ [,$?]X_/O?6J]>_Z!<_Y%/X^#/(!O?Y-?,(_[>WR#O\ [Q[]^S\N
M'7AU[_H%S_D4\?\ .#?!N;GY,?,,?7Z7_P"<@A[V,U_U?X*]:KUT?^$N?\BG
M_O!K\ @#Y,?,,D_F]_\ 9@_I_L/?NM]<O^@7+^11_P!X-VYM_P!E,?,/G\?]
MY!?X>Z@_ZC_@Z]UV?^$N7\BBW_9#5O\ '_9F?F'_ ,3\@_?J_P#%>?\ J_+K
MQQUU_P! N7\BCD_[(T.!]/\ 9FOF'P?\3_LP7O=?^+_V#U[KL_\ "7'^11;C
MX-<_^+-?,/\ ^Z!/O5?SZWUU_P! N7\BBW_9#5C]/^RF?F'];?\ BP9][Z]U
M[_H%R_D5:0?]D:L?K;_9F?F'?Z?3_LH'_BGOU<_Y.O==_P#0+C_(IM_V0US_
M %_V9GYAG_YX(>_5Z]UU_P! N7\BBY_YP;O_ $ ^3/S"-O\ ;?('_BOO=*=>
M&>N_^@7'^13?_LALV_I_LS/S"_I:W_90/^Q^OO5>O==?] N7\BB]O]D;_P#9
MFOF%]?\ $?[,%[]4CC_Q?6NNC_PES_D4_P#>#0''_>37S"N./ZGY!_U_P]V7
M/KUXX\^O?] N?\BC_O!H?0GCY-?,._\ \$$WO5"/]7^QUX&O7?\ T"Y_R*/^
M\&K_ .M\F?F);_X((^_#_5_JH.O==#_A+C_(IOS\&S_@/]F8^89^OTN?]F '
MO6?]G'^?KW79_P"$N?\ (H_[P:YXM_SDU\P[$GZ?]S!$^]_/^77J]=?] N7\
MBCC_ )P;//(_YR9^85OH>"?]F"/^QM[]U[KO_H%R_D4#C_9&KFQ_[F9^80'^
MO_V4%[\,YZ]6G77_ $"Y_P BFUS\&A:W)'R:^8?'^P_V8$^_$A>/7JUZTR_^
M&T?A-_T%1?\ #;XZ5'^R8?WX_@_^AK_2/VT1_#O]DE_TN_;_ .D0;\&Z_P#C
MXO\ <AK_ ([J_P!T7^V_9]ZX=;ZW-?\ H%R_D4VN/@R#_2WR:^8?^WO_ +,%
M_P 1[\<>O[.M5KU[_H%R_D56_P"R&KG_  ^3'S"O_O/R#'O?7J]>_P"@7/\
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M -F"'^]>_<#U[CUT?^$N7\BH<_[(U<?7CY,_,*YN#]#_ +,%]/?O\/6^N_\
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M '07OW7NO?\ 0+C_ "*/^\&?_9F?F'_]T%[]U[KW_0+C_(H_[P9_]F9^8?\
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M'X]^SU[KC_T"Y_R* IO\&U)%S?\ V9KYA+Q]3]?D$;6_V/OW#U_8>M5'7?\
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MJ?\ "?CO[X]=C[J_FG]D_*S ?(,;SW-B<7O_ '9V#OGKG)Y;J[/;-K^R.O\
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M72'R1[6JMA=E?*7<2[6Z5P-/L+L/=D.YLN^X]M;22.NS&S]K9VCQL9R&[J"
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0Z][]U[KWOW7NO>_=>Z__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
